A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R EFERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright Ó2003 by ICON Group International, Inc. Copyright Ó2003 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Tea: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-597-83642-6 1. Tea-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on tea. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications.
Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes & Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON TEA............................................................................................................ 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on Tea................................................................................................. 4 E-Journals: PubMed Central ....................................................................................................... 56 The National Library of Medicine: PubMed ................................................................................ 58 CHAPTER 2. NUTRITION AND TEA ................................................................................................ 173 Overview.................................................................................................................................... 173 Finding Nutrition Studies on Tea ............................................................................................. 173 Federal Resources on Nutrition ................................................................................................. 182 Additional Web Resources ......................................................................................................... 182 CHAPTER 3. ALTERNATIVE MEDICINE AND TEA.......................................................................... 203 Overview.................................................................................................................................... 203 The Combined Health Information Database............................................................................. 203 National Center for Complementary and Alternative Medicine................................................ 204 Additional Web Resources ......................................................................................................... 241 General References ..................................................................................................................... 314 CHAPTER 4. DISSERTATIONS ON TEA............................................................................................ 315 Overview.................................................................................................................................... 315 Dissertations on Tea .................................................................................................................. 315 Keeping Current ........................................................................................................................ 317 CHAPTER 5. CLINICAL TRIALS AND TEA ...................................................................................... 319 Overview.................................................................................................................................... 319 Recent Trials on Tea .................................................................................................................. 319 Keeping Current on Clinical Trials ........................................................................................... 320 CHAPTER 6. PATENTS ON TEA ...................................................................................................... 323 Overview.................................................................................................................................... 323 Patents on Tea............................................................................................................................ 323 Patent Applications on Tea........................................................................................................ 361 Keeping Current ........................................................................................................................ 374 CHAPTER 7. BOOKS ON TEA .......................................................................................................... 375 Overview.................................................................................................................................... 375 Book Summaries: Online Booksellers......................................................................................... 375 The National Library of Medicine Book Index ........................................................................... 377 Chapters on Tea ......................................................................................................................... 379 CHAPTER 8. PERIODICALS AND NEWS ON TEA ............................................................................ 383 Overview.................................................................................................................................... 383 News Services and Press Releases.............................................................................................. 383 Newsletter Articles .................................................................................................................... 389 Academic Periodicals covering Tea ............................................................................................ 389 CHAPTER 9. RESEARCHING MEDICATIONS................................................................................... 391 Overview.................................................................................................................................... 391 U.S. Pharmacopeia..................................................................................................................... 391 Commercial Databases ............................................................................................................... 408 Researching Orphan Drugs ....................................................................................................... 408 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 413 Overview.................................................................................................................................... 413 NIH Guidelines.......................................................................................................................... 413 NIH Databases........................................................................................................................... 415 Other Commercial Databases..................................................................................................... 418
viii Contents
APPENDIX B. PATIENT RESOURCES ............................................................................................... 419 Overview.................................................................................................................................... 419 Patient Guideline Sources.......................................................................................................... 419 Finding Associations.................................................................................................................. 422 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 425 Overview.................................................................................................................................... 425 Preparation................................................................................................................................. 425 Finding a Local Medical Library................................................................................................ 425 Medical Libraries in the U.S. and Canada ................................................................................. 425 ONLINE GLOSSARIES ................................................................................................................ 431 Online Dictionary Directories ................................................................................................... 432 TEA DICTIONARY ....................................................................................................................... 433 INDEX .............................................................................................................................................. 533
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with tea is indexed in search engines, such as www.google.com or others, a nonsystematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about tea, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to tea, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on tea. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to tea, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on tea. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON TEA Overview In this chapter, we will show you how to locate peer-reviewed references and studies on tea.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and tea, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “tea” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: ·
Dieter's brew make tea time a dangerous affair Source: FDA Consumer. December 1997. Contact: Superintendent of Documents, P.O. Box 37154, Pittsburgh, PA 15250-7954. (202) 512-1800. Summary: So-called dieter's teas, such as herbal teas containing senna, aloe, buckthorn, and other plant-derived laxatives, when consumed in excessive amounts, can cause diarrhea, vomiting, nausea, stomach cramps, chronic constipation, fainting and perhaps death. Kurtzweil discusses adverse effects of stimulant laxative teas.
·
Bad Karma Sours Spore of the Moment: Mushroom Tea Alert Source: Healthy Weight Journal. 9(5):93, 98; September/October 1995.
4
Tea
Contact: Healthy Weight Journal, 402 South 14th Street, Hettinger, ND 58639. (701) 5672646. Summary: This article provides insight into the use of mushroom tea to burn fat, help people lose weight, and act as a general cure-all. This fad has been linked to death and serious illness, prompting the Food and Drug Administration to issue a warning that mushroom tea may be harmful. Home-brewed versions of the tea prepared under nonsterile conditions may be prone to microbiological contamination.
Federally Funded Research on Tea The U.S. Government supports a variety of research studies relating to tea. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to tea. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore tea. The following is typical of the type of information found when searching the CRISP database for tea: ·
Project Title: 14TH FLAVOPROTEINS
INTERNATIONAL
CONGRESS
ON
FLAVINS
AND
Principal Investigator & Institution: Matthews, Rowena G. Professor; Biological Chemistry; University of Michigan at Ann Arbor 3003 South State, Room 1040 Ann Arbor, MI 481091274 Timing: Fiscal Year 2002; Project Start 01-JUN-2002; Project End 31-MAY-2003 Summary: (provided by applicant): This Congress will be the fourteenth in a continuing series of International Flavin Symposia, held every three years. The most recent conference was held in Konstanz Germany on August 29-September 4, 1999. The meeting for which funding is requested will be held from July 14-18, 2002 in St. John's College, Cambridge University, Cambridge, UK. These meetings offer an opportunity for students, postdoctoral fellows, and senior researchers to hold intensive discussions on current research in flavins and flavoproteins, and to present their own work in posters and talks. The Proceedings are published as a symposium volume which provides a useful reference for all participants. Sessions are planned on the following topics: New structures and mechanistic implication of simple flavoproteins; Electron transfer in complex flavoprotein systems; Flavins:light and biology; and New families-catalysis based on the fumarate reductase framework. Plenary lectures will be presented by Maria Vanoni (structure-function studies of glutamate synthases), Denis Stuehr (The NO synthase flavorptoein-kinetic and strucural studies to reveal its unique mechanisms 2
Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
5
of regulation), Sunny Xie (Single-molecule studies of flavoenzymes), and Gary Cecchini (Structural insights into the function and physiology of complex II). In addition, a session has been reserved for presentations to be selected from posters presented at the meeting. The afternoons are reserved for poster sessions, to ensure maximal interaction at these sessions, which have been traditionally very popular with participants. Tea will be served at each poster session. Presentations were selected by an International Organizing Committee with an eye to a diverse representation of speakers at the meeting. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: ACTIVE SITE AMINO ACIDS OF CAMP PHOSPHODIESTERASE 3A Principal Investigator & Institution: Colman, Robert W. Director; Temple University 406 Usb, 083-45 Philadelphia, PA 19122 Timing: Fiscal Year 2001 Summary: An increase of intracellular cAMP and cGMP produces potent inhibition of all platelet functions. Cyclic GMP inhibits cyclic AMP phosphodiesterase (cGI-PDE, PDE3A) and hydrolyzes cAMP, lowering its intracellular concentration. Inhibitors function as potent anti-platelet agents. Currently, the two anti-platelet agents with proven efficacy are aspirin, which inhibits cyclooxygenase-dependent synthesis of thromboxane A2 )TXA2), and clopidogrel or ticlopidine, which blocks away the ability of ADP to inhibit stimulated adenyl cyclase adenyl cyclase. Controlled trials show that both aspirin and ticlopidine are indicated in the secondary prevention of primary prevention. NO, a potent inhibitor of platelets by stimulating guanylate cyclase, elevates cGMP, which, by inhibiting PDE2A, elevates cAMP. By blocking all activating pathways in platelets when cAMP is increased intracellularly, the potential of PDE3 inhibitors is to modulate coronary artery reocclussion. PDE inhibitors have shown promise in animal models and in coronary stents in patients. The immediate goal is to identify critical amino acids in the active site of PDE. This information can be used by pharmaceutical companies to design clinically useful inhibitors with fewer side effects than the current ones. We hypothesize that there are distinct amino acids that facilitate the catalytic reaction, which hydrolyzes cAMP, that form the substrate binding site and that bind essential metal cations. We further postulate that although the inhibitor binding site for cGMP may overlap with the substrate binding site, there are distinct amino acids which interact with this nucleotide. The specific aims of this grant to test this hypothesis are as follows (1) We will synthesize new cGMP-alkylating affinity reagents (8-BDP-TcGMP, 2BDB-TcGMP, 2-BDB-TeA-3'5'MP and cGMPS-BDB), measure their incorporation, and test their ability to various concentrations to modulate hydrolysis of cAMP and the ability of cAMP, cGMP and AMP to protect against loss of inhibition. (2) We will identify, isolate and sequence the modified peptides labeled by these new cGMP affinity agents and those labeled by the cAMP affinity analog. The function of these residues will be evaluated in the modified enzyme by kinetics, substrate and metal binding. (3) Based on the results of Specific Aim 2, we will design and produce site-directed mutants to test our hypothesis that the amino acids responsible for cGMP binding in the active site of PDE3 differ from those interact with AMP. We will also continue to mutate conserved amino acids and evaluate their effect on enzyme kinetics, Km (cAMP binding), and Ki (cGMP binding), as well as the influence of metals such as Zn++ and Mn++. (4) Since no crystallographic domain based on homologies to other hydrolases in the structural database. A detailed description of PDE3A at the molecular level is important in understanding the role of platelets in hemostasis as well as in the rational design of inhibitors.
6
Tea
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: ALUMINUM BIOAVAILABILITY FROM FOODS Principal Investigator & Institution: Yokel, Robert A. Pharmaceutical Sciences; University of Kentucky 109 Kinkead Hall Lexington, KY 40506 Timing: Fiscal Year 2002; Project Start 08-FEB-2002; Project End 31-DEC-2004 Summary: There is concern about brain aluminum accumulation over the life span that might contribute to Alzheimer's disease and related neurodegenerative disorders. The overall objective of the proposed research is to test the null hypothesis that the bioavailability of Al is comparable from foods and from drinking water. If the null hypothesis is accepted the concern about Al intake for typical Americans should focus on food and not drinking water. The specific aims are to produce food products containing 26Al in the normal chemical species for these foods and determine Al oral bioavailability from these selected representative foods, compared to Al oral bioavailability from drinking water. Foods to be produced are a baked good and a processed cheese, in which 26Al will be incorporated during food production, and spinach and tea, in which 26Al will be incorporated during their hydroponic production. Al bioavailability will be determined from the area under the serum 26Al concentration x time curve after bolus administration of the 26Al-containing food compared to the equivalent term obtained from serum 27Al concentration produced by continuous intravenous 27Al infusion throughout the study. 26Al will be analyzed by accelerator mass spectroscopy; 27Al by atomic absorption spectroscopy. It is hypothesized that oral Al bioavailability from food will be less than from water, due to Al binding to food components that inhibit its absorption. The results will resolve the controversy whether drinking water contributes a significant amount of the Al that is absorbed by the human. The results will suggest whether health-based standards to regulate Al in drinking water should be considered by regulatory agencies or whether reduction of absorbed Al in the human can be more effectively achieved by reducing Al in foods. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: ANTIOXIDANT AND ANGIOGENESIS EFFECTS OF GREEN TEA VS EPIGALLOCATECHIN-3-GALLATE Principal Investigator & Institution: Nguyen, Mai H.; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, CA 90024 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-JUL-2003 Summary: Cancer is the second most common disease related cause of death in the USA. A combination of epidemiological and basic science evidence strongly suggests that diet and plant-derived phytochemicals may play an important role in cancer prevention. Thus, there is an urgent need for research on phytochemicals which may prevent cancer or which may be useful adjuncts in the prevention of cancer recurrence among successfully treated cancer survivors where prevention of cancer recurrence is vital. Green Tea contains potent antioxidants called polyphenols that have been shown to reduce tumor growth and metastasis capacity and angiogenesis in several studies. The four major catechins in green tea are: (-)-epicatecchin, (-)-epicatechin-3-gallate, (-)epigallocatechin, and (-)-epigallocatechin-3-gallate (EGCG). EGCG is the main component, accounting for 40% of the total polypenolic mixture, but it is not clear that this is the only component important in the action of green tea. Preliminary work suggests that these polyphenols protect DNA more than either Vitamin E or beta-
Studies
7
carotene in the retro-Ames assay. Anti-angiogenic strategies differ from other therapeutic agents because they are based on static effects on tumors and require prolonged administration. Dietary supplements such as green tea would be perhaps useful alone or in combination of other anti-angiogenic agents. The studies outlined in this proposal are aimed to compare the activities of standardized Green tea extracts and purified EGCG to provide a critical scientific support for future clinical studies of green tea dietary supplements versus proceeding with EGCG. Thus, the aims are: To compare EGCG with green tea catechin extract, examining DNA protection, and tumor cell growth. This aim will determine whether the antioxidant and DNA protective effects of green tea are due to other constituents other than ECGC. To compare anti-angiogenic potency of EGCG and green tea extract in vitro and in vivo. This aim will determine whether the growth inhibitory effects induced by green tea are due to EGCG or to additional catechins in the green tea mixture. To compare the bioavailability and antioxidant bioactivity of EGCG and mixed green tea catechins by measuring polyphenols, oxygen radical absorbing capacity (ORAC), lipid peroxidation, and white cell DNA base damage in timed blood samples from normal volunteers. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: AP-1 AND CHEMOPREVENTION NONMELANOMA SKIN CANCER
OF
UV
INDUCED
Principal Investigator & Institution: Bowden, G T.; University of Arizona P O Box 3308 Tucson, AZ 857223308 Timing: Fiscal Year 2001 Summary: The hypothesis to be tested in this project is that sustained induction of the transcription factor complex, AP-1, plays a functional role in UVB induced skin tumor promotion and the development of non-melanoma skin cancers. UVB irradiation of keratinocytes can result in both genotoxic initiating events including mutational activation of oncogenes and inactivation of tumor suppressor genes as well as epigenetic, promotional events such as induction of genes involved in cell proliferation and apoptotic cell death. UV irradiation of cells can bring about the transient activation of a number of transcription factor complexes including AP-1, NF-kappaB and p26TCF/elk-1. The focus of this proposal is on the complex, AP-1 and whether its induction plays a functional role in UVB induced promotion of non-melanoma skin cancers. AP-1 activation and enhanced expression of certain genes have been investigated in relation to cell proliferation and apoptotic cell death, biological effects of UVB that can play a role in tumor promotion. UVB irradiation could mediate both of these biological effects in keratinocytes through AP-1 activation. Based on preliminary studies in which we have shown in keratinocytes that UVB induces both AP-1 DNA binding and AP-1 transactivation., we are developing chemopreventive strategies using pharmacological agents that block AP-1 activation mediated by UVB. The agents of interest include retinoids, perillyl alcohol, a tea polyphenolic, epigallocatechin gallate (EGCG) and aspirin. The specific aims to address the hypothesis are: 1) to determine whether the expression of a dominant negative c-jun mutant protein in the epidermis of transgenic mice will block UVB induction of non-melanoma skin tumors by blocking AP-1 activation; 2) to determine whether atypical PKC's (PKCzeta and PKCgamma) are involved in UVB-induced c-fos transcription and AP-1 activation in cultured human keratinocytes and whether one or more of the MAP kinases (ERK1/2, JNK1/2, p38) are also involved in UVB-induced c-fos transcription; 3) to determine whether certain retinoids, perillyl alcohol or epigallocatechin gallate (EGCG) and aspirin can block UVBinduced AP-1 activation in cultured mouse and human keratinocytes, and in the mouse
8
Tea
epidermis; 4) to determine whether certain retinoids, perillyl alcohol or aspirin can inhibit UVB induced mouse skin tumor formation. These preclinical studies are designed to lead to the development of new strategies for the chemoprevention of human non- melanoma skin cancers. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BETA CATENIN PATHWAY AND CHEMOPREVENTION BY TEA Principal Investigator & Institution: Dashwood, Roderick H. Associate Professor; Oregon State University Corvallis, OR 973391086 Timing: Fiscal Year 2003; Project Start 17-MAR-2003; Project End 28-FEB-2008 Summary: There is interest in the possible health benefits of tea against chronic diseases, including cancer. This proposal tests the hypothesis that the inhibitory mechanisms of tea in the GI tract involve the beta-catenin/Apc pathway and expression of betacatenin/Tcf target genes. Most of the work uses a rat model of colon cancer in which the heterecyclic amine -amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine (PhIP) or 1,2dimethylhydrazine (DMH) are the initiating agents. Other studies in humans, Apc rain mice, and rainbow trout examine inhibition by tea according to the following aims: Aim 1. BLOCKING EFFECTS OF TEA - 1A. Compare the efficacy of white tea and green tea, and their major constituents, as blocking agents against PhIP-induced aberrant crypt foci (ACF) and colon tumors in the rat. 1B. Examine during the initiation phase the spectrum and frequency of Ctnnbl (beta-Catenin) and Apc mutations in ACF and colon tumors after tea treatment. 1C. Demonstrate a protective effect of tea, decaffeinated tea, caffeine and chlorophyllin in people consuming a dietary-relevant dose of PhlP. Aim 2. SUPPRESSING EFFECTS OF TEA - 2A. Compare the efficacy of white tea and green tea during the post-initiation phase of PhlP- and DMH-induced colon carcinogenesis. 2B. In the tumors from 2A, examine the spectrum and frequency of Ctnnbl and Apc mutations, and the expression of beta-catenin and beta-catenirdTcf/Lef target genes (cyclin D1, cjun, c-myc). 2C. In Apc min mice, show that tea suppresses intestinal tumorigenesis via downregulation of beta-catenin. 2D. Using the trout methylazoxymethanol acetate model, examine the dose-response for tumor suppression by tea, caffeine, and EGCG. Aim 3. BLOCKING AND SUPPRESSING MECHANISMS - 3A. Examine blocking mechanisms of tea, focusing on (i) degradation of ultimate carcinogens, (ii) inhibition of CYP1A2+NAT, and (iii) induction of UDPGT. 3B. In human colorectal cell lines and cells expressing mutant beta-catenins (i) show that tea downregulates beta-catenin and betacatenin/Tcf target gene expression, (ii) examine the relative efficiency of phosphorylation and ubiquitination of beta-catenin, and assembly of beta-catenin/Tcf on target genes, in the presence of tea, (iii) demonstrate that beta-catenilg/Tcf-mediated activation of c-jun and cyclin D1 can be overcome by inhibitory actions of tea on AP-1 and CDK's, and (iv) examine the dose-response for cell cycle attest versus apoptosis in cells expressing wt and mutant beta-catenins. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: BIOAVAILABILITY OF GREEN TEA COMPONENTS 1 PORCINE MODEL Principal Investigator & Institution: Mayersohn, Michael; Professor of Pharmaceutical Sciences; Pharmacy Practice and Science; University of Arizona P O Box 3308 Tucson, AZ 857223308 Timing: Fiscal Year 2001; Project Start 08-JAN-2001; Project End 31-DEC-2002
Studies
9
Summary: This 2-year R03 application has, as its specific objectives, the quantitative assessment of oral bioavailability of the putative cancer chemopreventive compounds present in green tea. These water-soluble, aromatic polyphenolic compounds are referred to as catechins. The activity of those compounds has been established from numerous in vitro and in vivo animal studies. Human clinical trials sponsored by the NCI are currently being conducted. The activity of those compounds has been established from numerous in vitro and in vivo animal studies. Human clinical trials sponsored by the NCI are currently being conducted. The compounds that have been identified include (i)-epigallocatechin-3- gallate (EGCG). Interest has focused on EGCG, since it appears to have the greatest activity. A critical , but sometimes overlooked issue in in vivo studies, is the completeness of oral absorption (bioavailability). Studies conducted to date have fatal flaws in experimental design. Therefore, we know little about the disposition and bioavailability of those compounds. We propose to develop a porcine model to characterize the disposition and bioavailability of EGCG following intravenous (iv) and oral dosing of two capsule formulations that are currently being used in clinical trials: "pure" and "polyphenol-E". The former contains the pure chemical form of EGCG and the latter is a more crude mixture of EGCG and the other cathechins. The porcine model (Yucatan minipig) is proposed because of the similarity of the gastrointestinal physiology and anatomy with humans. Furthermore, the swine appears to metabolize drugs in a fashion similar to humans. In year 01 each of 6 animals will receive a single iv dose (50-100 mg) and a single 200 mg dose of EGCG in the form of a "pure" and "polyphenol-E" capsule. Depending upon the estimation of within- and between-animal variation, a more powerful design may be employed, the semisimultaneous, single, extended single occasion design. These data will provide a complete characterization of the disposition and the absolute and relative bioavailability of EGCG. In Year 02 the effect of dose will be evaluated in a5-way cross-over study where each of 6 animals will be given an iv will permit calculation of absolute and relative bioavailability of EGCG and relative bioavailability of the other cathechins. A significant point that needs to be stressed, is that we will evaluate the same oral capsules in the porcine model that are being used in human clinical trials. This will permit a direct comparison of results from the porcine model with those from humans. The longterm aims of this proposal are to employ the porcine model to characterize the disposition kinetics and bioavailability of cancer chemopreventive and anti-cancer agents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BIOAVAILABILITY OF TEA POLYPHENOLS IN PROSTATE CANCER Principal Investigator & Institution: Henning, Susanne M. Medicine; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, CA 90024 Timing: Fiscal Year 2001; Project Start 15-APR-2001; Project End 31-MAR-2003 Summary: (provided by applicant): Tea has gained considerable attention as a cancer chemopreventive agent because of the growth inhibitory effect in cell cultures, anticarcinogenic effects in animal models and effect on risk reduction of cancer and heart disease in prospective human cohort studies. The polyphenol content in green tea and theaflavins and thearubigins in black tea have been suggested as responsible agents for the anticarcinogenic activity. A comparison of the polyphenol content of green and black tea prepared from tea bags from different manufacturers showed that due to the different content of tea leaves in the bag, some black tea preparations have similar catechin content compared to green tea preparations. It also has been shown that the antioxidant capacity as determined by the ORAC assay shows great variations among
10 Tea
different tea preparations with black tea showing the highest ORAC value. There are only a limited number of studies investigating the bioavailability of green and black tea. Therefore we propose to study the bioavailability of tea polyphenols and their effect on the serum antioxidative capacity from green tea compared to black tea and a green tea extract dietary supplement in men with prostate cancer before the time of prostatectomy. The serum will be also used to study the in vitro growth inhibiting effect in androgen-dependent LNCaP and androgen-independent PC-3 cell lines. Prostate cancer was selected as an excellent model to study the chemoprevention effect of tea catechins because prostate carcinoma are slow growing and often remain subclinical for an extended period of time. Therefore chemoprevention is particularly suited as a primary or adjuvant therapy for maintaining prostate cancer in a dormant state. An important consideration of the effectiveness of dietary supplements in disease prevention is the concentration issue. Catechin concentrations used in in vitro studies are frequently higher than plasma concentrations reached after tea consumption. There are no studies showing tissue concentrations of catechins in humans. Therefore we are proposing to measure prostate tissue concentration of catechins and theaflavins at the time of prostatectomy after 5 days of consumption of either green tea, black tea or a green tea extract dietary supplement. In addition prostate tissues will be analyzed for the enzyme activity of ornithine decarboxylase (ODC), an androgen-responsive, ratecontrolling enzyme in the polyamine biosynthesis. Urine will be analyzed for polyphenols to check compliance. The proposed studies will demonstrate if the consumption of 5 cups of green tea, black tea or green tea extract dietary supplement is sufficient to increase the concentration of catechin in prostate tissue to a level which can affect cellular processes contributing to carcinogenesis. Tea, serum, tissue and urine polyphenol concentrations will be analyzed using an HPLC method developed in our laboratory. The serum antioxidant capacity will be determined using the oxygen radical absorbance capacity assay recently established in our laboratory. ODC enzyme activity will be determined measuring the release of 14C CO2 from 14C ornithine. These studies will provide information important in designing studies to critically test the role of dietary supplementation in prostate cancer. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BIOMECHANICAL REGULATION OF RENAL NA AND K CHANNELS Principal Investigator & Institution: Kleyman, Thomas R. Professor of Medicine; Medicine; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, PA 15260 Timing: Fiscal Year 2002; Project Start 01-MAY-1996; Project End 30-JUN-2006 Summary: (provided by applicant): Renal tubular flow rates vary over time. Consequently, tubular epithelial cells are subjected to changes in hydrostatic pressure, membrane stretch and shear stress that ultimately affect cellular functions. Similarly, inflation of the urinary bladder subjects bladder epithelial cells to changes in hydrostatic pressure and membrane stretch. Epithelial Na channels (ENaC) and K secretory channels are present in the apical membrane of cortical collecting ducts (CCDs) and have key roles in transepithelial Na absorption and K secretion, respectively. CCDs respond to increases in flow with increases in both Na absorption as a result of activation of ENaCs, as well as increases in K secretion via TEA- and charybdotoxinsensitive maxi K channels, suggesting that biomechanical forces activate both ENaC and maxi K channels. Urinary bladder inflation is also associated with activation of both ENaCs as well as charybdotoxin-sensitive K channels. This application will address the
Studies 11
mechanism underlying the flow/stretch-dependence of ENaC and maxi K activation. Proposed studies will utilize CCDs, urinary bladders, and cultured epithelial cells to determine whether flow/stretch-mediated increases in Na absorption and K secretion result from increases in numbers (N) of Na and maxi K channels residing at the apical membrane, or from increases in channel open probability. The role of extracellular signaling molecules released in response to mechanical stimuli in modulating ENaC and maxi K activity will be defined, as will the role of intracellular Ca in modulating the response of maxi K channels to flow/stretch. These proposed studies should provide new information regarding the regulation of solute transport in the CCD and urinary bladder, and provide a framework for understanding the mechanisms of altered solute transport associated with disorders of the extracellular fluid volume. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CANCER RISK REDUCTION AND DIET: A COHORT STUDY OF WOMEN Principal Investigator & Institution: Zheng, Wei; Professor; Medicine; Vanderbilt University 3319 West End Ave. Nashville, TN 372036917 Timing: Fiscal Year 2003; Project Start 17-SEP-1996; Project End 31-MAY-2008 Summary: (provided by applicant): Although nutritional factors are thought to play a role in the etiology of over one -third of all human cancers, information about the preventive potential of specific dietary compounds is scanty. We propose herein the renewal of a large-scale cohort study that offers unique opportunities to fill such knowledge gaps. The Shanghai Women's Health Study SWHS) is a population-based cohort study of 75,049 Chinese women who were between 40 to 70 years of age at enrollment during 1997 to 2000 and lived in urban Shanghai, where intake levels of many hypothesized cancer-inhibitory dietary factors are high and diverse. Detailed information on dietary and other lifestyle factors was collected at baseline and again in a follow-up survey. Biological samples were collected from the 87.5 percent of cohort members. The cohort has been followed for cancer occurrence and deaths through linkage with the population-based Shanghai Cancer Registry and the Shanghai Vital Statistics Unit and biannual visits to all living cohort members. We propose in this 5year renewal to extend the follow-up of this cohort for five more years and to evaluate hypotheses related to the etiology of cancers of the breast, colorectum, lung, and stomach. The primary focus of the study is to determine whether certain diets, specifically those including regular tea drinking and high intakes of folate, soy foods, allium vegetables, and crucifers, are associated with a reduced risk of cancer. We also propose to conduct nested case-control studies of breast, lung, and colorectal cancers to evaluate whether the levels of blood folate and urinary isothiocyanate and phytoestrogens are inversely associated with the risk of these cancers. These biomarkers are aggregate measures of the level of intake, absorption, and metabolism and will provide added insight in elucidating the relations of dietary factors with cancer risk. We will further evaluate in the nested case-control studies whether the effect of dietary crucifer intake and urinary isothiocyanate excretion may be modified by genotypes of the GST-family genes. Finally, we propose to re-survey of all living cohort members to obtain updated information on usual dietary intake, physical activity, and other lifestyle factors. This will enable us to refine exposure assessment and characterize and evaluate how temporal changes in exposures may influence cancer risk. Because of it size, setting, and inventory of baseline information and biological specimens, the SWHS provides an exceptional opportunity to address dietary hypotheses for cancer that cannot be adequately investigated in any other existing cohort studies. The results from this study
12 Tea
may guide new strategies in the primary prevention of common cancer in both Western and Asian women. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CELL CYCLE REGULATION IN CANCER CHEMOPREVENTION Principal Investigator & Institution: You, Ming W.; University of Cincinnati 2624 Clifton Ave Cincinnati, OH 45221 Timing: Fiscal Year 2003; Project Start 23-MAY-2003; Project End 30-APR-2008 Summary: Increasing evidence suggest that green tea is a potent inhibitor of chemical carcinogenesis in rodents. The reported mechanisms for chemopreventive activity of green tea are antioxidation, induction of Phase II enzymes, inhibition of TNFalpha expression and release, inhibition of celt proliferation, and induction of apoptosis. Among these, cell cycle arrest and apoptosis induced by green tea are probably the most significant factors. However, the exact mechanism for the action of green tea on apoptosis and cell cycle arrest is not clear at present. The overall objective of this proposal is to characterize green tea preclinically as a potent lung cancer chemopreventive agent and to determine the molecular mechanism that underlie the efficacy of green tea in preventing lung cancer in mice. Previously, we and others have reported inhibition of lung tumor development using both A/J mice and p53 transgenic mice. We hypothesize that green tea will prevent chemically induced lung adenocarcinoma formation in a mutant mouse model with genetic changes commonly seen in human lung cancers, and the chemopreventive effect of green tea is, in part, mediated by AP-1, NFkappaB, or E2F1. Specific aims include: 1. To evaluate the effect of green tea on lung adenocarcinoma carcinogenesis in a transgenic mouse lung carcinoma model with genetic changes commonly seen in human lung cancers; 2. To evaluate chemopreventive effect of green tea against lung cancer by exposing mice to aerosolized EGCG in mutant mouse lung carcinoma model; 3. To examine the effect of green tea on cell cycle regulation and apoptotic activity of mouse lung tumors in vivo and lung tumor cell lines in vitro; 4. To investigate the mechanism of green tea's chemopreventive efficacy against lung cancer in mice. This proposal is timely and significant for the following reasons. Firstly, our proposed chemoprevention clinical trial of green tea against lung cancer in humans requires vigorous preclinical characterization of its efficacy and mechanism(s). Secondly, we will use a newly developed mutant mouse lung tumor model, which shares both histopathological features and genetic alterations (activated oncogenes and inactivated tumor suppressors) observed in human lung adenocarcinogenesis. And thirdly, we will conduct comprehensive animal bioassays to test the efficacy of green tea that is delivered via aerosol to significantly increase the efficacy of green tea in preventing lung cancer. The results from this proposal will providc a solid foundation for clinical trials of green tea as a lung cancer chemopreventive agent. Furthermore, the results from this proposal will also provide significant insights on how green tea affect the genes associated with cell cycle regulation and apoptosis during mouse lung carcinogenesis process. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: CELLS IN A COCULTURE OF NORMAL AND TRANFORMED SYRIAN HA Principal Investigator & Institution: Xu, Yong; Pharmacology and Toxicology; Indiana Univ-Purdue Univ at Indianapolis 620 Union Drive, Room 618 Indianapolis, IN 462025167
Studies 13
Timing: Fiscal Year 2001; Project Start 01-APR-2001; Project End 31-MAR-2003 Summary: (Applicant's Description) Preneoplastic cells are generated in human body during their living and working activities. When the control by both host and environmental determinants on the preneoplastic cells is not effective, a tumor will be resulted from the growth of single preneoplastic cell. The effect of surrounding normal cells on preneoplastic cells is a determinant in host, while chemopreventive agent functions as an environmental determinant. The control on tumor growth is affected by the interaction between the two determinants. Chemopreventive agent can show its effect by functioning directly on preneoplastic cells, or indirectly via the control of surrounding normal cells on preneoplastic cells. However, a dose-dependent interfering on surrounding normal cells may also decrease the control effect on preneoplastic cells. To clarify this dual effect of chemopreventive agent on preneoplastic cells is very important before using the chemopreventive agent in humans. This proposed study aims to investigate this interactive effect of chemopreventive agent and surrounding normal cells on the growth and death of preneoplastic cells. (-)-Epigallocatechin gallate (EGCG) in green tea and tea pigments (TP) in black tea are studied, when their cancer chemopreventive effects were reported in cells and animals and also suggested in humans. Three questions will be addressed in this study: a) if EGCG and TP have a dosedependent effect on the clonal growth or death of preneoplastic cells; b) if the effects result from the growth inhibition or killing mechanism directly on preneoplastic cells or indirectly through surrounding normal cells; and c) what are gene expression profile in the cells after regulated by EGCG and TP. A coculture model of normal and transformed Syrian Hamster Embryo (SHE) cells, mimicking in vivo growth environment of preneoplastic cells, will be used to address the questions. Under fluorescence microscopy, the clonal growth and death of single preneoplastic cell can be monitored during study period. The interfering effect between the tea components and normal cells on the growth or death of preneoplastic cells and the mechanism studies on generegulated cell proliferation and apoptosis in preneoplastic cells and surrounding normal cells will put insight in our knowledge about the process of cancer chemoprevention and also tumorigenesis. In addition, the success of this study may also provide a study model for cancer chemopreventive agents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CHEMISTRY & MECHANISMS OF TEA IN DISEASE PREVENTION Principal Investigator & Institution: Chung, Fung-Lung; Chief, Division of Carcinogenesis and Mo; Institute for Cancer Prevention 1 Dana Rd Valhalla, NY 10595 Timing: Fiscal Year 2003; Project Start 08-AUG-2003; Project End 31-JUL-2004 Summary: (provided by applicant): The Division of Agricultural and Food Chemistry of the American Chemical Society is organizing a symposium on "Chemistry and Mechanisms of Tea in Disease Prevention" for its annual national meeting on September 7-13, 2003 in New York City. It is timely to hold such a symposium because of the recent progress in our understanding of the molecular and cellular basis of tea in disease prevention, especially cancer prevention. New information has also been generated regarding the role of tea in the prevention of heart disease and aging. Some of the results of these studies are being or to be translated into studies in clinical settings. Therefore, this symposium will provide scientists an opportunity to critically review this field and a better perspective regarding the role of tea in the prevention of human chronic diseases. The symposium will be co-chaired by Drs. Fung-Lung Chung and John Weisburger of the American Health Foundation Cancer Center (AHFCC), Institute for Cancer Prevention and by Dr. James Crowell of the National Cancer Institute. We have
14 Tea
invited 14 speakers, whose work represents the frontier of this research area, to address the symposium. The American Chemical Society does not provide any financial support for participants of this symposium and financial support for other sources is not anticipated. Funds are sought to defray the costs of invited speakers at the oral symposium session. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CHEMOPREVENTION OF BASAL CELL CARCINOMAS IN BCNS PATIENTS Principal Investigator & Institution: Epstein, Ervin H. Research Professor; University of California San Francisco 500 Parnassus Ave San Francisco, CA 94122 Timing: Fiscal Year 2001 Summary: (Applicant's Description) The investigators of Project 1 will assess the chemoprevention of BCCs in BCNS patients. They will test the effects of chemopreventive agents on the development of basal Cell carcinomas (BCCs) in patients with the basal cell nevus syndrome (BCNS). The centerpiece will be a two year randomized double blind clinical trial of the chemopreventive effects of a standardized green tea aqueous extract. We will recruit patients with BCNS, focusing particularly on patients who develop high numbers of BCCs and who live near the participating clinical centers--in New York and San Francisco. We will identify the exact PTC gene mutation carried in each kindred using existing plus novel approaches including a protein truncation test to improve the yield of mutation detection. Subjects will ingest placebo or active agent for two years, and they will be monitored clinically by study investigators at intervals of three months. The end point assessed will be the number of new skin cancers per unit time. Potential toxicity as well as subject compliance (through the assay of tea components in subjects' blood) also will be monitored. One or more additional agents will be tested subsequently as chemopreventives in the same subjects; the selection of these agents will be based on the results of efficacy in trials in murine ptc+/- mice (see Project 2). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: CHEMOPREVENTION OF LUNG CANCER Principal Investigator & Institution: Anderson, Marshall W. Director; Environmental Health; University of Cincinnati 2624 Clifton Ave Cincinnati, OH 45221 Timing: Fiscal Year 2003; Project Start 23-MAY-2003; Project End 30-APR-2008 Summary: Lung cancer is the leading cause of death in men and women in the United States (160,000 new cases and 157,400 deaths in 2001). Although the relative risk of developing lung cancer declines in smokers who quit, former smokers remain at high risk for at least 5 years. Since smoking cessation is a major public health initiative, former smokers will increasingly account for a high percentage of lung cancer. A potential important approach to reduce the large number of tobacco caused cancer deaths is chemoprevention. The long-term goal o f our Chemoprevention of Lung Cancer Program Project is to develop chemopreventive strategies to reduce the incidents of lung cancer in high-risk current and former smokers. The Program Project will focus its chemoprevention strategies on Budesonide (a glucocorticoid agonist), green tea extracts (Polyphenon E), Myo-inositol, and difiuoromethylornithine (DFMO) for three reasons: i) they exhibit high chemopreventive efficacy in rodent models; ii) they are effective in the post-initiation period of carcinogenesis; and iii) they have a previous history of therapeutic or dietary administration to humans. Our Program Project
Studies 15
consists of four research projects designed by a group of lung cancer scientists to address our primary hypothesis--selective combination of chemoprevention agents can prevent the progression and formation ofpreneoplastic lesions in the respiratory epithelium. In summary, the Program Project will (1) conduct a Phase II trial to determine the efficacy and safety of green tea, the second most commonly consumed beverage after water for chemoprevention of lung cancer (Project I); (2) generate new information on the use of markers in cell survival pathways as intermediate endpoint biomarkers for chemoprevention trials (Project I-III); (3) facilitate a major new initiative to develop confocal miscroendoscopy as a non-biopsy method to assess the effect ofchemopreventive agents (Project I); (4) determine the scientific basis for combining chemopreventive agents in future Phase II trials by examining their ability to inhibit progression of preneoplasia to more advanced lesions in a mouse model for adenocarcinoma and a hamster model for upper respiratory squamous cell carcinoma (Project II-IV) and by clinical trials with single agents (Project I). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CHEMOPREVENTION OF LUNG CARCINOGENESIS USING GREEN TEA Principal Investigator & Institution: Hakim, Iman A. None; University of Arizona P O Box 3308 Tucson, AZ 857223308 Timing: Fiscal Year 2003; Project Start 07-APR-2003; Project End 31-MAR-2007 Summary: (provided by applicant) Many laboratory studies have shown an inhibitory action of green tea or the polyphenolic fraction of green tea in animal models of lung carcinogenesis. Thus, the role of tea drinking as a potential inhibitor of carcinogenesis merits careful evaluation. In our attempt at translating the abundant pre-clinical information and epidemiological data to the human population, we are proposing a Phase IIb 3-arm randomized, placebo controlled, double blinded green tea intervention trial among former smokers with chronic obstructive pulmonary disease (COPD) and >= 40 pack-years of smoking history. This population is targeted because they have been identified as having a high prevalence of premalignant dysplasia. Subjects will be randomly assigned to consume daily for six months either a standardized green tea (GT) beverage, or a defined green tea polyphenol (GTP) extract in capsule form, or placebo preparations. The hypotheses to be tested in the proposed research are 1) high consumption of GT or GTP can protect against cellular oxidative damage and 2) high consumption of GT or GTP can modulate the expression of genes involved in proliferation and apoptosis in a population at elevated risk of lung cancer. The primary endpoints will be improvement in markers of oxidative damage in DNA, lipids, and proteins (levels of 8-OHdG, 8-epi-PGF2, MDA, di-tyrosine, and catalase and glutathione peroxidase activities). The secondary endpoints will be exploratory to assess changes in the gene expression of biomarkers of proliferation (EGFR, PCNA, JUN, FOS, Ki-67) and apoptosis (bcl-2, caspase-3) in induced sputum, in addition, we will seek to determine if there are differences in adherence between the green tea preparation groups. We believe that a program of nutritional intervention by realistic dietary modifications that are effective, safe, and acceptable should be the cornerstone of lung cancer prevention strategy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: CHEMOPREVENTION OF PULMONARY CARCINOGENESIS Principal Investigator & Institution: Wattenberg, Lee; University of Cincinnati 2624 Clifton Ave Cincinnati, OH 45221
16 Tea
Timing: Fiscal Year 2003; Project Start 23-MAY-2003; Project End 30-APR-2008 Summary: The long-term objectives of the present proposal are to obtain data from chemopreventive studies in the hamster that will be useful in identifying agents likely to have efficacy in preventing cancer of the respiratory tract in the human. One specific aim is to evaluate three agents administered as single compounds for their capacity to inhibit squamous cell carcinogenesis of the upper respiratory tract of the Syrian Golden hamster. The three agents and their routes of administration are: green tea extract powder administered in the drinking water, budesonide administered by aerosol and myo-inositol administered in the diet. A second specific aim is to evaluate the efficacy of administration of combinations of two agents on their capacity to inhibit squamous cell carcinogenesis of the upper respiratory tract of the Syrian Golden hamster. The combinations will be selected from the agents enumerated above and also aerosol difluoromethylornithine which previously has been shown to have an inhibitory effect in the hamster model. The use of agent combinations can be valuable in decreasing the dose of individual compounds and thus possibly reducing adverse effects. The sequence of studies of agent efficacy will be selected so as to coordinate their use in the Clinical Trials Section-Project 1. A third aim is to determine molecular changes during squamous cell carcinogenesis of the upper respiratory tract of the hamster and to compare these with squamous cell carcinogenesis of the respiratory tract in the human. The hamster model employed entails six intratracheal administrations of the carcinogen MNU. With this procedure approximately 90% of the animals receiving carcinogen but no protective agent develop infiltrating squamous cell carcinomas of the upper respiratory tract, inhibition of the occurrence of these cancers would indicate that the chemopreventive agent has considerable potency and is a potential compound to further evaluate for use in the human. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CHEMOPREVENTION OF SUPERFICIAL BLADDER CANCER Principal Investigator & Institution: Belldegrun, Arie S. Associate Professor of Surgery; Urology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, CA 90024 Timing: Fiscal Year 2002; Project Start 07-AUG-2002; Project End 31-JUL-2007 Summary: The overall goals of this grant application are to 1) develop an effective chemoprevention strategy to reduce the risk of bladder cancer recurrence and to 2) investigate surrogate biomarkers that can serve as intermediate endpoints of the interventional efficacy of chemoprevention. Bladder cancer represents an important health problem in the United States and it currently ranks as the fourth most common cancer site in men and the eight most leading site in women. Since these tumors have a very high incidence of recurrence, the psychological and economic burden to the health care system of repeated diagnostic evaluations and therapy are substantial. Bladder cancer is an ideal model for studies of risk assessment early detection, chemoprevention and the development of intermediate biomarkers. Cigarette smoking represents the single most significant, preventable cause of bladder cancer and its carcinogenesis has a long latency period of close to twenty years following initial exposure, providing ample opportunities for intervention. Recently several potential surrogate end point markers have been developed for the detection of the clinically occult, premalignant phase of bladder cancer. These markers include the QFIA biomarker profile (DNA/M344/Actin Associated Protein) urinary basic fibroblast growth factor (bFGF) measurement, and Microsatellite Instability (MI) markers. Using the tumor recurrence rate as a primary end point and the biomarkers as secondary end points, we propose to perform a
Studies 17
randomized, placebo-controlled, clinical trial using two promising chemoprevention agents targeting specific biochemical pathways on a cohort of high risk individuals who are former smokers with a grater than 30 pack year smoking history. Eligible subjects will have had a previous episode of low grade, low stage cancer of the bladder who are at high risk to develop disease recurrence, but for whom the standard of care would be observation. We will also construct tissue microarrays using specimens obtained during the evaluation of this clinical cohort to perform present and future translational high throughput studies to study the expression of markers associated with genetic susceptibility and tumor progression, and to identify potential therapeutic targets for cancer prevention. This grant application will involve a multi-disciplinary approached based on organization into program cores. An Administrative Core will perform the overall oversight for all aspects of the proposed work. A Clinical Core will run the clinical trial. The development and evaluation of the proposed biomarkers will be performed by the Biomarker and Nutritional Cores. All tissue samples will be collected and stored, and tissue arrays constructed by the Tissue Core. Finally, the Biostatistics Core will help design the clinical trial and evaluate the measured endpoints. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: COHORT STUDY OF CANCER INHIBITORY FACTORS IN MEN Principal Investigator & Institution: Shu, Xiao O. Professor of Medicine; Medicine; Vanderbilt University 3319 West End Ave. Nashville, TN 372036917 Timing: Fiscal Year 2001; Project Start 01-JUL-2001; Project End 30-JUN-2006 Summary: This application is to establish a cohort of adult men in Shanghai for a longterm epidemiological study of cancer and other chronic diseases, with a focus on identifying modifiable protective dietary factors for cancers. This study will be built upon our recent success in the Shanghai Women's Health Study (SWHS) (R01CA70867), a prospective cohort study of 75,000 women. The specific aims of this study are: 1) to conduct in-person interviews and follow-up for cancer incidence and total mortality of 73,000 men who live in the seven SWHS communities and are primarily between age 40 to 70 years (67,005 of them are husbands of the SWHS participants); and 2) to collect and store baseline blood and urine samples from a subset of cohort members (N=30,000) and post-diagnostic blood samples from all men diagnosed with cancer (N=2270) during the follow-up period. This cohort study will enable us, in the first 5-year funding period to test a spectrum of etiologic hypotheses for major cancers. Specifically, we will focus on the examination of the potential cancer-inhibitory effects of the following foods (their major phytochemical constituents): tea (polyphenols), soy foods (isoflavones), allium vegetables (organosulfur compounds), crucifers (isothiocyanates, dithiolthiones, indoles), and dark green-leafy vegetables (lutein and others) and to explore the relation of cancer with specific oriental foods, such as bok choy, Chinese cabbage, white radish, ginger root, and ginseng. This proposed study will be highly cost-efficient since most of subjects have already been recruited into the study, as part of the SWHS. The procedures for follow-up and dietary assessment have been developed, and feasibility of the study has been clearly demonstrated. While hundreds of cancer epidemiological studies have been conducted, few have, as a primary goal, focused on identifying dietary protective factors. Men in Shanghai differ substantially from those in the U.S. in dietary and other exposure patterns, including high intake of tea, soy foods, and many other vegetables. Given such exposure patterns, this Proposed study will provide unique, unparalleled opportunities to examine many important etiologic hypotheses that cannot be addressed adequately among men in the U.S. and other Western countries. The stored blood and urine samples will be valuable for future studies of
18 Tea
biologic variables and their interactions with environmental factors in the etiology of cancers, particularly for testing novel hypotheses when new knowledge and laboratory technology become available. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: COMBINED EFFECTS OF TEA PLUS NSAIDS TOWARDS COLON CANCER Principal Investigator & Institution: Orner, Gayle A. None; Oregon State University Corvallis, OR 973391086 Timing: Fiscal Year 2003; Project Start 29-SEP-2003; Project End 31-AUG-2005 Summary: (provided by applicant): Colorectal cancer is the second leading cause of cancer deaths in the United States. According to the American Cancer Society, more than 130,000 Americans will be diagnosed with cancer of the colon or rectum this year. Fortunately researchers are making extraordinary progress in the development and/or identification of agents that may delay or prevent colorectal cancer. These include pharmaceuticals such as the non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are effective at preventing polyp formation in familial adenomatous polyposis (FAP) patients having a genetic predisposition to cancer. Epidemiological evidence suggests that long-term NSAID use is associated with a decreased risk of colon cancer in nonfamilial colon cancer as well. However, NSAIDs can produce serious side effects including gastrointestinal bleeding and even death. One strategy to minimize toxicity of NSAIDs is to use very low doses in combination with other agents having complementary modes of action. Tea prevents intestinal and/or colorectal cancer in a variety of animal models and may be a suitable alternative or complement to NSAID therapy. Our preliminary data shows that tea or a combination of tea plus the NSAID sulindac is highly effective at preventing the formation of tumors in Apc m_nmice. These mice have a mutation in Apc (same gene altered in FAP) and, like humans with FAP, are genetically predisposed to develQp large numbers of intestinal adenomas at an early age. This suggests that tea alone, or a combination of tea plus sulindac may be of benefit in treating humans with FAP. These studies will examine the benefits of tea and/or purified tea constituents plus NSAIDs as preventive agents towards colon cancer. The research proposed in this R21 will provide necessary preliminary data for use in subsequent R01 proposals on how dietary factors and pharmaceuticals interact in the prevention of cancer, and should help establish the primary investigator as an independent researcher. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: COMPARATIVE MECHANISMS OF CANCER CHEMOPREVENTION Principal Investigator & Institution: Bailey, George S. Distinguished Professor & Center Directo; None; Oregon State University Corvallis, OR 973391086 Timing: Fiscal Year 2003; Project Start 17-MAR-2003; Project End 28-FEB-2008 Summary: (provided by applicant): This amended program project focuses on cancer chemoprevention by a selected set of phytochemicals: the chlorophylls, indole-3carbinol, and tea polyphenols. Each of these in natural or derivative form is known to have protective efficacy in some animal models; however, molecular mechanisms and dose-response issues are not fully defined, combined chemopreventive approaches have received relatively little attention, the potential for tumor enhancement (by indole-3carbinol, for example) is not fully understood, and the role of maternal exposure to these agents in fetal health risk has not been explored. The proposed studies will provide a
Studies 19
systematic examination of the molecular mechanisms of cancer chemoprevention by these blocking agents and suppressing agents in standard rat models (mammary, liver), knockout and congenic mouse models (colon, lung), and a multi-organ rainbow trout model (stomach, liver), along with studies in human cell culture models. The results of this comparative approach will be translated into three biomarker intervention and bioavailability studies in human volunteers. In summary, the overall aim of this program project is to conduct highly interactive mechanism, tumorigenesis, and doseresponse studies in selected animal models, each having specific advantages for cancer chemoprevention research, and to translate the most promising results into initial human studies that may demonstrate chemoprevention promise in human populations. This goal will be achieved through three complementary, synergistic projects: 1) Chlorophylls as Trans-Species Blocking Agents (G. Bailey, PI); 2) Transplacental Chemoprotection and GI Bioavailability (D. Williams, PI); and 3) The a-Catenin Pathway and Chemoprotection by Tea (R. Dashwood, PI). Investigators will be aided by an Administrative Core (G. Bailey, Director), which oversees inter-project meetings and provides budgetary, reporting, and external advisory needs, and a Service Core, which provides selected animal, preparative chemistry, statistical, and other services (R. Dashwood, director). Dr. George Bailey will serve as Principal Investigator for the program project. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CONTROL INTERACTIONS
OF
PROSTATE
CANCER:
BOTANICAL/DRUG
Principal Investigator & Institution: Liao, Shutsung; Professor; Ben May Institute; University of Chicago 5801 S Ellis Ave Chicago, IL 60637 Timing: Fiscal Year 2001; Project Start 12-SEP-2001; Project End 31-MAY-2004 Summary: (provided by applicant): Prostate cancer is the most commonly diagnosed malignancy in American men and the second leading cause of cancer death in men. Androgen deprivation therapy has been the standard treatment against hormonedependent prostate cancer; unfortunately, androgen-independent cells usually emerge after a few years of androgen ablation therapy. Chemotherapy is often palliative at this stage, but it does not significantly increase the life span of prostate cancer patients. Because of this situation, many prostate cancer patients turn to alternative therapies to treat their disease, often without informing their physicians. In this proposal, two currently popular herbal preparations, green tea extracts and PC-SPES will be analyzed for their potential to affect the response of prostate cancer at different stages of progression to hormonal interventions, including androgens, anti-androgens, estrogens and inhibitors of 5(alpha)-reductase. In the first aim, it will be determined if green tea extracts and PC-SPES (and extracts of individual component herbs) affect the ability of androgens, anti-androgens and 5(alpha)-reductase inhibitors to control cell cycle processes and the growth of human prostate cancer LNCaP cells representing different stages of prostate cancer progression in culture and as tumor xenografts in athymic nude mice. In the second aim, it will be determined if green tea extracts and PC-SPES (and extracts of individual component herbs) affect the chemotherapeutic effects of epigallocatechin gallate on human prostate LNCaP cancer cells/tumors representing different stages of prostate cancer progression, in culture and in athymic mice. In the third aim, it will be determined if PC-SPES modulates the effects of estrogens and if estrogenic components of PC-SPES are responsible for effects on the cell cycle and the growth of prostate cancer cells representing different stages of prostate cancer progression in culture and in athymic mice.
20 Tea
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CONTROL OF TCR DATA AND TCR ALPHA REARRANGEMENT Principal Investigator & Institution: Krangel, Michael S. Associate Professor; Immunology; Duke University Durham, NC 27706 Timing: Fiscal Year 2002; Project Start 01-AUG-1989; Project End 31-JUL-2006 Summary: (provided by applicant): Cis-acting elements within T cell receptor (TCR) and immunoglobulin loci impart developmental regulation to V(D)J recombination by functioning as region- and developmental stage-specific modifiers of chromatin structure. The TCR alpha/delta locus provides a valuable model to unravel the complex mechanisms underlying this regulation, since it contains distinct sets of gene segments activated according to distinct developmental programs, and there is much known about the roles of two prominent enhancers, E-delta and E-alpha. However, full accounting for the complex locus dynamics requires better understanding of the ciselements with which the enhancers collaborate and the mechanisms by which ciselements translate activity into changes in chromatin structure and function. We will produce and analyze genetically manipulated versions of the endogenous murine TCR alpha/delta locus and transgenic reporter substrates to address mechanisms of regulation. In Aim I, we will assess the role of germline promoters as regulators of Jalpha accessibility and usage. Previous data indicate E-alpha to collaborate with the TEA promoter to regulate accessibility of 5' Ja segments and imply its interaction with additional elements to regulated more 3' Jas. We have identified a promoter that is a strong candidate for such a regulator, and will test this by gene targeting at the endogenous TCR alpha/delta locust. The role of germline transcription in accessibility and V(D)J recombination is unclear, We propose that enhancer- and promoter distal accessibility may depend critically on transcriptional elongation, and will test this in Aim II by inserting a transcriptional terminator into the Ja region. The factors determining TCR alpha/delta V gene usage are not understood. In Aim III, we will ask whether developmental changes in V segment chromatin structure determine whether members of the TCR alpha/delta V segment pool function as V-alpha's, V-deltas, or both. E-delta interacts with germline TCR delta promoters to provide accessibility for V(D)J recombination but does not activate germline TCR-a lpha promoters. In Aim IV, we will use transgenic reporters to functionally characterize germline J-delta promoters and to investigate the mechanisms restricting E-delta from activating the germline TCR alpha promoter TEA. The function of enhancer-associated nuclear matrix attachment regions (MARs) is unclear. In Aim V we will analyze human E-delta MAR function within a transgenic reporter, and murine E-delta MAR function within the endogenous locus, to test a dual function model in which these elements activate in DN thymocytes and repress in DP thymocytes, thereby contributing critically to developmental regulation by E-delta. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: CORE--ANALYTICAL CHEMISTRY FACILITY Principal Investigator & Institution: Prokopczyk, Bogdan; Institute for Cancer Prevention 1 Dana Rd Valhalla, NY 10595 Timing: Fiscal Year 2002; Project Start 01-JUL-2002; Project End 30-NOV-2002 Summary: The Analytical Chemistry Facility is the AHFCC's resource for modern chromatographic techniques and spectroscopic determinations. The Facility's dedicated, climate controlled mass spectroscopic (MS), nuclear magnetic resonance (NMR) and
Studies 21
infra-red (IR) laboratories are located at the lower level of the Naylor Dana Institute in Valhalla. The combined space is approximately 1650 sq. ft. The head of the Facility is Bogdan Prokopczyk, Ph.D. Key facility members include John Cunningham, MS (mass spectrometrist), high performance liquid chromatography (HPLC) expert Neil Trushin, MS, NMR spectrometrist Jyh-Ming Ling, Ph.D., and Jonathan Cox, instrument repair specialist. Members of the Facility provide researchers of the AHFCC expertise in development of modern chromatographic techniques including chromatography (GC), HPLC, spectroscopic determination and interpretation of spectral and analytical data. The major equipment housed in the Facility includes a Finnigan Model TSQ700 Tandem Quadruple Mass Spectrometer with performance gas GC and LC/MS/MSDS, HewlettPackard Model 5973 Mass Selective Detector interfaced with Hewlett-Packard Model 6890 Series Gas Chromatograph, 360 MHz Bruker AM 360 Wide Bore Superconducting Fourier Transform NMR Spectrometer, 90 MHz Joel NMR Spectrometer and Mattson Polaris Fourier Transform Model 10410 Infra-red Spectrometer. In addition the Facility is equipped with various GC and HPLC systems interfaced with various detectors and autosamplers. The GC detectors include: mass selective (MSD), flame ionization (FID), nitrogen-phosphorous (NPD), electron capture (ECD), and thermal energy analyzers (TEA). The HPLC detectors include: UV, variable wavelength, photodiode array fluorescence, electrochemical and radioflow. The Facility provides wide spectrum of services for all investigators of the Center. The Facility provides wide spectrum of services for all investigators of the Center. Main Services which focus on mass spectroscopy (MS), combined MS-gas chromatography (GC-MS), liquid chromatography-MS (LS-MS), NMR spectroscopy, FT-IR spectrometry are almost exclusively (over 98%) used by peer-reviewed, funded members of the AHFCC. The members of the Facility also assist investigators in in-house serving of various scientific instruments. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CORE--ORGANIC SYNTHESIS FACILITY Principal Investigator & Institution: Amin, Shantu G. Chief; Institute for Cancer Prevention 1 Dana Rd Valhalla, NY 10595 Timing: Fiscal Year 2002; Project Start 01-JUL-2002; Project End 30-NOV-2002 Summary: The Organic Synthesis Facility has grown into an integrated, essential part of the AHFCC research program in chemical, environmental, and endogenous carcinogenesis. It is equally involved in the Cancer Center's research on the chemoprevention of cancer, the development of biomarkers of uptake and metabolic activation of carcinogens, and the identification of etiologically significant host factors. Research activities of the Facility encompass the development of syntheses of carcinogens, their detoxification products, reactive species of metabolic activation, and DNA adducts formed with such species. The activities include the identification and synthesis of biomarkers of uptake and activation of environmental carcinogens that required deuterated, tritiated, and 14C- labeled isotopes. Needed agents are furnished to the Cancer Center's investigators for research projects supported by the NCI, NIDCR, NIEH, the Health Department of the Commonwealth of Massachusetts, and agencies such as the American Cancer Society. Requests amounts range from picograms for reference compounds to multigrams for large-scale bioassays. The structural integrity and purity of all agents is ensured by state-of-the-science technology, including HPLC, GC-MS, GC-TEA, TLC, UV, IR, FTIR, MS, and NMR. Scientists in the Facility are highly experienced in developing efficient synthetic routes for non-radiolabel and radioisotopelabeled polycyclic aromatic hydrocarbons, tobacco- specific N-nitrosamines, and other
22 Tea
environmental and nutritional carcinogens, their metabolites, and their DNA adducts. The Organic Synthesis Facility occupies 900 ft/2 in Unit 1 and, for the synthesis of isotope-labeled compounds 447 ft/2 of laboratory space at the lower level of NDI. The Facility's dedicated Carcinogen Synthesis Laboratory is equipped with several HPLCs, including one instrument with a beta-flow model IC radioactivity detector, and with a medium pressure liquid chromatograph. These instruments enable the analysis and purification of starting materials, intermediates, and end products. The laboratory hoods are equipped with glove boxes. There is also a walk-in hood, as required by regulatory statutes. The dedicated Selenium Laboratory, in which chemopreventive agents are prepared, has a special exhaust system in compliance with safety regulations for these chemicals. The dedicated Synthesis Laboratory for intermediates, nucleoside markers, and chemopreventive agents (other than selenium) is equipped with a photolysis set-up, HPLC with photo diode array detector, and two working hoods with a 24-h exhaust system. Radiolabeled syntheses are carried out in a dedicated laboratory that is accessed only upon approval by the Cancer Center's Safety Officer who also supervises adherence to safety regulations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CORE--PEPTIDE SYNTHESIS Principal Investigator & Institution: Ebling, Fanny; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, CA 90024 Timing: Fiscal Year 2001 Summary: The core was originally funded in late 1992, was operation by 1993, and has synthesized to date 2,096 individual peptides for used by 15 investigators. This averages 524 peptides per year. The new core will be improved by utilization of the MacroCrown method of peptide synthesis, which is more cost-effective than our earlier methods. The Core is cost- effective, providing a purified 15-mer peptide for a total cost of $217 (including costs of personnel, supplies and maintenance of equipment), compared to having that peptide synthesized by a commercial source, which would cost $800 on average. The core will provide synthesis of peptides varying in length from 9 to 16-mers for investigators studying T cell activation, antibody specificities, or sequences within large proteins which may have biologic activity. Four methods will be offered, with MacroCrown likely to be the most frequently used. The mother methods available will be multi-pin, tea-bag and the Advanced ChemTech automatic synthesizer. The least expensive method to give yields most investigators will need will be the MacroCrown technique. Peptides will be purified by HPLC and may be sent to another UCLA facility for mass spectrometry if the investigator needs to determine exact purity. Dr. Fanny Ebling will direct this facility, and Dr. Eli Sercarz will be Associate Director. We anticipate that approximately 14 investigators currently using this facility and working with MAMDC investigators will use this core regularly, and should be able to serve several additional investigators whose programs become related to the MAMDC projects. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: CORE--SYNTHESIS Principal Investigator & Institution: Ostresh, John M.; Torrey Pines Institute/Molecular Studies Molecular Studies San Diego, CA 92121 Timing: Fiscal Year 2001
Studies 23
Summary: The purpose of the synthesis core facility is to provide the following to Projects II, III and IV: 1) routine synthesis of individual compounds of iterations from synthetic combinatorial libraries based on protocols produced during the development of those libraries in Project I; and 2) resynthesis of synthetic combinatorial libraries to replenish inventory. The use of trained technicians to perform this work is an efficient and cost effective way to accomplish this work, which is more routine than initial development of the library. The proposed core facility is an expansion of an existing facility located within the laboratories of Torrey Pines Institute for Molecular Studies, the applicant organization. This facility will be able to output between 300 to 500 compounds per month, depending on the complexity of the particular synthetic reaction schemes used, as well as provide analytical and purification services. The facility's primary function will be to synthesize individual defined compounds based on the results of screening the positional scan formatted synthetic combinatorial libraries. Secondary, functions will include the synthesis of sub-libraries based on the iterative deconvolution method as necessary, and synthesis and purification of individual compounds as necessary. It is expected that in the later portion of this program project the resynthesis of depleted libraries will be required. The synthesis core facility will be located at Torrey Pines Institute for Molecular Studies and will occupy 1,300 square feet of assigned space. Routine solid phase synthesis will be carried out using the simultaneous multiple synthesis technique developed by the principal investigator (teabag method). This laboratory contains a full complement of equipment necessary for organic synthesis. The available analytical/purification equipment include: 1H and 13C NMR, LC-MS, MALDI-MS, analytical and preparative HPLCs, and HPCE. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CORE--TEA CHEMISTRY AND ANALYSIS Principal Investigator & Institution: Ho, Chi-Tang; Rutgers the St Univ of Nj New Brunswick Asb Iii New Brunswick, NJ 08901 Timing: Fiscal Year 2001; Project Start 17-SEP-2001; Project End 31-AUG-2006 Summary: (provided by applicant): The mission of the Tea Chemistry and Analysis (TC&R) Core is to facilitate the research activities of the four Projects of this Program Project by providing well-characterized tea preparations and purified tea constituents/metabolites and performing chemical analyses that are required by the four Projects. The specific aims are as follows: 1. Procure tea preparations and purify tea constituents. The caffeine and tea polyphenol contents in the tea preparations will be analyzed at the time of use. The stability of these compounds in solutions under experimental condition will be determined. 2. Determine plasma/tissue levels of catechins, caffeine, and their metabolites in selected samples from Projects 1 and 2. 3. Analyze the fatty acid compositions of fat pad samples from Projects 1 and 2. 4. Synthesize catechin metabolites and radio labeled compounds. These include O-methyl, glucuronide, and sulfate derivatives of EGCG and EGC, catechin ring fission metabolites M4 and M6, and theasinesins. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: DEVELOPMENT OF COMPLEX RETINAL FIELDS Principal Investigator & Institution: Grzywacz, Norberto M. Professor; Smith-Kettlewell Eye Research Institute Research Institute San Francisco, CA 94115 Timing: Fiscal Year 2001; Project Start 01-DEC-1996; Project End 31-AUG-2001
24 Tea
Summary: The long-term objective of the proposed research is to understand what processes contribute to the development of image information processing in the retinas of embryos and neonatal animals. This basic research could have important implications for future cure of genetic diseases of the retina. To achieve the objectives of the research, a theoretical framework was proposed, which shows how dendritic growth, light exposure, and spontaneous waves of activity (common to immature isolated retinas, but as yet not studied in vivo) can contribute to the development of retinal information processing. The specific questions being asked are: 1) Do developing retinas have spontaneous waves of activity in vivo? If so, what are the properties of this activity? To answer these questions, the eyes of developing turtles will be recorded with two electrodes simultaneously and the results analyzed with a new mathematical technique. The experiments will be performed under normal conditions and visually- and pharmacologically-abnormal ones. The data will then be compared to computer simulations performed with the theoretical framework. 2) Are spontaneous waves mediated by extracellular potassium and cholinergic synapses? To answer this question, a new technique for optically imaging Ca2+ in ganglion cells will be used. This technique will allow to obtain the waves' spatio-temporal profile across cells and thus, to test the predictions made by a recent model of these waves. In particular, this model predicts the effects of neostigmine, a cholinesterase inhibitor, Cs+ and TEA, two K+currents blockers, and Co2+, a synaptic blocker. 3) Does spontaneous activity contribute to the development of receptive- field size and orientation selectivity? To test whether waves contribute to the development of these properties, a technique to implant intraocularly a piece of polymer that slowly releases drugs mixed with it was developed. In the proposed experiments, the drugs will be neostigmine and Co2+. Incidence of orientation selectivity and receptive-field size will be measured for each of these conditions as a function of age, and the results compared to those of new computer simulations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DIETARY FACTORS IN THE ETIOLOGY OF CANCER IN SHANGHAI Principal Investigator & Institution: Ross, Ronald K. Professor; Preventive Medicine; University of Southern California 2250 Alcazar Street, Csc-219 Los Angeles, CA 90033 Timing: Fiscal Year 2002; Project Start 01-APR-1987; Project End 30-JUN-2007 Summary: (provided by applicant): This is a revised grant application requesting continued funding of a residential cohort of 18,244 men in Shanghai, China, assembled during 1986-89 when subjects were between the ages of 45 and 64 years. At recruitment, all cohort members provided detailed dietary and medical histories as well as blood and urine specimens. The cohort has been followed for the occurrence of cancer and death through routine ascertainment of new cases from the population-based Shanghai Cancer Registry and Shanghai Vital Statistics Units, and annual visits to all known surviving cohort members. To date, the cohort has accumulated 204,010 person-years of observation. Only 231 subjects have been lost to follow-up. There have been 1,463 incident cancer cases and 2,599 cohort members have died. The leading cancer sites are lung, liver, stomach, and colorectum. Stroke accounts for 23% of all deaths. Active follow-up of this cohort will continue for another 5 years. During the annual personal visit to each surviving cohort member, buccal cells will be collected to facilitate future etiologic studies involving DNA analysis. Although study investigators have been successful in harvesting DNA from serum samples collected at baseline, cost-based analysis revealed that it is more cost-effective for future gene-based studies to rely on
Studies 25
this new source of DNA. It is estimated that buccal cells will be collected from about 11,000 cohort subjects. During the next 5 years, a series of nested case-control studies will be conducted to further elucidate the interplay of genetic and dietary factors in influencing cancer risk. Specifically, study investigators will assess the roles of dietary aflatoxin and antioxidants (selenium, retinol, carotenoids, tea polyphenols) in cancers of the lung and liver; the role of dietary isothiocyanates in cancers of the stomach, esophagus, and colorectum; and the role of tea polyphenols in cancers of the stomach and esophagus. In all instances of diet-cancer investigations, relevant genes with potential modifying effects on the respective diet-cancer associations will be included in the investigations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DISPOSITION OF GINKGO FLAVONOIDS VIA RECYCLING Principal Investigator & Institution: Hu, Ming; Associate Professor; Pharmaceutical Sciences; Washington State University 423 Neill Hall Pullman, WA 99164 Timing: Fiscal Year 2001; Project Start 01-APR-2000; Project End 31-MAR-2003 Summary: The present proposal will focus on sequential anaerobic and aerobic metabolism of ginkgo-flavones by intestinal microflora, large intestine, and liver. This sequential metabolism of ginkgo-flavones is expected to be efficient and extensive, because flavonoids and their metabolites are expected to go through repeated enterohepatic recycling. The long-term goal of our study is to determine how this sequential metabolism plus repeated recycling affects the disposition of flavonoids, an important class of antioxidants presented in Ginkgo biloba and many other herbs (e.g., garlic, tea, chamomile, and others). The special focus of the present study is on how bacterial metabolism affects the overall disposition of ginkgo- flavonoids. The specific aims are to: (l) determine if bacteria will only take up ginkgo-flavones but not ginkgoflavone glycosides, because of expected poor permeability of glycosides through the bacterial walls; (2) determine the metabolism of each ginkgo-flavone and as a mixture in Ginkgo biloba extract by various groups of bacteria normally residing in human and rat large intestine under anaerobic conditions. (3) determine how parent compounds and metabolites formed through bacteria metabolism are absorbed in the large intestine,; (4) determine how these metabolites are further metabolized by the large intestine and the liver; and (5) determine how metabolite reshuffling, perhaps for multiple times, into the enterohepatic recycling loop will affect the over metabolic fate of ginkgo flavones and their metabolites. Through these exploratory studies, we would be able to test if a grand recycling scheme which involve sequential metabolism and/or secretion of flavonoids, their microbial and mammalian metabolites, is functionally critical to the disposition of ginkgo-flavonoids. By combining expertise from the two independent disciplines of microbiology and pharmaceutical sciences, we have the capability and the know-how to effectively test this complex hypothesis. if proven, this complex metabolic process will have profound impact on safety and efficacy of this herbal extract and other flavonoidrich herbal products. Through future animal and human studies in vivo, we would then determine how this grand recycling scheme influences the disposition of a variety of herbal and pharmaceutical products that also undergo, perhaps repeatedly, enterohepatic recycling. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
26 Tea
·
Project Title: DRUG-DIETARY INTERACTION
FLAVONOID
INTESTINAL
ABSORPTION
Principal Investigator & Institution: Rodriguez, Rosita J. None; Oregon State University Corvallis, OR 973391086 Timing: Fiscal Year 2001; Project Start 17-SEP-2001; Project End 31-AUG-2003 Summary: (provided by applicant): The opportunity for drug-dietary interaction is an everyday occurrence whether the interaction is with food, juice, or dietary supplements. Moreover, the consumption of flavonoids is being urged because of their multiple health benefits; thus, understanding the possible biological effects of the flavonoids on intestinal drug absorption is essential. Flavonoids may be a particularly important class of modulators due to their ubiquitous occurrence in foods and drinks of plant origin and their known interactions with P-glycoprotein (Pgp) and cytochrome P450 (CYP). These dietary constituents may modulate transport in the intestinal tract and significantly alter the absorption of important therapeutic agents. The increased systemic bioavailability of some drugs, nifedipine and felodipine, associated with ingestion of grapefruit juice represents a couple of widely publicized drug-dietary-interactions. An increase or decrease in drug absorption may be due to (i) alterations in Pgp mediated or non Pgp mediated transport and/or (ii) presystemic intestinal metabolism by CYP and/or the flavin-containing monooxygenases. Furthermore, patents have been filed which incorporate flavonoids as excipients in pharmaceutical formations with the intent to alter drug absorption. Thus, the specific hypothesis of this study is that dietary flavonoids can alter the Pgp-dependent or Pgp-independent transport of certain therapeutic drugs. Studies will be conducted using flavonoids belonging to different subclasses such as isoflavone, flavanone, flavonol, and flavanol (e.g., genistein, naringenin, quercetin, and epigallocatechin gallate, respectively) to gain an insight into structure-activity relationships in the alteration of transport of Pgp-dependent substrates and Pgp-independent substrates by these phytochemicals. The flavonoids will be evaluated using Caco-2 cells, a human intestinal cell line. These cells have been well characterized to express Pgp transporters and non Pgp transporters such as Na+/K+, Na+/H+, amino acids, peptides, bile acid, and vitamin B12. This project will provide new knowledge on how flavonoids affect the dynamic transport mechanisms located in the intestinal mucosa. Thus, the results of this study will increase our understanding of the role of flavonoids found in tea, vegetables, soy, and dietary supplements in the intestinal absorption of therapeutic drugs. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EFFECT OF TEA ON FORMATION AND GROWTH OF SKIN TUMORS Principal Investigator & Institution: Conney, Allan H. Chairman; Rutgers the St Univ of Nj New Brunswick Asb Iii New Brunswick, NJ 08901 Timing: Fiscal Year 2001; Project Start 17-SEP-2001; Project End 31-AUG-2006 Summary: (provided by applicant): In an earlier cancer chemoprevention study, we exposed SKH-1 mice to ultraviolet light (UV) twice a week for 22 weeks, and UV administration was stopped. The mice were tumor-free but they had hyperplasia and a high risk developing skin tumors during the next several months in the absence of further UV administration ("high risk mice"). This is a useful model that may be comparable to humans previously exposed to moderate/high levels of sunlight who have a high risk of developing skin cancer later in life even in the absence of continued heavy sunlight exposure. We plan to: 1. Compare the effects of orally administered
Studies 27
green tea, decaffeinated green tea, caffeine and (-)-epigallocatechin gallate (EGCG) on the formation and growth of nonmalignant and malignant skin tumors in "high risk mice." Nontumorous areas of the skin and epidermal tumors from these mice will be used for mechanism studies described in "2" and "3" below. 2. Determine molecular mechanisms for the effects of orally administered green tea, decaffeinated green tea, caffeine, and EGCG on the formation and growth of nonmalignant and malignant skin tumors in "high risk mice. " We will determine the effects of these treatments on proliferation and apoptosis and on key molecular signal transduction markers of proliferation and apoptosis in normal epidermis, hyperplastic epidermis, nonmalignant tumors and malignant tumors. 3. Determine the effects of oral administration of green tea, decaffeinated green tea, caffeine and EGCG in "high risk mice? on fat levels and evaluate the relationship between decreased fat levels and inhibition of carcinogenesis. Possible relationships between lipid levels, number of tumors per mouse and tumor size per mouse in individual mice will be determined. 4. Determine the effects of short-term and long-term topical applications of EGCG, caffeine and combinations of EGCG and caffeine to "high risk mice" on biomarkers of proliferation and apoptosis and on subcutaneous fat levels. Effects on the formation and growth of nonmalignant and malignant tumors will also be evaluated. We will compare the results of topical application studies with those from experiments with oral administration to determine possible mechanistic differences between the two modes of administration. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EPIDEMIOLOGIC AND BIOLOGIC PREDICTORS OF IVF SUCCESS Principal Investigator & Institution: Cramer, Daniel W. Professor; Brigham and Women's Hospital 75 Francis Street Boston, MA 02115 Timing: Fiscal Year 2001; Project Start 01-AUG-1994; Project End 31-JUL-2003 Summary: In 1994, more than 39,000 cycles involving ART were performed in the United States. Given the cost of approximately 8,000 per cycle, studies are needed which could improve the likelihood that ART will result in a successful pregnancy. In 1994, the investigators initiated a study of couples seeking ART that involved collect of baseline epidemiologic data, treatment variables, and biological specimens. The preliminary data collected on 927 couples, support published findings and suggest exciting new ones. Only 8 percent of women over the age of 39 years became pregnant other first ART cycle and the number of eggs retrieved during ART decline more rapidly after the age of 33 years. Key exposure examined in men and women included caffeine, alcohol, and tobacco. In women, smoking was the principal exposure that decreased number of eggs retrieved. The decrease occurred in both current and former smokers. In men, caffeine use decreased ART success. This association was not present if the ART cycle involved direct injection of sperm in eggs which suggests that caffeine (or tannins in coffee or tea) could be affecting ART success (or natural fertility) by interfering with sperm-egg penetration. Women with the primary diagnosis of endometriosis had fewer eggs retrieved, whereas diagnosis of hernia or varicocele was linked to decreased sperm concentration. Use of a gonadotropin releasing hormone agonist in a long or down regulation fashion prior to ovarian stimulation was associated with markedly better ART success and egg retrieval than used in the short or flare regimen. The joint effect of these female, male and treatment variables will be examined in discrete failure application, the investigators propose continuation of the study, anticipating that in increase in the sample size of 3,000 would allow them to examine important associations in diagnostic or treatment subgroups, as well as expand the power to study other intriguing preliminary findings. These include an association between endometriosis
28 Tea
and a polymorphic variant, known as N314D, a key gene in galactose metabolism; evidence that acetaminophen use may lower follicle stimulating hormone levels; and evidence that alcohol use in men adversely affect sperm morphology. The investigators' ability to study male factor infertility will be enhanced by collection of a blood specimen from men and retrieval of residual semen after ART. The continued goal is to assess the effect of epidemiologic and biologic markers and treatment-related variables of ART success and to address broader aspects of reproductive physiology by examining gamete number and quality as outcomes. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: GENOTYPES
EPIDEMIOLOGY
OF
PROSTATE
CANCER--ODC
AND
AR
Principal Investigator & Institution: Helzlsouer, Kathy J. Professor; Epidemiology; Johns Hopkins University 3400 N Charles St Baltimore, MD 21218 Timing: Fiscal Year 2001; Project Start 01-JUL-2000; Project End 30-JUN-2002 Summary: In keeping with the NCI initiative to stimulate innovative molecular epidemiologic research into the origins and progression of prostate cancer we plan to focus on the association between a new polymorphism found on the ornithine decarboxylase gene (ODC) and the development of prostate cancer. Ornithine Decarboxylase (ODC) is an enzyme in the polyamine biosynthetic pathway responsible for cellular proliferation and differentiation. Overexpression of ODC has been shown to predispose to both tumor growth and progression. We also plan to explore whether the association between the ODC genotype and the risk of prostate cancer varies by the presence of a polymorphism of the androgen receptor gene. This nested case-control study will be conducted using pre- diagnostic blood collected in 1989 as well as information on two separate questionnaires collected from men in Washington County in 1989 and 1996 as part of a large ongoing prospective study. 164 cases who have developed prostate cancer will be compared with 323 controls that are matched on age, gender and were free of other cancers at the time of diagnosis of the case. From the point of view of etiology, findings will aid in the understanding of inherited factors that influence tumor growth and progression in men with prostate cancer. From the point of view of prevention, we may be able to isolate a group of men that are at a higher risk of developing prostate cancer and possibly modify this risk by using drugs such as alphadifluoromethylornithine (DFMO) or green tea that have been shown to inhibit ornithine decarboxylase. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EPIGALLOCATECHIN ANGIOGENESIS
GALLATE,
PROSTATE
CANCER
&
Principal Investigator & Institution: Kim, Myoung; Molec Biology & Immuno; University of North Texas Hlth Sci Ctr Fort Worth, TX 761072699 Timing: Fiscal Year 2003; Project Start 01-SEP-2003; Project End 31-AUG-2005 Summary: (provided by applicant): Prostate cancer (PCA) is a second leading cause of cancer death in men over 65 years old. The progression of PCA from a latent to an aggressive form depends on the loss of androgen-dependency and the acquisition of the angiogenic phenotype. Consumption of green tea has been implicated in the lower incidence of various cancers including PCA in Chinese and Japanese men in a number of epidemiological studies. In recent laboratory studies, green tea catechins have been shown to inhibit the growth of PCA cell lines and the neovascularization in green tea
Studies 29
drinking mice. It has been shown that (-)- epigallocatechin-3-gallate (EGCG), one of green tea catechins, is the most potent in inhibiting tumor cell proliferation and angiogenesis. Tissue hypoxia is a key player in angiogenesis in part via the induction of angiogenic factor expression. It is our hypothesis that EGCG can prevent hypoxiainduced angiogenesis via the inhibition of angiogenic factor expression, ultimately inhibiting cancer cell proliferation and metastatic spread. To our knowledge no prior study has assessed the effect of EGCG on hypoxia-induced angiogenesis. In this application, we will test this hypothesis using human PCA cell lines, LNCaP and DU145, and in vivo studies using a transgenic animal model TRAMP (transgenic adenocarcinoma mouse prostate), that mimics the progressive form of human PCA. We will characterize the effect of EGCG on the expression of angiogenic factors (VEGF, IL-8, endothelin-1) by prostate cancer cells under normoxia and hypoxia. We will also determine if the expression of hypoxia induced factor (HIF)-lc_ and DNA binding activity of HIF-1 transcription factor complex can be regulated by EGCG under normoxia and hypoxia. HIF-l-mediated transcription activation will be investigated in EGCG treated cells under hypoxia. Lastly, we will investigate the angiogenesis and HIFlc_ expression in prostate tumors in TRAMP mice drinking EGCG-containing water. We believe that the outcome of this application will help further our understanding of antiangiogenic mechanism of EGCG and provide preclinical data on EGCG as a complimentary and alternative medicine agent to be used to prevent progression of PCA into angiogenic and metastatic cancer, thus prolonging the survival and quality of PCA patients. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EXPOSURE REDUCTION AND PREVENTION Principal Investigator & Institution: Knize, Mark G.; University of Calif-Lawrnc Lvrmr Nat Lab Lawrence Livermore National Lab Livermore, CA 94550 Timing: Fiscal Year 2002; Project Start 19-APR-2002; Project End 31-JAN-2007 Summary: (provided by applicant): Recent studies estimate that most human cancers result from modifiable lifestyle factors, including diet. Lowering exposure to heterocyclic amines (HAs), which are formed in cooked meats, is an obtainable goal that may have a real impact on cancer incidence. This proposal addresses: 1) safe cooking methods that reduce HA formation, 2) identifying unknown mutagens and establishing their potency, 3) understanding the influence of other foods on reducing human HA absorption, 4) mechanistic studies of inhibition of flavonoids and 5) establishing the relationship between dietary questionnaires and HAs in urine. Meat cooking will be investigated to understand the conditions that reduce the formation of heterocyclic amines while using microbiology to monitor food safety. New, unknown mutagens will be isolated from beef and their amounts determined in a survey of well-cooked foods. Additionally, the parameters responsible for high mutagenic potency in new and existing HAs will be investigated as structure/activity relationships. Since there is human exposure to HAs, we can now investigate HA-diet interactions in individuals via the analysis of urinary metabolites. Exploratory studies will determine if parsley, green tea, and fiber, each shown to be preventative in epidemiology studies, can affect the total human uptake and metabolism of one HA, PhIP. Enticing results in reducing mutations with the flavonoid apigenin compel us to investigate structure/inhibition relationships experimentally and with a computational model. To quantify the dietary dose of heterocyclic amines in the population and in individuals, HA biomarkers will be developed and related to dietary questionnaires that account for diverse cooking practices. In all, this interdisciplinary research to reduce exposure combines toxicology
30 Tea
with analytical chemistry, computational chemistry and physics to investigate heterocyclic amines and human cancer etiology. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EXPRESSION OF MRP2 AND OCTI TRANSPORTERS IN THE KIDNEY Principal Investigator & Institution: Welborn, John R. Biological Sciences; Mississippi State University P. O. Box 6156 Mississippi State, MS 39762 Timing: Fiscal Year 2001; Project Start 01-AUG-2001; Project End 31-JUL-2004 Summary: (Adapted from the Applicant's Abstract): The secretion of many toxic, xenobiotic, or pharmaceutical compounds from the body is a major function of the kidney. Renal secretion of these substances involves the integrated activity of a suite of transport proteins in the basolateral (peritubular) and apical (luminal) membranes of proximal tubules. Renal epithelial cells are often a target for xenobiotic compounds, producing nephrotoxicity, because of the central role that proximal tubules play in secretion. Certain types of cancer cells overexpress polyspecific transport proteins, which increase the efflux of a wide range of chemotherapeutic agents from the cell. This confers multidrug resistance, a significant clinical problem, to these cancer cells because transport activity keeps the cytoplasmic concentrations of the chemotherapeutic agents low. Transporters mediating secretion can be classified according to their substrates, handling either organic anions (OAs) or organic cations (OCs). Historically, most attention has focused on renal secretion processes handling of monovalent, low molecular weight (500 Da), polyvalent, conjugated OAs (such as leukotriene C4, LTC4). The transporters mediated the efflux of these substrates across the apical membrane are termed MRPs, multidrug resistance protein. The MRP isoform expressed in the kidney, and also in liver hepatocytes, is called MRP2 (also called cMOAT). Although both MRP1 and MRP2 overexpression have been associated with multidrug resistance, the physiological role of MPR2 in the kidney is undefined. This proposal will focus on transporters handling large polyvalent OAs (MRP2) and organic cations (OCT1) because there is much less known about the physiological role of these transporters and because of important technical issues. In this proposal experiments are outlined that will establish the relationship between long-term and short-term exposure of proximal tubule cells to MRP2 substrates and OCT substrates in terms of transport activity, transporter protein expression, and transporter mRNA expression. We suggest that transport of LTC4 and TEA will be upregulated in renal cells following extracellular exposure to these substrates. Upregulation of transport is expected to be a result of either transporter activity or transporter abundance. It is also expected that changes in transport will be reflected by parallel changes in mRNA expression. These studies will make use of cultured cell models and intact tubules to understand the characteristics of transporters working within the environment of an intact tubule epithelium. The proposed studies should result in a new, general model of the cellular strategy for increasing secretion in response to long- and short-term exposure to xenobiotic anions, and a more specific understanding of the physiological role of these transporters. The latter studies offer the potential of providing insight into intervention sites to alleviate multidrug resistance. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 31
·
Project Title: STUDIES
FLAVONOID
BIOAVAILABILITY
IN
HUMANS-CELLULAR
Principal Investigator & Institution: Walle, Thomas; Professor; Pharmacology; Medical University of South Carolina 171 Ashley Ave Charleston, SC 29425 Timing: Fiscal Year 2002; Project Start 01-FEB-1998; Project End 31-JUL-2006 Summary: (provided by applicant): The long-term goal of this research program is to increase our understanding of how cellular transport and metabolism influence the oral bioavailability of dietary flavonoids, a large class of compounds that has been implicated to play a major role in the prevention of human diseases, in particular cardiovascular disease and cancer. In Specific Aim 1 we will determine the interrelationships between SGLT1 and MRP2, including mechanisms involved, in the enterocyte absorption of flavonoid glycosides and the tea flavonoids, two main classes of dietary flavonoids. These studies will be undertaken in SGLT1- and MRP2-transfected cells and in the human intestinal absorption model Caco-2. The role of the potentially most important transporter, i.e. MRP2, will be directly examined in vivo in the MRP2deficient Tr- rat. In Specific Aim 2 we will investigate the interrelationships between CYPs, UGTs and SULTs, including the identification of the major isoforms involved, in the hepatic as well as intestinal metabolism of flavonoids. This will be done in microsomes as well as in intact cells, e.g. fresh human hepatocytes. These experiments will allow us to establish the major pathway(s) of metabolism of the flavonoids. In addition, autoinduction of flavonoid metabolism will be examined, mainly focusing on CYPs and UGTs. The importance of the UGT family of enzymes will be directly examined in vivo in the genetically deficient Gunn rat. In Specific Aim 3 we will determine the role and mechanisms of a) bacterial- and b) peroxidase-mediated catabolism of flavonoids, including covalent binding to protein. The experiments in a) will be conducted in gnotobiotic compared to normal rats as well as in samples from an in vivo human study. Complementary in vitro studies will include the identification of the bacterial pathway leading from quercetin to CO2 formation. The experiments in b) will be conducted in vitro, using pure enzymes and subcellular fractions, and then in intact cell systems in which production of reactive oxygen species as well as glutathione levels can be manipulated. Structure identification of metabolites as well as elucidation of covalent binding will be critical factors. The findings from the proposed studies should help us understand the bioavailability of the flavonoids, facilitating optimization of the chemopreventive utility of these natural or synthetic compounds. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: FLAVONOIDS HYPERTIGLYCERIDEMIA
IN
THE
AMELIORATION
OF
Principal Investigator & Institution: Theriault, Andre G. None; University of Hawaii at Manoa 2500 Campus Rd Honolulu, HI 96822 Timing: Fiscal Year 2003; Project Start 01-AUG-2003; Project End 30-APR-2005 Summary: (provided by applicant): The long term goal of this research project is to examine the influence of complementary and alternative medicine (CAM) bioflavonoidrich extracts (i.e. green tea leaf extracts, citrus bioflavonoids, and rutin) on the regulation of hepatic triglyceride-rich lipoprotein production in a hypertriglyceridemic model. Bioflavonoid-rich extracts have been claimed to protect against cardiovascular disease (CVD), in large part through its inhibitory effect on low density lipoprotein (LDL) oxidation. The potential benefit of these compounds in treating hyperlipidemia has also recently been shown in both animal and human studies. However, the molecular
32 Tea
mechanisms for this lipid-lowering action are not fully understood. We have recently shown that a citrus bioflavonoid administered to hypertriglyceridemic-insulin resistant (HIR) hamsters lowered blood triglyceride levels through the inhibition of hepatic microsomal triglyceride transfer protein (MTP) protein expression and diacylglycerol acyltransferase (DGAT) activity. These results are preliminary and need to be confirmed on a larger scale. Nonetheless, these results do unveil a potentially exciting area of research. The role of other lipogenic enzymes in VLDL production needs to be explored. Also, whether or not the assembly and secretion of hepatic apoB100-VLDL is altered need to be addressed. Moreover, it is not known if all bioflavonoids possess a triglyceride-lowering ability. Therefore, the specific aim of this study using both plasma and isolated hepatocytes is to investigate the effect of bioflavonoid-rich extracts on the in vivo and ex vivo VLDL production in HIR hamsters. This will be done by measuring the rate in VLDL secretion in plasma, and by using isolated hepatocytes, the synthesis and secretion of apoB-100 and triglyceride, and lipogenic enzyme expression and activity. By understanding the lipid lowering function of these products, we aimed at providing new information of these commonly used CAM products. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: GREEN KERATINOCYTES
TEA
POLYPHENOL
CHEMOPREVENTION
IN
Principal Investigator & Institution: Eckert, Richard L. Professor; Physiology and Biophysics; Case Western Reserve University 10900 Euclid Ave Cleveland, OH 44106 Timing: Fiscal Year 2002; Project Start 10-JUL-2002; Project End 30-JUN-2007 Summary: (provided by applicant): Cancer begins with a normal cell that, due to persistent environmental insult, is transformed, via a series of progressively more insidious steps, into a cancer cell. A major goal of chemopreventive therapy is to alter the normal cell response to the environmental agent with the goal of inhibiting disease. (-)-Epigallocatechin-3-gallate (EGCG) is an important bioactive antioxidant, derived from tea, that possesses remarkable cancer chemopreventive properties. Most studies with this agent are performed with cancer cells, however, it is equally important to understand whether these chemopreventive effects extend to normal pre-cancerous cells. Our initial studies show that EGCG increases normal keratinocyte differentiation, as assessed by EGCG-dependent up-regulation of involucrin (hINV) promoter activity, and increased cornified envelope formation. The hINV gene provides an ideal tool for studying the mechanism whereby EGCG regulates keratinocyte differentiation. The EGCG-associated response is mediated via an AP1 site within the hINV promoter and appears to involve a MAPK signaling cascade. Based on these results, we hypothesize that EGCG acts to prevent cancer development by promoting keratinocyte differentiation via an AP1 factor-dependent mechanism. The experiments outlined in this proposal are designed to shed light on the mechanism whereby EGCG stimulates keratinocyte differentiation. The ultimate goal is to better understand how green tea prevents skin cancer. Our first goal is to characterize the mechanisms whereby EGCG promotes an AP1-factor-dependent increase in hINV gene expression. To achieve this goal, we will measure EGCG effects on AP1 factor levels, AP1 factor/DNA interaction at the AP1 site, and AP1 factor phosphorylation state. Our second goal is to determine whether EGCG influences the p38 MAPK cascade that regulates hINV gene expression. This will be accomplished by examining the ability of dominant-negative kinases and pharmacologic inhibitors to modulate the EGCG-dependent regulation. Our third major goal is to evaluate whether EGCG can counter a pro-carcinogenic challenge - treatment with UVB. Fourth, it is important to affirm that EGCG has pro-differentiation promoting
Studies 33
properties in epidermis. We hypothesize that EGCG will enhance keratinocyte differentiation in vivo. We will test this hypothesis using a unique series of transgenic mice that encode varying length of the hINV promoter. These studies will make it possible to study the mechanism of EGCG-dependent in vivo regulation. The central goal of this proposal is to gain new information regarding the mechanism of EGCG action. It is hoped that these studies lead to the design of new strategies for enhancing the effectiveness of these agents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: GROWTH CONTROL OF PROSTATE CANCER CELLS BY PLANT PHENOLS Principal Investigator & Institution: Young, Charles Y. Senior Associate Consultant; Mayo Clinic Rochester 200 1St St Sw Rochester, MN 55905 Timing: Fiscal Year 2002; Project Start 04-JAN-2002; Project End 31-DEC-2005 Summary: (provided by applicant): Although significant improvements in early detection and treatment for prostate cancer have been made in the recent years, there are 190,000 newly diagnosed prostate cancer in the U. S. each year. It has been suggested that chemoprevention could be one of most effective ways for combating prostate cancer. Plant phenols are regular constituents of plant foods in human diets. Some of these compounds may have anti-cancer activities that may be useful for prostate cancer prevention. Our preliminary studies clearly showed that selected plant phenols have potent inhibitory effects on the expression and function of the androgen receptor (AR) and other regulatory factors. Androgens/androgen receptor (AR) are important risk factors for prostate cancer development. We hypothesize that tea plant phenols may play a role in repressing the development of prostate cancer by inhibiting the expression and function of the AR and other relevant genes. In this proposal, we will study the molecular mechanism by which plant phenols such as tea polyphenols affect the regulation of expression of the AR gene in prostate cells. Northern, western, and in vitro DNA-protein interaction assays as well as gene transfer experiments will be used to study the effects of tea phenols on the expression of the AR. One major goal of this proposal is to identify polyphenol responsive regulatory factors that influence the expression of AR. A recently developed transgenic mouse prostate cancer model will be used to study preventive effect of plant phenols on prostate cancer that is driven initially by androgens. It is expected this study will provide a solid and in-depth molecular basis for the potential role of plant phenols to inhibit the promotion and development of prostate cancer in humans. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: IDENTIFICATION OF GREEN TEA POLYPHENOL-TARGETED GENES Principal Investigator & Institution: Hsu, Stephen D. Oral Biol/Maxillofacial Path; Medical College of Georgia 1120 15Th St Augusta, GA 30912 Timing: Fiscal Year 2003; Project Start 12-JUN-2003; Project End 31-MAY-2005 Summary: (provided by applicant): Green tea polyphenols appear to be chemopreventive against certain cancers, including oral cancer; but how cancer cells succumb while normal cells survive this polyphenol exposure is not known. Lack of this information prevented clinical uses of polyphenols for oral cancer chemoprevention or treatment. The long-term goal of this investigation is to elucidate the signal pathways and mechanisms by which green tea polyphenols differentially target normal and
34 Tea
malignant cells to direct protective or apoptotic effects. Preliminary data from our laboratories have demonstrated that normal epithelial cells express p57 (KIP2) in response to green tea polyphenols in a dose- and time-dependent manner. We propose a novel concept, that green tea polyphenols are able to activate two pathways: 1) a p57mediated survival pathway, and/or 2) a caspase 3-dependent apoptosis pathway. The hypotheses to be tested is that p57 induction by green tea polyphenols in normal epithelial cells may serve an anti-apoptotic function, absence of the p57 response in malignant cells may result in induction of caspase 3-dependent apoptosis. The immediate goal of this proposal is to identify the survival or apoptotic genes that are regulated by green tea polyphenols. In this proposed project, the survival/apoptosis gene expression profile will be determined following green tea polyphenol exposure, in normal human epidermal keratinocytes and in human oral squamous cell carcinoma cells. Specifically, the levels of p57 expression induced by the most potent green tea polyphenol, (-)- epigallocatechin-3-gallate (EGCG), in normal human epithelial cells will be determined. Using RT-PCR, mRNA stability assay, Northern and Western blot analyses, the relationship between transcription/translation levels of p57 induction and the time/dose of EGCG will be established. The RNA samples at specific time points will be subjeted to gene array analysis and profiling. Not only will the expression profile of those genes that are either activated or suppressed by EGCG in normal or tumor cells, but promising cellular targets for future chemotherapeutic intervention may be identified. Data generated from this proposal may reveal novel drug targets for treatment of head and neck cancer. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: INHIBITION CONSTITUENTS
OF
CARCINOGENESIS
BY
TEA
AND
TEA
Principal Investigator & Institution: Yang, Chung S. Professor Ii & Chair; Chemical Biology; Rutgers the St Univ of Nj New Brunswick Asb Iii New Brunswick, NJ 08901 Timing: Fiscal Year 2001; Project Start 17-SEP-2001; Project End 31-AUG-2006 Summary: (provided by applicant) The inhibitory action of tea (Camellia sinenis) and tea components against carcinogenesis has been demonstrated in animal models. The overall goal of this program project is to elucidate the mechanisms of inhibition of carcinogenesis by tea and the active components involved. The common hypothesis is that tea polyphenols and caffeine, and their metabolites, inhibit carcinogenesis by suppressing cell proliferation and enhance apoptosis via modulating key signal transduction and metabolic pathways. The inhibition of AP-l related signaling pathways and arachidonic acid metabolism will receive major attention. A novel hypothesis to be tested is that tea consumption lowers body fat levels and this effect contributes to the inhibition of carcinogenesis. The themes of the three Projects are as follows: Project 1, "Effects of Tea on the Formation and Growth of Skin Tumors," will investigate the inhibition of skin carcinogenesis in UVB-induced high-risk mice by orally and topically applied tea, caffeine, and EGCG; the mechanisms of growth inhibition and apoptosis induction; and the role of "lowering body fat levels" in anticarcinogenesis. Project 2, "Inhibition of Lung Carcinogenesis and General Mechanistic Studies," will study the entailed mechanisms in vivo and in vitro (especially on the inhibition of signal transduction kinases), the biotransformation and tissue levels of tea constituents, and the biological activities of key constituents and metabolites. Project 3, "Modulation of Signal Transduction Pathways by Tea Components" will focus on mechanisms key? to the inhibition of cell transformation and apoptosis in cell lines by caffeine and polyphenols as well as their derivatives, using cell and molecular biology approaches.
Studies 35
Facilitated by the "Tea Chemistry and Analysis Core" and "Administrative Core, "the three Projects are highly interactive and integrated. Jointly, we intend to make major contributions to the use of tea for the I chemoprevention of cancer. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: INHIBITION OF SPONTANEOUS MUTATION IN MISMATCH MUTATORS Principal Investigator & Institution: Klein, Catherine B. Assistant Professor; Environmental Medicine; New York University School of Medicine 550 1St Ave New York, NY 10016 Timing: Fiscal Year 2001; Project Start 05-JAN-2001; Project End 31-DEC-2002 Summary: Scientific and public interest in the role of a "healthy diet" for prevention of cancer has sparked research on numerous dietary anti-carcinogenesis. However most studies have focused on reduction of mutagenic effects elicited by specific carcinogens. Few investigators have attempted to identify anti-mutagens that are effective in reducing spontaneous mutations may be more relevant to overall lifetime disease prevention than mitigating specific carcinogen effects. Defects in mismatch repair have been identified in patients with hereditary non-polyposis colorectal cancer (HNPCC, Lynch Syndrome II), a condition characterized by an increased spontaneous mutation rate and a high degree of genome instability. This proposal aims to study the ability of several anti- carcinogens, the tomato carotenoid lycopene, soybean extracts, and the green tea polyphenol epigallocatechin-3-gallate (EGCG), to reduce the the high levels of spontaneous mutations observed in mismatch repair deficient human cells. The project uses a novel mismatch repair cell line and a human HNPCC colon cancer cell line to study these agents. Our expertise in measuring low levels of spontaneous mutation rates allows us to investigate the hypothesis that increased spontaneous mutation rates conferred by loss of functional mismatch repair in humans cells may be mitigated by certain dietary components. In aims 1 and 2 we will directly measure the reduction of spontaneous mutation rates by lycopene, soybean products, and EGCG in two cell lines, each defective in one mismatch repair gene, hPMS2 or Hmlh1. Aim 3 will determine whether the same anti-carcinogens can also reduce the observed microsatellite instability that is coordinate with high levels of spontaneous mutations in these repair deficient cells. Aim 4 will evaluate whether our novel hPMS2 mutant cell line has acquired tumorigenic capacity as evidenced by growth in soft agar, and will coordinately evaluate whether this phenotype can be reversed by the addition of anticarcinogens. These studies will provide scientific evidence that dietary components may have protective effects against an important mutator phenotype that is characteristic of many cancers. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: FLAVONOIDS
INTERACTION
BETWEEN
IRINOTECAN
AND
DIETARY
Principal Investigator & Institution: Iyer, Lalitha V.; Sri International 333 Ravenswood Ave Menlo Park, CA 94025 Timing: Fiscal Year 2003; Project Start 18-AUG-2003; Project End 31-JUL-2005 Summary: (provided by applicant): Over 50% of cancer patients use alternative medicines regularly while undergoing chemotherapy. These products, though derived from natural sources, may contain active ingredients that may influence the disposition and/or therapeutic outcome of concomitantly administered chemotherapeutics. This
36 Tea
application will address the issue of drug/botanical interaction between the anticancer agent irinotecan (used against colorectal cancer) and the popular dietary flavonoids from soy (genistein and daidzein) and fruits and vegetables (chrysin and quercetin). Irinotecan has complex dispositional characteristics, with sequential metabolic activation and inactivation steps, biliary and urinary excretion. The PI has studied some of these pathways extensively and has shown that the enzyme UGT1A1 glucuronidates its active metabolite, SN-38, and that the multidrug resistance transporter, pglycoprotein (P-gp), plays a major role in irinotecan's biliary excretion. Flavonoids such as chrysin and quercetin are known inducers of UGT1A1. Our hypothesis are that (i) the selected dietary flavonoids will influence the disposition and toxicity of irinotecan via induction of the glucuronidation (by UGT1A1) of its active metabolite, SN-38; and (ii) induction of UGT1A1 by dietary flavonoids is influenced by genetic differences in the promoter region of the UGT1A1 gene. The specific aims are to (1) investigate the in vivo interaction of soy isoflavones, chrysin and quercetin with irinotecan in rats, (2) determine whether hepatic UGT1A1 induction by flavonoids is responsible for their interaction with irinotecan, and (3) investigate the influence of the TATA polymorphism in the promoter region of UGT1A1 on inducibility by these flavonoids. Aim 1 will involve in vivo pharmacokinetic, biliary, and urinary excretion studies with irinotecan after chronic pretreatment of rats with the selected dietary flavonoids. The potential induction of UGT1A1 will be studied in Aim 2 by measuring SN-38 glucuronidation in hepatocytes and liver microsomes from flavonoid treated rats, as well as by measuring UGT1A1 protein levels. In Aim 3, luciferase reporter assays will be performed to investigate UGT1A1 activity after pretreatment with flavonoids in Hep G2 cells transfected with known polymorphic forms (TA5,TA6,TA7,TA8) of the TATA sequence of UGT1A1. As irinotecan has a narrow therapeutic index, minor changes in its disposition can significantly modify the therapeutic outcome, so this investigation will have major potential benefits to cancer patients and oncologists. This pilot/developmental project will generate significant preliminary results to propose larger (R01) grants being planned by the PI and colleagues on the interaction between natural medications & dietary supplements and conventional chemotherapy, and its pharmacogenetic implications. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: ISOZYME IDENTIFICATION OF METABOLIC PATHWAYS OF HERBALS Principal Investigator & Institution: Gunaratna, P C.; Bioanalytical Systems, Inc. (Basi) 2701 Kent Ave West Lafayette, IN 479061389 Timing: Fiscal Year 2001; Project Start 05-SEP-2001; Project End 31-JUL-2002 Summary: (provided by applicant): This proposal will develop analytical methodology to identify key metabolic pathways and the metabolizing enzymes of botanicals responsible for drug interactions. Initially we will focus on the main active ingredients of widely used botanicals, green tea (epigallocatechin gallate), St. John's wort (hypericin and hyperforin), and milk thistle weed (silybin). Metabolism of these compounds will be investigated in vitro in liver microsomes and expressed human enzymes. Liquid chromatography coupled with tandem mass spectrometry will be used to identify the phase I metabolites. The cytochrome P450 isoforms will be identified using chemical inhibitor probes and specific expressed enzymes. Enzyme kinetic and inhibition parameters of these compounds will be evaluated to predict the interactions with known drugs. A web-accessible, interactive relational database will be developed to include the findings such as specific isoforms, metabolites formed, metabolic reactions
Studies 37
and enzyme kinetics and the inhibition constants of the above standards. The database will be expanded in Phase II to also include in vivo data of botanical extracts and their synergistic effects to provide information to pharmacists and physicians. PROPOSED COMMERCIAL APPLICATION: The procedures and automated methods developed in these studies will be used to provide contract research services to pharmaceutical/botanical industry. The research will result is a database that could be sold to healthcare professionals and pharmaceutical industry. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MATURATION AND MYOGENIC REACTIVITY OF CEREBRAL ARTERIES Principal Investigator & Institution: Geary, Greg G. Physiology and Pharmacology; Loma Linda University Loma Linda, CA 92350 Timing: Fiscal Year 2002; Project Start 01-JAN-2002; Project End 31-DEC-2005 Summary: (provided by applicant): We have shown that maturation increases the magnitude and sensitivity of myogenic reactivity in neonatal cerebral arteries compared to adult mice. Myogenic constriction first appears at 10 mm Hg in cerebral arteries from neonatal mice (5 d) compared to 40 mm Hg in cerebral arteries from adult mice (6-8 wk). Myogenic tone was maintained throughout each step increase in pressure in cerebral arteries from adult mice. In arteries from neonatal nice, myogenic tone was significantly greater at each pressure step compared to response in arteries from adult mice. Wall thickness was similar between groups. In a separate series of experiments, the contractile effect of tetraethylammonium (TEA; a KCa channel blocker) was determined in cerebral arteries from neonatal and adult mice. TEA caused adult and neonatal arteries to constrict; however, constriction in arteries from adult mice was significantly greater compared to arteries from neonatal mice suggesting that KCa channel activity is less in the neonate. Combined, our data suggest that arteries from neonatal mice possess the mechanisms necessary to constrict to increases in pressure. Furthermore, cerebral arteries from neonatal mice develop myogenic tone at lower pressures and to a greater extent compared to arteries from adult mice. Finally, vascular smooth muscle KCa channels modulate myogenic tone in arteries from neonatal mice to a lesser extent compared to arteries from adult mice. These findings have led to the general hypothesis that: maturation decreases the sensitivity and extends the range of pressure-induced myogenic tone of mouse cerebral blood vessels. In order to determine the effects of maturation on myogenic reactivity, pressure, microfluorometry, and electrophysiological experiments will be conducted in arteries taken from newborn (3-5 day) and adult mice (6-8 wk). To determine the relative importance of smooth muscle mechanisms, diameter, intracellular Ca++ and membrane potential experiments will be conducted in endothelium-denuded middle cerebral artery segments. These experiments will enable an unparalleled assessment of the mechanisms whereby maturation affects myogenic reactivity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: MATURATION OF NEURONAL FUNCTION AND ADENOSINE Principal Investigator & Institution: Wakade, Arun R. Professor; Wayne State University 656 W. Kirby Detroit, MI 48202 Timing: Fiscal Year 2002 Summary: (Applicant's abstract): More than 25 years ago we began studying the control of norepinephrine release by using a perfused neuroeffector model and extensively
38 Tea
characterized the physiological, pharmacological and biochemical properties of transmitter release. We extended investigations to include mechanisms at the cellular level by developing a model of cultured sympathetic neurons (SN) from chick embryo. We have established that NGF-supported SN take up tritiated norepinephrine (3H-NE), which can be released by physiologically relevant electrical stimulation. SN express classical ion channels, membrane receptors coupled to second messenger systems and Ca2+-dependent, regulated transmitter release. Agents which affect voltage-dependent Ca2+ entry or second messenger levels affect 3H-NE release in the expected manner. Thus, chick SN in culture are an excellent model of SN in vivo. However, we have noted three surprising and important differences in release properties in SN in culture compared to their counterparts in perfused organs. First, background release of transmitter in the non-stimulation period is low in sympathetic effector organs, but relatively high in cultured SN. Second, electrically evoked release is proportional to stimulation frequency in intact organs, but in cultured SN maximum release occurs at low frequency and does not increase with frequency. Third, the K+ channel blocker tetraethylammonium (TEA) greatly enhances release in neuroeffector organs, but has little effect on evoked release of 3H-NE in cultured SN. However, these abnormal release properties can be corrected when SN are co-cultured with cardiac cells. We have further demonstrated that cardiac cells cause a change in voltage-dependent Ca2+ entry and/or handling in neuritic regions of SN (sites of transmitter release) and modulate K+ currents in a manner which accounts for the changes in 3H-NE release properties. Most recently, we have discovered that chronic treatment of SN with adenosine (Ado) mimicks some effects of cardiac cells on SN release properties. Thus, Ado may well be the agent released by cardiac cells and responsible for modulation of Ca2+ handling and transmitter release in co-cultured SN. This proposal is intended to test this hypothesis and establish a new physiological role for Ado as a trophic molecule necessary for functional maturation of SN during development. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MECHANSIM ANGIOGENESIS
OF
TEA
CATECHIN'S
INHIBITION
OF
Principal Investigator & Institution: Meydani, Mohsen; Professor of Nutrition; None; Tufts University Boston Boston, MA 02111 Timing: Fiscal Year 2002; Project Start 05-JUN-2002; Project End 31-MAY-2004 Summary: (provided by applicant): Epidemiological data and experimental studies suggest that catechins of black or green tea with potent antioxidant activity have anticancer properties. Catechins can contribute to cancer prevention not only by the reduction of tumor cell growth, migration and invasion, but also by the inhibition of angiogenesis, an obligatory process for tumor growth. However, the exact molecular mechanism by which green tea catechins inhibit angiogenesis is not known. Using our in vitro tube formation assay by the human microvascular endothelial cells (HMVEC), we have tested the inhibitory effect of catechins on vascular endothelial growth factor (VEGF} signaling during angiogenesis. VEGF signaling is a multicomponent complex comprising vascular endothelial (VE)-cadherin/ b-catenin,/VEGF-receptor 2 (Flk1/KDR)/ phosphatidylinositol 3'(PI3)-kinase. Specifically, we have found that green tea catechins' inhibition of angiogenesis in HMVEC is mediatedl: 1) by disruption of vascular endothelial (VE)-cadherin/b-catenin complex, and inhibition of Akt phosphorylation, a downstream molecular pathway implicated in angiogenesis, and 2) by inhibition of oxidative stress-induced interleukin (IL)-8 production, a potent angiogenic factor. However, the exact molecular target(s) of catechins on the inhibition
Studies 39
of angiogenesis is yet to be elucidated. Given our data we propose the following model: Green tea catechins inhibit angiogenesis through disruption of VE-cadherin/b-catenin complex. The loss of complex formation results in inhibition of VEGF signaling and IL-8 gene expression. We propose to examine this model by testing the hypothesis: a) Green tea catechins disrupt VE-cadherin/ VEGF-receptor/ PI3-kinase complex formation. This hypothesis will be tested by co-immunoprecipitation assays and Western blots; b) Green tea catechins inhibit VEGF-induced PI3-kinase activation. This hypothesis will be examined by the PI3-kinase activity assay; c) Green tea catechins inhibit VEGF-induced IL-8 activation, and that this inhibition is mediated through a decrease in the PI3kinase/Akt pathway leading to decrease of NF-kB activation. This hypothesis will be tested by blocking the PI3-kinase/Akt pathway using wortmanin inhibition and measuring IL-8 production, IL-8 mRNA expression, and NF-kB activation. Validation of this model would help in better understanding the specific molecular targets of tea catechins' induced inhibition of angiogenesis and in developing future studies to develop cost-effective strategies to fight against cancer. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MODULATION OF CIGARETTE SMOKE INDUCED OXIDATIVE DAMAGE Principal Investigator & Institution: Fiala, Emerich S. Chief, Division of Molecular Biology; Institute for Cancer Prevention 1 Dana Rd Valhalla, NY 10595 Timing: Fiscal Year 2001; Project Start 17-JUN-1996; Project End 28-FEB-2006 Summary: Previously, we found that inhalation of cigarette smoke by guinea pigs fed a diet deficient in ascorbic acid (AA), induced nitric oxide synthase (iNOS), and increased the respiratory levels of 3-nitrotyrosine (3-NT) and 8-oxodeoxyguanosine (8-oxo-dG). All of these effects, indicative of inflammation and of protein and DNA damage, were significantly decreased in guinea pigs fed a diet high in AA. The work proposed here is a logical extension of these findings. We postulate that cigarette smoke-derived oxidants, probably H2O2 and/or peroxynitrite, activate the transcription factors NFkappaB and AP-1, and that this is an anti- apoptotic, tumor promoting event. We further propose that the activation of NF-kappaB and AP-1 will be inhibited by anti-oxidants, specifically AA, vitamin E, and the tea polyphenol, (-)-epigallocatechin gallate, given singly or in combination in the diet. To test these hypotheses, we propose short term (approximately 40 day) cigarette smoke inhalation studies in which we determine changes in the levels of DNA 8-oxo-dG, 8- nitroguanine and selected etheno adducts, and the modulation of NF- kappaB, AP-1, c-myc, matrix metalloproteinase-9, iNOS, 3NT, cell proliferation and apoptosis in the guinea pig respiratory system, and the effects on these factors by dietary antioxidants. Specific Aim 1 will furnish basic information on the time courses of formation and loss of 8- oxo-dG, ethene adducts and 8-nitroguanine in lung DNA, The studies in Specific Aims 2 and 3 will give information on the degree of activation of inflammation- and tumor promotion-related transcription factors NFkappaB, AP-1 and c-myc, and on the consequences of such activation, including induction of matrix metalloproteinase-9 and iNOS, the appearance of 3-NT in protein, appearance of 8-oxo-dG, ethano adducts and 8-nitroguanine in lung DNA, and in changes in cell proliferation and apoptosis. Studies will then be undertaken to determine how these molecular marker changes in cell proliferation and apoptosis. Studies will then be undertaken to determine how these molecular markers are affected by dietary antioxidants, and whether the effects of the antioxidants, when given in combination, are either null, additive, or synergistic. As Specific Aim 2, we will continue the development of a method for the quantitative determination of 3-NT. The extension
40 Tea
of this method, which has a sensitivity in the femtomol range for 3-NT (a marker for peroxynitrite-induced damage to proteins), to the array of 8- nitroguanine (a marker of peroxynitrite-induced damage to DNA), and to nitrated benzene metabolites generated in Project 2, will also be examined under this Aim. The results of our studies will read to a better understanding of the relationship of chronic respiratory inflammation to cigarette smoke-induced cancers, and the influence of dietary anti- oxidants. We expect that conclusions drawn into our research will be directly translatable to simple dietary intervention strategies in those smokers unable to quit. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MODULATION OF OXIDATIVE DAMAGE BY TEA POLYPHENOLS Principal Investigator & Institution: Wang, Jia-Sheng; None; Texas Tech University Health Scis Center Health Sciences Center Lubbock, TX 79430 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2003 Summary: (provided by applicant) The primary objective of this research project is to study the modulating effects of green tea polyphenols on reducing hepatocarcinogeninduced oxidative damages in high-risk human populations. Oxidative damage induced by reactive oxygen species in vivo plays important roles in human hepatocarcinogenesis primarily caused by chronic infection of hepatitis B/C viruses and exposure to dietary aflatoxins. The level of 8-hydroxy-2'- deoxyguanosine, a biomarker for oxidative DNA damage, increases in hepatitis B virus surface antigen positive and aflatoxin-exposed humans and in aflatoxin- treated animals. Dietary antioxidants are important components of cancer modulating agents, which have been proven to effectively target carcinogen biomarkers, including oxidative damages, in high-risk human populations. Among various identified dietary associated antioxidants, green tea and its polyphenols have been shown to be safe and highly effective in inhibition of a variety of carcinogeninduced oxidative damages, mutagenesis, and tumorigenesis in in vitro bioassays and in vivo animal models. The general hypothesis underlying this proposal is that green tea polyphenols have a protective effect against oxidative stress or damage induced by aflatoxin and hepatitis B/C viruses through the mechanisms of modulating aflatoxin metabolism and oxidated DNA damage. The specific aims include: (1) to determine antioxidative role of green tea polyphenols in inhibition of the level of 8-hydroxy-2'deoxyguanosine in urine samples collected from an intervention study of 120 participants who are double positive for hepatitis B virus surface antigen and aflatoxinalbumin adducts, and (2) to determine the modulating effect of green tea polyphenols on excretion of carcinogen detoxifying product, aflatoxin Bl-mercapturic acid in urine samples collected from the study participants. The results of this proposed study will help to understand the mechanisms of antioxidative role of tea polyphenols in modulating human hepatocarcinogenesis caused by hepatitis B/C viruses and aflatoxins. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: MODULATION OF SIGNAL TRANSDUCTION PATHWAYS BY TEA Principal Investigator & Institution: Dong, Zigang; Professor; Rutgers the St Univ of Nj New Brunswick Asb Iii New Brunswick, NJ 08901 Timing: Fiscal Year 2001; Project Start 17-SEP-2001; Project End 31-AUG-2006 Summary: (provided by applicant): The hypothesis to be tested in this Project is that caffeine, caffeine metabolites and tea polyphenols and their metabolites inhibit cell transformation, and tumor phenotype, and induce apoptosis synergistically or
Studies 41
additively through targeting different signal transduction molecules. Caffeine, tea polyphenols and other tea components have been shown to inhibit carcinogenesis in rodent and cell culture models. Our goal in this Project is to identify the molecular mechanisms/targets of anti-tumor effects exhibited by caffeine and its metabolites, tea polyphenols and their metabolites, and other tea components. We will use the JB6 mouse epidermal cells, a transformed mouse tumor cell line (RTIOl), a keratinocyte carcinoma cell line (PDV), and cells derived from gene knockout mice (e.g., p53 minus) to examine the anti-tumor promotion and anti-tumor phenotype activity of tea polyphenols, caffeine and their derivatives. The specific aims to address the hypothesis are: (1) To investigate the inhibition of cell transformation by caffeine, tea polyphenols, their metabolites, and their combinations in cell lines (JB6, RTIOl and PDV). (2) To determine whether inhibition of tumor promoter-induced cell transformation by caffeine metabolites, EGCG, and their combinations is through the modulation of AP-l, NF-kB or other signal transduction pathways. (3) To determine whether apoptosis is involved in the inhibition of cell transformation by caffeine, tea polyphenols and their metabolites and to determine which signal transduction mediates the induction of apoptosis. (4) To determine the structure-effect relationship of caffeine derivatives for inhibition of AP-1 and NF-kB activities and cell transformation. We have established experimental conditions through preliminary studies. These molecular mechanism studies are designed to lead to the development of better chemopreventive agents and to design more effective chemoprevention trials. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS Principal Investigator & Institution: Stratton, Steven P. Research Assistant Professor; None; University of Arizona P O Box 3308 Tucson, AZ 857223308 Timing: Fiscal Year 2001; Project Start 01-AUG-2000; Project End 31-JUL-2005 Summary: (Applicant's Description) Prevention is the most efficient way to reduce the incidence, morbidity, Nd mortality of cancer. Thus, development of new investigators in cancer prevention research is imperative. Steven P. Stratton, Ph.D. is a junior investigator in the field of cancer prevention; with training in analytical chemistry, toxicology, pharmacology, cancer therapeutics, cancer drug development, and cancer prevention epidemiology. The mentored training supported by this award will facilitate the development of Dr. Stratton into a fully independent investigator. This project will be conducted at the Arizona Cancer Center, a National Cancer Institute-designated comprehensive cancer center with an international reputation for excellence in cancer prevention research. The proposed studies will be performed under the aegis of the Chemoprevention of Skin Cancer Program Project at the University of Arizona. This project will focus on skin cancer chemoprevention mechanisms with polyphenolic derivatives of tea, Camellia sinensis. Green tea is one of the most widely consumed beverages in the world. Many studies both in vivo and in vitro suggest that polyphenolic compounds present in tea inhibit skin carcinogenesis, though the mechanism of action is still unknown. An understanding of this mechanism is crucial to the development of chemopreventive strategies using these compounds. This project will test the hypothesis that green tea polyphenols prevent UV radiation-induced skin carcinogenesis by modulating reactive oxygen-mediated alterations of normal cell function. Markers of reactive oxygen and secondary membrane damage will be used to explore the role of tea polyphenols in UV-induced skin cell transformation using human keratinocytes in vitro and an in vivo mouse skin model. The specific aims of this project
42 Tea
include analyzing the effects of green tea polyphenols on: (1) Cell membrane lipid peroxidation using new sensitive and specific GC/MS assays to quantify levels of oxidized biomolecules; (2) Cell cycle progression and expression of cell cycle control genes using flow cytometry and RNase protection techniques; (3) Regulation of transcription factor activation using an alkaline phosphatase reporter system; and (4) Apoptosis and translocation of relevant transcription factors using in situ molecular imaging techniques. Changes in levels of these markers will be used to establish links between antioxidant effects of tea polyphenols and possible direct effects on redoxsensitive downstream events. The overall goal of this project is to promote the development of an academic research career in cancer prevention within a framework of molecular chemoprevention mechanistic studies and training. Immediate goals include acquiring the scientific and technical expertise necessary for independent investigations of secondary cancer prevention mechanisms. Long-term career goals include development of new methods, assays, and expertise in redox-modulated biochemical processes; establishment of a molecular chemoprevention laboratory; development of collaborative research programs in molecular mechanisms of cancer prevention; and ultimately, development of chemopreventive therapies that reduce cancer morbidity and mortality. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MOLECULAR MECHANISMS OF PHENOLIC AGENT-INDUCED APOPTOSIS Principal Investigator & Institution: Kong, Tony Ah-Ng. Professor; Pharmaceutics; Rutgers the St Univ of Nj New Brunswick Asb Iii New Brunswick, NJ 08901 Timing: Fiscal Year 2002; Project Start 01-APR-2002; Project End 31-MAR-2007 Summary: (provided by applicant): Many studies have shown the inhibitory effect of polyphenolic compounds including green tea catechins (-)epigallocatechin 3-gallate (EGCG) against carcinogenesis in rodent models. These include cancers of the colorectal, liver, lung, skin, small intestine, and mammary gland. Our hypothesis is that the cancer chemoprevention effect of tea polyphenolic components such as EGCG, is through induction of apoptotic mechanisms involving the mitogen-activated protein kinases (MAPK) pathway, and the caspases pathway. The overall goal of this project is to identify the molecular mechanisms/targets of apoptotic signaling molecules exhibited by EGCG and other tea polyphenols. Such knowledge will help to develop better chemopreventive agents and to design more effective cancer chemoprevention clinical trials. To test this hypothesis, we will use different cell culture models with the following specific aims: (1) To investigate whether the activation of the MAPK (ERK, JNK, and p38) pathway by EGCG and other tea polyphenols in two human tumor cell line models (cervical squamous carcinoma HeLa, and colon HT29) is involved in apoptosis. Transfection studies with various cDNA constructs encoding for the MAPK cascade as well as structure-activity relationship of the tea polyphenols in MAPKinduced apoptosis will be performed. (2) To determine whether the stimulation of the caspase (the mitochondria-cytochrome c release pathway and the nonmitochondriacytochrome c release pathway) pathway induced by EGCG and other tea polyphenols in the two human tumor cell lines (HeLa and HT29) is involved in apoptosis. Transfection studies with cDNAs encoding the anti-apoptotic proteins (Bc12 and CrmA) and proapoptotic proteins (death receptors -Fas, TNFR, DR4/5, and Bax, Bid) as well as structure-activity relationship of the tea polyphenols in caspase-induced apoptosis will be performed. These studies will complement the studies in Aim 1 and will provide further understanding of the apoptotic signaling mechanisms of tea polyphenolic
Studies 43
compounds. Our long-term goal is to identify the molecular targets of the chemopreventive effect exhibited by EGCG and other tea polyphenols. Such knowledge will help to develop better chemopreventive compounds and to design more effective cancer chemoprevention clinical trials. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MOLECULAR TARGETS FOR PREVENTION OF CANCER BY GREEN TEA Principal Investigator & Institution: Mukhtar, Hasan; Professor, Vice Chair and Director of Re; Dermatology; University of Wisconsin Madison 750 University Ave Madison, WI 53706 Timing: Fiscal Year 2003; Project Start 12-JUN-2003; Project End 31-MAY-2008 Summary: (provided by applicant): In recent years, green tea has gained considerable interest as an agent that could reduce the risk of several cancer types. Data on cancer chemopreventive effects of green tea in many animal tumor model systems is convincing. The cancer chemopreventive effects of green tea appear to be mediated by its polyphenolic constituents (-) epigallocatechin-3-gallate (EGCG). Based on geographical observations and epidemiological evidence where Japanese and Chinese populations consuming green tea on a regular basis have the lowest incidence of PCa in the world, we hypothesized that green tea or its constituents are effective for chemopreventition of PCa. To test this hypothesis we initiated a program on chemoprevention of PCa by green tea. In our recent studies (Proc. Natl. Acad. Sci. USA 98:10350-5, 2001), employing a transgenic adenocarcinoma of the mouse prostate (TRAMP), a model that mimics progressive form of human prostatic disease, we have shown that oral infusion of a polyphenolic fraction isolated from green tea, at a human achievable dose (equivalent to six cups of green tea per day), significantly inhibits PCa development and its metastasis. One significant observation from this study was that oral infusion of green tea polyphenols resulted in an increased cancer free and overall survival of TRAMP mice. We extended these studies and more recently found that oral feeding of green tea polyphenols as the sole source of drinking fluid to TRAMP mice results in significant inhibition of vascular endothelial growth factor and matrix metalloproteases (MMP-2 and MMP-9) in dorsolateral prostate. This is an important observation suggesting the involvement of inhibition of angiogenesis and matrix degradation during green tea-mediated PCa chemoprevention. Of relevance to PCa, is the fact that once activated via certain stimuli, MMPs degrade insulin-like growth factor (IGFBP) resulting in the release of insulin-like growth factor (IGF). The present proposal capitalizes on our recent novel findings. The central hypothesis to be tested in this proposal is that "EGCG imparts chemopreventive and possibly cancer therapeutic effects against PCa and its metastasis via MMP inhibition-mediated modulation in IGF/IGFBP-3 autocrine/paracrine loop". Under the proposed specific aims we will investigate i) the chemopreventive potential of EGCG against the markers of angiogenesis and metastasis in human prostate carcinoma cells, ii) the chemopreventive potential of EGCG against PCa metastasis and angiogenesis under in vivo situation in athymic nude mice implanted with PCa cells, and in TRAMP mice and iii) the chemotherapeutic potential of EGCG against PCa metastasis and angiogenesis under in vivo situation in athymic nude mice implanted with PCa cells, and in TRAMP mice. Successful completion of this project will define the molecular targets for PCa Chemoprevention by EGCG a major objective of this RFA. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
44 Tea
·
Project Title: MULTI STEP TUMORIGENESIS, CONTROL OF CELL CYCLE ENTRY Principal Investigator & Institution: Land, Hartmut; Director, Center for Cancer Biology; Genetics; University of Rochester Orpa - Rc Box 270140 Rochester, NY 14627 Timing: Fiscal Year 2001; Project Start 01-MAR-2001; Project End 28-FEB-2006 Summary: Carcinogenesis is caused by multiple co-operating genetic lesions leading to a progressive deregulation of cellular signaling and cell cycle restriction point control. The mutations involved result in oncogene activation or loss of tumor-suppressor gene function. However, the mechanisms by which these mutant genes co-operate in malignant cell transformation are largely unknown. Our laboratory has shown that the co-operation of oncogenic lesions involves integration of multiple signals converging on the regulation of cell cycle-dependent kinase complexes. Here we propose to investigate the molecular mechanisms by which the c-myc oncogene co-operates with activated Ras/Raf signaling. The c-myc oncogene is frequently activated in human cancer and is a potent inducer of proliferation and apoptosis. One essential step in Myc-induced proliferation is the activation of Cyclin E-dependent kinase (Cyclin E/Cdk2). Using genetic and biochemical approaches in tissue culture, we recently made the surprising finding that activation of cyclin E/Cdk2 by c-myc requires the ability of D cyclins to sequester Gl cell cycle inhibitors p27Kip1 and p21Cip1 (Ckis). We now propose to investigate whether the capability of D cyclins to sequester Ckis plays an important role in the induction of cell division by activated c-myc in an intact organism. Moreover, we plan to tea the hypothesis that sequestration of Ckis by D cyclins may play a significant role in organ development and during multi-step carcinogenesis. This work will provide insight into developing signaling pathway-based strategies for cancer therapy in humans. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: PHASE II TRIAL OF POLYPHENON E IN FORMER SMOKERS Principal Investigator & Institution: Lam, Stephen L.; University of Cincinnati 2624 Clifton Ave Cincinnati, OH 45221 Timing: Fiscal Year 2003; Project Start 23-MAY-2003; Project End 30-APR-2008 Summary: The main purpose of this project is to evaluate, in a double blind, randomized, placebo controlled clinical trial, the chemopreventive efficacy and safety of a very promising food supplement - Polyphenon E (decaffeinated green tea polyphenol mixture), in smokers with bronchial intraepithelial neoplasia (IEN). 2,574 former heavy smokers (> 30 pack-years) > 45 years of age without evidence of overt lung cancer will be recruited over a 42 months period by an experienced clinical trial team with a track record of completing several consecutive NCI-sponsored chemoprevention trials on schedule. A unique sputum induction method combining high frequency chest wall oscillation and hypertonic saline nebulization will be used to reduce unsatisfactory sputum samples rate to 1.2 mm (bigger than the size of a bronchial biopsy). Onehundred and ten subjects with one or more IEN lesions >1.2 mm will receive Polyphenon E 1.6 g daily/Placebo for 6 months. The primary endpoint of the study will be combined nuclear morphometry and histopathology on bronchial biopsies before and 6 months after treatment. This surrogate endpoint biomarker (SEB) was developed and refined through several previous NCI sponsored trials. An innovative optical imaging technology - confocal microendoscopy, will be developed as a non-biopsy method to assess the effect of chemopreventive agents. Methylation of several biomarkers in sputa, bronchial brushes as well as BAL cells will be tested as SEB in central and peripheral airways and in surrogate organs using quantitative real time PCR. The extent to which
Studies 45
clinical-pathological response, modulation of cell cycle, cellular proliferation, and apoptosis in human can be correlated with those in animal tumor models will be determined by measuring the same biomarkers in the A/J mouse and hamster lung tumor models before and after treatment with Polyphenon E. The results will provide new information on the efficacy and safety of Polyphenon E for the chemoprevention of lung cancer. It will also provide new information on the use of SEBs for assessing the effect of chemoprevention. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PILOT STUDY--RED WINE /GREEN TEA & CELL CYCLE CONTROL Principal Investigator & Institution: Eto, Isao; University of Alabama at Birmingham Uab Station Birmingham, AL 35294 Timing: Fiscal Year 2003; Project Start 09-SEP-2003; Project End 31-AUG-2008 Summary: Objective: Laboratory studies with animals and cells in culture have shown cancer preventive activity of polyphenols isolated from red wine and green tea. However, the basic molecular mechanisms by which these polyphenols inhibit carcinogenesis have not been completely elucidated. The objective of this study is to use two of these polyphenols (resveratrol and epigallocatechin gallate (EGCG) (and investigate their effects on the cell cycle control of G1-to-S phase transition, a critical molecular event in the carcinogenic process. Two series of cells in culture will be used for this study: (1) JB6 mouse epidermal cells and (2) mammary epithelial cells. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: PILOT--GREEN TEA POLYPHENOL GENE EXPRESSION IN PROSTATE Principal Investigator & Institution: El-Galley, Rizk; University of Alabama at Birmingham Uab Station Birmingham, AL 35294 Timing: Fiscal Year 2003; Project Start 09-SEP-2003; Project End 31-AUG-2008 Summary: There is no text on file for this abstract. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: POLYPHENOLS AND CANCER Principal Investigator & Institution: Morre, D James. Dow Distinguished Professor; Purdue University West Lafayette West Lafayette, IN 479072040 Timing: Fiscal Year 2001 Summary: Our laboratories have identified a tumor- (cancer-) associated growth protein, tNOX, as a target for (-)-epigallocatechin gallate [EGCg], the principal anticancer tea catechin, to help explain the potential anti-cancer benefits of tea. NOX proteins are located at the cell surface and are responsible for the increase in cell size following cell division. Cells in which NOX activity is blocked are unable to enlarge in vitro. Therefore, they cease to divide and, after several days, undergo programmed cell death (apoptosis). The cancer-specific tNOX protein which is the potential tea target, differs from the non-cancer of constitutive CNOX protein primarily in its response to tNOX-targeted anti-tumor substances such as EGCg. At therapeutic doses such drugs slow the growth of cancer cells and inhibit tNOX but not that of CNOX and growth of non-cancer cells. The lack of effect on non-cancer but rapidly proliferating cells provides compelling evidence for the cancer specificity of the tNOX- response to EGCg and other tea catechins. This project is to utilize new information on synergy among polyphenols
46 Tea
in inhibiting tNOX and tumor growth to modify the activity of EGCg through combination of tea with other botanicals enriched, for example, in anti-cancer vanilloids and epicatechins. Also research will be done to identify the determinants of anti-cancer polyphenole bioavailability to include development of appropriate methodology. Basic studies will focus on 1) the mechanisms of catechin inhibition of cancer cell growth and induction of apoptosis, 2) the mechanism of cancer specificity of EGCg and 3) the basis of anti- cancer synergy among vanilloids, epicatechin and other polyphenols. Emphasis will be on development of clinically useful polyphenol compositions with health benefits in both cancer treatments and prevention. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: POLYPHENOLS AND INFLAMMATION Principal Investigator & Institution: Barnes, Stephen; Professor; Purdue University West Lafayette West Lafayette, IN 479072040 Timing: Fiscal Year 2001 Summary: Polyphenols are common constituents in botanical preparations available in over-the-counter preparations as well as in foods which are being recommended as being heart-healthy or cancer preventing. Although best known as antioxidants, their mechanisms of action also appear to include the estrogen receptor system and inhibition of protein kinases that form part of signal transduction cascades. However, the low blood concentrations of free polyphenols in blood are not consistent with their observed effects in animal models of chronic disease. This suggests that further metabolism occurs in the vicinity of the cells affected by the chronic disease, Since chronic disease is characterized by local production of oxidants, we hypothesize that the polyphenols are converted by the oxidants to novel metabolites with increased biologic activity. Specifically, we propose that polyphenols react with hypohalogenous acids (HOCl and HOBr) and with and with peroxynitrite to produce halogenated products. Using soy isoflavones as a model, we have already shown that they form mono- and dichlorinated and nitrated derivatives both in vitro and in cells induced to have respiratory bursts. The goals of this project are to determine (1) the products and rates of reaction of polyphenols with HOCl, HOBr and ONO2- using LC-MSMS and NMR; (2) the kinetics of the formation of halogenated and nitrated products of polyphenols and their physiological metabolites by inflammatory cells; (c) whether nitrated and/or halogenated polyphenols are found in tissue sites in animal models of cells; (3) whether nitrated and/or halogenated polyphenols are found in tissue sites in animal models of inflammatory disease; and (4) the effect of halogenation of polyphenols on their biochemical and biological action in model systems (cell proliferation, arterial vessel relaxation, EGF receptor autophosphorylation and estrogen receptor-dependent reporter gene expression). The polyphenols chosen for these experiments will be those that are the subject of research in the other main projects (daidzein and genistein) [Project 1], quercetin, reveratrol, and pro-anthrocyanins [Project 2] and tea polyphenols [Project 3]. In particular, the known metabolites of these polyphenols will be investigated. Polyphenols will be investigated. Polyphenols in botanical preparations developed via the activities of the Cores and the Pilot projects will also be evaluated in years 2-5. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 47
·
Project Title: POLYPHENOLS--MAMMARY CHEMOPREVENTION
&
PROSTATE
CANCER
Principal Investigator & Institution: Lamartiniere, Coral A. Professor; University of Alabama at Birmingham Uab Station Birmingham, AL 35294 Timing: Fiscal Year 2003; Project Start 09-SEP-2003; Project End 31-AUG-2008 Summary: Epidemiology and laboratory investigations suggest that soy, tea and grapes can have beneficial effects on human health, including breast and prostate cancers. Significant components of these foods are the polyphenolic compounds genistein, (-)epigallocatechin-3-gallate (EGCG) and resveratrol. These compounds were part of the diet of Asians who, following emigration to the United States and adoption of a western diet, lose protection against breast and prostate cancers. In the laboratory, it has been demonstrated that early life (prepubertal) genistein treatment alone programs against chemically-induced mammary cancer in rats. The cellular mechanism of genistein action has been shown to be linked to mammary gland and cell differentiation, thereby identifying potential gene and protein targets of genistein. The goal of this proposal is to investigate the potential of pure polyphenols, alone and in combination, to protect against breast and prostate cancers, with the emphasis on early dietary intervention for programming against mammary and prostate cancers, and to identify the signalling and others pathways by which the polyphenols have their effect. We will test the hypothesis that exposure to combinational polyphenolic nutrients will result in life-time additive or synergistic chemoprotective effects against these cancers. Our specific aims are: A) to investigate the potential of the polyphenols, genistein, EGCG and resveratrol, alone and in combination, to protect against chemically-induced mammary cancer in a rat model and spontaneously developing prostate cancer in a transgenic mouse model (TRAMP); B) to investigate the potential of these polyphenols to enhance mammary and prostate gland maturation and cell differentiation, and to regulate cell proliferation; C) to perform gene expression analyses in mammary glands/epithelial cell preparations of rats and prostates of mice exposed to polyphenols using high-density oligonucleotidebased GeneChips from Affymetrix and spotted oligonucleotide arrays; and D) to identify protein profiles that are differentially expressed in mammary glands of rats and prostate of TRAMP mice treated with polyphenols using proteomics technology. Determination of genes and proteins modulated by nutrient polyphenols at a critical stage of development will identify genetic pathways that play a role in determining cancer susceptibility. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PRECLIN. MODEL FOR PREVENTION OF NSCLC IN FORMER SMOKERS Principal Investigator & Institution: Schuller, Hildegard M. Distinguished Professor; Pathobiology; University of Tennessee Knoxville Knoxville, TN 37996 Timing: Fiscal Year 2003; Project Start 01-MAY-2003; Project End 30-APR-2006 Summary: (provided by applicant) The central hypothesis of this application is that growth regulating pathways expressed in human and mouse alveolar type II cell pulmonary adenocarcinomas (PAC type II) and in human and hamster pulmonary squamous cell carcinomas (SQCs) are antagonistic to those expressed in human and hamster Clara cell type pulmonary adenocarcinomas (PACCs). Chemoprevention studies applicable to former smokers therefore need to use models representing these differently regulated cancer types. Non-invasive methods need to be developed that allow to monitor the expression levels of these pathways in former smokers to asses
48 Tea
response to treatment and to ensure assignment of individuals to effective chemopreventive treatments while avoiding potentially cancer promoting agents. To achieve these goals in a preclinical setup, our specific aims are as follows: 1) We will characterize the effects of green tea, theophylline, beta-carotene, retinol, glucocorticoid beta- blockers, cAMP antaogonists, and inhibitors of cyclooxygenase-2 (COX-2) or 51ipooxygenase (5-.LOX) in human lung cancer cell lines derived from PAC type II, PACC or QSQC and in non-tumorigenic and tumorigenic mouse PAC type II cell lines. 2) We will synthesize iodine-125 and -123-labeled analogues of inhibitors of COX-2, cAMP-dependent PKA and 5-LOX for use in micro-photon emisssion tomography (micro-SPECT). We will verify the binding of these analogues to their cellular targets by in vitro binding assays, using human lung cancer cell lines characterized under aim 1 and by in vivo bio-distribution studies, using mice carrying xenographs of these human lung cancer cell lines. 3) We will study the chemopreventive effects of selected agents from aim 1 in bioassay experiments, using the A/J/mouse PAC type II model, the hamster PACC model and the hamster SQC model. The experimental designs will simulate chemoprevention in former smokers by starting the chemopreventive treatments at the time when tumor induction treatment has been discontinued and precancerous lesions are present in the animals. Evaluation of data will include histopathology, including immunostains for COX-2, PKA and 5-LOX as well as analysis of protein expression of these enzymes by Western blots in normal cells of origin of the induced tumors, premalignant lesions, and in lung cancers harvested by laser capture microscopy. 4) Using the iodine-125-1abeled analogues from aim 2, we will conduct micro-SPECT analysis of five randomly chosen animals per treatment group of aim 3 before, during and after completion of chemopreventive treatments and we will attempt to quantitate levels of COX-2, PKA, and 5-LOX in lung tissues and lung tumors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PRECLINICAL EVALUATION OF BLACK TEA EXTRACTS Principal Investigator & Institution: Evans, David A.; Wellgen, Inc. C/O Rutgers UnivCaft New Brunswick, NJ 08901 Timing: Fiscal Year 2002; Project Start 25-SEP-2002; Project End 31-MAR-2003 Summary: (provided by applicant): Many claims suggesting health beneficial effects of black tea and its components exist in the scientific and lay literature. One such presumed health benefit of tea consumption is decreased risk of cancer. In the United States, each year there are 93,800 new cases and 47,700 deaths due to colon cancer. Among cancer diseases, the evidence for the importance of diet and nutrition is strongest for colon cancer. Therefore, there is a need to find ways to prevent this disease. The overall goal of WellGen, Inc. is to find and develop value-added dietary supplements using sound scientific information. This proposal, entitled "Preclinical Evaluation of Black Tea Extracts" is consistent with our primary goal. Scientific information will be generated in model systems before evaluation in humans. Based on this knowledge, black tea dietary supplements will be developed. Black tea extracts, theaflavin mixtures derived from green tea, and purified chemicals that occur in black tea will be evaluated in three mouse models. All compounds will be evaluated in two mouse ear inflammation assays. Selected compounds will be evaluated in a Min mouse model for colon cancer. The following specific aims are designed to accomplish the overall goal for the 6 months of the Phase 1 study. 1. Prepare standardized, modified theaflavin extracts from decaffeinated green tea 2. Prepare from catechin precursors the following pure compounds: theatlavin(TF-1), theaflavin-3-monogallate and theaflavin-3'-monogallate ( the combination of these two isomers are referred to as TF-
Studies 49
2), and theaflavin-3,3'-digallate (TF-3) (200 mg each to evaluate in mouse ear models) 3. Evaluate decaffeinated black tea extract, theaflavin extracts and four pure theaflavin compounds in the 12-O-tetradecanoylphorbol-13 acetate (TPA) and arachidonic acid (AA) induced mouse ear models. 4. Evaluate decaffeinated black tea extract and theaflavin extracts in a Min mouse model 5. Conceptualize and analyze prototype product (dietary supplement) development strategy 6. Plan for biomarker endpoint colon cancer clinical studies Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PREVENTION OF CARTILAGE DEGRADATION BY GREEN TEA Principal Investigator & Institution: Haqqi, Tariq M. Associate Professor; Medicine; Case Western Reserve University 10900 Euclid Ave Cleveland, OH 44106 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-JUL-2007 Summary: (provided by applicant): Many studies have shown that green tea possesses anti-inflammatory properties. We recently showed that DBA/1 mice given green tea polyphenols (GTP) in drinking water had clinically mild arthritis and little histological evidence of cartilage damage and bone erosion. Several factors, including proinflammatory cytokines, contribute to the destruction of an arthritic joint. Osteoarthritis (OA) is the most common degenerative joint disorder in which the pro-inflammatory cytokine IL-1 has been shown to play a decisive role. Its effects include the inhibition of attempted cartilage repair and enhanced degradation of cartilage matrix, induction of collagenases and the second messenger nitric oxide (NO). Data from our preliminary studies showed that when the green tea catechin epigallocatechin-3-gallate (EGCG) was added to human chondrocyte cultures (1) inhibited IL-1 -induced cartilage matrix degradation; (2) inhibited IL-1 -induced production of NO; (3) inhibited IL-1 -induced activation of nuclear factor kappa B (NF-kB); and (4) mitogen activated protein kinase (MAPK) sub-groups c-jun amino terminal kinase (JNK) and p38-MAPK. Work proposed in this application is based on this solid preliminary data and is designed to understand in depth how EGCG inhibits IL-1-induced cartilage degradation. Using human chondrocytes we will investigate (1) the inhibition of IL-1-induced nitric oxide synthase (iNOS) gene expression by EGCG; (2) the modulation of stress responsive transcription factor NF-kB by EGCG; (3) modulation of activator protein-1 (AP-1) and the transcription factor RUNX-2 by EGCG; (4) inhibition of the MAPK signal transduction pathways by EGCG; and (5) inhibition of MMP-1 3 gene expression by EGCG. Results of these studies are expected to define the molecular basis of the anti-inflammatory effects of EGCG on human chondrocytes. The long term objective of these studies is to explore the use of EGCG or compounds derived from it in inhibiting the onset and or progression of cartilage destruction in arthritis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: PREVENTION OF PHOTOCARCINOGENESIS BY ANTIOXIDANT Principal Investigator & Institution: Katiyar, Santosh K. Assistant Professor; Dermatology; University of Alabama at Birmingham Uab Station Birmingham, AL 35294 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-JUL-2004 Summary: (provided by applicant)Chronic exposure to solar ultraviolet (UV) radiation, particularly UVB (290-320 nm), is primarily responsible for more than 1,000,000 new cases of nonmelanoma skin cancer each year in the USA alone, making it the most hazardous environmental carcinogen known for humans. Thus, there is an urgent need
50 Tea
to develop strategies to prevent the occurrence of cutaneous malignancies. It is well documented that UV radiation is a potent producer of reactive oxygen species (ROS), which play a critical role in cellular signal transduction pathways. Phosphorylation of cell signaling molecules is implicated in various skin diseases including skin cancer. One approach to reduce the risk of UV-induced ROS-mediated skin cancer is the use of antioxidant agents. Several studies led to a strong suggestion that the regular intake of polyphenolic antioxidants from green tea may be an appropriate and effective strategy to prevent some forms of human cancers. We and others have shown that a potyphenolic fraction isolated from green tea, and particularly its major and the most effective chemopreventive antioxidant constituent (-)-epigallocatechin-3-gallate (EGCG) has remarkable preventive effects against UV-induced skin carcinogenesis in mouse model. We found that treatment with EGCG to human skin before UV exposure inhibits UV-induced oxidative stress. The aim of this application is to defme the mechanism through which EGCG would prevent UV-induced oxidative stress-mediated cell signaling pathways in human skin. The central hypothesis to be tested in this proposal is that UV-induced oxidative stress causes phosphorylation of epidermal growth factor receptor (EGFR), and mitogen-activated protein kinases (MAPK), such as extracellular signal-regulated kinase (ERK1/2) and p38 in human skin. The corollary to our hypothesis is that topical treatment with EGCG before UV exposure of the skin will prevent UV radiation-induced oxidative stress, which in turn will inhibit oxidative stress-mediated phosphorylation of cellular signaling events. The inhibition of UVinduced oxidative stress- mediated signaling pathways by EGCG will prevent the occurrence of skin cancer. Validation of this hypothesis would have major implications for the importance of oxidative stress-mediated skin cancer, as well as offering promise for the development of novel intervention approaches to mitigate UV-induced cellular signaling events linked to skin cancer incidence by the use of antioxidants. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: REFINEMENT & UTILIZATION OF PTC +/- MODEL OF BCC Principal Investigator & Institution: Aszterbaum, Michelle; University of California San Francisco 500 Parnassus Ave San Francisco, CA 94122 Timing: Fiscal Year 2001 Summary: (Applicant's Description) We have established the first practical murine model of the most common human cancer-basal cell carcinomas-by exposing the skin of ptc +/- mice to repeated ultraviolet light irradiation. We propose a series of experiments first to refine this model by varying the wavelength, the degree, and the frequency of irradiation. We will test several additional variables including the effects of alternative environmental insults that appear to provoke human basal cell carcinomas-ionizing irradiation and arsenic as well as chemical carcinogens. We will validate the utility of this model by assessing chemopreventive agents that have been studied on humansretinoids, green tea aqueous extract, and low-fat diet and then will utilize the model to test for chemopreventive efficacy of tea preparations and inhibitors of COX-1 and of COX-2. We will also assess the influence of varied genetic backgrounds both on photoinduction of efficacy of chemopreventive agents. Lastly, we will survey human extracutaneous cancers aberrant hedgehog pathway signaling. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 51
·
Project Title: RISK FACTORS FOR PANCREATIC CANCER Principal Investigator & Institution: Lee, I-Min M. Assistant Professor of Medicine; Epidemiology; Harvard University (Sch of Public Hlth) Public Health Campus Boston, MA 02460 Timing: Fiscal Year 2001; Project Start 15-APR-2001; Project End 31-MAR-2003 Summary: (provided by Applicant) Pancreatic cancer is the ninth most commonly occurring cancer, but the fifth leading cause of cancer death in the US. It is one of the most rapidly fatal cancers, with 1- and 5-year survival of only 16 percent and 0.4 percent. As there are currently no effective treatments for this disease, prevention is of paramount importance. Only older age and cigarette smoking are well- established risk factors. The roles of other risk factors, such as pipe and cigar smoking, coffee, tea and alcohol consumption, the presence of diabetes mellitus, and physical activity are unclear. To provide more information, we propose to analyze the associations of these characteristics with pancreatic cancer risk using previously collected data. In 1962 or 1966 (1962/1966), 29,347 men and women, who were free of cancer and aged 30-79 years, returned a health questionnaire. Subjects also returned another health questionnaire in 1977. They provided a wide range of information on these two questionnaires, including data on cigarette, pipe and cigar smoking, coffee, tea and alcohol consumption, physician-diagnosed diabetes mellitus, and physical activity. Between 1962/1966 through 1993, 210 subjects died from pancreatic cancer. We request funds to collect another two years of mortality data through 1995 (given the costs constraints of the small grants program), bringing the total of pancreatic cancer deaths to an estimated 230. Power calculations show adequate power to detect moderate increases in relative risks (1.5-2.5) associated with these risk factors. This large database provides a unique and cost-effective opportunity to examine the associations of various characteristics, most of which are modifiable, with pancreatic cancer risk. Findings from these analyses will have public health significance for a highly fatal disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: ROLE OF HUMAN GAMMA DELTA T CELLS IN TUMOR IMMUNITY Principal Investigator & Institution: Bukowski, Jack F.; Brigham and Women's Hospital 75 Francis Street Boston, MA 02115 Timing: Fiscal Year 2001; Project Start 03-JUL-2001; Project End 30-JUN-2004 Summary: (provided by applicant): There is increasing evidence to suggest that gammadelta T cells play an important role in defense against a variety of malignancies in humans. Human gamma-delta T cells expand in vivo, and can become up to 42% of all peripheral blood T cells during non-Hodgkin's lymphoma. This gamma-delta T cell expansion can be recapitulated in vitro by culturing peripheral blood mononuclear cells (PBMC) with lymphoma or myeloma cell lines, and the expanded gamma-delta T cells from such cultures can kill a wide variety of lymphoid myeloid, and epithelial tumor cells. Reconstitution of severe combined immunodeficiency (SCID) mice with human gamma/delta T cells prolongs survival from lymphoma. However, the basis of tumor cell recognition by human gamma-delta T cells is poorly understood, and very little data exists regarding the in vivo regulation of human gamma-delta T cells. This lack of knowledge of human gamma-delta T cell cancer biology is critically important, since information from mouse gamma-deltaT cell studies cannot be readily extrapolated to humans, since non-peptide alkylamine and organophosphate antigens recognized by the dominant population of human peripheral blood gamma-delta T cells,
52 Tea
Vgamma2Vdelta T cells, are completely different from the protein antigens recognized by mouse gamma-delta T cells. This crucial difference between mouse and human gamma-delta T cells compels us to examine directly in an in vivo model of human neoplasia the behavior of human gamma T cells, and to explore receptor-ligand interactions between Vgamma2Vdelta T cells and lymphoid, myeloid, or epithelial tumor cells. We will identify which of these receptor-ligand interactions is important in human gamma-delta T cell-mediated antineoplastic activity in an in vivo SCID mouse model. We will attempt to activate, with specific antigens, human VgammaVdelta2 T cells transplanted into SCID mice to test the hypothesis that such activation will boost gamma-delta T cell-mediated antineoplastic effects. Finally, we will attempt to modulate gamma-delta T cell function in healthy humans by ingestion of antigens recognized by gamma/delta T cells. These studies will thus help define the role of VgammaVdelta2 T cells in human tumor immunity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: SKIN CANCER CHEMOPREVENTION Principal Investigator & Institution: Bickers, David R. Carl Truman Nelson Professor/Chair; University of California San Francisco 500 Parnassus Ave San Francisco, CA 94122 Timing: Fiscal Year 2001; Project Start 01-JUL-2001; Project End 30-JUN-2002 Summary: (Applicant's Description) Non-melanoma skin cancer (NMSC) is the most common type of human cancer and epidemiological evidence strongly implicates ultraviolet radiation in sunlight as the major cause of this form of malignancy. The most common type of NMSC is basal cell carcinoma (BCC) and there are two major types of BCC, those occurring sporadically and those that develop in patients with the genetic disorder known as the basal cell nevus syndrome (BCNS). Sun exposure is a crucial factor in the development of BCC in both populations and recent studies have shown that mutations in the human homologue of the Drosophila segment polarity gene PATCHED (PTC) occur in patients with BCNS and in patients with sporadic BCCs. In this project we plan to conduct a series of studies in SKH-l hairless mice, in patched gene knockout mice (ptc +/-) and in human volunteers to test the hypothesis that systemic administration of the chemopreventive agents, Polyphenone E, a mixture of constituents of green tea, Sulindac, an inhibitor of cyclooxygenase (COX) I and 2 and Celecoxib, an inhibitor of COX 2 can diminish the phototoxic response to ultraviolet B (UVB) and psoralen-ultraviolet A (PUVA) in the skin. Minimal erythema dose (MED) to UVB and minimum phototoxic dose (MPD) to PUVA will be employed to induce a localized phototoxic response in the skin of the animals and the human subjects and the ability of the systemically administered chemopreventive agents to protect against these responses determined. Surrogate biological markers of cancer risk including erythema and edema, apoptosis, c-jun, c-fos and ras p21 induction, BrUdr incorporation, proliferating cell nuclear antigen (PCNA) expression and epidermal growth factor (FGFR) phosphorylation will be assessed. Tumor studies in the animals will permit direct comparison of the susceptibility of the mouse strains to UVB induced tumors and the ability of the chemopreventive agents to reduce the risk of cancer. These studies are closely integrated with those in Projects 1 and 2 and will generate strong supportive data that can be correlated with the findings from those studies. This combined approach has the unique potential to more frilly define the anticarcinogenic effects of selected chemopreventive agents in human populations and to further characterize their mechanism of action. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 53
·
Project Title: TEA MODULATION OF COLON CARCINOGENESIS Principal Investigator & Institution: Wargovich, Michael J. Professor; Pathology and Microbiology; University of South Carolina at Columbia Byrnes Bldg., Room 501 Columbia, SC 29208 Timing: Fiscal Year 2002; Project Start 01-JUL-2002; Project End 30-JUN-2007 Summary: (provided by applicant): Green and black tea together represent the most commonly consumed beverages worldwide and is one of very few sources of phytochemicals with a broad chemopreventive activity against carcinogenesis. This activity and the lack of toxicity make tea an attractive agent for potential use in the reduction of human cancer risk. Consumption of green tea reduces risk for several cancers including lung, stomach, and pancreatic cancer. Recently it has been shown that habitual consumption of tea is associated with a reduced risk for colon cancer in a U.S. population. Nevertheless, much more research is needed before we can fully understand the cancer chemopreventive activities of tea and the possible application of tea in human cancer prevention. The overall goal of this project is to understand tea and cancer prevention by elucidating the mechanisms and identifying the active components involved. The Apc Min/+ mouse animal model for colon cancer and related cell lines will be used. This project will develop useful biomarkers, new agents (metabolites or analogs of the active components), and effective dosage forms for the prevention of human cancer. Specifically, we intend to test the hypothesis that orally administered tea is an effective inhibitor of carcinogenesis. The Min mouse and azoxymethane (AOM)treated Min mouse will be used as the animal models to conduct dose-response studies for the effect of tea on aberrant crypt foci and colon tumor formation. Possible differences between green tea and black tea and the effect of caffeine on colon tumorigenesis will be assessed. We next will determine the effect of green tea and black tea on the proliferation and apoptosis of cells in the colon and correlate it with the tumorigenesis results. To study the molecular mechanisms, tea will be tested for its ability to modulate AP-l, ERK, JNK, c-Jun, j3-catenin and other proteins in the colons of Min mice. To elucidate the mechanistic basis for the inhibition of colon turnorigenesis by green tea and black tea in the Min and AOMIMin mouse models studies on arachidonic acid metabolism, cyclooxygenase (COX) protein and mRNA levels, and activities of COX, lipoxygenase, and phospholipase A2 will be conducted with colon samples. Furthermore, studies examining the effect of tea polyphenols on the growth of human colon adenocarcinoma cells that have high levels of COX-2 expression will be conducted. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: PREVENTION
TEA
TARGETING
PROTEASOME--A
ROLE
IN
CANCER
Principal Investigator & Institution: Dou, Qing P. Biochem and Molecular Biology; University of South Florida 4202 E Fowler Ave Tampa, FL 33620 Timing: Fiscal Year 2001; Project Start 01-APR-2001; Project End 31-MAR-2003 Summary: (provided by applicant): Our long-term objective is to find a cancer-specific signal transduction pathway via which human tumor cells can be selectively targeted. The proteasome is responsible for the specific degradation of proteins that are intimately involved in cell survival and apoptosis, including the tumor suppressor p53, the cyclindependent kinase inhibitor p27 and the cell death inducer Bax. We have found that increased levels of proteasome-mediated Bax degradation correlate well with decreased levels of Bax protein in advanced human prostate cancer and that treatment of tumor
54 Tea
cells with a proteasome inhibitor accumulates Bax protein in the mitochondria, leading to cytochrome c release, caspase activation and apoptosis. We have also found that ester bond-containing tea polyphenols potently inhibit the tumor proteasome activity in vitro (IC50 86-194 nM) and in vivo (1-10 uM) at the concentrations found in the serum of green tea drinkers. This inhibition of the proteasome activity in tumor cells results in accumulation of several proteasome natural substrates, including Bax. Based on these results, we propose the following two Hypotheses. (1) One of prostate cancer risk factors is increased level of the proteasomal activity that selectively degrades growth suppressor proteins such as Bax. (2) Inhibition of the proteasome activity by ester bondcontaining tea polyphenols contributes to the prostate cancer-preventative and inhibitory activities of green tea documented previously. To address these hypotheses, we propose the following Specific Aims. Aim 1 is to evaluate potency and selectivity of tea polyphenols to inhibit the proteasome activity in prostate cancer cell extracts. Aim 2 is to evaluate potency and selectivity of tea polyphenols to inhibit the proteasome activity in intact prostate cancer cells. Aim 3 is to investigate the relationship between the abilities of tea polyphenols to inhibit the proteasome-mediated Bax degradation and to induce prostate cancer cell death. A Future Aim is to determine whether in vivo proteasome-inhibitory ability of tea polyphenols is related to their antitumor activity using nude mice bearing human prostate tumors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: THEAFLAVINS AND GALLIC ACID IN TEA Principal Investigator & Institution: Warden, Beverly A. Senior Research Scientist; Florida International University Division of Sponsored Research and Training Miami, FL 33199 Timing: Fiscal Year 2001 Summary: Flavonoids are a class of nutrients found in a large number of foods, particularly fruits and vegetables. There is a large number of flavonoid subclasses, most of which have been associated with antioxidant properties important in preventing chronic diseases. Epidemiological studies have demonstrated a protective effect of flavonoids in preventing cardiovascular disease in some populations. However, there is conflicting evidence as to their efficacy in preventing cancer. The long term goal of this research is to study the bioavailability and metabolism of specific subclasses of flavonoids so that future cohort and case controlled studies can be designed to produce more definitive results regarding the link between tea consumption and improve health through prevention of chronic disease. The objective of this proposal is to study the absorptive, metabolic, and excretory processes in humans associated with the intake of gallic acid (GA) and theaflavins (TF) found in regular black tea. The results of this study will help researchers to more fully understand the metabolism of one subclass of flavonoids which is highly consumed by humans. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: TRANSPLACENTAL BIOAVAILABILITY
CHEMOPROTECTION
AND
GI
Principal Investigator & Institution: Williams, David E. Professor; Oregon State University Corvallis, OR 973391086 Timing: Fiscal Year 2003; Project Start 17-MAR-2003; Project End 28-FEB-2008 Summary: Chemoprotection against cancer by dietary phytochemicals, including indole-3-carbinol (I3C), green tea polyphenols (GTP) and chlorophyllin (CHL) has been
Studies 55
demonstrated in animals, but little is known about modulation by phytochemicals of transplacental carcinogenesis or their efficacy and mechanisms of action in humans. Our hypothesis is that these phytochemicals will provide chemoprotection to fetus from PAH-induced transplacental carcinogenesis through blocking mechanisms involving the Aryl Hydrocarbon Receptor (Ahr) (I3C, GTP) or complex formation (CHL). This hypothesis will be tested by: * Examining the role of the Ahr in modulation of transplacental carcinogenesis utilizing the Ahr knockout mouse. * Determining PAH bioavailability to fetal target tissues by DNA 32p-postlabeling analysis. For chemoprotection to be effective transplacentally, phytochemicals must transverse two barriers, the GI and placenta. The Caco-2 cell monolayer system is an excellent in vitro model for GI absorption, metabolism and transport of drugs. The second hypothesis under test is stated in three parts. The Caco-2 cell monolayer in vitro model will (1) predict bioavailability in humans of proposed cancer chemoprotective agents, (2) test hypotheses related to mechanism including modulation of phase I and phase II enzymes and drug transport systems and (3) predict absorption and bioavailability of phytochemicals transplacentally in mice. These hypotheses will be tested by: * Measuring the Kinflux and Keflux, of individual components in GTP, I3C acid condensation products and CHL, singularly, and as mixtures. * Validating the Caco-2 cell monolayer model by administration of select phytochemicals to human volunteers and determining the extent of absorption and identity of serum metabolites. * Determining the potential for these phytochemieals to induce, inhibit and/or be substrates for human intestinal phase I and phase II enzymes and transporters. * Administering phytochemicals to the maternal mouse iv (by-passing GI and first-pass hepatic metabolism) and assessing bioavailability to the fetus to determine if Caco-2 absorption predicts placental bioavailability. These studies provide inportant new information on the efficacy and mechanism(s) of action of cancer chemoprotective phytochemicals. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: UCLA CENTER FOR DIETARY SUPPLEMENTS RESEARCH: BOTANICALS Principal Investigator & Institution: Heber, David; Professor/Chief; Medicine; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, CA 90024 Timing: Fiscal Year 2001; Project Start 30-SEP-1999; Project End 31-JUL-2004 Summary: This application proposes to establish the UCLA Center for Dietary Supplements Research: Botanicals (CDSRB) in order to foster interdisciplinary research to develop systematic evaluation of the safety and efficacy of botanical dietary supplements. We have assembled the multi-disciplinary scientific expertise required for the proposed CDSRB at the UCLA Center for Human Nutrition. to accomplish the following specific aims: 1) Identify, characterize and authenticate botanicals intended for use as dietary supplements or already being sold as dietary supplements; 2) Assess the bioavailability and bioactivity of botanical ingredients including phytochemical marker compounds and/or suspected or known active ingredients; 3) Identify active constituents in botanicals and explore their mechanisms of action in well-defined biological systems; 4) Conduct pre-clinical studies in cell culture and in animals; and 5) Conduct phase I and/or II clinical evaluations of botanicals. The UCLA CHN CDSRB will fulfill the critical need for additional basic and clinical research on the bioavailability and bioactivity of botanical ingredients, including phytochemical marker compounds and/or biologically active constituents in well-defined biological systems
56 Tea
and will then conduct pre-clinical studies in animals and clinical phase I and/or II evaluations of botanicals. In this application we outline three well developed R01 Research Projects (Chinese Red Yeast Rice, Green Tea, and St. John's Wort), four Pilot Studies (Echinacea, Flavonoids, Soy Isoflavones, and Plant Phytoestrogens, and three Scientific Cores in Agriculture and Botany, Analytic Phytochemistry, and Biostatistics/Clinical Pharmacology. An Administrative and Planning Core will administer the overall CDSRB, a New Investigator Award and Pilot Study Program support training and educational initiatives which will begin to address many of the issues outlined above. The UCLA School of Medicine is one of the top ten biomedical research institutions in the United States and will provide a rich interdisciplinary environment where the primary mission of the proposed Dietary Supplements Research Center in Botanicals can be achieved. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “tea” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for tea in the PubMed Central database: ·
Antimicrobial properties of tea (Camellia sinensis L.). by Hamilton-Miller JM. 1995 Nov; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=162950
·
Dual Role of the Saccharomyces cerevisiae TEA/ATTS Family Transcription Factor Tec1p in Regulation of Gene Expression and Cellular Development. by Kohler T, Wesche S, Taheri N, Braus GH, Mosch HU. 2002 Oct; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=126755
·
Epigallocatechin Gallate, a Potential Immunomodulatory Agent of Tea Components, Diminishes Cigarette Smoke Condensate-Induced Suppression of Anti-Legionella pneumophila Activity and Cytokine Responses of Alveolar Macrophages. by Matsunaga K, Klein TW, Friedman H, Yamamoto Y. 2002 Jul; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=120017
3 4
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
Studies 57
·
In Vitro Activities of Ketoconazole, Econazole, Miconazole, and Melaleuca alternifolia (Tea Tree) Oil against Malassezia Species. by Hammer KA, Carson CF, Riley TV. 2000 Feb; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=89709
·
In Vitro and In Vivo Activities of Tea Catechins against Helicobacter pylori. by Mabe K, Yamada M, Oguni I, Takahashi T. 1999 Jul; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=89367
·
In Vitro Susceptibilities of Lactobacilli and Organisms Associated with Bacterial Vaginosis to Melaleuca alternifolia (Tea Tree) Oil. by Hammer KA. 1999 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=89050
·
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. by Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. 2001 Aug 28; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=56964
·
Joint effects of citrus peel use and black tea intake on the risk of squamous cell carcinoma of the skin. by Hakim IA, Harris RB. 2001; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=45584
·
Killing K Channels with TEA +. by Khodakhah K, Melishchuk A, Armstrong CM. 1997 Nov 25; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=24309
·
Legionella pneumophila Replication in Macrophages Inhibited by Selective Immunomodulatory Effects on Cytokine Formation by Epigallocatechin Gallate, a Major Form of Tea Catechins. by Matsunaga K, Klein TW, Friedman H, Yamamoto Y. 2001 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=98432
·
Mechanism of Action of Melaleuca alternifolia (Tea Tree) Oil on Staphylococcus aureus Determined by Time-Kill, Lysis, Leakage, and Salt Tolerance Assays and Electron Microscopy. by Carson CF, Mee BJ, Riley TV. 2002 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=127210
·
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. by Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, Mukhtar H. 1999 Apr 13; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=16365
·
Purification and characterization of a novel class III peroxidase isoenzyme from tea leaves. by Kvaratskhelia M, Winkel C, Thorneley RN. 1997 Aug; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=158416
·
Purification and Characterization of Caffeine Synthase from Tea Leaves. by Kato M, Mizuno K, Fujimura T, Iwama M, Irie M, Crozier A, Ashihara H. 1999 Jun 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=59297
58 Tea
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with tea, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “tea” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for tea (hyperlinks lead to article summaries): ·
A Boston tea party. Author(s): Adams DD. Source: N Z Med J. 2000 July 14; 113(1113): 298. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10935577&dopt=Abstract
·
A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption. Author(s): McGee J, Patrick RS, Wood CB, Blumgart LH. Source: Journal of Clinical Pathology. 1976 September; 29(9): 788-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=977780&dopt=Abstract
·
A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Author(s): Bassett IB, Pannowitz DL, Barnetson RS. Source: The Medical Journal of Australia. 1990 October 15; 153(8): 455-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2145499&dopt=Abstract
·
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Author(s): Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, Anderson MW, Wiseman RW, Lubet RA, You M. Source: Cancer Research. 2000 February 15; 60(4): 901-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10706103&dopt=Abstract
6
PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
Studies 59
·
A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Author(s): Hindmarch I, Rigney U, Stanley N, Quinlan P, Rycroft J, Lane J. Source: Psychopharmacology. 2000 April; 149(3): 203-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10823400&dopt=Abstract
·
A new cause for CA19.9 elevation: heavy tea consumption. Author(s): Howaizi M, Abboura M, Krespine C, Sbai-Idrissi MS, Marty O, DjabbariSobhani M. Source: Gut. 2003 June; 52(6): 913-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12740355&dopt=Abstract
·
A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review. Author(s): Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K. Source: Cancer Detection and Prevention. 2000; 24(1): 91-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10757128&dopt=Abstract
·
A new function of green tea: prevention of lifestyle-related diseases. Author(s): Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H. Source: Annals of the New York Academy of Sciences. 2001 April; 928: 274-80. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11795518&dopt=Abstract
·
A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. Author(s): Jacquemin P, Hwang JJ, Martial JA, Dolle P, Davidson I. Source: The Journal of Biological Chemistry. 1996 September 6; 271(36): 21775-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8702974&dopt=Abstract
·
A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Author(s): Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. Source: Epidemiology (Cambridge, Mass.). 2001 November; 12(6): 695-700. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11679799&dopt=Abstract
·
A preliminary survey of filarial infection in a group of labour population at Maijan tea estate in Lakhimpur district, Assam. Author(s): Rahman NM, Bhattacharyya MN. Source: J Indian Med Assoc. 1971 June 16; 56(12): 363-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5118285&dopt=Abstract
60 Tea
·
A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Author(s): Nagano J, Kono S, Preston DL, Mabuchi K. Source: Cancer Causes & Control : Ccc. 2001 August; 12(6): 501-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11519758&dopt=Abstract
·
A single dose of tea with or without milk increases plasma antioxidant activity in humans. Author(s): Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA. Source: European Journal of Clinical Nutrition. 2000 January; 54(1): 87-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10694777&dopt=Abstract
·
A spot of tea. Author(s): McIntyre RV. Source: J Okla State Med Assoc. 1996 September; 89(9): 311. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8885534&dopt=Abstract
·
A study of neonatal deaths in the tea gardens of Dibrugarh district of upper Assam. Author(s): Phukan RK, Mahanta J. Source: J Indian Med Assoc. 1998 November; 96(11): 333-4, 337. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10218318&dopt=Abstract
·
A trial of oolong tea in the management of recalcitrant atopic dermatitis. Author(s): Uehara M, Sugiura H, Sakurai K. Source: Archives of Dermatology. 2001 January; 137(1): 42-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11176659&dopt=Abstract
·
A unique lab design fits the British to a tea. Author(s): Anderson A. Source: Science. 1991 July 26; 253(5018): 377-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1862338&dopt=Abstract
·
Absorption of caffeine from tea, coffee, and coca cola. Author(s): Marks V, Kelly JF. Source: Lancet. 1973 April 14; 1(7807): 827. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4121243&dopt=Abstract
·
Absorption, metabolism and antioxidative effects of tea catechin in humans. Author(s): Miyazawa T. Source: Biofactors (Oxford, England). 2000; 13(1-4): 55-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237200&dopt=Abstract
Studies 61
·
Accidental digitalis poisoning due to drinking herbal tea. Author(s): Bain RJ. Source: British Medical Journal (Clinical Research Ed.). 1985 June 1; 290(6482): 1624. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3924193&dopt=Abstract
·
Accidental poisoning by warfarin-contaminated herbal tea. Author(s): Norcross WA, Ganiats TG, Ralph LP, Seidel RG, Ikeda TS. Source: The Western Journal of Medicine. 1993 July; 159(1): 80-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8351917&dopt=Abstract
·
Action-based memory in Alzheimer's disease: a longitudinal look at tea making. Author(s): Rusted J, Sheppard L. Source: Neurocase : Case Studies in Neuropsychology, Neuropsychiatry, and Behavioural Neurology. 2002; 8(1-2): 111-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11997490&dopt=Abstract
·
Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Author(s): Chen C, Yu R, Owuor ED, Kong AN. Source: Arch Pharm Res. 2000 December; 23(6): 605-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11156183&dopt=Abstract
·
Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Author(s): Yu R, Jiao JJ, Duh JL, Gudehithlu K, Tan TH, Kong AN. Source: Carcinogenesis. 1997 February; 18(2): 451-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9054642&dopt=Abstract
·
Activity of tea tree oil on methicillin-resistant Staphylococcus aureus (MRSA) Author(s): Chan CH, Loudon KW. Source: The Journal of Hospital Infection. 1998 July; 39(3): 244-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9699148&dopt=Abstract
·
Activity of the tea component epicatechin gallate and analogues against methicillinresistant Staphylococcus aureus. Author(s): Hamilton-Miller JM, Shah S. Source: The Journal of Antimicrobial Chemotherapy. 2000 November; 46(5): 852-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11062217&dopt=Abstract
62 Tea
·
Acute airway obstruction after aspiration of boiling tea from teapot spout. Author(s): Williams EG, Dymock M. Source: Bmj (Clinical Research Ed.). 1993 October 9; 307(6909): 923. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8241858&dopt=Abstract
·
Acute anticholinergic syndrome following ingestion of Angel's Trumpet tea. Author(s): Hassell LH, MacMillan MW. Source: Hawaii Med J. 1995 July; 54(7): 669-70. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7558798&dopt=Abstract
·
Acute effects of herbal tea dust extracts on lung function. Author(s): Zuskin E, Kanceljak B, Witek TJ Jr, Schachter EN. Source: Chest. 1989 December; 96(6): 1327-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2684553&dopt=Abstract
·
Acute effects of ingestion of black and green tea on lipoprotein oxidation. Author(s): Hodgson JM, Puddey IB, Croft KD, Burke V, Mori TA, Caccetta RA, Beilin LJ. Source: The American Journal of Clinical Nutrition. 2000 May; 71(5): 1103-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10799371&dopt=Abstract
·
Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects. Author(s): Hodgson JM, Puddey IB, Burke V, Beilin LJ, Mori TA, Chan SY. Source: The British Journal of Nutrition. 2002 February; 87(2): 141-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11895166&dopt=Abstract
·
Acute hepatitis in a patient using a Chinese herbal tea--a case report. Author(s): Levi M, Guchelaar HJ, Woerdenbag HJ, Zhu YP. Source: Pharmacy World & Science : Pws. 1998 February; 20(1): 43-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9536471&dopt=Abstract
·
Addition of milk does not affect the absorption of flavonols from tea in man. Author(s): Hollman PC, Van Het Hof KH, Tijburg LB, Katan MB. Source: Free Radical Research. 2001 March; 34(3): 297-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11264903&dopt=Abstract
·
Adrenal tea leaves: Is the adrenal response to sepsis discernible? Author(s): Woolf PD. Source: Critical Care Medicine. 2001 February; 29(2): 450-1. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11246334&dopt=Abstract
Studies 63
·
Adverse effects of intravenous cannabis tea. Author(s): Mims RB, Lee JH. Source: Journal of the National Medical Association. 1977 July; 69(7): 491-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=875075&dopt=Abstract
·
Afternoon tea and carbolic. Author(s): Percival J. Source: Nursing Standard : Official Newspaper of the Royal College of Nursing. 1998 July 22-28; 12(44): 24-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9791463&dopt=Abstract
·
Airborne allergic contact dermatitis from tea tree oil. Author(s): De Groot AC. Source: Contact Dermatitis. 1996 November; 35(5): 304-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9007380&dopt=Abstract
·
Airway burns in an infant following aspiration of microwave-heated tea. Author(s): Garland JS, Rice TB, Kelly KJ. Source: Chest. 1986 October; 90(4): 621-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3757578&dopt=Abstract
·
Allergic and systemic contact dermatitis from Matricaria chamomilla tea. Author(s): Rodriguez-Serna M, Sanchez-Motilla JM, Ramon R, Aliaga A. Source: Contact Dermatitis. 1998 October; 39(4): 192-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9817225&dopt=Abstract
·
Allergic conjunctivitis to chamomile tea. Author(s): Subiza J, Subiza JL, Alonso M, Hinojosa M, Garcia R, Jerez M, Subiza E. Source: Ann Allergy. 1990 August; 65(2): 127-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2382873&dopt=Abstract
·
Allergic contact dermatitis due to guava tea. Author(s): Obi M, Miyazaki Y, Yokozeki H, Nishioka K. Source: Contact Dermatitis. 2001 February; 44(2): 116-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11205393&dopt=Abstract
·
Allergic contact dermatitis following use of a tea tree oil hand-wash not due to tea tree oil. Author(s): Greig JE, Thoo SL, Carson CF, Riley TV. Source: Contact Dermatitis. 1999 December; 41(6): 354-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10617229&dopt=Abstract
64 Tea
·
Allergic contact dermatitis from tea tree oil in a wart paint. Author(s): Bhushan M, Beck MH. Source: Contact Dermatitis. 1997 February; 36(2): 117-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9062759&dopt=Abstract
·
Allergic contact dermatitis from TEA-Coco hydrolyzed protein. Author(s): Emmett EA, Wright RC. Source: Archives of Dermatology. 1976 July; 112(7): 1008-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=938064&dopt=Abstract
·
Allergic contact dermatitis to tea tree oil with erythema multiforme-like id reaction. Author(s): Khanna M, Qasem K, Sasseville D. Source: American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society. 2000 December; 11(4): 238-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11123417&dopt=Abstract
·
Allergy to chamomile tea. Author(s): Casterline CL. Source: Jama : the Journal of the American Medical Association. 1980 July 25; 244(4): 330-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7392117&dopt=Abstract
·
Allergy to natural honeys and camomile tea. Author(s): Florido-Lopez JF, Gonzalez-Delgado P, Saenz de San Pedro B, Perez-Miranda C, Arias de Saavedra JM, Marin-Pozo JF. Source: International Archives of Allergy and Immunology. 1995 October; 108(2): 170-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7549505&dopt=Abstract
·
Amelioratory effect of barley tea drinking on blood fluidity. Author(s): Suganuma H, Inakuma T, Kikuchi Y. Source: J Nutr Sci Vitaminol (Tokyo). 2002 April; 48(2): 165-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12171439&dopt=Abstract
·
An epidemiological study of the health of Sri Lankan tea plantation workers associated with long term exposure to paraquat. Author(s): Senanayake N, Gurunathan G, Hart TB, Amerasinghe P, Babapulle M, Ellapola SB, Udupihille M, Basanayake V. Source: Br J Ind Med. 1993 March; 50(3): 257-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8457493&dopt=Abstract
Studies 65
·
An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Author(s): Lee MJ, Prabhu S, Meng X, Li C, Yang CS. Source: Analytical Biochemistry. 2000 March 15; 279(2): 164-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10706785&dopt=Abstract
·
An international human becoming hermeneutic study of Tom Hegg's A cup of Christmas Tea. Author(s): Baumann SL, Carroll KA, Damgaard GA, Millar B, Welch AJ. Source: Nursing Science Quarterly. 2001 October; 14(4): 316-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11873370&dopt=Abstract
·
An outbreak of acute diarrheal diseases caused by E. coli in a tea garden of upper Assam. Author(s): Nayak HK, Das HK, Mahanta J, Srivastava VK. Source: J Commun Dis. 1996 September; 28(3): 209-11. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8973023&dopt=Abstract
·
Anaesthesia and the law. Respiratory failure in a young child after aspiration of hot tea. Author(s): Brahams D. Source: Anaesthesia. 1989 October; 44(10): 858-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2589612&dopt=Abstract
·
Analysis of (-)-epigallocatechin gallate in human serum obtained after ingesting green tea. Author(s): Unno T, Kondo K, Itakura H, Takeo T. Source: Biosci Biotechnol Biochem. 1996 December; 60(12): 2066-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8988640&dopt=Abstract
·
Analysis of plasma and urinary tea polyphenols in human subjects. Author(s): Lee MJ, Wang ZY, Li H, Chen L, Sun Y, Gobbo S, Balentine DA, Yang CS. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1995 June; 4(4): 393-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7655336&dopt=Abstract
66 Tea
·
Analysis of tea polyphenols. Author(s): Beecher GR, Warden BA, Merken H. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 267-70. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202401&dopt=Abstract
·
Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Author(s): Li C, Meng X, Winnik B, Lee MJ, Lu H, Sheng S, Buckley B, Yang CS. Source: Chemical Research in Toxicology. 2001 June; 14(6): 702-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11409941&dopt=Abstract
·
Analytical method of measuring tea catechins in human plasma by solid-phase extraction and HPLC with electrochemical detection. Author(s): Umegaki K, Sugisawa A, Yamada K, Higuchi M. Source: J Nutr Sci Vitaminol (Tokyo). 2001 December; 47(6): 402-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11922115&dopt=Abstract
·
Anaphylactic reaction after the ingestion of chamomile tea: a study of cross-reactivity with other composite pollens. Author(s): Subiza J, Subiza JL, Hinojosa M, Garcia R, Jerez M, Valdivieso R, Subiza E. Source: The Journal of Allergy and Clinical Immunology. 1989 September; 84(3): 353-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2674263&dopt=Abstract
·
Anaphylactic reaction to chamomile tea. Author(s): Benner MH, Lee HJ. Source: The Journal of Allergy and Clinical Immunology. 1973 November; 52(5): 307-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4746793&dopt=Abstract
·
Anencephalus and maternal tea drinking: evidence for a possible association. Author(s): Fedrick J. Source: Proc R Soc Med. 1974 May; 67(5): 356-60. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4835282&dopt=Abstract
·
Antiallergic tea catechin, (-)-epigallocatechin-3-O-(3-O-methyl)-gallate, suppresses FcepsilonRI expression in human basophilic KU812 cells. Author(s): Fujimura Y, Tachibana H, Maeda-Yamamoto M, Miyase T, Sano M, Yamada K. Source: Journal of Agricultural and Food Chemistry. 2002 September 25; 50(20): 5729-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12236706&dopt=Abstract
Studies 67
·
Antiatherogenic effects of tea polyphenols (flavan-3-ols) in humans and apoEdeficient mice. Author(s): Tomita T, Miura Y, Chiba T, Kawai E, Umegaki K, Miura S, Koizumi H, Ikeda M, Tomita I. Source: Basic Life Sci. 1999; 66: 471-82. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10800457&dopt=Abstract
·
Antibacterial activity of black tea (Camelia sinensis) extract against Salmonella serotypes causing enteric fever. Author(s): Ciraj AM, Sulaim J, Mamatha B, Gopalkrishna BK, Shivananda PG. Source: Indian Journal of Medical Sciences. 2001 July; 55(7): 376-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11883337&dopt=Abstract
·
Antibacterial activity of tea (Camellia sinensis) and coffee (Coffee arabica) with special reference to Salmonella typhimurium. Author(s): Shetty M, Subbannayya K, Shivananda PG. Source: J Commun Dis. 1994 September; 26(3): 147-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7868837&dopt=Abstract
·
Anticariogenic effects of green tea. Author(s): Yu H, Oho T, Tagomori S, Morioka T. Source: Fukuoka Igaku Zasshi. 1992 April; 83(4): 174-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1607143&dopt=Abstract
·
Anti-cariogenic properties of tea (Camellia sinensis). Author(s): Hamilton-Miller JM. Source: Journal of Medical Microbiology. 2001 April; 50(4): 299-302. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11289514&dopt=Abstract
·
Anticholinergic intoxication with commercially available thorn apple tea. Author(s): Coremans P, Lambrecht G, Schepens P, Vanwelden J, Verhaegen H. Source: Journal of Toxicology. Clinical Toxicology. 1994; 32(5): 589-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7932919&dopt=Abstract
·
Anticholinergic poisoning associated with herbal tea. Author(s): Hsu CK, Leo P, Shastry D, Meggs W, Weisman R, Hoffman RS. Source: Archives of Internal Medicine. 1995 November 13; 155(20): 2245-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7487247&dopt=Abstract
68 Tea
·
Anticholinergic poisonings associated with commercial burdock root tea. Author(s): Rhoads PM, Tong TG, Banner W Jr, Anderson R. Source: Journal of Toxicology. Clinical Toxicology. 1984-85; 22(6): 581-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6535850&dopt=Abstract
·
Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Author(s): Nenoff P, Haustein UF, Brandt W. Source: Skin Pharmacol. 1996; 9(6): 388-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9055360&dopt=Abstract
·
Antigens in tea-beverage prime human Vgamma 2Vdelta 2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses. Author(s): Kamath AB, Wang L, Das H, Li L, Reinhold VN, Bukowski JF. Source: Proceedings of the National Academy of Sciences of the United States of America. 2003 May 13; 100(10): 6009-14. Epub 2003 April 28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12719524&dopt=Abstract
·
Anti-Helicobacter pylori activity of Chinese tea: in vitro study. Author(s): Yee YK, Koo MW. Source: Alimentary Pharmacology & Therapeutics. 2000 May; 14(5): 635-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10792128&dopt=Abstract
·
Anti-human immunodeficiency virus activity of oligosaccharides from rooibos tea (Aspalathus linearis) extracts in vitro. Author(s): Nakano M, Nakashima H, Itoh Y. Source: Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1997 April; 11 Suppl 3: 128-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9209319&dopt=Abstract
·
Anti-hyperglycemic effect of black tea (Camellia sinensis) in rat. Author(s): Gomes A, Vedasiromoni JR, Das M, Sharma RM, Ganguly DK. Source: Journal of Ethnopharmacology. 1995 March; 45(3): 223-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7623488&dopt=Abstract
·
Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Author(s): Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A. Source: Biological Chemistry. 2002 January; 383(1): 101-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11928805&dopt=Abstract
Studies 69
·
Antimicrobial properties of tea (Camellia sinensis L.). Author(s): Hamilton-Miller JM. Source: Antimicrobial Agents and Chemotherapy. 1995 November; 39(11): 2375-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8585711&dopt=Abstract
·
Antimutagenic and anticarcinogenic activity of tea polyphenols. Author(s): Kuroda Y, Hara Y. Source: Mutation Research. 1999 January; 436(1): 69-97. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9878691&dopt=Abstract
·
Antimutagenicity of Tochu tea (an aqueous extract of Eucommia ulmoides leaves): 2. Suppressing effect of Tochu tea on the urine mutagenicity after ingestion of raw fish and cooked beef. Author(s): Sasaki YF, Chiba A, Murakami M, Sekihashi K, Tanaka M, Takahoko M, Moribayashi S, Kudou C, Hara Y, Nakazawa Y, Nakamura T, Onizuka S. Source: Mutation Research. 1996 December 20; 371(3-4): 203-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9008721&dopt=Abstract
·
Antioxidant activity of soya hypocotyl tea in humans. Author(s): Watanabe S, Haba R, Terashima K, Arai Y, Miura T, Chiba H, Takamatsu K. Source: Biofactors (Oxford, England). 2000; 12(1-4): 227-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11216490&dopt=Abstract
·
Antioxidant polyphenols in tea, cocoa, and wine. Author(s): Dreosti IE. Source: Nutrition (Burbank, Los Angeles County, Calif.). 2000 July-August; 16(7-8): 6924. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10906600&dopt=Abstract
·
Antioxidant potential of green and black tea determined using the ferric reducing power (FRAP) assay. Author(s): Langley-Evans SC. Source: International Journal of Food Sciences and Nutrition. 2000 May; 51(3): 181-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10945114&dopt=Abstract
·
Antioxidant properties of ethanolic and aqueous extracts of green tea compared to black tea. Author(s): Wiseman H, Plitzanopoulou P, O'Reilly J. Source: Biochemical Society Transactions. 1996 August; 24(3): 390S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8878934&dopt=Abstract
70 Tea
·
Antioxidants in Chinese green tea. Author(s): Cheng TO. Source: Journal of the American College of Cardiology. 1998 April; 31(5): 1214. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9562027&dopt=Abstract
·
Antioxidants in tea. Author(s): Wiseman SA, Balentine DA, Frei B. Source: Critical Reviews in Food Science and Nutrition. 1997 December; 37(8): 705-18. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9447271&dopt=Abstract
·
Antioxidants in wine and tea. Author(s): Cheng TO. Source: Journal of the Royal Society of Medicine. 1999 March; 92(3): 157. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10396276&dopt=Abstract
·
Antioxidative effects of green tea polyphenols on free radical initiated and photosensitized peroxidation of human low density lipoprotein. Author(s): Liu Z, Ma LP, Zhou B, Yang L, Liu ZL. Source: Chemistry and Physics of Lipids. 2000 June; 106(1): 53-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10878235&dopt=Abstract
·
Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. Author(s): Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, Yun YP. Source: Journal of Cardiovascular Pharmacology. 2001 December; 38(6): 875-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11707691&dopt=Abstract
·
Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Author(s): Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, Yun YP. Source: Thrombosis Research. 1999 November 1; 96(3): 229-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10588466&dopt=Abstract
·
Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Author(s): Schnitzler P, Schon K, Reichling J. Source: Pharmazie. 2001 April; 56(4): 343-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11338678&dopt=Abstract
Studies 71
·
Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Author(s): Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA, Cummings JH. Source: The British Journal of Nutrition. 1998 February; 79(2): 133-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9536857&dopt=Abstract
·
Apoptosis induced by tea polyphenols in HL-60 cells. Author(s): Zhao Y, Cao J, Ma H, Liu J. Source: Cancer Letters. 1997 December 23; 121(2): 163-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9570354&dopt=Abstract
·
Apoptosis-inducing activity of a driselase digest fraction of green tea residue. Author(s): Katsuno Y, Koyama Y, Saeki K, Sazuka M, Ookawa K, Isemura M. Source: Biosci Biotechnol Biochem. 2001 January; 65(1): 198-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11272830&dopt=Abstract
·
Apoptosis-inducing activity of high molecular weight fractions of tea extracts. Author(s): Hayakawa S, Kimura T, Saeki K, Koyama Y, Aoyagi Y, Noro T, Nakamura Y, Isemura M. Source: Biosci Biotechnol Biochem. 2001 February; 65(2): 459-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11302190&dopt=Abstract
·
Apoptosis-inducing activity of polyphenol compounds derived from tea catechins in human histiolytic lymphoma U937 cells. Author(s): Saeki K, Sano M, Miyase T, Nakamura Y, Hara Y, Aoyagi Y, Isemura M. Source: Biosci Biotechnol Biochem. 1999 March; 63(3): 585-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10227148&dopt=Abstract
·
Application of near-infrared reflectance spectroscopy to the simultaneous prediction of alkaloids and phenolic substances in green tea leaves. Author(s): Schulz H, Engelhardt UH, Wegent A, Drews H, Lapczynski S. Source: Journal of Agricultural and Food Chemistry. 1999 December; 47(12): 5064-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10606573&dopt=Abstract
·
Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis. Author(s): Zeegers MP, Tan FE, Goldbohm RA, van den Brandt PA. Source: International Journal of Epidemiology. 2001 April; 30(2): 353-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11369742&dopt=Abstract
72 Tea
·
Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Author(s): Zeegers MP, Dorant E, Goldbohm RA, van den Brandt PA. Source: Cancer Causes & Control : Ccc. 2001 April; 12(3): 231-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11405328&dopt=Abstract
·
Arrhythmias related to coffee and tea. Author(s): Flynn JT. Source: Jama : the Journal of the American Medical Association. 1970 January 26; 211(4): 663. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5466945&dopt=Abstract
·
Aspiration of boiling tea leading to respiratory failure. Author(s): Brahams D. Source: Lancet. 1989 May 13; 1(8646): 1089. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2566044&dopt=Abstract
·
Aspiration of hot tea. Author(s): Mazrooa AA, Sissi WA. Source: Anaesthesia. 1990 October; 45(10): 884. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2240509&dopt=Abstract
·
Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Author(s): Nagata C, Kabuto M, Shimizu H. Source: Nutrition and Cancer. 1998; 30(1): 21-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9507508&dopt=Abstract
·
Association of serum lipids with coffee, tea, and egg consumption in free-living subjects. Author(s): Green MS, Jucha E. Source: Journal of Epidemiology and Community Health. 1986 December; 40(4): 324-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3655625&dopt=Abstract
·
Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS Study. Author(s): Green MS, Harari G. Source: Preventive Medicine. 1992 July; 21(4): 532-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1409495&dopt=Abstract
Studies 73
·
Atropine as possible contaminant of comfrey tea. Author(s): Awang DV, Kindack DG. Source: Lancet. 1989 July 1; 2(8653): 44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2567813&dopt=Abstract
·
Atropine as possible contaminant of comfrey tea. Author(s): Routledge PA, Spriggs TL. Source: Lancet. 1989 April 29; 1(8644): 963-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2565458&dopt=Abstract
·
Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NFkappaB) activation and cell death by tea extracts in neuronal cultures. Author(s): Levites Y, Youdim MB, Maor G, Mandel S. Source: Biochemical Pharmacology. 2002 January 1; 63(1): 21-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11754870&dopt=Abstract
·
Bancroftian filariasis in Namrup tea estate, district Dibrugarh, Assam. Author(s): Prakash A, Mohapatra PK, Das HK, Sharma RK, Mahanta J. Source: Indian J Public Health. 1998 October-December; 42(4): 103-7, 112. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10389521&dopt=Abstract
·
Bioactive ingredients: antioxidants and polyphenols in tea. Author(s): Dreosti IE. Source: Nutrition Reviews. 1996 November; 54(11 Pt 2): S51-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9110576&dopt=Abstract
·
Bioavailability of catechins from tea: the effect of milk. Author(s): van het Hof KH, Kivits GA, Weststrate JA, Tijburg LB. Source: European Journal of Clinical Nutrition. 1998 May; 52(5): 356-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9630386&dopt=Abstract
·
Bioavailability of flavonoids from tea. Author(s): Hollman PC, Tijburg LB, Yang CS. Source: Critical Reviews in Food Science and Nutrition. 1997 December; 37(8): 719-38. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9447272&dopt=Abstract
·
Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Author(s): Savage GP, Charrier MJ, Vanhanen L. Source: European Journal of Clinical Nutrition. 2003 March; 57(3): 415-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12627177&dopt=Abstract
74 Tea
·
Biological activity of Melaleuca alternifola (Tea Tree) oil component, terpinen-4-ol, in human myelocytic cell line HL-60. Author(s): Budhiraja SS, Cullum ME, Sioutis SS, Evangelista L, Habanova ST. Source: Journal of Manipulative and Physiological Therapeutics. 1999 September; 22(7): 447-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10519561&dopt=Abstract
·
Black and green tea and heart disease: a review. Author(s): Vinson JA. Source: Biofactors (Oxford, England). 2000; 13(1-4): 127-32. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237171&dopt=Abstract
·
Black tea consumption and cancer risk: a prospective study. Author(s): Heilbrun LK, Nomura A, Stemmermann GN. Source: British Journal of Cancer. 1986 October; 54(4): 677-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3778808&dopt=Abstract
·
Black tea consumption does not protect low density lipoprotein from oxidative modification. Author(s): McAnlis GT, McEneny J, Pearce J, Young IS. Source: European Journal of Clinical Nutrition. 1998 March; 52(3): 202-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9537306&dopt=Abstract
·
Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Author(s): Cherubini A, Beal MF, Frei B. Source: Free Radical Biology & Medicine. 1999 August; 27(3-4): 381-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10468212&dopt=Abstract
·
Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. Author(s): Klein RD, Fischer SM. Source: Carcinogenesis. 2002 January; 23(1): 217-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11756245&dopt=Abstract
·
Black tea theaflavins induce programmed cell death in cultured human stomach cancer cells. Author(s): Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, Nakanishi K, Sugimoto Y, Hasegawa M, Akatsuka R, Hara Y. Source: International Journal of Molecular Medicine. 1998 April; 1(4): 725-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9852288&dopt=Abstract
Studies 75
·
Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Author(s): Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1998 April; 7(4): 351-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9568793&dopt=Abstract
·
Blood pressure, coffee, tea and tobacco consumption: an epidemiological study in Algiers. Author(s): Lang T, Bureau JF, Degoulet P, Salah H, Benattar C. Source: European Heart Journal. 1983 September; 4(9): 602-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6641752&dopt=Abstract
·
Body iron status associated with tea consumption. Author(s): Farkas CS. Source: Can Med Assoc J. 1979 September 22; 121(6): 706. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=519607&dopt=Abstract
·
Brewing up good health. Research says tea packs power. Author(s): Frank GC. Source: Adv Nurse Pract. 2003 May; 11(5): 55-6. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12754985&dopt=Abstract
·
Brick tea consumption as the cause of dental fluorosis among children from Mongol, Kazak and Yugu populations in China. Author(s): Cao J, Zhao Y, Liu J. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1997 August; 35(8): 827-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9350228&dopt=Abstract
·
Brick tea fluoride as a main source of adult fluorosis. Author(s): Cao J, Zhao Y, Liu J, Xirao R, Danzeng S, Daji D, Yan Y. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2003 April; 41(4): 535-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12615125&dopt=Abstract
·
Burdock root tea poisoning. Author(s): Fletcher GF, Cantwell JD. Source: Jama : the Journal of the American Medical Association. 1978 October 6; 240(15): 1586. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=691140&dopt=Abstract
76 Tea
·
Burdock root tea poisoning. Case report involving a commercial preparation. Author(s): Bryson PD, Watanabe AS, Rumack BH, Murphy RC. Source: Jama : the Journal of the American Medical Association. 1978 May 19; 239(20): 2157. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=642161&dopt=Abstract
·
Cadmium and cobalt in tea and coffee and their relationship to cardiovascular disease. Author(s): Horwitz C, van der Linden SE. Source: South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1974 February 9; 48(6): 230-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4814501&dopt=Abstract
·
Caffeinated coffee and tea intake and its relationship to cigarette smoking: an analysis of the Second National Health and Nutrition Examination Survey (NHANES II). Author(s): Klesges RC, Ray JW, Klesges LM. Source: Journal of Substance Abuse. 1994; 6(4): 407-18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7780298&dopt=Abstract
·
Can black tea influence plasma total homocysteine concentrations? Author(s): Hodgson JM, Burke V, Beilin LJ, Croft KD, Puddey IB. Source: The American Journal of Clinical Nutrition. 2003 April; 77(4): 907-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12663290&dopt=Abstract
·
Can malt whisky be discriminated from blended whisky? The proof. A modification of Sir Ronald Fisher's hypothetical tea tasting experiment. Author(s): Chadwick SJ, Dudley HA. Source: British Medical Journal (Clinical Research Ed.). 1983 December 24-31; 287(6409): 1912-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6418270&dopt=Abstract
·
Can tea tree (Melaleuca alternifolia) oil prevent MRSA? Author(s): Anderson JN, Fennessy PA. Source: The Medical Journal of Australia. 2000 November 6; 173(9): 489. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11149307&dopt=Abstract
·
Cancer biomarkers in the field of tea. Author(s): Dreosti IE. Source: Cancer Letters. 1997 March 19; 114(1-2): 319-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9103321&dopt=Abstract
Studies 77
·
Cancer chemoprevention by green tea components. Author(s): Mukhtar H, Katiyar SK, Agarwal R. Source: Advances in Experimental Medicine and Biology. 1994; 354: 123-34. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8067281&dopt=Abstract
·
Cancer chemoprevention by polyphenols in green tea and artichoke. Author(s): Agarwal R, Mukhtar H. Source: Advances in Experimental Medicine and Biology. 1996; 401: 35-50. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8886125&dopt=Abstract
·
Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Author(s): Lin JK, Liang YC, Lin-Shiau SY. Source: Biochemical Pharmacology. 1999 September 15; 58(6): 911-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10509743&dopt=Abstract
·
Cancer chemoprevention by tea polyphenols. Author(s): Lin JK, Liang YC. Source: Proc Natl Sci Counc Repub China B. 2000 January; 24(1): 1-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10786933&dopt=Abstract
·
Cancer inhibition by green tea. Author(s): Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K, Nakachi K. Source: Mutation Research. 1998 June 18; 402(1-2): 307-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9675322&dopt=Abstract
·
Cancer mortality in relation to national consumption of cigarettes, solid fuel, tea and coffee. Author(s): Stocks P. Source: British Journal of Cancer. 1970 June; 24(2): 215-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5451565&dopt=Abstract
·
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Author(s): Fujiki H, Suganuma M, Okabe S, Sueoka E, Sueoka N, Fujimoto N, Goto Y, Matsuyama S, Imai K, Nakachi K. Source: Mutation Research. 2001 September 1; 480-481: 299-304. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11506822&dopt=Abstract
78 Tea
·
Cancer rates among drinkers of black tea. Author(s): Blot WJ, McLaughlin JK, Chow WH. Source: Critical Reviews in Food Science and Nutrition. 1997 December; 37(8): 739-60. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9447273&dopt=Abstract
·
Cancer-preventive effects of drinking green tea among a Japanese population. Author(s): Imai K, Suga K, Nakachi K. Source: Preventive Medicine. 1997 November-December; 26(6): 769-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9388788&dopt=Abstract
·
Candidate foods in the Asia-Pacific region for cardiovascular protection: Oriental tea. Author(s): Zhao W, Chen J. Source: Asia Pacific Journal of Clinical Nutrition. 2001; 10(2): 138-42. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11710354&dopt=Abstract
·
Capillary liquid chromatography/electrospray mass spectrometry for the separation and detection of catechins in green tea and human plasma. Author(s): Dalluge JJ, Nelson BC, Thomas JB, Welch MJ, Sander LC. Source: Rapid Communications in Mass Spectrometry : Rcm. 1997; 11(16): 1753-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9375410&dopt=Abstract
·
Cardiac effects of chamomile tea. Author(s): Gould L, Reddy CV, Gomprecht RF. Source: Journal of Clinical Pharmacology. 1973 November-December; 13(11): 475-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4490671&dopt=Abstract
·
Caribou bones and labrador tea. Author(s): Olsson K. Source: Can Nurse. 1989 February; 85(2): 18-21. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2914306&dopt=Abstract
·
Caries experience and sex related tea consumption amongst 13-14-year-old children in Palmyra, Syrian Arab Republic. Author(s): Cooper MH, Burhani HM, Schamschula RG, Barmes DE. Source: Community Dentistry and Oral Epidemiology. 1987 October; 15(5): 296. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3477365&dopt=Abstract
·
Caries preventive effect of wild tea (tsaang-gubat) among school children. Author(s): Parajas IL. Source: J Philipp Dent Assoc. 1995 December-1996 February; 47(3): 3-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9462048&dopt=Abstract
Studies 79
·
Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. Author(s): Arts IC, van De Putte B, Hollman PC. Source: Journal of Agricultural and Food Chemistry. 2000 May; 48(5): 1752-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10820090&dopt=Abstract
·
Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Author(s): Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D. Source: The American Journal of Clinical Nutrition. 2001 August; 74(2): 227-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11470725&dopt=Abstract
·
Catechin metabolites after intake of green tea infusions. Author(s): Pietta PG, Simonetti P, Gardana C, Brusamolino A, Morazzoni P, Bombardelli E. Source: Biofactors (Oxford, England). 1998; 8(1-2): 111-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9699018&dopt=Abstract
·
Catechins are bioavailable in men and women drinking black tea throughout the day. Author(s): Warden BA, Smith LS, Beecher GR, Balentine DA, Clevidence BA. Source: The Journal of Nutrition. 2001 June; 131(6): 1731-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11385060&dopt=Abstract
·
Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. Author(s): Adcocks C, Collin P, Buttle DJ. Source: The Journal of Nutrition. 2002 March; 132(3): 341-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11880552&dopt=Abstract
·
Catechol- and pyrogallol-type flavonoids. Analysis of tea catechins in plasma. Author(s): Umegaki K, Sano M, Tomita I. Source: Methods in Molecular Biology (Clifton, N.J.). 2002; 186: 247-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12013773&dopt=Abstract
·
Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Author(s): Ahmad N, Cheng P, Mukhtar H. Source: Biochemical and Biophysical Research Communications. 2000 August 28; 275(2): 328-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10964666&dopt=Abstract
80 Tea
·
Chamomile tea enema anaphylaxis. Author(s): Thien FC. Source: The Medical Journal of Australia. 2001 July 2; 175(1): 54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11476211&dopt=Abstract
·
Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands. Author(s): Shanks GD, Biomndo K, Hay SI, Snow RW. Source: Trans R Soc Trop Med Hyg. 2000 May-June; 94(3): 253-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10974991&dopt=Abstract
·
Characteristics of a (Na+-K+)-ATPase inhibitor in extracts of tea. Author(s): Sagnella GA, MacGregor GA. Source: The American Journal of Clinical Nutrition. 1984 July; 40(1): 36-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6331148&dopt=Abstract
·
Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma. Author(s): Nakagawa K, Miyazawa T. Source: Analytical Biochemistry. 1997 May 15; 248(1): 41-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9177723&dopt=Abstract
·
Chemopreventive effect of green tea (Camellia sinensis) against cigarette smokeinduced mutations (SCE) in humans. Author(s): Lee IP, Kim YH, Kang MH, Roberts C, Shim JS, Roh JK. Source: J Cell Biochem Suppl. 1997; 27: 68-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9591195&dopt=Abstract
·
Chemopreventive effect of green tea (Camellia sinensis) among cigarette smokers. Author(s): Shim JS, Kang MH, Kim YH, Roh JK, Roberts C, Lee IP. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1995 June; 4(4): 387-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7655335&dopt=Abstract
·
Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression. Author(s): Hsu S, Lewis JB, Borke JL, Singh B, Dickinson DP, Caughman GB, Athar M, Drake L, Aiken AC, Huynh CT, Das BR, Osaki T, Schuster GS. Source: Anticancer Res. 2001 November-December; 21(6A): 3743-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11911242&dopt=Abstract
Studies 81
·
Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Author(s): Lyn-Cook BD, Rogers T, Yan Y, Blann EB, Kadlubar FF, Hammons GJ. Source: Nutrition and Cancer. 1999; 35(1): 80-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10624710&dopt=Abstract
·
Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Author(s): Mitscher LA, Jung M, Shankel D, Dou JH, Steele L, Pillai SP. Source: Medicinal Research Reviews. 1997 July; 17(4): 327-65. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9211396&dopt=Abstract
·
Chernobyl radioactivity in a Turkish tea drinker. Author(s): Hayball MP, Dendy PP, Palmer KE, Szaz KF, Webster MJ, Whittaker MV. Source: Health Physics. 1989 December; 57(6): 1017-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2584017&dopt=Abstract
·
Chinese tea consumption and lower risk of Helicobacter infection. Author(s): Yee YK, Koo MW, Szeto ML. Source: Journal of Gastroenterology and Hepatology. 2002 May; 17(5): 552-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12084028&dopt=Abstract
·
Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. Author(s): Olthof MR, Hollman PC, Buijsman MN, van Amelsvoort JM, Katan MB. Source: The Journal of Nutrition. 2003 June; 133(6): 1806-14. Erratum In: J Nutr. 2003 August; 133(8): 2692. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12771321&dopt=Abstract
·
Chocolate as a source of tea flavonoids. Author(s): Arts IC, Hollman PC, Kromhout D. Source: Lancet. 1999 August 7; 354(9177): 488. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10465183&dopt=Abstract
·
Chocolate contains additional flavonoids not found in tea. Author(s): Lazarus SA, Hammerstone JF, Schmitz HH. Source: Lancet. 1999 November 20; 354(9192): 1825. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10577676&dopt=Abstract
82 Tea
·
Cigarette smoking, alcohol, tea and coffee consumption and pancreas cancer risk: a case-control study from Opole, Poland. Author(s): Zatonski WA, Boyle P, Przewozniak K, Maisonneuve P, Drosik K, Walker AM. Source: International Journal of Cancer. Journal International Du Cancer. 1993 February 20; 53(4): 601-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8436433&dopt=Abstract
·
Cigarette smoking, tea and coffee drinking, and subfecundity. Author(s): Olsen J. Source: American Journal of Epidemiology. 1991 April 1; 133(7): 734-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2018028&dopt=Abstract
·
Circulating endothelial cells: tea leaves for renal disease. Author(s): Segal MS, Bihorac A, Koc M. Source: American Journal of Physiology. Renal Physiology. 2002 July; 283(1): F11-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12060582&dopt=Abstract
·
Clinical and antibacterial effect of tea tree oil--a pilot study. Author(s): Arweiler NB, Donos N, Netuschil L, Reich E, Sculean A. Source: Clinical Oral Investigations. 2000 June; 4(2): 70-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11218503&dopt=Abstract
·
Clinical application of therapeutic erythrocytapheresis (TEA). Author(s): Valbonesi M, Bruni R. Source: Transfusion Science. 2000 June; 22(3): 183-94. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10831921&dopt=Abstract
·
Clinical experience with nordihydroguaiaretic acid--”chaparrel tea” in the treatment of cancer. Author(s): Smart CR, Hogle HH, Vogel H, Broom AD, Bartholomew D. Source: Rocky Mt Med J. 1970 November; 67(11): 39-43. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5480535&dopt=Abstract
·
Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Author(s): Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Source: Gut. 1998 November; 43(5): 699-704. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9824354&dopt=Abstract
Studies 83
·
Clonal production of tea tree oil high in terpinen-4-ol for use in formulations for the treatment of thrush. Author(s): Williams LR. Source: Complementary Therapies in Nursing & Midwifery. 1998 October; 4(5): 133-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9830943&dopt=Abstract
·
Cloning and expression of a human pro(tea)some beta-subunit cDNA: a homologue of the yeast PRE4-subunit essential for peptidylglutamyl-peptide hydrolase activity. Author(s): Gerards WL, Hop FW, Hendriks IL, Bloemendal H. Source: Febs Letters. 1994 June 13; 346(2-3): 151-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8013624&dopt=Abstract
·
Cloning of a human cDNA expressing a high voltage-activating, TEA-sensitive, typeA K+ channel which maps to chromosome 1 band p21. Author(s): Rudy B, Sen K, Vega-Saenz de Miera E, Lau D, Ried T, Ward DC. Source: Journal of Neuroscience Research. 1991 July; 29(3): 401-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1920536&dopt=Abstract
·
Coca tea and urinalysis for cocaine metabolites. Author(s): elSohly MA, Stanford DF, elSohly HN. Source: Journal of Analytical Toxicology. 1986 November-December; 10(6): 256. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3807327&dopt=Abstract
·
Cocaine in herbal tea. Author(s): Siegel RK, Elsohly MA, Plowman T, Rury PM, Jones RT. Source: Jama : the Journal of the American Medical Association. 1986 January 3; 255(1): 40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3940302&dopt=Abstract
·
Coffee and tea and the risk of recurrent colorectal adenomas. Author(s): Baron JA, Greenberg ER, Haile R, Mandel J, Sandler RS, Mott L. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1997 January; 6(1): 7-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8993790&dopt=Abstract
·
Coffee and tea consumption and breast disease. Author(s): Lawson DH, Jick H, Rothman KJ. Source: Surgery. 1981 November; 90(5): 801-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7302833&dopt=Abstract
84 Tea
·
Coffee and tea consumption and cancers of the bladder, colon and rectum. Author(s): Woolcott CG, King WD, Marrett LD. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 2002 April; 11(2): 137-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11984131&dopt=Abstract
·
Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. Author(s): Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pedoe H. Source: Journal of Epidemiology and Community Health. 1993 June; 47(3): 171-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8350026&dopt=Abstract
·
Coffee and tea consumption in relation to the risk of large bowel cancer: a review of epidemiologic studies. Author(s): Rosenberg L. Source: Cancer Letters. 1990 July 31; 52(3): 163-71. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2199027&dopt=Abstract
·
Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. Author(s): Woodward M, Tunstall-Pedoe H. Source: Journal of Epidemiology and Community Health. 1999 August; 53(8): 481-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10562866&dopt=Abstract
·
Coffee and tea consumption, dietary fat intake and serum cholesterol concentration of Finnish men and women. Author(s): Aro A, Pietinen P, Uusitalo U, Tuomilehto J. Source: Journal of Internal Medicine. 1989 August; 226(2): 127-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2769178&dopt=Abstract
·
Coffee and tea in psychiatric hospitals. Author(s): Rippere V. Source: Lancet. 1981 July 4; 2(8236): 48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6113421&dopt=Abstract
·
Coffee and tea influence pharmacokinetics of antipsychotic drugs. Author(s): Kulhanek F, Linde OK. Source: Lancet. 1981 August 15; 2(8242): 359-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6115126&dopt=Abstract
Studies 85
·
Coffee and tea intake and risk of cancers of the colon and rectum: a study of 3,530 cases and 7,057 controls. Author(s): Tavani A, Pregnolato A, La Vecchia C, Negri E, Talamini R, Franceschi S. Source: International Journal of Cancer. Journal International Du Cancer. 1997 October 9; 73(2): 193-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9335441&dopt=Abstract
·
Coffee and tea intake and the risk of myocardial infarction. Author(s): Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Source: American Journal of Epidemiology. 1999 January 15; 149(2): 162-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9921961&dopt=Abstract
·
Coffee intake and death from coronary heart disease. Coffee drinking was compared with tea drinking in monozygotic twins in 18th century. Author(s): Breimer L. Source: Bmj (Clinical Research Ed.). 1996 June 15; 312(7045): 1539. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8646159&dopt=Abstract
·
Coffee, tea and cholesterol. Author(s): Klatsky AL, Petitti DB, Armstrong MA, Friedman GD. Source: The American Journal of Cardiology. 1985 February 15; 55(5): 577-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3969902&dopt=Abstract
·
Coffee, tea and cigarette use. Author(s): Gilbert RM. Source: Can Med Assoc J. 1979 March 3; 120(5): 522, 524. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=436031&dopt=Abstract
·
Coffee, tea and coronary heart disease. Author(s): Thelle DS. Source: Current Opinion in Lipidology. 1995 February; 6(1): 25-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7735710&dopt=Abstract
·
Coffee, tea and VPB. Author(s): Prineas RJ, Jacobs DR Jr, Crow RS, Blackburn H. Source: J Chronic Dis. 1980; 33(2): 67-72. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6153390&dopt=Abstract
86 Tea
·
Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Author(s): Michels KB, Holmberg L, Bergkvist L, Wolk A. Source: Annals of Epidemiology. 2002 January; 12(1): 21-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11750236&dopt=Abstract
·
Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Author(s): Mikuls TR, Cerhan JR, Criswell LA, Merlino L, Mudano AS, Burma M, Folsom AR, Saag KG. Source: Arthritis and Rheumatism. 2002 January; 46(1): 83-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11817612&dopt=Abstract
·
Coffee, tea, and coronary heart-disease. Author(s): Herbel ES, Scala J. Source: Lancet. 1973 July 21; 2(7821): 152-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4124074&dopt=Abstract
·
Coffee, tea, and lifestyle. Author(s): Schwarz B, Bischof HP, Kunze M. Source: Preventive Medicine. 1994 May; 23(3): 377-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8078860&dopt=Abstract
·
Coffee, tea, and mortality. Author(s): Klatsky AL, Armstrong MA, Friedman GD. Source: Annals of Epidemiology. 1993 July; 3(4): 375-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8275213&dopt=Abstract
·
Coffee, tea, and plasma cholesterol: the Jerusalem Lipid Research Clinic prevalence study. Author(s): Yudkin J. Source: British Medical Journal (Clinical Research Ed.). 1985 November 9; 291(6505): 1353. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3933667&dopt=Abstract
·
Coffee, tea, and plasma cholesterol: the Jerusalem Lipid Research Clinic prevalence study. Author(s): Kark JD, Friedlander Y, Kaufmann NA, Stein Y. Source: British Medical Journal (Clinical Research Ed.). 1985 September 14; 291(6497): 699-704. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3929904&dopt=Abstract
Studies 87
·
Coffee, tea, or frostbite? A case report of inflight freezing hazard from dry ice. Author(s): Gamble WB, Bonnecarre ER. Source: Aviation, Space, and Environmental Medicine. 1996 September; 67(9): 880-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9025807&dopt=Abstract
·
Coffee, tea, or milk? Part 1: the service side of care delivery. Author(s): Barnes S. Source: Journal of Perianesthesia Nursing : Official Journal of the American Society of Perianesthesia Nurses / American Society of Perianesthesia Nurses. 2002 October; 17(5): 346-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12384904&dopt=Abstract
·
Coffee, tea, tobacco, and cancer of the large bowel. Author(s): Baron JA, Gerhardsson de Verdier M, Ekbom A. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1994 October-November; 3(7): 565-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7827586&dopt=Abstract
·
Combined contact allergy to tea tree oil and lavender oil complicating chronic vulvovaginitis. Author(s): Varma S, Blackford S, Statham BN, Blackwell A. Source: Contact Dermatitis. 2000 May; 42(5): 309-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10789871&dopt=Abstract
·
Comfrey herb tea and hepatic veno-occlusive disease. Author(s): Ridker PM, McDermott WV. Source: Lancet. 1989 March 25; 1(8639): 657-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2564469&dopt=Abstract
·
Comfrey herb tea-induced hepatic veno-occlusive disease. Author(s): Bach N, Thung SN, Schaffner F. Source: The American Journal of Medicine. 1989 July; 87(1): 97-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2741990&dopt=Abstract
·
Communication in rural health care: tea shops as a Channel. Author(s): Bhandari U, Bhandari V. Source: The Nursing Journal of India. 1983 February; 74(2): 33-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6552553&dopt=Abstract
88 Tea
·
Community-level determinants of child growth in an Indonesian tea plantation. Author(s): Paknawin-Mock J, Jarvis L, Jahari AB, Husaini MA, Pollitt E. Source: European Journal of Clinical Nutrition. 2000 May; 54 Suppl 2: S28-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10902985&dopt=Abstract
·
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Author(s): Steele VE, Kelloff GJ, Balentine D, Boone CW, Mehta R, Bagheri D, Sigman CC, Zhu S, Sharma S. Source: Carcinogenesis. 2000 January; 21(1): 63-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10607735&dopt=Abstract
·
Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Author(s): Williams SN, Shih H, Guenette DK, Brackney W, Denison MS, Pickwell GV, Quattrochi LC. Source: Chemico-Biological Interactions. 2000 November 1; 128(3): 211-29. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11064004&dopt=Abstract
·
Comparative study of antioxidant potential of tea with and without additives. Author(s): Tewari S, Gupta V, Bhattacharya S. Source: Indian J Physiol Pharmacol. 2000 April; 44(2): 215-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10846639&dopt=Abstract
·
Comparison of the effects in vitro of tea tree oil and plaunotol on methicillinsusceptible and methicillin-resistant strains of Staphylococcus aureus. Author(s): Hada T, Furuse S, Matsumoto Y, Hamashima H, Masuda K, Shiojima K, Arai T, Sasatsu M. Source: Microbios. 2001; 106 Suppl 2: 133-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11548201&dopt=Abstract
·
Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. Author(s): Buck DS, Nidorf DM, Addino JG. Source: The Journal of Family Practice. 1994 June; 38(6): 601-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8195735&dopt=Abstract
·
Concentration of marijuana metabolites in the urine after ingestion of hemp seed tea. Author(s): Steinagle GC, Upfal M. Source: Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 1999 June; 41(6): 510-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10390703&dopt=Abstract
Studies 89
·
Congou tea drinking and oesophageal cancer in South China. Author(s): Ke L, Yu P, Zhang ZX, Huang SS, Huang G, Ma XH. Source: British Journal of Cancer. 2002 February 1; 86(3): 346-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11875696&dopt=Abstract
·
Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Author(s): de Maat MP, Pijl H, Kluft C, Princen HM. Source: European Journal of Clinical Nutrition. 2000 October; 54(10): 757-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11083483&dopt=Abstract
·
Consumption of black tea and cancer risk: a prospective cohort study. Author(s): Goldbohm RA, Hertog MG, Brants HA, van Poppel G, van den Brandt PA. Source: Journal of the National Cancer Institute. 1996 January 17; 88(2): 93-100. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8537983&dopt=Abstract
·
Consumption of black tea elicits an increase in plasma antioxidant potential in humans. Author(s): Langley-Evans SC. Source: International Journal of Food Sciences and Nutrition. 2000 September; 51(5): 30915. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11103296&dopt=Abstract
·
Consumption of coffee or tea and symptoms of anxiety. Author(s): Eaton WW, McLeod J. Source: American Journal of Public Health. 1984 January; 74(1): 66-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6689844&dopt=Abstract
·
Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Author(s): O'Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA, Wiseman H. Source: The American Journal of Clinical Nutrition. 2001 June; 73(6): 1040-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11382657&dopt=Abstract
·
Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Author(s): van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB. Source: The American Journal of Clinical Nutrition. 1997 November; 66(5): 1125-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9356529&dopt=Abstract
90 Tea
·
Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Author(s): Benzie IF, Szeto YT, Strain JJ, Tomlinson B. Source: Nutrition and Cancer. 1999; 34(1): 83-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10453446&dopt=Abstract
·
Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Author(s): Olthof MR, Hollman PC, Zock PL, Katan MB. Source: The American Journal of Clinical Nutrition. 2001 March; 73(3): 532-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237928&dopt=Abstract
·
Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay. Author(s): Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio JC, Ronco A. Source: Lung Cancer (Amsterdam, Netherlands). 1998 February; 19(2): 101-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9567246&dopt=Abstract
·
Contact allergy due to tea tree oil and cross-sensitization to colophony. Author(s): Selvaag E, Eriksen B, Thune P. Source: Contact Dermatitis. 1994 August; 31(2): 124-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7750261&dopt=Abstract
·
Contact allergy related to TEA-PEG-3 cocamide sulfate and cocamidopropyl betaine in a shampoo. Author(s): Andersen KE, Roed-Petersen J, Kamp P. Source: Contact Dermatitis. 1984 September; 11(3): 192-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6499419&dopt=Abstract
·
Contact allergy to tea tree oil. Author(s): de Groot AC, Weyland JW. Source: Contact Dermatitis. 1993 May; 28(5): 309. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8365143&dopt=Abstract
·
Contact dermatitis associated with the use of tea-tree oil. Author(s): Apted JH. Source: The Australasian Journal of Dermatology. 1991; 32(3): 177. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1823114&dopt=Abstract
Studies 91
·
Contact dermatitis due to tea tree oil. Author(s): Bruynzeel DP. Source: Tropical Medicine & International Health : Tm & Ih. 1999 September; 4(9): 630. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10540304&dopt=Abstract
·
Contact dermatitis from chamomile tea. Author(s): Pereira F, Santos R, Pereira A. Source: Contact Dermatitis. 1997 June; 36(6): 307. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9237012&dopt=Abstract
·
Contaminated herbal tea as a potential source of chronic arsenic poisoning. Author(s): Parsons JS. Source: N C Med J. 1981 January; 42(1): 38-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6937737&dopt=Abstract
·
Continuity and change in a tea-cup: on the symbolic nature of tea-related behaviour among the aged. Author(s): Hazan H. Source: The Sociological Review. 1980 August; 28(3): 497-516. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6160619&dopt=Abstract
·
Controlling gingival bleeding with tea bags. Author(s): Steele SK. Source: Oncology Nursing Forum. 1992 May; 19(4): 663. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1603679&dopt=Abstract
·
Coronary mortality and living standard. II. Coffee, tea, cocoa, alcohol and tobacco. Author(s): Brummer P. Source: Acta Med Scand. 1969 July-August; 186(1-2): 61-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5807646&dopt=Abstract
·
Correlations between the concentrations of fluoride and some other constituents in tea infusions and their possible dental caries-preventive effect. Author(s): Speirs RL. Source: Archives of Oral Biology. 1983; 28(6): 471-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6578764&dopt=Abstract
·
Creatinine clearance overestimated glomerular filtration rate in a heavy tea-drinker. Author(s): De Giorgi A, De Negri F, Fioriti R, Giannarelli C, Carmassi F. Source: American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 2001 April; 37(4): 877-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11273893&dopt=Abstract
92 Tea
·
Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Author(s): Imai K, Nakachi K. Source: Bmj (Clinical Research Ed.). 1995 March 18; 310(6981): 693-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7711535&dopt=Abstract
·
Cryopreservation of tea (Camellia sinensis L.) seeds and embryonic axes. Author(s): Kim HH, Cha YS, Baek HJ, Cho EG, Chae YA, Engelmann F. Source: Cryo Letters. 2002 July-August; 23(4): 209-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12391481&dopt=Abstract
·
Cutaneous photochemoprotection by green tea: a brief review. Author(s): Ahmad N, Mukhtar H. Source: Skin Pharmacology and Applied Skin Physiology. 2001 March-April; 14(2): 6976. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11316965&dopt=Abstract
·
Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. Author(s): Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Source: Journal of the American Academy of Dermatology. 2001 March; 44(3): 425-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11209110&dopt=Abstract
·
Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. Author(s): Smith AY, Feddersen RM, Gardner KD Jr, Davis CJ Jr. Source: The Journal of Urology. 1994 December; 152(6 Pt 1): 2089-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7966683&dopt=Abstract
·
Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Author(s): Hausen BM, Reichling J, Harkenthal M. Source: American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society. 1999 June; 10(2): 68-77. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10357714&dopt=Abstract
·
Dermatomal pruritus precipitated by drinking excessive quantities of black tea. Author(s): Murphy LA, Buckley C. Source: The British Journal of Dermatology. 2000 December; 143(6): 1355-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11122071&dopt=Abstract
Studies 93
·
Determination of catechins in human urine subsequent to tea ingestion by highperformance liquid chromatography with electrochemical detection. Author(s): Yang B, Arai K, Kusu F. Source: Analytical Biochemistry. 2000 July 15; 283(1): 77-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10929811&dopt=Abstract
·
Dietary differences with green tea intake among middle-aged Japanese men and women. Author(s): Tsubono Y, Takahashi T, Iwase Y, Iitoi Y, Akabane M, Tsugane S. Source: Preventive Medicine. 1997 September-October; 26(5 Pt 1): 704-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9327480&dopt=Abstract
·
Diet-genotype interactions: an example from tea. Author(s): Loktionov A, Bingham SA, Cummings JH. Source: The British Journal of Nutrition. 1997 December; 78(6): 1043-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9497454&dopt=Abstract
·
Diuretic activity of an Equisetum bogotense tea (Platero herb): evaluation in healthy volunteers. Author(s): Lemus I, Garcia R, Erazo S, Pena R, Parada M, Fuenzalida M. Source: Journal of Ethnopharmacology. 1996 October; 54(1): 55-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8941869&dopt=Abstract
·
DNA binding of TEA/ATTS domain factors is regulated by protein kinase C phosphorylation in human choriocarcinoma cells. Author(s): Jiang SW, Dong M, Trujillo MA, Miller LJ, Eberhardt NL. Source: The Journal of Biological Chemistry. 2001 June 29; 276(26): 23464-70. Epub 2001 April 19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11313339&dopt=Abstract
·
Does application of tea bags to sore nipples while breastfeeding provide effective relief? Author(s): Lavergne NA. Source: Journal of Obstetric, Gynecologic, and Neonatal Nursing : Jognn / Naacog. 1997 January-February; 26(1): 53-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9017547&dopt=Abstract
·
Does she take sugar in her tea? Author(s): Berry A, Rhodes C. Source: Nurs Mirror. 1977 November 24; 145(21): 19. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=243253&dopt=Abstract
94 Tea
·
Does tea affect cardiovascular disease? A meta-analysis. Author(s): Peters U, Poole C, Arab L. Source: American Journal of Epidemiology. 2001 September 15; 154(6): 495-503. Erratum In: Am J Epidemiol 2002 April 15; 155(8): 781. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11549554&dopt=Abstract
·
Does tea tree oil have a place in the topical treatment of burns? Author(s): Faoagali J, George N, Leditschke JF. Source: Burns : Journal of the International Society for Burn Injuries. 1997 June; 23(4): 349-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9248647&dopt=Abstract
·
Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)epigallocatechin, into human plasma. Author(s): Nakagawa K, Okuda S, Miyazawa T. Source: Biosci Biotechnol Biochem. 1997 December; 61(12): 1981-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9438978&dopt=Abstract
·
Drink tea, America! Author(s): Douglas S. Source: Dentistry. 1986 April; 6(2): 20-1. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3460749&dopt=Abstract
·
Dynamic investigation of urine, Na, K and Ca excretion after administration of tea, ACTH and ACTH with calcium in patients with articular disease. Author(s): Stepan J, Bremova A. Source: Acta Rheumatol Scand. 1966; 12(3): 219-27. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4289280&dopt=Abstract
·
Earl Grey tea intoxication. Author(s): Finsterer J. Source: Lancet. 2002 April 27; 359(9316): 1484. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11988248&dopt=Abstract
·
Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Author(s): Duffy SJ, Vita JA, Holbrook M, Swerdloff PL, Keaney JF Jr. Source: Arteriosclerosis, Thrombosis, and Vascular Biology. 2001 June; 21(6): 1084-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11397724&dopt=Abstract
Studies 95
·
Effect of ascorbic acid and green tea on endogenous formation of Nnitrosodimethylamine and N-nitrosopiperidine in humans. Author(s): Vermeer IT, Moonen EJ, Dallinga JW, Kleinjans JC, van Maanen JM. Source: Mutation Research. 1999 July 16; 428(1-2): 353-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10518007&dopt=Abstract
·
Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Author(s): Yang GY, Liao J, Li C, Chung J, Yurkow EJ, Ho CT, Yang CS. Source: Carcinogenesis. 2000 November; 21(11): 2035-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11062165&dopt=Abstract
·
Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Author(s): Bingham SA, Vorster H, Jerling JC, Magee E, Mulligan A, Runswick SA, Cummings JH. Source: The British Journal of Nutrition. 1997 July; 78(1): 41-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9292758&dopt=Abstract
·
Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers. Author(s): Wolfram RM, Oguogho A, Efthimiou Y, Budinsky AC, Sinzinger H. Source: Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2002 May-June; 66(5-6): 529-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12144875&dopt=Abstract
·
Effect of black tea on lipid peroxide and glutathione levels in female rats. Author(s): Sur-Altiner D, Yenice B. Source: Drug Metabol Drug Interact. 2000; 16(4): 299-305. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11201308&dopt=Abstract
·
Effect of black tea on teeth. Author(s): Sarkar S, Sett P, Chowdhury T, Ganguly DK. Source: J Indian Soc Pedod Prev Dent. 2000 December; 18(4): 139-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11601182&dopt=Abstract
·
Effect of coffee and tea drinking on postprandial hypotension in older men and women. Author(s): Rakic V, Beilin LJ, Burke V. Source: Clinical and Experimental Pharmacology & Physiology. 1996 June-July; 23(6-7): 559-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8800584&dopt=Abstract
96 Tea
·
Effect of coffee and tea on blood levels and efficacy of antipsychotic drugs. Author(s): Bowen S, Taylor KM, Gibb IA. Source: Lancet. 1981 May 30; 1(8231): 1217-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6112560&dopt=Abstract
·
Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Author(s): Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Source: Alimentary Pharmacology & Therapeutics. 1994 June; 8(3): 283-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7918922&dopt=Abstract
·
Effect of different levels of an ascorbic acid and tea mixture on nonheme iron absorption from a typical Tunisian meal fed to healthy rats. Author(s): Hamdauoui M, Doghri T, Tritar B. Source: Annals of Nutrition & Metabolism. 1995; 39(5): 310-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8585701&dopt=Abstract
·
Effect of tea and coffee consumption on non-haem iron absorption: some questions about milk. Author(s): Farkas CS, Harding le Riche W. Source: Hum Nutr Clin Nutr. 1987 March; 41(2): 161-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3570873&dopt=Abstract
·
Effect of tea and coffee consumption on serum uric acid levels by liquidchromatographic and uricase methods. Author(s): Yuan SC, Wang CJ, Kuo HW, Maa MC, Hsieh YS. Source: Bulletin of Environmental Contamination and Toxicology. 2000 September; 65(3): 300-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10903352&dopt=Abstract
·
Effect of tea and other dietary factors on iron absorption. Author(s): Zijp IM, Korver O, Tijburg LB. Source: Critical Reviews in Food Science and Nutrition. 2000 September; 40(5): 371-98. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11029010&dopt=Abstract
·
Effect of tea drinking on muscular efficiency with special reference to relief of physiological fatigue. Author(s): Maitra SR, Koley J, Mukherjee SP, Koley BN. Source: J Exp Med Sci. 1967 September-December; 11(2): 56-62. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5623206&dopt=Abstract
Studies 97
·
Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Author(s): Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H. Source: The American Journal of Clinical Nutrition. 1997 August; 66(2): 261-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9250103&dopt=Abstract
·
Effect of tea on gastric acid secretion. Author(s): Dubey P, Sundram KR, Nundy S. Source: Digestive Diseases and Sciences. 1984 March; 29(3): 202-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6546540&dopt=Abstract
·
Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro. Author(s): Elattar TM, Virji AS. Source: Anticancer Res. 2000 September- October; 20(5B): 3459-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11131648&dopt=Abstract
·
Effect of tea prepared from leaves of Syzygium jambos on glucose tolerance in nondiabetic subjects. Author(s): Teixeira CC, Fuchs FD, Blotta RM, Knijnik J, Delgado IC, Netto MS, Ferreira E, Costa AP, Mussnich DG, Ranquetat GG, et al. Source: Diabetes Care. 1990 August; 13(8): 907-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2209336&dopt=Abstract
·
Effect of the administration of tea on the excretion of DMPEA. Author(s): Friedhoff AJ, Meller E, Schweitzer JW. Source: The American Journal of Psychiatry. 1972 March; 128(9): 1149-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5060838&dopt=Abstract
·
Effect of vegetables, tea, and soy on endogenous N-nitrosation, fecal ammonia, and fecal water genotoxicity during a high red meat diet in humans. Author(s): Hughes R, Pollock JR, Bingham S. Source: Nutrition and Cancer. 2002; 42(1): 70-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12235653&dopt=Abstract
·
Effects of cigarette smoking, alcohol, coffee and tea consumption on preterm delivery. Author(s): Berkowitz GS, Holford TR, Berkowitz RL. Source: Early Human Development. 1982 December 6; 7(3): 239-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7160334&dopt=Abstract
98 Tea
·
Effects of coffee and tea on lipoproteins and prostanoids. Author(s): Aro A, Kostiainen E, Huttunen JK, Seppala E, Vapaatalo H. Source: Atherosclerosis. 1985 October; 57(1): 123-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4074461&dopt=Abstract
·
Effects of deprivation and pre-loading on the experimental consumption of tea by alcoholics and social drinkers. Author(s): Williams RJ. Source: The British Journal of Addiction to Alcohol and Other Drugs. 1977 March; 72(1): 31-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=265723&dopt=Abstract
·
Effects of drinking green tea. Author(s): Roberts JA. Source: Bmj (Clinical Research Ed.). 1995 August 19; 311(7003): 513. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7647675&dopt=Abstract
·
Effects of fruit juices, processed vegetable juice, orange peel and green tea on endogenous formation of N-nitrosoproline in subjects from a high-risk area for gastric cancer in Moping County, China. Author(s): Xu GP, Song PJ, Reed PI. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 1993 July; 2(4): 327-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8358285&dopt=Abstract
·
Effects of green tea catechins on membrane fluidity. Author(s): Tsuchiya H. Source: Pharmacology. 1999 July; 59(1): 34-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10352424&dopt=Abstract
·
Effects of hot tea, coffee and water ingestion on physiological responses and mood: the role of caffeine, water and beverage type. Author(s): Quinlan P, Lane J, Aspinall L. Source: Psychopharmacology. 1997 November; 134(2): 164-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9399380&dopt=Abstract
·
Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Author(s): Hong J, Smith TJ, Ho CT, August DA, Yang CS. Source: Biochemical Pharmacology. 2001 November 1; 62(9): 1175-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11705450&dopt=Abstract
Studies 99
·
Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Author(s): Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ. Source: European Journal of Clinical Nutrition. 2001 October; 55(10): 881-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11593350&dopt=Abstract
·
Effects of several tea components on acid resistance of human tooth enamel. Author(s): Yu H, Oho T, Xu LX. Source: Journal of Dentistry. 1995 April; 23(2): 101-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7738265&dopt=Abstract
·
Effects of soaking temperature and soaking time during preparation of water extract of tea on anticlastogenicity against environmental tobacco smoke in the sisterchromatid exchange assay. Author(s): Zhou R, Zhou Y, Chen D, Li S, Haug A. Source: Toxicology Letters. 2000 April 10; 115(1): 23-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10817628&dopt=Abstract
·
Effects of tea catechin inhalation on methicillin-resistant Staphylococcus aureus in elderly patients in a hospital ward. Author(s): Yamada H, Ohashi K, Atsumi T, Okabe H, Shimizu T, Nishio S, Li XD, Kosuge K, Watanabe H, Hara Y. Source: The Journal of Hospital Infection. 2003 March; 53(3): 229-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12623326&dopt=Abstract
·
Effects of tea catechins on the ERE-regulated estrogenic activity. Author(s): Kuruto-Niwa R, Inoue S, Ogawa S, Muramatsu M, Nozawa R. Source: Journal of Agricultural and Food Chemistry. 2000 December; 48(12): 6355-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11312808&dopt=Abstract
·
Effects of tea consumption on nutrition and health. Author(s): Yang CS, Landau JM. Source: The Journal of Nutrition. 2000 October; 130(10): 2409-12. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11015465&dopt=Abstract
·
Effects of tea on carcinogenesis in animal models and humans. Author(s): Yang CS, Chen L, Lee MJ, Landau JM. Source: Advances in Experimental Medicine and Biology. 1996; 401: 51-61. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8886126&dopt=Abstract
100 Tea
·
Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. Author(s): Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M. Source: Journal of Agricultural and Food Chemistry. 1999 June; 47(6): 2350-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10794635&dopt=Abstract
·
Effects of tea polyphenols on the signal transduction pathways. Author(s): Dong Z, Nomura M, Huang C, Ma WY. Source: Advances in Experimental Medicine and Biology. 2001; 492: 55-67. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11480675&dopt=Abstract
·
Effects on blood pressure of drinking green and black tea. Author(s): Hodgson JM, Puddey IB, Burke V, Beilin LJ, Jordan N. Source: Journal of Hypertension. 1999 April; 17(4): 457-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10404946&dopt=Abstract
·
Efficacy and safety of tea tree oil as a topical antimicrobial agent. Author(s): Carson CF, Riley TV, Cookson BD. Source: The Journal of Hospital Infection. 1998 November; 40(3): 175-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9830588&dopt=Abstract
·
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Author(s): Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J. Source: The American Journal of Clinical Nutrition. 1999 December; 70(6): 1040-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10584049&dopt=Abstract
·
Efficacy of herbal tea preparation in infantile colic. Author(s): Weizman Z, Alkrinawi S, Goldfarb D, Bitran C. Source: The Journal of Pediatrics. 1993 April; 122(4): 650-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8463920&dopt=Abstract
·
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Author(s): Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE, Ellis LM. Source: British Journal of Cancer. 2001 March 23; 84(6): 844-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11259102&dopt=Abstract
Studies 101
·
Endocrine tea leaves: validity of a hormonal profile in predicting patient outcome. Author(s): Woolf PD. Source: Critical Care Medicine. 1995 January; 23(1): 3-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8001383&dopt=Abstract
·
Environmental factors and chronic unexplained dyspepsia. Association with acetaminophen but not other analgesics, alcohol, coffee, tea, or smoking. Author(s): Talley NJ, McNeil D, Piper DW. Source: Digestive Diseases and Sciences. 1988 June; 33(6): 641-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3371135&dopt=Abstract
·
Epigallocatechin gallate. The major causative agent of green tea-induced asthma. Author(s): Shirai T, Sato A, Hara Y. Source: Chest. 1994 December; 106(6): 1801-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7988204&dopt=Abstract
·
Epigallocatechin gallate-induced histamine release in patients with green tea-induced asthma. Author(s): Shirai T, Sato A, Chida K, Hayakawa H, Akiyama J, Iwata M, Taniguchi M, Reshad K, Hara Y. Source: Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 1997 July; 79(1): 65-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9236503&dopt=Abstract
·
Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. Author(s): Nam S, Smith DM, Dou QP. Source: The Journal of Biological Chemistry. 2001 April 20; 276(16): 13322-30. Epub 2001 January 26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11278274&dopt=Abstract
·
Evaluation of Teknaf Enteric Agar (TEA): A modified MacConkey's Agar for the isolation of Shigella dysenteriae type 1 and Shigella flexneri. Author(s): Munshi MM, Morshed MG, Ansaruzzaman M, Alam K, Kay A, Aziz KM, Rahaman MM. Source: Journal of Tropical Pediatrics. 1997 October; 43(5): 307-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9364131&dopt=Abstract
102 Tea
·
Evaluation of the antigenotoxic potential of monomeric and dimeric flavanols, and black tea polyphenols against heterocyclic amine-induced DNA damage in human lymphocytes using the Comet assay. Author(s): Dhawan A, Anderson D, de Pascual-Teresa S, Santos-Buelga C, Clifford MN, Ioannides C. Source: Mutation Research. 2002 March 25; 515(1-2): 39-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11909753&dopt=Abstract
·
Evaluation of the effect of data pre-treatment procedures on classical pattern recognition and principal components analysis: a case study for the geographical classification of tea. Author(s): Moreda-Pineiro A, Marcos A, Fisher A, Hill SJ. Source: Journal of Environmental Monitoring : Jem. 2001 August; 3(4): 352-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11523433&dopt=Abstract
·
Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Author(s): Kris-Etherton PM, Keen CL. Source: Current Opinion in Lipidology. 2002 February; 13(1): 41-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11790962&dopt=Abstract
·
Exaggerated precocious centromere separation in cells of a human breast cancer line treated with a green tea extract. Author(s): Hsu TC, Zhao Y, Wang RY, Dickerson R, Liang JC, Wang X, Wu Y. Source: International Journal of Oncology. 1998 March; 12(3): 617-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9472101&dopt=Abstract
·
Excessive tea consumption can inhibit the efficacy of oral iron treatment in irondeficiency anemia. Author(s): Gabrielli GB, De Sandre G. Source: Haematologica. 1995 November-December; 80(6): 518-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8647516&dopt=Abstract
·
Extrinsic tooth discoloration by metals and chlorhexidine. II. Clinical staining produced by chlorhexidine, iron and tea. Author(s): Addy M, Moran J. Source: British Dental Journal. 1985 November 23; 159(10): 331-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3865675&dopt=Abstract
·
False diagnosis of maple syrup urine disease owing to ingestion of herbal tea. Author(s): Sewell AC, Mosandl A, Bohles H. Source: The New England Journal of Medicine. 1999 September 2; 341(10): 769. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10475807&dopt=Abstract
Studies 103
·
Fatal hepatitis after herbal tea. Author(s): Mostefa-Kara N, Pauwels A, Pines E, Biour M, Levy VG. Source: Lancet. 1992 September 12; 340(8820): 674. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1355234&dopt=Abstract
·
Fatal veno-occlusive disease of the liver associated with herbal tea consumption and radiation. Author(s): Feigen M. Source: Aust N Z J Med. 1984 February; 14(1): 61-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6590010&dopt=Abstract
·
Fertility of women workers on tea estates in Assam. Author(s): Gilroy AB. Source: The Indian Journal of Medical Research. 1966 December; 54(12): 1168-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5975547&dopt=Abstract
·
Filariasis in the labour population of a tea estate in Upper Assam. Author(s): Dutta P, Gogoi BK, Chelleng PK, Bhattacharyya DR, Khan SA, Goswami BK, Mahanta J. Source: The Indian Journal of Medical Research. 1995 June; 101: 245-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7672834&dopt=Abstract
·
Finally I have mastered a cup of tea. Author(s): Nichols EG. Source: Journal of Gerontological Nursing. 1976 July-August; 2(4): 6-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1048154&dopt=Abstract
·
First-derivative spectrophotometric and gas-liquid chromatographic determination of caffeine in foods and pharmaceuticals. I. Rapid determination of caffeine in coffee, tea and soft drinks. Author(s): Abdel-Moety EM. Source: Z Lebensm Unters Forsch. 1988 May; 186(5): 412-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3388978&dopt=Abstract
·
Fluoride and tea. Author(s): Jenkins GN. Source: Lancet. 1969 November 1; 2(7627): 960-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4186618&dopt=Abstract
104 Tea
·
Fluoride and tea. Author(s): Cook HA. Source: Lancet. 1969 August 9; 2(7615): 329. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4184252&dopt=Abstract
·
Fluoride concentration and pH of iced tea products. Author(s): Behrendt A, Oberste V, Wetzel WE. Source: Caries Research. 2002 November-December; 36(6): 405-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12459612&dopt=Abstract
·
Fluoride concentrations in three types of commercially packed tea drinks in Taiwan. Author(s): Lung SC, Hsiao PK, Chiang KM. Source: Journal of Exposure Analysis and Environmental Epidemiology. 2003 January; 13(1): 66-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12595885&dopt=Abstract
·
Fluoride in tea--its dental significance: a review. Author(s): Kavanagh D, Renehan J. Source: J Ir Dent Assoc. 1998; 44(4): 100-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10530119&dopt=Abstract
·
Fluoride intake and its safety among heavy tea drinkers in a British fluoridated city. Author(s): Jenkins GN. Source: Proc Finn Dent Soc. 1991; 87(4): 571-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1775485&dopt=Abstract
·
Food-poisoning due to copper in the morning tea. Author(s): Nicholas PO. Source: Lancet. 1968 July 6; 2(7558): 40-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4172697&dopt=Abstract
·
Foxglove tea poisoning. Author(s): Dickstein ES, Kunkel FW. Source: The American Journal of Medicine. 1980 July; 69(1): 167-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7386503&dopt=Abstract
·
Free radical scavenging by green tea polyphenols. Author(s): Zhao B, Guo Q, Xin W. Source: Methods Enzymol. 2001; 335: 217-31. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11400370&dopt=Abstract
Studies 105
·
Functional characterization of the promoter for the human germ-line T cell receptor J alpha (TEA) transcript. Author(s): de Chasseval R, de Villartay JP. Source: European Journal of Immunology. 1993 June; 23(6): 1294-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8388796&dopt=Abstract
·
Gallic acid metabolites are markers of black tea intake in humans. Author(s): Hodgson JM, Morton LW, Puddey IB, Beilin LJ, Croft KD. Source: Journal of Agricultural and Food Chemistry. 2000 June; 48(6): 2276-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10888536&dopt=Abstract
·
Gastric mucosal morphology in tropics and influence of spices, tea and smoking. Author(s): Tygai KP, Mukhopadhyay AK, Agarwal HH, Naik SR, Malik GB, Cupta DN, Chuttani HK. Source: Nutr Metab. 1974; 17(3): 129-35. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4462037&dopt=Abstract
·
Gastro-intestinal availability of aluminium from tea. Author(s): Powell JJ, Greenfield SM, Parkes HG, Nicholson JK, Thompson RP. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1993 June; 31(6): 449-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8514217&dopt=Abstract
·
Gee, honey, why does the iced tea have a garlic taste? Arsenic intoxication. Author(s): Mack RB. Source: N C Med J. 1983 November; 44(11): 753-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6580553&dopt=Abstract
·
Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a casecontrol study of a high-incidence area in Jiangsu Province, China. Author(s): Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP, Ding JH, Su P, Hu X, Xu TL, Sugimura H, Tajima K. Source: Cancer Letters. 2002 December 15; 188(1-2): 95-102. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12406553&dopt=Abstract
·
Green and black tea consumption by humans: impact on polyphenol concentrations in feces, blood and urine. Author(s): He YH, Kies C. Source: Plant Foods for Human Nutrition (Dordrecht, Netherlands). 1994 October; 46(3): 221-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7855093&dopt=Abstract
106 Tea
·
Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Author(s): Brown MD. Source: Alternative Medicine Review : a Journal of Clinical Therapeutic. 1999 October; 4(5): 360-70. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10559550&dopt=Abstract
·
Green tea and cancer chemoprevention. Author(s): Suganuma M, Okabe S, Sueoka N, Sueoka E, Matsuyama S, Imai K, Nakachi K, Fujiki H. Source: Mutation Research. 1999 July 16; 428(1-2): 339-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10518005&dopt=Abstract
·
Green tea and cancer in humans: a review of the literature. Author(s): Bushman JL. Source: Nutrition and Cancer. 1998; 31(3): 151-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9795966&dopt=Abstract
·
Green tea and colon cancer. Author(s): Kono S. Source: Japanese Journal of Cancer Research : Gann. 1992 June; 83(6): 669. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1644669&dopt=Abstract
·
Green tea and gastric cancer in Japan. Author(s): Kono S. Source: The New England Journal of Medicine. 2001 June 14; 344(24): 1867-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11407354&dopt=Abstract
·
Green tea and gastric cancer. Author(s): Sano T, Sasako M. Source: The New England Journal of Medicine. 2001 March 1; 344(9): 675-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11228285&dopt=Abstract
·
Green tea and its catechins inhibit breast cancer xenografts. Author(s): Sartippour MR, Heber D, Ma J, Lu Q, Go VL, Nguyen M. Source: Nutrition and Cancer. 2001; 40(2): 149-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11962250&dopt=Abstract
·
Green tea and skin. Author(s): Katiyar SK, Ahmad N, Mukhtar H. Source: Archives of Dermatology. 2000 August; 136(8): 989-94. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10926734&dopt=Abstract
Studies 107
·
Green tea and skin--anticarcinogenic effects. Author(s): Mukhtar H, Katiyar SK, Agarwal R. Source: The Journal of Investigative Dermatology. 1994 January; 102(1): 3-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8288907&dopt=Abstract
·
Green tea and the risk of gastric cancer in Japan. Author(s): Tsubono Y, Nishino Y, Komatsu S, Hsieh CC, Kanemura S, Tsuji I, Nakatsuka H, Fukao A, Satoh H, Hisamichi S. Source: The New England Journal of Medicine. 2001 March 1; 344(9): 632-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11228277&dopt=Abstract
·
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Author(s): Stammler G, Volm M. Source: Anti-Cancer Drugs. 1997 March; 8(3): 265-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9095331&dopt=Abstract
·
Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Author(s): Yee WL, Wang Q, Agdinaoay T, Dang K, Chang H, Grandinetti A, Franke AA, Theriault A. Source: Molecular and Cellular Biochemistry. 2002 January; 229(1-2): 85-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11936850&dopt=Abstract
·
Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Author(s): Lamy S, Gingras D, Beliveau R. Source: Cancer Research. 2002 January 15; 62(2): 381-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11809684&dopt=Abstract
·
Green tea catechins such as (-)-epicatechin and (-)-epigallocatechin accelerate Cu2+induced low density lipoprotein oxidation in propagation phase. Author(s): Yamanaka N, Oda O, Nagao S. Source: Febs Letters. 1997 January 20; 401(2-3): 230-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9013893&dopt=Abstract
·
Green tea composition, consumption, and polyphenol chemistry. Author(s): Graham HN. Source: Preventive Medicine. 1992 May; 21(3): 334-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1614995&dopt=Abstract
108 Tea
·
Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. Author(s): Sachinidis A, Seul C, Seewald S, Ahn H, Ko Y, Vetter H. Source: Febs Letters. 2000 April 7; 471(1): 51-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10760511&dopt=Abstract
·
Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Author(s): Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H. Source: Biochemical and Biophysical Research Communications. 2001 October 19; 288(1): 101-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11594758&dopt=Abstract
·
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. Author(s): Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Source: Journal of the National Cancer Institute. 1997 December 17; 89(24): 1881-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9414176&dopt=Abstract
·
Green tea consumption and chronic atrophic gastritis: a cross-sectional study in a green tea production village. Author(s): Shibata K, Moriyama M, Fukushima T, Kaetsu A, Miyazaki M, Une H. Source: J Epidemiol. 2000 September; 10(5): 310-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11059513&dopt=Abstract
·
Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Author(s): Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Source: Preventive Medicine. 1992 July; 21(4): 526-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1409494&dopt=Abstract
·
Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Author(s): Tokunaga S, White IR, Frost C, Tanaka K, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H. Source: Annals of Epidemiology. 2002 April; 12(3): 157-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11897173&dopt=Abstract
Studies 109
·
Green tea consumption and the risk of pancreatic and colorectal cancers. Author(s): Ji BT, Chow WH, Hsing AW, McLaughlin JK, Dai Q, Gao YT, Blot WJ, Fraumeni JF Jr. Source: International Journal of Cancer. Journal International Du Cancer. 1997 January 27; 70(3): 255-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9033623&dopt=Abstract
·
Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Author(s): Chen ZP, Schell JB, Ho CT, Chen KY. Source: Cancer Letters. 1998 July 17; 129(2): 173-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9719459&dopt=Abstract
·
Green tea experiments in lab, clinic yield mixed results. Author(s): Webb T. Source: Journal of the National Cancer Institute. 2000 July 5; 92(13): 1038-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10880545&dopt=Abstract
·
Green tea extract and aged garlic extract inhibit anion transport and sickle cell dehydration in vitro. Author(s): Ohnishi ST, Ohnishi T, Ogunmola GB. Source: Blood Cells, Molecules & Diseases. 2001 January-February; 27(1): 148-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11358376&dopt=Abstract
·
Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Author(s): Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, Mutanen M. Source: European Journal of Nutrition. 1999 June; 38(3): 149-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10443337&dopt=Abstract
·
Green tea extract does not affect urinary markers of lipid peroxidation or thromboxane or nitric oxide synthesis during a high-linoleic acid diet in healthy females. Author(s): Freese R, Basu S, Mutanen M. Source: Lipids. 1999; 34 Suppl: S317. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10419191&dopt=Abstract
110 Tea
·
Green tea extract inhibits nucleoside transport and potentiates the antitumor effect of antimetabolites. Author(s): Zhen Y, Cao S, Xue Y, Wu S. Source: Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'o Hsueh Tsa Chih / Chinese Academy of Medical Sciences. 1991 March; 6(1): 1-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1786398&dopt=Abstract
·
Green tea for remission maintenance in Crohn's disease? Author(s): Alic M. Source: The American Journal of Gastroenterology. 1999 June; 94(6): 1710-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10364058&dopt=Abstract
·
Green tea in chemoprevention of cancer. Author(s): Mukhtar H, Ahmad N. Source: Toxicological Sciences : an Official Journal of the Society of Toxicology. 1999 December; 52(2 Suppl): 111-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10630599&dopt=Abstract
·
Green tea in chemoprevention of cancer. Author(s): Katiyar SK, Agarwal R, Mukhtar H. Source: Compr Ther. 1992 October; 18(10): 3-8. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1458814&dopt=Abstract
·
Green tea intake in relation to serum lipid levels in Middle-aged Japanese men and women. Author(s): Tsubono Y, Tsugane S. Source: Annals of Epidemiology. 1997 May; 7(4): 280-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9177111&dopt=Abstract
·
Green tea monograph. Author(s): McKenna DJ, Hughes K, Jones K. Source: Alternative Therapies in Health and Medicine. 2000 May; 6(3): 61-8, 70-2, 74 Passim. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10802908&dopt=Abstract
·
Green tea or rosemary extract added to foods reduces nonheme-iron absorption. Author(s): Samman S, Sandstrom B, Toft MB, Bukhave K, Jensen M, Sorensen SS, Hansen M. Source: The American Journal of Clinical Nutrition. 2001 March; 73(3): 607-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237939&dopt=Abstract
Studies 111
·
Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Author(s): Annabi B, Lachambre MP, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R. Source: Biochimica Et Biophysica Acta. 2002 January 30; 1542(1-3): 209-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11853893&dopt=Abstract
·
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Author(s): Katiyar SK, Afaq F, Perez A, Mukhtar H. Source: Carcinogenesis. 2001 February; 22(2): 287-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11181450&dopt=Abstract
·
Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis. Author(s): Smith DM, Dou QP. Source: International Journal of Molecular Medicine. 2001 June; 7(6): 645-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11351279&dopt=Abstract
·
Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Author(s): Ahmad N, Gupta S, Mukhtar H. Source: Archives of Biochemistry and Biophysics. 2000 April 15; 376(2): 338-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10775421&dopt=Abstract
·
Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. Author(s): Balasubramanian S, Efimova T, Eckert RL. Source: The Journal of Biological Chemistry. 2002 January 18; 277(3): 1828-36. Epub 2001 November 06. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11698415&dopt=Abstract
·
Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Author(s): Katiyar SK, Perez A, Mukhtar H. Source: Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2000 October; 6(10): 3864-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11051231&dopt=Abstract
112 Tea
·
Green tea polyphenolic antioxidants and skin photoprotection (Review). Author(s): Katiyar SK, Elmets CA. Source: International Journal of Oncology. 2001 June; 18(6): 1307-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11351267&dopt=Abstract
·
Green tea polyphenols and cancer: biologic mechanisms and practical implications. Author(s): Ahmad N, Mukhtar H. Source: Nutrition Reviews. 1999 March; 57(3): 78-83. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10101921&dopt=Abstract
·
Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Author(s): Li HC, Yashiki S, Sonoda J, Lou H, Ghosh SK, Byrnes JJ, Lema C, Fujiyoshi T, Karasuyama M, Sonoda S. Source: Japanese Journal of Cancer Research : Gann. 2000 January; 91(1): 34-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10744042&dopt=Abstract
·
Green tea polyphenols inhibit oxidant-induced DNA strand breakage in cultured lung cells. Author(s): Leanderson P, Faresjo AO, Tagesson C. Source: Free Radical Biology & Medicine. 1997; 23(2): 235-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9199885&dopt=Abstract
·
Green tea polyphenols may be useful in the treatment of androgen-mediated skin disorders. Author(s): Shaw JC. Source: Archives of Dermatology. 2001 May; 137(5): 664. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11346351&dopt=Abstract
·
Green tea polyphenols: DNA photodamage and photoimmunology. Author(s): Katiyar SK, Bergamo BM, Vyalil PK, Elmets CA. Source: Journal of Photochemistry and Photobiology. B, Biology. 2001 December 31; 65(2-3): 109-14. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11809367&dopt=Abstract
·
Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin. Author(s): Zhao JF, Zhang YJ, Jin XH, Athar M, Santella RM, Bickers DR, Wang ZY. Source: The Journal of Investigative Dermatology. 1999 December; 113(6): 1070-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10594754&dopt=Abstract
Studies 113
·
Green tea regulates cell cycle progression in oral leukoplakia. Author(s): Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG. Source: Head & Neck. 1998 September; 20(6): 528-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9702540&dopt=Abstract
·
Green tea, mistletoe, and more: Canadians test alternative cancer therapies. Author(s): Holzman D. Source: Journal of the National Cancer Institute. 1997 May 21; 89(10): 683-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9168180&dopt=Abstract
·
Green tea: biochemical and biological basis for health benefits. Author(s): Liao S, Kao YH, Hiipakka RA. Source: Vitam Horm. 2001; 62: 1-94. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11345896&dopt=Abstract
·
Green tea: what's brewing? Author(s): Wood GS. Source: Archives of Dermatology. 2000 August; 136(8): 1051. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10926742&dopt=Abstract
·
Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Author(s): Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Source: Cancer Causes & Control : Ccc. 1995 November; 6(6): 532-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8580302&dopt=Abstract
·
Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate. Author(s): Liberto M, Cobrinik D. Source: Cancer Letters. 2000 June 30; 154(2): 151-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10806303&dopt=Abstract
·
Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Author(s): Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Source: Cancer Letters. 1995 September 25; 96(2): 239-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7585463&dopt=Abstract
114 Tea
·
Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea. Author(s): Otsuka T, Ogo T, Eto T, Asano Y, Suganuma M, Niho Y. Source: Life Sciences. 1998; 63(16): 1397-403. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9952285&dopt=Abstract
·
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgeninsensitive human prostate carcinoma cells. Author(s): Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Source: Toxicology and Applied Pharmacology. 2000 April 1; 164(1): 82-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10739747&dopt=Abstract
·
Has the tea been ruined? Author(s): Kohlmeier L. Source: The British Journal of Nutrition. 1997 July; 78(1): 1-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9292754&dopt=Abstract
·
Heliotropium lasiocarpum Fisch and Mey identified as cause of veno-occlusive disease due to a herbal tea. Author(s): Culvenor CC, Edgar JA, Smith LW, Kumana CR, Lin HJ. Source: Lancet. 1986 April 26; 1(8487): 978. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2871276&dopt=Abstract
·
Hemorrhagic diathesis caused by drinking an herbal tea. Author(s): Hogan RP 3rd. Source: Jama : the Journal of the American Medical Association. 1983 May 20; 249(19): 2679-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6133016&dopt=Abstract
·
Hepatic veno-occlusive disease due to toxic alkaloid herbal tea. Author(s): Kumana CR, Ng M, Lin HJ, Ko W, Wu PC, Todd D. Source: Lancet. 1983 December 10; 2(8363): 1360-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6139688&dopt=Abstract
·
Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. Author(s): Roulet M, Laurini R, Rivier L, Calame A. Source: The Journal of Pediatrics. 1988 March; 112(3): 433-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3346784&dopt=Abstract
Studies 115
·
Hepatotoxicity due to comfrey herb tea. Author(s): Ridker PN, McDermont WV. Source: The American Journal of Medicine. 1989 December; 87(6): 701. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2629737&dopt=Abstract
·
Herb drinks: camomile tea. Author(s): Farnsworth NR, Morgan BM. Source: Jama : the Journal of the American Medical Association. 1972 July 24; 221(4): 410. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5067856&dopt=Abstract
·
Herbal intoxication. Psychoactive effects from herbal cigarettes, tea, and capsules. Author(s): Siegel RK. Source: Jama : the Journal of the American Medical Association. 1976 August 2; 236(5): 473-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=947067&dopt=Abstract
·
Herbal tea asthma. Author(s): Blanc PD, Trainor WD, Lim DT. Source: Br J Ind Med. 1986 February; 43(2): 137-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3947570&dopt=Abstract
·
Herbal tea in the treatment of diabetes mellitus. Author(s): Ryan EA, Imes S, Wallace C, Jones S. Source: Clinical and Investigative Medicine. Medecine Clinique Et Experimentale. 2000 October; 23(5): 311-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11055324&dopt=Abstract
·
Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Author(s): Kumana CR, Ng M, Lin HJ, Ko W, Wu PC, Todd D. Source: Gut. 1985 January; 26(1): 101-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3965360&dopt=Abstract
·
Herbal tea: an alternative to regular tea for those who form calcium oxalate stones. Author(s): McKay DW, Seviour JP, Comerford A, Vasdev S, Massey LK. Source: Journal of the American Dietetic Association. 1995 March; 95(3): 360-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7860952&dopt=Abstract
116 Tea
·
Hippuric acid as a major excretion product associated with black tea consumption. Author(s): Clifford MN, Copeland EL, Bloxsidge JP, Mitchell LA. Source: Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 2000 March; 30(3): 317-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10752646&dopt=Abstract
·
Holding tea groups: a home visiting program for chronic schizophrenics. Author(s): MacKenzie KR, Anderson J. Source: Hosp Community Psychiatry. 1974 August; 25(8): 509 Passim. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4366857&dopt=Abstract
·
How to make a good cup of tea: exploring the scripts of thought-disordered and nonthought-disordered patients. Author(s): Griggs SA, Green DW. Source: The British Journal of Medical Psychology. 1983 June; 56 (Pt 2): 125-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6882694&dopt=Abstract
·
HPLC determination of catechins and caffeine in tea. Differentiation of green, black and instant teas. Author(s): Fernandez PL, Martin MJ, Gonzalez AG, Pablos F. Source: The Analyst. 2000 March; 125(3): 421-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10829341&dopt=Abstract
·
Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Author(s): Bukowski JF, Morita CT, Brenner MB. Source: Immunity. 1999 July; 11(1): 57-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10435579&dopt=Abstract
·
Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Author(s): Yang CS, Lee MJ, Chen L. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1999 January; 8(1): 83-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9950244&dopt=Abstract
·
Humoral tea leaves: what's at the bottom of the cup? Author(s): Woolf P. Source: Critical Care Medicine. 1995 December; 23(12): 1943-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7497715&dopt=Abstract
Studies 117
·
Hypertension and its risk factors in tea garden workers of Assam. Author(s): Hazarika NC, Biswas D, Narain K, Kalita HC, Mahanta J. Source: Natl Med J India. 2002 March-April; 15(2): 63-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12044117&dopt=Abstract
·
Hypokalemia associated with herbal tea ingestion. Author(s): Satko SG, Burkart JM. Source: Nephron. 2001 January; 87(1): 97-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11174037&dopt=Abstract
·
Hypokalemia with syncope caused by habitual drinking of oolong tea. Author(s): Aizaki T, Osaka M, Hara H, Kurokawa S, Matsuyama K, Aoyama N, Soma K, Ohwada T, Izumi T. Source: Intern Med. 1999 March; 38(3): 252-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10337936&dopt=Abstract
·
I recommended the use of sassafrass tea postpartum to help combat mastitis. Author(s): Lieberman L. Source: Midwifery Today Childbirth Educ. 1993 Summer; (26): 9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8267737&dopt=Abstract
·
Identification and quantitation of alkaloids in coca tea. Author(s): Jenkins AJ, Llosa T, Montoya I, Cone EJ. Source: Forensic Science International. 1996 February 9; 77(3): 179-89. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8819993&dopt=Abstract
·
Identification of a methylated tea catechin as an inhibitor of degranulation in human basophilic KU812 cells. Author(s): Tachibana H, Sunada Y, Miyase T, Sano M, Maeda-Yamamoto M, Yamada K. Source: Biosci Biotechnol Biochem. 2000 February; 64(2): 452-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10737211&dopt=Abstract
·
Identification of potent odorants in Japanese green tea (Sen-cha). Author(s): Kumazawa K, Masuda H. Source: Journal of Agricultural and Food Chemistry. 1999 December; 47(12): 5169-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10606589&dopt=Abstract
·
III.3.b GC-TEA determination of N-nitrosoproline in urine to provide an index for endogenous N-nitrosation. Author(s): Ohshima H. Source: Iarc Sci Publ. 1983; (45): 333-41. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6618612&dopt=Abstract
118 Tea
·
Immunological and respiratory changes in tea workers. Author(s): Zuskin E, Kanceljak B, Skuric Z, Ivankovic D. Source: International Archives of Occupational and Environmental Health. 1985; 56(1): 57-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4030117&dopt=Abstract
·
Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Author(s): Rice-Evans C. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 262-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202400&dopt=Abstract
·
In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Author(s): Hammer KA, Carson CF, Riley TV. Source: Antimicrobial Agents and Chemotherapy. 2000 February; 44(2): 467-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10639388&dopt=Abstract
·
In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Author(s): Banes-Marshall L, Cawley P, Phillips CA. Source: British Journal of Biomedical Science. 2001; 58(3): 139-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11575735&dopt=Abstract
·
In vitro mineral availability from digested tea: a rich dietary source of managanese. Author(s): Powell JJ, Burden TJ, Thompson RP. Source: The Analyst. 1998 August; 123(8): 1721-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10071387&dopt=Abstract
·
In vitro screening of tea leaves effective against dental caries. Author(s): Onisi M, Okumura F, Murakami Y. Source: Koku Eisei Gakkai Zasshi. 1978 January; 27(4): 279-87. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=292656&dopt=Abstract
·
In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Author(s): Hammer KA, Carson CF, Riley TV. Source: Antimicrobial Agents and Chemotherapy. 1999 January; 43(1): 196. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10094671&dopt=Abstract
Studies 119
·
In vivo antioxidant effect of green and black tea in man. Author(s): Serafini M, Ghiselli A, Ferro-Luzzi A. Source: European Journal of Clinical Nutrition. 1996 January; 50(1): 28-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8617188&dopt=Abstract
·
In vivo antioxidant effect of green tea. Author(s): Sung H, Nah J, Chun S, Park H, Yang SE, Min WK. Source: European Journal of Clinical Nutrition. 2000 July; 54(7): 527-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10918460&dopt=Abstract
·
Inactivation of human type A and B influenza viruses by tea-seed saponins. Author(s): Hayashi K, Sagesaka YM, Suzuki T, Suzuki Y. Source: Biosci Biotechnol Biochem. 2000 January; 64(1): 184-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10705466&dopt=Abstract
·
Incidence of hookworm among the workers in tea garden. Author(s): Ali SS, Barbhuiya MA, Rahman AK, Chowdhury SA. Source: Bangladesh Med Res Counc Bull. 1985 December; 11(2): 69-74. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3837665&dopt=Abstract
·
Increased urinary excretion of Al after drinking tea. Author(s): Koch KR, Pougnet MA, de Villiers S, Monteagudo F. Source: Nature. 1988 May 12; 333(6169): 122. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3367985&dopt=Abstract
·
Increasing malaria during an eradication programme. A study on the tea estates in Assam, 1964-68. Author(s): Gilroy AB. Source: Trans R Soc Trop Med Hyg. 1970; 64(4): 555-61. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5485616&dopt=Abstract
·
Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Author(s): Chung LY, Cheung TC, Kong SK, Fung KP, Choy YM, Chan ZY, Kwok TT. Source: Life Sciences. 2001 January 26; 68(10): 1207-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11228105&dopt=Abstract
·
Induction of apoptosis by the oolong tea polyphenol theasinensin A through cytochrome c release and activation of caspase-9 and caspase-3 in human U937 cells. Author(s): Pan MH, Liang YC, Lin-Shiau SY, Zhu NQ, Ho CT, Lin JK. Source: Journal of Agricultural and Food Chemistry. 2000 December; 48(12): 6337-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11312805&dopt=Abstract
120 Tea
·
Induction of apoptosis in human stomach cancer cells by green tea catechins. Author(s): Hibasami H, Komiya T, Achiwa Y, Ohnishi K, Kojima T, Nakanishi K, Akashi K, Hara Y. Source: Oncol Rep. 1998 March-April; 5(2): 527-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9468594&dopt=Abstract
·
Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)epigallocatechin-3-gallate. Author(s): Paschka AG, Butler R, Young CY. Source: Cancer Letters. 1998 August 14; 130(1-2): 1-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9751250&dopt=Abstract
·
Influence of drinking green tea on breast cancer malignancy among Japanese patients. Author(s): Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Source: Japanese Journal of Cancer Research : Gann. 1998 March; 89(3): 254-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9600118&dopt=Abstract
·
Influence of green tea and its three major components upon low-density lipoprotein oxidation. Author(s): Yokozawa T, Dong E. Source: Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie. 1997 December; 49(5): 329-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9455677&dopt=Abstract
·
Influence of tea catechins on the digestive tract. Author(s): Hara Y. Source: J Cell Biochem Suppl. 1997; 27: 52-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9591193&dopt=Abstract
·
Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Author(s): August DA, Landau J, Caputo D, Hong J, Lee MJ, Yang CS. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1999 August; 8(8): 709-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10744131&dopt=Abstract
Studies 121
·
Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Author(s): Muto S, Fujita K, Yamazaki Y, Kamataki T. Source: Mutation Research. 2001 August 8; 479(1-2): 197-206. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11470492&dopt=Abstract
·
Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Author(s): Bertolini F, Fusetti L, Rabascio C, Cinieri S, Martinelli G, Pruneri G. Source: Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2000 August; 14(8): 1477-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10942245&dopt=Abstract
·
Inhibition of carcinogenesis by tea. Author(s): Yang CS, Maliakal P, Meng X. Source: Annual Review of Pharmacology and Toxicology. 2002; 42: 25-54. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11807163&dopt=Abstract
·
Inhibition of carcinogenesis by tea. Author(s): Yang CS. Source: Nature. 1997 September 11; 389(6647): 134-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9296488&dopt=Abstract
·
Inhibition of carcinogenesis by tea: bioavailability of tea polyphenols and mechanisms of actions. Author(s): Yang CS, Kim S, Yang GY, Lee MJ, Liao J, Chung JY, Ho CT. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 213-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202391&dopt=Abstract
·
Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Author(s): Uesato S, Kitagawa Y, Kamishimoto M, Kumagai A, Hori H, Nagasawa H. Source: Cancer Letters. 2001 September 10; 170(1): 41-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11448533&dopt=Abstract
·
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Author(s): Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Source: Carcinogenesis. 1998 April; 19(4): 611-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9600345&dopt=Abstract
122 Tea
·
Inhibition of LDL oxidation by green tea extract. Author(s): Luo M, Kannar K, Wahlqvist ML, O'Brien RC. Source: Lancet. 1997 February 1; 349(9048): 360-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9024405&dopt=Abstract
·
Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Author(s): Isemura M, Saeki K, Minami T, Hayakawa S, Kimura T, Shoji Y, Sazuka M. Source: Annals of the New York Academy of Sciences. 1999 June 30; 878: 629-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10415792&dopt=Abstract
·
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Author(s): Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Source: Proceedings of the National Academy of Sciences of the United States of America. 2001 August 28; 98(18): 10350-5. Epub 2001 Aug 14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11504910&dopt=Abstract
·
Inhibition of radical reaction of apolipoprotein B-100 and alpha-tocopherol in human plasma by green tea catechins. Author(s): Hashimoto R, Yaita M, Tanaka K, Hara Y, Kojo S. Source: Journal of Agricultural and Food Chemistry. 2000 December; 48(12): 6380-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11312811&dopt=Abstract
·
Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Author(s): Jodoin J, Demeule M, Beliveau R. Source: Biochimica Et Biophysica Acta. 2002 January 30; 1542(1-3): 149-59. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11853888&dopt=Abstract
·
Inhibition of tumorigenesis by chemicals from garlic and tea. Author(s): Yang CS, Wang ZY, Hong JY. Source: Advances in Experimental Medicine and Biology. 1994; 354: 113-22. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8067280&dopt=Abstract
·
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Author(s): Jung YD, Ellis LM. Source: International Journal of Experimental Pathology. 2001 December; 82(6): 309-16. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11846837&dopt=Abstract
Studies 123
·
Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogenactivated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Author(s): Katiyar SK, Afaq F, Azizuddin K, Mukhtar H. Source: Toxicology and Applied Pharmacology. 2001 October 15; 176(2): 110-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11601887&dopt=Abstract
·
Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation. Author(s): Yang TT, Koo MW. Source: Atherosclerosis. 2000 January; 148(1): 67-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10580172&dopt=Abstract
·
Inhibitory effect of Chinese tea on N-nitrosation in vitro and in vivo. Author(s): Wang H, Wu Y. Source: Iarc Sci Publ. 1991; (105): 546-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1855915&dopt=Abstract
·
Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Author(s): Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J, Guillen JM. Source: Anti-Cancer Drugs. 1996 June; 7(4): 461-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8826614&dopt=Abstract
·
Inhibitory effect of tea catechins on collagenase activity. Author(s): Makimura M, Hirasawa M, Kobayashi K, Indo J, Sakanaka S, Taguchi T, Otake S. Source: J Periodontol. 1993 July; 64(7): 630-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8396176&dopt=Abstract
·
Inhibitory effects of green tea and grape juice on the phenol sulfotransferase activity of mouse intestines and human colon carcinoma cell line, Caco-2. Author(s): Tamura H, Matsui M. Source: Biological & Pharmaceutical Bulletin. 2000 June; 23(6): 695-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10864017&dopt=Abstract
·
Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Author(s): Sakanaka S, Aizawa M, Kim M, Yamamoto T. Source: Biosci Biotechnol Biochem. 1996 May; 60(5): 745-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8704303&dopt=Abstract
124 Tea
·
Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci. Author(s): Matsumoto M, Minami T, Sasaki H, Sobue S, Hamada S, Ooshima T. Source: Caries Research. 1999 November-December; 33(6): 441-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10529529&dopt=Abstract
·
Interaction between T antigen and TEA domain of the factor TEF-1 derepresses simian virus 40 late promoter in vitro: identification of T-antigen domains important for transcription control. Author(s): Berger LC, Smith DB, Davidson I, Hwang JJ, Fanning E, Wildeman AG. Source: Journal of Virology. 1996 February; 70(2): 1203-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8551581&dopt=Abstract
·
Interaction of chlorpromazine with tea and coffee. Author(s): Cheeseman HJ, Neal MJ. Source: British Journal of Clinical Pharmacology. 1981 August; 12(2): 165-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7197984&dopt=Abstract
·
Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh. Author(s): Gilgen DD, Mascie-Taylor CG, Rosetta LL. Source: Tropical Medicine & International Health : Tm & Ih. 2001 June; 6(6): 449-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11422959&dopt=Abstract
·
Intra uterine contraceptive device in a tea estate. Author(s): Chakravarty BB. Source: Indian Med J. 1966 October; 60(10): 195. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5977004&dopt=Abstract
·
Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Author(s): Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Source: The American Journal of Clinical Nutrition. 2002 May; 75(5): 880-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11976162&dopt=Abstract
·
In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. Author(s): Hammer KA, Carson CF, Riley TV. Source: The Journal of Antimicrobial Chemotherapy. 1998 November; 42(5): 591-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9848442&dopt=Abstract
Studies 125
·
Iron absorption in the thalassemia syndromes and its inhibition by tea. Author(s): de Alarcon PA, Donovan ME, Forbes GB, Landaw SA, Stockman JA 3rd. Source: The New England Journal of Medicine. 1979 January 4; 300(1): 5-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=758174&dopt=Abstract
·
Is children's or parents' coffee or tea consumption associated with the risk for type 1 diabetes mellitus in children? Childhood Diabetes in Finland Study Group. Author(s): Virtanen SM, Rasanen L, Aro A, Ylonen K, Lounamaa R, Akerblom HK, Tuomilehto J. Source: European Journal of Clinical Nutrition. 1994 April; 48(4): 279-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8039488&dopt=Abstract
·
Is the cancer protective effect correlated with growth inhibitions by green tea (-)epigallocatechin gallate mediated through an antioxidant mechanism? Author(s): Cutter H, Wu LY, Kim C, Morre DJ, Morre DM. Source: Cancer Letters. 2001 January 26; 162(2): 149-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11146219&dopt=Abstract
·
Japanese green tea as a cancer preventive in humans. Author(s): Fujiki H, Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Kozu T, Sakai Y. Source: Nutrition Reviews. 1996 November; 54(11 Pt 2): S67-70. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9110578&dopt=Abstract
·
Kombucha, the fermented tea: microbiology, composition, and claimed health effects. Author(s): Greenwalt CJ, Steinkraus KH, Ledford RA. Source: J Food Prot. 2000 July; 63(7): 976-81. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10914673&dopt=Abstract
·
K-TEA Mathematics scores of learning disabled students in resource and inclusive settings. Author(s): Brasher G, Goldman R, Sapp GL. Source: Psychological Reports. 1997 June; 80(3 Pt 1): 773-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9198377&dopt=Abstract
·
Lead poisoning from drinking Kombucha tea brewed in a ceramic pot. Author(s): Phan TG, Estell J, Duggin G, Beer I, Smith D, Ferson MJ. Source: The Medical Journal of Australia. 1998 December 7-21; 169(11-12): 644-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9887919&dopt=Abstract
126 Tea
·
Left cerebral hemi-neglect following carotid TEA: diagnostic, pathogenetic and therapeutic considerations. Author(s): Debus ES, Mullges W, Sailer MA, Reith HB, Franke S. Source: Int Surg. 1998 July-September; 83(3): 194-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9870772&dopt=Abstract
·
Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial. Author(s): Ihme N, Kiesewetter H, Jung F, Hoffmann KH, Birk A, Muller A, Grutzner KI. Source: European Journal of Clinical Pharmacology. 1996; 50(6): 443-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8858269&dopt=Abstract
·
Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins. Author(s): Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Source: Infection and Immunity. 2001 June; 69(6): 3947-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11349063&dopt=Abstract
·
Lemon-tea drinkers--a group at risk? Author(s): Phillips M. Source: The New England Journal of Medicine. 1979 November 1; 301(18): 1005-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=492222&dopt=Abstract
·
Lethal ingestion of Chinese herbal tea containing ch'an su. Author(s): Ko RJ, Greenwald MS, Loscutoff SM, Au AM, Appel BR, Kreutzer RA, Haddon WF, Jackson TY, Boo FO, Presicek G. Source: The Western Journal of Medicine. 1996 January; 164(1): 71-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8779214&dopt=Abstract
·
Letter: Coffee, tea, and apnea. Author(s): Deutsch ME. Source: Jama : the Journal of the American Medical Association. 1976 August 16; 236(7): 823. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=947261&dopt=Abstract
·
Letter: Fluoride and tea. Author(s): Cook HA, France BA. Source: Lancet. 1976 June 26; 1(7974): 1419. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=59067&dopt=Abstract
Studies 127
·
Letter: Oesophageal cancer and hot tea. Author(s): Brunning DA. Source: Lancet. 1974 February 16; 1(7851): 272. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4130282&dopt=Abstract
·
Letter: Salutary tea and abominable coffee. Author(s): Filip L. Source: The New England Journal of Medicine. 1974 February 7; 290(6): 347. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4809299&dopt=Abstract
·
Letter: Tea toxicity. Author(s): Gilbert RM. Source: Jama : the Journal of the American Medical Association. 1976 September 27; 236(13): 1452. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=785046&dopt=Abstract
·
Lifetime consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Author(s): Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Runia S, Boyle P. Source: International Journal of Cancer. Journal International Du Cancer. 1992 February 20; 50(4): 514-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1537615&dopt=Abstract
·
Liver dysfunction and tea eating. Author(s): Murphy KJ. Source: The Medical Journal of Australia. 1975 September 13; 2(11): 428-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1186551&dopt=Abstract
·
Lung cancer risk and mutagenicity of tea. Author(s): Tewes FJ, Koo LC, Meisgen TJ, Rylander R. Source: Environmental Research. 1990 June; 52(1): 23-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2351126&dopt=Abstract
·
Mabi bark tea. Author(s): Seaforth C. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1993 April; 162: 568-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8481759&dopt=Abstract
128 Tea
·
Malaria survey in Tarajulie tea estate and adjoining hamlets in Sonitpur District, Assam. Author(s): Dev V. Source: Indian J Malariol. 1996 March; 33(1): 21-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8690129&dopt=Abstract
·
Mate, coffee, and tea consumption and risk of cancers of the upper aerodigestive tract in southern Brazil. Author(s): Pintos J, Franco EL, Oliveira BV, Kowalski LP, Curado MP, Dewar R. Source: Epidemiology (Cambridge, Mass.). 1994 November; 5(6): 583-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7841239&dopt=Abstract
·
Measurement of plasma concentrations of vasodilators and metabolites by the TEA Analyzer. Author(s): Yu WC, Goff EU. Source: Biopharmaceutics & Drug Disposition. 1983 October-December; 4(4): 311-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6419790&dopt=Abstract
·
Mechanism of cancer chemopreventive activity of green Tea. Author(s): Mukhtar H, Ahmad N. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 234-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202395&dopt=Abstract
·
Mechanisms of action of antioxidants as exemplified in vegetables, tomatoes and tea. Author(s): Weisburger JH. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1999 September-October; 37(9-10): 943-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10541449&dopt=Abstract
·
Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNFalpha expression. Author(s): Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H. Source: Biofactors (Oxford, England). 2000; 13(1-4): 67-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237202&dopt=Abstract
·
Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Author(s): Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Source: Japanese Journal of Cancer Research : Gann. 1997 July; 88(7): 639-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9310136&dopt=Abstract
Studies 129
·
Mechanisms of inhibition of carcinogenesis by tea. Author(s): Yang CS, Chung JY, Yang GY, Li C, Meng X, Lee MJ. Source: Biofactors (Oxford, England). 2000; 13(1-4): 73-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237203&dopt=Abstract
·
Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Author(s): Okabe S, Ochiai Y, Aida M, Park K, Kim SJ, Nomura T, Suganuma M, Fujiki H. Source: Japanese Journal of Cancer Research : Gann. 1999 July; 90(7): 733-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10470285&dopt=Abstract
·
Mechanistic findings of green tea as cancer preventive for humans. Author(s): Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K, Kimura S. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 225-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202393&dopt=Abstract
·
Mediastinal veno-occlusive disease associated with herbal tea ingestion. Author(s): Mehta NJ, Karmody AM, McKneally MF. Source: N Y State J Med. 1986 November; 86(11): 604-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3467230&dopt=Abstract
·
Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. Author(s): Carson CF, Ashton L, Dry L, Smith DW, Riley TV. Source: The Journal of Antimicrobial Chemotherapy. 2001 September; 48(3): 450-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11533019&dopt=Abstract
·
Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Author(s): Hammer KA, Carson CF, Riley TV. Source: Medical Mycology : Official Publication of the International Society for Human and Animal Mycology. 2000 October; 38(5): 355-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11092382&dopt=Abstract
·
Melaleuca oil (tea tree oil) dermatitis. Author(s): Knight TE, Hausen BM. Source: Journal of the American Academy of Dermatology. 1994 March; 30(3): 423-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8113455&dopt=Abstract
130 Tea
·
Mental health. Tea for three. Author(s): Tennant D. Source: Nurs Times. 1989 February 22-28; 85(8): 72-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2928246&dopt=Abstract
·
Meteorologic influences on Plasmodium falciparum malaria in the Highland Tea Estates of Kericho, Western Kenya. Author(s): Shanks GD, Hay SI, Stern DI, Biomndo K, Snow RW. Source: Emerging Infectious Diseases. 2002 December; 8(12): 1404-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12498655&dopt=Abstract
·
Microanastomosis of temporal external artery (TEA) to middle cerebral artery (MCA) branch in 150 cases of cerebrovascular occlusive disease. Author(s): Mrowka R. Source: Zentralblatt Fur Neurochirurgie. 1984; 45(3): 233-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6506934&dopt=Abstract
·
Micronucleus formation in peripheral-blood lymphocytes from smokers and the influence of alcohol- and tea-drinking habits. Author(s): Xue KX, Wang S, Ma GJ, Zhou P, Wu PQ, Zhang RF, Xu Z, Chen WS, Wang YQ. Source: International Journal of Cancer. Journal International Du Cancer. 1992 March 12; 50(5): 702-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1544703&dopt=Abstract
·
Miscarriage prevention tea affects plasma beta-endorphin concentrations in women with early threatened abortions. Author(s): Sun F, Yan DQ, Zhang CL, Yu J, Xiao EN. Source: The American Journal of Chinese Medicine. 1999; 27(2): 277-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10467461&dopt=Abstract
·
Modulation of obesity by a green tea catechin. Author(s): Kao YH, Hiipakka RA, Liao S. Source: The American Journal of Clinical Nutrition. 2000 November; 72(5): 1232-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11063454&dopt=Abstract
·
Mood and drinking: a naturalistic diary study of alcohol, coffee and tea. Author(s): Steptoe A, Wardle J. Source: Psychopharmacology. 1999 January; 141(3): 315-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10027513&dopt=Abstract
Studies 131
·
Morbidity and mortality due to malaria in Tarajulie Tea Estate, Assam, India. Author(s): Gogoi SC, Dev V, Phookan S. Source: Southeast Asian J Trop Med Public Health. 1996 September; 27(3): 526-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9185263&dopt=Abstract
·
More than sympathy: tea now brews up health benefits and gourmet appeal. Author(s): Morrow J. Source: U.S. News & World Report. 2000 February 7; 128(5): 59. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11184139&dopt=Abstract
·
Mortality among female practitioners of Chanoyu (Japanese “tea-ceremony”). Author(s): Sadakata S, Fukao A, Hisamichi S. Source: The Tohoku Journal of Experimental Medicine. 1992 April; 166(4): 475-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1502694&dopt=Abstract
·
Mortality risks of oesophageal cancer associated with hot tea, alcohol, tobacco and diet in Japan. Author(s): Kinjo Y, Cui Y, Akiba S, Watanabe S, Yamaguchi N, Sobue T, Mizuno S, Beral V. Source: J Epidemiol. 1998 October; 8(4): 235-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9816815&dopt=Abstract
·
Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Author(s): Bakerink JA, Gospe SM Jr, Dimand RJ, Eldridge MW. Source: Pediatrics. 1996 November; 98(5): 944-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8909490&dopt=Abstract
·
Muscarinic receptor-mediated inhibition of voltage-activated Ca current in neuroblastoma x glioma hybrid (NG 108-15) cells--reduction of muscarinic agonist and antagonist potency by tetraethylammonium (TEA). Author(s): Caulfield MP. Source: Neuroscience Letters. 1991 June 24; 127(2): 165-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1881626&dopt=Abstract
·
Nanoparticles in plant extracts: influence of drugs on the formation of nanoparticles and precipitates in black tea infusions. Author(s): Groning R, Breitkreutz J, Baroth V, Muller RS. Source: European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences. 2002 March; 15(2): 149-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11849911&dopt=Abstract
132 Tea
·
Natural effective half-life of 137Cs in tea plants. Author(s): Unlu MY, Topcuoglu S, Kucukcezzar R, Varinlioglu A, Gungor N, Bulut AM, Gungor E. Source: Health Physics. 1995 January; 68(1): 94-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7989202&dopt=Abstract
·
Natural history of peptic ulcer disease in Poland. Part IV. Dietary habits, mode of eating, coffee, tea, tobacco and alcohol, addiction's. Author(s): Ruzyllo E, Szostak D. Source: Mater Med Pol. 1989 October-December; 21(4): 313-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2489246&dopt=Abstract
·
Nature of plant stimulators in the production of Acetobacter xylinum (“tea fungus”) biofilm used in skin therapy. Author(s): Fontana JD, Franco VC, de Souza SJ, Lyra IN, de Souza AM. Source: Applied Biochemistry and Biotechnology. 1991 Spring; 28-29: 341-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1929372&dopt=Abstract
·
Niacin, thiamin, iron and protein status of humans as affected by the consumption of tea (Camellia sinensis) infusions. Author(s): Wang RS, Kies C. Source: Plant Foods for Human Nutrition (Dordrecht, Netherlands). 1991 October; 41(4): 337-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1796091&dopt=Abstract
·
No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Author(s): Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, Meinders AE, Pijl H. Source: Arteriosclerosis, Thrombosis, and Vascular Biology. 1998 May; 18(5): 833-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9598844&dopt=Abstract
·
No tea until three? Author(s): Ali K, Spinks J. Source: Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention. 2003 March; 9(1): 92-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12642572&dopt=Abstract
·
Nursing care study--liver failure: drank cup of tea unaided! Author(s): Gratton F. Source: Nurs Mirror. 1982 January 13; 154(2): 46-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6915565&dopt=Abstract
Studies 133
·
Occupational asthma due to tea dust. Author(s): Cartier A, Malo JL. Source: Thorax. 1990 March; 45(3): 203-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2330553&dopt=Abstract
·
Occupational exposure of Sri Lankan tea plantation workers to paraquat. Author(s): Chester G, Gurunathan G, Jones N, Woollen BH. Source: Bulletin of the World Health Organization. 1993; 71(5): 625-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8261566&dopt=Abstract
·
Oleander tea: herbal draught of death. Author(s): Haynes BE, Bessen HA, Wightman WD. Source: Annals of Emergency Medicine. 1985 April; 14(4): 350-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4039113&dopt=Abstract
·
O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-Omethyltransferase. Author(s): Zhu BT, Patel UK, Cai MX, Conney AH. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2000 September; 28(9): 1024-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10950844&dopt=Abstract
·
On Call. I am a subscriber to Harvard Men's Health Watch, but I am writing about my wife, not myself. She's only 58 and she's always been healthy, but over the past year she's been bothered by shaking and trembling in her hands, particularly when she's pouring tea or eating dinner. Her doctor gave her a blood pressure pill, but she's never had high blood pressure. Does she have Parkinson's? Should I take her to a specialist? Author(s): Simon HB. Source: Harvard Men's Health Watch. 2002 February; 6(7): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11869988&dopt=Abstract
·
On technology, science, and tea: what are we doing and why? Author(s): Ausman JI. Source: Surgical Neurology. 2001 December; 56(6): 406-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11755981&dopt=Abstract
·
One for tea, not two. Author(s): Davis SG, Murray JA. Source: Clinical and Laboratory Haematology. 1996 December; 18(4): 289-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9054705&dopt=Abstract
134 Tea
·
Oolong tea increases metabolic rate and fat oxidation in men. Author(s): Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, Komatsu T, Sawaki T, Ishikura Y, Hosoda K. Source: The Journal of Nutrition. 2001 November; 131(11): 2848-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11694607&dopt=Abstract
·
Oolong tea polyphenol extract induces apoptosis in human stomach cancer cells. Author(s): Hibasami H, Jin ZX, Hasegawa M, Urakawa K, Nakagawa M, Ishii Y, Yoshioka K. Source: Anticancer Res. 2000 November-December; 20(6B): 4403-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11205279&dopt=Abstract
·
Opium-tea and prevalence of HIV-1 infection among intravenous drug users in Vienna, Austria, 1986-1991. Author(s): Loimer N. Source: British Journal of Addiction. 1992 July; 87(7): 1078-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1643402&dopt=Abstract
·
Oral fluphenazine and tea and coffee drinking. Author(s): Wallace SM, Suveges LG, Blackburn JL, Korchinski ED, Midha KK. Source: Lancet. 1981 September 26; 2(8248): 691. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6116064&dopt=Abstract
·
Pancreas cancer and coffee and tea consumption: a case-control study. Author(s): Kinlen LJ, McPherson K. Source: British Journal of Cancer. 1984 January; 49(1): 93-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6691902&dopt=Abstract
·
Pesticide exposure of applicators working in tea plantations. Author(s): Wan H. Source: Bulletin of Environmental Contamination and Toxicology. 1990 September; 45(3): 459-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2257342&dopt=Abstract
·
Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. Author(s): Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Source: The Journal of Nutrition. 2001 April; 131(4): 1207-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11285327&dopt=Abstract
Studies 135
·
Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin. Author(s): Dvorakova K, Dorr RT, Valcic S, Timmermann B, Alberts DS. Source: Cancer Chemotherapy and Pharmacology. 1999; 43(4): 331-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10071985&dopt=Abstract
·
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Author(s): Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2001 January; 10(1): 53-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11205489&dopt=Abstract
·
Phase I trial of oral green tea extract in adult patients with solid tumors. Author(s): Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS. Source: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2001 March 15; 19(6): 1830-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11251015&dopt=Abstract
·
Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin. Author(s): Zhao J, Jin X, Yaping E, Zheng ZS, Zhang YJ, Athar M, DeLeo VA, Mukhtar H, Bickers DR, Wang ZY. Source: Photochemistry and Photobiology. 1999 October; 70(4): 637-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10546558&dopt=Abstract
·
Physiological functions of tea polyphenols: Part 2. Author(s): Hara Y. Source: Am Biotechnol Lab. 1994 August; 12(9): 18. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7765153&dopt=Abstract
·
Plaque surface area after rinsing with a low-level fluoride-containing Darjeeling tea. Author(s): Attin T, Hilgers RD, Zimmermann C, Kielbassa AM, Hellwig E. Source: European Journal of Oral Sciences. 1995 December; 103(6): 416-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8747680&dopt=Abstract
136 Tea
·
Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Author(s): van het Hof KH, Wiseman SA, Yang CS, Tijburg LB. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 203-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202389&dopt=Abstract
·
Plasma concentrations of individual tea catechins after a single oral dose in humans. Author(s): Van Amelsvoort JM, Van Hof KH, Mathot JN, Mulder TP, Wiersma A, Tijburg LB. Source: Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 2001 December; 31(12): 891-901. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11780763&dopt=Abstract
·
Plasma levels of aluminium after tea ingestion in healthy volunteers. Author(s): Drewitt PN, Butterworth KR, Springall CD, Moorhouse SR. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1993 January; 31(1): 19-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8444383&dopt=Abstract
·
Poke root herbal tea poisoning. Author(s): Lewis WH, Smith PR. Source: Jama : the Journal of the American Medical Association. 1979 December 21; 242(25): 2759-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=501875&dopt=Abstract
·
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. Author(s): Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albini A. Source: Aids (London, England). 2002 April 12; 16(6): 939-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11919502&dopt=Abstract
·
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVBinduced inflammatory responses and infiltration of leukocytes in human skin. Author(s): Katiyar SK, Matsui MS, Elmets CA, Mukhtar H. Source: Photochemistry and Photobiology. 1999 February; 69(2): 148-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10048310&dopt=Abstract
·
Poppy tea and the baker's first seizure. Author(s): Nelson LS, Hung OL. Source: Lancet. 1997 December 20-27; 350(9094): 1859; Author Reply 1859-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9428289&dopt=Abstract
Studies 137
·
Poppy tea and the baker's first seizure. Author(s): Nowack R. Source: Lancet. 1997 December 20-27; 350(9094): 1859; Author Reply 1859-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9428288&dopt=Abstract
·
Poppy tea and the baker's first seizure. Author(s): Trathen B, Byers S. Source: Lancet. 1997 December 20-27; 350(9094): 1858-9; Author Reply 1859-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9428287&dopt=Abstract
·
Poppy tea and the baker's first seizure. Author(s): King MA, McDonough MA, Drummer OH, Berkovic SF. Source: Lancet. 1997 September 6; 350(9079): 716. Erratum In: Lancet 1997 October 18; 350(9085): 1182. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9291914&dopt=Abstract
·
Poppy tea dependence. Author(s): Unnithan S, Strang J. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1993 December; 163: 813-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8306126&dopt=Abstract
·
Poppy tea drinking in East Anglia. Author(s): London M, O'Regan T, Aust P, Stockford A. Source: British Journal of Addiction. 1990 October; 85(10): 1345-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2265295&dopt=Abstract
·
Possible contribution of green tea drinking habits to the prevention of stroke. Author(s): Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, Kato K, et al. Source: The Tohoku Journal of Experimental Medicine. 1989 April; 157(4): 337-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2741170&dopt=Abstract
·
Potential therapeutic applications of tea in dermatology. Author(s): Alexis AF, Jones VA, Stiller MJ. Source: International Journal of Dermatology. 1999 October; 38(10): 735-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10561043&dopt=Abstract
138 Tea
·
Potential use of tea extract as a complementary mouthwash: comparative evaluation of two commercial samples. Author(s): Esimone CO, Adikwu MU, Nwafor SV, Okolo CO. Source: Journal of Alternative and Complementary Medicine (New York, N.Y.). 2001 October; 7(5): 523-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11719944&dopt=Abstract
·
Power tea (Lippia multiflora)--a potent hypertensive therapy. Author(s): Noamesi BK. Source: West Afr J Pharmacol Drug Res. 1977 June; 4(1): 33-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=602177&dopt=Abstract
·
Presence of aldose reductase inhibitors in tea leaves. Author(s): Sakai I, Izumi SI, Murano T, Okuwaki S, Makino T, Suzuki T. Source: Japanese Journal of Pharmacology. 2001 March; 85(3): 322-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11325026&dopt=Abstract
·
Prevalence of bancroftian filariasis in a foot-hill tea garden of upper Assam. Author(s): Khan AM, Dutta P, Khan SA, Baruah NK, Sarma CK, Mahanta J. Source: J Commun Dis. 1999 June; 31(2): 145-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10810604&dopt=Abstract
·
Prevention in tea and coffee scalds. Author(s): Gonski L. Source: The Medical Journal of Australia. 1979 November 3; 2(9): 484. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=522786&dopt=Abstract
·
Prevention of carcinogenesis by tea polyphenols. Author(s): Yang CS, Prabhu S, Landau J. Source: Drug Metabolism Reviews. 2001 August-November; 33(3-4): 237-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768768&dopt=Abstract
·
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Author(s): Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, Mukhtar H. Source: Proceedings of the National Academy of Sciences of the United States of America. 1999 April 13; 96(8): 4524-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10200295&dopt=Abstract
Studies 139
·
Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Author(s): Ruch RJ, Cheng SJ, Klaunig JE. Source: Carcinogenesis. 1989 June; 10(6): 1003-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2470525&dopt=Abstract
·
Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Author(s): Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Source: Biofactors (Oxford, England). 2000; 13(1-4): 49-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237198&dopt=Abstract
·
Preventive medicine: time for another Boston Tea Party. Author(s): Jameson MG. Source: American Journal of Preventive Medicine. 1995 July-August; 11(4): 213. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7495594&dopt=Abstract
·
Probable antagonism of warfarin by green tea. Author(s): Taylor JR, Wilt VM. Source: The Annals of Pharmacotherapy. 1999 April; 33(4): 426-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10332534&dopt=Abstract
·
Probable gastrointestinal toxicity of Kombucha tea: is this beverage healthy or harmful? Author(s): Srinivasan R, Smolinske S, Greenbaum D. Source: Journal of General Internal Medicine : Official Journal of the Society for Research and Education in Primary Care Internal Medicine. 1997 October; 12(10): 643-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9346462&dopt=Abstract
·
Production paroxysmal nocturnal hemoglobinuria-like red blood cells by tea. Author(s): Benjamin LJ, Goldstein BD, Distenfeld A, Troll W. Source: American Journal of Hematology. 1977; 2(3): 245-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=596368&dopt=Abstract
·
Prophylactic effect of tea on pathogenic micro-organism infection to human and animals. (1). Growth inhibitive and bacteriocidal effect of tea on food poisoning and other pathogenic enterobacterium in vitro. Author(s): Ryu E. Source: Int J Zoonoses. 1980 December; 7(2): 164-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7251263&dopt=Abstract
140 Tea
·
Prophylactic effect of tea on pathogenic microorganism infections to humans and animals. (II). Protozoacidal effect on Toxoplasma gondii in vitro and mice. Author(s): Ryu E. Source: Int J Zoonoses. 1982 December; 9(2): 126-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7169306&dopt=Abstract
·
Prostate cancer chemoprevention by green tea. Author(s): Gupta S, Ahmad N, Mukhtar H. Source: Semin Urol Oncol. 1999 May; 17(2): 70-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10332919&dopt=Abstract
·
Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Author(s): Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H. Source: Cancer Research. 1999 May 1; 59(9): 2115-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10232597&dopt=Abstract
·
Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Author(s): Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, Wang MR, Guo CH, Yu SZ, Kurtz RC, Hsieh CC. Source: International Journal of Cancer. Journal International Du Cancer. 2001 May 15; 92(4): 600-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11304697&dopt=Abstract
·
Protective effects of tea polyphenols against oxidative damage to red blood cells. Author(s): Grinberg LN, Newmark H, Kitrossky N, Rahamim E, Chevion M, Rachmilewitz EA. Source: Biochemical Pharmacology. 1997 November 1; 54(9): 973-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9374417&dopt=Abstract
·
Protective role of black tea against oxidative damage of human red blood cells. Author(s): Halder J, Bhaduri AN. Source: Biochemical and Biophysical Research Communications. 1998 March 27; 244(3): 903-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9535765&dopt=Abstract
·
Psychotic illness following 'mabi bark tea' consumption. Author(s): Hassiotis A, Taylor J. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1992 September; 161: 404-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1393313&dopt=Abstract
Studies 141
·
Pulmonary function and symptoms in herbal tea workers. Author(s): Castellan RM, Boehlecke BA, Petersen MR, Thedell TD, Merchant JA. Source: Chest. 1981 April; 79(4 Suppl): 81S-85S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7471896&dopt=Abstract
·
Pulmonary granulomatosis caused by aspirated green tea. Author(s): Sakamoto O, Saita N, Yamasaki H, Tamanoi M, Ando M. Source: Chest. 1994 July; 106(1): 308-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8020300&dopt=Abstract
·
Radioprotective effects of (-)-epigallocatechin 3-O-gallate (green-tea tannin) in mice. Author(s): Uchida S, Ozaki M, Suzuki K, Shikita M. Source: Life Sciences. 1992; 50(2): 147-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1731169&dopt=Abstract
·
Rapid “tea-bag” peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Author(s): Sallberg M, Ruden U, Magnius LO, Norrby E, Wahren B. Source: Immunology Letters. 1991 September; 30(1): 59-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1720419&dopt=Abstract
·
Re: Consumption of black tea and cancer risk: a prospective cohort study. Author(s): Mukhtar H. Source: Journal of the National Cancer Institute. 1996 June 5; 88(11): 768. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8637037&dopt=Abstract
·
Re: Does tea affect cardiovascular disease? A meta-analysis. Author(s): Thrift AG, Donnan GA. Source: American Journal of Epidemiology. 2002 September 1; 156(5): 490; Author Reply 490-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12196320&dopt=Abstract
·
Reading the tea leaves of psychotropic drug utilization evaluation. Author(s): Shorr RI. Source: Journal of the American Geriatrics Society. 1995 December; 43(12): 1441-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7490401&dopt=Abstract
·
Reanalysis of Blanc PD et al, “Use of herbal products, coffee or black tea, and overthe-counter medications as self treatments among adults with asthma”. Author(s): Blanc PD, Kuschner WG, Katz PP, Yelin EH. Source: The Journal of Allergy and Clinical Immunology. 2000 July; 106(1 Pt 1): 196. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10887326&dopt=Abstract
142 Tea
·
Rebuttal to TV show: “coffee, tea or radiation”. Author(s): Quinn JL. Source: Radiol Technol. 1975 September-October; 47(2): 90-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1188085&dopt=Abstract
·
Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Author(s): Chantre P, Lairon D. Source: Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2002 January; 9(1): 3-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11924761&dopt=Abstract
·
Red wine, green tea and vitamins: do their antioxidants play a role in immunologic protection against cancer or even AIDS? Author(s): Mathe G. Source: Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 1999 May; 53(4): 165-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10392288&dopt=Abstract
·
Red wine, tea, and antioxidants. Author(s): Serafini M, Ghiselli A, Ferro-Luzzi A. Source: Lancet. 1994 August 27; 344(8922): 626. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7915001&dopt=Abstract
·
Red wine, tea, and antioxidants. Author(s): Melville CA. Source: Lancet. 1994 August 27; 344(8922): 626. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7915000&dopt=Abstract
·
Reduced risk of esophageal cancer associated with green tea consumption. Author(s): Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. Source: Journal of the National Cancer Institute. 1994 June 1; 86(11): 855-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8182766&dopt=Abstract
·
Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Author(s): Henry JP, Stephens-Larson P. Source: Hypertension. 1984 May-June; 6(3): 437-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6539755&dopt=Abstract
Studies 143
·
Reduction of dental plaque deposition in humans by oolong tea extract. Author(s): Ooshima T, Minami T, Aono W, Tamura Y, Hamada S. Source: Caries Research. 1994; 28(3): 146-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8033186&dopt=Abstract
·
Regeneration of alpha-tocopherol in human low-density lipoprotein by green tea catechin. Author(s): Zhu QY, Huang Y, Tsang D, Chen ZY. Source: Journal of Agricultural and Food Chemistry. 1999 May; 47(5): 2020-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10552489&dopt=Abstract
·
Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Author(s): Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N, Tominaga S. Source: Cancer Letters. 2001 June 26; 167(2): 175-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11369139&dopt=Abstract
·
Regular ingestion of black tea improves brachial artery vasodilator function. Author(s): Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ. Source: Clinical Science (London, England : 1979). 2002 February; 102(2): 195-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11834139&dopt=Abstract
·
Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. Author(s): Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, Puddey IB. Source: The Journal of Nutrition. 2002 January; 132(1): 55-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11773508&dopt=Abstract
·
Regulation of intestinal glucose transport by tea catechins. Author(s): Shimizu M, Kobayashi Y, Suzuki M, Satsu H, Miyamoto Y. Source: Biofactors (Oxford, England). 2000; 13(1-4): 61-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237201&dopt=Abstract
·
Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Author(s): Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Doi Y, Kawano T, Nakagaki O, Takada K, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A. Source: Annals of Epidemiology. 2000 August; 10(6): 401-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10964006&dopt=Abstract
144 Tea
·
Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. Author(s): Kono S, Shinchi K, Wakabayashi K, Honjo S, Todoroki I, Sakurai Y, Imanishi K, Nishikawa H, Ogawa S, Katsurada M. Source: J Epidemiol. 1996 September; 6(3): 128-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8952216&dopt=Abstract
·
Reproducibility and relative validity of a questionnaire to assess intake of black tea polyphenols in epidemiological studies. Author(s): Hakim IA, Hartz V, Harris RB, Balentine D, Weisgerber UM, Graver E, Whitacre R, Alberts D. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2001 June; 10(6): 667-78. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11401918&dopt=Abstract
·
Rereading the tea leaves. Author(s): Joel LA. Source: The American Journal of Nursing. 1998 November; 98(11): 7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9826924&dopt=Abstract
·
Respiratory disease in tea workers in Sri Lanka. Author(s): Uragoda CG. Source: Thorax. 1980 February; 35(2): 114-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7376114&dopt=Abstract
·
Respiratory disorders and allergies in tea packers. Author(s): Abramson MJ, Sim MR, Fritschi L, Vincent T, Benke G, Rolland JM. Source: Occupational Medicine (Oxford, England). 2001 June; 51(4): 259-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11463870&dopt=Abstract
·
Respiratory function in tea workers. Author(s): Zuskin E, Skuric Z. Source: Br J Ind Med. 1984 February; 41(1): 88-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6691940&dopt=Abstract
·
Respiratory symptoms and respiratory function in workers exposed to tea fluff. Author(s): Hill B, Waldron HA. Source: The Annals of Occupational Hygiene. 1996 October; 40(5): 491-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8888632&dopt=Abstract
Studies 145
·
Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator. Author(s): Bhagavan S, Ibarreta D, Ma D, Kozikowski AP, Etcheberrigaray R. Source: Neurobiology of Disease. 1998 September; 5(3): 177-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9848089&dopt=Abstract
·
Reversal of cancer multidrug resistance by tea polyphenol in KB cells. Author(s): Mei Y, Wei D, Liu J. Source: Journal of Chemotherapy (Florence, Italy). 2003 June; 15(3): 260-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12868553&dopt=Abstract
·
Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. Author(s): Sperl W, Stuppner H, Gassner I, Judmaier W, Dietze O, Vogel W. Source: European Journal of Pediatrics. 1995 February; 154(2): 112-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7720737&dopt=Abstract
·
Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Author(s): Chow WH, Swanson CA, Lissowska J, Groves FD, Sobin LH, NasierowskaGuttmejer A, Radziszewski J, Regula J, Hsing AW, Jagannatha S, Zatonski W, Blot WJ. Source: International Journal of Cancer. Journal International Du Cancer. 1999 June 11; 81(6): 871-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10362132&dopt=Abstract
·
Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Author(s): Ahmad N, Adhami VM, Gupta S, Cheng P, Mukhtar H. Source: Archives of Biochemistry and Biophysics. 2002 February 1; 398(1): 125-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11811957&dopt=Abstract
·
RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter. Author(s): Villey I, de Chasseval R, de Villartay JP. Source: European Journal of Immunology. 1999 December; 29(12): 4072-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10602018&dopt=Abstract
·
Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Author(s): Carson CF, Riley TV. Source: Contact Dermatitis. 2001 August; 45(2): 65-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11553113&dopt=Abstract
146 Tea
·
Sassafras and herb tea. Potential health hazards. Author(s): Segelman AB, Segelman FP, Karliner J, Sofia RD. Source: Jama : the Journal of the American Medical Association. 1976 August 2; 236(5): 477. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=947068&dopt=Abstract
·
Sassafras tea and diaphoresis. Author(s): Haines JD Jr. Source: Postgraduate Medicine. 1991 September 15; 90(4): 75-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1891436&dopt=Abstract
·
Savings accounts for family planning, an illustration from the tea estates of India. Author(s): Ridker R. Source: Stud Fam Plann. 1971 July; 2(7): 150-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5164355&dopt=Abstract
·
Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Author(s): Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ. Source: Cell Biophys. 1989 April; 14(2): 175-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2472207&dopt=Abstract
·
Scavenging effects of Aspalathus linealis (Rooibos tea) on active oxygen species. Author(s): Yoshikawa T, Naito Y, Oyamada H, Ueda S, Tanigawa T, Takemura T, Sugino S, Kondo M. Source: Advances in Experimental Medicine and Biology. 1990; 264: 171-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2173870&dopt=Abstract
·
Screening of anticarcinogenic ingredients in tea polyphenols. Author(s): Han C. Source: Cancer Letters. 1997 March 19; 114(1-2): 153-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9103276&dopt=Abstract
·
Secretaries. More than tea and typing. Author(s): Dix A. Source: Health Serv J. 1996 November 28; 106(5531): 24-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10163224&dopt=Abstract
Studies 147
·
Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Author(s): Liao S, Hiipakka RA. Source: Biochemical and Biophysical Research Communications. 1995 September 25; 214(3): 833-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7575552&dopt=Abstract
·
Sensitivity of titanium brackets to the corrosive influence of fluoride-containing toothpaste and tea. Author(s): Harzer W, Schroter A, Gedrange T, Muschter F. Source: Angle Orthod. 2001 August; 71(4): 318-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11510642&dopt=Abstract
·
Sensory acceptance of Japanese green tea and soy products is linked to genetic sensitivity to 6-n-propylthiouracil. Author(s): Gayathri Devi A, Henderson SA, Drewnowski A. Source: Nutrition and Cancer. 1997; 29(2): 146-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9427978&dopt=Abstract
·
Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia. Author(s): Kamijo Y, Soma K, Asari Y, Ohwada T. Source: Vet Hum Toxicol. 1999 December; 41(6): 381-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10592946&dopt=Abstract
·
Sexually transmitted diseases. More than tea and sympathy. Author(s): Sadler C. Source: Nurs Times. 1988 December 7-13; 84(49): 30-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3205806&dopt=Abstract
·
She should have been at home having tea and cakes. Author(s): Jackson G. Source: Int J Clin Pract. 2002 June; 56(5): 323. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12137436&dopt=Abstract
·
Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Author(s): Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Source: Circulation. 2001 July 10; 104(2): 151-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11447078&dopt=Abstract
148 Tea
·
SK4/IK1-like channels mediate TEA-insensitive, Ca2+-activated K+ currents in bovine parotid acinar cells. Author(s): Takahata T, Hayashi M, Ishikawa T. Source: American Journal of Physiology. Cell Physiology. 2003 January; 284(1): C127-44. Epub 2002 October 09. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12388063&dopt=Abstract
·
Smoking status and its effect on cardiorespiratory system, body dimension and plucking performance of Oraon tea garden labourers. Author(s): Roy SK. Source: Anthropol Anz. 1998 June; 56(2): 151-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9653507&dopt=Abstract
·
Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women's Health Study. Author(s): Harnack LJ, Anderson KE, Zheng W, Folsom AR, Sellers TA, Kushi LH. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1997 December; 6(12): 1081-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9419407&dopt=Abstract
·
Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States). Author(s): Slattery ML, West DW. Source: Cancer Causes & Control : Ccc. 1993 November; 4(6): 559-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8280834&dopt=Abstract
·
Soil contamination with geohelminth ova in a tea plantation. Author(s): Edirisinghe JS, Weilgama DJ. Source: Ceylon Med J. 1997 December; 42(4): 167-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9476399&dopt=Abstract
·
Some aspects of occupational safety and health in green tea workers. Author(s): Mirbod SM, Fujita S, Miyashita K, Inaba R, Iwata H. Source: Ind Health. 1995; 33(3): 101-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8543474&dopt=Abstract
·
Some basic features of the new sleep-aid tea (SAT) for the treatment of insomnia. Author(s): Shiyi L. Source: Sleep Res Online. 2000; 3(2): 49-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11382900&dopt=Abstract
Studies 149
·
Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Author(s): Conney AH, Lou YR, Xie JG, Osawa T, Newmark HL, Liu Y, Chang RL, Huang MT. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1997 November; 216(2): 234-45. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9349692&dopt=Abstract
·
Staining of residual caries under freshly-packed amalgam restorations exposed to tea/chlorhexidine in vitro. Author(s): Kidd EA, Joyston-Bechal S, Smith MM. Source: Int Dent J. 1990 August; 40(4): 219-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2397953&dopt=Abstract
·
Statistical analysis of salivary pH changes after the intake of black tea and yerba mate supplemented with sweeteners. Author(s): Lopez de Bocanera ME, Koss de Stisman MA, Bru de Labanda E, Chervonagura de Gepner A. Source: J Oral Sci. 1999 June; 41(2): 81-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10453132&dopt=Abstract
·
Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Author(s): Li C, Lee MJ, Sheng S, Meng X, Prabhu S, Winnik B, Huang B, Chung JY, Yan S, Ho CT, Yang CS. Source: Chemical Research in Toxicology. 2000 March; 13(3): 177-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10725114&dopt=Abstract
·
Studies on aluminium leaching from cookware in tea and coffee and estimation of aluminium content in toothpaste, baking powder and paan masala. Author(s): Rajwanshi P, Singh V, Gupta MK, Kumari V, Shrivastav R, Ramanamurthy M, Dass S. Source: The Science of the Total Environment. 1997 January 30; 193(3): 243-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9092078&dopt=Abstract
·
Studies on genetic polymorphism in relation to malaria in tea gardens of Dibrugarh district, Assam. Author(s): Balgir RS, Dutta LP. Source: Indian J Malariol. 1990 December; 27(4): 237-41. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2093007&dopt=Abstract
150 Tea
·
Studies on the toxicity of triethylaluminum (TEA). Author(s): Miura T, Nakajima T, Hara I, Hashimoto K, Kusumoto S, Kanai R, Uda K. Source: Int Arch Arbeitsmed. 1972; 29(3): 189-200. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5036156&dopt=Abstract
·
Successful green tea nebulization therapy for subglottic tracheal stenosis due to MRSA infection. Author(s): Yamashita S, Yokoyama K, Matsumiya N, Yamaguchi H. Source: The Journal of Infection. 2001 April; 42(3): 222-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11545562&dopt=Abstract
·
Supplementation of Jurkat T cells with green tea extract decreases oxidative damage due to iron treatment. Author(s): Erba D, Riso P, Colombo A, Testolin G. Source: The Journal of Nutrition. 1999 December; 129(12): 2130-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10573539&dopt=Abstract
·
Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate. Author(s): Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK. Source: Carcinogenesis. 1999 April; 20(4): 733-6. Erratum In: Carcinogenesis 1999 July; 20(7): 1383. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10223207&dopt=Abstract
·
Susceptibility of Plasmodium falciparum to chloroquine in tea garden tribes of Assam, India. Author(s): Gogoi SC, Dev V, Choudhury B, Phookan S. Source: Southeast Asian J Trop Med Public Health. 1995 June; 26(2): 228-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8629050&dopt=Abstract
·
Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Author(s): Hammer KA, Carson CF, Riley TV. Source: American Journal of Infection Control. 1996 June; 24(3): 186-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8806995&dopt=Abstract
·
Sweet preference, consumption of sweet tea and dental caries; studies in urban and rural Iraqi populations. Author(s): Jamel HA, Sheiham A, Watt RG, Cowell CR. Source: Int Dent J. 1997 August; 47(4): 213-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9532462&dopt=Abstract
Studies 151
·
Sweeteners: consumer acceptance in tea. Author(s): Sprowl DJ, Ehrcke LA. Source: Journal of the American Dietetic Association. 1984 September; 84(9): 1020-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6470371&dopt=Abstract
·
Systemic contact dermatitis from tea tree oil. Author(s): de Groot AC, Weyland JW. Source: Contact Dermatitis. 1992 October; 27(4): 279-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1451515&dopt=Abstract
·
Tea and atherosclerosis. Author(s): Young W, Hotovec RL, Romero AG. Source: Nature. 1967 December 9; 216(119): 1015-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6066548&dopt=Abstract
·
Tea and cancer prevention: an evaluation of the epidemiologic literature. Author(s): Kohlmeier L, Weterings KG, Steck S, Kok FJ. Source: Nutrition and Cancer. 1997; 27(1): 1-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8970175&dopt=Abstract
·
Tea and cancer: a review of the epidemiological evidence. Author(s): Blot WJ, Chow WH, McLaughlin JK. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 1996 December; 5(6): 425-38. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9061273&dopt=Abstract
·
Tea and coffee brews are not dietary sources of vitamin K-1 (phylloquinone). Author(s): Booth SL, Madabushi HT, Davidson KW, Sadowski JA. Source: Journal of the American Dietetic Association. 1995 January; 95(1): 82-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7798585&dopt=Abstract
·
Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Author(s): Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR, Albanes D. Source: Nutrition and Cancer. 1998; 31(1): 41-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9682247&dopt=Abstract
152 Tea
·
Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Author(s): Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T, Tominaga S. Source: Cancer Causes & Control : Ccc. 1998 March; 9(2): 209-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9578298&dopt=Abstract
·
Tea and coronary heart disease: protection through estrogen-like activity? Author(s): Geleijnse JM, Witteman JC, Launer LJ, Lamberts SW, Pols HA. Source: Archives of Internal Medicine. 2000 November 27; 160(21): 3328-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11088099&dopt=Abstract
·
Tea and coronary heart disease: the flavonoid quercetin is more bioavailable from rutin in women than in men. Author(s): Erlund I, Alfthan G, Maenpaa J, Aro A. Source: Archives of Internal Medicine. 2001 August 13-27; 161(15): 1919-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11493148&dopt=Abstract
·
Tea and fertility. Author(s): Wilcox AJ, Weinberg CR. Source: Lancet. 1991 May 11; 337(8750): 1159-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1674032&dopt=Abstract
·
Tea and health. Author(s): Rajgopal T. Source: J Indian Med Assoc. 2001 February; 99(2): 93-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11482810&dopt=Abstract
·
Tea and health. Author(s): Trevisanato SI, Kim YI. Source: Nutrition Reviews. 2000 January; 58(1): 1-10. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10697388&dopt=Abstract
·
Tea and health. Author(s): Yang CS. Source: Nutrition (Burbank, Los Angeles County, Calif.). 1999 November-December; 15(11-12): 946-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10575676&dopt=Abstract
Studies 153
·
Tea and health: a historical perspective. Author(s): Weisburger JH. Source: Cancer Letters. 1997 March 19; 114(1-2): 315-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9103320&dopt=Abstract
·
Tea and health: the underlying mechanisms. Author(s): Weisburger JH. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 271-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202402&dopt=Abstract
·
Tea and heart disease. Author(s): Walsh GP. Source: Lancet. 1997 March 8; 349(9053): 735. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9078231&dopt=Abstract
·
Tea and prostate cancer. Author(s): Chhabra SK, Yang CS. Source: Epidemiologic Reviews. 2001; 23(1): 106-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11588833&dopt=Abstract
·
Tea and sympathy. and Guinness too. Author(s): Lavery M. Source: Nursing Standard : Official Newspaper of the Royal College of Nursing. 1995 November 8-14; 10(7): 50-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8546966&dopt=Abstract
·
Tea and sympathy on wheels. Author(s): Smith J. Source: Health Serv J. 1990 January 25; 100(5185): 122-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10103681&dopt=Abstract
·
Tea and sympathy. Author(s): Davies H. Source: Nurs Times. 1993 March 24-30; 89(12): 53. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8247856&dopt=Abstract
·
Tea and tea polyphenols in cancer prevention. Author(s): Yang CS, Yang GY, Chung JY, Lee MJ, Li C. Source: Advances in Experimental Medicine and Biology. 2001; 492: 39-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11480674&dopt=Abstract
154 Tea
·
Tea and tea polyphenols in cancer prevention. Author(s): Yang CS, Chung JY, Yang G, Chhabra SK, Lee MJ. Source: The Journal of Nutrition. 2000 February; 130(2S Suppl): 472S-478S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10721932&dopt=Abstract
·
Tea as a source of Acinetobacter baumannii ventilator-associated pneumonia? Author(s): Hauer T, Jonas D, Dettenkofer M, Daschner FD. Source: Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America. 1999 September; 20(9): 594. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10501254&dopt=Abstract
·
Tea bags and sore nipples. Author(s): Schrob M. Source: Journal of Human Lactation : Official Journal of International Lactation Consultant Association. 1992 December; 8(4): 195-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1288551&dopt=Abstract
·
Tea breaks could help calm fluoride debate. Author(s): Wilks C. Source: British Dental Journal. 2000 January 22; 188(2): 61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10689765&dopt=Abstract
·
Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. Author(s): Nakagawa K, Ninomiya M, Okubo T, Aoi N, Juneja LR, Kim M, Yamanaka K, Miyazawa T. Source: Journal of Agricultural and Food Chemistry. 1999 October; 47(10): 3967-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10552751&dopt=Abstract
·
Tea catechins and related polyphenols as anti-cancer agents. Author(s): Isemura M, Saeki K, Kimura T, Hayakawa S, Minami T, Sazuka M. Source: Biofactors (Oxford, England). 2000; 13(1-4): 81-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11237204&dopt=Abstract
·
Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Author(s): Kondo T, Ohta T, Igura K, Hara Y, Kaji K. Source: Cancer Letters. 2002 June 28; 180(2): 139-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12175544&dopt=Abstract
Studies 155
·
Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Author(s): Osada K, Takahashi M, Hoshina S, Nakamura M, Nakamura S, Sugano M. Source: Comparative Biochemistry and Physiology. Toxicology & Pharmacology : Cbp. 2001 February; 128(2): 153-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11239828&dopt=Abstract
·
Tea chemicals confirmed as cancer-busting compounds. Author(s): Morris K. Source: The Lancet Oncology. 2002 May; 3(5): 262. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12067792&dopt=Abstract
·
Tea consumption and cancer risk. Author(s): La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. Source: Nutrition and Cancer. 1992; 17(1): 27-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1574442&dopt=Abstract
·
Tea consumption and cancer. Author(s): Katiyar SK, Mukhtar H. Source: World Review of Nutrition and Dietetics. 1996; 79: 154-84. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9111814&dopt=Abstract
·
Tea consumption and iron status. Author(s): Temme EH, Van Hoydonck PG. Source: European Journal of Clinical Nutrition. 2002 May; 56(5): 379-86. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12001007&dopt=Abstract
·
Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Author(s): Ohno Y, Wakai K, Genka K, Ohmine K, Kawamura T, Tamakoshi A, Aoki R, Senda M, Hayashi Y, Nagao K, et al. Source: Japanese Journal of Cancer Research : Gann. 1995 November; 86(11): 1027-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8567392&dopt=Abstract
·
Tea consumption and mortality after acute myocardial infarction. Author(s): Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Source: Circulation. 2002 May 28; 105(21): 2476-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12034652&dopt=Abstract
156 Tea
·
Tea consumption and risk of bladder and kidney cancers in a population-based casecontrol study. Author(s): Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF, Cantor KP. Source: American Journal of Epidemiology. 2000 February 15; 151(4): 377-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10695596&dopt=Abstract
·
Tea consumption and risk of cancer of the colon and rectum. Author(s): Cerhan JR, Putnam SD, Bianchi GD, Parker AS, Lynch CF, Cantor KP. Source: Nutrition and Cancer. 2001; 41(1-2): 33-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12094626&dopt=Abstract
·
Tea consumption and the prevalence of coronary heart disease in Saudi adults: results from a Saudi national study. Author(s): Hakim IA, Alsaif MA, Alduwaihy M, Al-Rubeaan K, Al-Nuaim AR, Al-Attas OS. Source: Preventive Medicine. 2003 January; 36(1): 64-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12473426&dopt=Abstract
·
Tea consumption and the reduced risk of colon cancer -- results from a national prospective cohort study. Author(s): Su LJ, Arab L. Source: Public Health Nutrition. 2002 June; 5(3): 419-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12003653&dopt=Abstract
·
Tea consumption and the risk of colorectal cancer in Sweden. Author(s): Terry P, Wolk A. Source: Nutrition and Cancer. 2001; 39(2): 176-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11759277&dopt=Abstract
·
Tea consumption, lipid metabolism, and atherosclerosis. Author(s): Kritz H, Sinzinger H. Source: Wiener Klinische Wochenschrift. 1997 December 23; 109(24): 944-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9491537&dopt=Abstract
·
Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality. Author(s): Stensvold I, Tverdal A, Solvoll K, Foss OP. Source: Preventive Medicine. 1992 July; 21(4): 546-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1409496&dopt=Abstract
Studies 157
·
Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Author(s): Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC. Source: Urology. 1999 November; 54(5): 823-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10565741&dopt=Abstract
·
Tea drinking and bone mineral density in older women. Author(s): Hegarty VM, May HM, Khaw KT. Source: The American Journal of Clinical Nutrition. 2000 April; 71(4): 1003-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10731510&dopt=Abstract
·
Tea drinking and haemostasis: a randomized, placebo-controlled, crossover study in free-living subjects. Author(s): Vorster H, Jerling J, Oosthuizen W, Cummings J, Bingham S, Magee L, Mulligan A, Runswick S. Source: Haemostasis. 1996 January-February; 26(1): 58-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8698279&dopt=Abstract
·
Tea flavonoids and cardiovascular disease: a review. Author(s): Tijburg LB, Mattern T, Folts JD, Weisgerber UM, Katan MB. Source: Critical Reviews in Food Science and Nutrition. 1997 December; 37(8): 771-85. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9447275&dopt=Abstract
·
Tea flavonoids and cardiovascular health. Author(s): Riemersma RA, Rice-Evans CA, Tyrrell RM, Clifford MN, Lean ME. Source: Qjm : Monthly Journal of the Association of Physicians. 2001 May; 94(5): 277-82. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11353103&dopt=Abstract
·
Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Author(s): Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC. Source: Archives of Internal Medicine. 1999 October 11; 159(18): 2170-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10527294&dopt=Abstract
·
Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Author(s): Wiseman S, Mulder T, Rietveld A. Source: Antioxidants & Redox Signalling. 2001 December; 3(6): 1009-21. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11813977&dopt=Abstract
158 Tea
·
Tea flavonols in cardiovascular disease and cancer epidemiology. Author(s): Hollman PC, Feskens EJ, Katan MB. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 198-202. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202388&dopt=Abstract
·
Tea for all? Author(s): SoRelle R. Source: Circulation. 2002 May 28; 105(21): E9109-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12034673&dopt=Abstract
·
Tea for two. Author(s): Sherman P. Source: Midwifery Today Childbirth Educ. 1994 Spring; (29): 22-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8148902&dopt=Abstract
·
Tea maker's asthma. Author(s): Uragoda CG. Source: Br J Ind Med. 1970 April; 27(2): 181-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5428639&dopt=Abstract
·
Tea polyphenol intake and changes in serum pepsinogen levels. Author(s): Hamajima N, Tajima K, Tominaga S, Matsuura A, Kuwabara M, Okuma K. Source: Japanese Journal of Cancer Research : Gann. 1999 February; 90(2): 136-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10189883&dopt=Abstract
·
Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Author(s): Ren F, Zhang S, Mitchell SH, Butler R, Young CY. Source: Oncogene. 2000 April 6; 19(15): 1924-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10773882&dopt=Abstract
·
Tea tannin components modify the induction of sister-chromatid exchanges and chromosome aberrations in mutagen-treated cultured mammalian cells and mice. Author(s): Imanishi H, Sasaki YF, Ohta T, Watanabe M, Kato T, Shirasu Y. Source: Mutation Research. 1991 January; 259(1): 79-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1899132&dopt=Abstract
Studies 159
·
Tea therapy? Out of the cup, into the lab. Author(s): Vastag B. Source: Journal of the National Cancer Institute. 1998 October 21; 90(20): 1504-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9790539&dopt=Abstract
·
Tea time. Author(s): Greiner B. Source: Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses. 1997 May-June; 22(3): 152. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9171724&dopt=Abstract
·
Tea tree oil allergy: what is the offending agent? Report of three cases of tea tree oil allergy and review of the literature. Author(s): Rubel DM, Freeman S, Southwell IA. Source: The Australasian Journal of Dermatology. 1998 November; 39(4): 244-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9838722&dopt=Abstract
·
Tea tree oil and anaerobic (bacterial) vaginosis. Author(s): Blackwell AL. Source: Lancet. 1991 February 2; 337(8736): 300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1671134&dopt=Abstract
·
Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. Author(s): Caelli M, Porteous J, Carson CF, Heller R, Riley TV. Source: The Journal of Hospital Infection. 2000 November; 46(3): 236-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11073734&dopt=Abstract
·
Tea tree oil in the treatment of tinea pedis. Author(s): Tong MM, Altman PM, Barnetson RS. Source: The Australasian Journal of Dermatology. 1992; 33(3): 145-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1303075&dopt=Abstract
·
Tea tree oil poisoning. Author(s): Moss A. Source: The Medical Journal of Australia. 1994 February 21; 160(4): 236. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8309407&dopt=Abstract
·
Tea tree oil: the science behind the antimicrobial hype. Author(s): Allen P. Source: Lancet. 2001 October 13; 358(9289): 1245. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11675072&dopt=Abstract
160 Tea
·
Tea with Sir William Osler. Author(s): Weatherall DJ. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 October 5; 161(7): 837-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10530303&dopt=Abstract
·
TEA(+)-sensitive KCNQ1 constructs reveal pore-independent access to KCNE1 in assembled I(Ks) channels. Author(s): Kurokawa J, Motoike HK, Kass RS. Source: The Journal of General Physiology. 2001 January; 117(1): 43-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11134230&dopt=Abstract
·
Tea, sympathy and the psychiatric nurse. Author(s): McDermott G, Purryag T. Source: Nursing Standard : Official Newspaper of the Royal College of Nursing. 1995 June 28-July 4; 9(40): 46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7619696&dopt=Abstract
·
Tea: not immoral, illegal, or fattening, but is it innocuous? Author(s): Oudesluys-Murphy AM, Oudesluys N. Source: Lancet. 2002 September 14; 360(9336): 878. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12243952&dopt=Abstract
·
Tea--a potent agent to prevent disease? Author(s): Najemnik C, Sinzinger H, Kritz H. Source: Wiener Klinische Wochenschrift. 1999 April 9; 111(7): 259-61. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10355036&dopt=Abstract
·
Teas and tea components as inhibitors of carcinogen formation in model systems and man. Author(s): Stich HF. Source: Preventive Medicine. 1992 May; 21(3): 377-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1614999&dopt=Abstract
·
Teeth, tea and Tibetans. Author(s): Marchant H. Source: Community Dent Health. 1991 December; 8(4): 369-72. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1790482&dopt=Abstract
Studies 161
·
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Author(s): Naasani I, Seimiya H, Tsuruo T. Source: Biochemical and Biophysical Research Communications. 1998 August 19; 249(2): 391-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9712707&dopt=Abstract
·
Temporal variations in biting density and rhythm of Culex quinquefasciatus in tea agro-ecosystem of Assam, India. Author(s): Mahanta B, Handique R, Dutta P, Narain K, Mahanta J. Source: Southeast Asian J Trop Med Public Health. 1999 December; 30(4): 804-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10928380&dopt=Abstract
·
Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Author(s): Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Source: Inflammation Research : Official Journal of the European Histamine Research Society. [et Al.]. 2000 November; 49(11): 619-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11131302&dopt=Abstract
·
The “pink spot,” 3,4-dimethoxyphenylethylamine, common tea, and schizophrenia. Author(s): Stabenau JR, Creveling CR, Daly J. Source: The American Journal of Psychiatry. 1970 November; 127(5): 611-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5491537&dopt=Abstract
·
The antibacterial activity of tea in vitro and in vivo (in patients with impetigo contagiosa). Author(s): Sharquie KE, al-Turfi IA, al-Salloum SM. Source: The Journal of Dermatology. 2000 November; 27(11): 706-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11138536&dopt=Abstract
·
The antimicrobial activity of tea tree oil. Author(s): Carson CF, Riley TV. Source: The Medical Journal of Australia. 1994 February 21; 160(4): 236. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8309408&dopt=Abstract
·
The antimutagenic and anticarcinogenic effects of tea, garlic and other natural foods in China: a review. Author(s): Chen J. Source: Biomed Environ Sci. 1992 March; 5(1): 1-17. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1586461&dopt=Abstract
162 Tea
·
The bio-availability of fluoride from black tea. Author(s): Simpson A, Shaw L, Smith AJ. Source: Journal of Dentistry. 2001 January; 29(1): 15-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11137634&dopt=Abstract
·
The chemistry of tea flavonoids. Author(s): Balentine DA, Wiseman SA, Bouwens LC. Source: Critical Reviews in Food Science and Nutrition. 1997 December; 37(8): 693-704. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9447270&dopt=Abstract
·
The chemopreventive effects of tea on human oral precancerous mucosa lesions. Author(s): Li N, Sun Z, Han C, Chen J. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 218-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202392&dopt=Abstract
·
The comparative tea staining potential of phenolic, chlorhexidine and anti-adhesive mouthrinses. Author(s): Addy M, Moran J, Newcombe R, Warren P. Source: Journal of Clinical Periodontology. 1995 December; 22(12): 923-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8613560&dopt=Abstract
·
The composition of tea infusions examined in relation to the association between mortality and water hardness. Author(s): Anderson W, Hollins JG, Bond PS. Source: J Hyg (Lond). 1971 March; 69(1): 1-15. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5291748&dopt=Abstract
·
The consumption of coffee and tea in Canada and the United States. Author(s): Burns L, Little JA, Shanoff HM. Source: The American Journal of Clinical Nutrition. 1966 November; 19(5): 370. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5923595&dopt=Abstract
·
The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. Author(s): Manly T, Anderson V, Nimmo-Smith I, Turner A, Watson P, Robertson IH. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2001 November; 42(8): 1065-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11806689&dopt=Abstract
Studies 163
·
The effect of Chinese tea on the occurrence of esophageal tumors induced by Nnitrosomethylbenzylamine formed in vivo. Author(s): Xu Y, Chi H. Source: Biomed Environ Sci. 1990 December; 3(4): 406-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2096845&dopt=Abstract
·
The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. Author(s): Haji Faraji M, Haji Tarkhani A. Source: Journal of Ethnopharmacology. 1999 June; 65(3): 231-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10404421&dopt=Abstract
·
The effect of sugar-free green tea chew candies on the degree of inflammation of the gingiva. Author(s): Krahwinkel T, Willershausen B. Source: European Journal of Medical Research. 2000 November 30; 5(11): 463-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11121366&dopt=Abstract
·
The effect of tea consumption on oxidative stress in smokers and nonsmokers. Author(s): Klaunig JE, Xu Y, Han C, Kamendulis LM, Chen J, Heiser C, Gordon MS, Mohler ER 3rd. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1999 April; 220(4): 249-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10202398&dopt=Abstract
·
The effect of weekly iron supplementation on anaemia and on iron deficiency among female tea pluckers in Bangladesh. Author(s): Gilgen D, Mascie-Taylor CG. Source: Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association. 2001 June; 14(3): 185-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11424510&dopt=Abstract
·
The effectiveness of seven denture cleansers on tea stain removal from PMMA acrylic resin. Author(s): Jagger DC, Al-Akhazam L, Harrison A, Rees JS. Source: Int J Prosthodont. 2002 November-December; 15(6): 549-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12475160&dopt=Abstract
·
The effects of black tea and other beverages on aspects of cognition and psychomotor performance. Author(s): Hindmarch I, Quinlan PT, Moore KL, Parkin C. Source: Psychopharmacology. 1998 October; 139(3): 230-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9784078&dopt=Abstract
164 Tea
·
The effects of phenolic components of tea on the production of pro- and antiinflammatory cytokines by human leukocytes in vitro. Author(s): Crouvezier S, Powell B, Keir D, Yaqoob P. Source: Cytokine. 2001 March 7; 13(5): 280-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11243706&dopt=Abstract
·
The effects of tea catechins on fecal conditions of elderly residents in a long-term care facility. Author(s): Goto K, Kanaya S, Ishigami T, Hara Y. Source: J Nutr Sci Vitaminol (Tokyo). 1999 January; 45(1): 135-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10360248&dopt=Abstract
·
The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study. Author(s): Lindenmuth GF, Lindenmuth EB. Source: Journal of Alternative and Complementary Medicine (New York, N.Y.). 2000 August; 6(4): 327-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10976979&dopt=Abstract
·
The erosive effect of herbal tea on dental enamel. Author(s): Brunton PA, Hussain A. Source: Journal of Dentistry. 2001 November; 29(8): 517-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11700200&dopt=Abstract
·
The evening tea break ritual--a case study. Author(s): Lee DS. Source: Contemp Nurse. 1999 March; 8(1): 227-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10514600&dopt=Abstract
·
The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells. Author(s): Hofbauer R, Frass M, Gmeiner B, Handler S, Speiser W, Kapiotis S. Source: Wiener Klinische Wochenschrift. 1999 April 9; 111(7): 278-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10355038&dopt=Abstract
·
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Author(s): Galanis DJ, Lee J, Kolonel LN. Source: Cancer. 1997 May 1; 79(9): 1840-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9129004&dopt=Abstract
Studies 165
·
The influence of coffee with milk and tea with milk on the bioavailability of tetracycline. Author(s): Jung H, Peregrina AA, Rodriguez JM, Moreno-Esparza R. Source: Biopharmaceutics & Drug Disposition. 1997 July; 18(5): 459-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9210983&dopt=Abstract
·
The irreplaceable image: Black tea delays recovery from iron-deficiency anemia. Author(s): Mahlknecht U, Weidmann E, Seipelt G. Source: Haematologica. 2001 May; 86(5): 559. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11410431&dopt=Abstract
·
The Japanese Tea Ceremony and stress management. Author(s): Keenan J. Source: Holistic Nursing Practice. 1996 January; 10(2): 30-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8550688&dopt=Abstract
·
The medicinal action of androgens and green tea epigallocatechin gallate. Author(s): Liao S. Source: Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. 2001 December; 7(4): 369-74. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11773671&dopt=Abstract
·
The methyl xanthine hypothesis: does tea consumption by Tibetan natives blunt the effects of high altitude? Author(s): Larrick JW. Source: Medical Hypotheses. 1991 February; 34(2): 99-104. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2041498&dopt=Abstract
·
The morning tea break ritual: a case study. Author(s): Lee DS. Source: International Journal of Nursing Practice. 2001 April; 7(2): 69-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11811319&dopt=Abstract
·
The natural history of periodontal disease. The correlation of selected microbiological parameters with disease severity in Sri Lankan tea workers. Author(s): Preus HR, Anerud A, Boysen H, Dunford RG, Zambon JJ, Loe H. Source: Journal of Clinical Periodontology. 1995 September; 22(9): 674-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7593696&dopt=Abstract
166 Tea
·
The nutraceutical benefit, part I: green tea. Author(s): Sato T, Miyata G. Source: Nutrition (Burbank, Los Angeles County, Calif.). 2000 April; 16(4): 315-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10758375&dopt=Abstract
·
The propensity of different brands of tea and coffee to cause staining associated with chlorhexidine. Author(s): Leard A, Addy M. Source: Journal of Clinical Periodontology. 1997 February; 24(2): 115-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9062858&dopt=Abstract
·
The relationship of fluorosis and brick tea drinking in Chinese Tibetans. Author(s): Cao J, Bai X, Zhao Y, Liu J, Zhou D, Fang S, Jia M, Wu J. Source: Environmental Health Perspectives. 1996 December; 104(12): 1340-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9118877&dopt=Abstract
·
The role of dogs in transmission of gastrointestinal parasites in a remote tea-growing community in northeastern India. Author(s): Traub RJ, Robertson ID, Irwin P, Mencke N, Thompson RC. Source: Am J Trop Med Hyg. 2002 November; 67(5): 539-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12479559&dopt=Abstract
·
The role of tea in human health: an update. Author(s): McKay DL, Blumberg JB. Source: Journal of the American College of Nutrition. 2002 February; 21(1): 1-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11838881&dopt=Abstract
·
The samurai and the tea master show us the meaning of excellence. Author(s): Phippen ML. Source: Aorn Journal. 1991 January; 53(1): 8, 10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1994834&dopt=Abstract
·
The Second International Scientific Symposium on Tea & Human Health, September 14th, 1998. Author(s): Phipps RP. Source: Nutrition (Burbank, Los Angeles County, Calif.). 1999 November-December; 15(11-12): 968-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10575685&dopt=Abstract
Studies 167
·
The study of gastric mechanics and flow: a Mad Hatter's tea party starting to make sense? Author(s): Horowitz M, Dent J. Source: Gastroenterology. 1994 July; 107(1): 302-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8020676&dopt=Abstract
·
The tea leaves of small trials. Author(s): Harrington DP. Source: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 1999 May; 17(5): 1336-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10334516&dopt=Abstract
·
The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Author(s): Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, Hart PH. Source: Inflammation Research : Official Journal of the European Histamine Research Society. [et Al.]. 2001 April; 50(4): 213-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11392609&dopt=Abstract
·
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. Author(s): Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY. Source: The Journal of Nutrition. 2001 September; 131(9): 2248-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11533262&dopt=Abstract
·
Thermal epiglottitis after swallowing hot tea. Author(s): Harjacek M, Kornberg AE, Yates EW, Montgomery P. Source: Pediatric Emergency Care. 1992 December; 8(6): 342-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1454643&dopt=Abstract
·
Three cases of angel's trumpet tea-induced psychosis in adolescent substance abusers. Author(s): Gopel C, Laufer C, Marcus A. Source: Nordic Journal of Psychiatry. 2002; 56(1): 49-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11869466&dopt=Abstract
·
Thromboendarterectomy (TEA) in the recipient as a major risk of arterial complication after kidney transplantation. Author(s): Belli L, De Carlis L, Belli LS, Del Favero E, Puttini M, Aseni P, Rondinaria GF, Meroni A, Beati C. Source: International Angiology : a Journal of the International Union of Angiology. 1989 October-December; 8(4): 206-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2634717&dopt=Abstract
168 Tea
·
Time for tea? Author(s): Sadler C. Source: Nurs Times. 1992 August 26-September 1; 88(35): 34-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1523128&dopt=Abstract
·
Tipi. A popular analgesic tea: a double-blind cross-over trial in osteoarthritis. Author(s): Ferraz MB, Pereira RB, Iwata NM, Atra E. Source: Clin Exp Rheumatol. 1991 March-April; 9(2): 205-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2060165&dopt=Abstract
·
Tomatoes, Pap smears, and tea? Adopting behaviors that may prevent reproductive cancers and improve health. Author(s): Furniss K. Source: Journal of Obstetric, Gynecologic, and Neonatal Nursing : Jognn / Naacog. 2000 November-December; 29(6): 641-52. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11110335&dopt=Abstract
·
Tooth surface pH during drinking of black tea. Author(s): Simpson A, Shaw L, Smith AJ. Source: British Dental Journal. 2001 April 14; 190(7): 374-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11338040&dopt=Abstract
·
Toxic effects of a herbal tea mixture in two newborns. Author(s): Rosti L, Nardini A, Bettinelli ME, Rosti D. Source: Acta Paediatrica (Oslo, Norway : 1992). 1994 June; 83(6): 683. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7919774&dopt=Abstract
·
Toxicity of tea containing pyrrolizidine alkaloids. Author(s): Spang R. Source: The Journal of Pediatrics. 1989 December; 115(6): 1025. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2585219&dopt=Abstract
·
Toxicity of the essential oil of Melaleuca alternifolia or tea tree oil. Author(s): Carson CF, Riley TV. Source: Journal of Toxicology. Clinical Toxicology. 1995; 33(2): 193-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7897762&dopt=Abstract
Studies 169
·
Traditional tea drinking in Senegal. A real source of fluoride intake for the population. Author(s): Yam AA, Kane AW, Cisse D, Gueye MM, Diop L, Agboton P, Faye M. Source: Odontostomatol Trop. 1999 September; 22(87): 25-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11372150&dopt=Abstract
·
Transmission of bancroftian filariasis in tea agro-ecosystem of Assam, India. Author(s): Mahanta B, Handique R, Narain K, Dutta P, Mahanta J. Source: Southeast Asian J Trop Med Public Health. 2001 September; 32(3): 581-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11944721&dopt=Abstract
·
Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Author(s): Vaidyanathan JB, Walle T. Source: Pharmaceutical Research. 2001 October; 18(10): 1420-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11697467&dopt=Abstract
·
Treatment of hookworm anaemias in tea gardens. Author(s): Ganguli B. Source: Indian Med J. 1967 March; 61(3): 83. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6040064&dopt=Abstract
·
Treatment of tea burns in Asian children. Author(s): Richards AM, Arnstein PA. Source: Burns : Journal of the International Society for Burn Injuries. 1996 November; 22(7): 580-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8909769&dopt=Abstract
·
Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Author(s): Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Source: Tropical Medicine & International Health : Tm & Ih. 1999 April; 4(4): 284-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10357864&dopt=Abstract
·
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin3-gallate. Author(s): Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Source: Cancer. 2001 February 15; 91(4): 822-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11241252&dopt=Abstract
170 Tea
·
Two stages of cancer prevention with green tea. Author(s): Fujiki H. Source: Journal of Cancer Research and Clinical Oncology. 1999 November; 125(11): 58997. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10541965&dopt=Abstract
·
Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. Author(s): Kaegi E. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1998 April 21; 158(8): 1033-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9580732&dopt=Abstract
·
Uranium trace analysis of a chewable betel-leaf preparation and tea leaves. Author(s): Chakarvarti SK, Dhiman J, Nagpaul KK. Source: Health Physics. 1981 January; 40(1): 78-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7216788&dopt=Abstract
·
Urinary excretion of benzoylecgonine following ingestion of Health Inca Tea. Author(s): Jackson GF, Saady JJ, Poklis A. Source: Forensic Science International. 1991 January-February; 49(1): 57-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2032667&dopt=Abstract
·
Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Author(s): Sun CL, Yuan JM, Lee MJ, Yang CS, Gao YT, Ross RK, Yu MC. Source: Carcinogenesis. 2002 September; 23(9): 1497-503. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12189193&dopt=Abstract
·
Urine levels of aluminum after drinking tea. Author(s): Wu J, Zhou CY, Wong MK, Lee HK, Ong CN. Source: Biological Trace Element Research. 1997 June; 57(3): 271-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9359993&dopt=Abstract
·
Use of herbal products, coffee or black tea, and over-the-counter medications as selftreatments among adults with asthma. Author(s): Blanc PD, Kuschner WG, Katz PP, Smith S, Yelin EH. Source: The Journal of Allergy and Clinical Immunology. 1997 December; 100(6 Pt 1): 789-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9438488&dopt=Abstract
Studies 171
·
Variability in caffeine consumption from coffee and tea: possible significance for epidemiological studies. Author(s): Stavric B, Klassen R, Watkinson B, Karpinski K, Stapley R, Fried P. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1988 February; 26(2): 111-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3366410&dopt=Abstract
·
Ventilatory function in workers exposed to tea and wood dust. Author(s): Al Zuhair YS, Whitaker CJ, Cinkotai FF. Source: Br J Ind Med. 1981 November; 38(4): 339-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7317296&dopt=Abstract
·
Ventilatory function of factory workers exposed to tea dust. Author(s): Jayawardana PL, Udupihille M. Source: Occupational Medicine (Oxford, England). 1997 February; 47(2): 105-9. Erratum In: Occup Med (Oxf) 1997 July; 47(5): 323. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9156481&dopt=Abstract
·
Vitamin C is one of the lipolytic substances in green tea. Author(s): Hasegawa N, Niimi N, Odani F. Source: Phytotherapy Research : Ptr. 2002 March; 16 Suppl 1: S91-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11933152&dopt=Abstract
·
Vitll statistics of tea estates in Assam--1960 to 1968. Author(s): Gilroy AB. Source: The Indian Journal of Medical Research. 1970 September; 58(9): 1290-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5505215&dopt=Abstract
·
Weekly variation in work-output of pluckers in tea gardens in northern West Bengal. Author(s): Roy SK, Majumder PP. Source: Journal of Biosocial Science. 1988 October; 20(4): 485-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3192560&dopt=Abstract
·
What are the current indications for total elbow arthroplasty? Report of a case using allograft for TEA. Author(s): Weiss AA, Berman AT, O'Brien J. Source: Orthopedics. 1993 February; 16(2): 237-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8441725&dopt=Abstract
172 Tea
·
When health means afternoon tea. Author(s): Pratt MA. Source: Ky Nurse. 1987 November-December; 35(6): 15-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3695550&dopt=Abstract
·
Why drinking green tea could prevent cancer. Author(s): Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Source: Nature. 1997 June 5; 387(6633): 561. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9177339&dopt=Abstract
·
Why is health relatively poor on Sri Lanka's tea estates. Author(s): Perera RS. Source: Social Science & Medicine (1982). 1992 September; 35(5): 743-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1439925&dopt=Abstract
·
Why is health relatively poor on Sri Lanka's tea estates? Author(s): Gajanayake I, Caldwell JC, Caldwell P. Source: Social Science & Medicine (1982). 1991; 32(7): 793-804. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2028274&dopt=Abstract
·
Women's center opening. Tea for two hundred. Author(s): Stephens B. Source: Profiles Healthc Mark. 1991 April; (42): 30-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10111028&dopt=Abstract
·
Women's Royal Voluntary Service: more than just tea and sympathy. Author(s): Drummond P. Source: Health Soc Serv J. 1983 August 11; 93(4859): 968-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10263764&dopt=Abstract
·
Xiaoke tea, a Chinese herbal treatment for diabetes mellitus. Author(s): Hale PJ, Horrocks PM, Wright AD, Fitzgerald MG, Nattrass M, Bailey CJ. Source: Diabetic Medicine : a Journal of the British Diabetic Association. 1989 November; 6(8): 675-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2532099&dopt=Abstract
·
Zinc bioavailability and tea consumption. Studies in healthy humans consuming selfselected and laboratory-controlled diets. Author(s): Ganji V, Kies CV. Source: Plant Foods for Human Nutrition (Dordrecht, Netherlands). 1994 October; 46(3): 267-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7855098&dopt=Abstract
173
CHAPTER 2. NUTRITION AND TEA Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and tea.
Finding Nutrition Studies on Tea The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “tea” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7
Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
174 Tea
Additional consumer oriented references include: ·
Antioxidant activity of tea unaffected milk. Source: Leigh, E. HerbalGram. Austin, TX : American Botanical Council and the Herb Research Foundation. 2000. (50) page 25. 0899-5648
·
Black tea may protect heart health. Source: Leigh, E. HerbalGram. Austin, TX : American Botanical Council and the Herb Research Foundation. 2000. (48) page 24-25. 0899-5648
·
Brewed, bottled, or powdered: testing the health power of tea. Source: Anonymous Consum-Repage 1999 November; 64(11): 60-1 0010-7174
·
Diet. Tea and health. Source: Anonymous Harv-Health-Lett. 2000 October; 25(12): 2-3 1052-1577
·
Dieter's brews make tea time a dangerous affair. Source: Kurtzweil, P. FDA-consum. Rockville, Md. : Food and Drug Administration, Department of Health & Human Services. July/August 1997. volume 31 (5) page 6-11. 0362-1332
·
Green and black teas show antioxidant activity. Source: Leigh, E. HerbalGram. Austin, TX : American Botanical Council and the Herb Research Foundation. Fall 1997. (41) page 20. 0899-5648
·
Green tea is good for you, but black tea boasts just as many benefits. Source: Golub, C. Environ-nutr. New York : Environmental Nutrition, Inc.,. July 2002. volume 25 (7) page 1, 4. 0893-4452
·
Green tea polyphenols and cancer: biologic mechanisms and practical implications. Author(s): Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, OH 44106, USA. Source: Ahmad, N Mukhtar, H Nutr-Revolume 1999 March; 57(3): 78-83 0029-6643
·
Is decaf tea healthy? Source: Anonymous Harv-Health-Lett. 2001 January; 26(3): 3 1052-1577
·
Its time for iced tea: refreshing, healthful, but oh, so sweet. Source: Neville, K. Environ-nutr. New York : Environmental Nutrition, Inc.,. July 2000. volume 23 (7) page 5. 0893-4452
·
Japanese green tea as a cancer preventive in humans. Author(s): Saitama Cancer Center Research Institute, Japan. Source: Fujiki, H Suganuma, M Okabe, S Komori, A Sueoka, E Sueoka, N Kozu, T Sakai, Y Nutr-Revolume 1996 November; 54(11 Pt 2): S67-70 0029-6643
·
Kombucha tea: miracle cure-all or health risk? Source: Klausner, A. Environmental-nutrition (USA). (August 1995). volume 18(8) page 2. tea edible fungi nutrient drug interactions risk disease control 0893-4452
·
Lower risk of colorectal and pancreatic cancers seen in green tea drinkers. Source: Webb, D. HerbalGram. Austin, TX : American Botanical Council and the Herb Research Foundation. Fall 1998. (44) page 17-18. 0899-5648
·
Reading tea leaves for health benefits. Source: Tufts-University-diet-and-nutrition-letter (USA). (October 1995). volume 13(8) page 4-6. tea disease control neoplasms cardiovascular diseases meal patterns men women 0747-4105
Nutrition 175
·
Rediscovering tea. Author(s): University of Georgia, Athens, GA. Source: Gutman, R.L. Ryu, B.H. HerbalGram (USA). (Sum 1996). (no. 37) page 33-48. history camellia medicinal properties 0899-5648
·
Tea and heart disease. Source: Anonymous Harv-Heart-Lett. 2002 August; 12(12): 5-7 1051-5313
·
Tea as a protective agent in cardiovascular health. Source: Langley Evans, S. Nutr-food-sci. Bradford, West Yorkshire, England : MCB University Press. Mar/June 2001. volume 31 (2/3) page 75-78. 0034-6659
·
Tea for two--green and black brew offer health benefits. Source: Forman, A. Environ-nutr. New York : Environmental Nutrition, Inc.,. May 1999. volume 22 (5) page 1, 6. 0893-4452
·
Tea for you? Possible health benefits are being studied. Source: Anonymous Mayo-Clin-Health-Lett. 2001 September; 19(9): 7 0741-6245
·
Tea oxalate. Source: Massey, L K Nutr-Revolume 2000 March; 58(3 Pt 1): 88-9 0029-6643
·
Teas your taste buds. Source: Gladstar, R. Veg-times. Mt. Morris, Ill. : Vegetarian Times. December 1993. (196) page 78, 80-81. 0164-8497
·
The influence of tea on iron and aluminum bioavailability in the rat. Source: Anonymous Nutr-Revolume 1991 September; 49(9): 287-9 0029-6643
·
Tonic in a teapot. Source: Anonymous Consum-Repage 2003 March; 68(3): 40-3 0010-7174
The following information is typical of that found when using the “Full IBIDS Database” to search for “tea” (or a synonym): ·
A prospective study of stomach cancer death in relation to green tea consumption in Japan. Author(s): Department of Public Health, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
[email protected] Source: Hoshiyama, Y Kawaguchi, T Miura, Y Mizoue, T Tokui, N Yatsuya, H Sakata, K Kondo, T Kikuchi, S Toyoshima, H Hayakawa, N Tamakoshi, A Ohno, Y Yoshimura, T Br-J-Cancer. 2002 July 29; 87(3): 309-13 0007-0920
·
Action-based memory in Alzheimer's disease: a longitudinal look at tea making. Author(s): Laboratory of Experimental Psychology, University of Sussex, Brighton BN1 9QG, UK.
[email protected] Source: Rusted, Jennifer Sheppard, Linda Neurocase. 2002; 8(1-2): 111-26 1355-4794
·
Activity-guided fractionation of green tea extract with antiproliferative activity against human stomach cancer cells. Author(s):
[email protected] Source: Kinjo, J Nagao, T Tanaka, T Nonaka, G Okawa, M Nohara, T Okabe, H BiolPharm-Bull. 2002 September; 25(9): 1238-40 0918-6158
·
Anticariogenic effects of black tea (Camellia sinensis) in caries prone-rats. Author(s): Division of Periodontology, Faculty of Dentistry, McGill University, 740 Docteur Penfield Street, Room 417, Montreal, Quebec, Canada H3A 1A4.
[email protected] Source: Touyz, L Z Amsel, R Quintessence-Int. 2001 September; 32(8): 647-50 0033-6572
176 Tea
·
Antifungal effect of Australian tea tree oil on Malassezia pachydermatis isolated from canines suffering from cutaneous skin disease. Author(s): Institute of Pharmaceutical Biology, Ruprecht-Karls-University Heidelberg, Germany. Source: Weseler, A Geiss, H K Saller, R Reichling, J Schweiz-Arch-Tierheilkd. 2002 May; 144(5): 215-21 0036-7281
·
Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Source: Benelli, R. Vene, R. Bisacchi, D. Garbisa, S. Albini, A. Biol-Chem. Berlin; New York : W. de Gruyter, c1996-. January 2002. volume 383 (1) page 101-105. 1431-6730
·
Antiradical efficiency of tea components. Source: Sun, T. Ho, C.T. J-food-lipids. Trumbull, CT : Food & Nutrition Press, 1993-. Sept 2001. volume 8 (3) page 231-238. 1065-7258
·
Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Source: Bachrach, U. Wang, Y.C. Amino-acids. Wien; New York : Springer-Verlag, c1991-. February 2002. volume 22 (1) page 1-13. 0939-4451
·
Chemical studies on antioxidant mechanism of tea catechins: analysis of radical reaction products of catechin and epicatechin with 2,2-diphenyl-1-picrylhydrazyl. Author(s): Department of Food Science and Center for Advanced Food Technology, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901-8520, USA.
[email protected] Source: Sang, S Cheng, X Stark, R E Rosen, R T Yang, C S Ho, C T Bioorg-Med-Chem. 2002 July; 10(7): 2233-7 0968-0896
·
Chemoprevention of oral cancer by green tea. Author(s): Department of Oral Biology and Maxillofacial Pathology, School of Dentistry, Medical College of Georgia, Augusta, USA. Source: Hsu, Stephen D Singh, Baldev B Lewis, Jill B Borke, James L Dickinson, Douglas P Drake, Laura Caughman, Gretchen B Schuster, George S Gen-Dent. 2002 Mar-April; 50(2): 140-6 0363-6771
·
Coffee and tea consumption and cancers of the bladder, colon and rectum. Author(s): Department of Community Health Sciences, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada. Source: Woolcott, C G King, W D Marrett, L D Eur-J-Cancer-Prevolume 2002 April; 11(2): 137-45 0959-8278
·
Comparison of heating extraction procedures for Al, Ca, Mg, and Mn in tea samples. Author(s): Departamento de Quimica, Universidade Federal de Sao Carlos, SP, Brazil. Source: Costa, Leticia M Gouveia, Sandro T Nobrega, Joaquim A Anal-Sci. 2002 March; 18(3): 313-8 0910-6340
·
Comparison of microdilution and disc diffusion methods in assessing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. Author(s): University of Hacettepe, School of Health Services, Department of Microbiology and Clinical Microbiology, Ankara, Turkey. Source: Ergin, A Arikan, S J-Chemother. 2002 October; 14(5): 465-72 1120-009X
·
Congou tea drinking and oesophageal cancer in South China. Author(s): Preventive Branch, Shantou University Medical College, Shantou 515031, China.
[email protected]
Nutrition 177
Source: Ke, L Yu, P Zhang, Z X Huang, S S Huang, G Ma, X H Br-J-Cancer. 2002 February 1; 86(3): 346-7 0007-0920 ·
Determination of caffeine in tea samples by Fourier transform infrared spectrometry. Author(s): Department of Analytical Chemistry, University of Valencia, Edifici Jeroni Munoz, 50th Dr. Moliner, 46100 Burjassot, Valencia, Spain. Source: Ohnsmann, J Quintas, G Garrigues, S De La Guardia, M Anal-Bioanal-Chem. 2002 October; 374(3): 561-5 1618-2642
·
Differential effect of TEA on long-term synaptic modification in hippocampal CA1 and dentate gyrus in vitro. Author(s): Department of Biomedical Engineering, University of Southern California, Los Angeles 90089, USA.
[email protected] Source: Song, D Xie, X Wang, Z Berger, T W Neurobiol-Learn-Mem. 2001 November; 76(3): 375-87 1074-7427
·
Differential modulation of growth and glutathione metabolism in cultured rat astrocytes by 4-hydroxynonenal and green tea polyphenol, epigallocatechin-3-gallate. Author(s): Department of Anatomy, Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates. Source: Ahmed, I John, A Vijayasarathy, C Robin, M A Raza, H Neurotoxicology. 2002 September; 23(3): 289-300 0161-813X
·
Effect of tea polyphenols on masugi nephritis of rabbit. Author(s): Zhejiang Univ., Hangzhou (China). College of Life Science Source: Xiu fang, H. Ji shuang, C. Xian qiang, Y. Pakistan-Journal-of-Biological-Sciences (Pakistan). (July 2002). volume 5(7) page 784-788. rabbits nephritis therapy tea polyphenols disease control kidneys tissue analysis 1028-8880
·
Effects of tea from Turnera ulmifolia L. on mouse gastric mucosa support the Turneraceae as a new source of antiulcerogenic drugs. Author(s): Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), SP, Brazil. Source: Gracioso, Jde S Vilegas, W Hiruma Lima, C A Souza Brito, A R Biol-Pharm-Bull. 2002 April; 25(4): 487-91 0918-6158
·
Effects of tea polyphenols on cerebral lipid peroxidation, liver and renal functions in rats after repeated +Gz stress. Author(s): Institute of Aviation Medicine, Beijing, China. Source: Zhan, H Chen, L M Xin, Y M Tang, G X Wen, J Space-Med-Med-Eng-(Beijing). 1999 February; 12(1): 1-5 1002-0837
·
Evidence for grape, wine and tea polyphenols as modulators of atherosclerosis and ischemic heart disease in humans. Source: Dubick, M.A. Omaye, S.T. J-nutraceuticals-funct-med-foods. Binghamton, NY : Pharmaceutical Products Press, an imprint of the Haworth Press, Inc., c1997-. 2001. volume 3 (3) page 67-93. 1089-4179
·
Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Author(s): Nutrition Department, The Pennsylvania State University, University Park, Pennsylvania, USA. Source: Kris Etherton, Penny M Keen, Carl L Curr-Opin-Lipidol. 2002 February; 13(1): 41-9 0957-9672
178 Tea
·
Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Author(s): Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston 29425, USA. Source: Vaidyanathan, J B Walle, T Drug-Metab-Dispos. 2002 August; 30(8): 897-903 0090-9556
·
Green tea and prostate cancer. Author(s): Department of Urology, University Hospitals of Cleveland, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. Source: Gupta, Sanjay Mukhtar, Hasan Urol-Clin-North-Am. 2002 February; 29(1): 49-57, viii 0094-0143
·
Green tea as a potent antioxidant in alcohol intoxication. Author(s): Department of Analytical Chemistry, Medical Academy of Bialystok, Bialystok, Poland.
[email protected] Source: Skrzydlewska, E Ostrowska, J Stankiewicz, A Farbiszewski, R Addict-Biol. 2002 July; 7(3): 307-14 1355-6215
·
Green tea catechins evoke a phasic contraction in rat aorta via H2O2-mediated multiple-signalling pathways. Author(s): Department of Pharmacology, School of Medicine, Zhejiang University, Hubin Campus, Hangzhou, People's Republic of China. Source: Shen, J Z Zheng, X F Wei, E Q Kwan, C Y Clin-Exp-Pharmacol-Physiol. 2003 JanFebruary; 30(1-2): 88-95 0305-1870
·
Green tea extract protects against early alcohol-induced liver injury in rats. Source: Arteel, G.E. Uesugi, T. Bevan, L.N. Gabele, E. Wheeler, M.D. McKim, S.E. Thurman, R.G. Biol-Chem. Berlin; New York : W. de Gruyter, c1996-. Mar/April 2002. volume 383 (3/4) page 663-670. 1431-6730
·
Green tea is good for you, but black tea boasts just as many benefits. Source: Golub, C. Environ-nutr. New York : Environmental Nutrition, Inc.,. July 2002. volume 25 (7) page 1, 4. 0893-4452
·
Green tea polyphenol blocks h(2)o(2)-induced interleukin-8 production from human alveolar epithelial cells. Author(s): Department of Thoracic Surgery, Kyoto University, Japan. Source: Matsuoka, K Isowa, N Yoshimura, T Liu, M Wada, H Cytokine. 2002 June 7; 18(5): 266-73 1043-4666
·
Identification and antioxidant activity of several pigments from the residual green tea (Camellia sinensis) after hot water extraction. Author(s): Department of Food and Nutrition, Hiroshima Jhogakuin University, Higashi-Ku, Hiroshima 732-0063, Japan. Source: Higashi Okai, K Yamazaki, M Nagamori, H Okai, Y J-UOEH. 2001 December 1; 23(4): 335-44 0387-821X
·
Immediate treatment of frostbite using rapid rewarming in tea decoction followed by combined therapy of pentoxifylline, aspirin & vitamin C. Author(s): Cold Physiology Department, Defence Institute of Physiology & Allied Sciences, Defence Research & Development Organization, Lucknow Road, Timarpur, Delhi 110054, India. Source: Purkayastha, S S Bhaumik, G Chauhan, S K Banerjee, P K Selvamurthy, W Indian-J-Med-Res. 2002 July; 116: 29-34 0971-5916
Nutrition 179
·
In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. Author(s): Department of Microbiology, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia.
[email protected] Source: Hammer, K A Carson, C F Riley, T V J-Antimicrob-Chemother. 2002 August; 50(2): 195-9 0305-7453
·
Inhibition of carcinogenesis by tea. Author(s): Laboratory for Cancer Research, Department of Chemical Biology, College of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 088548020, USA.
[email protected] Source: Yang, Chung S Maliakal, Pius Meng, Xiaofeng Annu-Rev-Pharmacol-Toxicol. 2002; 42: 25-54 0362-1642
·
Inhibition of fibroblast growth factors by green tea. Author(s): Department of Surgery, Division of Oncology, University of California-Los Angeles, Los Angeles, CA 90095, USA. Source: Sartippour, M R Heber, D Zhang, L Beatty, P Elashoff, D Elashoff, R Go, V L Brooks, M N Int-J-Oncol. 2002 September; 21(3): 487-91 1019-6439
·
Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3gallate. Author(s): Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA. Source: Afaq, F Adhami, V M Ahmad, N Mukhtar, H Oncogene. 2003 February 20; 22(7): 1035-44 0950-9232
·
Inhibitory effect of condensed tannins isolated from Korean green tea against xanthine oxidase. Author(s): Yeungnam University, Kyongsan (Korea Republic). Department of Food Science and Technology Source: Cho, Y.J. Chun, S.S. Choi, C. Journal-of-the-Korean-Society-of-Food-andNutrition (Korea Republic). (August 1993). volume 22(4) page 418-422. 0253-3154
·
Is there a link between tea consumption and cardiovascular disease. Source: Spidel, M. Can-home-econ-j. Ottawa : Canadian Home Economics Association,. 2001. volume 51 (1) page 44-47. 0008-3763
·
Multielement determination and speciation of major-to-trace elements in black tea leaves by ICP-AES and ICP-MS with the aid of size exclusion chromatography. Author(s): Department of Applied Chemistry, Graduate School of Engineering, Nagoya University, Chikusa, Japan. Source: Matsuura, H Hokura, A Katsuki, F Itoh, A Haraguchi, H Anal-Sci. 2001 March; 17(3): 391-8 0910-6340
·
Novel EPR characterization of the antioxidant activity of tea leaves. Author(s): Department of Chemistry, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.
[email protected] Source: Morsy, M A Khaled, M M Spectrochim-Acta-A-Mol-Biomol-Spectrosc. 2002 April; 58(6): 1271-7 1386-1425
180 Tea
·
Phytotherapy of chronic dermatitis and pruritus of dogs with a topical preparation containing tea tree oil (Bogaskin). Author(s): Department of Internal Medicine/Naturheilkunde, University of Zurich.
[email protected] Source: Fitzi, J Furst Jucker, J Wegener, T Saller, R Reichling, J Schweiz-Arch-Tierheilkd. 2002 May; 144(5): 223-31 0036-7281
·
Prevention of carcinogenesis by tea polyphenols. Author(s): Laboratory for Cancer Research, College of Pharmacy, Rutgers, The State University of New Jersey, Piscataway 08854-8020, USA.
[email protected] Source: Yang, C S Prabhu, S Landau, J Drug-Metab-Revolume 2001 Aug-November; 33(3-4): 237-53 0360-2532
·
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinduced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Author(s): Department of Pharmacology, Medicinal Toxicology Research Center, Inha University, Inchon, South Korea. Source: Choi, J Y Park, C S Kim, D J Cho, M H Jin, B K Pie, J E Chung, W G Neurotoxicology. 2002 September; 23(3): 367-74 0161-813X
·
Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Author(s): Department of Analytical Chemistry, Medical Academy of Bialystok, Poland.
[email protected] Source: Skrzydlewska, E Ostrowska, J Farbiszewski, R Michalak, K Phytomedicine. 2002 April; 9(3): 232-8 0944-7113
·
Protective effects of green tea polyphenols and their major component, (-)epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Author(s): Laboratory of Visual Information Processing, Department of Molecular and Cell Biophysics, Institute of Biophysics, Academia Sinica, 15 Datun Road, Chaoyang District, Beijing 100101, P.R. China. Source: Nie, G Cao, Y Zhao, B Redox-Repage 2002; 7(3): 171-7 1351-0002
·
Protective effects of tea polyphenols on mild hypobaric hypoxia induced pulmonary free radical metabolic disorder in mice. Author(s): Institute of Aviation Medicine, Beijing, China. Source: Zhan, H Lu, J Y Zhang, Q J Li, T Xin, Y M Space-Med-Med-Eng-(Beijing). 2001 April; 14(2): 79-83 1002-0837
·
Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Author(s): Laboratoires Arkopharma, Carros, France.
[email protected] Source: Chantre, P Lairon, D Phytomedicine. 2002 January; 9(1): 3-8 0944-7113
·
Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. Author(s): Department of Public Health, Faculty of Medicine, Tottori University, Yonago, Japan. Source: Iwai, Nobuo Ohshiro, Hitoshi Kurozawa, Youichi Hosoda, Takenobu Morita, Hikari Funakawa, Kazuhiko Okamoto, Mikizo Nose, Takayuki J-Epidemiol. 2002 May; 12(3): 191-8 0917-5040
Nutrition 181
·
Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Author(s): Department of Technical Physics, Peking University, 100871, People's Republic of, Beijing, China.
[email protected] Source: Zhu, A Wang, X Guo, Z Nucl-Med-Biol. 2001 August; 28(6): 735-40 0969-8051
·
Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells. Author(s): First Department of Surgery, Kobe University School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
[email protected] Source: Takada, M Ku, Y Toyama, H Suzuki, Y Kuroda, Y Hepatogastroenterology. 2002 Jul-August; 49(46): 928-31 0172-6390
·
Tea tree oil reduces histamine-induced oedema in murine ears. Author(s): Department of Microbiology and Infectious Diseases, School of Medicine and Flinders Medical Research Institute, Flinders University, Adelaide, Australia. Source: Brand, C Townley, S L Finlay Jones, J J Hart, P H Inflamm-Res. 2002 June; 51(6): 283-9 1023-3830
·
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Author(s): Department of Microbiology and Infectious Diseases, School of Medicine, Flinders Medical Research Institute, Flinders University, Adelaide, Australia. Source: Brand, C Grimbaldeston, M A Gamble, J R Drew, J Finlay Jones, J J Hart, P H Inflamm-Res. 2002 May; 51(5): 236-44 1023-3830
·
Teas your taste buds. Source: Gladstar, R. Veg-times. Mt. Morris, Ill. : Vegetarian Times. December 1993. (196) page 78, 80-81. 0164-8497
·
The distribution of minerals and flavonoids in the tea plant (Camellia sinensis). Author(s): Department of Pharmaceutical and Toxicological Chemistry, Faculty of Pharmacy Federico II University, Naples, Italy.
[email protected] Source: Ferrara, L Montesano, D Senatore, A Farmaco. 2001 May-July; 56(5-7): 397-401 0014-827X
·
The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Source: Wang, Y.C. Bachrach, U. Amino-acids. Wien; New York : Springer-Verlag, c1991-. March 2002. volume 22 (2) page 131-143. 0939-4451
·
Tonic in a teapot. Source: Anonymous Consum-Repage 2003 March; 68(3): 40-3 0010-7174
·
Transmission of bancroftian filariasis in tea agro-ecosystem of Assam, India. Author(s): Department of Life Sciences, Dibrugarh University, Assam, India. Source: Mahanta, B Handique, R Narain, K Dutta, P Mahanta, J Southeast-Asian-J-TropMed-Public-Health. 2001 September; 32(3): 581-4 0125-1562
·
Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Author(s): Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Source: Satchell, A C Saurajen, A Bell, C Barnetson, R S Australas-J-Dermatol. 2002 August; 43(3): 175-8 0004-8380
182 Tea
·
Use of oolong tea extract staining of soft-tissue specimens in low-vacuum scanning electron microscope with a cooling stage. Author(s): Central Institute for Electron Microscopic Research, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan.
[email protected] Source: Sasaki, Y Sato, S Adachi, A Dan, Y Nishimura, M Med-Electron-Microsc. 2001 December; 34(4): 254-7 0918-4287
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: ·
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
·
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
·
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
·
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
·
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
·
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
·
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
·
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: ·
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
·
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
·
Google: http://directory.google.com/Top/Health/Nutrition/
·
Healthnotes: http://www.healthnotes.com/
·
Open Directory Project: http://dmoz.org/Health/Nutrition/
·
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
·
WebMDÒHealth: http://my.webmd.com/nutrition
Nutrition 183
·
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
The following is a specific Web list relating to tea; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: ·
Vitamins Niacin Source: Integrative Medicine Communications; www.drkoop.com Pantothenic Acid and Pantethine Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin A Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin B3 (Niacin) Source: Integrative Medicine Communications; www.drkoop.com Vitamin B6 Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin C Source: Healthnotes, Inc. www.healthnotes.com Vitamin C Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin E Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin K Alternative names: Menadione, Menaphthone, Menaquinone, Phylloquinone Source: Integrative Medicine Communications; www.drkoop.com Vitamin K Source: Prima Communications, Inc.www.personalhealthzone.com
·
Minerals Calcium D-glucarate Source: Healthnotes, Inc. www.healthnotes.com Cheese, aged (firm & grating) Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,277,00.html
184 Tea
Chondroitin Source: Prima Communications, Inc.www.personalhealthzone.com Cisplatin Source: Healthnotes, Inc. www.healthnotes.com Copper Source: Healthnotes, Inc. www.healthnotes.com Gabapentin Source: Healthnotes, Inc. www.healthnotes.com Iodine Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,888,00.html Iron Source: Healthnotes, Inc. www.healthnotes.com Iron Alternative names: Ferrous Sulfate Source: Integrative Medicine Communications; www.drkoop.com Manganese Source: Healthnotes, Inc. www.healthnotes.com Quercetin Source: Healthnotes, Inc. www.healthnotes.com Quercetin Source: Integrative Medicine Communications; www.drkoop.com Quercetin Source: Prima Communications, Inc.www.personalhealthzone.com Selenium Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10055,00.html Sodium Fluoride Source: Healthnotes, Inc. www.healthnotes.com Stinging Nettle Alternative names: Urtica dioica, Urtica urens, Nettle Source: Integrative Medicine Communications; www.drkoop.com Zinc Source: Healthnotes, Inc. www.healthnotes.com
Nutrition 185
Zinc Source: Prima Communications, Inc.www.personalhealthzone.com ·
Food and Diet Abalone Source: Healthnotes, Inc. www.healthnotes.com Acorn squash Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,190,00.html Amaranth Source: Healthnotes, Inc. www.healthnotes.com Amaranth Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,69,00.html Apples Source: Healthnotes, Inc. www.healthnotes.com Artichokes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,28,00.html Asparagus Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,7,00.html Athlete’s Foot Source: Healthnotes, Inc. www.healthnotes.com Athletic Performance Source: Healthnotes, Inc. www.healthnotes.com Avocados Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,46,00.html Baguettes Source: Healthnotes, Inc. www.healthnotes.com Bananas Source: Healthnotes, Inc. www.healthnotes.com Barley Source: Healthnotes, Inc. www.healthnotes.com
186 Tea
Barley Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,70,00.html BASIL Source: The Canadian Internet Directory for Holistic Help, WellNet, Health and Wellness Network; www.wellnet.ca Beans, fresh Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,8,00.html Beef Source: Healthnotes, Inc. www.healthnotes.com Beef Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,85,00.html Beets Source: Healthnotes, Inc. www.healthnotes.com Beets Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,10,00.html Beverages Source: Healthnotes, Inc. www.healthnotes.com Blood Type Diet Source: Healthnotes, Inc. www.healthnotes.com Bluefish Source: Healthnotes, Inc. www.healthnotes.com Bluefish Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,164,00.html Bok Choy Source: Healthnotes, Inc. www.healthnotes.com Bok choy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,148,00.html
Nutrition 187
Brazil nuts Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,115,00.html Bread Source: Healthnotes, Inc. www.healthnotes.com Broccoflower Source: Healthnotes, Inc. www.healthnotes.com Broccoli Source: Healthnotes, Inc. www.healthnotes.com Broccoli Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,11,00.html Brussels sprouts Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,12,00.html Buckwheat Source: Healthnotes, Inc. www.healthnotes.com Buffalo Source: Healthnotes, Inc. www.healthnotes.com Bulgur Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,305,00.html Burdock Alternative names: Arctium lappa Source: Healthnotes, Inc. www.healthnotes.com Burdock Alternative names: Arctium lappa, Arctium minus, Arctium tomentosum Source: Integrative Medicine Communications; www.drkoop.com Burdock Source: Prima Communications, Inc.www.personalhealthzone.com Butternut squash Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,189,00.html
188 Tea
Cabbage Source: Healthnotes, Inc. www.healthnotes.com Cabbage, green Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,13,00.html Cabbage, red Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,166,00.html Cabbage, Savoy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,204,00.html Carp Source: Healthnotes, Inc. www.healthnotes.com Carrots Source: Healthnotes, Inc. www.healthnotes.com Carrots Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,14,00.html Cartilage Source: Prima Communications, Inc.www.personalhealthzone.com Catfish Source: Healthnotes, Inc. www.healthnotes.com Cauliflower Source: Healthnotes, Inc. www.healthnotes.com Cauliflower Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,15,00.html Cheese Alternatives Source: Healthnotes, Inc. www.healthnotes.com Chicken Source: Healthnotes, Inc. www.healthnotes.com Chicken Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,86,00.html
Nutrition 189
Chickpeas Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,106,00.html Chili peppers Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,132,00.html Chocolate Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,179,00.html Cinnamon Alternative names: Cinnamomum zeylanicum Source: Healthnotes, Inc. www.healthnotes.com Clams Source: Healthnotes, Inc. www.healthnotes.com Clams Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,159,00.html Cod Source: Healthnotes, Inc. www.healthnotes.com Coffee Source: Healthnotes, Inc. www.healthnotes.com Coffee Substitutes Source: Healthnotes, Inc. www.healthnotes.com Cold Cereals Source: Healthnotes, Inc. www.healthnotes.com Collards Source: Healthnotes, Inc. www.healthnotes.com Corn, fresh Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,17,00.html Corn-Free Diet Source: Healthnotes, Inc. www.healthnotes.com Crab Source: WholeHealthMD.com, LLC. www.wholehealthmd.com
190 Tea
Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,167,00.html Crocodile and Alligator Source: Healthnotes, Inc. www.healthnotes.com Cucumbers Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,18,00.html Duck Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,87,00.html Eggplants Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,19,00.html Eggs Source: Healthnotes, Inc. www.healthnotes.com Eggs Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,98,00.html Fast Recipes Index Source: Healthnotes, Inc. www.healthnotes.com Fasting Diet Source: Healthnotes, Inc. www.healthnotes.com Fat Alternatives and Fat Replacers Source: Healthnotes, Inc. www.healthnotes.com Feingold Diet Source: Healthnotes, Inc. www.healthnotes.com Ferrous Sulfate Source: Integrative Medicine Communications; www.drkoop.com Fiddlehead ferns Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,245,00.html Fish, lean Source: WholeHealthMD.com, LLC. www.wholehealthmd.com
Nutrition 191
Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,93,00.html Flour, nonwheat Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,303,00.html Fresh Pasta Source: Healthnotes, Inc. www.healthnotes.com Game Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,88,00.html Goose Source: Healthnotes, Inc. www.healthnotes.com Goose Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,89,00.html Grains Source: Healthnotes, Inc. www.healthnotes.com Grape leaves Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,246,00.html Greens, cooking Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,22,00.html Guinea Fowl Source: Healthnotes, Inc. www.healthnotes.com Half-and-Half Source: Healthnotes, Inc. www.healthnotes.com Halibut Source: Healthnotes, Inc. www.healthnotes.com High Cholesterol Source: Healthnotes, Inc. www.healthnotes.com Honey Source: WholeHealthMD.com, LLC. www.wholehealthmd.com
192 Tea
Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,283,00.html Hypoglycemia Source: Healthnotes, Inc. www.healthnotes.com Jerusalem Artichoke Source: Healthnotes, Inc. www.healthnotes.com Jerusalem artichokes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,39,00.html Kale Source: Healthnotes, Inc. www.healthnotes.com Kale Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,127,00.html Kohlrabi Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,319,00.html Kombu Source: Healthnotes, Inc. www.healthnotes.com Lamb Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,90,00.html Lamb and Mutton Source: Healthnotes, Inc. www.healthnotes.com Leeks Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,24,00.html Lemons Source: Healthnotes, Inc. www.healthnotes.com Lemons Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,55,00.html
Nutrition 193
Lentils Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,99,00.html Lettuce & other salad greens Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,196,00.html Limes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,210,00.html Low Back Pain Source: Healthnotes, Inc. www.healthnotes.com Low-Allergen Diet Source: Healthnotes, Inc. www.healthnotes.com Low-Fat Diet Source: Healthnotes, Inc. www.healthnotes.com Low-Fat Recipes Index Source: Healthnotes, Inc. www.healthnotes.com Low-Oxalate Diet Source: Healthnotes, Inc. www.healthnotes.com Low-Salt Diet Source: Healthnotes, Inc. www.healthnotes.com Mackerel Source: Healthnotes, Inc. www.healthnotes.com Macrobiotic Diet Source: Healthnotes, Inc. www.healthnotes.com Mahi Mahi Source: Healthnotes, Inc. www.healthnotes.com Malanga Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,255,00.html Meal Substitutes Source: Healthnotes, Inc. www.healthnotes.com Melons Source: Healthnotes, Inc. www.healthnotes.com
194 Tea
Milk Source: Healthnotes, Inc. www.healthnotes.com Milk Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,95,00.html Millet Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,72,00.html Miso Source: Healthnotes, Inc. www.healthnotes.com Monkfish Source: Healthnotes, Inc. www.healthnotes.com Monounsaturated Fats Source: Healthnotes, Inc. www.healthnotes.com Mullet Source: Healthnotes, Inc. www.healthnotes.com Mushrooms Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,25,00.html Mussels Source: Healthnotes, Inc. www.healthnotes.com Mussels Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,172,00.html Mustard Greens Source: Healthnotes, Inc. www.healthnotes.com Napa Cabbage Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,187,00.html Nopales (cactus pads) Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,236,00.html
Nutrition 195
Nuts Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,84,00.html Oats Alternative names: Avena sativa Source: Healthnotes, Inc. www.healthnotes.com Okra Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,26,00.html Onions Source: Healthnotes, Inc. www.healthnotes.com Orange Roughy Source: Healthnotes, Inc. www.healthnotes.com Oranges Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,59,00.html Ostrich and Emu Source: Healthnotes, Inc. www.healthnotes.com Oysters Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,160,00.html Parsnips Source: Healthnotes, Inc. www.healthnotes.com Parsnips Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,29,00.html Partridge Source: Healthnotes, Inc. www.healthnotes.com Pasta Source: Healthnotes, Inc. www.healthnotes.com Pasta, wheat Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,82,00.html
196 Tea
Pears Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,62,00.html Peas Source: Healthnotes, Inc. www.healthnotes.com Peas, fresh Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,30,00.html Pecan Rice Source: Healthnotes, Inc. www.healthnotes.com Peppers, bell, green Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,130,00.html Peppers, bell, red Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,131,00.html Peppers, sweet Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,31,00.html Persimmon Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,63,00.html Pike Source: Healthnotes, Inc. www.healthnotes.com Polyunsaturated Fats Source: Healthnotes, Inc. www.healthnotes.com Pomegranates Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,216,00.html Porcini Mushrooms Source: Healthnotes, Inc. www.healthnotes.com Pork Source: Healthnotes, Inc. www.healthnotes.com
Nutrition 197
Potatoes Source: Healthnotes, Inc. www.healthnotes.com Potatoes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,270,00.html Quail Source: Healthnotes, Inc. www.healthnotes.com Radishes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,33,00.html Raisins & Currants Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,67,00.html Ramen Noodles Source: Healthnotes, Inc. www.healthnotes.com Rice, brown Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,103,00.html Rice, white Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,75,00.html Rutabagas Source: Healthnotes, Inc. www.healthnotes.com Rutabagas Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,202,00.html Sablefish Source: Healthnotes, Inc. www.healthnotes.com Salmon Source: Healthnotes, Inc. www.healthnotes.com Salmon Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,102,00.html
198 Tea
Sausage Source: Healthnotes, Inc. www.healthnotes.com Scallops Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,184,00.html Sea Bass Source: Healthnotes, Inc. www.healthnotes.com Shark Source: Healthnotes, Inc. www.healthnotes.com Shiitake Mushroom Source: Healthnotes, Inc. www.healthnotes.com Shrimp Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,177,00.html Soba Noodles Source: Healthnotes, Inc. www.healthnotes.com Soy Source: Prima Communications, Inc.www.personalhealthzone.com Soy and Protein Shakes Source: Healthnotes, Inc. www.healthnotes.com Soy milk Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,200,00.html Soybeans Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,105,00.html Soy-Free Diet Source: Healthnotes, Inc. www.healthnotes.com Spaghetti squash Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,222,00.html Spinach Source: Healthnotes, Inc. www.healthnotes.com
Nutrition 199
Spinach Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,35,00.html Sports Drinks Source: Healthnotes, Inc. www.healthnotes.com Squash, summer Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,37,00.html Squash, winter Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,38,00.html Squid Source: Healthnotes, Inc. www.healthnotes.com Squid Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,229,00.html Sunflower seeds Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,158,00.html Sweet Peppers Source: Healthnotes, Inc. www.healthnotes.com Sweet potatoes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,40,00.html Swiss chard Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,140,00.html Swordfish Source: Healthnotes, Inc. www.healthnotes.com Taro root Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,263,00.html
200 Tea
Tea Source: Healthnotes, Inc. www.healthnotes.com Tempeh Source: Healthnotes, Inc. www.healthnotes.com Texmati Rice Source: Healthnotes, Inc. www.healthnotes.com Tofu Source: Healthnotes, Inc. www.healthnotes.com Tomatoes Source: Healthnotes, Inc. www.healthnotes.com Tomatoes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,41,00.html Triticale Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,77,00.html Trout Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,286,00.html Tuna Source: Healthnotes, Inc. www.healthnotes.com Tuna Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,137,00.html Turkey Source: Healthnotes, Inc. www.healthnotes.com Turkey Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,92,00.html Turnips Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,42,00.html
Nutrition 201
Tyramine-Free Diet Source: Healthnotes, Inc. www.healthnotes.com Veal Source: Healthnotes, Inc. www.healthnotes.com Venison Source: Healthnotes, Inc. www.healthnotes.com Wakame Source: Healthnotes, Inc. www.healthnotes.com Walnuts Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,100,00.html Water Source: Healthnotes, Inc. www.healthnotes.com Water chestnuts Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,43,00.html Weight Loss and Obesity Source: Healthnotes, Inc. www.healthnotes.com Weight Management Index Source: Healthnotes, Inc. www.healthnotes.com Wheat Source: Healthnotes, Inc. www.healthnotes.com Wheat Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,78,00.html Whitefish Source: Healthnotes, Inc. www.healthnotes.com Winter Squash Source: Healthnotes, Inc. www.healthnotes.com Yams Source: Healthnotes, Inc. www.healthnotes.com Yogurt Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,97,00.html
202 Tea
Zucchini Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,183,00.html
203
CHAPTER 3. ALTERNATIVE MEDICINE AND TEA Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to tea. At the conclusion of this chapter, we will provide additional sources.
The Combined Health Information Database The Combined Health Information Database (CHID) is a bibliographic database produced by health-related agencies of the U.S. federal government (mostly from the National Institutes of Health) that can offer concise information for a targeted search. The CHID database is updated four times a year at the end of January, April, July, and October. Check the titles, summaries, and availability of CAM-related information by using the “Simple Search” option at the following Web site: http://chid.nih.gov/simple/simple.html. In the drop box at the top, select “Complementary and Alternative Medicine.” Then type “tea” (or synonyms) in the second search box. We recommend that you select 100 “documents per page” and to check the “whole records” options. The following was extracted using this technique: ·
Patient Education and Herbal Dietary Supplements Source: American Journal of Health-System Pharmacists. 57(21):1997-2003. November 2000. Summary: This article discusses the importance of educating patients about herbal dietary supplements. It reviews how to ask about dietary supplements when taking a patient's medical history and the difficulties in and importance of standardizing botanicals to ensure product quality. The article then provides specific information about several herbal dietary supplements, including echinacea, ginger, turmeric, valerian, and green tea. 57 references.
·
Alternative Medicines Gain in Popularity, Merit Closer Scrutiny Source: Journal of the National Cancer Institute. 91(13): 1104-1105. July 7, 1999.
204 Tea
Summary: This journal article discusses current research into complementary and alternative medicine (CAM) therapies for cancer. The National Center for Complementary and Alternative Medicine (NCCAM), established as the Office of Alternative Medicine in 1991, gained its status as a center in the fall of 1998. NCCAM supports 13 clinical research centers to examine the efficacy, safety, and validity of CAM therapies, and to support basic, preclinical, clinical, and epidemiological studies of these therapies. The National Cancer Institute (NCI) recently formed the Office of Cancer Complementary and Alternative Medicine, which works directly with NCCAM. The NCI office will help support studies of interest to cancer research. The University of Texas Center for Alternative Medicine Research (UT-CAM) is the NCCAM-supported center specializing in alternative therapies and prevention for cancer. UT-CAM is studying such therapies as melatonin, mistletoe, the herbal extract Flor-Essence, and 714-X. Other natural therapies being studied include green tea, ginseng, oleander, Chinese herbal medicines, and dietary approaches.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to tea and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “tea” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to tea: ·
(-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Author(s): Vergote D, Cren-Olive C, Chopin V, Toillon RA, Rolando C, Hondermarck H, Le Bourhis X. Source: Breast Cancer Research and Treatment. 2002 December; 76(3): 195-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12462380&dopt=Abstract
·
A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Author(s): Chen PC, Wheeler DS, Malhotra V, Odoms K, Denenberg AG, Wong HR. Source: Inflammation. 2002 October; 26(5): 233-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12238566&dopt=Abstract
·
A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. Author(s): Ahn WS, Huh SW, Bae SM, Lee IP, Lee JM, Namkoong SE, Kim CK, Sin JI. Source: Dna and Cell Biology. 2003 March; 22(3): 217-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12804120&dopt=Abstract
Alternative Medicine 205
·
A novel convenient process to obtain a raw decaffeinated tea polyphenol fraction using a lignocellulose column. Author(s): Sakanaka S. Source: Journal of Agricultural and Food Chemistry. 2003 May 7; 51(10): 3140-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12720405&dopt=Abstract
·
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Author(s): Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. Source: Cancer. 2003 March 15; 97(6): 1442-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12627508&dopt=Abstract
·
A prospective study of stomach cancer death in relation to green tea consumption in Japan. Author(s): Hoshiyama Y, Kawaguchi T, Miura Y, Mizoue T, Tokui N, Yatsuya H, Sakata K, Kondo T, Kikuchi S, Toyoshima H, Hayakawa N, Tamakoshi A, Ohno Y, Yoshimura T; Japan Collaborative Cohort Study Group. Source: British Journal of Cancer. 2002 July 29; 87(3): 309-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12177800&dopt=Abstract
·
A yoga teacher with persistent cheilitis. Author(s): Biswas R, Dalal M. Source: Int J Clin Pract. 2003 May; 57(4): 340-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12800469&dopt=Abstract
·
Accumulation of epigallocatechin quinone dimers during tea fermentation and formation of theasinensins. Author(s): Tanaka T, Mine C, Watarumi S, Fujioka T, Mihashi K, Zhang YJ, Kouno I. Source: Journal of Natural Products. 2002 November; 65(11): 1582-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12444680&dopt=Abstract
·
Action of green tea catechin on bone metabolic disorder in chronic cadmiumpoisoned rats. Author(s): Choi JH, Rhee IK, Park KY, Park KY, Kim JK, Rhee SJ. Source: Life Sciences. 2003 August 8; 73(12): 1479-89. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12865088&dopt=Abstract
·
Activity-guided fractionation of green tea extract with antiproliferative activity against human stomach cancer cells. Author(s): Kinjo J, Nagao T, Tanaka T, Nonaka G, Okawa M, Nohara T, Okabe H.
206 Tea
Source: Biological & Pharmaceutical Bulletin. 2002 September; 25(9): 1238-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12230128&dopt=Abstract ·
Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Author(s): Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, Mantani N, Terasawa K, Ochiai H. Source: Microbiol Immunol. 2002; 46(7): 491-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12222936&dopt=Abstract
·
Aluminium and fluoride concentrations of three tea varieties growing at Lantau Island, Hong Kong. Author(s): Fung KF, Zhang ZQ, Wong JW, Wong MH. Source: Environmental Geochemistry and Health. 2003 June; 25(2): 219-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12901167&dopt=Abstract
·
An anticlastogenic in vivo micronucleus assay for tea. Author(s): Edwin D, Geetha VR, Vishwanathan H, Usha Rani MV. Source: J Environ Biol. 2002 October; 23(4): 373-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12674376&dopt=Abstract
·
Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol. Author(s): Roy M, Chakrabarty S, Sinha D, Bhattacharya RK, Siddiqi M. Source: Mutation Research. 2003 February-March; 523-524: 33-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12628501&dopt=Abstract
·
Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. Author(s): M C S, K S, Kuttan R. Source: Journal of Ethnopharmacology. 2002 November; 83(1-2): 109-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12413715&dopt=Abstract
·
Antidiarrhoeal activity of hot water extract of black tea (Camellia sinensis). Author(s): Besra SE, Gomes A, Ganguly DK, Vedasiromoni JR. Source: Phytotherapy Research : Ptr. 2003 April; 17(4): 380-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12722145&dopt=Abstract
·
Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. Author(s): Hammer KA, Carson CF, Riley TV.
Alternative Medicine 207
Source: Journal of Applied Microbiology. 2003 October; 95(4): 853-860. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12969301&dopt=Abstract ·
Antifungal effect of Australian tea tree oil on Malassezia pachydermatis isolated from canines suffering from cutaneous skin disease. Author(s): Weseler A, Geiss HK, Saller R, Reichling J. Source: Schweiz Arch Tierheilkd. 2002 May; 144(5): 215-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12070905&dopt=Abstract
·
Antiinflammatory action of EGCG, the main component of green tea, through STAT1 inhibition. Author(s): Tedeschi E, Suzuki H, Menegazzi M. Source: Annals of the New York Academy of Sciences. 2002 November; 973: 435-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12485906&dopt=Abstract
·
Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms. Author(s): Groppo FC, Ramacciato JC, Simoes RP, Florio FM, Sartoratto A. Source: Int Dent J. 2002 December; 52(6): 433-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553397&dopt=Abstract
·
Antimutagenic activity of selenium-enriched green tea toward the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline. Author(s): Amantana A, Santana-Rios G, Butler JA, Xu M, Whanger PD, Dashwood RH. Source: Biological Trace Element Research. 2002 May; 86(2): 177-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12008980&dopt=Abstract
·
Antimutagenic effects of black tea (World Blend) and its two active polyphenols theaflavins and thearubigins in Salmonella assays. Author(s): Gupta S, Chaudhuri T, Seth P, Ganguly DK, Giri AK. Source: Phytotherapy Research : Ptr. 2002 November; 16(7): 655-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12410547&dopt=Abstract
·
Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. Author(s): Frei B, Higdon JV. Source: The Journal of Nutrition. 2003 October; 133(10): 3275S-84S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14519826&dopt=Abstract
·
Antioxidant effects of green tea polyphenols on free radical initiated peroxidation of rat liver microsomes. Author(s): Cai YJ, Ma LP, Hou LF, Zhou B, Yang L, Liu ZL.
208 Tea
Source: Chemistry and Physics of Lipids. 2002 December; 120(1-2): 109-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12426080&dopt=Abstract ·
Antioxidant effects of tea: evidence from human clinical trials. Author(s): Rietveld A, Wiseman S. Source: The Journal of Nutrition. 2003 October; 133(10): 3285S-92S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14519827&dopt=Abstract
·
Antioxidative activity of green tea polyphenol in cholesterol-fed rats. Author(s): Yokozawa T, Nakagawa T, Kitani K. Source: Journal of Agricultural and Food Chemistry. 2002 June 5; 50(12): 3549-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12033827&dopt=Abstract
·
Anti-proliferative and differentiation-inducing activities of the green tea catechin epigallocatechin-3-gallate (EGCG) on the human eosinophilic leukemia EoL-1 cell line. Author(s): Lung HL, Ip WK, Wong CK, Mak NK, Chen ZY, Leung KN. Source: Life Sciences. 2002 December 6; 72(3): 257-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12427485&dopt=Abstract
·
Antiviral properties of prodelphinidin B-2 3'-O-gallate from green tea leaf. Author(s): Cheng HY, Lin CC, Lin TC. Source: Antivir Chem Chemother. 2002 July; 13(4): 223-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12495210&dopt=Abstract
·
Autonomic nervous responses according to preference for the odor of jasmine tea. Author(s): Inoue N, Kuroda K, Sugimoto A, Kakuda T, Fushiki T. Source: Biosci Biotechnol Biochem. 2003 June; 67(6): 1206-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12843644&dopt=Abstract
·
Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Author(s): Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Source: International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity. 2002 November; 26(11): 1459-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12439647&dopt=Abstract
·
Bioactivity of well-defined green tea extracts in multicellular tumor spheroids. Author(s): Mueller-Klieser W, Schreiber-Klais S, Walenta S, Kreuter MH. Source: International Journal of Oncology. 2002 December; 21(6): 1307-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12429982&dopt=Abstract
Alternative Medicine 209
·
Black tea extract and dental caries formation in hamsters. Author(s): Linke HA, LeGeros RZ. Source: International Journal of Food Sciences and Nutrition. 2003 January; 54(1): 89-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12701240&dopt=Abstract
·
Black tea extract supplementation decreases oxidative damage in Jurkat T cells. Author(s): Erba D, Riso P, Foti P, Frigerio F, Criscuoli F, Testolin G. Source: Archives of Biochemistry and Biophysics. 2003 August 15; 416(2): 196-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12893297&dopt=Abstract
·
Black tea prevents cigarette smoke-induced oxidative damage of proteins in guinea pigs. Author(s): Misra A, Chattopadhyay R, Banerjee S, Chattopadhyay DJ, Chatterjee IB. Source: The Journal of Nutrition. 2003 August; 133(8): 2622-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12888648&dopt=Abstract
·
Black tea represents a major source of dietary phenolics among regular tea drinkers. Author(s): Rechner AR, Wagner E, Van Buren L, Van De Put F, Wiseman S, Rice-Evans CA. Source: Free Radical Research. 2002 October; 36(10): 1127-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12516885&dopt=Abstract
·
Bread and tea: a study of the integration of low-income immigrants from other Caribbean territories into Trinidad. Author(s): Valtonen K. Source: Int Migr Rev. 1996 Winter; 30(4): 995-1019. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12347794&dopt=Abstract
·
Can teatime increase one's lifetime? Author(s): Nakachi K, Eguchi H, Imai K. Source: Ageing Research Reviews. 2003 January; 2(1): 1-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12437992&dopt=Abstract
·
Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Author(s): Lin JK. Source: Arch Pharm Res. 2002 October; 25(5): 561-71. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12433185&dopt=Abstract
·
Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Author(s): Lambert JD, Yang CS.
210 Tea
Source: Mutation Research. 2003 February-March; 523-524: 201-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12628518&dopt=Abstract ·
Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Author(s): Bachrach U, Wang YC. Source: Amino Acids. 2002; 22(1): 1-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12025870&dopt=Abstract
·
Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Author(s): Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D. Source: Nutrition and Cancer. 2003; 45(2): 226-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12881018&dopt=Abstract
·
CELLULAR UPTAKE AND EFFLUX OF THE TEA FLAVONOID (-)- EPICATECHIN3-GALLATE IN THE HUMAN INTESTINAL CELL LINE CACO-2. Author(s): Vaidyanathan J, Walle T. Source: The Journal of Pharmacology and Experimental Therapeutics. 2003 September 11 [epub Ahead of Print] http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12970388&dopt=Abstract
·
Characterization of antioxidants present in bitter tea (Ligustrum pedunculare). Author(s): Chen ZY, Wong IY, Leung MW, He ZD, Huang Y. Source: Journal of Agricultural and Food Chemistry. 2002 December 18; 50(26): 7530-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12475266&dopt=Abstract
·
Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea. Author(s): Linden KG, Carpenter PM, McLaren CE, Barr RJ, Hite P, Sun JD, Li KT, Viner JL, Meyskens FL. Source: Recent Results Cancer Res. 2003; 163: 165-71; Discussion 264-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12903852&dopt=Abstract
·
Chemoprevention of oral cancer by green tea. Author(s): Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS. Source: Gen Dent. 2002 March-April; 50(2): 140-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12004708&dopt=Abstract
·
Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Author(s): Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J.
Alternative Medicine 211
Source: Archives of Internal Medicine. 2003 June 23; 163(12): 1448-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12824094&dopt=Abstract ·
Cloning of beta-primeverosidase from tea leaves, a key enzyme in tea aroma formation. Author(s): Mizutani M, Nakanishi H, Ema J, Ma SJ, Noguchi E, Inohara-Ochiai M, Fukuchi-Mizutani M, Nakao M, Sakata K. Source: Plant Physiology. 2002 December; 130(4): 2164-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12481100&dopt=Abstract
·
Collective poisoning with hallucinogenous herbal tea. Author(s): Balikova M. Source: Forensic Science International. 2002 August 14; 128(1-2): 50-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12208022&dopt=Abstract
·
Comparative antimutagenic and anticlastogenic effects of green tea and black tea: a review. Author(s): Gupta S, Saha B, Giri AK. Source: Mutation Research. 2002 September; 512(1): 37-65. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12220589&dopt=Abstract
·
Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha. Author(s): Trompezinski S, Denis A, Schmitt D, Viac J. Source: Archives of Dermatological Research. 2003 July; 295(3): 112-6. Epub 2003 June 13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12811578&dopt=Abstract
·
Comparison of green tea extract and epigallocatechin gallate on blood pressure and contractile responses of vascular smooth muscle of rats. Author(s): Lim DY, Lee ES, Park HG, Kim BC, Hong SP, Lee EB. Source: Arch Pharm Res. 2003 March; 26(3): 214-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12723935&dopt=Abstract
·
Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Author(s): Hirano R, Momiyama Y, Takahashi R, Taniguchi H, Kondo K, Nakamura H, Ohsuzu F. Source: The American Journal of Cardiology. 2002 November 15; 90(10): 1150-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12423723&dopt=Abstract
212 Tea
·
Comparison of microdilution and disc diffusion methods in assessing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. Author(s): Ergin A, Arikan S. Source: Journal of Chemotherapy (Florence, Italy). 2002 October; 14(5): 465-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12462426&dopt=Abstract
·
Complex effects of different green tea catechins on human platelets. Author(s): Lill G, Voit S, Schror K, Weber AA. Source: Febs Letters. 2003 July 10; 546(2-3): 265-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12832052&dopt=Abstract
·
Contribution of hydrogen peroxide to the cytotoxicity of green tea and red wines. Author(s): Chai PC, Long LH, Halliwell B. Source: Biochemical and Biophysical Research Communications. 2003 May 16; 304(4): 650-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12727203&dopt=Abstract
·
Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Author(s): Cai Y, Anavy ND, Chow HH. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2002 November; 30(11): 1246-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12386131&dopt=Abstract
·
Determination of catechins in human plasma after commercial canned green tea ingestion by high-performance liquid chromatography with electrochemical detection using a microbore column. Author(s): Kotani A, Miyashita N, Kusu F. Source: Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2003 May 25; 788(2): 269-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12705967&dopt=Abstract
·
Determination of catechins in matcha green tea by micellar electrokinetic chromatography. Author(s): Weiss DJ, Anderton CR. Source: J Chromatogr A. 2003 September 5; 1011(1-2): 173-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14518774&dopt=Abstract
·
Determination of phenolic compounds in dietary supplements and tea blends containing Echinacea by liquid chromatography with coulometric electrochemical detection. Author(s): Luo W, Ang CY, Gehring TA, Heinze TM, Lin LJ, Mattia A.
Alternative Medicine 213
Source: J Aoac Int. 2003 March-April; 86(2): 202-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12723906&dopt=Abstract ·
Determination of tea components with antioxidant activity. Author(s): Cabrera C, Gimenez R, Lopez MC. Source: Journal of Agricultural and Food Chemistry. 2003 July 16; 51(15): 4427-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12848521&dopt=Abstract
·
Determination of the antioxidant capacity of samples of different types of tea, or of beverages based on tea or other herbal products, using a superoxide dismutase biosensor. Author(s): Campanella L, Bonanni A, Tomassetti M. Source: Journal of Pharmaceutical and Biomedical Analysis. 2003 August 8; 32(4-5): 72536. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12899963&dopt=Abstract
·
Determination of the total concentration and speciation of Al(III) in tea infusions. Author(s): Alberti G, Biesuz R, Profumo A, Pesavento M. Source: Journal of Inorganic Biochemistry. 2003 September 15; 97(1): 79-88. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14507463&dopt=Abstract
·
Differential Activation of MAPK and ICE/Ced-3 Protease in Chemical-Induced ApoptosisThe Role of Oxidative Stress in the Regulation of Mitogen-activated Protein Kinases (MAPKs) leading to Gene Expression and Survival or Activation of Caspases leading to Apoptosis. Author(s): Kong AN, Yu R, Lei W, Mandlekar S, Tan TH, Ucker DS. Source: Restorative Neurology and Neuroscience. 1998; 12(2,3): 63-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12671299&dopt=Abstract
·
Differential modulation of growth and glutathione metabolism in cultured rat astrocytes by 4-hydroxynonenal and green tea polyphenol, epigallocatechin-3-gallate. Author(s): Ahmed I, John A, Vijayasarathy C, Robin MA, Raza H. Source: Neurotoxicology. 2002 September; 23(3): 289-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12387357&dopt=Abstract
·
Differentiation of Japanese green tea cultivars as revealed by RFLP analysis of phenylalanine ammonia-lyase DNA. Author(s): Matsumoto S, Kiriiwa Y, Takeda Y. Source: Tag. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik. 2002 May; 104(6-7): 998-1002. Epub 2002 February 22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12582605&dopt=Abstract
214 Tea
·
Direct determination of free amino acids and sugars in green tea by anion-exchange chromatography with integrated pulsed amperometric detection. Author(s): Ding Y, Yu H, Mou S. Source: J Chromatogr A. 2002 December 27; 982(2): 237-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12489879&dopt=Abstract
·
Direct reduction of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP-DNA adduct formation. Author(s): Lin DX, Thompson PA, Teitel C, Chen JS, Kadlubar FF. Source: Mutation Research. 2003 February-March; 523-524: 193-200. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12628517&dopt=Abstract
·
Direct scavenging of nitric oxide and superoxide by green tea. Author(s): Nakagawa T, Yokozawa T. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2002 December; 40(12): 1745-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12419687&dopt=Abstract
·
DNA degradation by water extract of green tea in the presence of copper ions: implications for anticancer properties. Author(s): Malik A, Azam S, Hadi N, Hadi SM. Source: Phytotherapy Research : Ptr. 2003 April; 17(4): 358-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12722140&dopt=Abstract
·
Does 5% tea tree oil shampoo reduce dandruff? Author(s): Prensner R. Source: The Journal of Family Practice. 2003 April; 52(4): 285-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12681088&dopt=Abstract
·
Drug interaction of herbal tea containing St. John's wort with cyclosporine. Author(s): Alscher DM, Klotz U. Source: Transplant International : Official Journal of the European Society for Organ Transplantation. 2003 July; 16(7): 543-4. Epub 2003 April 02. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12677367&dopt=Abstract
·
Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. Author(s): Chung JH, Han JH, Hwang EJ, Seo JY, Cho KH, Kim KH, Youn JI, Eun HC. Source: The Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2003 October; 17(13): 1913-5. Epub 2003 August 01. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12897059&dopt=Abstract
Alternative Medicine 215
·
Effect of green tea catechin on arachidonic acid cascade in chronic cadmium-poisoned rats. Author(s): Choi JH, Chang HW, Rhee SJ. Source: Asia Pacific Journal of Clinical Nutrition. 2002; 11(4): 292-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12495261&dopt=Abstract
·
Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Author(s): Priyadarshi S, Valentine B, Han C, Fedorova OV, Bagrov AY, Liu J, Periyasamy SM, Kennedy D, Malhotra D, Xie Z, Shapiro JI. Source: Kidney International. 2003 May; 63(5): 1785-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12675854&dopt=Abstract
·
Effect of green tea extracted polyphenol on ischemia/reperfusion injury after cold preservation of rat lung. Author(s): Omasa M, Fukuse T, Matsuoka K, Inui K, Hyon SH, Wada H. Source: Transplantation Proceedings. 2003 February; 35(1): 138-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12591339&dopt=Abstract
·
Effect of green tea in the prevention and reversal of fasting-induced intestinal mucosal damage. Author(s): Asfar S, Abdeen S, Dashti H, Khoursheed M, Al-Sayer H, Mathew T, AlBader A. Source: Nutrition (Burbank, Los Angeles County, Calif.). 2003 June; 19(6): 536-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12781855&dopt=Abstract
·
Effect of green tea polyphenols on angiogenesis induced by an angiogenin-like protein. Author(s): Maiti TK, Chatterjee J, Dasgupta S. Source: Biochemical and Biophysical Research Communications. 2003 August 15; 308(1): 64-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12890480&dopt=Abstract
·
Effect of Increased Tea Consumption on Oxidative DNA Damage among Smokers: A Randomized Controlled Study. Author(s): Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S, Talbot W. Source: The Journal of Nutrition. 2003 October; 133(10): 3303S-9S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14519830&dopt=Abstract
·
Effect of particle size in preparative reversed-phase high-performance liquid chromatography on the isolation of epigallocatechin gallate from Korean green tea. Author(s): Kim JI, Hong SB, Row KH.
216 Tea
Source: J Chromatogr A. 2002 March 8; 949(1-2): 275-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11999744&dopt=Abstract ·
Effect of selenium on increasing the antioxidant activity of tea leaves harvested during the early spring tea producing season. Author(s): Xu J, Yang F, Chen L, Hu Y, Hu Q. Source: Journal of Agricultural and Food Chemistry. 2003 February 12; 51(4): 1081-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12568576&dopt=Abstract
·
Effect of selenium on the yield and quality of green tea leaves harvested in early spring. Author(s): Hu Q, Xu J, Pang G. Source: Journal of Agricultural and Food Chemistry. 2003 May 21; 51(11): 3379-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12744670&dopt=Abstract
·
Effect of tea catechins on cellular lipid peroxidation and cytotoxicity in HepG2 cells. Author(s): Murakami C, Hirakawa Y, Inui H, Nakano Y, Yoshida H. Source: Biosci Biotechnol Biochem. 2002 July; 66(7): 1559-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12224642&dopt=Abstract
·
Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Author(s): Lee SY, Kim CY, Lee JJ, Jung JG, Lee SR. Source: Brain Research Bulletin. 2003 August 30; 61(4): 399-406. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12909283&dopt=Abstract
·
Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats. Author(s): Zhang G, Miura Y, Yagasaki K. Source: Biosci Biotechnol Biochem. 2002 April; 66(4): 711-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12036040&dopt=Abstract
·
Effects of external factors on the interaction of tea catechins with lipid bilayers. Author(s): Kajiya K, Kumazawa S, Nakayama T. Source: Biosci Biotechnol Biochem. 2002 November; 66(11): 2330-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12506968&dopt=Abstract
·
Effects of green tea catechin on prostaglandin synthesis of renal glomerular and renal dysfunction in streptozotocin-induced diabetic rats. Author(s): Rhee SJ, Kim MJ, Kwag OG.
Alternative Medicine 217
Source: Asia Pacific Journal of Clinical Nutrition. 2002; 11(3): 232-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12230238&dopt=Abstract ·
Effects of green tea on carcinogen-induced hepatic CYP1As in C57BL/6 mice. Author(s): Yang M, Yoshikawa M, Arashidani K, Kawamoto T. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 2003 October; 12(5): 391-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14512804&dopt=Abstract
·
Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. Author(s): Pan T, Fei J, Zhou X, Jankovic J, Le W. Source: Life Sciences. 2003 January 17; 72(9): 1073-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12495785&dopt=Abstract
·
Effects of oolong tea on metabolism of plasma fat in mice under restraint stress. Author(s): Kurihara H, Fukami H, Koda H, Tsuruoka N, Sugiura N, Shibata H, Tanaka T. Source: Biosci Biotechnol Biochem. 2002 September; 66(9): 1955-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12400698&dopt=Abstract
·
Effects of tea components on the response of GABA(A) receptors expressed in Xenopus Oocytes. Author(s): Hossain SJ, Hamamoto K, Aoshima H, Hara Y. Source: Journal of Agricultural and Food Chemistry. 2002 July 3; 50(14): 3954-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12083865&dopt=Abstract
·
Effects of tea from Turnera ulmifolia L. on mouse gastric mucosa support the Turneraceae as a new source of antiulcerogenic drugs. Author(s): Gracioso Jde S, Vilegas W, Hiruma-Lima CA, Souza Brito AR. Source: Biological & Pharmaceutical Bulletin. 2002 April; 25(4): 487-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11995930&dopt=Abstract
·
Elevation of P-glycoprotein function by a catechin in green tea. Author(s): Wang EJ, Barecki-Roach M, Johnson WW. Source: Biochemical and Biophysical Research Communications. 2002 September 20; 297(2): 412-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12237135&dopt=Abstract
·
Elimination of Deleterious Effects of Free Radicals in Murine Skin Carcinogenesis by Black Tea Infusion, Theaflavins & Epigallocatechin Gallate. Author(s): Saha P, Das S.
218 Tea
Source: Asian Pac J Cancer Prev. 2002; 3(3): 225-230. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12718579&dopt=Abstract ·
Empowering a tea-plantation community to improve its micronutrient health. Author(s): Gopaldas T, Gujral S. Source: Food Nutr Bull. 2002 June; 23(2): 143-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12094664&dopt=Abstract
·
Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract. Author(s): Melzig MF, Janka M. Source: Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2003; 10(6-7): 494-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=13678233&dopt=Abstract
·
Enzymology of methylation of tea catechins and inhibition of catechol-Omethyltransferase by (-)-epigallocatechin gallate. Author(s): Lu H, Meng X, Yang CS. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2003 May; 31(5): 572-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12695345&dopt=Abstract
·
Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Author(s): Wu CH, Yang YC, Yao WJ, Lu FH, Wu JS, Chang CJ. Source: Archives of Internal Medicine. 2002 May 13; 162(9): 1001-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11996609&dopt=Abstract
·
Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. Author(s): Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Source: The Journal of Biological Chemistry. 2002 September 20; 277(38): 34933-40. Epub 2002 July 12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12118006&dopt=Abstract
·
Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Author(s): Han MK. Source: Experimental & Molecular Medicine. 2003 April 30; 35(2): 136-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12754418&dopt=Abstract
·
Epigallocatechin gallate, a potential immunomodulatory agent of tea components, diminishes cigarette smoke condensate-induced suppression of anti-Legionella pneumophila activity and cytokine responses of alveolar macrophages. Author(s): Matsunaga K, Klein TW, Friedman H, Yamamoto Y.
Alternative Medicine 219
Source: Clinical and Diagnostic Laboratory Immunology. 2002 July; 9(4): 864-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12093687&dopt=Abstract ·
Epimerization of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3O-gallate: relationship between epimerization and chemical structure. Author(s): Suzuki M, Sano M, Yoshida R, Degawa M, Miyase T, Maeda-Yamamoto M. Source: Journal of Agricultural and Food Chemistry. 2003 January 15; 51(2): 510-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12517118&dopt=Abstract
·
Factors affecting the levels of tea polyphenols and caffeine in tea leaves. Author(s): Lin YS, Tsai YJ, Tsay JS, Lin JK. Source: Journal of Agricultural and Food Chemistry. 2003 March 26; 51(7): 1864-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12643643&dopt=Abstract
·
Fast determination of catechins and xanthines in tea beverages by micellar electrokinetic chromatography. Author(s): Bonoli M, Colabufalo P, Pelillo M, Gallina Toschi T, Lercker G. Source: Journal of Agricultural and Food Chemistry. 2003 February 26; 51(5): 1141-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12590448&dopt=Abstract
·
Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA. Author(s): Lanigan RS, Yamarik TA. Source: International Journal of Toxicology. 2002; 21 Suppl 2: 95-142. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12396676&dopt=Abstract
·
Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatonin. Author(s): Weinreb O, Mandel S, Youdim MB. Source: Annals of the New York Academy of Sciences. 2003 May; 993: 351-61; Discussion 387-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12853328&dopt=Abstract
·
Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Author(s): Vaidyanathan JB, Walle T. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2002 August; 30(8): 897-903. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12124307&dopt=Abstract
220 Tea
·
Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Author(s): Lu H, Meng X, Li C, Sang S, Patten C, Sheng S, Hong J, Bai N, Winnik B, Ho CT, Yang CS. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2003 April; 31(4): 452-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12642472&dopt=Abstract
·
Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis. Author(s): Gupta SK, Halder N, Srivastava S, Trivedi D, Joshi S, Varma SD. Source: Ophthalmic Research. 2002 July-August; 34(4): 258-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12297700&dopt=Abstract
·
Green tea and prostate cancer. Author(s): Gupta S, Mukhtar H. Source: The Urologic Clinics of North America. 2002 February; 29(1): 49-57, Viii. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12109355&dopt=Abstract
·
Green tea and risk of breast cancer in Asian Americans. Author(s): Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC. Source: International Journal of Cancer. Journal International Du Cancer. 2003 September 10; 106(4): 574-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12845655&dopt=Abstract
·
Green tea as a potent antioxidant in alcohol intoxication. Author(s): Skrzydlewska E, Ostrowska J, Stankiewicz A, Farbiszewski R. Source: Addiction Biology. 2002 July; 7(3): 307-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12126490&dopt=Abstract
·
Green tea catechin improves microsomal phospholipase A2 activity and the arachidonic acid cascade system in the kidney of diabetic rats. Author(s): Rhee SJ, Choi JH, Park MR. Source: Asia Pacific Journal of Clinical Nutrition. 2002; 11(3): 226-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12230237&dopt=Abstract
·
Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Author(s): Tang FY, Meydani M. Source: Nutrition and Cancer. 2001; 41(1-2): 119-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12094614&dopt=Abstract
Alternative Medicine 221
·
Green tea catechins as novel antitumor and antiangiogenic compounds. Author(s): Demeule M, Michaud-Levesque J, Annabi B, Gingras D, Boivin D, Jodoin J, Lamy S, Bertrand Y, Beliveau R. Source: Current Medicinal Chemistry. Anti-Cancer Agents. 2002 July; 2(4): 441-63. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12678730&dopt=Abstract
·
Green tea catechins evoke a phasic contraction in rat aorta via H2O2-mediated multiple-signalling pathways. Author(s): Shen JZ, Zheng XF, Wei EQ, Kwan CY. Source: Clinical and Experimental Pharmacology & Physiology. 2003 January-February; 30(1-2): 88-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12542460&dopt=Abstract
·
Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Author(s): Maeda K, Kuzuya M, Cheng XW, Asai T, Kanda S, Tamaya-Mori N, Sasaki T, Shibata T, Iguchi A. Source: Atherosclerosis. 2003 January; 166(1): 23-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12482547&dopt=Abstract
·
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Author(s): Tang FY, Nguyen N, Meydani M. Source: International Journal of Cancer. Journal International Du Cancer. 2003 October 10; 106(6): 871-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12918064&dopt=Abstract
·
Green Tea Constituent (-)-Epigallocatechin-3-Gallate Inhibits Hep G2 Cell Proliferation and Induces Apoptosis through p53-Dependent and Fas-Mediated Pathways. Author(s): Kuo PL, Lin CC. Source: Journal of Biomedical Science. 2003 March-April; 10(2): 219-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12595758&dopt=Abstract
·
Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Author(s): Singh AK, Seth P, Anthony P, Husain MM, Madhavan S, Mukhtar H, Maheshwari RK. Source: Archives of Biochemistry and Biophysics. 2002 May 1; 401(1): 29-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12054484&dopt=Abstract
·
Green tea epigallocatechin-3-gallate inhibits platelet signalling pathways triggered by both proteolytic and non-proteolytic agonists.
222 Tea
Author(s): Deana R, Turetta L, Donella-Deana A, Dona M, Maria Brunati A, De Michiel L, Garbisa S. Source: Thrombosis and Haemostasis. 2003 May; 89(5): 866-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12719785&dopt=Abstract ·
Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase. Author(s): Rodriguez-Caso C, Rodriguez-Agudo D, Sanchez-Jimenez F, Medina MA. Source: Cellular and Molecular Life Sciences : Cmls. 2003 August; 60(8): 1760-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14521154&dopt=Abstract
·
Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Author(s): Kojima-Yuasa A, Hua JJ, Kennedy DO, Matsui-Yuasa I. Source: Life Sciences. 2003 July 25; 73(10): 1299-313. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12850245&dopt=Abstract
·
Green tea extract inhibits the lymphatic absorption of cholesterol and alphatocopherol in ovariectomized rats. Author(s): Loest HB, Noh SK, Koo SI. Source: The Journal of Nutrition. 2002 June; 132(6): 1282-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12042447&dopt=Abstract
·
Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet. Author(s): Young JF, Dragstedt LO, Haraldsdottir J, Daneshvar B, Kal MA, Loft S, Nilsson L, Nielsen SE, Mayer B, Skibsted LH, Huynh-Ba T, Hermetter A, Sandstrom B. Source: The British Journal of Nutrition. 2002 April; 87(4): 343-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12064344&dopt=Abstract
·
Green tea extract protects against early alcohol-induced liver injury in rats. Author(s): Arteel GE, Uesugi T, Bevan LN, Gabele E, Wheeler MD, McKim SE, Thurman RG. Source: Biological Chemistry. 2002 March-April; 383(3-4): 663-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12033455&dopt=Abstract
·
Green tea extracts can counteract the modification of fatty acid composition induced by doxorubicin in cultured cardiomyocytes. Author(s): Hrelia S, Bordoni A, Angeloni C, Leoncini E, Toschi TG, Lercker G, Biagi PL. Source: Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2002 May-June; 66(5-6): 519-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12144873&dopt=Abstract
Alternative Medicine 223
·
Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. Author(s): Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN. Source: The Journal of Nutrition. 2002 August; 132(8): 2307-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12163680&dopt=Abstract
·
Green tea polyphenol blocks h(2)o(2)-induced interleukin-8 production from human alveolar epithelial cells. Author(s): Matsuoka K, Isowa N, Yoshimura T, Liu M, Wada H. Source: Cytokine. 2002 June 7; 18(5): 266-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12161102&dopt=Abstract
·
Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. Author(s): Yamamoto T, Hsu S, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, Lockwood P, Ueta E, Osaki T, Schuster G. Source: The Journal of Pharmacology and Experimental Therapeutics. 2003 October; 307(1): 230-6. Epub 2003 September 03. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12954803&dopt=Abstract
·
Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. Author(s): Hofmann CS, Sonenshein GE. Source: The Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2003 April; 17(6): 702-4. Epub 2003 February 05. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12586742&dopt=Abstract
·
Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Author(s): Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM. Source: Free Radical Biology & Medicine. 2002 October 15; 33(8): 1097-105. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12374621&dopt=Abstract
·
Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3dependent apoptosis. Author(s): Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, Athar M, Porter AG, Schuster G. Source: Anticancer Res. 2003 March-April; 23(2B): 1533-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12820420&dopt=Abstract
224 Tea
·
Green tea polyphenols enhance sodium nitroprusside-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Author(s): Zhang Y, Zhao B. Source: Journal of Neurochemistry. 2003 September; 86(5): 1189-200. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12911627&dopt=Abstract
·
Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. Author(s): Hsu S, Bollag WB, Lewis J, Huang Q, Singh B, Sharawy M, Yamamoto T, Schuster G. Source: The Journal of Pharmacology and Experimental Therapeutics. 2003 July; 306(1): 29-34. Epub 2003 March 27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12663686&dopt=Abstract
·
Green tea polyphenols inhibit metalloproteinase activities in the skin, muscle, and blood of rainbow trout. Author(s): Saito M, Saito K, Kunisaki N, Kimura S. Source: Journal of Agricultural and Food Chemistry. 2002 November 20; 50(24): 7169-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12428978&dopt=Abstract
·
Green tea: cancer preventive beverage and/or drug. Author(s): Fujiki H, Suganuma M, Imai K, Nakachi K. Source: Cancer Letters. 2002 December 15; 188(1-2): 9-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12406542&dopt=Abstract
·
Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness. Author(s): Shirai T, Reshad K, Yoshitomi A, Chida K, Nakamura H, Taniguchi M. Source: Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology. 2003 September; 33(9): 1252-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12956747&dopt=Abstract
·
Growth inhibition, induction of apoptosis by green tea constituent (-)epigallocatechin-3-gallate in cultured rabbit lens epithelial cells. Author(s): Huang W, Li S, Zeng J, Liu Y, Wu M, Zhang M. Source: Yan Ke Xue Bao. 2000 September; 16(3): 194-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12579647&dopt=Abstract
·
HPLC fingerprinting and estimation of the bioactive components of Clutia richardiana L. as a potential hypoglycemic herbal tea. Author(s): Abourashed EA, Ganzera M, Khan IA, Khan S, Mossa JS, El-Feraly FS.
Alternative Medicine 225
Source: Phytotherapy Research : Ptr. 2003 June; 17(6): 657-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12820235&dopt=Abstract ·
Hydroxyl radical and hypochlorous acid scavenging activity of small centaury (Centaurium erythraea) infusion. A comparative study with green tea (Camellia sinensis). Author(s): Valentao P, Fernandes E, Carvalho F, Andrade PB, Seabra RM, Bastos ML. Source: Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2003; 10(6-7): 517-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=13678237&dopt=Abstract
·
Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Author(s): Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT, Yang CS. Source: Chemical Research in Toxicology. 2002 August; 15(8): 1042-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12184788&dopt=Abstract
·
Identification of potent odorants in Chinese jasmine green tea scented with flowers of Jasminum sambac. Author(s): Ito Y, Sugimoto A, Kakuda T, Kubota K. Source: Journal of Agricultural and Food Chemistry. 2002 August 14; 50(17): 4878-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12166975&dopt=Abstract
·
Identification of potent odorants in different green tea varieties using flavor dilution technique. Author(s): Kumazawa K, Masuda H. Source: Journal of Agricultural and Food Chemistry. 2002 September 25; 50(20): 5660-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12236694&dopt=Abstract
·
Identification of potential aryl hydrocarbon receptor antagonists in green tea. Author(s): Palermo CM, Hernando JI, Dertinger SD, Kende AS, Gasiewicz TA. Source: Chemical Research in Toxicology. 2003 July; 16(7): 865-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12870889&dopt=Abstract
·
Identification of processed Japanese green tea based on polymorphisms generated by STS-RFLP analysis. Author(s): Kaundun SS, Matsumoto S. Source: Journal of Agricultural and Food Chemistry. 2003 March 26; 51(7): 1765-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12643627&dopt=Abstract
·
Immediate systemic hypersensitivity reaction associated with topical application of Australian tea tree oil. Author(s): Mozelsio NB, Harris KE, McGrath KG, Grammer LC.
226 Tea
Source: Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 2003 January-February; 24(1): 73-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12635581&dopt=Abstract ·
Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. Author(s): Hirasawa M, Takada K, Makimura M, Otake S. Source: Journal of Periodontal Research. 2002 December; 37(6): 433-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12472837&dopt=Abstract
·
In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. Author(s): Hammer KA, Carson CF, Riley TV. Source: The Journal of Antimicrobial Chemotherapy. 2002 August; 50(2): 195-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12161399&dopt=Abstract
·
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. Author(s): Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. Source: The Journal of Antimicrobial Chemotherapy. 2003 May; 51(5): 1223-9. Epub 2003 March 28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12668571&dopt=Abstract
·
Indonesian tea mistletoe (Scurrula oortiana) stem extract increases tumour cell sensitivity to tumour necrosis factor alpha (TNFalpha). Author(s): Murwani R. Source: Phytotherapy Research : Ptr. 2003 April; 17(4): 407-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12722151&dopt=Abstract
·
Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells. Author(s): Yoo HG, Shin BA, Park JC, Kim HS, Kim WJ, Chay KO, Ahn BW, Park RK, Ellis LM, Jung YD. Source: Anticancer Res. 2002 November-December; 22(6A): 3373-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12530089&dopt=Abstract
·
Induction of p57 is required for cell survival when exposed to green tea polyphenols. Author(s): Hsu S, Yu FS, Lewis J, Singh B, Borke J, Osaki T, Athar M, Schuster G. Source: Anticancer Res. 2002 November-December; 22(6C): 4115-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553041&dopt=Abstract
Alternative Medicine 227
·
Induction of UDP-glucuronosyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Author(s): Embola CW, Sohn OS, Fiala ES, Weisburger JH. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2002 June; 40(6): 841-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11983278&dopt=Abstract
·
Influence of green tea polyphenol in rats with arginine-induced renal failure. Author(s): Yokozawa T, Cho EJ, Nakagawa T. Source: Journal of Agricultural and Food Chemistry. 2003 April 9; 51(8): 2421-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12670191&dopt=Abstract
·
Ingestion of tea tree oil (Melaleuca oil) by a 4-year-old boy. Author(s): Morris MC, Donoghue A, Markowitz JA, Osterhoudt KC. Source: Pediatric Emergency Care. 2003 June; 19(3): 169-171. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12813303&dopt=Abstract
·
Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Author(s): Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Han C, Chen J, Huang MT, Yang CS. Source: Carcinogenesis. 2002 August; 23(8): 1307-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12151348&dopt=Abstract
·
Inhibition of adenovirus infection and adenain by green tea catechins. Author(s): Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Source: Antiviral Research. 2003 April; 58(2): 167-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12742577&dopt=Abstract
·
Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Author(s): Satoh K, Sakamoto Y, Ogata A, Nagai F, Mikuriya H, Numazawa M, Yamada K, Aoki N. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2002 July; 40(7): 925-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12065214&dopt=Abstract
·
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3gallate is associated with prostate cancer cell apoptosis. Author(s): Kazi A, Smith DM, Zhong Q, Dou QP. Source: Molecular Pharmacology. 2002 October; 62(4): 765-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12237322&dopt=Abstract
228 Tea
·
Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Author(s): Dashwood WM, Orner GA, Dashwood RH. Source: Biochemical and Biophysical Research Communications. 2002 August 23; 296(3): 584-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12176021&dopt=Abstract
·
Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3gallate. Author(s): Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH. Source: The Journal of Urology. 2003 September; 170(3): 773-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12913695&dopt=Abstract
·
Inhibition of fibroblast growth factors by green tea. Author(s): Sartippour MR, Heber D, Zhang L, Beatty P, Elashoff D, Elashoff R, Go VL, Brooks MN. Source: International Journal of Oncology. 2002 September; 21(3): 487-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12168090&dopt=Abstract
·
Inhibition of matrix-proteases by polyphenols: chemical insights for antiinflammatory and anti-invasion drug design. Author(s): Sartor L, Pezzato E, Dell'Aica I, Caniato R, Biggin S, Garbisa S. Source: Biochemical Pharmacology. 2002 July 15; 64(2): 229-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12123743&dopt=Abstract
·
Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3gallate. Author(s): Afaq F, Adhami VM, Ahmad N, Mukhtar H. Source: Oncogene. 2003 February 20; 22(7): 1035-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12592390&dopt=Abstract
·
Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. Author(s): Oku N, Matsukawa M, Yamakawa S, Asai T, Yahara S, Hashimoto F, Akizawa T. Source: Biological & Pharmaceutical Bulletin. 2003 September; 26(9): 1235-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12951464&dopt=Abstract
·
Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Author(s): Okamoto M, Leung KP, Ansai T, Sugimoto A, Maeda N.
Alternative Medicine 229
Source: Oral Microbiology and Immunology. 2003 June; 18(3): 192-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12753472&dopt=Abstract ·
Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (matrilysin). Author(s): Oneda H, Shiihara M, Inouye K. Source: Journal of Biochemistry. 2003 May; 133(5): 571-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12801907&dopt=Abstract
·
Inhibitory effects of tea and caffeine on UV-induced carcinogenesis: relationship to enhanced apoptosis and decreased tissue fat. Author(s): Conney AH, Lu YP, Lou YR, Huang MT. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 2002 August; 11 Suppl 2: S28-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12570332&dopt=Abstract
·
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. Author(s): Naftalin RJ, Afzal I, Cunningham P, Halai M, Ross C, Salleh N, Milligan SR. Source: British Journal of Pharmacology. 2003 October; 140(3): 487-499. Epub 2003 August 26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12970085&dopt=Abstract
·
Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. Author(s): Levites Y, Amit T, Youdim MB, Mandel S. Source: The Journal of Biological Chemistry. 2002 August 23; 277(34): 30574-80. Epub 2002 June 10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058035&dopt=Abstract
·
Kinetics of reduction of ferrylmyoglobin by (-)-epigallocatechin gallate and green tea extract. Author(s): Hu M, Skibsted LH. Source: Journal of Agricultural and Food Chemistry. 2002 May 8; 50(10): 2998-3003. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11982432&dopt=Abstract
·
Lack of inhibitory effects of green tea catechins in 1,2-dimetylhydrazine-induced rat intestinal carcinogenesis model: comparison of the different formulations, administration routes and doses. Author(s): Hirose M, Yamaguchi T, Mizoguchi Y, Akagi K, Futakuchi M, Shirai T.
230 Tea
Source: Cancer Letters. 2002 December 15; 188(1-2): 163-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12406561&dopt=Abstract ·
Leakage of K+ ions from Staphylococcus aureus in response to tea tree oil. Author(s): Hada T, Inoue Y, Shiraishi A, Hamashima H. Source: Journal of Microbiological Methods. 2003 June; 53(3): 309-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12689708&dopt=Abstract
·
Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Author(s): Carson CF, Mee BJ, Riley TV. Source: Antimicrobial Agents and Chemotherapy. 2002 June; 46(6): 1914-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12019108&dopt=Abstract
·
Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Author(s): Weisburger JH, Chung FL. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2002 August; 40(8): 1145-54. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12067577&dopt=Abstract
·
Microemulsion electrokinetic chromatography for the analysis of green tea catechins: Effect of the cosurfactant on the separation selectivity. Author(s): Pomponio R, Gotti R, Luppi B, Cavrini V. Source: Electrophoresis. 2003 May; 24(10): 1658-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12761797&dopt=Abstract
·
Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. Author(s): Zhang H, Spitz MR, Tomlinson GE, Schabath MB, Minna JD, Wu X. Source: Cancer Detection and Prevention. 2002; 26(6): 411-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12507225&dopt=Abstract
·
Modulation of Arsenic Induced Cytotoxicity by Tea. Author(s): Sinha D, Roy M, Dey S, Siddiqi M, Bhattacharya R. Source: Asian Pac J Cancer Prev. 2003; 4(3): 233-237. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14507244&dopt=Abstract
·
Molecular targets for green tea in prostate cancer prevention. Author(s): Adhami VM, Ahmad N, Mukhtar H.
Alternative Medicine 231
Source: The Journal of Nutrition. 2003 July; 133(7 Suppl): 2417S-2424S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12840218&dopt=Abstract ·
More than just a propagandist for tea: religious argument and advice on a healthy life in the work of the Dutch physician Cornelis Bontekoe (1647-1685). Author(s): Schweikardt C. Source: Medical History. 2003 July; 47(3): 357-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12905919&dopt=Abstract
·
Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)epigallocatechin-3-gallate. Author(s): Levites Y, Amit T, Mandel S, Youdim MB. Source: The Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2003 May; 17(8): 952-4. Epub 2003 March 28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12670874&dopt=Abstract
·
Neuroprotective effects of the green tea components theanine and catechins. Author(s): Kakuda T. Source: Biological & Pharmaceutical Bulletin. 2002 December; 25(12): 1513-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12499631&dopt=Abstract
·
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. Author(s): Dona M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Source: Journal of Immunology (Baltimore, Md. : 1950). 2003 April 15; 170(8): 4335-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12682270&dopt=Abstract
·
No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Author(s): Koizumi Y, Tsubono Y, Nakaya N, Nishino Y, Shibuya D, Matsuoka H, Tsuji I. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2003 May; 12(5): 472-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12750246&dopt=Abstract
·
Novel EPR characterization of the antioxidant activity of tea leaves. Author(s): Morsy MA, Khaled MM. Source: Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy. 2002 April; 58(6): 1271-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11993474&dopt=Abstract
232 Tea
·
Oolong tea increases energy metabolism in Japanese females. Author(s): Komatsu T, Nakamori M, Komatsu K, Hosoda K, Okamura M, Toyama K, Ishikura Y, Sakai T, Kunii D, Yamamoto S. Source: J Med Invest. 2003 August; 50(3-4): 170-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=13678386&dopt=Abstract
·
Oxalate content and calcium binding capacity of tea and herbal teas. Author(s): Charrier MJ, Savage GP, Vanhanen L. Source: Asia Pacific Journal of Clinical Nutrition. 2002; 11(4): 298-301. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12495262&dopt=Abstract
·
PCDD/PCDF, chlorinated pesticides and PAH in Chinese teas. Author(s): Fiedler H, Cheung CK, Wong MH. Source: Chemosphere. 2002 March; 46(9-10): 1429-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12002472&dopt=Abstract
·
Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Author(s): Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS. Source: Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2003 August 15; 9(9): 3312-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12960117&dopt=Abstract
·
Pharmacokinetics of tea catechins after ingestion of green tea and (-)epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Author(s): Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2002 October; 11(10 Pt 1): 1025-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12376503&dopt=Abstract
·
Phytotherapy of chronic dermatitis and pruritus of dogs with a topical preparation containing tea tree oil (Bogaskin). Author(s): Fitzi J, Furst-Jucker J, Wegener T, Saller R, Reichling J. Source: Schweiz Arch Tierheilkd. 2002 May; 144(5): 223-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12070906&dopt=Abstract
·
Polyphenols from Honeybush tea (Cyclopia intermedia). Author(s): Kamara BI, Brandt EV, Ferreira D, Joubert E.
Alternative Medicine 233
Source: Journal of Agricultural and Food Chemistry. 2003 June 18; 51(13): 3874-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12797758&dopt=Abstract ·
Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. Author(s): Kazi A, Smith DM, Daniel K, Zhong S, Gupta P, Bosley ME, Dou QP. Source: In Vivo. 2002 November-December; 16(6): 397-403. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12494882&dopt=Abstract
·
Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Author(s): Pan T, Jankovic J, Le W. Source: Drugs & Aging. 2003; 20(10): 711-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12875608&dopt=Abstract
·
Powdered green tea has antilipogenic effect on Zucker rats fed a high-fat diet. Author(s): Hasegawa N, Yamda N, Mori M. Source: Phytotherapy Research : Ptr. 2003 May; 17(5): 477-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12748982&dopt=Abstract
·
Preferred age for assessment of qualitative and quantitative characteristics of the essential oil of tea tree (Melaleuca alternifolia) seedlings prior to plantation establishment. Author(s): Russell MF, Southwell I. Source: Journal of Agricultural and Food Chemistry. 2003 July 16; 51(15): 4254-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12848493&dopt=Abstract
·
Presence of two forms of methylated (-)-epigallocatechin-3-gallate in green tea. Author(s): Amarowicz R, Shahidi F. Source: Die Nahrung. 2003 February; 47(1): 21-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12653431&dopt=Abstract
·
Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato- and cholangiocarcinogenesis in mice by green tea infusion. Author(s): Umemura T, Kai S, Hasegawa R, Kanki K, Kitamura Y, Nishikawa A, Hirose M. Source: Carcinogenesis. 2003 June; 24(6): 1105-9. Epub 2003 April 24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12807750&dopt=Abstract
·
Prevention of hepatic ischemia-reperfusion injury by green tea extract. Author(s): Zhong Z, Froh M, Connor HD, Li X, Conzelmann LO, Mason RP, Lemasters JJ, Thurman RG.
234 Tea
Source: American Journal of Physiology. Gastrointestinal and Liver Physiology. 2002 October; 283(4): G957-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12223356&dopt=Abstract ·
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinduced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Author(s): Choi JY, Park CS, Kim DJ, Cho MH, Jin BK, Pie JE, Chung WG. Source: Neurotoxicology. 2002 September; 23(3): 367-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12387363&dopt=Abstract
·
Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rat by green tea leaves. Author(s): Sato D, Matsushima M. Source: International Journal of Urology : Official Journal of the Japanese Urological Association. 2003 March; 10(3): 160-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622713&dopt=Abstract
·
Protection of tea melanin on hydrazine-induced liver injury. Author(s): Hung YC, Sava VM, Blagodarsky VA, Hong MY, Huang GS. Source: Life Sciences. 2003 January 17; 72(9): 1061-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12495784&dopt=Abstract
·
Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Author(s): Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K. Source: Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2002 April; 9(3): 232-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12046864&dopt=Abstract
·
Protective effect of green tea extract against the erythrocytic oxidative stress injury during mycobacterium tuberculosis infection in mice. Author(s): Guleria RS, Jain A, Tiwari V, Misra MK. Source: Molecular and Cellular Biochemistry. 2002 July; 236(1-2): 173-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12190117&dopt=Abstract
·
Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Author(s): Lee SR, Im KJ, Suh SI, Jung JG. Source: Phytotherapy Research : Ptr. 2003 March; 17(3): 206-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12672147&dopt=Abstract
Alternative Medicine 235
·
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Author(s): Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, Bae SM, Lee IP. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 2003 October; 12(5): 383-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14512803&dopt=Abstract
·
Protective effects of green tea polyphenols and their major component, (-)epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Author(s): Nie G, Cao Y, Zhao B. Source: Redox Report : Communications in Free Radical Research. 2002; 7(3): 171-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12189048&dopt=Abstract
·
Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells. Author(s): Wei D, Mei Y, Liu J. Source: Biotechnology Letters. 2003 February; 25(4): 291-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12882539&dopt=Abstract
·
Quantitative characterization of flavonoid compounds in Rooibos tea (Aspalathus linearis) by LC-UV/DAD. Author(s): Bramati L, Minoggio M, Gardana C, Simonetti P, Mauri P, Pietta P. Source: Journal of Agricultural and Food Chemistry. 2002 September 25; 50(20): 5513-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12236672&dopt=Abstract
·
Relation of coffee, green tea, and caffeine intake to gallstone disease in middle-aged Japanese men. Author(s): Ishizuk H, Eguchi H, Oda T, Ogawa S, Nakagawa K, Honjo S, Kono S. Source: European Journal of Epidemiology. 2003; 18(5): 401-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12889685&dopt=Abstract
·
Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. Author(s): Iwai N, Ohshiro H, Kurozawa Y, Hosoda T, Morita H, Funakawa K, Okamoto M, Nose T. Source: J Epidemiol. 2002 May; 12(3): 191-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12164320&dopt=Abstract
·
Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Author(s): Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH.
236 Tea
Source: Mutation Research. 2002 September 30; 506-507: 121-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12351151&dopt=Abstract ·
Seasonal, spatial, and interspecific variation in quercetin in Apocynum venetum and Poacynum hendersonii, Chinese traditional herbal teas. Author(s): Ma M, Hong CL, An SQ, Li B. Source: Journal of Agricultural and Food Chemistry. 2003 April 9; 51(8): 2390-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12670186&dopt=Abstract
·
Sharing a bowl of tea. Author(s): Sen S. Source: Integration. 1993 June; (36): 2-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12286476&dopt=Abstract
·
Signal transduction pathways: targets for green and black tea polyphenols. Author(s): Park AM, Dong Z. Source: J Biochem Mol Biol. 2003 January 31; 36(1): 66-77. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12542977&dopt=Abstract
·
Simultaneous determination of all polyphenols in vegetables, fruits, and teas. Author(s): Sakakibara H, Honda Y, Nakagawa S, Ashida H, Kanazawa K. Source: Journal of Agricultural and Food Chemistry. 2003 January 29; 51(3): 571-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12537425&dopt=Abstract
·
Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Author(s): Katiyar SK. Source: Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 2003 September; 3(3): 234-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12871030&dopt=Abstract
·
Soy phytochemicals and tea bioactive components synergistically inhibit androgensensitive human prostate tumors in mice. Author(s): Zhou JR, Yu L, Zhong Y, Blackburn GL. Source: The Journal of Nutrition. 2003 February; 133(2): 516-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12566493&dopt=Abstract
·
Spirituality and clinical care. Spirituality is not everyone's cup of tea for treating addiction. Author(s): Day E, Wilkes S, Copello A. Source: Bmj (Clinical Research Ed.). 2003 April 19; 326(7394): 881. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12705237&dopt=Abstract
Alternative Medicine 237
·
Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Author(s): Hong J, Lu H, Meng X, Ryu JH, Hara Y, Yang CS. Source: Cancer Research. 2002 December 15; 62(24): 7241-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12499265&dopt=Abstract
·
Steeped in health. Ordinary tea may help fight cancer, heart disease and, now, infection. Author(s): Gorman C. Source: Time. 2003 May 5; 161(18): 86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12747035&dopt=Abstract
·
Stimulatory effect of oral administration of green tea and caffeine on locomotor activity in SKH-1 mice. Author(s): Michna L, Lu YP, Lou YR, Wagner GC, Conney AH. Source: Life Sciences. 2003 August 1; 73(11): 1383-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12850499&dopt=Abstract
·
Studies on human fetal lens crystallins under oxidative stress and protective effects of tea polyphenols. Author(s): Xiang H, Pan S, Li S. Source: Yan Ke Xue Bao. 1998 September; 14(3): 170-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12580027&dopt=Abstract
·
Studies with black tea and its constituents on leukemic cells and cell lines. Author(s): Das M, Chaudhuri T, Goswami SK, Murmu N, Gomes A, Mitra S, Besra SE, Sur P, Vedasiromoni JR. Source: J Exp Clin Cancer Res. 2002 December; 21(4): 563-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12636103&dopt=Abstract
·
Superoxide dismutase activity enhanced by green tea inhibits lipid accumulation in 3T3-L1 cells. Author(s): Mori M, Hasegawa N. Source: Phytotherapy Research : Ptr. 2003 May; 17(5): 566-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12749002&dopt=Abstract
·
Suppression of cytotoxin-induced cell death in isolated hepatocytes by tea catechins. Author(s): Kagaya N, Tagawa Y, Nagashima H, Saijo R, Kawase M, Yagi K. Source: European Journal of Pharmacology. 2002 August 30; 450(3): 231-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12208314&dopt=Abstract
238 Tea
·
Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of betacatenin signaling by a combination of tea plus sulindac. Author(s): Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Dashwood RH. Source: Carcinogenesis. 2003 February; 24(2): 263-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12584176&dopt=Abstract
·
Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells. Author(s): Takada M, Ku Y, Toyama H, Suzuki Y, Kuroda Y. Source: Hepatogastroenterology. 2002 July-August; 49(46): 928-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12143244&dopt=Abstract
·
Synergistic Capsicum-tea mixtures with anticancer activity. Author(s): Morre DJ, Morre DM. Source: The Journal of Pharmacy and Pharmacology. 2003 July; 55(7): 987-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12906756&dopt=Abstract
·
Synthetic analogs of green tea polyphenols as proteasome inhibitors. Author(s): Smith DM, Wang Z, Kazi A, Li LH, Chan TH, Dou QP. Source: Molecular Medicine (Cambridge, Mass.). 2002 July; 8(7): 382-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12393936&dopt=Abstract
·
Tea and cancer prevention: studies in animals and humans. Author(s): Chung FL, Schwartz J, Herzog CR, Yang YM. Source: The Journal of Nutrition. 2003 October; 133(10): 3268S-74S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14519825&dopt=Abstract
·
Tea as a functional food for oral health. Author(s): Wu CD, Wei GX. Source: Nutrition (Burbank, Los Angeles County, Calif.). 2002 May; 18(5): 443-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11985958&dopt=Abstract
·
Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX). Author(s): Morre DJ, Morre DM, Sun H, Cooper R, Chang J, Janle EM. Source: Pharmacology & Toxicology. 2003 May; 92(5): 234-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12753411&dopt=Abstract
·
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Author(s): Higdon JV, Frei B.
Alternative Medicine 239
Source: Critical Reviews in Food Science and Nutrition. 2003; 43(1): 89-143. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587987&dopt=Abstract ·
Tea consumption and ovarian cancer risk: a case-control study in China. Author(s): Zhang M, Binns CW, Lee AH. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2002 August; 11(8): 713-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12163323&dopt=Abstract
·
Tea enhances insulin activity. Author(s): Anderson RA, Polansky MM. Source: Journal of Agricultural and Food Chemistry. 2002 November 20; 50(24): 7182-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12428980&dopt=Abstract
·
Tea tree oil dermatitis associated with linear IgA disease. Author(s): Perrett CM, Evans AV, Russell-Jones R. Source: Clinical and Experimental Dermatology. 2003 March; 28(2): 167-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12653706&dopt=Abstract
·
Tea tree oil reduces histamine-induced oedema in murine ears. Author(s): Brand C, Townley SL, Finlay-Jones JJ, Hart PH. Source: Inflammation Research : Official Journal of the European Histamine Research Society. [et Al.]. 2002 June; 51(6): 283-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12088268&dopt=Abstract
·
Tea tree oil reduces histamine-induced skin inflammation. Author(s): Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH. Source: The British Journal of Dermatology. 2002 December; 147(6): 1212-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12452873&dopt=Abstract
·
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Author(s): Brand C, Grimbaldeston MA, Gamble JR, Drew J, Finlay-Jones JJ, Hart PH. Source: Inflammation Research : Official Journal of the European Histamine Research Society. [et Al.]. 2002 May; 51(5): 236-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12056511&dopt=Abstract
·
The association of 137Cs with various components of tea leaves fermented from Chernobyl contaminated green tea. Author(s): Polar E.
240 Tea
Source: Journal of Environmental Radioactivity. 2002; 63(3): 265-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12440515&dopt=Abstract ·
The epidemiology of tea consumption and colorectal cancer incidence. Author(s): Arab L, Il'yasova D. Source: The Journal of Nutrition. 2003 October; 133(10): 3310S-8S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14519831&dopt=Abstract
·
The green tea polyphenol, epigallocatechin-3-gallate, protects against the oxidative cellular and genotoxic damage of UVA radiation. Author(s): Tobi SE, Gilbert M, Paul N, McMillan TJ. Source: International Journal of Cancer. Journal International Du Cancer. 2002 December 10; 102(5): 439-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12432544&dopt=Abstract
·
The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Author(s): Kimura M, Umegaki K, Kasuya Y, Sugisawa A, Higuchi M. Source: European Journal of Clinical Nutrition. 2002 December; 56(12): 1186-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12494303&dopt=Abstract
·
The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Author(s): Wang YC, Bachrach U. Source: Amino Acids. 2002; 22(2): 131-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12395181&dopt=Abstract
·
Treatment of dandruff with 5% tea tree oil shampoo. Author(s): Satchell AC, Saurajen A, Bell C, Barnetson RS. Source: Journal of the American Academy of Dermatology. 2002 December; 47(6): 852-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12451368&dopt=Abstract
·
Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Author(s): Vayalil PK, Elmets CA, Katiyar SK. Source: Carcinogenesis. 2003 May; 24(5): 927-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12771038&dopt=Abstract
·
Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Author(s): Satchell AC, Saurajen A, Bell C, Barnetson RS.
Alternative Medicine 241
Source: The Australasian Journal of Dermatology. 2002 August; 43(3): 175-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12121393&dopt=Abstract ·
Urinary concentrations of morphine after the administration of herbal teas containing Papaveris fructus in relation to doping analysis. Author(s): Van Thuyne W, Van Eenoo P, Delbeke FT. Source: Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2003 March 5; 785(2): 245-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12554137&dopt=Abstract
·
Volatile N-nitrosamine inhibition after intake Korean green tea and Maesil (Prunus mume SIEB. et ZACC.) extracts with an amine-rich diet in subjects ingesting nitrate. Author(s): Choi SY, Chung MJ, Sung NJ. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2002 July; 40(7): 949-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12065217&dopt=Abstract
·
Why did green tea not protect against coronary artery disease but protect against myocardial infarction? Author(s): Cheng TO. Source: The American Journal of Cardiology. 2003 May 15; 91(10): 1290-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12745129&dopt=Abstract
·
Zygosaccharomyces kombuchaensis, a new ascosporogenous yeast from 'Kombucha tea'. Author(s): Kurtzman CP, Robnett CJ, Basehoar-Powers E. Source: Fems Yeast Research. 2001 July; 1(2): 133-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12702358&dopt=Abstract
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: ·
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
·
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
·
Chinese Medicine: http://www.newcenturynutrition.com/
·
drkoop.comÒ: http://www.drkoop.com/InteractiveMedicine/IndexC.html
·
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
·
Google: http://directory.google.com/Top/Health/Alternative/
·
Healthnotes: http://www.healthnotes.com/
242 Tea
·
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
·
Open Directory Project: http://dmoz.org/Health/Alternative/
·
HealthGate: http://www.tnp.com/
·
WebMDÒHealth: http://my.webmd.com/drugs_and_herbs
·
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
·
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
The following is a specific Web list relating to tea; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: ·
General Overview Abdominal Wall Inflammation Source: Integrative Medicine Communications; www.drkoop.com Acne Source: Integrative Medicine Communications; www.drkoop.com Acne Source: Prima Communications, Inc.www.personalhealthzone.com Acne Vulgaris Source: Healthnotes, Inc. www.healthnotes.com Age-Related Cognitive Decline Source: Healthnotes, Inc. www.healthnotes.com AIDS and HIV Source: Integrative Medicine Communications; www.drkoop.com Alcohol Withdrawal Source: Healthnotes, Inc. www.healthnotes.com Alcoholism Source: Integrative Medicine Communications; www.drkoop.com Allergic Rhinitis Source: Integrative Medicine Communications; www.drkoop.com Allergies Alternative names: Hay Fever Source: Prima Communications, Inc.www.personalhealthzone.com Alopecia Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 243
Alzheimer's Disease Source: Integrative Medicine Communications; www.drkoop.com Alzheimer's Disease, Non-Alzheimer's Dementia, and Normal Age-Related Memory Loss Source: Prima Communications, Inc.www.personalhealthzone.com Amenorrhea Source: Healthnotes, Inc. www.healthnotes.com Amenorrhea Source: Integrative Medicine Communications; www.drkoop.com Amyloidosis Source: Integrative Medicine Communications; www.drkoop.com Anaphylaxis Source: Integrative Medicine Communications; www.drkoop.com Anemia Source: Integrative Medicine Communications; www.drkoop.com Angina Source: Integrative Medicine Communications; www.drkoop.com Anorexia Nervosa Source: Integrative Medicine Communications; www.drkoop.com Anxiety Source: Healthnotes, Inc. www.healthnotes.com Anxiety Source: Integrative Medicine Communications; www.drkoop.com Arteriosclerosis Source: Integrative Medicine Communications; www.drkoop.com Asthma Source: Integrative Medicine Communications; www.drkoop.com Asthma Source: Prima Communications, Inc.www.personalhealthzone.com Atherosclerosis Source: Healthnotes, Inc. www.healthnotes.com Atherosclerosis Source: Integrative Medicine Communications; www.drkoop.com Atherosclerosis and Heart Disease Prevention Source: Prima Communications, Inc.www.personalhealthzone.com
244 Tea
Athlete's Foot Source: Healthnotes, Inc. www.healthnotes.com Attention Deficit Hyperactivity Disorder Source: Integrative Medicine Communications; www.drkoop.com Bell's Palsy Source: Healthnotes, Inc. www.healthnotes.com Benign Prostatic Hyperplasia Source: Healthnotes, Inc. www.healthnotes.com Benign Prostatic Hyperplasia Source: Integrative Medicine Communications; www.drkoop.com Birth Defects Prevention Source: Healthnotes, Inc. www.healthnotes.com Bites and Stings, Insect Source: Integrative Medicine Communications; www.drkoop.com Blood Sugar, Low Source: Integrative Medicine Communications; www.drkoop.com Bone Cancer Source: Integrative Medicine Communications; www.drkoop.com Bone Infection Source: Integrative Medicine Communications; www.drkoop.com BPH Source: Integrative Medicine Communications; www.drkoop.com Brain Cancer Source: Integrative Medicine Communications; www.drkoop.com Breast Cancer Source: Healthnotes, Inc. www.healthnotes.com Breast Cancer Source: Integrative Medicine Communications; www.drkoop.com Brittle Nails Source: Healthnotes, Inc. www.healthnotes.com Bronchitis Source: Healthnotes, Inc. www.healthnotes.com Bronchitis Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 245
Bulimia Nervosa Source: Integrative Medicine Communications; www.drkoop.com Burns Source: Integrative Medicine Communications; www.drkoop.com Bursitis Source: Integrative Medicine Communications; www.drkoop.com Cancer Source: Integrative Medicine Communications; www.drkoop.com Cancer Prevention (Reducing the Risk) Source: Prima Communications, Inc.www.personalhealthzone.com Candida/Yeast Hypersensitivity Syndrome Source: Prima Communications, Inc.www.personalhealthzone.com Candidiasis Source: Integrative Medicine Communications; www.drkoop.com Canker Sores Source: Healthnotes, Inc. www.healthnotes.com Carpal Tunnel Syndrome Source: Integrative Medicine Communications; www.drkoop.com Cataracts Source: Integrative Medicine Communications; www.drkoop.com Cavities, dental Source: Integrative Medicine Communications; www.drkoop.com Celiac Disease Source: Healthnotes, Inc. www.healthnotes.com Cellulitis Source: Integrative Medicine Communications; www.drkoop.com Chickenpox and Shingles Source: Integrative Medicine Communications; www.drkoop.com Chronic Candidiasis Source: Healthnotes, Inc. www.healthnotes.com Chronic Fatigue Syndrome Source: Integrative Medicine Communications; www.drkoop.com Chronic Obstructive Pulmonary Disease Source: Integrative Medicine Communications; www.drkoop.com
246 Tea
Chronic Venous Insufficiency Source: Healthnotes, Inc. www.healthnotes.com Cirrhosis Source: Integrative Medicine Communications; www.drkoop.com Cluster Headache Source: Healthnotes, Inc. www.healthnotes.com Cold Sores Source: Integrative Medicine Communications; www.drkoop.com Colds and Flus Source: Prima Communications, Inc.www.personalhealthzone.com Colic Source: Healthnotes, Inc. www.healthnotes.com Colon Cancer Source: Healthnotes, Inc. www.healthnotes.com Colorectal cancer Source: Integrative Medicine Communications; www.drkoop.com Colorectal Cancer Source: Integrative Medicine Communications; www.drkoop.com Common cold Source: Integrative Medicine Communications; www.drkoop.com Common Cold Source: Integrative Medicine Communications; www.drkoop.com Common Cold/Sore Throat Source: Healthnotes, Inc. www.healthnotes.com Congestive Heart Failure Source: Integrative Medicine Communications; www.drkoop.com Conjunctivitis Source: Integrative Medicine Communications; www.drkoop.com Conjunctivitis and Blepharitis Source: Healthnotes, Inc. www.healthnotes.com Constipation Source: Integrative Medicine Communications; www.drkoop.com Coronary Artery Disease Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 247
Cough Source: Healthnotes, Inc. www.healthnotes.com Cough Source: Integrative Medicine Communications; www.drkoop.com Crohn's Disease Source: Healthnotes, Inc. www.healthnotes.com Crohn's Disease Source: Integrative Medicine Communications; www.drkoop.com Cutaneous Drug Reactions Source: Integrative Medicine Communications; www.drkoop.com Cyclic Mastalgia Alternative names: Cyclic Mastitis, Fibrocystic Breast Disease Source: Prima Communications, Inc.www.personalhealthzone.com Cystic Fibrosis Source: Healthnotes, Inc. www.healthnotes.com Cystic Fibrosis Source: Integrative Medicine Communications; www.drkoop.com Dementia Source: Integrative Medicine Communications; www.drkoop.com Depression Source: Healthnotes, Inc. www.healthnotes.com Depression Source: Integrative Medicine Communications; www.drkoop.com Depression (Mild to Moderate) Source: Prima Communications, Inc.www.personalhealthzone.com Dermatitis Source: Integrative Medicine Communications; www.drkoop.com Diabetes Source: Healthnotes, Inc. www.healthnotes.com Diabetes Source: Prima Communications, Inc.www.personalhealthzone.com Diabetes Mellitus Source: Integrative Medicine Communications; www.drkoop.com Diarrhea Source: Healthnotes, Inc. www.healthnotes.com
248 Tea
Diarrhea Source: Integrative Medicine Communications; www.drkoop.com Dysmenorrhea Source: Healthnotes, Inc. www.healthnotes.com Dysmenorrhea Source: Integrative Medicine Communications; www.drkoop.com Dysphagia Source: Integrative Medicine Communications; www.drkoop.com Ear Infection Source: Integrative Medicine Communications; www.drkoop.com Eating Disorders Source: Healthnotes, Inc. www.healthnotes.com Eczema Source: Healthnotes, Inc. www.healthnotes.com Eczema Source: Integrative Medicine Communications; www.drkoop.com Eczema Source: Prima Communications, Inc.www.personalhealthzone.com Edema Source: Integrative Medicine Communications; www.drkoop.com Emphysema Source: Integrative Medicine Communications; www.drkoop.com Endocarditis Source: Integrative Medicine Communications; www.drkoop.com Endometriosis Source: Integrative Medicine Communications; www.drkoop.com Epilepsy Source: Healthnotes, Inc. www.healthnotes.com Epilepsy Source: Integrative Medicine Communications; www.drkoop.com Erythema Source: Integrative Medicine Communications; www.drkoop.com Female Infertility Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 249
Fever of Unknown Origin Source: Integrative Medicine Communications; www.drkoop.com Fibrocystic Breast Disease Source: Healthnotes, Inc. www.healthnotes.com Fibromyalgia Source: Integrative Medicine Communications; www.drkoop.com Flu Source: Integrative Medicine Communications; www.drkoop.com Food Allergy Source: Integrative Medicine Communications; www.drkoop.com Food Poisoning Source: Integrative Medicine Communications; www.drkoop.com Frostbite Source: Integrative Medicine Communications; www.drkoop.com Gallbladder Disease Source: Integrative Medicine Communications; www.drkoop.com Gastritis Source: Healthnotes, Inc. www.healthnotes.com Gastritis Source: Integrative Medicine Communications; www.drkoop.com Gastroesophageal Reflux Disease Source: Healthnotes, Inc. www.healthnotes.com Gastroesophageal Reflux Disease Source: Integrative Medicine Communications; www.drkoop.com Glaucoma Source: Integrative Medicine Communications; www.drkoop.com Gout Source: Integrative Medicine Communications; www.drkoop.com Hair Disorders Source: Integrative Medicine Communications; www.drkoop.com Hair Loss Source: Integrative Medicine Communications; www.drkoop.com Hay Fever Source: Healthnotes, Inc. www.healthnotes.com
250 Tea
Hay Fever Source: Integrative Medicine Communications; www.drkoop.com Heart Attack Source: Healthnotes, Inc. www.healthnotes.com Heart Attack Source: Integrative Medicine Communications; www.drkoop.com Heartburn Source: Integrative Medicine Communications; www.drkoop.com Hemorrhoids Source: Healthnotes, Inc. www.healthnotes.com Hemorrhoids Source: Integrative Medicine Communications; www.drkoop.com Hepatitis Source: Healthnotes, Inc. www.healthnotes.com Herpes Simplex Virus Source: Integrative Medicine Communications; www.drkoop.com Herpes Zoster and Varicella Viruses Source: Integrative Medicine Communications; www.drkoop.com High Cholesterol Source: Integrative Medicine Communications; www.drkoop.com High Cholesterol Source: Prima Communications, Inc.www.personalhealthzone.com High Triglycerides Source: Healthnotes, Inc. www.healthnotes.com HIV and AIDS Source: Integrative Medicine Communications; www.drkoop.com HIV and AIDS Support Source: Healthnotes, Inc. www.healthnotes.com Hives Source: Healthnotes, Inc. www.healthnotes.com Hypercholesterolemia Source: Integrative Medicine Communications; www.drkoop.com Hyperkalemia Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 251
Hypertension Source: Healthnotes, Inc. www.healthnotes.com Hyperthyroidism Source: Integrative Medicine Communications; www.drkoop.com Hypochondriasis Source: Integrative Medicine Communications; www.drkoop.com Hypoglycemia Source: Integrative Medicine Communications; www.drkoop.com Hypoparathyroidism Source: Integrative Medicine Communications; www.drkoop.com Hypothermia Source: Integrative Medicine Communications; www.drkoop.com Hypothyroidism Source: Integrative Medicine Communications; www.drkoop.com Immune Function Source: Healthnotes, Inc. www.healthnotes.com Incontinence, Urinary Source: Integrative Medicine Communications; www.drkoop.com Indigestion, Heartburn, and Low Stomach Acidity Source: Healthnotes, Inc. www.healthnotes.com Infantile Colic Source: Integrative Medicine Communications; www.drkoop.com Infection Source: Healthnotes, Inc. www.healthnotes.com Infection Source: Integrative Medicine Communications; www.drkoop.com Inflammatory Bowel Disease Source: Integrative Medicine Communications; www.drkoop.com Inflammatory Bowel Disease, Crohn's Source: Integrative Medicine Communications; www.drkoop.com Influenza Source: Integrative Medicine Communications; www.drkoop.com Insect Bites and Stings Source: Integrative Medicine Communications; www.drkoop.com
252 Tea
Insomnia Source: Healthnotes, Inc. www.healthnotes.com Insomnia Source: Integrative Medicine Communications; www.drkoop.com Insomnia Source: Prima Communications, Inc.www.personalhealthzone.com Intestinal Parasites Source: Integrative Medicine Communications; www.drkoop.com Iron-Deficiency Anemia Source: Healthnotes, Inc. www.healthnotes.com Irritable Bowel Syndrome Source: Healthnotes, Inc. www.healthnotes.com Irritable Bowel Syndrome Source: Integrative Medicine Communications; www.drkoop.com Kidney Stones Source: Healthnotes, Inc. www.healthnotes.com Kidney Stones Source: Integrative Medicine Communications; www.drkoop.com Laryngitis Source: Integrative Medicine Communications; www.drkoop.com Leukemia Source: Integrative Medicine Communications; www.drkoop.com Leukoplakia Source: Healthnotes, Inc. www.healthnotes.com Liver Cirrhosis Source: Healthnotes, Inc. www.healthnotes.com Liver Disease Source: Integrative Medicine Communications; www.drkoop.com Low Back Pain Source: Integrative Medicine Communications; www.drkoop.com Low Blood Sugar Source: Integrative Medicine Communications; www.drkoop.com Lung Cancer Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 253
Lung Cancer Source: Integrative Medicine Communications; www.drkoop.com Lupus Source: Integrative Medicine Communications; www.drkoop.com Lymphoma Source: Integrative Medicine Communications; www.drkoop.com Macular Degeneration Source: Healthnotes, Inc. www.healthnotes.com Menopausal Symptoms (Other Than Osteoporosis) Source: Prima Communications, Inc.www.personalhealthzone.com Menopause Source: Integrative Medicine Communications; www.drkoop.com Menstrual Pain Source: Integrative Medicine Communications; www.drkoop.com Migraine Headache Source: Integrative Medicine Communications; www.drkoop.com Migraine Headaches Source: Healthnotes, Inc. www.healthnotes.com Miscarriage Source: Integrative Medicine Communications; www.drkoop.com Multiple Sclerosis Source: Healthnotes, Inc. www.healthnotes.com Multiple Sclerosis Source: Integrative Medicine Communications; www.drkoop.com Mumps Source: Integrative Medicine Communications; www.drkoop.com Muscular Dystrophy Source: Integrative Medicine Communications; www.drkoop.com Myocardial Infarction Source: Integrative Medicine Communications; www.drkoop.com Nail Disorders Source: Integrative Medicine Communications; www.drkoop.com Nausea Source: Prima Communications, Inc.www.personalhealthzone.com
254 Tea
Obesity Source: Integrative Medicine Communications; www.drkoop.com Obesity Source: Integrative Medicine Communications; www.drkoop.com Osgood-Schlatter Disease Source: Healthnotes, Inc. www.healthnotes.com Osteoarthritis Source: Healthnotes, Inc. www.healthnotes.com Osteoarthritis Source: Integrative Medicine Communications; www.drkoop.com Osteoarthritis Source: Prima Communications, Inc.www.personalhealthzone.com Osteomyelitis Source: Integrative Medicine Communications; www.drkoop.com Osteoporosis Source: Healthnotes, Inc. www.healthnotes.com Osteoporosis Source: Prima Communications, Inc.www.personalhealthzone.com Otitis Media Source: Integrative Medicine Communications; www.drkoop.com Pancreatic Insufficiency Source: Healthnotes, Inc. www.healthnotes.com Parasitic Infection, Intestinal Source: Integrative Medicine Communications; www.drkoop.com Parkinson's Disease Source: Integrative Medicine Communications; www.drkoop.com Pelvic Inflammatory Disease Source: Integrative Medicine Communications; www.drkoop.com Peptic Ulcer Source: Healthnotes, Inc. www.healthnotes.com Peptic Ulcer Source: Integrative Medicine Communications; www.drkoop.com Pericarditis Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 255
Periodontal Disease Alternative names: Gum Disease Source: Prima Communications, Inc.www.personalhealthzone.com Peritonitis Source: Integrative Medicine Communications; www.drkoop.com Pertussis Source: Integrative Medicine Communications; www.drkoop.com Pharyngitis Source: Integrative Medicine Communications; www.drkoop.com Photodermatitis Source: Integrative Medicine Communications; www.drkoop.com Pink Eye Source: Integrative Medicine Communications; www.drkoop.com PMS Source: Integrative Medicine Communications; www.drkoop.com PMS Alternative names: Premenstrual Stress Syndrome Source: Prima Communications, Inc.www.personalhealthzone.com Post Traumatic Stress Disorder Source: Integrative Medicine Communications; www.drkoop.com Potassium, Excess in Blood Source: Integrative Medicine Communications; www.drkoop.com Preeclampsia Source: Integrative Medicine Communications; www.drkoop.com Pregnancy and Postpartum Support Source: Healthnotes, Inc. www.healthnotes.com Premenstrual Syndrome Source: Healthnotes, Inc. www.healthnotes.com Premenstrual Syndrome Source: Integrative Medicine Communications; www.drkoop.com Prostate Cancer Source: Healthnotes, Inc. www.healthnotes.com Prostate Cancer Source: Integrative Medicine Communications; www.drkoop.com Prostate Enlargement Source: Integrative Medicine Communications; www.drkoop.com
256 Tea
Prostate Infection Source: Integrative Medicine Communications; www.drkoop.com Prostatitis Source: Integrative Medicine Communications; www.drkoop.com Psoriasis Source: Integrative Medicine Communications; www.drkoop.com PTSD Source: Integrative Medicine Communications; www.drkoop.com Pulmonary Edema Source: Integrative Medicine Communications; www.drkoop.com Pulmonary Hypertension Source: Integrative Medicine Communications; www.drkoop.com Pyloric Stenosis Source: Integrative Medicine Communications; www.drkoop.com Radiation Damage Source: Integrative Medicine Communications; www.drkoop.com Raynaud's Phenomenon Source: Integrative Medicine Communications; www.drkoop.com Recurrent Ear Infections Source: Healthnotes, Inc. www.healthnotes.com Reiter's Syndrome Source: Integrative Medicine Communications; www.drkoop.com Rheumatoid Arthritis Source: Healthnotes, Inc. www.healthnotes.com Rheumatoid Arthritis Source: Integrative Medicine Communications; www.drkoop.com Rheumatoid Arthritis Source: Prima Communications, Inc.www.personalhealthzone.com Rickets/Osteomalacia Source: Healthnotes, Inc. www.healthnotes.com Roseola Source: Integrative Medicine Communications; www.drkoop.com Seizure Disorders Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 257
Senile Dementia Source: Integrative Medicine Communications; www.drkoop.com Sexual Dysfunction Source: Integrative Medicine Communications; www.drkoop.com Sexually Transmitted Diseases Source: Integrative Medicine Communications; www.drkoop.com Shingles and Chickenpox Source: Integrative Medicine Communications; www.drkoop.com Sinus Congestion Source: Healthnotes, Inc. www.healthnotes.com Sinus Headache Source: Integrative Medicine Communications; www.drkoop.com Sinus Infection Source: Integrative Medicine Communications; www.drkoop.com Sinusitis Source: Healthnotes, Inc. www.healthnotes.com Sinusitis Source: Integrative Medicine Communications; www.drkoop.com Skin Cancer Source: Integrative Medicine Communications; www.drkoop.com Skin Infection Source: Integrative Medicine Communications; www.drkoop.com Sleeplessness Source: Integrative Medicine Communications; www.drkoop.com Sore Throat Source: Integrative Medicine Communications; www.drkoop.com Spastic Colon Source: Integrative Medicine Communications; www.drkoop.com Spontaneous Abortion Source: Integrative Medicine Communications; www.drkoop.com Sprains and Strains Source: Healthnotes, Inc. www.healthnotes.com Sprains and Strains Source: Integrative Medicine Communications; www.drkoop.com
258 Tea
STDs Source: Integrative Medicine Communications; www.drkoop.com Stomach Inflammation Source: Integrative Medicine Communications; www.drkoop.com Stress Source: Integrative Medicine Communications; www.drkoop.com Stroke Source: Healthnotes, Inc. www.healthnotes.com Stroke Source: Integrative Medicine Communications; www.drkoop.com Sunburn Source: Integrative Medicine Communications; www.drkoop.com Systemic Lupus Erythematosus Source: Healthnotes, Inc. www.healthnotes.com Systemic Lupus Erythematosus Source: Integrative Medicine Communications; www.drkoop.com Tendinitis Source: Integrative Medicine Communications; www.drkoop.com Tension Headache Source: Healthnotes, Inc. www.healthnotes.com Tension Headache Source: Integrative Medicine Communications; www.drkoop.com Thyroid Inflammation Source: Integrative Medicine Communications; www.drkoop.com Thyroiditis Source: Integrative Medicine Communications; www.drkoop.com Toothache Source: Integrative Medicine Communications; www.drkoop.com Ulcerative Colitis Source: Healthnotes, Inc. www.healthnotes.com Ulcerative Colitis Source: Integrative Medicine Communications; www.drkoop.com Urethral Inflammation Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 259
Urethritis Source: Integrative Medicine Communications; www.drkoop.com Urinary Incontinence Source: Integrative Medicine Communications; www.drkoop.com Urinary Tract Infection Source: Healthnotes, Inc. www.healthnotes.com Urinary Tract Infection in Women Source: Integrative Medicine Communications; www.drkoop.com UTI Source: Integrative Medicine Communications; www.drkoop.com Uveitis Source: Integrative Medicine Communications; www.drkoop.com Vaginal Inflammation Source: Integrative Medicine Communications; www.drkoop.com Vaginitis Source: Healthnotes, Inc. www.healthnotes.com Vaginitis Source: Integrative Medicine Communications; www.drkoop.com Varicella and Herpes Zoster Viruses Source: Integrative Medicine Communications; www.drkoop.com Varicose Veins Source: Integrative Medicine Communications; www.drkoop.com Varicose Veins Source: Prima Communications, Inc.www.personalhealthzone.com Viral Hepatitis Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin B12 Deficiency Source: Healthnotes, Inc. www.healthnotes.com Warts Source: Integrative Medicine Communications; www.drkoop.com Water Retention Source: Integrative Medicine Communications; www.drkoop.com Whooping Cough Source: Integrative Medicine Communications; www.drkoop.com
260 Tea
Wilson's Disease Source: Healthnotes, Inc. www.healthnotes.com Wound Healing Source: Healthnotes, Inc. www.healthnotes.com Wounds Source: Integrative Medicine Communications; www.drkoop.com Yeast Infection Source: Healthnotes, Inc. www.healthnotes.com Yeast Infection Source: Integrative Medicine Communications; www.drkoop.com ·
Alternative Therapy 21 Day Rejuvenation Program Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/t.html A Course in Miracles Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/c.html Acupressure Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,662,00.html Acupuncture anesthesia Alternative names: acupuncture analgesia acupuncture assisted anesthesia anesthetic acupuncture Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/a.html Alexander Technique Alternative names: Alexander method F.M. Alexander Technique Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/a.html Alexander technique Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,665,00.html
Alternative Medicine 261
Applied kinesiology Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,711,00.html Aromatherapy Source: Healthnotes, Inc. www.healthnotes.com Aromatherapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,664,00.html Art therapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,671,00.html Aston-Patterning Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/a.html Aston-patterning Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10118,00.html Atlantean Healing Ray Training Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/a.html Bikram Yoga Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/b.html Biofeedback Source: Healthnotes, Inc. www.healthnotes.com Biofeedback Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,675,00.html Chakra healing light energy implantations Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/c.html
262 Tea
Chi Healing Alternative names: Fa Chi Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/c.html Chiropractic Source: Healthnotes, Inc. www.healthnotes.com Chu Chong Alternative names: Group Healing Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/c.html Color therapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,683,00.html Craniosacral therapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,685,00.html Dance therapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,687,00.html Daniel's Diet Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/d.html Diet #7 Alternative names: Diet No. 7 Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/d.html Divine will healing Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/d.html Facilitated communication Alternative names: FC Facilitated Communication therapy facilitated communication training [FCT] Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/f.html
Alternative Medicine 263
Fasting Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,694,00.html Feldenkrais Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,695,00.html Grape Cure Alternative names: grape diet Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/g.html Guided imagery Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,699,00.html Harner Method Shamanic Counseling Alternative names: HMSC Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/h.html Herbal Medicine Source: Integrative Medicine Communications; www.drkoop.com Huna Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/h.html Hydrotherapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,705,00.html Hyperdimensional Healing Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/h.html Hypno-Meditation Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/h.html
264 Tea
Hypnotherapy Source: Integrative Medicine Communications; www.drkoop.com Hypnotherapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,706,00.html Kobayashi Technique Alternative names: Applied Kobayashi Techniques Kobayashi Techniques Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/k.html Lymphasizing Alternative names: The Art of Lymphatic System Activation The Art of Lymphasizing The Fine Art of Lymphasizing The Science of Lymphasizing Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/l.html Macrobiotics Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,714,00.html Magical diet Alternative names: magical diets Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/m.html Massage Source: Integrative Medicine Communications; www.drkoop.com Massage therapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,716,00.html Medicine Cards Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/m.html Meditation Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,717,00.html Music therapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com
Alternative Medicine 265
Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,719,00.html Myotherapy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,931,00.html Native American medicine Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,721,00.html Naturopathic Medicine Source: Healthnotes, Inc. www.healthnotes.com Naturopathy Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,722,00.html New Age Shiatsu Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/n.html Osteopathy Source: Integrative Medicine Communications; www.drkoop.com Pathwork Alternative names: The Pathwork Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/p.html Periosteal acupuncture Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/p.html Prayer Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,728,00.html Qigong Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,729,00.html
266 Tea
Quan Yin Method Alternative names: Quan Yin Method of meditation Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/q.html Reiki Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,731,00.html Rolfing Movement Integration Alternative names: RMI Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/r.html Soul part integration Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/s.html Spiritual Surgery Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/s.html Sufi healing Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/s.html TaeUIJu Healing Meditation Alternative names: TaeUIJu TaeUIJu healing TaeUIJu meditation Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/t.html Tai Chi Source: Integrative Medicine Communications; www.drkoop.com Tai chi Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,737,00.html Taiji Wuxigong Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/t.html
Alternative Medicine 267
Tatwa meditation Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/t.html Tensegrity Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/t.html Testing for Stomach Acidity Source: Healthnotes, Inc. www.healthnotes.com The Awakened Life Alternative names: The Awakened Life program Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/a.html Therapeutic Touch Source: Integrative Medicine Communications; www.drkoop.com Traditional Chinese Medicine Source: Integrative Medicine Communications; www.drkoop.com Trager approach Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,741,00.html Transcendental Meditation Alternative names: TM Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/t.html Wu Ming Qigong Alternative names: Wu Ming Qigong system Taoist Wu Ming Qigong Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/w.html Yoga Source: Healthnotes, Inc. www.healthnotes.com Yoga Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,746,00.html
268 Tea
Zen Macrobiotics Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/z.html ·
Chinese Medicine Anshen Buxin Wan Alternative names: Anshen Buxin Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Anshen%20Buxin%20Wan&m h=10&sb=---&view_records=View+Records Anyou Alternative names: Eucalyptus Oil; Oleum Eucalypti Source: Chinese Materia Medica Babao Kunshun Wan Alternative names: (Ba Bao Kun Shun Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Babao%20Kunshun%20Wan& mh=10&sb=---&view_records=View+Records Baibu Alternative names: Stemona Root; Radix Stemonae Source: Chinese Materia Medica Baiguo Alternative names: Ginkgo Seed; Semen Ginkgo Source: Chinese Materia Medica Baihe Gujin Wan Alternative names: Baihe Gujin Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Baihe%20Gujin%20Wan&mh= 10&sb=---&view_records=View+Records Baiji Alternative names: Common Bletilla Tuber; Rhizoma Bletillae Source: Chinese Materia Medica
Alternative Medicine 269
Baizi Yangxin Wan Alternative names: Baizi Yangxin Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Baizi%20Yangxin%20Wan&m h=10&sb=---&view_records=View+Records Bajitian Alternative names: Morinda Root; Radix Morindae Officinalis Source: Chinese Materia Medica Baolong Wan Alternative names: Baolong Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Baolong%20Wan&mh=10&sb =---&view_records=View+Records Bazhen Wan Alternative names: Bazhen Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Bazhen%20Wan&mh=10&sb= ---&view_records=View+Records Bazhen Yimu Wan Alternative names: Bazhen Yimu Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Bazhen%20Yimu%20Wan&mh =10&sb=---&view_records=View+Records Biejia Alternative names: Turtle Shell; Carapax Trionycis Source: Chinese Materia Medica Chayou Alternative names: Tea-seed Oil; Oleum Camelliae Source: Chinese Materia Medica Chuanbeimu Alternative names: Tendrilleaf Fritillary Bulb; Chuanbeimu (Chuan Bei Mu); Buibus Fritiliariae Cirrhosae Source: Chinese Materia Medica Chuanwu Alternative names: Common Monkshood Mother Root; Radix Aconiti Source: Chinese Materia Medica
270 Tea
Chuanxion Alternative names: Chuanxiong Chatiao Pills; Chuanxiong Chatiao Wan Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Chuanxiong%20Chatiao%20W an&mh=10&sb=---&view_records=View+Records Chuanxiong Chatiao San Alternative names: Chuanxiong Chatiao Powder Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Chuanxiong%20Chatiao%20Sa n&mh=10&sb=---&view_records=View+Records Dabuyin Wan Alternative names: Dabuyin Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Dabuyin%20Wan&mh=10&sb =---&view_records=View+Records Dahuang Alternative names: Rhubarb; Radix et Rhizoma Rhei Source: Chinese Materia Medica Dandouchi Alternative names: Fermented Soybean; Semen Sojae Preparatum Source: Chinese Materia Medica Dihuang Alternative names: Digitalis Leaf; Yangdihuangye; Folium Digitalis Source: Chinese Materia Medica Dingkun Dan Alternative names: Dingkun Pills; Dingkun Dan (Ding Kun Dan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Dingkun%20Dan&mh=10&sb =---&view_records=View+Records Dingxiang Alternative names: Clove; Flos Caryophylli Source: Chinese Materia Medica Dingxiang Luoleyou Alternative names: Ocimum Oil; Oleum Ocimi Gratissimi Source: Chinese Materia Medica
Alternative Medicine 271
Erlong Zuoci Wan Alternative names: Erlong Zuoci Pills; Erlong Zuoci Wan (Er Long Zuo Ci Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Erlong%20Zuoci%20Wan&mh =10&sb=---&view_records=View+Records Erzhi Wan Alternative names: Erzhi Pills; Erzhi Wan (Er Zhi Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Erzhi%20Wan&mh=10&sb=--&view_records=View+Records Ezhu Alternative names: Zedoray Rhizome; Rhizoma Curcumae Source: Chinese Materia Medica Fengfang Alternative names: Honeycomb; Nidus Vespae Source: Chinese Materia Medica Fengliaoxing Fengshi Dieda Yaojiu Alternative names: Fengliaoxing Fengshi Dieda Wine Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Fengliaoxing%20Fengshi%20D ieda%20Yaojiu&mh=10&sb=---&view_records=View+Records Fuling Alternative names: Indian Bread; Poria Source: Chinese Materia Medica Fupenzi Alternative names: Palmleaf Raspberry Fruit; Fructus Rubi Source: Chinese Materia Medica Fuzi Alternative names: Beivedere Fruit; Difuzi; Fructus Kochiae Source: Chinese Materia Medica Gengnian'an Pian Alternative names: Gengnian'an Tablets Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Gengnian%27an%20Pian&mh =10&sb=---&view_records=View+Records
272 Tea
Gouji Alternative names: Cibot Rhizome; Rhizoma Cibotii Source: Chinese Materia Medica Guijia Alternative names: Tortoise Shell; Carapax et Plastrum Testudinis Source: Chinese Materia Medica Guilu Bushen Wan Alternative names: Guilu Bushen Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Guilu%20Bushen%20Wan&m h=10&sb=---&view_records=View+Records Heche Dazao Wan Alternative names: Heche Dazao Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Heche%20Dazao&mh=10&sb= ---&view_records=View+Records Heshouwu Alternative names: Fleeceflower Root; Radix Polygoni Multiflori Source: Chinese Materia Medica Hongshen Alternative names: Red Ginseng; Radix Ginseng Rubra Source: Chinese Materia Medica Houpo Alternative names: Officinal Magnolia Bark; Cortex Magnoliae Officinalis Source: Chinese Materia Medica Houpohua Alternative names: Officinal Magnolia Flower; Flos Magnoliae Offcinalis Source: Chinese Materia Medica Huangjing Alternative names: Solomonseal Rhizome; Rhizoma Polygonati Source: Chinese Materia Medica Huangqi Alternative names: Milkvetch; Radix Astragali Source: Chinese Materia Medica Huangqin Alternative names: Baical Skullcap Root; Radix Scutellariae Source: Chinese Materia Medica
Alternative Medicine 273
Huazheng Huisheng Pian Alternative names: Huazheng Huisheng Tablets Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Huazheng%20Huisheng%20Pi an&mh=10&sb=---&view_records=View+Records Hujisheng Alternative names: Colored Mistletoe Herb; Herba Visci Source: Chinese Materia Medica Hupo Baolong Wan Alternative names: Hupo Baolong Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Hupo%20Baolong%20Wan&m h=10&sb=---&view_records=View+Records Jianbu Wan Alternative names: Jianbu Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Jianbu%20Wan&mh=10&sb=--&view_records=View+Records Jianghuang Alternative names: Turmeric; Rhizoma Curcumae Longae Source: Chinese Materia Medica Jisheng Shenqi Wan Alternative names: Jisheng Shenqi Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Jisheng%20Shenqi%20Wan&m h=10&sb=---&view_records=View+Records Jiuyi San Alternative names: Jiuyi Powder Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Jiuyi%20San&mh=10&sb=--&view_records=View+Records
274 Tea
Jixueteng Gao Alternative names: Jixueteng Concentrated Decoction Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Jixueteng%20Gao&mh=10&sb =---&view_records=View+Records Juhua Alternative names: Chrysanthemum Flower; Flos Chrysanthemi Source: Chinese Materia Medica Kanggu Zengsheng Wan Alternative names: Kanggu Zengsheng Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Kanggu%20Zengsheng%20Wa n&mh=10&sb=---&view_records=View+Records Lianqiao Alternative names: Weeping Forsythia Capsule; Fructus Forsythiae Source: Chinese Materia Medica Lurong Alternative names: Hairy Deer-horn (Hairy Antler); Cornu Cervi Pantotrichum Source: Chinese Materia Medica Mabo Alternative names: Puff-ball; Lasiosphaera seu Calvatia Source: Chinese Materia Medica Machixian Alternative names: Purslane Herb; Herba Portulacae Source: Chinese Materia Medica Manshanhong Alternative names: Dahurian Rhododendron Leaf; Folium Rhododendri Daurici Source: Chinese Materia Medica Manshanhongyou Alternative names: Daurian Rhododendron Oil; Oleum Rhododendri Daurici Source: Chinese Materia Medica Mengshi Guntan Wan Alternative names: Mengshi Guntan Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Mengshi%20Guntan%20Wan &mh=10&sb=---&view_records=View+Records
Alternative Medicine 275
Miaoji Wan Alternative names: Miaoji Pills Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Miaoji%20Wan&mh=10&sb=--&view_records=View+Records Mugua Alternative names: Common Floweringquince Fruit; Fructus Chaenomelis Source: Chinese Materia Medica Mujingyou Alternative names: Negundo Chastetree Oil; Oleum Viticis Negundo Source: Chinese Materia Medica Nuzhenzi Alternative names: Glossy Privet Fruit; Fructus Ligustri Lucidi Source: Chinese Materia Medica Oleum Menthae Alternative names: Peppermint Oil Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Oleum%20Menthae&mh=10& sb=---&view_records=View+Records Qibao Meiran Keli Alternative names: Qibao Meiran Granules Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Qibao%20Meiran%20Keli&mh =10&sb=---&view_records=View+Records Qingxiangzi Alternative names: Feather Cockscomb Seed; Semen Celosiae Source: Chinese Materia Medica Rouguiyou Alternative names: Cassia Bark Oil; Oleum Cinnamomi Source: Chinese Materia Medica Sangjisheng Alternative names: Chinese Taxillus Herb; Herba Taxilli Source: Chinese Materia Medica Sangpiaoxiao Alternative names: Egg Capsule of Mantid; Ootheca Mantidis Source: Chinese Materia Medica
276 Tea
Sangshen Alternative names: Mulberry Fruit; Fructus Mori Source: Chinese Materia Medica Sanqi Shangyao Pian Alternative names: Sanqi Shangyao Tablets; Sanqi Shangyao Pian
(San Qi Shang Yao Pi An) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Sanqi%20Shangyao%20Pian& mh=10&sb=---&view_records=View+Records Shaii Alternative names: Seabuckthorn Fruit; Fructus Hippophae Source: Chinese Materia Medica Shancigu Alternative names: Appendiculate Cremastra Pseudobulb or Common Pleione Pseudobulb; Pseudobulbus Cremastrae seu Pleiones Source: Chinese Materia Medica Shanzhuyu Alternative names: Asiatic Cornelian Cherry Fruit; Fructus Corni Source: Chinese Materia Medica Shedan Chenpi San Alternative names: Shedan Chenpi Powder; Shedan Chenpi San
(She Dan Chen Pi San) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Shedan%20Chenpi%20San&m h=10&sb=---&view_records=View+Records Shenrong Baifeng Wan Alternative names: Shenrong Baifeng Pills; Shenrong Baifeng Wan
(Shen Rong Bai Feng Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Shenrong%20Baifeng%20Wan &mh=10&sb=---&view_records=View+Records Shenrong Guben Pian Alternative names: Shenrong Guben Tablets; Shenrong Guben Pian
(Shen Rong Gu Ben Pi An) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Shenrong%20Guben%20Pian& mh=10&sb=---&view_records=View+Records
Alternative Medicine 277
Shihu Yeguang Wan Alternative names: Shihu Yeguang Pills; Shihu Yeguang Wan
(Shi Hu Ye Guang Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Shihu%20Yeguang%20Wan& mh=10&sb=---&view_records=View+Records Shiquan Dabu Wan Alternative names: Shiquan Dabu Pills; Shiquan Dabu Wan
(Shi Qu An Da Bu Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Shiquan%20Dabu%20Wan&m h=10&sb=---&view_records=View+Records Shudihuang Alternative names: Prepared Rehmannia Root; Radix Rehmanniae Preparata Source: Chinese Materia Medica Shuiniujiao Alternative names: Buffalo Horn; Cornu Bubali Source: Chinese Materia Medica Sini Tang Alternative names: Sini Mixture; Sini Tang
(Si Ni Tang) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Sini%20Tang&mh=10&sb=--&view_records=View+Records Suoyang Gujing Wan Alternative names: Suoyang Gujing Pills; Suoyang Gujing Wan
(Suo Yang Gu Jing Wan) Source: Pharmacopoeia Commission of the Ministry of Health, People's Republic of China Hyperlink: http://www.newcenturynutrition.com/cgilocal/patent_herbs_db/db.cgi?db=default&Chinese=Suoyang%20Gujing%20Wan& mh=10&sb=---&view_records=View+Records Tiandong Alternative names: Cochinchinese Asparagus Root; Radix Asparagi Source: Chinese Materia Medica Tianma Alternative names: Tall Gastrodia Tuber; Rhizoma Gastrodiae Source: Chinese Materia Medica
278 Tea
Wubeizi Alternative names: Chinese Gall; Galla Chinensis Source: Chinese Materia Medica Wumei Alternative names: Smoked Plum; Fructus Mume Source: Chinese Materia Medica Wuweizi Alternative names: Chinese Magnoliavine Fruit; Fructus Schisandrae Source: Chinese Materia Medica Xiangfu Alternative names: Nutgrass Galingale Rhizome; Rhizoma Cyperi Source: Chinese Materia Medica Xiebai Alternative names: Longstamen Onion Bulb; Xiebai (Xie Bai); Bulbus Aiiii Macrostemi Source: Chinese Materia Medica Xixiancao Alternative names: Siegesbeckia Herb; Herba Siegesbeckiae Source: Chinese Materia Medica Xuanshen Alternative names: Figwort Root; Radix Scrophulariae Source: Chinese Materia Medica Xuduan Alternative names: Himalayan Teasel Root; Radix Dipsaci Source: Chinese Materia Medica Yejuhua Alternative names: Wild Chrysanthemum Flower; Flos Chrysanthemi Indici Source: Chinese Materia Medica Yujin Alternative names: Turmeric Root Tuber; Radix Curcumae Source: Chinese Materia Medica Yuzhu Alternative names: Fragrant Solomonseal Rhizome; Rhizoma Polygonati Odorati Source: Chinese Materia Medica Zaojiaoci Alternative names: Chinese Honeylocust Spine; Spina Gleditsiae Source: Chinese Materia Medica Zhichuanwu Alternative names: Monkshood Mother Root; Radix Aconiti Preparata Source: Chinese Materia Medica
Alternative Medicine 279
Zhiheshouwu Alternative names: Prepared FLeeceflower Root; Radix Polygoni Multiflori Preparata Source: Chinese Materia Medica Zhizi Alternative names: Cape Jasmine Fruit; Fructus Gardeniae Source: Chinese Materia Medica Zhuzishen Alternative names: Largeleaf Japanese Ginseng Rhizome; Rhizoma Panacis Majoris Source: Chinese Materia Medica Ziheche Alternative names: Human Placenta; Placenta Hominis Source: Chinese Materia Medica ·
Herbs and Supplements 5-HTP Source: Integrative Medicine Communications; www.drkoop.com 5-Hydroxytryptophan (5-HTP) Source: Integrative Medicine Communications; www.drkoop.com Acanthopanax senticosus Source: Integrative Medicine Communications; www.drkoop.com Achillea Alternative names: Yarrow; Achillea millefolium L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Achillea millefolium Source: Integrative Medicine Communications; www.drkoop.com Aesculus Alternative names: Horse Chestnut; Aesculus hippocastanum L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Agrimony Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,833,00.html Althaea officinalis Source: Integrative Medicine Communications; www.drkoop.com Aluminum Hydroxide Source: Healthnotes, Inc. www.healthnotes.com
280 Tea
American Scullcap Alternative names: Scutellaria lateriflora Source: Healthnotes, Inc. www.healthnotes.com Amoxicillin Source: Healthnotes, Inc. www.healthnotes.com Andrographis Alternative names: Andrographis paniculata Source: Healthnotes, Inc. www.healthnotes.com Androstenedione Source: Healthnotes, Inc. www.healthnotes.com Angelica sinensis Source: Integrative Medicine Communications; www.drkoop.com Anticonvulsants Source: Healthnotes, Inc. www.healthnotes.com Antioxidants Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10004,00.html Antiviral Drugs Source: Healthnotes, Inc. www.healthnotes.com Apium graveolens Source: Integrative Medicine Communications; www.drkoop.com Arctium Alternative names: Burdock, Gobo; Arctium lappa L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Arctium lappa Source: Integrative Medicine Communications; www.drkoop.com Arctium minus Source: Integrative Medicine Communications; www.drkoop.com Arctostaphylos Alternative names: Bearberry; Arctostaphylos uva-ursi (L.) Spreng. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Aristolochia Alternative names: Snakeroot, Guaco; Aristolochia sp Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Arnica Alternative names: Arnica montana Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 281
Arnica Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,753,00.html Arnica montana Source: Integrative Medicine Communications; www.drkoop.com Ashwagandha Alternative names: Withania somniferum Source: Healthnotes, Inc. www.healthnotes.com Ashwagandha Source: Prima Communications, Inc.www.personalhealthzone.com Asian Ginseng Alternative names: Panax ginseng Source: Integrative Medicine Communications; www.drkoop.com Astragalus Alternative names: Astragalus membranaceus Source: Healthnotes, Inc. www.healthnotes.com Astragalus Alternative names: Astragalus membranaceus, Astragalus membranaceus var. mongholicus, Huang-qi, Milk-Vetch Root Source: Integrative Medicine Communications; www.drkoop.com Astragalus Source: Prima Communications, Inc.www.personalhealthzone.com Astragalus Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10006,00.html Astragalus membranaceus Source: Integrative Medicine Communications; www.drkoop.com Astragalus mongholicus Alternative names: Astragalus membranaceus, Astragalus membranaceus var. mongholicus, Huang-qi, Milk-Vetch Root Source: Integrative Medicine Communications; www.drkoop.com Atropine Source: Healthnotes, Inc. www.healthnotes.com Australian Fevertree Source: Integrative Medicine Communications; www.drkoop.com
282 Tea
Ava Source: Integrative Medicine Communications; www.drkoop.com Barberry Alternative names: Berberis vulgaris Source: Healthnotes, Inc. www.healthnotes.com Barberry Alternative names: Berberis vulgaris, Berberry Source: Integrative Medicine Communications; www.drkoop.com Bee products Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,756,00.html Berberis Alternative names: Barberry; Berberis sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Berberis vulgaris Source: Integrative Medicine Communications; www.drkoop.com Berberry Source: Integrative Medicine Communications; www.drkoop.com Beta-Carotene Source: Prima Communications, Inc.www.personalhealthzone.com Betaine (Trimethylglycine) Source: Healthnotes, Inc. www.healthnotes.com Betula Alternative names: Birch; Betula sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Bilberry Alternative names: Vaccinium myrtillus, European Blueberry, Huckleberry Source: Integrative Medicine Communications; www.drkoop.com Bilberry Source: Prima Communications, Inc.www.personalhealthzone.com Bilberry Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10007,00.html Bitter Melon Alternative names: Momordica charantia Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 283
Bitter Melon Source: Prima Communications, Inc.www.personalhealthzone.com Black Cohosh Alternative names: Cimicifuga racemosa (actea), Black Snakeroot Source: Integrative Medicine Communications; www.drkoop.com Black cohosh Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10009,00.html Black Snakeroot Alternative names: Black Cohosh Source: Integrative Medicine Communications; www.drkoop.com Blackberry Alternative names: Rubus fructicosus Source: Healthnotes, Inc. www.healthnotes.com Blackberry Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,837,00.html Blessed Thistle Alternative names: Cnicus benedictus Source: Healthnotes, Inc. www.healthnotes.com Bloodroot Source: Prima Communications, Inc.www.personalhealthzone.com Blue Flag Alternative names: Iris versicolor Source: Healthnotes, Inc. www.healthnotes.com Blueberry Alternative names: Vaccinium spp. Source: Healthnotes, Inc. www.healthnotes.com Boneset Alternative names: Eupatorium perfoliatum Source: Healthnotes, Inc. www.healthnotes.com Borago Alternative names: Borage; Borago officinalis Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Boric Acid Source: Healthnotes, Inc. www.healthnotes.com
284 Tea
Brahmi Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Bromelain Source: Healthnotes, Inc. www.healthnotes.com Buchu Alternative names: Barosma betulina, Agathosma betulina, Agathosma crenultata Source: Healthnotes, Inc. www.healthnotes.com Bupleurum Alternative names: Bupleurum chinense, Bupleurum falcatum Source: Healthnotes, Inc. www.healthnotes.com Butcher's broom Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10010,00.html Calendula Alternative names: Calendula officinalis Source: Healthnotes, Inc. www.healthnotes.com Calendula Source: Prima Communications, Inc.www.personalhealthzone.com Calendula Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10011,00.html Camellia sinensis Alternative names: Green Tea Source: Integrative Medicine Communications; www.drkoop.com Capsaicin Source: Integrative Medicine Communications; www.drkoop.com Capsicum frutescens Source: Integrative Medicine Communications; www.drkoop.com Caraway Alternative names: Carum carvi Source: Healthnotes, Inc. www.healthnotes.com Cardec DM Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 285
Cascara Alternative names: Cascara sagrada, Rhamnus purshiani cortex Source: Healthnotes, Inc. www.healthnotes.com Cascara sagrada Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10013,00.html Cat’s Claw Alternative names: Uncaria tomentosa Source: Healthnotes, Inc. www.healthnotes.com Catechins Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,1023,00.html Catnip Alternative names: Nepeta cataria Source: Healthnotes, Inc. www.healthnotes.com Cat's Claw Alternative names: Uncaria tomentosa Source: Integrative Medicine Communications; www.drkoop.com Cayenne Alternative names: Capsicum annuum, Capsicum frutescens Source: Healthnotes, Inc. www.healthnotes.com Cayenne Alternative names: Capsicum frutescens, Capsicum spp., Capsaicin, Chili Pepper, Red Pepper Source: Integrative Medicine Communications; www.drkoop.com Cayenne Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,765,00.html Celery extract Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10014,00.html Celery Seed Alternative names: Apium graveolens Source: Integrative Medicine Communications; www.drkoop.com Centella Source: Integrative Medicine Communications; www.drkoop.com
286 Tea
Centella asiatica Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Chamaemelum nobile Source: Integrative Medicine Communications; www.drkoop.com Chamomile Alternative names: Matricaria recutita Source: Healthnotes, Inc. www.healthnotes.com Chamomile Source: Prima Communications, Inc.www.personalhealthzone.com Chamomile Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,766,00.html Chaparral Alternative names: Larrea tridentata Source: Healthnotes, Inc. www.healthnotes.com Chaparral Source: The Canadian Internet Directory for Holistic Help, WellNet, Health and Wellness Network; www.wellnet.ca Chasteberry Source: Prima Communications, Inc.www.personalhealthzone.com Chasteberry Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,767,00.html Chemotherapy Source: Healthnotes, Inc. www.healthnotes.com Cherry fruit extract Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10015,00.html Chickweed Alternative names: Stellaria media Source: Healthnotes, Inc. www.healthnotes.com Chili Pepper Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 287
Chinese Angelica Source: Integrative Medicine Communications; www.drkoop.com Chinese Scullcap Alternative names: Scutellaria baicalensis Source: Healthnotes, Inc. www.healthnotes.com Chlorhexidine Source: Healthnotes, Inc. www.healthnotes.com Chlorzoxazone Source: Healthnotes, Inc. www.healthnotes.com Cimicifuga racemosa (actea) Alternative names: Black Cohosh Source: Integrative Medicine Communications; www.drkoop.com Cinnamomum Alternative names: Cinnamon; Cinnamomum zeylanicum Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Ciprofloxacin Source: Healthnotes, Inc. www.healthnotes.com Cleavers Alternative names: Galium aparine Source: Healthnotes, Inc. www.healthnotes.com Codeine Source: Healthnotes, Inc. www.healthnotes.com Coenzyme Q Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,768,00.html Coenzyme Q10 (CoQ10) Source: Prima Communications, Inc.www.personalhealthzone.com Coleus Alternative names: Coleus forskohlii Source: Healthnotes, Inc. www.healthnotes.com Colloidal oatmeal Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10107,00.html Colloidal Silver Source: Healthnotes, Inc. www.healthnotes.com
288 Tea
Coltsfoot Alternative names: Tussilago farfara Source: Healthnotes, Inc. www.healthnotes.com Comfrey Alternative names: Symphytum officinale Source: Healthnotes, Inc. www.healthnotes.com Conjugated linoleic acid Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10102,00.html Cranberry Alternative names: Vaccinium macrocarpon Source: Healthnotes, Inc. www.healthnotes.com Cranberry Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10019,00.html Cranesbill Alternative names: Geranium maculatum Source: Healthnotes, Inc. www.healthnotes.com Crataegus Alternative names: Hawthorn; Crataegus oxyacantha L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Crataegus laevigata Source: Integrative Medicine Communications; www.drkoop.com Crataegus monogyna Source: Integrative Medicine Communications; www.drkoop.com Curcuma Alternative names: Turmeric; Curcuma longa L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Cyclophosphamide Source: Healthnotes, Inc. www.healthnotes.com Cynara artichoke Alternative names: Artichoke; Cynara scolymus L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Damiana Alternative names: Turnera diffusa Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 289
Dandelion Alternative names: Taraxacum officinale Source: Healthnotes, Inc. www.healthnotes.com Dandelion Alternative names: Taraxacum officinale Source: Integrative Medicine Communications; www.drkoop.com Dandelion Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10021,00.html Danggui Alternative names: Angelica sinensis, Chinese Angelica, Dang Gui, Danngui, Dong Qua, Tang Kuei, Tan Kue Bai zhi(Note: Dong quai should not be confused with Angelica root or Angelica seed.) Source: Integrative Medicine Communications; www.drkoop.com Devil's Claw Alternative names: Harpagophytum procumbens, Harpagophytum zeyheri Source: Integrative Medicine Communications; www.drkoop.com Devil's claw Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,970,00.html Digestive Enzymes Source: Healthnotes, Inc. www.healthnotes.com Digestive enzymes Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10051,00.html Docetaxel Source: Healthnotes, Inc. www.healthnotes.com Dong Quai Alternative names: Angelica sinensis Source: Healthnotes, Inc. www.healthnotes.com Dong Quai Alternative names: Angelica sinensis, Chinese Angelica, Dang Gui, Danngui, Dong Qua, Tang Kuei, Tan Kue Bai zhi(Note: Dong quai should not be confused with Angelica root or Angelica seed.) Source: Integrative Medicine Communications; www.drkoop.com Dong quai (angelica) Source: WholeHealthMD.com, LLC. www.wholehealthmd.com
290 Tea
Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,774,00.html Echinacea Alternative names: Echinacea angustifolia, Echinacea pallida, Echinacea purpurea, Purple Coneflower Source: Integrative Medicine Communications; www.drkoop.com Echinacea Source: Prima Communications, Inc.www.personalhealthzone.com Echinacea Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,775,00.html Echinacea angustifolia Source: Integrative Medicine Communications; www.drkoop.com Echinacea pallida Source: Integrative Medicine Communications; www.drkoop.com Echinacea purpurea Source: Integrative Medicine Communications; www.drkoop.com Elderberry Alternative names: Sambucus nigra Source: Healthnotes, Inc. www.healthnotes.com Elderberry Source: Prima Communications, Inc.www.personalhealthzone.com Elderberry Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10024,00.html Elecampane Alternative names: Inula helenium Source: Healthnotes, Inc. www.healthnotes.com Elecampane Source: Prima Communications, Inc.www.personalhealthzone.com Eleuthero Alternative names: Siberian Ginseng, Eleuthero; Acanthopanax/Eleutherococcus senticosus Rupr. & Maxim. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Eleuthero Alternative names: Eleutherococcus senticosus, Acanthopanax senticosus Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 291
Eleuthero Source: Integrative Medicine Communications; www.drkoop.com Eleutherococcus senticosus Source: Integrative Medicine Communications; www.drkoop.com English Lavendar Source: Integrative Medicine Communications; www.drkoop.com Ephedra Alternative names: Ephedra sinica, Ephedra intermedia, Ephedra equisetina Source: Healthnotes, Inc. www.healthnotes.com Ephedra Source: Prima Communications, Inc.www.personalhealthzone.com Ephedra (Ma huang) Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,777,00.html Ephedrine and Pseudoephedrine Source: Healthnotes, Inc. www.healthnotes.com Equisetum Alternative names: Horsetail; Equisetum arvense L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Equisetum arvense Source: Integrative Medicine Communications; www.drkoop.com Erythromycin Source: Healthnotes, Inc. www.healthnotes.com Eucalyptus Alternative names: Eucalyptus globulus Source: Healthnotes, Inc. www.healthnotes.com Eucalyptus Alternative names: Eucalyptus globulus, Eucalyptus fructicetorum, polybractea, smithii, Australian Fevertree Source: Integrative Medicine Communications; www.drkoop.com Eucalyptus Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,778,00.html Eucalyptus globulus Source: Integrative Medicine Communications; www.drkoop.com
292 Tea
Eugenia Clove Alternative names: Cloves; Eugenia sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org European Blueberry Source: Integrative Medicine Communications; www.drkoop.com Eyebright Alternative names: Euphrasia officinalis Source: Healthnotes, Inc. www.healthnotes.com Eyebright Source: Prima Communications, Inc.www.personalhealthzone.com False Unicorn Alternative names: Chamaelirium luteum Source: Healthnotes, Inc. www.healthnotes.com False unicorn root Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10075,00.html Felodipine Source: Healthnotes, Inc. www.healthnotes.com Fennel Alternative names: Foeniculum vulgare Source: Healthnotes, Inc. www.healthnotes.com Fennel Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,849,00.html Fennel Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/foods_view/0,1523,20,00.html Feverfew Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,780,00.html Flavonoids Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,782,00.html Fluorouracil Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 293
Foeniculum Alternative names: Fennel; Foeniculum vulgare Mill Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Fo-Ti Alternative names: Polygonum multiflorum Source: Healthnotes, Inc. www.healthnotes.com French Lavendar Source: Integrative Medicine Communications; www.drkoop.com Garcinia cambogia Alternative names: Citrin, Gambooge Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Garcinia man Alternative names: Mangosteen; Garcinia mangostana Linn. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Garcinia sp Alternative names:. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Gentian Alternative names: Gentiana lutea Source: Healthnotes, Inc. www.healthnotes.com German Chamomile Alternative names: Matricaria recutita Source: Integrative Medicine Communications; www.drkoop.com Ginger Alternative names: Zingiber officinale Source: Integrative Medicine Communications; www.drkoop.com Ginger Source: Prima Communications, Inc.www.personalhealthzone.com Ginger Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,787,00.html Ginkgo Alternative names: Ginkgo biloba Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Ginkgo Source: Prima Communications, Inc.www.personalhealthzone.com
294 Tea
Ginkgo biloba Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,788,00.html Ginseng Source: Prima Communications, Inc.www.personalhealthzone.com Glucosamine Source: Integrative Medicine Communications; www.drkoop.com Glucosamine Source: Prima Communications, Inc.www.personalhealthzone.com Glucosamine Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,790,00.html Glycyrrhiza glabra Source: Integrative Medicine Communications; www.drkoop.com Glycyrrhiza1 Alternative names: Licorice; Glycyrrhiza glabra L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Goldenrod Alternative names: Solidago virgaurea Source: Integrative Medicine Communications; www.drkoop.com Goldenseal Source: Prima Communications, Inc.www.personalhealthzone.com Goldenseal Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,791,00.html Gotu Kola Alternative names: Centella asiatica Source: Healthnotes, Inc. www.healthnotes.com Gotu Kola Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Gotu kola Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10031,00.html
Alternative Medicine 295
Greater Celandine Alternative names: Chelidonium majus Source: Healthnotes, Inc. www.healthnotes.com Green Tea Alternative names: Camellia sinensis Source: Healthnotes, Inc. www.healthnotes.com Green Tea Source: Healthnotes, Inc. www.healthnotes.com Green Tea Alternative names: Camellia sinensis Source: Integrative Medicine Communications; www.drkoop.com Green Tea Source: Prima Communications, Inc.www.personalhealthzone.com Green tea Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10032,00.html Guaraná Source: Healthnotes, Inc. www.healthnotes.com Gymnema Alternative names: Gurmar; Gymnema sylvestre Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Haloperidol Source: Healthnotes, Inc. www.healthnotes.com Harpagophytum procumbens Source: Integrative Medicine Communications; www.drkoop.com Harpagophytum zeyheri Source: Integrative Medicine Communications; www.drkoop.com Hawthorn Alternative names: Crataegus monogyna, Crataegus laevigata Source: Integrative Medicine Communications; www.drkoop.com Hawthorn Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10035,00.html Herbal Medicine Source: Healthnotes, Inc. www.healthnotes.com
296 Tea
Hibiscus Alternative names: Hibiscus, Roselle; Hibiscus sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Hops Alternative names: Humulus lupulus Source: Healthnotes, Inc. www.healthnotes.com Horehound Alternative names: Marrubium vulgare Source: Healthnotes, Inc. www.healthnotes.com Horehound Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10036,00.html Horse Chestnut Source: Prima Communications, Inc.www.personalhealthzone.com Horse chestnut Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10037,00.html Horseradish Alternative names: Cochlearia armoracia Source: Healthnotes, Inc. www.healthnotes.com Horsetail Alternative names: Equisetum arvense Source: Healthnotes, Inc. www.healthnotes.com Horsetail Alternative names: Equisetum arvense, Scouring Rush, Shave Grass Source: Integrative Medicine Communications; www.drkoop.com Horsetail Source: Prima Communications, Inc.www.personalhealthzone.com Horsetail Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10105,00.html Huang-qi Source: Integrative Medicine Communications; www.drkoop.com Huckleberry Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 297
Humulus Alternative names: Hops; Humulus lupulus L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Huperzia Source: Healthnotes, Inc. www.healthnotes.com Hydrastis Alternative names: Goldenseal; Hydrastis canadensis L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Hydrocotyle Source: Integrative Medicine Communications; www.drkoop.com Hypericum perforatum Alternative names: St. John's Wort Source: Integrative Medicine Communications; www.drkoop.com Hyssop Alternative names: Hyssopus officinalis Source: Healthnotes, Inc. www.healthnotes.com Illicium Alternative names: Star Anise; Illicium verum (Hook, F.) Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Indian Pennywort Source: Integrative Medicine Communications; www.drkoop.com Indinavir Source: Healthnotes, Inc. www.healthnotes.com Ipriflavone Source: Healthnotes, Inc. www.healthnotes.com Ivy Leaf Alternative names: Hedera helix Source: Healthnotes, Inc. www.healthnotes.com Ivy leaf Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10112,00.html Juniper Alternative names: Juniperus communis Source: Healthnotes, Inc. www.healthnotes.com Juniper Berry Source: Prima Communications, Inc.www.personalhealthzone.com
298 Tea
Kava Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,798,00.html Kava Kava Alternative names: Piper methysticum, Ava Source: Integrative Medicine Communications; www.drkoop.com Klamathweed Alternative names: St. John's Wort Source: Integrative Medicine Communications; www.drkoop.com Klamathweed Source: Integrative Medicine Communications; www.drkoop.com Kudzu Source: Prima Communications, Inc.www.personalhealthzone.com Lapacho Source: Integrative Medicine Communications; www.drkoop.com Lapacho Source: Prima Communications, Inc.www.personalhealthzone.com Lavandula Alternative names: Lavender; Lavandula sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Lavandula angustifolia Source: Integrative Medicine Communications; www.drkoop.com Lavender Alternative names: Lavandula officinalis Source: Healthnotes, Inc. www.healthnotes.com Lavender Alternative names: Lavandula angustifolia, English Lavendar, French Lavendar Source: Integrative Medicine Communications; www.drkoop.com Lavender Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,799,00.html Lecithin Source: Prima Communications, Inc.www.personalhealthzone.com Lemon Balm Alternative names: Melissa officinalis Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 299
Lemon Balm Alternative names: Melissa officinalis, Melissa Source: Integrative Medicine Communications; www.drkoop.com Licorice Alternative names: Glycyrrhiza glabra, Glycyrrhiza uralensis Source: Healthnotes, Inc. www.healthnotes.com Licorice Alternative names: Glycyrrhiza glabra, Spanish Licorice Source: Integrative Medicine Communications; www.drkoop.com Licorice Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,801,00.html Ligustrum Alternative names: Ligustrum lucidum Source: Healthnotes, Inc. www.healthnotes.com Limetree Source: Integrative Medicine Communications; www.drkoop.com Linden Alternative names: Tilia spp. Source: Healthnotes, Inc. www.healthnotes.com Linden Alternative names: Tilia cordata, Tilia platyphyllos, Limetree Source: Integrative Medicine Communications; www.drkoop.com Lipase Source: Healthnotes, Inc. www.healthnotes.com Lipase Source: Integrative Medicine Communications; www.drkoop.com Lobelia Alternative names: Lobelia inflata Source: Healthnotes, Inc. www.healthnotes.com Lomotil, Lonox Source: Healthnotes, Inc. www.healthnotes.com Luffa Alternative names: Luffa sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Mad-dog Skullcap Source: Integrative Medicine Communications; www.drkoop.com
300 Tea
Maitake Alternative names: Grifola frondosa Source: Healthnotes, Inc. www.healthnotes.com Maitake Source: Prima Communications, Inc.www.personalhealthzone.com MAO Inhibitors Source: Prima Communications, Inc.www.personalhealthzone.com Marsh Pennywort Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Marshmallow Alternative names: Althea officinalis Source: Healthnotes, Inc. www.healthnotes.com Marshmallow Alternative names: Althaea officinalis Source: Integrative Medicine Communications; www.drkoop.com Marshmallow Source: Prima Communications, Inc.www.personalhealthzone.com Marshmallow Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10042,00.html Matricaria Alternative names: Chamomile; Matricaria chamomilla Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Matricaria recutita Source: Integrative Medicine Communications; www.drkoop.com Meadowsweet Alternative names: Filipendula ulmaria Source: Healthnotes, Inc. www.healthnotes.com Medium-Chain Triglycerides Source: Prima Communications, Inc.www.personalhealthzone.com Melaleuca Alternative names: Tea Tree Oil; Melaleuca alternifolia Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Melatonin Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 301
Melatonin Source: Prima Communications, Inc.www.personalhealthzone.com Melissa Source: Integrative Medicine Communications; www.drkoop.com Melissa Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10043,00.html Melissa officinalis Source: Integrative Medicine Communications; www.drkoop.com Menadione Source: Integrative Medicine Communications; www.drkoop.com Menaphthone Source: Integrative Medicine Communications; www.drkoop.com Menaquinone Source: Integrative Medicine Communications; www.drkoop.com Mentha Alternative names: Pennyroyal; Mentha/Hedeoma pulegium Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Mentha x piperita Source: Integrative Medicine Communications; www.drkoop.com Metformin Source: Healthnotes, Inc. www.healthnotes.com Methotrexate Source: Healthnotes, Inc. www.healthnotes.com Metoclopramide Source: Healthnotes, Inc. www.healthnotes.com Mifepristone Source: Healthnotes, Inc. www.healthnotes.com Milk Thistle Alternative names: Silybum marianum, Carduus marianus Source: Healthnotes, Inc. www.healthnotes.com Milk Thistle Alternative names: Silybum marianum, St. Mary's Thistle Source: Integrative Medicine Communications; www.drkoop.com
302 Tea
Milk thistle Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10044,00.html Milk-Vetch Root Source: Integrative Medicine Communications; www.drkoop.com Mistletoe Alternative names: Viscum album Source: Healthnotes, Inc. www.healthnotes.com Mistletoe Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10109,00.html Momordica Alternative names: Bitter Gourd, Karela; Momordica charantia Linn. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Motherwort Alternative names: Leonurus cardiaca Source: Healthnotes, Inc. www.healthnotes.com Muira puama Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10045,00.html Mullein Alternative names: Verbascum thapsus Source: Healthnotes, Inc. www.healthnotes.com Mullein Source: Prima Communications, Inc.www.personalhealthzone.com Mullein flower Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,865,00.html Musa Banana Alternative names: Plantain, Banana; Musa sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Myrrh Alternative names: Commiphora molmol Source: Healthnotes, Inc. www.healthnotes.com N-Acetyl-Glucosamine Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 303
Natural progesterone cream Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10099,00.html Nettle Source: Integrative Medicine Communications; www.drkoop.com Nettle Source: Prima Communications, Inc.www.personalhealthzone.com Nettle Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10048,00.html Oak Alternative names: Quercus spp. Source: Healthnotes, Inc. www.healthnotes.com Oak bark Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10108,00.html Ocimum Alternative names: Basil, Albahaca; Ocimum basilicum Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Olive Leaf Alternative names: Olea europa Source: Healthnotes, Inc. www.healthnotes.com OPCs (Oligomeric Proanthocyanidins) Source: Prima Communications, Inc.www.personalhealthzone.com Oral Corticosteroids Source: Healthnotes, Inc. www.healthnotes.com Oregano/Wild Marjoram Alternative names: Origanum vulgare Source: Healthnotes, Inc. www.healthnotes.com Oregon Grape Alternative names: Berberis aquifolium Source: Healthnotes, Inc. www.healthnotes.com Origanum Alternative names: Oregano; Origanum vulgare Source: Alternative Medicine Foundation, Inc. www.amfoundation.org
304 Tea
Paclitaxel Source: Healthnotes, Inc. www.healthnotes.com Panax Alternative names: Ginseng; Panax ginseng Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Panax ginseng Source: Integrative Medicine Communications; www.drkoop.com Parsley Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,869,00.html Passiflora incarnata Source: Integrative Medicine Communications; www.drkoop.com Passion Flower Alternative names: Passiflora incarnata Source: Healthnotes, Inc. www.healthnotes.com Passionflower Alternative names: Passiflora incarnata Source: Integrative Medicine Communications; www.drkoop.com Passionflower Source: Prima Communications, Inc.www.personalhealthzone.com Pau D’arco Alternative names: Tabebuia avellanedae, Tabebuia impestiginosa Source: Healthnotes, Inc. www.healthnotes.com Pau d'Arco Alternative names: Tabebuia avellanedae, Lapacho Source: Integrative Medicine Communications; www.drkoop.com Pau d'arco Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,811,00.html Penicillamine Source: Healthnotes, Inc. www.healthnotes.com Penicillin V Source: Healthnotes, Inc. www.healthnotes.com Pennyroyal Alternative names: Hedeoma pulegoides, Mentha pulegium Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 305
Peppermint Alternative names: Mentha piperita Source: Healthnotes, Inc. www.healthnotes.com Peppermint Alternative names: Mentha x piperita Source: Integrative Medicine Communications; www.drkoop.com Peppermint Source: Prima Communications, Inc.www.personalhealthzone.com Peppermint Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,812,00.html Phenelzine Source: Healthnotes, Inc. www.healthnotes.com Phenobarbital Source: Healthnotes, Inc. www.healthnotes.com Phenylalanine Source: Integrative Medicine Communications; www.drkoop.com Phosphorus Source: Integrative Medicine Communications; www.drkoop.com Phylloquinone Source: Integrative Medicine Communications; www.drkoop.com Phytolacca Alternative names: Poke root, Endod; Phytolacca dodecandra L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Picrorhiza Alternative names: Picrorhiza kurroa Source: Healthnotes, Inc. www.healthnotes.com Pimpinella Alternative names: Anise; Pimpinella anisum (L) Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Piper methysticum Source: Integrative Medicine Communications; www.drkoop.com Piper nigrum Alternative names: Black Pepper Source: Alternative Medicine Foundation, Inc. www.amfoundation.org
306 Tea
Plantago psyllium Alternative names: Psyllium, Ispaghula; Plantago psyllium/ovata Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Plantain Alternative names: Plantago lanceolata, Plantago major Source: Healthnotes, Inc. www.healthnotes.com Potentilla Alternative names: Cinquefoil, Silverweed; Potentilla sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Prickly Ash Alternative names: Zanthoxylum clava-herculis, Zanthoxylum americanum Source: Healthnotes, Inc. www.healthnotes.com Progesterone Source: Healthnotes, Inc. www.healthnotes.com Protease Inhibitors Source: Prima Communications, Inc.www.personalhealthzone.com Psyllium Alternative names: Plantago ovata, Plantago ispaghula Source: Healthnotes, Inc. www.healthnotes.com Psyllium Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,814,00.html Purple Coneflower Source: Integrative Medicine Communications; www.drkoop.com Pygeum Alternative names: Prunus africanum, Pygeum africanum Source: Healthnotes, Inc. www.healthnotes.com Pygeum africanum Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10052,00.html Raspberry Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,1061,00.html Red Clover Alternative names: Trifolium pratense Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 307
Red Clover Alternative names: Trifolium pratense , beebread, cow clover, cow grass, meadow clover, purple clover Source: Integrative Medicine Communications; www.drkoop.com Red Clover Source: Prima Communications, Inc.www.personalhealthzone.com Red Elm Source: Integrative Medicine Communications; www.drkoop.com Red Pepper Source: Integrative Medicine Communications; www.drkoop.com Red Raspberry Alternative names: Rubus idaeus Source: Healthnotes, Inc. www.healthnotes.com Red Raspberry Source: Prima Communications, Inc.www.personalhealthzone.com Reishi Alternative names: Ganoderma lucidum Source: Healthnotes, Inc. www.healthnotes.com Ribes Alternative names: Black Currant; Ribes nigrum L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Roman Chamomile Alternative names: Chamaemelum nobile Source: Integrative Medicine Communications; www.drkoop.com Rosemary Alternative names: Rosmarinus officinalis Source: Healthnotes, Inc. www.healthnotes.com Rosmarinus Alternative names: Rosemary; Rosmarinus officinalis L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Sabal serrulata Source: Integrative Medicine Communications; www.drkoop.com Sage Alternative names: Salvia officinalis Source: Healthnotes, Inc. www.healthnotes.com SAMe (S-Adenosylmethionine) Source: Prima Communications, Inc.www.personalhealthzone.com
308 Tea
Sandalwood Alternative names: Santalum album Source: Healthnotes, Inc. www.healthnotes.com Sanguinaria Alternative names: Bloodroot; Sanguinaria canadensis L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Sassafras Alternative names: Sassafras albidum (Nuttall) Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Saw Palmetto Alternative names: Serenoa serrulata, Serenoa repens, Sabal serrulata Source: Healthnotes, Inc. www.healthnotes.com Saw Palmetto Alternative names: Serenoa repens, Sabal serrulata Source: Integrative Medicine Communications; www.drkoop.com Scouring Rush Source: Integrative Medicine Communications; www.drkoop.com Scutellaria lateriflora Source: Integrative Medicine Communications; www.drkoop.com Serenoa repens Source: Integrative Medicine Communications; www.drkoop.com Shave Grass Source: Integrative Medicine Communications; www.drkoop.com Siberian Ginseng Alternative names: Eleutherococcus senticosus, Acanthopanax senticosus, Eleuthero Source: Integrative Medicine Communications; www.drkoop.com Siberian ginseng Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,821,00.html Silybum marianum Source: Integrative Medicine Communications; www.drkoop.com Skullcap Alternative names: Scutellaria lateriflora, Mad-dog Skullcap Source: Integrative Medicine Communications; www.drkoop.com Skullcap Source: Prima Communications, Inc.www.personalhealthzone.com
Alternative Medicine 309
Slippery Elm Alternative names: Ulmus rubra, Ulmus fulva Source: Healthnotes, Inc. www.healthnotes.com Slippery Elm Alternative names: Ulmus fulva, Red Elm, Sweet Elm Source: Integrative Medicine Communications; www.drkoop.com Slippery elm Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10056,00.html Solidago virgaurea Source: Integrative Medicine Communications; www.drkoop.com Spanish Licorice Source: Integrative Medicine Communications; www.drkoop.com Spirulina and kelp Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10058,00.html St. John's Wort Alternative names: Hypericum perforatum, Klamathweed Source: Integrative Medicine Communications; www.drkoop.com St. John's Wort Source: Prima Communications, Inc.www.personalhealthzone.com St. John's wort Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,824,00.html St. Mary's Thistle Source: Integrative Medicine Communications; www.drkoop.com Stevia Alternative names: Stevia rebaudiana Source: Healthnotes, Inc. www.healthnotes.com Stevia Source: Prima Communications, Inc.www.personalhealthzone.com Sulindac Source: Healthnotes, Inc. www.healthnotes.com
310 Tea
Sundew Alternative names: Drosera rotundifolia, Drosera ramentacea, Drosera intermedia, Drosera anglica Source: Healthnotes, Inc. www.healthnotes.com Sweet Elm Source: Integrative Medicine Communications; www.drkoop.com Swertia Alternative names: Swertia sp Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Symphytum Alternative names: Comfrey; Symphytum officinale L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Syzygium Clove Alternative names: Clove, Jamun; Syzygium sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Tabebuia avellanedae Source: Integrative Medicine Communications; www.drkoop.com Tanacetum v Alternative names: Tansy; Tanacetum vulgare (L.) Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Tang Kuei Source: Integrative Medicine Communications; www.drkoop.com Taraxacum Alternative names: Dandelion; Taraxacum officinale (Dhudhal) Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Taraxacum officinale Source: Integrative Medicine Communications; www.drkoop.com Tea Tree Alternative names: Melaleuca alternifolia Source: Healthnotes, Inc. www.healthnotes.com Tea Tree Source: Prima Communications, Inc.www.personalhealthzone.com Terminalia Alternative names: Myrobalans; Terminalia arjuna Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Theophylline/Aminophylline Source: Healthnotes, Inc. www.healthnotes.com
Alternative Medicine 311
Thuja plicata Alternative names: Western Red Cedar Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Thyme Alternative names: Thymus vulgaris Source: Healthnotes, Inc. www.healthnotes.com Thymus Alternative names: Thyme; Thymus vulgaris Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Tilia cordata Source: Integrative Medicine Communications; www.drkoop.com Tilia platyphyllos Source: Integrative Medicine Communications; www.drkoop.com Traditional Chinese Medicine Herbs Source: Healthnotes, Inc. www.healthnotes.com Tricyclic Antidepressants Source: Healthnotes, Inc. www.healthnotes.com Trigonella Alternative names: Fenugreek; Trigonella foenum graecum L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Turmeric Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10062,00.html Ulmus fulva Source: Integrative Medicine Communications; www.drkoop.com Uncaria tomentosa Source: Integrative Medicine Communications; www.drkoop.com Urtica dioica Source: Integrative Medicine Communications; www.drkoop.com Urtica urens Source: Integrative Medicine Communications; www.drkoop.com Uva ursi Alternative names: Arctostaphylos uva-ursi Source: Healthnotes, Inc. www.healthnotes.com Uva Ursi Source: Prima Communications, Inc.www.personalhealthzone.com
312 Tea
Uva ursi Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10063,00.html Vaccinium myrtillus Source: Integrative Medicine Communications; www.drkoop.com VacciniumB Alternative names: Bilberry; Vaccinium myrtillus L. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Valerian Alternative names: Valeriana officinalis Source: Integrative Medicine Communications; www.drkoop.com Valerian Source: WholeHealthMD.com, LLC. www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10064,00.html Valeriana officinalis Source: Integrative Medicine Communications; www.drkoop.com Valproic Acid Source: Healthnotes, Inc. www.healthnotes.com Vervain Alternative names: Verbena officinalis Source: Healthnotes, Inc. www.healthnotes.com Viburnum Alternative names: Cramp Bark, Highbush Cranberry; Viburnum sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Vitex Alternative names: Chaste; Vitex agnus-castus Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Warfarin Source: Healthnotes, Inc. www.healthnotes.com Warfarin Alternative names: Coumadin Source: Prima Communications, Inc.www.personalhealthzone.com White Willow Source: Prima Communications, Inc.www.personalhealthzone.com White willow bark Source: WholeHealthMD.com, LLC. www.wholehealthmd.com
Alternative Medicine 313
Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10069,00.html Wild Indigo Alternative names: Baptisia tinctoria Source: Healthnotes, Inc. www.healthnotes.com Willow Alternative names: Salix alba Source: Healthnotes, Inc. www.healthnotes.com Willow Bark Alternative names: There are several species of willow includingSalix alba, Salix nigra, Salix fragilis, Salix purpurea, Salix babylonica, White Willow, European Willow, Black Willow, Pussy Willow, Crack Willow, Purple Willow, Weeping Willow, Liu-zhi Source: Integrative Medicine Communications; www.drkoop.com Witch Hazel Alternative names: Hamamelis virginiana Source: Healthnotes, Inc. www.healthnotes.com Wormwood Alternative names: Artemisia absinthium Source: Healthnotes, Inc. www.healthnotes.com Yarrow Alternative names: Achillea millefolium Source: Healthnotes, Inc. www.healthnotes.com Yarrow Alternative names: Achillea millefolium, Milfoil Source: Integrative Medicine Communications; www.drkoop.com Yarrow Source: Prima Communications, Inc.www.personalhealthzone.com Yellow Dock Alternative names: Rumex crispus Source: Healthnotes, Inc. www.healthnotes.com Yerba Santa Source: Prima Communications, Inc.www.personalhealthzone.com Yucca Alternative names: Yucca schidigera , Yucca spp. Source: Healthnotes, Inc. www.healthnotes.com Zanthoxylum Alternative names: Prickly Ash; Zanthoxylum sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org
314 Tea
Zingiber Alternative names: Ginger; Zingiber officinale Roscoe Source: Alternative Medicine Foundation, Inc. www.amfoundation.org Zingiber officinale Source: Integrative Medicine Communications; www.drkoop.com Zizyphus Alternative names: Jujube; Ziziphus sp. Source: Alternative Medicine Foundation, Inc. www.amfoundation.org
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
315
CHAPTER 4. DISSERTATIONS ON TEA Overview In this chapter, we will give you a bibliography on recent dissertations relating to tea. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “tea” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on tea, we have not necessarily excluded non-medical dissertations in this bibliography.
Dissertations on Tea ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to tea. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: ·
A Remote Sensing - Microclimatic Study for Estimating Regional Evapotranspiration from Tea (Camellia sinensis) at Kericho, Kenya by Kairu, E. N., Phd from McGill University (Canada), 1989, 212 pages http://wwwlib.umi.com/dissertations/fullcit/NN63489
·
Allium Vegetables, Green Tea, Genetic Susceptibilities, Cox-2 and Stomach Cancer by Setiawan, Veronica Wendy; Phd from University of California, Los Angeles, 2002, 174 pages http://wwwlib.umi.com/dissertations/fullcit/3045618
·
Biochemical Analysis for Identification of Quality in Black Tea (Camellia sinensis) by Wright, Louwrance Peter; Dphil from University of Pretoria (south Africa), 2002 http://wwwlib.umi.com/dissertations/fullcit/f348417
·
Clinical and Pre-clinical Pharmacokinetics of Green Tea Polyphenols by Cai, Yan; Phd from The University of Arizona, 2002, 130 pages http://wwwlib.umi.com/dissertations/fullcit/3073202
316 Tea
·
Compost Teas and Compost Amended Container Media for Plant Disease Control by Scheuerell, Steven J. Phd from Oregon State University, 2003, 173 pages http://wwwlib.umi.com/dissertations/fullcit/3080159
·
Control of Vascular Smooth Muscle Cell Matrix Synthesis and Proliferation by Bmyb and Green Tea Polyphenol by Hofmann, Claudia Sofia; Phd from Boston University, 2003, 238 pages http://wwwlib.umi.com/dissertations/fullcit/3072381
·
Factors Associated with Use, Dependence and Problem Consequences Application of a Common Process Model of Substance Abuse to Coffee and Tea by Graham, Kathryn Marie; Phd from The University of Western Ontario (canada), 1988 http://wwwlib.umi.com/dissertations/fullcit/NL40771
·
Green Tea Extract and Individual Green Tea Flavonoids: Interactions with the Aryl Hydrocarbon Receptor and Effects on Human Hepatic Cytochrome P450 1a Expression by Williams, Susanne N. Phd from University of Colorado Health Sciences Center, 2002, 139 pages http://wwwlib.umi.com/dissertations/fullcit/3045849
·
Identification and Characterization of Tea Catechin Metabolites in Humans and Animals: Pharmacokinetics and Potential Biological Activities by Meng, Xiaofeng; Phd from Rutgers the State University of New Jersey - New Brunswick, 2002, 178 pages http://wwwlib.umi.com/dissertations/fullcit/3055072
·
Inhibition of Bladder Tumor Growth by the Green Tea Derivative Egcg (epigallocatechin-gallate) by Kemberling, J. Karl; Msbs from Medical College of Ohio at Toledo, 2002, 38 pages http://wwwlib.umi.com/dissertations/fullcit/1410508
·
Mechanistic Studies on the Phase II Metabolism and Absorption of Tea Catechins by Lu, Hong; Phd from Rutgers the State U. of N.j. - New Brunswick and U.m.d.n.j., 2002, 162 pages http://wwwlib.umi.com/dissertations/fullcit/3066734
·
Mechanistic Studies on Tumor Cell Cycle Disruption and Apoptosis by Green Tea Polyphenols and N-thiolated Beta-lactams by Smith, David Matthew; Phd from University of South Florida, 2002, 195 pages http://wwwlib.umi.com/dissertations/fullcit/3071326
·
Modulation of Arachidonic Acid Metabolism by Tea Polyphenols and Curcuminoids in the Gastrointestinal Tract: a Possible Chemopreventive Mechanism by Hong, Jungil; Phd from Rutgers the State University of New Jersey - New Brunswick, 2002, 163 pages http://wwwlib.umi.com/dissertations/fullcit/3055058
·
Role of Digestion, Iron and Protein on the Antioxidant Effect of Green and Black Tea in Caco2 Cells by Joseph, Shama Vasanthi; Ms from Michigan State University, 2002, 67 pages http://wwwlib.umi.com/dissertations/fullcit/1411941
·
The Effects of Green Tea on Breast Cancer and I Kappa B Alpha on Mammary Gland Development by Kavanagh, Kathryn Therese; Phd from Boston University, 2002, 218 pages http://wwwlib.umi.com/dissertations/fullcit/3054530
Dissertations 317
Keeping Current Ask the medical librarian at your library if it has full and unlimited access to the ProQuest Digital Dissertations database. From the library, you should be able to do more complete searches via http://wwwlib.umi.com/dissertations.
319
CHAPTER 5. CLINICAL TRIALS AND TEA Overview In this chapter, we will show you how to keep informed of the latest clinical trials concerning tea.
Recent Trials on Tea The following is a list of recent trials dedicated to tea.8 Further information on a trial is available at the Web site indicated. ·
Treatment of Functional Abdominal Pain in Children: Evaluation Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities
of
Condition(s): recurrent abdominal pain Study Status: This study is currently recruiting patients. Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) Purpose - Excerpt: The purpose of this study is to investigate novel methods from CAM aimed at alleviating chronic pain related to functional bowel disorders in children. To that end, two CAM modalities will be investigated independently of each other, namely Guided Imagery and the use of Chamomile teas as a form of botanical therapy. Functional abdominal pain is defined as pain unrelated to an identifiable organic gastrointestinal disorder. The two subcategories of functional bowel disorders examined by this study will be RAP and IBS. The definition of RAP in children will follow Apley's classic definition of paroxysmal abdominal pain occurring in children between the ages of 4 and 16 years that persists for more than three months, with a frequency of three or more episodes of abdominal pain over a three month interval. A similar pattern of abdominal pain relieved by defecation and/or associated with altered bowel habits and/or stool consistency will be defined as IBS. Despite the above definitions, note that the typical frequency of pain episodes associated with functional bowel disorders is at least three times per month. Study Type: Interventional Contact(s): see Web site below 8
These are listed at www.ClinicalTrials.gov.
320 Tea
Web Site: http://clinicaltrials.gov/ct/show/NCT00010933 ·
Green Tea Consumption and Coronary Heart Disease Condition(s): Cardiovascular Diseases; Coronary Disease; Heart Diseases Study Status: This study is completed. Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) Purpose - Excerpt: To examine the prospective association of green tea consumption to the incidence and mortality of coronary heart disease (CHD) using multivariate analysis while controlling for the potential confounding effects of cholesterol, triglycerides, glucose and dietary nutrients. Study Type: Observational Contact(s): see Web site below Web Site: http://clinicaltrials.gov/ct/show/NCT00005548
Keeping Current on Clinical Trials The U.S. National Institutes of Health, through the National Library of Medicine, has developed ClinicalTrials.gov to provide current information about clinical research across the broadest number of diseases and conditions. The site was launched in February 2000 and currently contains approximately 5,700 clinical studies in over 59,000 locations worldwide, with most studies being conducted in the United States. ClinicalTrials.gov receives about 2 million hits per month and hosts approximately 5,400 visitors daily. To access this database, simply go to the Web site at http://www.clinicaltrials.gov/ and search by “tea” (or synonyms). While ClinicalTrials.gov is the most comprehensive listing of NIH-supported clinical trials available, not all trials are in the database. The database is updated regularly, so clinical trials are continually being added. The following is a list of specialty databases affiliated with the National Institutes of Health that offer additional information on trials: ·
For clinical studies at the Warren Grant Magnuson Clinical Center located in Bethesda, Maryland, visit their Web site: http://clinicalstudies.info.nih.gov/
·
For clinical studies conducted at the Bayview Campus in Baltimore, Maryland, visit their Web site: http://www.jhbmc.jhu.edu/studies/index.html
·
For cancer trials, visit the National Cancer Institute: http://cancertrials.nci.nih.gov/
·
For eye-related trials, visit and search the Web page of the National Eye Institute: http://www.nei.nih.gov/neitrials/index.htm
·
For heart, lung and blood trials, visit the Web page of the National Heart, Lung and Blood Institute: http://www.nhlbi.nih.gov/studies/index.htm
·
For trials on aging, visit and search the Web site of the National Institute on Aging: http://www.grc.nia.nih.gov/studies/index.htm
·
For rare diseases, visit and search the Web site sponsored by the Office of Rare Diseases: http://ord.aspensys.com/asp/resources/rsch_trials.asp
Clinical Trials 321
·
For alcoholism, visit the National Institute on Alcohol Abuse and Alcoholism: http://www.niaaa.nih.gov/intramural/Web_dicbr_hp/particip.htm
·
For trials on infectious, immune, and allergic diseases, visit the site of the National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov/clintrials/
·
For trials on arthritis, musculoskeletal and skin diseases, visit newly revised site of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health: http://www.niams.nih.gov/hi/studies/index.htm
·
For hearing-related trials, visit the National Institute on Deafness and Other Communication Disorders: http://www.nidcd.nih.gov/health/clinical/index.htm
·
For trials on diseases of the digestive system and kidneys, and diabetes, visit the National Institute of Diabetes and Digestive and Kidney Diseases: http://www.niddk.nih.gov/patient/patient.htm
·
For drug abuse trials, visit and search the Web site sponsored by the National Institute on Drug Abuse: http://www.nida.nih.gov/CTN/Index.htm
·
For trials on mental disorders, visit and search the Web site of the National Institute of Mental Health: http://www.nimh.nih.gov/studies/index.cfm
·
For trials on neurological disorders and stroke, visit and search the Web site sponsored by the National Institute of Neurological Disorders and Stroke of the NIH: http://www.ninds.nih.gov/funding/funding_opportunities.htm#Clinical_Trials
323
CHAPTER 6. PATENTS ON TEA Overview Patents can be physical innovations (e.g. chemicals, pharmaceuticals, medical equipment) or processes (e.g. treatments or diagnostic procedures). The United States Patent and Trademark Office defines a patent as a grant of a property right to the inventor, issued by the Patent and Trademark Office.9 Patents, therefore, are intellectual property. For the United States, the term of a new patent is 20 years from the date when the patent application was filed. If the inventor wishes to receive economic benefits, it is likely that the invention will become commercially available within 20 years of the initial filing. It is important to understand, therefore, that an inventor’s patent does not indicate that a product or service is or will be commercially available. The patent implies only that the inventor has “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States. While this relates to U.S. patents, similar rules govern foreign patents. In this chapter, we show you how to locate information on patents and their inventors. If you find a patent that is particularly interesting to you, contact the inventor or the assignee for further information. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical patents that use the generic term “tea” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on tea, we have not necessarily excluded non-medical patents in this bibliography.
Patents on Tea By performing a patent search focusing on tea, you can obtain information such as the title of the invention, the names of the inventor(s), the assignee(s) or the company that owns or controls the patent, a short abstract that summarizes the patent, and a few excerpts from the description of the patent. The abstract of a patent tends to be more technical in nature, while the description is often written for the public. Full patent descriptions contain much more information than is presented here (e.g. claims, references, figures, diagrams, etc.). We will
9Adapted
from the United States Patent and Trademark Office: http://www.uspto.gov/web/offices/pac/doc/general/whatis.htm.
324 Tea
tell you how to obtain this information later in the chapter. The following is an example of the type of information that you can expect to obtain from a patent search on tea: ·
Antibacterial agent containing tea extract or active fraction thereof and.beta.-lactam antibiotic Inventor(s): Hamilton-Miller; Jeremy Marcis Tom (London, GB) Assignee(s): Royal Free Hospital School of Medicine (GB) Patent Number: 5,879,683 Date filed: September 25, 1996 Abstract: The invention provides a method of inhibiting production of bacteria which constitutively express PBP2' or bacteria which inducibly express PBP2' in the presence of a.beta.-lactam antibiotic, by administering an effective amount of an extract of tea to the bacteria. The tea extract contains at least one active principle of dried tea and being extractable from processed dried tea with hot water and this active principle is capable, on administration, of restoring the activity against methicillin-resistant Staphylococcus aureus (MRSA) of a.beta.-lactam antibiotic. Preferably, the extract of tea can be administered to a human or animal subject together with a.beta.-lactam antibiotic. Excerpt(s): The present invention relates to a novel composition with antibacterial activity and its use. In particular, the composition has activity against methicillinresistant Staphylococcus aureus (MRSA). Staphylococcus aureus is a gram-positive bacteria which is recognised in the clinical microbiology laboratory by its ability to make coagulase. S. aureus is often carried by humans. Reference may be made to Bergey's manual of Determinative Bacteriology (9th edition, 1993) for details of further classification of S. aureus. S. aureus may acquire resistance to antibiotics. Patients in hospitals can become infected with MRSA which can lead to serious illness or even death. Strains of S. aureus which can be considered resistant to methicillin are those strains in which growth occurs in the presence of 8.mu.g/ml methicillin (National Committee for Clinical Laboratory Standards, 1990--Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (second edition). Document M7-A2. NCCLS, Villanova, Pa., U.S.A.). Infections with MRSA can be treated with a group of antibiotics called the glycopeptides; these are expensive and potentially toxic. What is most worrying is that this is the only widely available treatment; resistance to the glycopeptides has emerged in closely related bacteria, and could easily emerge too in MRSA. Web site: http://www.delphion.com/details?pn=US05879683__
·
Antiviral filter air cleaner impregnated with tea extract Inventor(s): Nashimoto; Kazuo (Chigasaki, JP), Tashiro; Yoshikazu (Chigasaki, JP), Kosaka; Yoshiomi (Chigasaki, JP), Hara; Yukihiko (Fujieda, JP) Assignee(s): Matsushita Seiko Co., Ltd. (Osaka, JP), Mitsui Norin Co., Ltd. (Tokyo, JP) Patent Number: 5,747,053 Date filed: May 9, 1996 Abstract: The present invention provides a medicated gargling cup with which it is possible to form a liquid for gargling effective for preventing cold by merely pouring water into the cup; an antiviral mask having a nonwoven fabric impregnated with a tea
Patents 325
extract, which mask can be easily produced commercially and is capable of maintaining a high virus trapping performance, inactivating the trapped viruses and preventing them from being rescattered; an antiviral filter and an antifungal, antibacterial and antiviral filter comprising in laminations a dust collecting filter and a filter impregnated with a tea extract; an air cleaner and an air cleaner-humidifier comprising the antiviral filter. Excerpt(s): The present invention relates to the antiviral techniques making use of tea extracts having the effect of inactivating the viruses. More particularly it relates to a cup used for gargling for preventing cold caused by the influenza viruses, etc. an antiviral mask which can prevent the infectious viruses from entering the mask wearer's system from the mouth and/or the nose by trapping the viruses floating in the air at a high rate and inactivating the trapped viruses; an antiviral filter which is capable of trapping the viruses floating in the ambient air at a high rate and inactivating the trapped viruses to clean the air; an antifungal, antibacterial and antiviral filter which can trap fungi, bacteria and/or viruses floating in the air to kill or inactivate the trapped fungi, bacteria and/or viruses, thereby to clean the air; an air cleaner; and an air cleaner-humidifier comprising said filter. Liquid gargling agents have been hitherto commercially available, and in use thereof, they were usually put into a cup containing water to form a liquid for gargling. Various types of gargling agents have been placed on the market, among which tea polyphenols, which are the natural tea extracts having a potency to inactivate the influenza viruses, are known as a typical example (Patent Kokai No. 3101623). The influenza viruses, which are pathogenic viruses of cold, tend to cause spread of influenza through aerial or droplet infection at a crowded place, so the development of an antiviral mask capable of trapping and inactivating the influenza viruses to prevent the infectious viruses from entering a human body has been desired. Web site: http://www.delphion.com/details?pn=US05747053__ ·
Aqueous tea extract concentrate stable at ambient temperature Inventor(s): Lehmberg; Gregg Lance (Somerset, NJ), Ma; Sheng Xue (Altamonte Springs, FL) Assignee(s): Thomas J. Lipton Co., division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,274,187 Date filed: February 28, 1997 Abstract: A stable tea concentrate of about 50% to about 70% tea solids is prepared by aqueous extraction. Excerpt(s): This invention generally relates to tea concentrates having about 50 to about 70% or even higher tea solids. Shelf stable tea concentrates are highly desirable and have several applications. These include: the ability to supply a natural tea concentrate for use in Ready-to-Drink tea and Fountain tea products; as a tea concentrate product for retail sale; and as a preferred method of transporting tea solids. The advantages of a tea concentrate over a powder or a dilute tea extract are that better tea character is obtained. In addition, less energy is employed than for a powder and less weight and volume are needed for shipping a concentrate than for a dilute extract. In the prior art, tea concentrates were considered to be physically unstable, which prevented their use in many tea products. However, it is believed that under certain conditions tea products made from tea concentrates have better quality (e.g., flavor, freshness, etc.) than
326 Tea
powders and are more economical than tea powder or dilute tea extract. Therefore, it is highly desirable to have a shelf stable tea concentrate. Web site: http://www.delphion.com/details?pn=US06274187__ ·
Aromatizing tea with geranyl acetone and.delta.-decalactone Inventor(s): Horman; Ian (Corseaux, CH), Cazenave; Paul (Chavornay, CH) Assignee(s): Societe d'Assistance Technique pour Produits Nestle S.A. (La Tour-de-Peilz, CH) Patent Number: 4,015,024 Date filed: November 7, 1975 Abstract: A flavoring agent is provided for a tea composition to impart various flavors. The flavoring agent consisting essentially of geranyl acetone and.delta.-decalactone in a ratio of 1:1 to 1:2 and is used in an amount of 0.5 to 9 ppm of.delta.-decalactone based on the soluble tea solids. Excerpt(s): This invention relates to the aromatising of beverages. More particularly, the invention is concerned with strengthening the aroma of tea in beverages based on tea. Instant teas are generally prepared by extracting black tea leaves followed by concentration and, if desired, drying. During these operations, however, a large part of the volatile substances responsible for flavour is lost. In some cases, they can be recovered by condensation and then re-incorporated in the tea extract. In most cases, however, the aforementioned volatile substances have undergone changes which make them unsuitable for re-incorporation. In cases such as these, it may be advisable to aromatise the extract with suitable compositions. British Patent Specification 1,306,017 describes certain compositions used as aroma strengtheners in tea for imparting a note of freshness. These compositions are mostly based on compounds whose presence in the aroma of tea is well known. In addition, they are frequently highly complex. The compositions are added to modify or restore tea flavor and aroma. Web site: http://www.delphion.com/details?pn=US04015024__
·
Aspirin-tea coprecipitates for treating inflammation Inventor(s): Lybrand; Robert Archie (Ashland, VA), Bell; Louis Gary (Richmond, VA) Assignee(s): A. H. Robins Company, Incorporated (Richmond, VA) Patent Number: 4,003,999 Date filed: May 8, 1975 Abstract: A novel coprecipitate of aspirin and tea is described. The coprecipitate is prepared by acidification of a solution of aspirin and tea. In vivo pharmacological evaluation of the coprecipitate shows that the therapeutic activity of aspirin has been retained and the side effects commonly associated with aspirin such as irritation of the gastric mucosa, bleeding and ulceration have been markedly reduced. Excerpt(s): The present invention relates to anti-inflammatory compositions and is more particularly concerned with certain coprecipitates of tea and aspirin which retain the anti-inflammatory activity of aspirin and prevent gastric irritation, bleeding and ulceration, therapeutic compositions containing said coprecipitates as active ingredients
Patents 327
and methods for the preparation of said coprecipitates. It has long been known that orally administered aspirin often causes gastric irritation and in some instances bleeding and ulceration in warm-blooded animals. Undispersed particles of aspirin may lodge in the folds of the stomach tissue or may adhere to the surface of tissue or there may be insufficient liquids to suspend the aspirin. These conditions may lead quickly to gastric lesions and bleeding. Aspirin may be particularly damaging to certain individuals who require large dosages and treatment for extended periods of time. Attempts to reduce gastric irritation have been made by combining aspirin with aluminum and magnesium adjuncts or by other buffering materials and the efficacy of such combinations has not been fully determined and is still the subject of medical debate. Reduced gastric irritation has been reported using aspirincaseinate by Feinblatt, T. M. and Ferguson, E. A., "Aspirin-Caseinate in Patients with Gastric Sensitivity to Plain Aspirin," New York State Journal of Medicine, Vol. 63 (19), Oct. 1, 1963, p2805-2807. Coprecipitates of lignosulfonate and anti-inflammatory compounds which have been shown to possess a high degree of anti-inflammatory activity and which prevent gastric irritation are the subject of copending application Ser. No. 459,828 filed Apr. 10, 1974, now abandoned which was a continuation-in-part application of copending application Ser. No. 271,986 filed July 14, 1972, now abandoned, which was a continuation-in-part of copending application Ser. No. 89,999, now abandoned. Web site: http://www.delphion.com/details?pn=US04003999__ ·
Banana flower tea Inventor(s): Ashikawa; James K. (320 Fernando Ave., Palo Alto, CA 94306) Assignee(s): none reported Patent Number: 6,180,160 Date filed: March 6, 2000 Abstract: A tea is made from the flowers of a banana plant from the genus Musa. Also described is the method of making a banana flower tea using steps including cutting, drying, and roasting under certain conditions. Excerpt(s): From the earliest time herbal plants have been used to treat and heal or comfort the sick. In recent years the medicinal value of herbs have been rediscovered. Even pharmaceutical companies have renewed their effort to search for potent new drugs in wild tropical plants. Today display shelves in supermarkets, major drug stores, and health food stores are filled with hundreds of natural or artificially enriched and flavored teas but nutritionally and healthwise none of these can equal banana blossom tea. Rich in vitamins, minerals, amino acids, and other essential nutrients, it is the world's most beneficial tea. It is naturally rich in potassium and magnesium, minerals that have been clinically proven to benefit the heart by reducing high blood pressure, heart attacks, and strokes. It is believed that banana flowers are also rich in antioxidants and tannins. Antioxidants are chemicals known to help prevent cancers and combat aging and tannins have been reported to prevent bladder and urinary tract infections in women. Interestingly, banana flower also contains nutrients that bees convert into royal jelly that are needed by bee colonies to survive. Endowed with these beneficial nutrients and disease fighting chemicals, Banana blossom tea is the greatest tea since the discovery of tea in China over 4000 years ago. Naturally caffein free, not artificially decaffeinated, this pleasant, mildly aromatic tea will complement any meal and is the perfect after dinner and bed time beverage. It is great for people of all ages, from children to senior citizens and is the tea naturally designed for people with glaucoma,
328 Tea
hypertension, hyperthyroidism, hypoglycemia, and other illnesses. It is truly the TEA OF THE NEW MILLENNIUM. South East Asians consider banana flowers a health food and to this day use the flowers to prepare tasty native cuisines. Banana flowers, however, have remained virtually unknown to people living in temperate regions of the world because banana is a tropical plant and, but for some ornamental varieties, does not thrive in cold climate. Web site: http://www.delphion.com/details?pn=US06180160__ ·
Beverage compositions containing green tea solids, electrolytes and carbohydrates to provide improved cellular hydration and drinkability Inventor(s): Kuznicki; James Thaddeus (Cincinnati, OH), Turner; Lana Sandman (Cincinnati, OH) Assignee(s): The Procter & Gamble Company (Cincinnati, OH) Patent Number: 5,681,569 Date filed: November 6, 1995 Abstract: This invention relates to a composition, preferably in the form of a beverage, whereby cellular hydration and drinkability are enhanced by the combination of green tea solids with selected levels and types of electrolytes and carbohydrates. The compositions comprise (a) from about 0.01% to about 0.35% flavanols; (b) from about 0.01% to about 0.3% sodium ions; (c) from about 0.005% to about 0.08% potassium ions; (d) from about 0.1% to about 20% of a carbohydrate which provides; (i) from about 0.05% to about 10.0% fructose; (ii) from about 0.05% to about 10.0% glucose; and (e) water. Excerpt(s): This invention relates to a composition, preferably in the form of a beverage, whereby cellular hydration and drinkability are enhanced by the combination of green tea solids with selected levels and types of electrolytes and carbohydrates. Moderate physical activity, prolonged exercise or working in hot, humid environments causes excessive loss of minerals and body fluids through perspiration and breathing. Physical activity, such as exercise, particularly in the heat, places a great metabolic demand on a human body. Heat generated during exercise is dissipated during sweating. Sweat which is lost from the body during exercise can produce a state of dehydration or hypohydration. Associated with dehydration is an impairment of the body's heat dissipation and performance capacity. It is well known that loss of water, electrolytes, and depletion of carbohydrates are the primary causes of fatigue which can impair work capacity. To maintain performance it is necessary to replace the lost water, electrolytes, carbohydrates and other nutrients. Web site: http://www.delphion.com/details?pn=US05681569__
·
Beverage intermediate and method for coextracting tea leaves and other vegetable material Inventor(s): Spisak; Martin John (Parlin, NJ), Lehmberg; Gregg Lance (Somerset, NJ) Assignee(s): Thomas J. Lipton Co., Division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,096,365 Date filed: November 22, 1995
Patents 329
Abstract: A process for the preparation of a black tea extract which includes blending black tea leaves with water which contains another acidic vegetable material, extracting at 70.degree. to 100.degree. F. for a time sufficient to achieve good contact of the tea leaves with the water, afterwards separating the aqueous extract from the solid material and clarifying the extract. The extract may then be used to prepare a final product having good acid stability, good clarity and good color over the shelf life of the product. Excerpt(s): The present invention relates to an improved process for the preparation of a soluble tea extract which when formulated into a finished beverage has improved acid stability, good clarity and consistent color over the shelf life of the product. During the production of tea extracts, certain substances are extracted from the tea leaves which are insoluble in cold water and result in a cloudy formation when the extract is added to cold water. Although these substances may be removed by cooling the hot aqueous tea extract to precipitate them, there is a loss of up to about 30% of the total tea solids if the precipitated portion is then discarded, thus leading to a substantial loss of normal flavoring and color components. In addition, selected vegetable components may be added to tea to produce various effects, taste and the like. In one instance hibiscus flower extract is added to improve clarity and in U.S. Pat. No. 4,357,361, hibiscus or other vegetable materials are employed to improve the solubility of the powder by first extracting the vegetable material and then using this extract in a further extraction of black tea. It has now been found that by employing a co-extraction of a blend of the tea leaves and selected vegetable material at the same time rather than in series that in addition to the improved solubility sought by the prior art, the beverage prepared from such co-extraction has better acid stability, is clearer and has a more stable color over the shelf life of the product. While not wishing to be bound thereby, It is theorized that the co-extraction with the hibiscus or indeed any acidic herb results in an extraction at relatively acid pH. When the resulting extract is polished acid insolubles are removed thus resulting is improved clarity and acid stability in the finished beverage. In addition, the pH of the co-extract is about 4.0 which reduces the risk of microorganism growth during processing. Web site: http://www.delphion.com/details?pn=US06096365__ ·
Black leaf tea Inventor(s): Humphrey; Philip Graham (Raunds, GB), Quinlan; Paul Thomas (Kempston, GB) Assignee(s): Lipton, Division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,036,991 Date filed: December 1, 1997 Abstract: A leaf tea especially blended from a black tea and a green tea so that it contains catechins and phenols in a ratio between 0.15 to 0.4, but preferably between 0.2 and 0.3. Such a product resembles black tea but typically possesses an antioxidant activity that is 10% or more higher than that the same mass of the black tea alone. The black tea is preferably low grown while the green tea is preferably from an Assam jat. Excerpt(s): The present invention relates to a leaf tea that looks and tastes like a black tea but contains an uncharacteristically high amount of catechins. Such a product can be made by blending a carefully selected combination of black and green teas. With the exception of water, tea is the most widely consumed of all beverages. In fact, the worldwide per capita consumption has been estimated at 0.1 litre per day. Most of the
330 Tea
tea consumed in the Western World is so called black tea which is obtained by harvesting new leaves of the plant Camellia sinensis and withering, rolling, enzymatically oxidizing, firing and sorting them. However the leaves can be processed without the oxidation step to produce what is known as green tea. Such tea is widely consumed in parts of the People's Republic of China, Japan, North Africa and the Middle East. In another variation oolong tea is prepared by partial oxidation. That is also commonly consumed in parts of the People's Republic of China. Web site: http://www.delphion.com/details?pn=US06036991__ ·
Black tea manufacture Inventor(s): Patil; Rajesh Hanamantagouda (Mumbai, IN), Raju; Krishnamurthy (Bangalore, IN), Virkar; Prakesh Dattatraya (Bangalore, IN) Assignee(s): Lipton, division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,348,224 Date filed: March 16, 2000 Abstract: A method for manufacturing black leaf tea. The method involves macerating freshly plucked tea leaves, treating the leaves with ammonium bicarbonate, fermenting the treated leaves, firing the leaves to arrest fermentation and then drying them to yield black leaf tea. Excerpt(s): The invention relates to a method of manufacturing black tea. More particularly, a modification of the standard method of black tea manufacture that provides a significant improvement in liquor quality. In the manufacture of black tea, young leaves usually 2-3 leaves and a bud are plucked and withered for about 12-24 hours to reduce moisture and to bring about desirable chemical/Biochemical changes. Withering process allows certain chemical and biochemical changes to occur and also the moisture content of the leaves is brought down from 90% to 50-70%. The tea leaves are then macerated using a Cut-tear-and curl machine (CTC machine) or rolled using rollers. This disrupts the cellular integrity of leaf tissues and allows oxidation of catechins by enzyme polyphenol oxidase which results in the development of colour pigments i.e. theaflavin and thearubigins. The macerated leaves are fermented for a suitable time and then fired at a high temperature to stop the enzyme activity. The taste of black tea is a result of the complex interaction, between the polyphenols, caffeine, theaflavins and thearubigins that occurs during the fermentation. This interaction also contributes to the brightness, briskness, colour, thickness and body of black tea. Web site: http://www.delphion.com/details?pn=US06348224__
·
Capsules containing freeze-dried, powdered green tea leaves Inventor(s): Rohdewald; Peter (Altenberge, DE) Assignee(s): Freeze Dry Foods, GmbH (Greven, DE) Patent Number: 5,993,867 Date filed: September 4, 1997 Abstract: The invention relates to a process for producing a preparation containing the polyphenols of green tea (Thea chinensis) in readily available, unoxidised form, in which fresh green tea leaves are cooled until the activity of the phenol oxidases therein
Patents 331
has dropped to at most 1% of the value at normal temperature and at the same time or immediately afterwards the water acting as the reaction medium is removed. Products made by this process are packed in capsules soluble in hot water. Excerpt(s): The present invention concerns a process for the production of a preparation which contains the polyphenols of green tea (Thea chinensis) in readily available, nonoxidised form, which is characterised in that one cools fresh green tea leaves until the activity of the contained phenol oxidases has decreased to at most 1% of the value at normal temperature and simultaneously or immediately thereafter the water effective as reaction medium is removed and products produced according to this process. It is known that unfermented (green) tea, besides the action as enjoyable material, also displays pharmacological properties which are suitable for the prevention of diseases in that, on the one hand, the anti-oxidative capacity of the human or animal organism is increased and, furthermore, the vascular system, especially the capillary system, is protected. The anti-oxidative properties of unfermented tea can be attributed to the ability of the polyphenols contained in the leaves of Thea chinensis, especially the gallocatechins, to inactivate free radicals. Summaries referring to this are to be found in Lit. 1 of the accompanying bibliography. Web site: http://www.delphion.com/details?pn=US05993867__ ·
Cinnamic acid for use in tea containing beverages Inventor(s): Cirigliano; Michael Charles (Cresskill, NJ), Franke; William Conrad (Cranbury, NJ), Kemly; Meghan Mary (Mahwah, NJ), McKenna; Raymond Thomas (Scotch Plains, NJ), Rothenberg; Paul John (New Milford, NJ) Assignee(s): Lipton, Division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,036,986 Date filed: October 28, 1997 Abstract: An aqueous based tea solids containing beverage is taught which also contains a sufficient amount of cinnamic acid its salts and esters as a flavoring/antimicrobial compound and employs a hurdle approach with selected levels of water hardness, polyphosphate, sequestrants, pH adjustment, benzoic acid and sorbic acid to prevent microbiological outgrowth while simultaneously contributing to the pleasant flavor of the beverage thus making the beverage acceptable both organoleptically and microbiologically. Excerpt(s): The present invention relates to the use of a natural or synthetically prepared flavorant material which also acts as an antimicrobial in aqueous based beverages containing tea solids. This material is trans cinnamic acid as well as its salts and esters. Acidified and native pH ready-to-drink (RTD) tea beverages, in the 2.5-6.5 pH range regardless of packaging are known to be susceptible to spoilage. As compared to cans, tea beverages packaged in glass and plastic bottles (because of increased O.sub.2 ingress), as well as tea beverages at the higher range of the pH spectrum, are even more sensitive to yeast and mold spoilage than canned teas. There are many different processes for preparing and packaging or bottling ready-to-drink (RTD) teas. For example, in one process the bottles can all be sterilized and the tea beverage first pasteurized and then bottled at high temperature. Each of these high temperature treatments requires a large capital investment for equipment and if there were many different bottling plants the costs of equipping each of these multiple plants with such high temperature equipment would be prohibitive if not impossible to justify.
332 Tea
Web site: http://www.delphion.com/details?pn=US06036986__ ·
Cold soluble powdered tea extracts Inventor(s): Lunder; Tito-Livio (Lausanne, CH), Nielsen; Corine-Madeleine (Lausanne, CH) Assignee(s): Societe d'Assistance Technique pour Produits Nestle S.A. (Lausanne, CH) Patent Number: 4,440,796 Date filed: July 9, 1982 Abstract: A process for the production of a cold soluble powdered tea extract wherein a hot soluble powdered tea extract is treated with a mixture of from 25% to 65% by weight of a carboxylic acid and from 15% to 65% by weight of a carboxylic acid salt based on the weight of the hot soluble powdered tea extract and ground to the desired particle size. Excerpt(s): The present invention relates to the production of a cold-soluble powdered tea extract. The traditional methods of producing instant tea, which usually consist of the steps of extraction, aroma processing, dehazing and drying, do not give cold soluble powders. The achievement of cold-water solubility necessitates some additional processing of the extracted tea which contains a considerable amount of cold-water insoluble material formed by tea cream and polymers of polyphenols. This additional processing involves the solubilisation of the tea cream by chemicals or enzymes which is both time and energy consuming. We have now found that a cold soluble tea powder may be prepared by a very simple treatment of traditional hot soluble powdered tea extract with a carboxylic acid and salt thereof, wherein a tea cream solubilisation step is unnecessary, thus economising on both time and energy. In this invention "hot soluble powdered tea extract" means a powdered tea extract prepared by traditional methods which is soluble in hot water but not in cold water; it is also to be understood that the carboxylic acids and the carboxylic acid salts are food-grade. Web site: http://www.delphion.com/details?pn=US04440796__
·
Cold soluble tea Inventor(s): Lunder; Tito L. (Lausanne, CH), Nielsen; Corine M. (Lausanne, CH) Assignee(s): Nestec S.A. (Vevey, CH) Patent Number: 4,552,769 Date filed: April 1, 1985 Abstract: A process for preparing a powdered tea extract characterized in that black tea leaves are extracted with hot water to give a first extract which is separated from the tea leaves, concentrated to a solids content of from 5% to 12.5%, and then cooled to a temperature from 5.degree. C. to 15.degree. C. to form an insoluble cream which is separated from the concentrated first extract and then extracted with water at a temperature of from 40.degree. C. to 70.degree. C. to give a second extract which is separated from the remaining insoluble cream, after which the first and second extracts are mixed and dried. Excerpt(s): The present invention relates to a process for the production of a cold soluble tea product and more particularly to the production of a powdered tea extract which is
Patents 333
readily and completely soluble in cold water. The traditional methods of producing instant tea, which usually consist of the steps of hot-water extraction, aroma processing, dehazing and drying, do not give cold soluble powders. For example, black tea extracts, and especially instant black tea, when made to beverage concentration become turbid if the beverage is allowed to cool to room temperature or below. This turbidity is caused by a precipitate of a complex between caffeine and polyphenols which in the trade is normally referred to as "tea cream". This tea cream which is extracted by the hot-water is insoluble in cold-water and the achievement of cold-water solubility usually necessitates some additional processing of the extracted tea. This additional processing may involve simply cooling the hot aqueous tea extract to precipitate the cold-water insoluble tea cream and discarding it, or it may involve the solubilisation of the cold-water insoluble tea cream by chemicals or enzymes. However, in the former method, discarding all the precipitated tea cream results in discarding disproportionately large amounts of tea solids (up to 25%) including tannins, the black tea colour and the physiologically active principle of tea, namely, caffeine. In the latter method the reconstituted beverage is very foamy and has exceedingly poor stability, palatability and drinking properties. At the present time, there is a desire to produce completely natural tea extracts i.e. tea extracts which are prepared without the addition of any chemicals. For instance, it has been proposed to extract the tea leaves with cold, rather than with hot water in order to achieve cold-water solubility. Although the cold-water insoluble teacream is not extracted during cold-water extraction and the reconstituted beverage is substantially cold-water soluble, the yield is very low. Web site: http://www.delphion.com/details?pn=US04552769__ ·
Cold water extractable tea leaf and process Inventor(s): Sanderson; Gary Warner (Englewood, NJ), Hoefler; Andrew Charles (Cresskill, NJ), Graham; Harold Nathaniel (Englewood, NJ), Coggon; Philip (Orangeburg, NY) Assignee(s): Thomas J. Lipton, Inc. (Englewood Cliffs, NJ) Patent Number: 4,051,264 Date filed: November 16, 1976 Abstract: Cold water extractable tea leaf is prepared by treatment of fresh green tea with the enzyme tannase under anaerobic conditions. The cold water extractable tea leaf is also used to prepare an instant tea product. Excerpt(s): The present invention relates to a process for obtaining cold water extractable tea leaf and to the improved products thereby obtained. In particular, the invention relates to a method of treating fresh green tea leaf with the enzyme tannase to produce dry tea leaf, green, black or oolong, which is cold water extractable, and which has a full complement of the tea flavor associated with the corresponding prior art processes. Black tea is usually prepared by subjecting freshly picked tea leaves to a series of processing conditions including the withering and rolling of freshly harvested leaves, followed by a fermentation step (enzymatic oxidation) during which much of the characteristic color, flavor and aroma of black tea are developed. The fermentation is stopped after a suitable period of time by "firing" (drying at temperatures ranging from about 65.degree. C to about 100.degree. C) the tea to inactivate the enzymes causing the fermentation and to complete the development of the flavor and color of the tea product. The extent of fermentation varies, in commercial practice, from black to various gradations between green and black. Partially fermented teas are known as "oolong"
334 Tea
teas. Green teas are made by firing green tea before fermentation has taken place. The green, oolong, and black teas of commerce each provide a beverage having distinctive flavor and color characteristics. When conventional teas are extracted with cold water for short periods of time (less than 15 minutes), the tea beverage produced has a low concentration of extractable tea solids, a very light color and almost no tea-like taste. Water at temperatures of about 100.degree. C is usually employed to obtain a satisfactory beverage with prior art tea leaves. Web site: http://www.delphion.com/details?pn=US04051264__ ·
Cold water infusing leaf tea Inventor(s): Goodsall; Christopher William (Bedford, GB), Jones; Timothy Graham (Bedford, GB), Mitei; Joseph Kipsiele (Kericho, KE), Parry; Andrew David (Bedford, GB), Safford; Richard (Bedford, GB), Thiru; Ambalavanar (Bedford, GB) Assignee(s): Lipton, division of Conopco, Inc. (Englewood Cliffe, NJ) Patent Number: 6,482,450 Date filed: February 7, 2000 Abstract: A method for preparing a cold water infusing leaf tea. Green tea leaves are macerated, treated with tannase, fermented in the presence of hydrogen peroxide in an amount that is sufficient to activate endogenous peroxidases to oxidise gallic acid and other compounds that are liberated by the tannase treatment, and then dried. The final product is a black leaf tea that infuses in hot or cold water to give good flavour and colour. Excerpt(s): The present invention relates to a method for manufacturing cold water infusing leaf tea. The method involves fermenting tannase pre-treated dhool (macerated tea leaves) under solid-state conditions in the presence of hydrogen peroxide. The dried leaf product infuses in cold water to give good flavour and colour. Black leaf tea is traditionally produced by oxidising and drying freshly plucked green tea leaves. Tea, the beverage, is generally prepared in Commonwealth countries by brewing these tea leaves in freshly boiled water for a few minutes and adding milk, and perhaps a little sugar. However in some countries, notably the United States (or more accurately, parts thereof) tea is more commonly enjoyed as an iced beverage. Such a beverage cannot be prepared conveniently by infusing traditionally manufactured tea leaves in cold water. Instead, Americans either infuse the leaves in hot water, remove the leaves and place the infusion in a refrigerator until it is ready to consume or place tea leaves in cold water in sunlight to infuse slowly over a period of hours. Web site: http://www.delphion.com/details?pn=US06482450__
·
Cold water soluble tea Inventor(s): Ganesan; Velu (District Tinsukia, IN), Ganguli; Shovan (Bangalore, IN), Garg; Kush (District Tinsukia, IN), Patel; Mushtaq (Karlsruhe, DE), Sinkar; Vilas Pandurang (Bangalore, IN), Subramanian; Narayasaswami (Bangalore, IN) Assignee(s): Lipton, division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,589,575 Date filed: March 22, 2001
Patents 335
Abstract: A process for manufacturing a black leaf tea that is infusible in hot or cold water. The process involves macerating freshly plucked tea leaves, allowing them to ferment, firing the leaves to arrest fermentation and then drying them to yield black leaf tea, wherein the tea leaves are treated with a solubilising compound selected ascorbic acid, dehydroascorbic acid, 1-scorbamic acid, 5-phenyl-3,4-diketo-gamma-butyrolactone (4-phenyl-2,3-diketo-gamma-butyrolactone) or their salts and mixtures thereof in an amount that is sufficient for the black leaf tea to be soluble in water at 5 to 100.degree. C. Excerpt(s): This invention relates to a process for obtaining cold water infusible or extractable tea and to the products obtained thereby that have good colour and flavour. Leaf tea may be prepared as green leaf tea or black leaf tea. Generally, to prepare black leaf tea fresh green leaves of the plant Camellia sinensis are withered (subjected to mild drying), comminuted, fermented (in which process enzymes in the tea leaf use atmospheric oxygen to oxidise various substrates to produce brown-coloured products) and then fired (to dry the tea leaves). Green leaf tea is not exposed to the fermentation process. Partial fermentation may be used to produce intermediate-type teas known as "oolong" tea. Tea is consumed as a hot beverage or a cold beverage such as iced tea. The numerous compounds in the leaves that give the beverage its unique organoleptical properties are only sparingly soluble in cold water so tea is usually infused in water at temperatures close to 100.degree. C. When iced tea is desired the tea is infused in water at about 100.degree. C. and then chilled in a refrigerator for example until it is cold. Unfortunately this can take several hours. Web site: http://www.delphion.com/details?pn=US06589575__ ·
Color and shelf stable beverage compositions containing tea extract Inventor(s): Kirksey; Sanford Theodore (Cincinnati, OH), Ekanayake; Athula (Cincinnati, OH), Pultinas, Jr. Edmund Paul (Cincinnati, OH), Jones; Judith Ann (Cleves, OH), Stradling, Jr. Richard Fiske (Cincinnati, OH) Assignee(s): The Procter & Gamble Company (Cincinnati, OH) Patent Number: 5,780,086 Date filed: January 3, 1996 Abstract: The present invention relates to color and shelf stable beverage compositions comprising:a) from about 0.4% to about 1.5% tea extract wherein the level of caffeine is from about 0.85% to about 3.2%; and the tea solids content is from about 12% to about 60%;b) from about 10 ppm to about 40 ppm colorant;c) from about 300 ppm to about 1500 ppm erythorbic acid or ascorbic acid;d) from about 0.5% to about 8.0% citric acid;e) an effective amount of sweetener; andf) water; andwherein the tea extract contains unoxidized flavanols. Excerpt(s): The present invention relates to shelf stable beverages containing tea extract, colorant and/or juice. The beverages have the characteristics of the added color and resist browning and precipitation common in tea containing beverages. Recent increases in sales and consumption of tea beverages have substantially increased the number of entrants of ready-to-drink tea containing products into the market. At the present time, many tea containing beverages are sold in the form of bottled, canned or carton-boxed products. Many of the beverages contain black tea extract with fruit juice, fruit aroma or fruit flavors, while others contain only tea flavors. Few products contain green tea extract due to the instability of the unoxidized flavanols and their astringent flavor. Yet green tea is believed to have therapeutic benefits. In commercially available beverages,
336 Tea
such as Snapple (Sunset Foods) and Fruit Tea Twister (Tropicana) the tea flavor (i.e. green grassy, woody notes) and astringency often overpower the fruit flavor. Another apparent disadvantage is the appearance. The product color is typically limited to the color of the tea extract (i.e. brown, muddy). Still another disadvantage is that the published health benefits of the unoxidized flavanols (green tea solids) are not realized by the consumer because black tea which contain polymerized flavanols or tea flavors are typically used in these beverages. Web site: http://www.delphion.com/details?pn=US05780086__ ·
Complex of tea-leaf extract and active aluminum hydroxide Inventor(s): Hara; Yukihiko (Shizuoka, JP), Asai; Hajime (Nagoya, JP), Kitamikado; Tadashi (Inuyama, JP), Yamamoto; Hajimu (Nagoya, JP), Okushio; Kazuo (Shizuoka, JP), Nakamura; Kozo (Tokyo, JP) Assignee(s): Mitsui Norin Co., Ltd. (Tokyo, JP) Patent Number: 4,913,909 Date filed: October 2, 1986 Abstract: Extract of tea leaves or (-)-epigallocatechin gallate as the principal ingredient of the extract forms a complex with active aluminum hydroxide. The animal test using rats has established that these complexes have therapeutic effect for gastric ulcers, e.g. pylorus-ligated ulcer and indomethacin-induced ulcer, when orally administered. Tests were also undertaken for the effect on the secretion of gastric juice and acute toxicity of these complexes using rats and mice as the test animals. Excerpt(s): The present invention relates to a complex of tea-leaf extract, of which the principal ingredient is (-)-epigallocatechin gallate, referred to as EGCg hereinbelow, and active aluminum hydroxide or a complex of the EGCg per se and active aluminum hydroxide. The complex of the present invention has excellent antiulcer activity, antipeptic activity and antacid activity so that it is useful as a therapeutic medicine for digestive ulcers. The complex of the present invention is a novel material not known in the prior art. The inventors have previously undertaken extensive investigations on an industrial method for the preparation of tealeaf extract containing EGCg as the principal ingredient, which is one of the starting materials for the preparation of the inventive complex, and the results are disclosed in Japanese Patent Kokai No. 59-219384 (See also U.S. Pat. No. 4,673,530). They further have continued investigations on a method for the fractionation of catechin compounds from the tea-leaf extract and the results are disclosed in Japanese Patent Kokai No. 60-13780 (See also U.S. Pat. No. 4,613,672). Web site: http://www.delphion.com/details?pn=US04913909__
·
Composition and process for producing thickened coffee, tea or cocoa beverages Inventor(s): Meister; Jeffery D. (Plymouth, MN), O'Connor; Donna Jean (Maple Grove, MN) Assignee(s): Novartis Nutrition AG (Bern, CH) Patent Number: 6,586,034 Date filed: December 6, 2001
Patents 337
Abstract: An improved thickened instant coffee beverage mix, comprising a mix of from about 15-90%, preferably 27%, maltodextrin with the rest, to 100%, of an agglomerated starch, and also 0.05-2.0% of mono- and di-glycerides or other wetting agents such as propylene glycol, glycerin, sorbitan monosterate and other emulsifiers, including 0.0510.0% vegetable oils, together with coffee flavorants, which can be quickly dissolved in water of at least 120.degree. F. water without delay or forming clumps; and an improved thickened instant tea or cocoa beverage mix which can be quickly dissolved in water of at least 120.degree. F. water without delay or forming clumps, comprising 1250% agglomerated starch as the thickening agent, together with sugar and protein components. Excerpt(s): The present invention relates generally to compositions which when mixed with hot water, yield thickened coffee, tea or cocoa beverages, and to the process for obtaining such compositions. Thickened beverages are used by patients in long term health care facilities and hospitals to address a swallowing condition known as dysphasia. It has been known that patients with swallowing problems are capable of handling thickened beverages. Because of the nature of this condition, it is important that the patient receive a product that is smooth textured and free of lumps. The degree of thickening needed is determined by the severity of the swallowing condition. Therefore, the beverage must also be consistent in terms of thickness from use to use. In recent years many new products have been introduced to address this need. These have included dry mixes, in which a starch is spooned into a liquid and mixed, as well as ready to serve thickened drinks. While the powered products have worked acceptably well in cold beverages, they have been unsuccessful in hot applications. Currently, agglomerated pre-gelatinized starches are sold in the health care market for use as thickeners for beverages, either hot or cold beverages. Standard pre-gelatinized starches are generally difficult to mix into liquids. The process of agglomeration is a common technique used to improve the instantness of dry powders and mixes. The process involves, essentially, the sticking together of fine powder to form a bigger particle. In doing so, this product will have a lower bulk density and disperse more easily into liquids. Web site: http://www.delphion.com/details?pn=US06586034__ ·
Composition and process for the production of a mixture for a tea drink with fruit flavour Inventor(s): Greither; Otto (Bruckmuhl, DE), Brunner; Peter (Bruckmuhl, DE) Assignee(s): Salus-Haus Dr. Med. Otto Greither Inhaber Otto Greither (Bruchkmuhl, DE) Patent Number: 4,851,252 Date filed: June 11, 1987 Abstract: The present invention provides a process for the production of a mixture for a tea drink with fruit flavour, wherein a fruit concentrate is mixed with a powder of plant parts, the fruit concentrate is dried and the dried fruit concentrate is subsequently mixed with dried plant parts. Excerpt(s): The present invention is concerned with a process for the production of a mixture for a tea drink with a fruit flavour, as well as a tea mixture thereby produced and the use thereof. Tea mixtures with a fruit flavour are very favoured for the preparation of an infusion drink with an aromatic flavour. For this purpose, there are
338 Tea
prepared, on the one hand, black tea mixtures which have a fruit aroma and, on the other hand, herbal teas which are prepared from parts of various plants. Furthermore, for the quick perparation of tea with a fruit flavour, instant tea drinks are also commercially available. These instant tea drinks consist of dried extracts of individual herbs or fruits or mixtures of various herbs or fruits and known carrier materials, such as sugar, milk sugar, maltodextrins and the like. Furthermore, instant teas can contain ethereal oils and aroma materials for aromatisation. A disadvantage of the known aromatised tea mixtures is that, on the one hand, the palette of flavour types is limited and, on the other hand, in the case of adding aroma materials, the complete aroma of the fruit in question cannot be produced since the aroma materials mostly only consist of one or of a few main components of a fruit aroma of complex composition. Web site: http://www.delphion.com/details?pn=US04851252__ ·
Composition containing grass plant, water-soluble dietary fibers, oligosaccharides, lactic acid bacteria and green tea Inventor(s): Tsusaki; Shinji (Fukuoka, JP), Takagaki; Kinya (Fukuoka, JP) Assignee(s): Toyo Shinyaku Co., Ltd. (JP) Patent Number: 6,423,309 Date filed: April 10, 2001 Abstract: A processed food excellent for activating superoxidase dismutase is disclosed. The food contains 30 to 70% by weight of barley, wheat, rye or oats; 1 to 50% by weight of water soluble dietary fibers; 1 to 10% by weight of oligosaccharides; 0.5 to 5% by weight of powdered lactic acid bacteria and 5 to 15% by weight of powdered green tea. A method of making the food and a method for activating superoxide dismutase using the food is also disclosed. Excerpt(s): The present invention relates to processed food that is excellent in activating superoxide dismutase (hereinafter, referred to as SOD). Young leaves of grass plants such as barley are rich in vitamins, minerals and dietary fibers, and are attracting attention as a material having the effects of adsorption of harmful substances, improvement of the intestinal environment, suppression of the absorption of cholesterol, prevention of a rapid increase in the blood glucose level after eating, etc. On the other hand, in recent years, there have been an increasing number of reports that free radicals such as active oxygen cause a large number of diseases such as hypertension, cerebral stroke, myocardial infarction, pneumosclerosis, hepatitis, nephritis, atopic dermatitis, Parkinson's disease, cataracts, gout, pulmonary emphysema, dermatitis, gastritis, pneumonia, arthritis, stenocardia, senility, rheumatics, and arteriosclerosis. For example, it is known that when excessive active oxygen is present, normal cells are damaged and become cancer cells. At present, how to reduce such active oxygen is a serious issue to maintain our health. Web site: http://www.delphion.com/details?pn=US06423309__
Patents 339
·
Concentrated tea extract Inventor(s): Hoogstad; Bruin (Bedford, GB) Assignee(s): Thomas J. Lipton, Inc. (Englewood Cliffs, NJ) Patent Number: 5,198,259 Date filed: February 16, 1989 Abstract: The present invention relates to a process for the preparation of a concentrated tea extract comprising the steps of:(a) extracting tea-leaves with water having a temperature between 15.degree. and 50.degree. C. and separating the first extract from the tea-leaves;(b) extracting tea-leaves which have previously been extracted with water between 15.degree. and 50.degree. C. for a second time, with water having a temperature of more than 50.degree. C. and separating the second extract from the tealeaves;(c) concentrating said first extract to obtain a first concentrate;(d) concentrating said second extract to obtain a second concentrate; and(e) combining said first and second concentrate,wherein said first extract is concentrated by subjecting it to reverse osmosis at a temperature between 20.degree. and 50.degree. C. and said second extract is concentrated between 50.degree. and 100.degree. C. Excerpt(s): The present invention relates to a process for the preparation of a concentrated tea extract. Concentrated tea extracts are commonly used as a base for the preparation of instant tea. A well-known method to prepare instant tea involves the freeze-drying of a frozen concentrated tea extract as described in EP 133 772. The preparation of a concentrated tea extract usually involves an extraction step, wherein tea-leaves are extracted with water, followed by a concentration step wherein the solids content of the extract is increased. Web site: http://www.delphion.com/details?pn=US05198259__
·
Cosmetic sunscreen composition containing green tea and a sunscreen Inventor(s): McCook; John P. (Guilford, CT), Meyers; Alan J. (Trumbull, CT), Dobkowski; Brian J. (Milford, CT), Burger; Allan R. (Passaic, NJ) Assignee(s): Elizabeth Arden Co., Division of Conopco, Inc. (New York, NY) Patent Number: 5,306,486 Date filed: March 1, 1993 Abstract: A cosmetic composition is provided which includes green tea and a sunscreen compound which is effective to at least partially block ultraviolet radiation from harming human skin, and a pharmaceutically acceptable carrier. Excerpt(s): The invention concerns a cosmetic composition with an improved sunblock system. A tan long has been considered physically attractive and a status symbol. Especially in northern climates, a winter tan advertises the wearer as a person recently returned from a glorious vacation. Tans are also associated with sufficient leisure time and identifying the person as sports oriented. Unfortunately, recent studies have shown that sunlight can have significant adverse medical effects. Premature skin aging and even cancer have been implicated with exposure to sunlight. These concerns have been heightened by evidence that the earth's ozone layer has suffered severe depletion in recent years. Ozone is recognized as the stratospheric component shielding against the harmful forms of ultraviolet radiation.
340 Tea
Web site: http://www.delphion.com/details?pn=US05306486__ ·
Decaffeinating coffee and tea Inventor(s): Theissing; Peter (Dortmund, DE), Saamer; Peter (Iserlohn-Hennen, DE), Korner; Jorg-Peter (Hagen, DE) Assignee(s): Uhde GmbH (Dortmund, DE) Patent Number: 5,153,015 Date filed: December 31, 1991 Abstract: A process and apparatus for extracting ingredient substances from natural products by means of a pressurized fluid, particularly for decaffeinating tea leaves by means of carbon dioxide, wherein the ingredient substances are bound by an adsorbent, preferably activated carbon. The fluid is conducted through a product layer, the thickness of which in flow direction is small in comparision with that transversely of the flow direction and the fluid is passed through the product layer with changing, especially increasing, velocity. The apparatus includes a cylindrical high-pressure vessel with annular cylindrical baskets for accommodating the natural product and/or the adsorbent, and the gas flows from a cylindrical outer range to a cylindrical inner range. The time required for the treatment of leafy natural product is reduced, the flow paths of the fluid are shortened, thus diminishing the risk of clogging, and the fluid flow velocity is reduced. Excerpt(s): The invention relates to a process and apparatus for extracting ingredient substances from natural products by means of a pressure fluid, particularly for decaffeinating tea leaves by means of carbon dioxide, wherein the ingredient substances are bound by an adsorbent, preferably activated carbon. It is known to introduce, e.g., tea leaves in a high-pressure vessel through which pressurized carbon dioxide is conducted in axial direction. The effluent carbon dioxide is fed to a separate adsorber for binding the caffeine. Furthermore, it is known to recycle the carbon dioxide for this purpose. The known procedure involves considerable disadvantages. Thus, very slender and long vessels have to be used for stability reasons which results in enormous dumping heights. This, in turn, leads to extended extraction times because the carbon dioxide flow velocity has to be low. In such an arrangement, the first tea leaf layers in flow direction remain exposed to the carbon dioxide flow even when the caffeine has already been extracted. However, the process must be continued until the last tea leaf layers in flow direction have been treated. By the time this has happened, the carbon dioxide has also extracted the aroma from all the preceding layers. Web site: http://www.delphion.com/details?pn=US05153015__
·
Density control system for tea packaging apparatus Inventor(s): Hazelwood; Geoffrey (New Farnley, GB2) Assignee(s): Baker Perkins Holdings Limited (Peterborough, GB2) Patent Number: 4,404,787 Date filed: February 20, 1981 Abstract: A machine for packaging tea includes a rotary dispensing drum having rows of circumferentially spaced pockets into which tea flows by gravity through outlets at
Patents 341
the bottom of a hopper. The tea is deposited in piles from the pockets on a web of packaging material which travels in contact with the periphery of the drum. The portion of the hopper containing the outlets is movable in relation to the drum so as to vary the effective area of the outlets and therefore the size of the deposited piles of tea. Excerpt(s): This invention relates to machines for packaging free flowing solid materials, such for example as tea, of the type comprising a rotary dispensing drum having in its periphery a row of circumferentially spaced pockets, a feed hopper to contain the material to be packaged which is disposed above the drum and has an outlet at its lower end through which the material flows by gravity into successive pockets in the drum as the drum rotates, means for feeding a lower web of packaging material into contact with the periphery of the drum so that it covers the filled pockets and leaves the bottom of the drum in a substantially horizontal run carrying spaced piles of material deposited on the web from successive pockets in the drum, and means for superposing an upper web of packaging material on the lower web to cover the piles of material and sealing the webs together around the perimeter of each pile. During a production run of such a machine for producing tea bags there are inevitably changes during the run in the density of the tea being packaged. Since the weight of tea in the bags must remain constant this necessitates a compensating adjustment of the machine while it is running. Hitherto such adjustment has been by means of plungers which are movable in unison into and out of the pockets to vary the volume of the pockets by an adjustment made by the machine operator whenever check weighing of the bags shows that such adjustment is necessary. Web site: http://www.delphion.com/details?pn=US04404787__ ·
Deodorizing composition containing tea tree and eucalyptus oils Inventor(s): Kling; Kimberly Mark (Norton Shores, MI), Kling; Edward Albert (Norton Shores, MI) Assignee(s): D.S.C. Products, Inc. (Muskegon, MI) Patent Number: 6,019,963 Date filed: November 20, 1998 Abstract: A deodorizing dispersion effective for reducing the odor intensity of an odorous material, the dispersion including effective amounts of tea tree oil and eucalyptus oil, preferably dispersed in an aqueous carrier phase. The dispersion optionally includes dispersing agents, such as thickeners, surfactants, and solvents, to promote the stability and uniformity of the dispersion and provide cleaning and detergency attributes. Excerpt(s): The present invention relates to deodorizing dispersions, and more particularly, to deodorizing dispersions incorporating tea tree and eucalyptus oils. Materials can take on an offensive odor under several circumstances. For example, a carpet that has been exposed to water from storm, flood, overflow, or pipe breakage will smell of the mold and mildew that subsequently form in the carpet. Also, a fabric or carpet can smell of urine and feces deposited by a pest or household pet. The growth of microorganisms associated with such deposits or floods can contribute significantly to the foul smell. Further, entire contents of fire-damaged buildings may retain the strong smell of smoke. Neuman Industries, Inc. supplies a deodorizing composition under the NC 2000 trademark. The NC 2000 contains an unspecified amount of eucalyptus oil; the
342 Tea
other components are not disclosed. The NC 2000 product has been applied as a fine mist in the air to deodorize pig farms. Web site: http://www.delphion.com/details?pn=US06019963__ ·
Device for the production of aroma extracts from coffee or tea Inventor(s): Chan; Kwan W. (West Point, HK) Assignee(s): Melitta-Werke Bentz & Sohn (Minden, DE) Patent Number: 4,898,090 Date filed: November 3, 1988 Abstract: An improved apparatus for the production of aromatic extracts from coffee or tea is of the type having a filter vessel and a collecting container, wherein the filter vessel has a plurality of detent lugs which are received within detent recesses disposed in an upper rim portion of the collecting container for detachable engagement therewith. This construction results in the secure connection of the filter vessel atop the collecting container, for preventing accidental detachment of the filter vessel while permitting intentional detachment of the filter vessel by proper manipulation of a handle portion of the filter vessel to disengage the detent lugs. Excerpt(s): The present invention relates to a device for the production of aroma extracts from coffee or tea, which includes a filter vessel for receiving the ground coffee or tea for producing a filtrate liquid, and a collecting container for the filtrate, wherein the filter vessel can be placed on top of the collecting container. This type of device is needed for performing manual filtering operations as well as for machines for making coffee and tea. The ground coffee or tea is placed in the filter vessel which usually accommodates a paper filter therein. Then hot water is introduced into the filter vessel. By contacting the ground coffee or tea, the hot water extracts aromatics therefrom, the filtrate then flowing into the collecting container disposed beneath the filter vessel. For performing manual filter operations, the filter vessel is manually placed atop the collecting container. Further, constructions for coffee and tea machines are known in which the filter vessel is fixedly connected to the housing of the coffee or tea machine. Web site: http://www.delphion.com/details?pn=US04898090__
·
Effervescent green tea extract formulation Inventor(s): Xiong; Weihong (Salt Lake City, UT), Quan; Danyi (Salt Lake City, UT), Patel; Dinesh C. (Salt Lake City, UT) Assignee(s): XEL Herbaceuticals, Inc. (Salt Lake City, UT) Patent Number: 6,299,925 Date filed: June 29, 1999 Abstract: A solid state water soluble formulation in granular or tablet form is provided. The formulation is a natural products formulation containing a green tea plant extract in combination with other ingredients which create an effervescent liquid composition upon dispensing the formulation in a liquid. The liquid form of administration, as well as the effervescent properties of the dissolved formulation increase bioavailability of the advantageous components of the green tea plants such as Polyphenols, by increasing absorption speed and amount in the human body. The formulation may include
Patents 343
additional components such as, other plant extracts, vitamins, ionic minerals, and other substances purported to be of a health benefit. Excerpt(s): The present invention relates generally to a green tea extract formulation which maximizes release and delivery of a therapeutic extract contained therein to the human body. More particularly, it concerns an effervescent tablet containing a green tea extract which is dispensed in a liquid for consumption. Nearly 4,000 years ago, the people of the far east recognized many general health and refreshment benefits from the consumption of green tea. Such recognition has led to a wide spread use of tea which has even gained cultural status and significance in many areas of the world. However, the specific health benefits of green tea consumption have been little understood until recently. Today, scientific evidence has linked certain positive health effects, including anti-cancer and anti-heart disease effects, to various components of green tea. Specifically, positive effects in fending off cancer, heart disease, and other health benefits come from the green tea components of Catechins polyphenols, Polysaccharides, Flavonoids, Vitamin B complex, Vitamin C, Vitamin E, r-Amino Butyric Acid, and Fluoride. Polyphenols, otherwise known as catechins, and particularly epigallocatechin gallate (EGCG) have shown anti-microbial, anti-mutagenic, and anticarcinogenic effects when administered in significant doses. Web site: http://www.delphion.com/details?pn=US06299925__ ·
Enzymatic clarification of tea extracts Inventor(s): Agbo; Francis (Warwick, NY), Spradlin; Joseph E. (Monroe, NY) Assignee(s): Kraft Foods, Inc. (Northfield, IL) Patent Number: 5,445,836 Date filed: May 12, 1994 Abstract: A process for producing a tea extract which forms little or no haze when stored at refrigeration temperatures. The process comprises incubating a mixture of oxidase, tannase and tea extract, and then separating insoluble solids from the tea extract. The tea extract is preferably a concentrate which is subsequently diluted to provide a ready-to-drink beverage. Haze which develops on cold storage of the extract or of tea beverages prepared from the extract is significantly reduced. Excerpt(s): The present invention relates to a method of producing a tea beverage and, more particularly, to the enzymatic treatment of a tea extract with oxidase and tannase to produce tea extract which forms little or no haze when stored at refrigeration temperatures, and to tea extracts so produced. Instant tea beverages are typically available to consumers as a canned or bottled, single-strength beverage ready for consumption or as a concentrate which is diluted with water to form a drinkable tea beverage. Tea extracts are prepared commercially by extraction of the leaves with water at elevated temperature and then separating the aqueous tea extract, usally a concentrate, from the leaves. The separated tea extract contains both soluble and insoluble tea solids and must undergo a series of additional processing steps to reduce the amount of insoluble solids. Conventional methods of removing insoluble tea solids are known as decreaming processes and utilize adjustments in process variables, such as temperature, to cause precipitation of the insoluble tea solids, followed by centrifugation, filtration or other equivalent techniques to remove precipitate complexes. Conventional decreaming processes are described in Takino, U.S. Pat. No. 3,959,497, which relates to the use of tannase to provide a decreamed tea concentrate
344 Tea
which provides a tea of improved astringency and color without turbidity. Takino notes that cream solids removed by conventional decreaming contain desirable tea color and astringency. Takino treats the cream solids with tannase to recover tea color and astringency. Takino discloses treatment of the tea extract either prior to or after centrifugation to remove the cream and also disclose treatment of the separated cream. Web site: http://www.delphion.com/details?pn=US05445836__ ·
Enzymatic method for production of instant tea Inventor(s): Petersen; Bent R. (Copenhagen, DK) Assignee(s): Novo Industri A/S (DK) Patent Number: 4,483,876 Date filed: May 3, 1983 Abstract: Enzymatic method for production of instant tea, comprising treating tea leaves with an SPS-ase preparation, whereby the extract yield is improved, and instant tea made with the extract exhibits superior clarity. Excerpt(s): This invention relates to the production of instant teas, especially cold water soluble instant teas. Instant tea production is described in World Coffee & Tea, April 1972, Pp. 54-57. The feasibility and economy of instant tea products are very dependent on the extract yield. The prior art has suggested improving yield of instant tea by subjecting the tea leaves to an enzyme treatment with conventional pectinases, cellulases, amylases, and proteases, reference being made to DT 2229401, SU 683709, GB 1459529, and JA 7110919. However, relatively low extract yields are obtained. Now surprisingly, it has been found that the extract yield of instant tea can be dramatically improved, if the tea leaves are treated with an SPS-ase containing enzyme preparation. Web site: http://www.delphion.com/details?pn=US04483876__
·
Enzymatic solubilization of tea cream Inventor(s): Takino; Yoshinori (Tokyo, JA) Assignee(s): The Coca-Cola Co. (Atlanta, GA) Patent Number: 3,959,497 Date filed: July 30, 1970 Abstract: A cold water-soluble tea concentrate or tea powder that when reconstituted gives a tea of improved astringency and color without turbidity is produced from tea extracts, and preferably black tea extracts, by treating the tea extract or tea cream with appropriate enzymes. Excerpt(s): This invention relates to a novel method for solubilizing the cold water insoluble portion of extracted tea solids by the use of an appropriate enzyme, preferably the enzyme tannase. More specifically, the invention relates to a method for treating tea extracts, and preferably black tea extracts, to produce a water-soluble tea or tea powder of improved astrigency and color without turbidity by contacting the tea extract or other medium containing the tea cream or the tea cream itself with an appropriate enzyme, preferably the enzyme tannase. Green tea includes freshly gathered tea leaves, tea leaves that have been freshly gathered and dried immediately, tea leaves that have been heat
Patents 345
treated before drying and aqueous extracts of these leaves. In each instance, the green tea has undergone substantially no fermentation to the black state. Black tea, on the other hand, is generally made from green tea leaves by subjecting tea leaves to a series of processing conditions including (1) withering, (2) rolling or otherwise disintegrating, (3) fermenting and (4) firing. Rolling or other disintegration initiates the enzymic reactions of fermentation, during which the characteristic color, flavor and aroma of black tea are developed. When the fermentation has progressed sufficently, the tea leaves are fired (i.e., dried). This arrests the enzymic reactions and the resulting product possesses the characteristic appearance of black tea. (See, for example, Millin, D. J. & Rustidge, D. W. (1967) Process Biochemistry 2 No. 6 page 9). Web site: http://www.delphion.com/details?pn=US03959497__ ·
Enzymatic treatment of black tea leaf Inventor(s): Tsai; Chee-Hway (Cincinnati, OH) Assignee(s): The Procter & Gamble Company (Cincinnati, OH) Patent Number: 4,639,375 Date filed: August 12, 1983 Abstract: A process for the enzymatic treatment of black tea leaf is disclosed. In particular, black tea leaf is wetted with water containing tannase and one or more cellwall-digesting enzymes, such as cellulase, pectinase, papain, or hemicellulase, prior to extraction. The enzyme-moistened tea leaf is incubated in a closed system at room temperature for a few hours. The enzyme-treated tea is then neutralized with a suitable food grade base and the enzymes are inactivated by heating. The resulting treated tea can be extracted and processed in the usual manner or dried for use in tea bags in the usual manner. As a result, a higher yield of tea is obtained and the resulting instant tea has better solubility in cold water than conventional teas. The bag tea products an infusion which does not form haze at cold temperatures. Excerpt(s): This invention relates to the enzymatic treatment of black leaf tea. Tea processing technology is aimed at modifying the chemical composition of the raw tea leaf material in order to produce new flavor and aroma compounds, responsible for the taste, color and aroma of the manufactured teas that are so highly valued by the consumer. Green tea leaf has a bitter taste and grassy odor. This is transformed into an aromatic and flavorful manufactured tea by biochemical processes which are well known. In the production of conventional black tea, the tea leaves undergo the following treatment processes: (1) withering, (2) rolling and sorting, (3) fermentation, (4) firing, and (5) final sorting of the dried tea. These steps are described in excellent detail by Bokuchava et al., "Biochemistry and Technology of Tea Manufacture", CRC Critical Reviews and Science and Nutrition, 12 (4) pp. 309-370 (July 1980), which is incorporated herein by reference. The fermentation process for conversion of green teas to black tea is well known to involve a variety of enzymes, including those used herein. This role of enzymes is well summarized in two articles, Sanderson and Coggon, ACS Symposium Series, 47, 12-26 (1977), and Roberts, J. Sci. Food Agric., 3, 193 (1952). Web site: http://www.delphion.com/details?pn=US04639375__
346 Tea
·
Enzymatically extracted tea concentrate with xanthan gum which is stable at ambient temperature Inventor(s): Lehmberg; Gregg Lance (Somerset, NJ), Ma; Sheng Xue (Altamonte Springs, FL) Assignee(s): Thomas J. Lipton Co., Division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,036,982 Date filed: December 11, 1996 Abstract: Stable tea concentrates containing xanthan gum are shown. The concentrates are prepared by the use of selected cell wall lysis enzymes. Excerpt(s): This invention generally relates to tea concentrates having about 20 to about 70% or even higher tea solids. Shelf stable tea concentrates are highly desirable and have several applications. These include: the ability to supply a natural tea concentrate for use in Ready-to-Drink tea and Fountain tea products; as a tea concentrate product for retail sale; and as a preferred method of transporting tea solids. The advantages of a tea concentrate over a powder or a dilute tea extract are that better tea character is obtained. In addition, less energy is employed than for a powder and less weight and volume are needed for shipping a concentrate than for a dilute extract. In the prior art, tea concentrates were considered to be physically unstable, which prevented their use in many tea products. However, it is believed that under certain conditions tea products made from tea concentrates have better quality (e.g., flavor, freshness, etc.) than powders and are more economical than tea powder or dilute tea extract. Therefore, it is highly desirable to have a shelf stable tea concentrate. Web site: http://www.delphion.com/details?pn=US06036982__
·
Enzyme extraction process for tea Inventor(s): Lehmberg; Gregg Lance (Somerset, NJ), Balentine; Douglas Ashley (River Vale, NJ), Hang; Robert Steven (North Bergen, NJ), Gobbo; Steven Alphonse (Secaucus, NJ) Assignee(s): Lipton, Division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 5,952,023 Date filed: June 27, 1997 Abstract: An improved process for the preparation of acid stable instant tea. Enzymatic extraction of black tea leaf using an enzyme cocktail adjusted to a critical pH is employed. Black tea is extracted with water containing tannase and one or more cell wall digesting enzymes, such as cellulase, pectinase, hemicellulase or VISCOZYME at a selected pH. The resulting tea extract can then be pasteurized, polished and made into a finished beverage or concentrated and dried in the usual manner. As a result, natural tea products are obtained which have improved acid stability, good color and good clarity. Excerpt(s): The present invention relates to an improved process for obtaining instant tea and to the improved products thereby obtained. In particular, the invention relates to a method of treating black tea leaf with an enzyme cocktail including tannase and selected cell wall lysis enzymes such as cellulase, mascerase and carbohydrases, for example, VISCOZYME L obtainable from NOVO Industri A/S, Denmark, to produce instant tea which has improved acid stability with good cold water solubility, good clarity and tea color and which has a full complement of tea flavor. The improvement is
Patents 347
in the pH of the enzyme solution used for the extraction process. Enzymatic treatment of tea leaves either continuously or batchwise for the production of instant teas offers many benefits for the resulting convenience beverage product. These include better acid stability, color, clarity, cold water solubility, flavor and higher yield. Continuous processing of tea leaf with enzymes is an economical method of providing the necessary operating conditions of time, temperature, enzyme concentration and water for the enzymes to be effective. The high throughput needed for commercial production is also accommodated by continuous processing with minimal complexity compared to batch operation. The long contact times required for enzymes to be used effectively makes batch processing complex and requires a large capital investment in equipment to provide the residence time. Continuous, plug flow treatment reduces the amount and complexity of equipment needed to treat tea leaf with enzymes and allows for easy integration to downstream continuous extraction process equipment. Consistent, reproducible results is a further benefit of continuous treatment. Web site: http://www.delphion.com/details?pn=US05952023__ ·
Eucalyptus tea Inventor(s): Shimabukuro; Kenji (Nago, JP) Assignee(s): Yugen Kaisha Okinawa Yukali Farm (Okinawa, JP) Patent Number: 5,595,779 Date filed: March 1, 1995 Abstract: This invention relates to a Eucalyptus tea prepared by steaming, rumpletwisting and drying Eucalyptus leaves, which contains a large amount of soluble polysaccharides and tannins, and further richly contains inorganic components such as potassium, sodium and calcium. Excerpt(s): The present invention relates to tea made from Eucalyptus leaves, which richly contains aroma and nutrients. As tea made from leaves other than green tea leaves, there have been well known, for example, wulung tea, Gymnema tea, Silvervine tea, Ashitaba tea, Olive tea, and Saururaceous tea. Although such teas contain plenty of vitamins, they contain less tannic components known as the mixtures of catechins, which have been reported to have various effects such as an effect on intestinal orders, a controlling effect on absorption of glucides from the intestine, a controlling effect in the production of glucides having an excretion accelerative action on cholesterol and lipids giving lesions to living tissues and organs (i.e., antioxidizing action), an anticancer action, an anticancerity, a controlling action of hypercholesterol, an antihypertensive action and antibacterial action. Web site: http://www.delphion.com/details?pn=US05595779__
·
Extracting black tea and coffee and closed extractor therefor Inventor(s): Saito; Isamu (201, 3-12, 1-CHOME, Akabanedai, Kita-ku, Tokyo, JP) Assignee(s): none reported Patent Number: 4,112,830 Date filed: January 15, 1976
348 Tea
Abstract: Method and apparatus for making tea or coffee for drinking comprising heaping tea in an extractor and subjecting successive areas of the heaped tea to periodic sprinkling during successive intervals of sprinkling, with cold tap water, each followed by intervals of wet-expanding the tea until the tea is substantially completely wetexpanded. The sprinkling intervals are timed to allow the wet-expanding to take place after each sprinkling of a same area and without collapsing of the wet-expanded tea. The tea resulting from the wetting is filtered out while removing air bubbles therefrom. The extractor has a sprinkler continuously driven during the sprinkling period and the filtrate is taken out through a pipe perforated axially extending into a filtrate-receiving container. The filtrate is delivered as a tea drink and may be stored in a glass container or the like for prolonged periods without loss of flavor. Coffee is made in the same apparatus by using powdered coffee sprinkled with cold tap water and wet-expanded, filtered while removing air bubbles therefrom and then stored for delivery as a drink. The extractor has a vacuum pump that controls the flow-rate with the filter of the extracted tea or coffee maintaining the tea leaves or coffee constantly immersed to insure freedom thereof from contact with the air. Excerpt(s): This invention relates generally to the extracting of coffee and black tea and more particularly to apparatus for extracting a ground powdered coffee and fine leaves of black tea in water at room temperature. Conventional extracting apparatus for extracting a drink of coffee or tea from a ground powder of coffee and fine leaves of black tea at low temperatures are known. Generally the extraction is carried out in an open condition such that various factors effecting the loss of flavor, transparency of the filtrate and fragrance of the coffee and black tea drink occur. Heretofore these unfavorable causes of loss of flavor etc. have not been dealt with by the known extractors. An investigation by the applicant of known extraction apparatus for coffee and tea as to the construction of the filter, the filtering process, the relationship between flow-down quality and flow-down speed of extracted solutions, the influence of oxidation (deterioration of flavor), has been carried out. Furthermore the ingress of bacteria floating in open air resulting from the exposure of the coffee and black tea during their extraction effecting a loss of flavor and change in quality (unfavorable preservation), the stirring processes and stirring apparatus etc. have been such that unfavorable results occur. That is to say these various factors have resulted in production of coffee or tea that does not have the optimum flavor and cannot be stored for long periods. Web site: http://www.delphion.com/details?pn=US04112830__ ·
Extracting tea using an aqueous solution of ammonium bicarbonate or ammonia Inventor(s): Collier; Peter Dudley (Rushden, EN), Penman; Alistair (Rushden, EN), Trussell; Frederick John (Ampthill, EN) Assignee(s): Thomas J. Lipton, Inc. (Englewood Cliffs, NJ) Patent Number: 3,971,858 Date filed: August 30, 1974 Abstract: The yield in the aqueous extraction of tea leaf is improved by using an aqueous solution of ammonium bicarbonate or of ammonia as the extractant. Excerpt(s): Products such as instant tea, for instance cold-water soluble (iced) instant tea, conventionally involve hot-water extraction of tea leaf. Such processes are described by Nicholas Pintauro in Food Processing Review No. 11 published 1970 by Noyes Data
Patents 349
Corporation, New Jersey at pages 29 to 63 and reference can particularly be made to Seltzer and Saporito's U.S. Pat. No. 2,902,368. Although excellent products are obtained it has long been appreciated that an improvement in yield, of soluble tea solids, would be highly desirable. Use of temperatures above 100.degree.C leads to improved yields but is costly in energy-requirements and in equipment. The principal object of the invention is to provide a method of extracting tea leaf in substantially higher yield than that obtained simply using hot-water extraction. It has been found that if an aqueous solution of ammonium bicarbonate or of ammonia is used to extract soluble solids from tea leaf there is at least about 30% increase in yield based on the yield obtained using water but otherwise the same conditions. Web site: http://www.delphion.com/details?pn=US03971858__ ·
Extraction process of tea with enzymes Inventor(s): Lehmberg; Gregg Lance (Somerset, NJ), Balentine; Douglas Ashley (River Vale, NJ), Hang; Robert Steven (North Bergen, NJ), Gobbo; Steven Alphonse (Secaucus, NJ) Assignee(s): Lipton (Englewood Cliffs, NJ) Patent Number: 5,925,389 Date filed: June 27, 1997 Abstract: A process for the preparation of acid stable instant tea. Enzymatic extraction of black tea leaf with water containing tannase and one or more cell wall digesting enzymes, such as cellulase, pectinase, hemicellulase or VISCOZYME is employed. The resulting tea extract can then be pasteurized, polished, and made into a finished beverage or concentrated and dried in the usual manner. As a result, natural tea products are obtained which have improved acid stability, good color and good clarity. Excerpt(s): The present invention relates to a process for obtaining instant tea and to the improved products thereby obtained. In particular, the invention relates to a method of treating black tea leaf with an enzyme cocktail including tannase, and selected cell wall lysis enzymes such as cellulase, mascerase, and carbohydrases for example, VISCOZYME L obtainable from NOVO Industri A/S Denmark, to produce instant tea which has improved acid stability with good cold water solubility, good clarity and good tea color, and which has a full complement of tea flavor. Enzymatic treatment of tea leaves, either continuously or batch wise, for the production of instant teas offers many benefits for the resulting convenience beverage product. These include better acid stability, color, clarity, cold water solubility, flavor and higher yield. Continuous processing of tea leaf with enzymes is an economical method of providing the necessary operating conditions of time, temperature, enzyme concentration and water for the enzymes to be effective. The high throughput needed for commercial production is also accommodated by continuous processing with minimal complexity compared to batch operation. The long contact times required for enzymes to be used effectively makes batch processing complex and requires a large capital investment in equipment to provide the residence time. Continuous, plug flow treatment reduces the amount and complexity of equipment needed to treat tea leaf with enzymes and allows for easy integration to downstream continuous extraction process equipment. Consistent, reproducible results is a further benefit of continuous treatment. Web site: http://www.delphion.com/details?pn=US05925389__
350 Tea
·
Filter device for making tea Inventor(s): Siemensma; Sidonius V. (Bedum, NL) Assignee(s): U.S. Philips Corporation (New York, NY) Patent Number: 4,527,467 Date filed: January 30, 1984 Abstract: A device for use in brewing tea comprises a bowl having an outlet aperture formed in its bottom for discharge of brewed tea; an outlet tube communicating with the outlet aperture and extending upwardly from the bottom of the bowl; and a sleeve surrounding and spaced from the outlet tube to provide an annular siphon passageway therebetween, the upper end of the sleeve being closed and the lower end of the sleeve resting on the bowl bottom. Capillary inlet apertures are formed in the lower portion of the sleeve, the dimensional relationship of the capillary inlet apertures to the annular siphon passageway being such that, when the capillary inlet apertures are exposed by the fall of the liquid level in the bowl, the static pressure of the liquid retained in the annular siphon passageway is balanced by the capillary pressure of the liquid retained in the capillary inlet apertures, with the result that the passage of air bubbles through the capillary inlet apertures is prevented. Thereby, upon addition of further liquid to the bowl, the siphoning operation immediately resumes. Excerpt(s): This invention relates to a filter device for making tea, comprising a filter vessel provided with siphoning means for the discharge of tea brewed in the vessel, the siphoning means comprising an outlet pipe which extends upwards from the bottom of the filter vessel and a sleeve which surrounds said pipe so that a passage for liquid is formed between the pipe and the sleeve, and which is closed at its upper end and is formed in its lower portion with inlet apertures. Such a filter device is known from published Netherlands Patent application No. 7 807 403. In the operation of this known filter device, siphoning ceases at the instant at which the falling level of liquid in the filter vessel reaches the inlet apertures of the siphoning means, because then an air bubble is drawn into the siphoning means through the apertures. When water is next supplied to the filter vessel, siphoning will not begin again until the instant at which the liquid level reaches the upper edge of the outlet pipe. As described in such patent application, such a filter device is very suitable for receiving drops from a trickling coffee filter. It is an object of the present invention to provide a filter device for making tea, in which when a siphoning operation has been completed, another will begin immediately water is next poured into the filter vessel. Web site: http://www.delphion.com/details?pn=US04527467__
·
Filter for making portions of coffee or tea Inventor(s): Woltermann; Erich H. (Ameisenweg 3, 4950 Minden, DE) Assignee(s): none reported Patent Number: 4,859,337 Date filed: July 10, 1987 Abstract: The invention relates to A filter for making portions of coffee or tea, comprising a substantially cup-shaped supporting vessel having a pouring-in opening at the top, a chamber for filling with liquid and having an outlet opening at the bottom, and a filter insert disposed in the supporting vessel above the outlet opening, wherein
Patents 351
the filter insert (5) comprises a filter mat and extends approximately parallel to the inner wall of the supporting vessel and its periphery is connected to the supporting vessel (1) in the edge region of the pouring-in opening (2). Excerpt(s): The invention relates to a filter for making portions of coffee or tea, comprising a substantially cup-shaped supporting vessel having a pouring-in opening at the top, a chamber for filling with liquid and having an outlet opening at the bottom, and a filter insert disposed in the supporting vessel spaced above the outlet opening. Known filters for making portions of coffee or tea comprise an insert in the form of a mat disposed horizontally on both sides of the ground coffee, measured portions of which are disposed inside the mat. This arrangement, however, does not ensure optimum use of the ground coffee when water is poured on. Known filters, already filled with ground coffee, come in large packages which are made air-tight and filled with inert gas to prevent the ground coffee from losing its aroma during storage. However, when the large package is opened to take out an individual filter, the filters remaining in the package no longer have an aroma seal, and consequently the quality of the coffee suffers after prolonged use. The object of the invention, starting from a filter of the initially-described kind, is to improve it so that the powdered coffee in the filter is used in optimum manner and so as to ensure that the quality is not impaired even after long storage. Another aim is to produce and pack the filter according to the invention in an economic, completely automatic manner. Web site: http://www.delphion.com/details?pn=US04859337__ ·
Filter pouch cleaner and method for cleaning coffee or tea maker Inventor(s): West; Steve F. (Upland, CA) Assignee(s): Coffee Dispenser Cleaner Company, LLC (Orange, CA) Patent Number: 5,656,583 Date filed: December 5, 1995 Abstract: A filter pouch cleaner for cleaning coffee and tea makers, has a top and bottom filter layer made from tea bag paper. The top and bottom filter layers are joined together along and adjacent to their outer edges to form a sealed pouch therebetween. The pouch is filled with a powdered cleaner compound that includes trisodium phosphate, sodium metasillicate and sodium perborate, along with soda ash as a filler. To facilitate the biodegradability and the safety of the cleaner compound, tripolyphosphate and a trace of blue dye powder are included in the cleaner compound. Excerpt(s): This invention relates to coffee and tea makers, and more particularly to a filter pouch cleaner that facilitates the cleaning of the brewing and dispensing equipment of a tea or coffee maker. Millions of cups of coffee and tea are brewed and consumed each and every day. As each pot of coffee or tea is brewed, the brewing cycle releases coffee and tannin oils from the coffee and tea. These oils are deposited as a brown oily residue on the coffee and tea makers' brewing and dispensing equipment. The oily residue tends be acidic and, thus, tends to sour the taste of the coffee or tea, especially when the residue is left to build up over a long period of time. Thus, it is desirable to clean the brewing and dispensing equipment, i.e., the brew basket, pot or server, spouts, sight glass, etc., to avoid brewing harsh or sour tasting coffee or tea. Currently, cleaning procedures vary from using salt and ice to using bleach. Many liquid commercial cleaners have been developed for glass decanters, airpots, and glass lined thermal servers. Powders such as urn cleaners have also been developed. These
352 Tea
powders usually comes in bulk supply, which requires the user to measure an amount to be used, or may come in a measured amount in an envelope. The user will normally, in the case of a liquid cleaner, squeeze a soft plastic bottle with a tilt top closure into the pot or server and, in the case of a powder, merely place the loose powder into an open filter in the brew basket, and then add hot water or run the brew cycle to activate the concentration of the cleaner. In either case, using these cleaners to clean the coffee or tea makers is less than convenient since it requires a certain amount of manipulation and, in some cases, measurement of the cleaner. Web site: http://www.delphion.com/details?pn=US05656583__ ·
Filtering device for producing extracts from coffee or tea Inventor(s): Hauslein; Reinhard (Minden, DE) Assignee(s): Melitta-Werke Bentz & Sohn KG (Minden, DE) Patent Number: 4,162,054 Date filed: June 8, 1978 Abstract: A filter vessel arranged to receive a liquid-permeable filter bag for producing a coffee or tea beverage, the filter vessel having, at its bottom, a filtrate outlet in the form of a siphon which prevents dripping after completion of the filtering process. Excerpt(s): The present invention relates to a filtering device for producing aromatic extracts from coffee or tea, which device is of the type that includes a filter vessel and a filter bag. In known filtering devices of the above-mentioned type, the outlet of the filter vessel is in the form of one or a plurality of perforation bores at the lowest point of the filter vessel provided to assure complete emptying of the vessel. If one or a plurality of outlet bores are disposed at the lowest point of the filter vessel there exists the drawback that upon completion of the filtering proces and after removal of the filtering device from the pot to receive the filtrate, any remaining filtrate will continue to drip outside of the pot and can soil the region around the pot. This is a particular drawback in coffeemakers in which the filtering device is suspended in the machine and remains there after completion of the filtering process since in such a case the remaining filtrate drips onto the surface of the warming plate of the coffeemaker, where it burns in, or scorches. Web site: http://www.delphion.com/details?pn=US04162054__
·
Flavoring materials for use in tea containing beverages Inventor(s): Cirigliano; Michael Charles (Cresskill, NJ), Farrell; Francis John (Madison, NJ), McKenna; Raymond Thomas (Scotch Plains, NJ), Rothenberg; Paul John (New Milford, NJ) Assignee(s): Lipton, Division of Conopco, Inc. (Englewood Cliffs, NJ) Patent Number: 6,022,576 Date filed: October 28, 1997 Abstract: An aqueous based tea solids containing beverage is taught which also contains a sufficient amount of a selected substituted phenyl flavoring/antimicrobial compound to prevent microbial outgrowth while simultaneously contributing to the pleasant flavor of the beverage thus making the beverage acceptable both organoleptically and
Patents 353
microbiologically. Optionally selected "hurdles" or stepwise antimicrobial controls are also employed. Excerpt(s): The present invention relates to the use of natural and synthetically prepared flavorant materials which also act as antimicrobials in aqueous based beverages containing tea solids. These materials are selected substituted phenyl compounds. Acidified and native pH ready-to-drink (RTD) tea beverages, in the 2.5-6.5 pH range regardless of packaging are known to be susceptible to spoilage. As compared to cans, tea beverages packaged in glass and plastic bottles (because of increased O.sub.2 ingress), as well as tea beverages at the higher range of the pH spectrum, are even more sensitive to yeast and mold spoilage than canned teas. There are many different processes for preparing and packaging or bottling ready-to-drink (RTD) teas. For example, in one process the bottles can all be sterilized and the tea beverage first pasteurized and then bottled at high temperature. Each of these high temperature treatments requires a large capital investment for equipment and if there were many different bottling plants the costs of equipping each of these multiple plants with such high temperature equipment would be prohibitive if not impossible to justify. Web site: http://www.delphion.com/details?pn=US06022576__ ·
Flowable frozen tea mix concentrate which contains high levels of sugar Inventor(s): Vietti; Michael J. (Cincinnati, OH), Pflaumer; Phillip F. (Hamilton, OH), Brabbs; William J. (Cincinnati, OH) Assignee(s): The Procter & Gamble Co. (Cincinnati, OH) Patent Number: 4,717,579 Date filed: May 7, 1986 Abstract: Frozen tea mix concentrates which contain high levels of sugar and are flowable at freezer temperatures are disclosed. These tea mix concentrates comprise from about 0.5 to about 2% by weight tea solids and from about 40 to about 70% by weight of a sugar component. This sugar comprises a particular mixture of fructose and dextrose monosaccharides, sucrose, glucose-based di- and tri-saccharides selected from maltose, isomaltose, maltotriose, isomaltotriose and mixtures thereof, plus other polysaccharides commonly present in corn syrups. The tea mix concentrates also preferably include an edible acid to provide a lower pH (about 4 or less at 20.degree. C.), and a flavoring such as lemon. Excerpt(s): The present invention relates to a frozen tea mix concentrate which contains high levels of sugar and is flowable at freezer temperatures. Tea mix products usually contain a tea extract, a sweetener such as sugar, and an optional flavoring such as lemon. These products are most commonly available in the U.S. as granular instant tea mixes, or as ready-to-drink canned products. Liquid tea mix concentrates are sold primarily to foodservice or institutional customers, rather than directly to the consumer. The concentrates, like instant tea, require the addition of water to prepare a tea beverage for consumption. Many consumers prefer that the tea beverage have a fresh brewed flavor. Preserving fresh brewed flavor in a liquid tea mix concentrate is difficult. By contrast, freezing the liquid tea mix concentrate would permit the preservation of fresh brewed flavor. Accordingly, consumers would likely prefer a frozen form of a tea mix concentrate for flavor reasons. Web site: http://www.delphion.com/details?pn=US04717579__
354 Tea
·
Freeze-dried ginseng berry tea Inventor(s): Chen; Jau-Fei (Orem, UT) Assignee(s): E Excel Internatioanal Inc. (Springville, CT) Patent Number: 6,210,738 Date filed: November 12, 1999 Abstract: The present invention relates to novel compositions of freeze-dried ginseng berry and other natural health promoting ingredients in a mixture suitable for making tea. The compositions and methods of preferred embodiments of the present invention provide a natural vitamin containing composition for making a tea beverage which can be consumed hot or cold and which provides the consumer with a refreshing, delicious, stimulating and healthful experience. Excerpt(s): The present invention relates generally to the field of botanical and nutritional food products and more particularly to botanical teas comprising ginseng berry ingredients. Preferred embodiments of the present invention comprise novel compositions of freeze-dried ginseng berry and other beneficial ingredients prepared for human consumption. The human physiological need for vitamins has been well established. Regular dietary consumption of vitamins is essential to good health. Various organizations and government agencies have published recommended quantities for vitamin consumption. One well known standard in the United States is the U.S. Recommended Daily Allowance (RDA) which recommends quantities for the daily intake of vitamins. While the need for vitamins is well known, the average person fails to consume the recommended daily intake of vitamins through their normal diet. Often this is due to a busy work schedule that encourages the consumption of "fast food" that is high in fat and sugar content. For others, food rich in vitamin content may just not be readily available. Whatever the reason, many people do not consume enough vitamins in their daily diet. Web site: http://www.delphion.com/details?pn=US06210738__
·
Fruit tea process and product Inventor(s): Zaimi; Majid (7777 Fay Ave., Suite #131, La Jolla, CA 92037) Assignee(s): none reported Patent Number: 5,238,700 Date filed: December 24, 1992 Abstract: A tea is made from a hard-fleshed, light-colored fruit such as the quince by a process of first grating the flesh of the fruit, heating the gratings to dry the grated strips and brown them slightly, and then grilling the mass on a hot, oil-less surface until the fruit turns a darker brown. The shredded mass is then removed from the heat. When steeped in boiling water, it produces a naturally sweet caffeine-free imitation of real tea. Excerpt(s): Many tea lovers have difficulty drinking regular tea because of the caffeine, or an allergic reaction to one of the chemical constituents of tea. Many of these people dearly love tea, especially in those countries where tea drinking is a tradition and in which enormous quantities of tea are consumed annually. Certain of these people feel truly deprived not to be able to partake of the tea flavor and aroma to which they have
Patents 355
become so familiar over the years before having to quit consuming tea. Although there are herb teas, typically these do not taste good, and lack the flavor and aroma of real tea. Often they are used for medicinal purposes, and are not really produced for the pleasure of tea consumption. Decaffeinated tea does not taste good, and does not eliminate the problem of allergies to other chemical constituents of the tea besides caffeine. There is a need for a tea that is free of caffeine and free of the typical constituents of normal tea leaves that cause allergic reactions, and that tastes like tea and has the steaming aroma of hot tea. Web site: http://www.delphion.com/details?pn=US05238700__ ·
Glutathione, green tea, grape seed extract to neutralize tobacco free radicals Inventor(s): Hersh; Theodore (Atlanta, GA), Hersh; Rebecca (Atlanta, GA) Assignee(s): Thione International, Inc. (Atlanta, GA) Patent Number: 6,470,894 Date filed: May 11, 2001 Abstract: A composition for inclusion within a cigarette, cigar, pipe or smokeless tobacco. The composition can be included within the tobacco itself, a filter for filtering tobacco smoke once burned or even within the paper or wrapper surrounding the tobacco product. In the cigarette filter, be it internal or external filters, the antioxidant complex is capable of scavenging and neutralizing the free radicals emanating from the burning or heated tobacco and passing through the filter as the smoker inhales. The composition is also capable of reducing free radical damage to the oro-pharyngeal cavity, respiratory tract and lungs resulting from tobacco smoke. The composition includes glutathione and preferably L-glutathione and green tea and/or grape seed extract. Excerpt(s): The present invention deals with the combination of various synergistic antioxidants, enzymatic co-factors and amino acids in appropriate delivery vehicles employed in cigarette filters and in external filters such as cigarette and cigar "holders," in "pipe filters" and in tobacco, wrappers and papers and in so-called smokeless tobacco as a means of preventing or ameliorating signs and symptoms and complications to the oro-pharyngeal cavity, respiratory tract and lungs from damage by tobacco smoke and tobacco chewed induced free radical species. The present invention can be employed in filter cigarettes, unfiltered cigarettes, cigars, pipes, and smokeless tobacco products. The deleterious effects of tobacco abuse are well known and regulatory agencies as well as the public constantly react to these scientific and epidemiologic evidences. Tobacco is indeed a worldwide public health hazard accounting for significant morbidity and mortality. Although smoking places an abundant oxidant insult to the oral cavity, respiratory tract and lungs, evidence supports the notion that the oxidant burden is on the entire organism of the smoker. Smoking promotes development or enhancement of atherosclerosis, causing cardiovascular disease, chronic obstructive pulmonary disease, recently labeled "smoker's lung," cutaneous damage, especially to the face, called "smoker's face," and various forms of cancer, including carcinomas of the mouth, pharynx, esophagus and lung. Tobacco is a substance consisting of the dried leaves and stems of the plant Nicotiana tabacum. Tobacco contains the drug nicotine, which is very addictive. The plant is native to North America and now is grown worldwide. Tobacco abuse has been identified as the single most preventable cause of disease, morbidity and mortality, for tobacco smoke contains many toxic chemicals, in tar and gas phase smoke.
356 Tea
Web site: http://www.delphion.com/details?pn=US06470894__ ·
Green tea beverages manufacturing process Inventor(s): Kinugasa; Hitoshi (Shizuoka, JP), Sasame; Masami (Shizuoka, JP), Matsumoto; Nobuo (Shizuoka, JP), Shimaoka; Kenji (Shizuoka, JP), Ueno; Yoko (Shizuoka, JP), Niino; Hitoshi (Shizuoka, JP), Okanoya; Kazunori (Shizuoka, JP), Kobayashi; Izumi (Shizuoka, JP) Assignee(s): Ito En, Ltd. (Tokyo, JP) Patent Number: 6,387,428 Date filed: August 14, 2000 Abstract: In order to produce green tea beverages which have a good flavor and a good balance of the fragrant components and do not form unpleasant precipitates, such green tea beverage are produced by a method including an extracting step consisting of two extraction steps, a first step in which green tea leaves are extracted at an applied pressure to obtain a pressure extract (step 1) and a second step in which green tea leaves are extracted under atmospheric pressure, followed by microfiltration to obtain an atmospheric extract (step 2), and a mixing step in which the pressure extract and the atmospheric extract obtained in the respective step are mixed at a mixing ratio determined on the basis of the weight of the raw tea leaves (step 3). This method can provide the production of drinks which have a good flavor and a good balance of the fragrant components and in addition, do not result in formation of deposits, and are suitable for beverages, in particular, for packing into PET bottles by mixing, at a predetermined ratio, the pressure extract from step 1, which is rich in suitable fragrance but short in astringency and tastiness, and the atmospheric extract from step 2, which is intense in astringency and tastiness and provided with a good color tone. Excerpt(s): The present invention relates to a manufacturing process of green tea beverages having good flavor, in which deterioration in the color tone and unpleasant precipitates do not occur even during storage for a long time, and in particular, green tea beverages which are most suitable for beverages to be packed in transparent containers. As means for increasing the fragrance of green tea beverages, for example, Japanese Patent Laid-open Publication No. Hei 11-262359 discloses methods for fragrance to be given off in which undried tea leaves are roasted in a cauldron. Firing green tea leaves enhances an aroma characteristic of fired tea leaves by heating, improving the flavor of tea. When green tea leaves are fired, however, such a treatment tends to deteriorate the color tone of the extracted solution. In the case of beverages for packing into transparent containers, in particular, therefore the color tone of drinks is an important aspect of product values and this deterioration has been a serious problem in the production of green tea beverages for packing into transparent containers. Web site: http://www.delphion.com/details?pn=US06387428__
·
Green tea composition and molding matter thereof, and process for producing them Inventor(s): Omura; Teijiro (Shizuoka, JP) Assignee(s): Jinseido Company, Limited (Shizuoka, JP) Patent Number: 6,627,244 Date filed: April 26, 2001
Patents 357
Abstract: A green tea composition comprising 100 parts by weight of green tea leaf, and 0.01 to 30 parts by weight of trehalose; a process for producing a green tea composition, comprising the steps of heat-treating fresh tea leaf, drying the heat-treated leaf, and crushing the dried leaf, wherein the fresh leaf is brought into contact with trehalose before or after or simultaneously with the heat treatment of the fresh leaf; a molding matter of a green tea composition, obtained by molding a green tea composition comprising 35 to 80% by weight of granulated or powdered green tea (component (A)), 10 to 60% by weight of maltose (component (B)), and 1 to 20% by weight of trehalose (component (C)); and a process for producing a molding matter of a green tea composition, comprising the step of molding the above green tea composition. Excerpt(s): The present invention relates not only to green tea compositions and molding matter thereof that retain the taste and the color characteristic of green tea after fresh green tea leaves have been treated with heat and trehalose for the prevention of oxidatio and discoloration and that can fully exhibit the pharmacological effects of catechins and chlorophylls by retaining them at high concentrations, but also to the methods of producing them. A recent report has attracted particular attention that catechins contained in green tea have various pharmacological effects, that is, an antioxidant effect for preventing aging, an antimicrobial, antiviral effect, a bloodcholesterol-controlling effect, an anti-vassopressor effect, a hypoglycemic effect, an antidiabetic effect, a platelet aggregation inhibitory effect, a thrombus formation preventing effect, an antineoplastic effect, and an anticarcinogenic effect. However, the catechins in green tea are converted to brownish substances after undergoing nonenzymatic oxidation although they are converted to theaflavins and other orange-red substances to show bright colors by enzymatic oxidation when green tea leaves are oxidized to black tea by fermentation. This explains a reason that green tea itself is discolored or remains yellowish when hot water is poured on. Web site: http://www.delphion.com/details?pn=US06627244__ ·
Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color Inventor(s): Ekanayake; Athula (Cincinnati, OH), Bunger; John Robert (Hebron, KY), Mohlenkamp, Jr. Marvin Joseph (Cincinnati, OH) Assignee(s): The Procter & Gamble Company (Cincinnati, OH) Patent Number: 6,063,428 Date filed: February 26, 1996 Abstract: Green tea extracts having improved clarity and color. These extracts are obtained by treating the green tea extract with an amount of a food grade cation exchange resin effective to remove metal cations present in the extract. The treated extract is then contacted nanofiltration membrane while the treated extract is at a temperature of from about 100.degree. to about 140.degree. F. (from about 37.8.degree. to about 60.degree. C.) to provide a filtered green tea extract as the permeate. These green tea extracts can be included in a variety of beverages and are especially useful in suppressing the characteristic aftertaste of aspartame in diet beverages. Excerpt(s): This application relates to a process for preparing green tea extracts having improved clarity and color. This application particularly relates to a process for preparing these green tea extracts involving treatment with a cation exchange material, followed by nanofiltration. This application further relates to beverages prepared with
358 Tea
these green tea extracts. Green tea extracts initially contain high levels of unoxidized flavanols, especially monomeric catechins such as epicatechin, epigallocatechin, epigallocatechingallate and epicatechingallate that impart a desired taste quality (astringency) to the tea beverage. Unfortunately, these catechin components (molecular weight of from about 200 to about 500) can be oxidized to higher molecular weight polyphenols, especially the theaflavins and thearubigins, in the presence of other components in the extract. These other components include metal ions (especially calcium, magnesium, manganese, aluminum, zinc and iron), certain partially oxidized organic intermediates (especially quinones) that are formed when the green tea is initially extracted, and dissolved oxygen. These metal ions in the extract act as a catalyst, and along with the quinones and dissolved oxygen, convert the catechins to oxidized polyphenols that impart a less desirable, lingering astringency to green tea beverages. These oxidized polyphenols that are formed by the oxidation of the catechins can interact and react with other materials in the green tea extract, such as caffeine, protein, pectins and/or metal ions, to form even larger and heavier complexes that eventually precipitate out. As a result, the tea beverage turns from the desired pale green color to an unappealing brown color over time. More importantly, the tea beverage becomes cloudy, turbid and develops a visible precipitate within a few days. Web site: http://www.delphion.com/details?pn=US06063428__ ·
Heat sealable tea bag paper and process of producing same Inventor(s): Heinrich; Gunter (Gernsbach, DE) Assignee(s): Unicon Papier und Kanststoffhandel sgesellschaft mbH (Gernsbach, DE) Patent Number: 5,173,154 Date filed: September 16, 1991 Abstract: The tea bag paper comprises a first phase of natural fibers in a weight percentage of from 60% to 85%, and a second phase of heat-sealable synthetic fibers with the remainder of the weight percentage of from 15% to 40%. The second phase penetrates the first phase in such a way that both sides of the paper are adapted to be heat-sealed, with the unit area weight of the paper being between 10 and 15 g/m.sup.2. The tea bag paper exhibits enhanced tea diffusion, and may be processed on special high-speed automatic tea packing machines, because it is heat-sealable on either side thereof. Excerpt(s): The present invention relates to a tea bag paper, comprising a first phase of natural fibers and a second phase of heat-sealing synthetic fibers. Furthermore, the present invention relates to a process of producing such a tea bag paper, and a tea bag made from said paper. Heat-sealable tea bag papers are known which have a unit area weight of at least 16 g/m.sup.2, and which may be processed into tea bags on highspeed automatic packing machines at a rate of up to 4,000 units per minute. Normally, these tea bag papers consist of about 75% of natural fibers and about 25% of heat-sealing synthetic materials. European patent specification 00 39 686 describes a multi-phase heat-sealing fibrous material and the process of producing same. In this multi-phase material, portions of a high tea diffusion and such of a low tea diffusion are provided alternately. This is obtained in that the portions of high tea diffusion have a substantially smaller proportion (percentage) of heat-sealing fibers than the portions of lower diffusion. Apart from the complex process described in said publication, the weight of the tea bag is relatively high with 16.5 g/m.sup.2. Further, owing to the irregular distribution of the heat-sealing fibers for defining portions of high and low diffusion,
Patents 359
there is the risk that upon sealing of the tea bag, its seams are less resistant in boiling water than the seams of a bag which has been formed from a paper having a continuously uniform heat-sealing layer. Web site: http://www.delphion.com/details?pn=US05173154__ ·
Heat-treated tea and method for preparing the same Inventor(s): Ashikawa; Keitaro (408, Ishikawa, Numazu-shi, Shizuoka-ken, JP) Assignee(s): none reported Patent Number: 4,526,796 Date filed: March 21, 1983 Abstract: The present invention provides a novel heat-treated tea. The heat-treated tea is obtained by placing green tea leaves in a tea drier, supplying the drier with dry air heated externally to 200.degree. to 300.degree. C. and heating the drier from outside to heat the tea leaves to 200.degree. to 300.degree. C. for 20 to 60 minutes. The tea obtained is brown in color and can be served by brewing in hot water as is done with the traditional green or roasted tea. It has special flavor and aroma different from the traditional teas. The extract of said heat-treated tea is effective in disinfection or preventing hung-over or stiff shoulder. Additional of said extract to wheat flour for making noodles and breads will improve the taste and quality of the product. Excerpt(s): The present invention relates to a novel heat-treated tea and a method for preparing the same. Various types of tea such as green tea, roasted tea, black tea, Oolong tea, etc. are widely enjoyed not only for their taste but also for their sedative and diuretic effects. Recent studies revealed that green tea contains an ingredient which suppresses mutation of cells, and its effect in preventing cancers and aging process is anticipated. The present invention aims to provide a novel heat-treated tea which contains a large amount of pharmacologically useful substances and yet maintains its taste and a method for preparing the same. Web site: http://www.delphion.com/details?pn=US04526796__
·
Holder for filter bags for preparing tea and the like Inventor(s): Muller; Herbert (Im Elm 24a, 5450 Neuwied 21, DE) Assignee(s): none reported Patent Number: 4,510,654 Date filed: June 30, 1983 Abstract: A holder for filter bags for preparing tea and similar beverages. A clamping body is provided which is embodied in a manner similar to a hair clip, and has three legs which extend approximately parallel to one another. The two outer legs are preloaded relative to one another in a known manner in such a way that they can be brought out of one stable end position (closed position) by closing the angular aperture between the central leg and the two outer legs into the other stable end position (closed position), in which respective slot-like, narrow openings remain between the edges of the central leg and the respectively adjacent edges of the two outer legs. Also provided is a chain, one end of which is fastened to the clamping body, and the other end of
360 Tea
which is provided with a hook which is suitable for fastening the chain on components of a brewing container. Excerpt(s): The present invention relates to a holder for filter bags for preparing tea and similar beverages. Various embodiments of holders for such filter bags are known, some of which have proven to be quite satisfactory in practice. However, the constructions involved with the filter holders which have been offered in the marketplace require a relatively great expenditure for material. Furthermore, some of these holders are also relatively complicated, so that a simple operation thereof is not possible. An object of the present invention is to provide a novel and practical filter holder for filter bags for preparing tea and similar beverages, which filter bag holder is distinguished by an amazingly simple handling and that also can be manufactured considerably more economically than is the case with heretofore known filter bag holders for preparing tea and the like. Web site: http://www.delphion.com/details?pn=US04510654__ ·
Holder for multiple string suspended tea bags Inventor(s): Holman; Norman W. (Midtown Professional Bldg., Ste. 2-B, 14 W. Jordan St., Pensacola, FL 32501) Assignee(s): none reported Patent Number: 5,129,524 Date filed: October 3, 1990 Abstract: The invention is a holder for multiple string suspended tea bags. In its preferred embodiment, it consists of a rigid rod, the end of which is concentrically encased in an end cap, and kept in place with an end cap holder. A plurality of spring means are suspended from the rod by means of tabs attached and secured to the rod. The tabs are kept separated by washer-like spacers and end spacers concentrically placed around the rod. Tea bag strings and tea bags are held vertically suspended in hot water for brewing.In other embodiments of the invention, the rod is replaced with a Tshaped beam from which a tab-spring means may be suspended or which has a plurality of notches along its upper edge to hold the tea bag string and tea bag.In different embodiments of the invention the rod or beam in a horizontal position may either be placed on the other rim of a cup or vessel or attached at opposite sides of the underneath of a vessel cover. Excerpt(s): The invention relates to a holder for multiple string suspended tea bags. It is often desirable to brew either large quantities of tea or tea of variable strengths. To accomplish this, it is necessary to vary the number of tea bags placed in the boiling water and to keep them separated. Placing several stringed tea bags unaided in a cup or a vessel results in the tangling of the strings. As the tea bags must be removed individually, the brew strength of the tea can vary considerably and it is possible to burn one's fingers in the hot water, or lose the string in the water. Further, it is desirable that the tea bag holder be easily transportable. Previous tea bag holders only allowed for one tea bag to be brewed at a time or required the use of specially designed vessels. U.S. Pat. No. 4,602,557 discloses a cup with a notch on its rim. A specially designed cup is required. In its preferred embodiment, the present invention can be transported by the user and used in connection with any cup or other tea brewing vessel. U.S. pat. No. 4,619,830, which discloses a beverage filter unit and support discloses the use of a
Patents 361
pouch-like tea holder, but is not compatible with conventional tea bags. Neither invention discloses its use with multiple tea bags. Web site: http://www.delphion.com/details?pn=US05129524__
Patent Applications on Tea As of December 2000, U.S. patent applications are open to public viewing.10 Applications are patent requests which have yet to be granted. (The process to achieve a patent can take several years.) The following patent applications have been filed since December 2000 relating to tea: ·
Apparatus for the production of ginkgo leaf tea Inventor(s): Fang, Pao-Hsien; (Belmont, MA) Correspondence: RICHARD J. BIRCH; P.O. BOX 1818; NEW LONDON; NH; 03257; US Patent Application Number: 20030127454 Date filed: January 4, 2002 Abstract: Ginkgo leaves contain many beneficial chemicals which can be transferred into a preparation of tea. However, the leaves contain 2-hexenal, a chemical which is toxic and has an unpleasant taste. Therefore, removal of the 2-hexenal is an essential step for the tea production. This removal is accomplished in this invention by a microwave apparatus, which has the advantage of a rapid rate of treatment at great energy efficiency. Therefore, this invention provides an effective means for large scale ginkgo leaf tea production. Excerpt(s): The utility of ginkgo biloba leaves has received wide attention in recent years, ranging from simple drink stuff to nutritional supplement and medicinal agent. The present invention is related to the ginkgo tea, specifically it is concerned with the removal of the 2-hexenal from the initial ginkgo leaves to produce a safe and palatable substance. Toward this objective, a patent exists (U.S. Pat. No. 5,888,571, Mar. 30, 1999, Inventor: Seung Chang Choi). Choi's process involves thermal treatment at various temperature ranges at various time intervals, which are consequently time consuming and energy wasting. The present invention is to eliminate these defects through a microwave irradiation. Other benefits will also be described in the present invention. A presently known method to eliminate 2-hexenal for producing ginkgo leaf tea is given by the 1999 patent of Choi (U.S. Pat. No. 5,888,571). The principle is a thermal decomposition of 2-hexenal. In this process, the raise of the leaf temperature is by roasting through an indirect heat transfer between the wall of the roaster and the ginkgo leaves, and the contact among the assembly of the leaves. An objective of the present invention is to utilize a different principle for the decomposition of 2-hexenal based on a direct interaction between the ginkgo leaves and the microwave energy. Therefore, the energy is invested principally in the strategic material, namely the ginkgo leaves, where energy is required to achieve the treatment. Consequently, a massive energy consumption involved in the thermal process is eliminated. At the same time, the temperature can be raised as well as dropped rapidly, therefore the thermal lag is practically eliminated. The result will be an efficient controlled system in which both mechanical efficiency and the medicinal efficacy can be expected at the same time with
10
This has been a common practice outside the United States prior to December 2000.
362 Tea
an energy economy. The production of ginkgo tea in this invention consists of (1) construction of the apparatus for the tea production and (2) method of the operation, and will be described sequentially. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Black tea extract for prevention of disease Inventor(s): Chen, Kuang Yu; (Belle Mead, NJ), Ho, Chi-Tang; (East Brunswick, NJ), Rosen, Robert T. (Monroe Township, NJ), Ghai, Geetha; (Murray Hill, NJ) Correspondence: Louis M. Heidelberger, Esq. Reed Smith LLP; 2500 One Liberty Place; 1650 Market Street; Philadelphia; PA; 19103; US Patent Application Number: 20020146472 Date filed: November 14, 2001 Abstract: Compositions and methods for preventing and treating disease are provided. The compositions are extracts of black tea that include a mixture of theaflavin-3-gallate and theaflavin-3'-gallate. Excerpt(s): Epidemiological studies have suggested that tea may have a protective role in disease, including certain human cancers. Catechin polyphenols isolated from green tea have been shown to inhibit proliferation of cultured mammalian cells including colon carcinoma, lung carcinoma, breast carcinoma, melanoma, and leukemic cells (Lea, M. A. et al. 1993. Cancer Lett. 68:231-236; Valcic, S. et al. 1996. Anticancer Drugs 7:461468). It has been reported that a major green tea catechin polyphenol, (-)epigallocatechin gallate (EGCG), inhibits growth of human tumor cells, including Caco-2 colorectal cancer cells, Hs578T breast cancer cells, and SV40-transformed W138 cells, but has little or no inhibitory effect on the growth of their normal counterparts (Chen, Z. P. et al. 1998. Cancer Lett. 129:173-179). Black tea extracts have also been shown to be potent in inhibiting tumorigenesis in several animal model systems, including skin (Javed, S. et al. 1998. Biomed. Environ. Sci. 11:30-7-313), lung (Yang, G. Y. et al. 1997. Carcinogenesis 18:2361-2365), colon (Weisburger, J. H. et al. 1998. Carcinogenesis 19:229-232), esophagus (Morse, M. A. et al. 1997. Nutr. Cancer 29:7-12), and mammary gland (Rogers, A. E. et al. 1998. Carcinogenesis 19:1269-1273). The major black tea polyphenols have been characterized to be theaflavin (TF-1), theaflavin-3-gallate and theaflavin-3'-gallate mixture (TF-2), and theaflavin-3,3'-digallate (TF-3). These theaflavin polyphenols are fermentation products derived from green tea polyphenols and are responsible for the characteristic color, fragrance and taste of black tea. The biological effects of each individual black tea polyphenol have not been well-studied in terms of their molecular mechanisms. TF-3 has been shown to be as potent as EGCG from green tea inhibiting the growth of human A431 carcinoma cells and in reducing autophosphorylation of EGF and PDGF receptors (Liang, Y. C. et al. 1999. Carcinogenesis 20:733-736). There are no reports of the activity of any other black tea polyphenols. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Patents 363
·
Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses Inventor(s): Castillo, Gerardo; (Seattle, WA), Choi, Paula Y. (Bothell, WA), Snow, Alan D. (Lynnwood, WA) Correspondence: PATRICK M. DWYER; PROTEOTECH, INC. SUITE 114; 1818 WESTLAKE AVENUE N; SEATLE; WA; 98109; US Patent Application Number: 20020086067 Date filed: December 29, 2000 Abstract: Green tea and other natural and synthetic sources of catechins, and bioflavanoids, flavanols, flavandiols, flavanoids, and tannins or derivatives thereof, are disclosed for the preparation of a pharmaceutical composition or dietary supplement for the treatment, prevention or management of amyloidosis in a mammalian subject susceptible to, or afflicted by, such a disease. Use of the green tea and its constituents and methods of use are also disclosed. Methods for promoting, maintaining or enhancing in a patient one or more of the mental or cognitive qualities selected from the group of mental or cognitive qualities consisting of mental acuity, mental alertness, cognitive well being, normal brain function, cognitive ability, mental performance, memory, concentration, mental sharpness, mental clarity, short term memory, normal brain function, and learning, the method comprising the step of administering to the patient a therapeutically effective amount of plant matter from a plant of the genus Camellia, species sinensis are also disclosed. Excerpt(s): The invention relates to compositions and methods for treating Alzheimer's Disease and other amyloidoses, and to methods for isolating pharmaceutical agents from plant matter, more particularly, it relates to uses, compositions and methods for therapeutic intervention in Alzheimer's disease and other amyloidoses and in Lewy body and Parkinson's disease using plant matter and derivatives thereof. Alzheimer's disease is characterized by the accumulation of a 39-43 amino acid peptide termed the beta-amyloid protein or A.beta., in a fibrillar form, existing as extracellular amyloid plaques and as amyloid within the walls of cerebral blood vessels. Fibrillar A.beta. amyloid deposition in Alzheimer's disease is believed to be detrimental to the patient and eventually leads to toxicity and neuronal cell death, characteristic hallmarks of Alzheimer's disease. Accumulating evidence implicates amyloid as a major causative factor of Alzheimer's disease pathogenesis. A variety of other human diseases also demonstrate amyloid deposition and usually involve systemic organs (i.e. organs or tissues lying outside the central nervous system), with the amyloid accumulation leading to organ dysfunction or failure. In Alzheimer's disease and "systemic" amyloid diseases, there is currently no cure or effective treatment, and the patient usually dies within 3 to 10 years from disease onset. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
364 Tea
·
Cloning of novel gene sequences expressed and repressed during winter dormancy in the apical buds of tea ( Camellia sinensis L. (O.) Kuntze) bush Inventor(s): Ahuja, Paramvir Singh; (Palampur, IN), Lal, Lakhvir; (Palampur, IN), Kumar, Sanjay; (Palampur, IN) Correspondence: Allan Ratner; RatnerPrestia; PO Box 980; Valley Forge; PA; 19482-0980; US Patent Application Number: 20030180723 Date filed: March 31, 2001 Abstract: The present invention relates to cloning of novel gene sequences expressed and repressed during winter dormancy in the apical buds of Camellia sinensis L. (O.) Kuntze (hereinafter, referred to tea) bush, particularly, relates to identification, cloning and analysis of novel 3 prime (hereinafter called as 3') ends of the genes (gene in the present invention refers to the deoxyribonucleic acid (hereinafter known as, DNA) sequences that are expressed and repressed in winter-dormant apical buds of tea. 3' end refers to that end of DNA which has free hydroxyl group at 3rd position of the carbohydrate moiety of the DNA molecule. Excerpt(s): Not applicable. Not applicable. Not applicable. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
Glutathione, green tea, grape seed extract to neutralize tobacco free radicals Inventor(s): Hersh, Theodore; (Atlanta, GA), Hersh, Rebecca; (Atlanta, GA) Correspondence: Malcolm B. Wittenberg; Crosby, Heafey, Roach & May; Suite 2000; Two Embarcadero Center; San Francisco; CA; 94111; US Patent Application Number: 20020117180 Date filed: May 11, 2001 Abstract: A composition for inclusion within a cigarette, cigar, pipe or smokeless tobacco. The composition can be included within the tobacco itself, a filter for filtering tobacco smoke once burned or even within the paper or wrapper surrounding the tobacco product. In the cigarette filter, be it internal or external filters, the antioxidant complex is capable of scavenging and neutralizing the free radicals emanating from the burning or heated tobacco and passing through the filter as the smoker inhales. The composition is also capable of reducing free radical damage to the oro-pharyngeal cavity, respiratory tract and lungs resulting from tobacco smoke. The composition includes glutathione and preferaby L-glutathione and green tea and/or grape seed extract. Excerpt(s): The present application is a continuation-in-part of U.S. application Ser. No. 09/185,172 filed Nov. 3, 1998 which, in turn, is a continuation-in-part of U.S. application Ser. No. 08/933,696, now U.S. Pat. No. 5,829,449. The present invention deals with the combination of various synergistic antioxidants, enzymatic co-factors and amino acids in appropriate delivery vehicles employed in cigarette filters and in external filters such as cigarette and cigar "holders," in "pipe filters" and in tobacco, wrappers and papers and in so-called smokeless tobacco as a means of preventing or ameliorating signs and symptoms and complications to the oro-pharyngeal cavity, respiratory tract and lungs from damage by tobacco smoke and tobacco chewed induced free radical species. The present invention can be employed in filter cigarettes, unfiltered cigarettes, cigars, pipes,
Patents 365
and smokeless tobacco products. The deleterious effects of tobacco abuse are well known and regulatory agencies as well as the public constantly react to these scientific and epidemiologic evidences. Tobacco is indeed a worldwide public health hazard accounting for significant morbidity and mortality. Although smoking places an abundant oxidant insult to the oral cavity, respiratory tract and lungs, evidence supports the notion that the oxidant burden is on the entire organism of the smoker. Smoking promotes development or enhancement of atherosclerosis, causing cardiovascular disease, chronic obstructive pulmonary disease, recently labeled "smoker's lung," cutaneous damage, especially to the face, called "smoker's face," and various forms of cancer, including carcinomas of the mouth, pharynx, esophagus and lung. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Green tea composition and molding matter thereof, and process for producing them Inventor(s): Omura, Teijiro; (Shizuoka-Shi, JP) Correspondence: William R. Evans; Ladas & Parry; 26 West 61 Street; New York; NY; 10023; US Patent Application Number: 20020028281 Date filed: April 26, 2001 Abstract: A green tea composition comprising 100 parts by weight of green tea leaf, and 0.01 to 30 parts by weight of trehalose; a process for producing a green tea composition, comprising the steps of heat-treating fresh tea leaf, drying the heat-treated leaf, and crushing the dried leaf, wherein the fresh leaf is brought into contact with trehalose before or after or simultaneously with the heat treatment of the fresh leaf; a molding matter of a green tea composition, obtained by molding a green tea composition comprising 35 to 80% by weight of granulated or powdered green tea (component (A)), 10 to 60% by weight of maltose (component (B)), and 1 to 20% by weight of trehalose (component (C)); and a process for producing a molding matter of a green tea composition, comprising the step of molding the above green tea composition. The green tea composition and the molding matter thereof undergo neither oxidation nor discoloration, so that they can preserve their green colors for a long period of time. In addition, they contain catechins at concentrations high enough to show the pharmacological effects of catechins. Excerpt(s): The present invention relates not only to green tea compositions and molding matter thereof that retain the taste and the color characteristic of green tea after fresh green tea leaves have been treated with heat and trehalose for the prevention of oxidatio and discoloration and that can fully exhibit the pharmacological effects of catechins and chlorophylls by retaining them at high concentrations, but also to the methods of producing them. A recent report has attracted particular attention that catechins contained in green tea have various pharmacological effects, that is, an antioxidant effect for preventing aging, an antimicrobial, antiviral effect, a bloodcholesterol-controlling effect, an anti-vassopressor effect, a hypoglycemic effect, an antidiabetic effect, a platelet aggregation inhibitory effect, a thrombus formation preventing effect, an antineoplastic effect, and an anticarcinogenic effect. However, the catechins in green tea are converted to brownish substances after undergoing nonenzymatic oxidation although they are converted to theaflavins and other orange-red substances to show bright colors by enzymatic oxidation when green tea leaves are
366 Tea
oxidized to black tea by fermentation. This explains a reason that green tea itself is discolored or remains yellowish when hot water is poured on. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Green tea prepared using a steamer Inventor(s): Maeda, Hiroshi; (Newport Beach, CA) Correspondence: KNOBBE MARTENS OLSON & BEAR LLP; 2040 MAIN STREET; FOURTEENTH FLOOR; IRVINE; CA; 92614; US Patent Application Number: 20030082288 Date filed: December 5, 2002 Abstract: A method of making a tasty beverage from powdered tea prepared by heating and foaming a preparation obtained by adding powdered tea to water or milk, etc., using a steam-jet supplied by a steamer of, for instance, a coffee espresso machine. Excerpt(s): The present invention relates to a method for preparing beverages and more particularly to a method for preparing beverages made of powdered tea. Tea is a beverage that has been enjoyed by many people including the Japanese since ancient times. In recent years, however, the components of tea have been scientifically studied, and it has been ascertained that tea is very good for the health of human beings. In order to insure effective ingestion of the active components of tea that is good for the health, it is desirable that the tea leaves themselves be ingested. For this purpose, the use of powdered tea, which is prepared by processing tea leaves "as is", is ideal. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
High-pressure tea steep device Inventor(s): Liu, Tzeng-Shyang; (Taipei, TW) Correspondence: TROXELL LAW OFFICE PLLC; 5205 LEESBURG PIKE; SUITE 1404; FALLS CHURCH; VA; 22041; US Patent Application Number: 20020170438 Date filed: May 16, 2001 Abstract: The present invention is a high-pressure tea steep device which is mounted with a base body, the said base body is disposed with a boiler therein, a container is inserted onto a predetermined position of the said base body, the said container is communicated with the boiler via a conduit, a filter basket is situated inside the said container, and a plurality of pores are disposed on the bottom plane of the said filter basket; when in use, the pressured hot water in the boiler is poured toward the container through the conduit at a certain speed such that the hot water can evenly and rapidly pass through the tea leaf powder inside the filter basket and then discharge from the container, thereby enabling not only the accomplishment of the steeping work in an extremely short time, but also the extraction of the essence of the tea leaves. Excerpt(s): The present invention is a high-pressure tea steep device, a device utilizing the pressuring method to pass the hot water through a container loaded with tea leaf powder that enabling the hot water to rapidly mix with the tea leaf powder inside the container and the extraction of the essence of the tea leaves, furthermore, accomplishing
Patents 367
the tea steeping work in an extremely short time and making the steeped tea with better flavor than that generally requiring a certain period of steeping time. Accordingly, the traditional way of tea steeping is to warm the teakettle first by the hot water, then to put a proper amount of tea leaves into the teakettle; after allowing the tea leaves to spread a little inside the warm teakettle, the hot water is poured into the teakettle; however, this method needs to steep tea leaves in the hot water for a certain period of time for making the tea leaves spread and the hot water permeate into the tea leaves, thereby to obtain tea mixed completely with the tea leaves; which not only takes a long steeping time, but also is not easy to control the length of time that usually ends either too short for the tea leaves to spread or so long that the flavor of the tea leaves loses and that is not very ideal. In view of the mentioned shortcomings occurred during the conventional tea steeping process, the inventor of the present invention addressed the key problems and started to improve the coffee brewing device in order to search for a rational solution; however, since the filter basket of the said coffee brewing device is too small to load the amount of tea leaves needed for one steep and the handle bar of the container for accommodating the filter basket is not big and strong enough for the user to hold; following continuous research and design, the present invention of a high pressure tea steep device is finally culminated. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Method for microproduction of tea plants from leaf explants Inventor(s): Sandal, Indra; (Himachal Pradesh, IN), Bhattacharya, Amita; (Himachal Pradesh, IN), Ahuja, P.S. (Himachal Pradesh, IN), Sharma, Madhu; (Himachal Pradesh, IN) Correspondence: FOLEY & LARDNER; Washington Harbour; Suite 500; 3000 K Street, N.W. Washington; DC; 20007-5109; US Patent Application Number: 20020137208 Date filed: March 22, 2001 Abstract: The present invention relates to novel method for micropropagation of tea plants from explants obtained from completely folded, half opened or fully expanded leaves via callus phase, by culturing the explants on different media. Excerpt(s): The present invention relates to an efficient method for micropropagation of tea plants (Camellia sinensis) using explants excised from leaves. Tea is a popular caffeine containing beverage with anti-cancerous properties (Jankun et al. Why drinking green tea could prevent cancer, Nature 5:561; 1997). Although the genus Camellia has many species, only C. sinensis (L.) O. Kuntze or tea and its different cultivars are commercially important (Barua D. N. ed. Science and practice in tea culture, Tea Research Association Calcutta; 53-68; 1989). Tea cultivation is not only an important employment generator but is also a major foreign exchange earner in all the tea growing areas of the world (Wilson, K. C. Botany and Plant Improvement in Wilson R. C., ed. Coffea Cocoa and Tea. CABI Publishing, Wallingford, UK: 167-173; 1999). However, the total production of tea is not sufficient enough to meet the demands of the domestic and the world markets (Kabra, G. D. Tea statistics for 1999 in Tea time, Vol VIII, No. 3 September-November 99, 30-31; 1999). The yield and quality of tea is further reduced by different biotic (fungi, pests and viruses) and abiotic (frost, hail, chilling, drought, nutritional deficiencies etc.) stresses (Wilson, K. C. Botany and Plant Improvement in Wilson R. C., ed. Coffea, Cocoa and Tea. CABI Publishing, Wallingford, UK: 167-173; 1999).
368 Tea
Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Method for producing instantly soluble tea tablets Inventor(s): Chen, Zhi; (Memphis, TN) Correspondence: LAW OFFICES OF CLEMENT CHENG; 17220 NEWHOPE STREET #127; FOUNTAIN VALLEY; CA; 92708; US Patent Application Number: 20030044505 Date filed: August 31, 2001 Abstract: A process for producing instantly soluble tea tablets, comprising of the steps of: creating tea extract by soaking and extracting pulverized dry tea leaves with hot water and isolating the tea extract from the extracted mixture by filtering out insoluble residues; then concentrating said tea extract by evaporating a portion of water from said tea extract; adding food grade additives to adjust flavor; vacuum freeze-drying concentrated flavored tea extract to remove all volatile components to obtain tea powder. The tealeaves can be green tea, black tea, flower tea, red tea and herb tea. Adhesion agents and dispersing agents can be mixed with the freeze-dried tea powder, and then pressing into different three-dimension-shaped tablets. Excerpt(s): Tea has been an important part of our lives. It is esteemed as a detoxifying food item in the Chinese culture. People from all over the world use it as a stimulant. Traditionally, tea must be prepared by brewing the tealeaves in the hot water. Instantly soluble tea tablets have not been in use due to the difficulty in maintaining proper taste. People can avoid the trouble of boiling hot water for brewing tea. Instantly soluble tea tablets would be light, easy to be utilized, and sanitary to handle. Through this method, the flavor, color, and taste of the tea are preserved in the instantly soluble tea tablets. Tea tablet preparation starts first with steeping the dried tea leaves with hot water, condensing and concentrating the extract, flavoring the tea to desired taste, evaporating and drying the remaining extract into powder. Auxiliary ingredients are added to make the final tea tablets. This method can be applied but not limited to green tea, fermented tea, Oolong tea, flower tea, and various herbal teas. The instantly soluble tea tablets can be made into cubical, spherical, rectangular, cylindrical, and various shapes. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
Natural teas for increasing stamina and method of preparing the same Inventor(s): Nam, Jong Hyun; (Los Angeles, CA) Correspondence: Thomas M. Galgano, Esq. Galgano & Burke; Suite 135; 300 Rabro Drive; Hauppauge; NY; 11788; US Patent Application Number: 20030086983 Date filed: March 11, 2002 Abstract: The present invention relates to natural teas and a method of preparing the same, which is effective in increasing sexual ability or stamina. According to the present invention, there are provided relatively inexpensive natural teas in the form of liquid natural teas, powders, segments, or concentrated extracts, in which Rhodiola sachalinensis, and Cuscutae Semens and/or Torilidis Fructus; Rhodiola sachalinensis and a parasitic plant; or a mixture of all the above herbs is contained as principal
Patents 369
elements, to which at least one species selected from the group consisting of Alnus japonica, Salviae Radix, Polyglae Radix, schizandra and lycium is optionally added. Where the natural teas of the present invention are drunk two times one day, an excellent effect of increasing stamina can be obtained. Excerpt(s): The present invention relates generally to natural teas for increasing stamina and a method of preparing the same. More particularly, the present invention relates to natural teas having an effect of increasing stamina, and a method of preparing the same, in which an extract from a parasitic plant, an extract from Polyglae Radix, an extract from Torilidis Fructus, an extract from Salviae Radix, an extract from Alnus japonica, or a combination thereof, is added to an extract from Rhodiola sachalinensis A. Bor. The human with excellent intellectuality recognizes a sex not only as a simple way for preservation of the species but also an important way for operating happy and pleasant family life. Today, operation of happy and pleasant family life is regarded as significantly affecting domestic happiness, although it is not essential therefor. As domestic happiness is linked with social vital power and national prosperity, its importance cannot be overlooked. Particularly in males, increasing stamina or sexual ability has been desired from ancient times, and strong stamina has been also regarded as the masculine symbol. However, it is reported through many literatures that sexual ability of the human, particularly the male, is seriously decreased from various viewpoints including a reduction in spermatozoon number, due to contamination of air, water resources and soil according to highly advanced industry, contamination of foods caused by excessive use of agricultural chemicals and treatment with preservative agents, instant foods, acute stress in harsh competition society, lack of exercise according to a busy life, and the like. Meanwhile, as the material richness is increased, and particularly an opportunity to be exposed to the sexual stimulation is highly increased due to development of mass media and an increase in netizen number, a concern about a sex is more increased. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Tea catechins as cancer specific proliferation inhibitors Inventor(s): Morre, D. James; (West Lafayette, IN), Morre, Dorothy M. (West Lafayette, IN) Correspondence: PENNIE AND EDMONDS; 1155 AVENUE OF THE AMERICAS; NEW YORK; NY; 100362711 Patent Application Number: 20020176897 Date filed: March 19, 2002 Abstract: The invention described herein encompasses a methods and compositions of treating cancer or solid tumors comprising the administration of a therapeutically effective amount of catechins, a group of polyphenols found in green tea, to a mammal in need of such therapy. Compositions of catechins include but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC). The unique compositions of the invention contain various combinations of the catechins, alone or in combination with each other or other therapeutic agents and are used to treat primary and metastatic cancers in humans. The invention also encompasses the varying modes of administration of the therapeutic compounds.
370 Tea
Excerpt(s): This application claims benefit of U.S. provisional application serial No. 60/126,893, filed Mar. 30, 1999 and U.S. provisional application serial No. 60/151,109, filed Aug. 27, 1999. The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea leaves. The unique compositions of the invention contain various amounts of the catechins, including combinations of catechins, or catechins and other therapeutic agents. These compositions are particularly useful for the treatment of primary and metastatic cancers in humans. The invention also encompasses the varying modes of administration of the therapeutic compounds or compositions. Tea is generally in the form of black, oolong, and green tea, all originating from the tea plant, Camellia sinensis. Tea is cultivated in approximately thirty countries worldwide, and is consumed globally. Although the level of tea consumption varies around the world, it is believed that tea consumption is second only to water (Ahmad et al., 1998, Nutrition and Chemical Toxicity, John Wiley and Sons, Sussex, England, pp. 301-343). Black tea is consumed predominantly in Western and some Asian countries and green tea is consumed predominantly in China, Japan, India, and a few countries in North Africa and the Middle East (Ahmad et al., 1998, Nutrition and Chemical Toxicity, John Wiley and Sons, Sussex, England, pp. 301-343). Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Tea catechins in sustained release formulations as cancer specific proliferation inhibitors Inventor(s): Chang, Michael N. (Brisbane, CA), Cooper, Raymond; (Mountain View, CA), Morre, Dorothy M. (West Lafayette, IN), Morre, D. James; (West Lafayette, IN) Correspondence: PENNIE AND EDMONDS; 1155 AVENUE OF THE AMERICAS; NEW YORK; NY; 100362711 Patent Application Number: 20020176898 Date filed: April 3, 2002 Abstract: The invention described herein encompasses a methods and compositions of treating cancer or solid tumors comprising the administration of a therapeutically effective amount of catechins, a group of polyphenols found in green tea, to a mammal in need of such therapy. Compositions of catechins include but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC). The unique compositions of the invention contain various combinations of the catechins, alone or in combination with each other or other therapeutic agents and are used to treat primary and metastatic cancers in humans. The invention also encompasses the varying modes of administration of the therapeutic compounds, including a sustained release formulation which may be used as a therapeutic compound for the treatment of cancer or as a dietary supplement for the prevention of cancer. Excerpt(s): This is a continuation-in-part of U.S. patent application Ser. No. 09/537,211, filed on Mar. 29, 2000, which is incorporated herein, by reference, in its entirety, and which in turn claims benefit to U.S. provisional application serial No. 60/126,893 filed Mar. 30, 1999 and U.S. provisional application serial no. 60/151,109 filed Aug. 27, 1999. The present invention relates to novel methods and sustained release compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg),
Patents 371
epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea leaves. The unique sustained release compositions of the invention contain various amounts of the catechins, including combinations of catechins, or catechins and other therapeutic agents. The invention also encompasses the varying modes of administration of the therapeutic compounds, such as a sustained release formulation which is used as a therapeutic compound for the treatment of cancer or as a dietary supplement for the prevention of cancer. Tea is generally in the form of black, oolong, and green tea, all originating from the tea plant, Camellia sinensis. Tea is cultivated in approximately thirty countries worldwide, and is consumed globally. Although the level of tea consumption varies around the world, it is believed that tea consumption is second only to water (Ahmad et al., 1998, Nutrition and Chemical Toxicity, John Wiley and Sons, Sussex, England, pp. 301-343). Black tea is consumed predominantly in Western and some Asian countries and green tea is consumed predominantly in China, Japan, India, and a few countries in North Africa and the Middle East (Ahmad et al., 1998, Nutrition and Chemical Toxicity, John Wiley and Sons, Sussex, England, pp. 301-343). Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Tea infuser with manual agitator Inventor(s): Kerr, Helen; (Toronto, CA) Correspondence: MARK KUSNER; Highland Place; Suite 310; 6151 Wilson Mills Road; Highland Heights; OH; 44143; US Patent Application Number: 20030101873 Date filed: December 4, 2001 Abstract: An infuser vessel (1) for containing solid particles (2) while immersed in a liquid, such as loose tea leaves in hot water, where the perforated infuser vessel (1) includes a manually movable piston (7) operated with a flexible wire (11) topped with a manual grip (12) extending upwardly from the liquid, whereby tea leaves (2) within the vessel (1) may be manually agitated to increase the speed and efficacy of infusion, while the manual grip (12) remains high and dry above the liquid. Excerpt(s): The invention relates to an infuser for containing solid particles while immersed in a liquid, such as loose tea leaves in hot water, where the perforated infuser vessel includes a manually movable piston operated with a flexible wire topped with a manual grip extending upwardly from the liquid, whereby tea leaves within the vessel may be manually agitated to increase the speed and efficacy of infusion, while the manual grip remains high and dry. Containers for infusion of tea, spices and other condiment particles are immersed into liquid such as hot water, oils and beverages, and generally utilize an enclosed screen or perforated container to eliminate the need to strain the solid particles from the liquid after infusion. Solid particles such as tea leaves are contained within the infuser vessel and are exposed to the liquid by passage of liquid through the screen or perforation of the vessel. In the case of tea and other infusions, manufactured tea bags or use of cheese cloth to wrap spices in a package perform the same function in a disposable format. A disadvantage of these infusers is that the user of a manufactured tea bag for example has no control over the amount of tea used and therefore the strength of tea produced depends on the user regulating the time of infusion or requires the user to agitate the tea bag with a spoon or suspending string. As well, use of premanufactured tea bags prevents the user from utilising their
372 Tea
own selected mix or from creating different mixes of tea flavours to suit their own particular taste. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Tea manufacture Inventor(s): Pal, Jayati; (Bangalore, IN), Virkar, Prakash Dattatraya; (Bangalore, IN), Mohan, Ravi; (Tamil Nadu, IN), Chakrabarti, Pratyaya; (Bangalore, IN), Mohan, Suri Krishna; (Bangalore, IN), Rao, Tanuja Venugopal; (Bangalore, IN) Correspondence: UNILEVER; PATENT DEPARTMENT; 45 RIVER ROAD; EDGEWATER; NJ; 07020; US Patent Application Number: 20030113406 Date filed: September 9, 2002 Abstract: A process to make tea with higher yields of a desired size comprising the steps of:(a) withering green leaf tea and optionally other materials(b) size reduction(c) fermentation(d) extrusion of the size reduced or fermented tea leaf mass through holes in a perforated body(e) cutting the extrudate(e) dryingThe desired size of the tea is preferably Broken Orange Pekoe (BOP), Broken Pekoe (BP) or Broken Orange Pekoe Souchung (BOPS). Excerpt(s): The present invention relates to a process for making a black leaf tea product of a desired size and shape. More particularly, the invention relates to a process to make a black leaf tea product in which the proportion of the product having a larger particle size is increased. Methods of preparing black leaf teas are well-known to those skilled in the art. Generally, to prepare black leaf tea, fresh green leaves of the plant Camellia sinensis are subjected to mild drying (the withering stage), are processed to reduce the size of the leaf and to disrupt the cell structure (the size reducing stage), fermented (in which process enzymes in the tea leaf use atmospheric oxygen to oxidise various substrates to produce brown-coloured products) and then fired (to dry the tea leaves). Depending on the particular process used, particularly at the size reducing stage, different grades of tea are produced. Processes in which the size reduction of the withered green leaf tea is performed by an orthodox roller or a rotovane tend to give larger leaf sizes in the black leaf tea product than processes in which the withered leaf tea is treated more dratically for example in a CTC (cut-tear-curl) process. Orthodox manufacture tends to give grades a black tea product which are graded as Whole Leaf grades whereas the use of the rotovane tends to give a black tea product that is graded as Brokens and CTC tends to give a black tea product which is graded as Fannings. See "tea--Cultivation to Consumption" edited by K. C. Willson and M. N. Clifford, Chapman and Hall, 1992 page 501. Black leaf tea with a larger particle size is considered a premium tea and commands a higher price than the smaller grades (Fannings and Dusts). All the above processes however give significant amounts of smaller grades of tea. Typically, a process as usually employed in the tea industry yields a maximum of 60% of black leaf tea product having the desired larger particle size. It is an object of the present invention to provide black leaf tea product in which the proportion of the product having a larger particle size is increased. Preferably the proportion of the black leaf tea product which would be graded as Brokens is increased. More specifically the proportion of the black leaf tea graded as Broken Orange Pekoe (BOP), Broken Pekoe (BP) and/or Broken Orange Pekoe Souchung (BOPS) is increased. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Patents 373
·
Tea polyphenol esters and analogs thereof for cancer prevention and treatment Inventor(s): Smith, David M. (Tampa, FL), Dou, Q. Ping; (Tampa, FL), Nam, Sangkil; (Tampa, FL) Correspondence: PATENT ADMINSTRATOR; KATTEN MUCHIN ZAVIS; SUITE 1600; 525 WEST MONROE STREET; CHICAGO; IL; 60661; US Patent Application Number: 20020151582 Date filed: October 11, 2001 Abstract: Disclosed herein are ester-bond containing tea polyphenols that has a susceptibility to nucleophilic attack, their analogs and pharmaceutically acceptable salts, method for inhibiting proteasomal chymotrypsin-like activity in vivo and in vitro, methods for cancer treatment with tea-derived polyphenols, such as EGCG, ECG, GCG, or CG, as well as pharmaceutical compositions comprising the same. Excerpt(s): The present application claims priority from U.S. provisional application Ser. No. 60/239,101 filed on Oct. 11, 2000, the disclosure of which is hereby incorporated by reference in its entirety. The present invention relates to polyphenol esters derived from green and black teas, and analogs thereof, which are potent inhibitors of the growth of cancerous cells. Specifically, the invention relates to polyphenol esters that inhibit chymotrypsin-like, but not trypsin-like, proteasome activity, whereby tumor cells are arrested in G.sub.1 phase and selective apoptosis of cancerous cells is promoted. Therefore, the invention relates to novel polyphenol esters and their use in the prevention and treatment of conditions characterized by abnormal cellular proliferation. Although tea-derived polyphenols affect numerous cancer-related proteins and have been shown to have anti-tumor property, their precise molecular targets have not been identified. The ubiquitin-proteasome system plays a critical role in the specific degradation of cellular proteins (Hochstrasser, 1995, Curr Opin Cell Biol 7:215-23), and one of the proteasome's functions is to protect tumor cells against apoptosis (Dou et al., 1999, Drug Resistance Updates 2:215-223). The chymotrypsin-like, but not trypsin-like, activity of the proteasome is associated with tumor cell survival (An et al., 1998, Cell Death Differ 5:1062-75; Lopes et al., 1997, J Biol Chem 272:12893-6). Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
Tea product Inventor(s): Stabler, Peter Joseph; (Bedford, GB), Parry, Andrew David; (Bedford, GB), Blair, Ruth Louisa; (Bedford, GB) Correspondence: UNILEVER; PATENT DEPARTMENT; 45 RIVER ROAD; EDGEWATER; NJ; 07020; US Patent Application Number: 20030077373 Date filed: July 2, 2002 Abstract: Black leaf tea that has the appearance of orthodox processed black tea but has the infusion characteristics of CTC processed black leaf tea. Various methods are given to define orthodox appearance and CTC infusion character. Excerpt(s): The present invention relates to a tea product, more specifically, certain black leaf teas that resemble orthodox processed tea but possess infusion characteristics more
374 Tea
similar to that of CTC processed tea. Leaf tea may be prepared as green leaf tea or black leaf tea. Generally, to prepare black leaf tea fresh green leaves of the plant Camellia sinensis are withered (subjected to mild drying), comminuted, fermented (in which process enzymes in the tea leaf use atmospheric oxygen to oxidize various substrates to produce brown-coloured products) and then fired (to dry the tea leaves). Green leaf tea is not exposed to the fermentation process. Partial fermentation may be used to produce intermediate-type teas known as "oolong" tea. Conventional wisdom dictates that in black tea manufacture tea must be macerated in some way to liberate the fermentative enzymes and their substrates within the leaves. One can macerate tea in many ways but broadly speaking there are two main mechanised methods for doing this. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Keeping Current In order to stay informed about patents and patent applications dealing with tea, you can access the U.S. Patent Office archive via the Internet at the following Web address: http://www.uspto.gov/patft/index.html. You will see two broad options: (1) Issued Patent, and (2) Published Applications. To see a list of issued patents, perform the following steps: Under “Issued Patents,” click “Quick Search.” Then, type “tea” (or synonyms) into the “Term 1” box. After clicking on the search button, scroll down to see the various patents which have been granted to date on tea. You can also use this procedure to view pending patent applications concerning tea. Simply go back to http://www.uspto.gov/patft/index.html. Select “Quick Search” under “Published Applications.” Then proceed with the steps listed above.
375
CHAPTER 7. BOOKS ON TEA Overview This chapter provides bibliographic book references relating to tea. In addition to online booksellers such as www.amazon.com and www.bn.com, excellent sources for book titles on tea include the Combined Health Information Database and the National Library of Medicine. Your local medical library also may have these titles available for loan.
Book Summaries: Online Booksellers Commercial Internet-based booksellers, such as Amazon.com and Barnes&Noble.com, offer summaries which have been supplied by each title’s publisher. Some summaries also include customer reviews. Your local bookseller may have access to in-house and commercial databases that index all published books (e.g. Books in PrintÒ). IMPORTANT NOTE: Online booksellers typically produce search results for medical and non-medical books. When searching for “tea” at online booksellers’ Web sites, you may discover nonmedical books that use the generic term “tea” (or a synonym) in their titles. The following is indicative of the results you might find when searching for “tea” (sorted alphabetically by title; follow the hyperlink to view more details at Amazon.com): ·
20,000 Secrets of Tea: The Most Effective Ways to Benefit from Nature's Healing Herbs by Victoria Zak; ISBN: 0440235294; http://www.amazon.com/exec/obidos/ASIN/0440235294/icongroupinterna
·
A Cozy Book of Herbal Teas: Recipes, Remedies, and Folk Wisdom by Mindy Toomay; ISBN: 1559585684; http://www.amazon.com/exec/obidos/ASIN/1559585684/icongroupinterna
·
Aromatic Teas and Herbal Infusions by Laura Fronty, et al (1997); ISBN: 0517708760; http://www.amazon.com/exec/obidos/ASIN/0517708760/icongroupinterna
·
Celestial Seasonings Cookbook: Cooking With Tea by Jennifer Siegel, et al (1996); ISBN: 0517200147; http://www.amazon.com/exec/obidos/ASIN/0517200147/icongroupinterna
·
Chinese Health Tea by Dang Yi; ISBN: 780005554X; http://www.amazon.com/exec/obidos/ASIN/780005554X/icongroupinterna
376 Tea
·
Cooking With Green Tea by Ying Chang Compestine, et al; ISBN: 1583330658; http://www.amazon.com/exec/obidos/ASIN/1583330658/icongroupinterna
·
Cooking With Tea: Techniques and Recipes for Appetizers, Entrees, Desserts, and More by Robert Wemischner, et al (2000); ISBN: 9625938168; http://www.amazon.com/exec/obidos/ASIN/9625938168/icongroupinterna
·
Drink to Your Health: Delicious, Easy-To-Prepare Juices, Smoothies, Teas, Soups, and Other Beverages That Deliver Vitality and Immunity by Anita Hirsch (2000); ISBN: 1569246513; http://www.amazon.com/exec/obidos/ASIN/1569246513/icongroupinterna
·
Eat Tea: Savory and Sweet Dishes Flavored with the World's Most Versatile Ingredient by Joanna Pruess (Author), John Harney (Author); ISBN: 158574350X; http://www.amazon.com/exec/obidos/ASIN/158574350X/icongroupinterna
·
Food Phytochemicals for Cancer Prevention II: Teas, Spices, and Herbs (Acs Symposium Series, No 547) by Chi-Tang Ho (Editor), et al; ISBN: 0841227691; http://www.amazon.com/exec/obidos/ASIN/0841227691/icongroupinterna
·
Fortune-Telling by Tea Leaves: A Practical Guide to the Ancient Art of Tasseography by Sasha Fenton (1996); ISBN: 0261666223; http://www.amazon.com/exec/obidos/ASIN/0261666223/icongroupinterna
·
Fun in a Teacup: Your Complete Guide to Tea Leaf Reading. by Ian. McKinnie; ISBN: 0912310618; http://www.amazon.com/exec/obidos/ASIN/0912310618/icongroupinterna
·
Green Tea For Health & Vitality: Healthful Alternatives Series by Jorg Dr Zittlau (1999); ISBN: 0806959096; http://www.amazon.com/exec/obidos/ASIN/0806959096/icongroupinterna
·
Green Tea: Antioxidant Power to Fight Disease (Good Health Guides) by Debasis Bagchi (1999); ISBN: 0879839341; http://www.amazon.com/exec/obidos/ASIN/0879839341/icongroupinterna
·
Healing Teas: How to Prepare and Use Teas to Maximize Your Health by Marie Nadine Antol (1996); ISBN: 0895297078; http://www.amazon.com/exec/obidos/ASIN/0895297078/icongroupinterna
·
Healthy Teas: Green-Black-Herbal-Fruit by Tammy Safi (2001); ISBN: 079465004X; http://www.amazon.com/exec/obidos/ASIN/079465004X/icongroupinterna
·
Heinerman's Encyclopedia of Juices Teas & Tonics by John Heinerman (1996); ISBN: 0132342049; http://www.amazon.com/exec/obidos/ASIN/0132342049/icongroupinterna
·
Herbal Tea Gardens: 22 Plans for Your Enjoyment & Well-Being by Marietta Marshall Marcin (1999); ISBN: 1580171060; http://www.amazon.com/exec/obidos/ASIN/1580171060/icongroupinterna
·
Herbal Tea Remedies: Tisanes, Cordials and Tonics for Health and Healing by Jessica Houdret (2001); ISBN: 0754808149; http://www.amazon.com/exec/obidos/ASIN/0754808149/icongroupinterna
·
Herbal Teas by Richard Craze (2001); ISBN: 0785813845; http://www.amazon.com/exec/obidos/ASIN/0785813845/icongroupinterna
Books 377
·
Herbal Teas for Lifelong Health (Storey Country Wisdom Bulletin, A-220) by Kathleen L. Brown, Jeanine Pollak (1999); ISBN: 1580172679; http://www.amazon.com/exec/obidos/ASIN/1580172679/icongroupinterna
·
Herbal Teas: 101 Nourishing Blends for Daily Health and Vitality by Kathleen Brown, et al (1999); ISBN: 1580170994; http://www.amazon.com/exec/obidos/ASIN/1580170994/icongroupinterna
·
Kombucha Phenomenon: The Miracle Health Tea: How to Safely Make and Use Kombucha by Betsy Pryor, Sanford Holst; ISBN: 188726311X; http://www.amazon.com/exec/obidos/ASIN/188726311X/icongroupinterna
·
Kombucha Rediscovered!: A Guide to the Medicinal Benefits of an Ancient Healing Tea by Klaus Kaufmann (1996); ISBN: 0920470645; http://www.amazon.com/exec/obidos/ASIN/0920470645/icongroupinterna
·
Kombucha Tea for your Health and Healing: The Most In-Depth Guide Available by Alick Bartholomew, et al; ISBN: 1858600499; http://www.amazon.com/exec/obidos/ASIN/1858600499/icongroupinterna
·
Kombucha: Tea Mushroom: The Essential Guide by Christopher Hobbs; ISBN: 188436005X; http://www.amazon.com/exec/obidos/ASIN/188436005X/icongroupinterna
·
Making Your Own Gourmet Tea Drinks: Black Teas, Green Teas, Scented Teas, Herb Teas, Iced Teas, and More by Mathew Tekulsky (1995); ISBN: 0517700301; http://www.amazon.com/exec/obidos/ASIN/0517700301/icongroupinterna
·
The Book of Coffee & Tea: A Guide to the Appreciation of Fine Coffees, Teas, and Herbal Beverages by Joel Schapira, et al (1996); ISBN: 0312140991; http://www.amazon.com/exec/obidos/ASIN/0312140991/icongroupinterna
·
The Book of Green Tea by Christine Dattner, et al (2003); ISBN: 0789308533; http://www.amazon.com/exec/obidos/ASIN/0789308533/icongroupinterna
·
The Book of Green Tea by Diana Rosen (1998); ISBN: 1580170900; http://www.amazon.com/exec/obidos/ASIN/1580170900/icongroupinterna
·
The Book of Herbal Teas: A Guide to Gathering, Brewing, and Drinking by Sara Perry, et al (1997); ISBN: 0811813371; http://www.amazon.com/exec/obidos/ASIN/0811813371/icongroupinterna
·
The Book of Tea by John P. Beilenson, Lana Kleinschmidt (Illustrator) (1995); ISBN: 0880889284; http://www.amazon.com/exec/obidos/ASIN/0880889284/icongroupinterna
·
The Book of Tea by Kakuzo Okakura (Author) (1966); ISBN: 0486200701; http://www.amazon.com/exec/obidos/ASIN/0486200701/icongroupinterna
·
The Herbal Home Remedy Book: Simple Recipes for Tinctures, Teas, Salves, Tonics, and Syrups by Joyce A. Wardwell (1998); ISBN: 1580170161; http://www.amazon.com/exec/obidos/ASIN/1580170161/icongroupinterna
The National Library of Medicine Book Index The National Library of Medicine at the National Institutes of Health has a massive database of books published on healthcare and biomedicine. Go to the following Internet site, http://locatorplus.gov/, and then select “Search LOCATORplus.” Once you are in the search
378 Tea
area, simply type “tea” (or synonyms) into the search box, and select “books only.” From there, results can be sorted by publication date, author, or relevance. The following was recently catalogued by the National Library of Medicine:11 ·
A dissertation upon tea: explaining its nature and properties by many new experiments: and demonstrating from philosophical principles, the various effects it has on different constitutions: to which is added the natural history of tea: and a detection of the several frauds used in preparing it: also a discourse on the virtues of sage and water, and an enquiry into the reasons why the same food is not equally agreeable to all constitutions: in a letter to the Right Honourable Mary Lady Malton Author: Short, Thomas,; Year: 1970; London: Printed by W. Bowyer, for Fletcher Gyles., 1730
·
A treatise on tobacco, tea, coffee, and chocolate:. the whole illustrated with copper plates, exhibiting the tea utensils of the Chinese and Perians Author: Paulli, Simon,; Year: 1972; London: Printed for T. Osborne., J. Hildyard, at York, M. Bryson, at Newcastle, and J. Leake, at Bath, 1746
·
Account of a petechial febricula: some brief notices of the deleterious and medicinal effects of green tea: a case of dropsy, by conversion of disease from the cutaneous to the serous and cellular membranes Author: Percival, Edward,; Year: 1987; Dublin: Printed for Hodges and M'Arthur., 1817
·
All about tea, by William H. Ukers. Author: Ukers, William Harrison,; Year: 1968; New York, The
·
An essay on the use and abuse of tea: being a mechanical account of its action upon human bodies; with an attempt towards adjusting the difference between perspiration and sweat Author: Tabor, Stephen J. W. (Stephen James Wilson), former owner.; Year: 1955; London: Printed for John Clarke., 1725
·
Antifungal activity of tea tree oil in vitro: a report for the Rural Industries Research and Development Corporation Author: Hammer, K. A. (Katherine A.); Year: 1807; Barton, ACT: Rural Industries Research; Development Corp., c2001; ISBN: 0642582343
·
Antimicrobial activity of tea tree oil: a report for the Rural Industries Research and Development Corporation Author: Carson, C. F. (Christine F.); Year: 1961; Barton, ACT: Rural Industries Research; Development Corporation, c1998; ISBN: 0642540993
·
Chemical and biological properties of tea infusions Author: Schubert, R. (Ralph); Year: 1725; Frankfurt: U; M, 1997; ISBN: 392132419X
·
Chemistry and applications of green tea Author: Yamamoto, Takehiko.; Year: 1700; Boca Raton: CRC Press, c1997; ISBN: 0849340063 http://www.amazon.com/exec/obidos/ASIN/0849340063/icongroupinterna
·
Clinical thermometers; report to the President on investigation no. TEA-IA-1 under section 351(d)(2)(5) of the Trade expansion act of 1962. Author: United States. Tariff Commission.; Year: 1746; Washington, D. C., 1963
·
Coffee, tea, chocolate, and the brain Author: Nehlig, Astrid.; Year: 1975; London; New York: Taylor; Francis, 2004; ISBN: 0415306914
11
In addition to LOCATORPlus, in collaboration with authors and publishers, the National Center for Biotechnology Information (NCBI) is currently adapting biomedical books for the Web. The books may be accessed in two ways: (1) by searching directly using any search term or phrase (in the same way as the bibliographic database PubMed), or (2) by following the links to PubMed abstracts. Each PubMed abstract has a "Books" button that displays a facsimile of the abstract in which some phrases are hypertext links. These phrases are also found in the books available at NCBI. Click on hyperlinked results in the list of books in which the phrase is found. Currently, the majority of the links are between the books and PubMed. In the future, more links will be created between the books and other types of information, such as gene and protein sequences and macromolecular structures. See http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Books.
Books 379
http://www.amazon.com/exec/obidos/ASIN/0415306914/icongroupinterna ·
Coffee, tea, mate, methylxanthines, and methylglyoxal. Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.; Year: 1975; [Geneva, Switzerland]: World Health Organization; International Agency for Research on Cancer, 1991; ISBN: 9283212517 http://www.amazon.com/exec/obidos/ASIN/9283212517/icongroupinterna
·
Green tea: health benefits and applications Author: Hara, Yukihiko,; Year: 1955; New York: Marcel Dekker, c2001; ISBN: 0824704703 http://www.amazon.com/exec/obidos/ASIN/0824704703/icongroupinterna
·
Guide to tea drinkers; Year: 1975; New York: Pekin
·
Herbal teas. Author: Law, Donald.; Year: 1956; Rustington, Health Science Press [1968]
·
Panacea: a poem upon tea: in two canto's Author: Tate, Nahum,; Year: 1954; London: Printed by and for J. Roberts, 1700
·
Proceedings of the International Symposium on tea Science; Year: 1970; Kanaya, Shizuoka, Japan: The Committee, 1991
·
Remarks on Mr. Mason's treatise upon tea.; Year: 1959; London, 1745
·
Soluble tea production processes. Author: Pintauro, Nicholas.; Year: 1939; Park Ridge, N. J., Noyes Data Corp., 1970
·
Standards of medical care for tea plantations in India; a report. Author: Jones, Emrys Lloyd.; Year: 1730; [New Dehli?] Ministry of Labour, 1947
·
Tea: bioactivity and therapeutic potential Author: Zhen, Yong-su.; Year: 1963; London; New York: Taylor; Francis, 2002; ISBN: 0415273455 http://www.amazon.com/exec/obidos/ASIN/0415273455/icongroupinterna
·
Tea the drink of pleasure and of health, by W. Gordon Stables. Author: Stables, Gordon,; Year: 1883; London, Field; Tuer [etc., 1883]
·
Tea tree: the genus Melaleuca Author: Southwell, Ian.; Year: 1965; Amsterdam: Harwood Academic Publishers: OPA, c1999; ISBN: 9057024179 http://www.amazon.com/exec/obidos/ASIN/9057024179/icongroupinterna
·
The compleat family physician: or, Universal medical repository: containing the causes, symptoms, preventions, and cures, of all the various maladies to which human nature is liable: with an account of every celebrated spa, British and foreign: and strictures on quackery: to which are added, the family surgery: the compleat British herbal: observations on tea, coffee, tobacco, and snuf: and a great variety of most extraordinary cases in physic and surgery: the whole forming a compleat body of domestic medicine, calculated as well to assist gentlemen of the Faculty, as for the use of private families Author: Smythson, Hugh.; Year: 1935; London: Printed for Harrison and Co., 1785
·
The relation of tea drinking to disorders of the nervous sytem Author: Bullard, William Norton,; Year: 1960; [Boston, Mass.?: s.n, 1887?]
Chapters on Tea In order to find chapters that specifically relate to tea, an excellent source of abstracts is the Combined Health Information Database. You will need to limit your search to book chapters and tea using the “Detailed Search” option. Go to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find book chapters, use the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and
380 Tea
language you prefer, and the format option “Book Chapter.” Type “tea” (or synonyms) into the “For these words:” box. The following is a typical result when searching for book chapters on tea: ·
Fluids Source: in Green, W.F. First Year: Hepatitis B. New York, NY: Marlowe and Company. 2002. p. 219-227. Contact: Available from Marlowe and Company. 161 William Street, 16th Floor, New York, NY 10038. PRICE: $15.95 plus shipping and handling. ISBN: 1569245339. Summary: Viral hepatitis B (liver infection) is one of the most preventable medical conditions due to the availability of a hepatitis B vaccine, yet an estimated 100,000 people in the United States are infected each year, and 6,000 die from complications. When the author of this book was diagnosed in 1993, he decided to be proactive in his quest to understand and manage his illness. In this chapter, the author focuses on what readers might be learning about by the end of the first year after they receive their diagnosis of hepatitis B virus (HBV) infection, discussing fluids and hydration. In nontechnical language, the author discusses the importance of staying hydration, the use of herbal teas in place of soft drinks, green tea and its nutritional components, dairy products, and what to drink at a restaurant. The second section of the chapter addresses how to incorporate 'liver-friendly' foods into one's diet.
·
Hyperoxaluria and Nephrolithiasis Source: in Bayless, T.M. and Hanauer, S.B. Advanced Therapy of Inflammatory Bowel Disease. Hamilton, Ontario: B.C. Decker Inc. 2001. p. 475-478. Contact: Available from B.C. Decker Inc. 20 Hughson Street South, P.O. Box 620, L.C.D. 1 Hamilton, Ontario L8N 3K7. (905) 522-7017 or (800) 568-7281. Fax (905) 522-7839. Email:
[email protected]. Website: www.bcdecker.com. PRICE: $129.00 plus shipping and handling. ISBN: 1550091220. Summary: This chapter on hyperoxaluria (excessive amounts of oxalate in the urine) and nephrolithiasis (kidney stones) is from the second edition of a book devoted to the details of medical, surgical, and supportive management of patients with Crohn's disease (CD) and Ulcerative Colitis (UC), together known as inflammatory bowel disease (IBD). The finding of kidney stones in association with IBD occurs with a frequency ranging from 1 percent to 5 percent. The author cautions that not all kidney stones found in patients with IBD are oxalate stones. Chemical analysis of a passed stone or of the urine must be made before enteric hyperoxaluria (the urologic term for IBD associated hyperoxaluria) can be assumed to be the cause of the nephrolithiasis. Kidney stones classically present as renal colic (pain in the area of the kidneys). Unfortunately, in patients with IBD a high index of suspicion is necessary, because the pain associated with the kidney stone may easily (and erroneously) be attributed to the underlying IBD. Microscopic hematuria (blood in the urine) is suggestive of the diagnosis. The treatment for acute, symptomatic kidney stones is initially narcotic analgesia (pain medication) with copious hydration in an attempt to help the patient pass the stone spontaneously. If this is unsuccessful, a urologist is consulted, and the stone can be removed transureterally, surgically, or by using extracorporeal shock wave lithotripsy (ESWL). Once alleviation of the stone is accomplished, preventing stone recurrence becomes important. Prevention strategies include restriction of dietary oxalate (common sources include rhubarb, spinach, beets, peanuts, chocolate, parsley, celery, tea, and coffee) and protein reduction (protein is an indirect dietary source of oxalate). 3 tables. 9 references.
Books 381
·
Chemoprevention Source: in Ord, R.A. and Blanchaert, R.H., eds. Oral Cancer: The Dentist's Role in Diagnosis, Management, Rehabilitation, and Prevention. Chicago, IL: Quintessence Publishing Co, Inc. 1999. p. 231-237. Contact: Available from Quintessence Publishing Co, Inc. 551 Kimberly Drive, Carol Stream, IL 60188-9981. (800) 621-0387. Fax (630) 682-3288. E-mail:
[email protected]. Website: www.quintpub.com. PRICE: $79.00 plus shipping and handling. ISBN: 0867153571. Summary: Carcinogenesis (the development of cancer) is postulated to be a multistep process. Initiation events, which result in DNA damage, are followed by a reversible promotion phase, and finally by progression to full malignant cancer. This chapter on chemoprevention is from a book on oral cancer written specifically for dental health care providers, including dental students, general dentists, dental specialists, and hygienists. The author hypothesizes that premalignant intraepithelial neoplasia (dysplasia, or changes in cell structure) defined as a localized abnormal proliferation of cells that precedes malignant invasion, may represent a stage of carcinogenesis that is reversible. Chemoprevention refers to the administration of an agent to prevent a cancer from occurring. The agent can be a drug or a natural product, should be easy to administer, cause little or no toxicity, cause no long term adverse sequelae, be affordable, and, ideally, need to be administered only for a short time, relative to a lifetime. The author reviews the current status of clinical trials for prevention of the initial head and neck tumor in patients at high risk for developing the disease, as well as trials for prevention of second primary tumors after an initial tumor has received curative treatment. Agents discussed include retinoids, beta carotene, N acetylcysteine, nonsteroidal antiinflammatory agents (NSAIDs), vitamin E, interferons, curcumin, and green tea. 31 references.
·
Therapy of Oral Diseases Source: in Eisen, D. and Lynch, D.P. Mouth: Diagnosis and Treatment. St. Louis, MO: Mosby, Inc. 1998. p. 277-289. Contact: Available from Harcourt Health Sciences. Book Order Fulfillment Department, 11830 Westline Industrial Drive, St. Louis, MO 63146-9988. Website: www.mosby.com. PRICE: $79.95 plus shipping and handling. ISBN: 0815131054. Summary: The identification and treatment of oral manifestations of systemic diseases require close collaboration with appropriate medical and dental specialists in the fields of dermatology, infectious disease, rheumatology, endocrinology, and hematology, as well as the dental specialties of oral and maxillofacial pathology, oral and maxillofacial surgery, and periodontology. This chapter on the therapy of oral diseases is from a textbook on the mouth that offers information to primary care physicians and to many specialists in medicine and dentistry. Topics include general principles, the treatment of oral pain, the topical treatment of inflammatory oral diseases, systemic treatment of inflammatory oral diseases, retinoids for leukoplakia, antiviral therapy for herpes infections, antifungal therapy, burning mouth syndrome, and natural alternatives (including green tea). 5 tables. 36 references.
·
Allergic and Toxic Contact Stomatitis Source: in Bork, K., et al. Diseases of the Oral Mucosa and the Lips. Orlando, FL: W.B. Saunders Company. 1993. p. 181-189.
382 Tea
Contact: Available from W.B. Saunders Company. Order Fulfillment, 6277 Sea Harbor Drive, Orlando, FL 32887-4430. (800) 545-2522 (individuals) or (800) 782-4479 (schools); Fax (800) 874-6418 or (407) 352-3445; http://www.wbsaunders.com. PRICE: $99.00 plus shipping and handling. ISBN: 0721640397. Summary: This chapter, from a textbook on diseases of the oral mucosa and the lips, discusses allergic and toxic contact stomatitis. The authors note that allergic contact reactions are in general extremely rare in the oral mucosa and far less common than on the skin. Topics include allergic contact stomatitis, dental materials (metal prostheses, plastic prostheses, cements, glazes and veneers, amalgam, and adhesives), other allergens in the mouth, irritant contact stomatitis, leukoedema, nicotinic stomatitis (from the action of heat and nicotine on the hard palate), and exogenous tooth pigmentation, from coffee, Thi, smoking, or medications. For each topic, the authors describe the clinical features and present brief therapeutic recommendations. Full-color photographs illustrate the chapter; references are provided for some sections. 9 figures. 2 tables. 54 references. (AA-M).
383
CHAPTER 8. PERIODICALS AND NEWS ON TEA Overview In this chapter, we suggest a number of news sources and present various periodicals that cover tea.
News Services and Press Releases One of the simplest ways of tracking press releases on tea is to search the news wires. In the following sample of sources, we will briefly describe how to access each service. These services only post recent news intended for public viewing.
PR Newswire To access the PR Newswire archive, simply go to http://www.prnewswire.com/. Select your country. Type “tea” (or synonyms) into the search box. You will automatically receive information on relevant news releases posted within the last 30 days. The search results are shown by order of relevance.
Reuters Health The Reuters’ Medical News and Health eLine databases can be very useful in exploring news archives relating to tea. While some of the listed articles are free to view, others are available for purchase for a nominal fee. To access this archive, go to http://www.reutershealth.com/en/index.html and search by “tea” (or synonyms). The following was recently listed in this archive for tea: ·
Drinking tea may lower bad cholesterol - USDA study Source: Reuters Health eLine Date: October 01, 2003 http://www.reutershealth.com/archive/2003/10/01/eline/links/20031001elin003.htm l
384 Tea
·
FDA advises people not to drink star anise teas Source: Reuters Health eLine Date: September 11, 2003
·
Topical tea polyphenols may block UV light-induced carcinogenesis Source: Reuters Industry Breifing Date: September 09, 2003
·
Lotion made from tea may block skin cancer Source: Reuters Health eLine Date: September 09, 2003
·
Green tea compound blocks bladder tumors in rats Source: Reuters Health eLine Date: August 13, 2003
·
Anticancer effects of green tea may relate to blockage of hydrocarbon receptor Source: Reuters Industry Breifing Date: August 08, 2003
·
Consumption of tea products may lower cholesterol levels Source: Reuters Industry Breifing Date: June 25, 2003
·
Tea compounds may fight bad breath Source: Reuters Health eLine Date: May 20, 2003
·
Drink tea to stay germ-free: report Source: Reuters Health eLine Date: April 21, 2003
·
Chinese tea ingredient may help newborn jaundice Source: Reuters Health eLine Date: March 27, 2003
·
Smoking, tea drinking tied to urinary incontinence Source: Reuters Health eLine Date: March 06, 2003
·
Green tea doesn't treat advanced prostate cancer Source: Reuters Health eLine Date: March 04, 2003
Periodicals and News 385
·
Black tea may lower heart disease risks Source: Reuters Health eLine Date: January 01, 2003
·
Green tea may protect against heart attack Source: Reuters Health eLine Date: December 12, 2002
·
Fire fears spur US recall of 'tea light' candles Source: Reuters Health eLine Date: December 11, 2002
·
Tea may reduce risk of cancer, heart disease: Forum Source: Reuters Health eLine Date: September 25, 2002
·
Topical application of tea components inhibit UVB-induced tumorigenesis Source: Reuters Industry Breifing Date: August 27, 2002
·
Man's herbal tea use linked to liver damage Source: Reuters Health eLine Date: July 17, 2002
·
Compounds in tea may keep bones strong: study Source: Reuters Health eLine Date: May 13, 2002
·
Tea may protect heart attack survivors: study Source: Reuters Health eLine Date: May 06, 2002
·
Cigarettes, tea linked to lower Parkinson's risk Source: Reuters Health eLine Date: April 19, 2002
·
Green tea slows mouse muscular-dystrophy condition Source: Reuters Health eLine Date: April 04, 2002
·
Tea may help keep blood flowing after fatty meal Source: Reuters Health eLine Date: February 26, 2002
386 Tea
·
Antioxidant levels of common teas vary widely Source: Reuters Health eLine Date: February 26, 2002
·
How green tea may fight inflammation Source: Reuters Health eLine Date: January 28, 2002
·
Green tea chemical may prevent brain damage Source: Reuters Health eLine Date: October 12, 2001
·
Black tea may cut heart disease risk: study Source: Reuters Health eLine Date: October 08, 2001
·
Scientists identify black tea's anti-cancer secret Source: Reuters Health eLine Date: August 29, 2001
·
Tea, chocolate may be heart-healthy snacks Source: Reuters Health eLine Date: August 06, 2001
·
Green tea linked to reduced breast cancer risk Source: Reuters Health eLine Date: July 18, 2001
·
Unilever warns ice tea bottles could burst Source: Reuters Health eLine Date: July 02, 2001
·
Study suggests black tea helps prevent cavities Source: Reuters Health eLine Date: May 23, 2001
·
Tea may fight viruses, researchers suggest Source: Reuters Health eLine Date: May 21, 2001
·
Green tea may protect against stomach disorder Source: Reuters Health eLine Date: May 21, 2001
Periodicals and News 387
·
Burn hazard prompts recall of 24,000 tea kettles Source: Reuters Health eLine Date: April 30, 2001
·
Arizona Iced Tea potential subject of FDA review Source: Reuters Health eLine Date: April 04, 2001
·
Green tea may not prevent stomach cancer: study Source: Reuters Health eLine Date: February 28, 2001
·
Oolong tea may relieve symptoms of atopic dermatitis Source: Reuters Health eLine Date: January 25, 2001
·
Wine, tea may protect against non-fatal heart attack Source: Reuters Health eLine Date: December 27, 2000
·
Tea may benefit blood vessels Source: Reuters Health eLine Date: November 13, 2000
·
Clarification: Herbal tea and breastfeeding Source: Reuters Health eLine Date: November 09, 2000
·
Herbal tea can pose hidden dangers in breast-feeding Source: Reuters Health eLine Date: November 01, 2000
·
Green tea consumption enhances plasma antioxidant capacity Source: Reuters Industry Breifing Date: August 17, 2000
·
Green tea may fight skin cancer but needs more study Source: Reuters Health eLine Date: August 16, 2000
·
Tea tree oil effectively kills resistant microorganisms Source: Reuters Industry Breifing Date: June 13, 2000
388 Tea
·
White tea may help fight cancer Source: Reuters Health eLine Date: March 30, 2000
·
Drinking tea may reduce fracture risk in elderly Source: Reuters Health eLine Date: March 30, 2000
·
Tea may be good for your heart Source: Reuters Health eLine Date: March 07, 2000
·
Green tea extract may promote weight loss Source: Reuters Health eLine Date: December 30, 1999
·
Green tea extract promotes energy expenditure, fat oxidation Source: Reuters Medical News Date: December 27, 1999
The NIH Within MEDLINEplus, the NIH has made an agreement with the New York Times Syndicate, the AP News Service, and Reuters to deliver news that can be browsed by the public. Search news releases at http://www.nlm.nih.gov/medlineplus/alphanews_a.html. MEDLINEplus allows you to browse across an alphabetical index. Or you can search by date at the following Web page: http://www.nlm.nih.gov/medlineplus/newsbydate.html. Often, news items are indexed by MEDLINEplus within its search engine.
Business Wire Business Wire is similar to PR Newswire. To access this archive, simply go to http://www.businesswire.com/. You can scan the news by industry category or company name.
Market Wire Market Wire is more focused on technology than the other wires. To browse the latest press releases by topic, such as alternative medicine, biotechnology, fitness, healthcare, legal, nutrition, and pharmaceuticals, access Market Wire’s Medical/Health channel at http://www.marketwire.com/mw/release_index?channel=MedicalHealth. Or simply go to Market Wire’s home page at http://www.marketwire.com/mw/home, type “tea” (or synonyms) into the search box, and click on “Search News.” As this service is technology oriented, you may wish to use it when searching for press releases covering diagnostic procedures or tests.
Periodicals and News 389
Search Engines Medical news is also available in the news sections of commercial Internet search engines. See the health news page at Yahoo (http://dir.yahoo.com/Health/News_and_Media/), or you can use this Web site’s general news search page at http://news.yahoo.com/. Type in “tea” (or synonyms). If you know the name of a company that is relevant to tea, you can go to any stock trading Web site (such as http://www.etrade.com/) and search for the company name there. News items across various news sources are reported on indicated hyperlinks. Google offers a similar service at http://news.google.com/.
BBC Covering news from a more European perspective, the British Broadcasting Corporation (BBC) allows the public free access to their news archive located at http://www.bbc.co.uk/. Search by “tea” (or synonyms).
Newsletter Articles Use the Combined Health Information Database, and limit your search criteria to “newsletter articles.” Again, you will need to use the “Detailed Search” option. Go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. Go to the bottom of the search page where “You may refine your search by.” Select the dates and language that you prefer. For the format option, select “Newsletter Article.” Type “tea” (or synonyms) into the “For these words:” box. You should check back periodically with this database as it is updated every three months. The following is a typical result when searching for newsletter articles on tea: ·
Dieter's Brews Make Tea Time a Dangerous Affair Source: FDA Consumer. July/August 1997. Contact: FDA, HFI-40, Rockville, MD 20857. Email:
[email protected]. Website: http://www.fda.gov/. Summary: Kurtzweil discusses so-called dieters' teas, which are advertised as weightloss beverages. The author says the main effect of these drinks is diarrhea, as the main ingredient is usually a laxative. This is not effective as a weight-loss method, and may be dangerous. She discusses the possible warning signs of overdose or misuse and points out that all such preparations must carry a warning label.
Academic Periodicals covering Tea Numerous periodicals are currently indexed within the National Library of Medicine’s PubMed database that are known to publish articles relating to tea. In addition to these sources, you can search for articles covering tea that have been published by any of the periodicals listed in previous chapters. To find the latest studies published, go to http://www.ncbi.nlm.nih.gov/pubmed, type the name of the periodical into the search box, and click “Go.”
390 Tea
If you want complete details about the historical contents of a journal, you can also visit the following Web site: http://www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi. Here, type in the name of the journal or its abbreviation, and you will receive an index of published articles. At http://locatorplus.gov/, you can retrieve more indexing information on medical periodicals (e.g. the name of the publisher). Select the button “Search LOCATORplus.” Then type in the name of the journal and select the advanced search option “Journal Title Search.”
391
CHAPTER 9. RESEARCHING MEDICATIONS Overview While a number of hard copy or CD-ROM resources are available for researching medications, a more flexible method is to use Internet-based databases. Broadly speaking, there are two sources of information on approved medications: public sources and private sources. We will emphasize free-to-use public sources.
U.S. Pharmacopeia Because of historical investments by various organizations and the emergence of the Internet, it has become rather simple to learn about the medications recommended for tea. One such source is the United States Pharmacopeia. In 1820, eleven physicians met in Washington, D.C. to establish the first compendium of standard drugs for the United States. They called this compendium the U.S. Pharmacopeia (USP). Today, the USP is a non-profit organization consisting of 800 volunteer scientists, eleven elected officials, and 400 representatives of state associations and colleges of medicine and pharmacy. The USP is located in Rockville, Maryland, and its home page is located at http://www.usp.org/. The USP currently provides standards for over 3,700 medications. The resulting USP DIÒ Advice for the PatientÒ can be accessed through the National Library of Medicine of the National Institutes of Health. The database is partially derived from lists of federally approved medications in the Food and Drug Administration’s (FDA) Drug Approvals database, located at http://www.fda.gov/cder/da/da.htm. While the FDA database is rather large and difficult to navigate, the Phamacopeia is both user-friendly and free to use. It covers more than 9,000 prescription and over-the-counter medications. To access this database, simply type the following hyperlink into your Web browser: http://www.nlm.nih.gov/medlineplus/druginformation.html. To view examples of a given medication (brand names, category, description, preparation, proper use, precautions, side effects, etc.), simply follow the hyperlinks indicated within the United States Pharmacopeia (USP). Below, we have compiled a list of medications associated with tea. If you would like more information on a particular medication, the provided hyperlinks will direct you to ample documentation (e.g. typical dosage, side effects, drug-interaction risks, etc.). The following
392 Tea
drugs have been mentioned in the Pharmacopeia and other sources as being potentially applicable to tea: Acyclovir ·
Systemic - U.S. Brands: Zovirax http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202008.html
Alendronate ·
Systemic - U.S. Brands: Fosamax http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202794.html
Amantadine ·
Systemic - U.S. Brands: Symmetrel http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202024.html
Aminobenzoate Potassium ·
Systemic - U.S. Brands: Potaba http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202025.html
Amphetamines ·
Systemic - U.S. Brands: Adderall; Desoxyn; Desoxyn Gradumet; Dexedrine; Dexedrine Spansule; DextroStat http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202031.html
Amprenavir ·
Systemic - U.S. Brands: Agenerase http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203778.html
Anesthetics ·
Dental - U.S. Brands: Anbesol Maximum Strength Gel; Anbesol Maximum Strength Liquid; Anbesol Regular Strength Gel; Anbesol Regular Strength Liquid; Anbesol, Baby; Benzodent; Chloraseptic Lozenges; Chloraseptic Lozenges, Children's; Dentapaine; Dent-Zel-Ite; Hurricaine; Numzi http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202038.html
·
Topical - U.S. Brands: Almay Anti-itch Lotion; Americaine Topical Anesthetic First Aid Ointment; Americaine Topical Anesthetic Spray; Butesin Picrate; DermaFlex; Dermoplast; Lagol; Nupercainal Cream; Nupercainal Ointment; Pontocaine Cream; Pontocaine Ointment; Pramegel; Prax; http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202042.html
Anticholinergics/Antispasmodics ·
Systemic - U.S. Brands: Anaspaz; A-Spas S/L; Banthine; Bentyl; Cantil; Cystospaz; Cystospaz-M; Donnamar; ED-SPAZ; Gastrosed; Homapin; Levbid; Levsin; Levsin/SL; Levsinex Timecaps; Pro-Banthine; Quarzan; Robinul; Robinul Forte; Symax SL; Transderm-Scop http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202049.html
Researching Medications 393
Anticonvulsants, Hydantoin ·
Systemic - U.S. Brands: Cerebyx; Dilantin; Dilantin Infatabs; Dilantin Kapseals; Dilantin-125; Mesantoin; Peganone; Phenytex http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202052.html
Anticonvulsants, Succinimide ·
Systemic - U.S. Brands: Celontin; Zarontin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202053.html
Antidiabetic Agents, Sulfonylurea ·
Systemic - U.S. Brands: Amaryl; DiaBeta; Diabinese; Dymelor; Glucotrol; Glucotrol XL; Glynase PresTab; Micronase; Orinase; Tolinase http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202742.html
Antifungals, Azole ·
Systemic - U.S. Brands: Diflucan; Nizoral; Sporanox http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202697.html
Antihemophilic Factor ·
Systemic - U.S. Brands: Alphanate; Bioclate; Helixate; Humate-P; Hyate:C; Koate-HP; Kogenate; Monarc-M; Monoclate-P; Recombinate http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202671.html
Antihistamines ·
Systemic - U.S. Brands: Aller-Chlor; AllerMax Caplets; Aller-med; Atarax; Banophen; Banophen Caplets; Benadryl; Benadryl Allergy; Bromphen; Calm X; Chlo-Amine; Chlorate; Chlor-Trimeton; Chlor-Trimeton Allergy; Chlor-Trimeton Repetabs; Claritin; Claritin Reditabs; Compoz; Conta http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202060.html
Antihistamines and Decongestants ·
Systemic - U.S. Brands: A.R.M. Maximum Strength Caplets; Actagen; Actifed; Actifed Allergy Nighttime Caplets 20; Alcomed; Alcomed 2-60; Allent; Allercon; Allerest Maximum Strength; Allerfrim; Allerphed; Amilon; Anamine; Anamine T.D. Andec; Andec-TR; Aprodrine; Atrofed; Atrohi http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202061.html
Antihistamines, Decongestants, and Analgesics ·
Systemic - U.S. Brands: Aclophen; Actifed Cold & Sinus; Actifed Cold & Sinus Caplets; Actifed Sinus Nighttime; Actifed Sinus Nighttime Caplets; Alka-Seltzer Plus Allergy Medicine Liqui-Gels; Alka-Seltzer Plus Cold Medicine; Alka-Seltzer Plus Cold Medicine Liqui-Gels; Allerest http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202062.html
Antihistamines, Decongestants, and Anticholinergics ·
Systemic - U.S. Brands: Note: http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202653.html
394 Tea
Antihistamines, Phenothiazine-Derivative ·
Systemic - U.S. Brands: Anergan 25; Anergan 50; Antinaus 50; Pentazine; Phenazine 25; Phenazine 50; Phencen-50; Phenergan; Phenergan Fortis; Phenergan Plain; Phenerzine; Phenoject-50; Pro-50; Promacot; Pro-Med 50; Promet; Prorex-25; Prorex-50; Prothazine; Prothazine Plain; Sho http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202063.html
Anti-Inflammatory Drugs, Nonsteroidal ·
Systemic - U.S. Brands: Actron; Advil; Advil Caplets; Advil, Children's; Aleve; Anaprox; Anaprox DS; Ansaid; Bayer Select Ibuprofen Pain Relief Formula Caplets; Cataflam; Clinoril; Cotylbutazone; Cramp End; Daypro; Dolgesic; Dolobid; EC-Naprosyn; Excedrin IB; Excedrin IB Caple http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202743.html
Antimyasthenics ·
Systemic - U.S. Brands: Mestinon; Mestinon Timespans; Mytelase Caplets; Prostigmin; Regonol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202065.html
Appetite Suppressants, Sympathomimetic ·
Systemic - U.S. Brands: Adipex-P; Adipost; Bontril PDM; Bontril Slow-Release; Didrex; Fastin; Ionamin; Mazanor; Melfiat; Obenix; Obezine; Phendiet; Phendiet105; Phentercot; Phentride; Plegine; Prelu-2; Pro-Fast; PT 105; Sanorex; Tenuate; Tenuate Dospan; Tepanil Ten-Tab; Teram http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202069.html
Ardeparin ·
Systemic - U.S. Brands: Normiflo http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203494.html
Atovaquone ·
Systemic - U.S. Brands: Mepron http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202648.html
Attapulgite ·
Oral - U.S. Brands: Diar-Aid; Diarrest; Diasorb; Diatrol; Donnagel; Kaopectate; Kaopek; K-Pek; Parepectolin; Rheaban http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202076.html
Benzodiazepines ·
Systemic - U.S. Brands: Alprazolam Intensol; Ativan; Dalmane; Diastat; Diazepam Intensol; Dizac; Doral; Halcion; Klonopin; Librium; Lorazepam Intensol; Paxipam; ProSom; Restoril; Serax; Tranxene T-Tab; Tranxene-SD; Tranxene-SD Half Strength; Valium; Xanax http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202084.html
Researching Medications 395
Beta-Adrenergic Blocking Agents ·
Systemic - U.S. Brands: Betapace; Blocadren; Cartrol; Corgard; Inderal; Inderal LA; Kerlone; Levatol; Lopressor; Normodyne; Sectral; Tenormin; Toprol-XL; Trandate; Visken; Zebeta http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202087.html
Bismuth Subsalicylate ·
Oral - U.S. Brands: Bismatrol; Pepto-Bismol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202092.html
Bronchodilators, Adrenergic ·
Oral/Injection - U.S. Brands: Adrenalin; Alupent; Ana-Guard; Brethine; Bricanyl; EpiPen Auto-Injector; EpiPen Jr. Auto-Injector; Isuprel; Proventil; Proventil Repetabs; Ventolin; Volmax http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202096.html
Bronchodilators, Theophylline ·
Systemic - U.S. Brands: Aerolate Sr; Asmalix; Choledyl; Choledyl SA; Elixophyllin; Lanophyllin; Phyllocontin; Quibron-T Dividose; Quibron-T/SR Dividose; Respbid; Slo-Bid Gyrocaps; Slo-Phyllin; Theo-24; Theobid Duracaps; Theochron; Theo-Dur; Theolair; Theolair-SR; Theo-Time; Th http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/201945.html
Caffeine ·
Systemic - U.S. Brands: Cafcit; Caffedrine Caplets; Dexitac Stay Alert Stimulant; Enerjets; Keep Alert; Maximum Strength SnapBack Stimulant Powders; NoDoz Maximum Strength Caplets; Pep-Back; Quick Pep; Ultra Pep-Back; Vivarin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202105.html
Carbamazepine ·
Systemic - U.S. Brands: Atretol; Carbatrol; Epitol; Tegretol; Tegretol-XR http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202111.html
Cephalosporins ·
Systemic - U.S. Brands: Ancef; Ceclor; Ceclor CD; Cedax; Cefadyl; Cefizox; Cefobid; Cefotan; Ceftin; Cefzil; Ceptaz; Claforan; Duricef; Fortaz; Keflex 20; Keftab 20; Kefurox; Kefzol; Mandol; Maxipime; Mefoxin; Monocid; Omnicef; Rocephin; Suprax; Tazicef; Tazidime; Vantin; Velo http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html
Chloramphenicol ·
Systemic - U.S. Brands: Chloromycetin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202127.html
Chlordiazepoxide and Amitriptyline ·
Systemic - U.S. Brands: Limbitrol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202129.html
396 Tea
Cholestyramine ·
Oral - U.S. Brands: Questran http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202137.html
Citrates ·
Systemic - U.S. Brands: Bicitra; Citrolith; Oracit; Polycitra Syrup; Polycitra-K; Polycitra-K Crystals; Polycitra-LC; Urocit-K http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202144.html
Clarithromycin ·
Systemic - U.S. Brands: Biaxin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202667.html
Clindamycin ·
Systemic - U.S. Brands: Cleocin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202145.html
·
Topical - U.S. Brands: Clinda-Derm http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202146.html
Colestipol ·
Oral - U.S. Brands: Colestid http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202161.html
Corticosteroids Glucocorticoid Effects ·
Systemic - U.S. Brands: Acetocot; A-hydroCort; Amcort; A-MethaPred; Aristocort; Aristocort Forte; Aristopak; Aristospan; Articulose-50; Articulose-L.A. Celestone; Celestone Phosphate; Celestone Soluspan; Cinalone 40; Cinonide 40; Clinacort; Clinalog; Cordrol; Cortastat; Corta http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202018.html
Cromolyn ·
Inhalation - U.S. Brands: Intal http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202166.html
Cyclosporine ·
Systemic - U.S. Brands: Neoral; Sandimmune; SangCya http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202176.html
Cysteamine ·
Systemic - U.S. Brands: Cystagon http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202772.html
Dalteparin ·
Systemic - U.S. Brands: Fragmin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202910.html
Danaparoid ·
Systemic - U.S. Brands: Orgaran http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203583.html
Researching Medications 397
Decongestants and Analgesics ·
Systemic - U.S. Brands: Actifed Sinus Daytime; Actifed Sinus Daytime Caplets; Advil Cold and Sinus; Advil Cold and Sinus Caplets; Alka-Seltzer Plus Sinus Medicine; Allerest No-Drowsiness Caplets; Aspirin-Free Bayer Select Sinus Pain Relief Caplets; BC Cold Powder Non-Drowsy Fo http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202184.html
Dextromethorphan ·
Systemic - U.S. Brands: Cough-X; Creo-Terpin; Trocal http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202187.html
Didanosine ·
Systemic - U.S. Brands: Videx http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202616.html
Difenoxin and Atropine ·
Systemic - U.S. Brands: Motofen http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202193.html
Dihydroergotamine ·
Nasal-Systemic - U.S. Brands: Migranal http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203569.html
Diphenoxylate and Atropine ·
Systemic - U.S. Brands: Lofene; Logen; Lomocot; Lomotil; Lonox; Vi-Atro http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202200.html
Disulfiram ·
Systemic - U.S. Brands: Antabuse http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202603.html
Diuretics, Loop ·
Systemic - U.S. Brands: Bumex; Edecrin; Lasix; Myrosemide http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202205.html
Diuretics, Thiazide ·
Systemic - U.S. Brands: Aquatensen; Diucardin; Diulo; Diuril; Enduron; Esidrix; Hydro-chlor; Hydro-D; HydroDIURIL; Hydromox; Hygroton; Metahydrin; Microzide; Mykrox; Naqua; Naturetin; Oretic; Renese; Saluron; Thalitone; Trichlorex 10; Zaroxolyn http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202208.html
Dyphylline ·
Systemic - U.S. Brands: Dilor; Dilor-400; Lufyllin; Lufyllin-400 http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202752.html
Enoxaparin ·
Systemic - U.S. Brands: Lovenox http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202686.html
398 Tea
Epoetin ·
Systemic - U.S. Brands: Epogen; Procrit http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202214.html
Epoprostenol ·
Systemic - U.S. Brands: Flolan http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203429.html
Ergotamine, Belladonna Alkaloids, and Phenobarbital ·
Systemic - U.S. Brands: Bellergal-S http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202217.html
Erythromycin and Sulfisoxazole ·
Systemic - U.S. Brands: Eryzole; Pediazole http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202224.html
Erythromycins ·
Systemic - U.S. Brands: E.E.S. E-Base; E-Mycin; ERYC; EryPed; Ery-Tab; Erythro; Erythrocin; Erythrocot; Ilosone; Ilotycin; My-E; PCE; Wintrocin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202223.html
Estrogens and Progestins Oral Contraceptives ·
Systemic - U.S. Brands: Alesse; Brevicon; Demulen 1/35; Demulen 1/50; Desogen; Estrostep; Estrostep Fe; Genora 0.5/35; Genora 1/35; Genora 1/50; Intercon 0.5/35; Intercon 1/35; Intercon 1/50; Jenest; Levlen; Levlite; Levora 0.15/30; Lo/Ovral; Loestrin 1.5/30; Loestrin 1/20; Lo http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202228.html
Ethambutol ·
Systemic - U.S. Brands: Myambutol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202229.html
Ethchlorvynol ·
Systemic - U.S. Brands: Placidyl http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202230.html
Etidronate ·
Systemic - U.S. Brands: Didronel http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202233.html
Factor Ix ·
Systemic - U.S. Brands: BeneFix; Mononine http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202674.html
Felbamate ·
Systemic - U.S. Brands: Felbatol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202711.html
Researching Medications 399
Fentanyl ·
Transdermal-Systemic - U.S. Brands: Duragesic http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202702.html
Fluoxetine ·
Systemic - U.S. Brands: Prozac; Sarafem http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202247.html
Fluticasone ·
Inhalation-Local - U.S. Brands: Flovent http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203649.html
Fructose, Dextrose, and Phosphoric Acid ·
Oral - U.S. Brands: Emetrol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202251.html
Furazolidone ·
Oral - U.S. Brands: Furoxone http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202252.html
Glatiramer Acetate ·
Systemic - U.S. Brands: Copaxone http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203473.html
Griseofulvin ·
Systemic - U.S. Brands: Fulvicin-U/F; Grisactin; Gris-PEG http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202268.html
Growth Hormone ·
Systemic - U.S. Brands: Genotropin; Genotropin Miniquick; Humatrope; Norditropin; Nutropin; Nutropin AQ; Protropin; Saizen; Serostim http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202269.html
Halofantrine ·
Systemic - U.S. Brands: Halfan http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202677.html
Haloperidol ·
Systemic - U.S. Brands: Haldol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202278.html
Headache Medicines, Ergot Derivative-Containing ·
Systemic - U.S. Brands: Cafergot; Cafertine; Cafetrate; D.H.E. 45; Ercaf; ErgoCaff; Ergomar; Ergostat; Gotamine; Migergot; Wigraine http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202216.html
400 Tea
Histamine H 2 -Receptor Antagonists ·
Systemic - U.S. Brands: Axid; Axid AR; Mylanta AR Acid Reducer; Pepcid; Pepcid AC Acid Controller; Pepcid I.V. Pepcid RPD; Tagamet; Tagamet HB; Zantac; Zantac EFFERdose Granules; Zantac EFFERdose Tablets http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202283.html
Hydroxypropyl Cellulose ·
Ophthalmic - U.S. Brands: Lacrisert http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202289.html
Hydroxypropyl Methylcellulose ·
Ophthalmic - U.S. Brands: Gonak; Goniosoft; Goniosol; Lacril; Ocucoat; Tearisol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202290.html
Indinavir ·
Systemic - U.S. Brands: Crixivan http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203523.html
Insulin ·
Systemic - U.S. Brands: Humulin 50/50; Humulin 70/30; Humulin 70/30 Pen; Humulin L; Humulin N; Humulin N Pen; Humulin R; Humulin R, Regular U500 (Concentrated); Humulin U; Lente; Lente Iletin II; Novolin 70/30; Novolin 70/30 PenFill; Novolin 70/30 Prefilled; Novolin L; Novoli http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203298.html
Insulin Aspart ·
Systemic - U.S. Brands: NovoLog http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500253.html
Insulin Glargine ·
Systemic - U.S. Brands: Lantus http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500147.html
Insulin Lispro ·
Systemic - U.S. Brands: Humalog http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203622.html
Interferon, Beta-1B ·
Systemic - U.S. Brands: Betaseron http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203538.html
Iron Supplements ·
Systemic - U.S. Brands: DexFerrum; Femiron; Feosol; Feostat; Feostat Drops; Feratab; Fer-gen-sol; Fergon; Fer-In-Sol Capsules; Fer-In-Sol Drops; Fer-In-Sol Syrup; Fer-Iron Drops; Fero-Gradumet; Ferospace; Ferralet; Ferralet Slow Release; Ferralyn Lanacaps; Ferra-TD; Ferretts; http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202305.html
Researching Medications 401
Isoniazid ·
Systemic - U.S. Brands: Laniazid; Nydrazid http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202307.html
Kaolin and Pectin ·
Oral - U.S. Brands: Kao-Spen; Kapectolin; K-P http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202313.html
Ketorolac ·
Systemic - U.S. Brands: Toradol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202318.html
Lamivudine ·
Systemic - U.S. Brands: Epivir; Epivir-HBV http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202292.html
·
Systemic - U.S. Brands: Epivir; Epivir-HBV http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202791.html
·
Systemic - U.S. Brands: Epivir; Epivir-HBV http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203689.html
Lamotrigine ·
Systemic - U.S. Brands: Lamictal http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202786.html
Laxatives ·
Oral - U.S. Brands: Afko-Lube; Afko-Lube Lax 40; Agoral Marshmallow; Agoral Raspberry; Alaxin; Alophen; Alphamul; Alramucil Orange; Alramucil Regular; Bilagog; Bilax; Bisac-Evac; Black-Draught; Black-Draught Lax-Senna; Carter's Little Pills; Cholac; Chronulac; Cillium; Cit http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202319.html
·
Rectal - U.S. Brands: Bisco-Lax; Ceo-Two; Dacodyl; Deficol; Dulcolax; Fleet Babylax; Fleet Bisacodyl; Fleet Enema; Fleet Enema for Children; Fleet Enema Mineral Oil; Fleet Glycerin Laxative; Fleet Laxative; Sani-Supp; Senokot; Theralax; Therevac Plus; Therevac-SB http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202320.html
Levocarnitine ·
Systemic - U.S. Brands: Carnitor http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202325.html
Levodopa ·
Systemic - U.S. Brands: Atamet; Larodopa; Sinemet; Sinemet CR http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202326.html
Lidocaine and Prilocaine ·
Topical - U.S. Brands: EMLA http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203679.html
402 Tea
Lithium ·
Systemic - U.S. Brands: Cibalith-S; Eskalith; Lithane; Lithobid; Lithonate; Lithotabs http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202330.html
Loperamide ·
Oral - U.S. Brands: Imodium http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202332.html
Lopinavir and Ritonavir ·
Systemic - U.S. Brands: Kaletra http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500251.html
Loracarbef ·
Systemic - U.S. Brands: Lorabid http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202680.html
Mesalamine ·
Rectal - U.S. Brands: Canasa; Rowasa http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202351.html
Metformin ·
Systemic - U.S. Brands: Glucophage http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202756.html
Methenamine ·
Systemic - U.S. Brands: Hiprex; Mandelamine; Urex http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202354.html
Methyldopa ·
Systemic - U.S. Brands: Aldomet http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202359.html
Methylphenidate ·
Systemic - U.S. Brands: Concerta; Ritalin; Ritalin-SR http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202361.html
Methysergide ·
Systemic - U.S. Brands: Sansert http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202363.html
Metoclopramide ·
Systemic - U.S. Brands: Octamide; Reglan http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202364.html
Mirtazapine ·
Systemic - U.S. Brands: Remeron http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203490.html
Researching Medications 403
Naratriptan ·
Systemic - U.S. Brands: Amerge http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203513.html
Narcotic Analgesics and Acetaminophen ·
Systemic - U.S. Brands: Allay; Anexsia 5/500; Anexsia 7.5/650; Anolor DH 5; Bancap-HC; Capital with Codeine; Co-Gesic; Darvocet-N 100; Darvocet-N 50; DHCplus; Dolacet; Dolagesic; Duocet; E-Lor; Endocet; EZ III; Hycomed; HycoPap; Hydrocet; Hydrogesic; HY-PHEN; Lorcet 10/650; L http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202392.html
Narcotic Analgesics and Aspirin ·
Systemic - U.S. Brands: Damason-P; Darvon Compound-65; Empirin with Codeine No.3; Empirin with Codeine No.4; Endodan; Lortab ASA; Panasal 5/500; PC-Cap; Percodan; Percodan-Demi; Propoxyphene Compound-65; Roxiprin; Synalgos-DC; Talwin Compound http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202393.html
Narcotic Analgesics for Pain Relief ·
Systemic - U.S. Brands: Astramorph PF; Buprenex; Cotanal-65; Darvon; DarvonN; Demerol; Dilaudid; Dilaudid-5; Dilaudid-HP; Dolophine; Duramorph; Hydrostat IR; Kadian; Levo-Dromoran; M S Contin; Methadose; MS/L; MS/L Concentrate; MS/S; MSIR; Nubain; Numorphan; OMS Concentrate; http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202390.html
Nateglinide ·
Systemic - U.S. Brands: Starlix http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500277.html
Neomycin ·
Oral - U.S. Brands: Mycifradin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202396.html
Niacin for High Cholesterol ·
Systemic - U.S. Brands: Endur-Acin; Nia-Bid; Niac; Niacels; Niacor; Nico-400; Nicolar; Slo-Niacin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202404.html
Nicotine ·
Systemic - U.S. Brands: Habitrol; Nicorette; Nicotrol; Prostep http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202407.html
Nitrofurantoin ·
Systemic - U.S. Brands: Furadantin; Macrobid; Macrodantin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202414.html
Nystatin ·
Oral - U.S. Brands: Mycostatin; Nilstat; Nystex http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202417.html
404 Tea
Octreotide ·
Systemic - U.S. Brands: Sandostatin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202421.html
Ondansetron ·
Systemic - U.S. Brands: Zofran http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202424.html
Paroxetine ·
Systemic - U.S. Brands: Paxil http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202717.html
Penicillins ·
Systemic - U.S. Brands: Amoxil; Bactocill; Beepen-VK; Betapen-VK; Bicillin L-A; Cloxapen; Crysticillin 300 A.S. Dycill; Dynapen; Geocillin; Geopen; Ledercillin VK; Mezlin; Nafcil; Nallpen; Omnipen; Omnipen-N; Pathocil; Pen Vee K; Pentids; Permapen; Pfizerpen; Pfizerpen-AS; Pi http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202446.html
Penicillins and Beta-Lactamase Inhibitors ·
Systemic - U.S. Brands: Augmentin; Timentin; Unasyn; Zosyn http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202705.html
Phenothiazines ·
Systemic - U.S. Brands: Chlorpromazine Hydrochloride Intensol; Compazine; Compazine Spansule; Mellaril; Mellaril Concentrate; Mellaril-S; Permitil; Permitil Concentrate; Prolixin; Prolixin Concentrate; Prolixin Decanoate; Prolixin Enanthate; Serentil; Serentil Concentrate; Ste http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202457.html
Phosphates ·
Systemic - U.S. Brands: K-Phos M. F. K-Phos Neutral; K-Phos No. 2; K-Phos Original; Neutra-Phos; Neutra-Phos-K; Uro-KP-Neutral http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202463.html
Polyethylene Glycol and Electrolytes ·
Local - U.S. Brands: Co-Lav; Colovage; Colyte; Colyte-flavored; Go-Evac; GoLYTELY; NuLYTELY; OCL http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202636.html
Primidone ·
Systemic - U.S. Brands: Myidone; Mysoline http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202479.html
Pseudoephedrine ·
Systemic - U.S. Brands: Cenafed; Decofed; Efidac/; Genaphed; Myfedrine; Sudafed http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202489.html
Researching Medications 405
Pyrantel ·
Oral - U.S. Brands: Pin-X http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202490.html
Rabies Immune Globulin ·
Systemic - U.S. Brands: BayRab; Hyperab; Imogam http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202718.html
Racemethionine ·
Systemic - U.S. Brands: M-Caps; Pedameth; Uracid http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202727.html
Rifampin ·
Systemic - U.S. Brands: Rifadin; Rimactane http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202511.html
Rimantadine ·
Systemic - U.S. Brands: Flumadine http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202771.html
Rizatriptan ·
Systemic - U.S. Brands: Maxalt; Maxalt-MLT http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203620.html
Rofecoxib ·
Systemic - U.S. Brands: Vioxx http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203782.html
Salicylates ·
Systemic - U.S. Brands: Acuprin 81; Amigesic; Anacin Caplets; Anacin Maximum Strength; Anacin Tablets; Anaflex 750; Arthritis Pain Ascriptin; Arthritis Pain Formula; Arthritis Strength Bufferin; Arthropan; Aspergum; Aspirin Regimen Bayer Adult Low Dose; Aspirin Regimen Bayer R http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202515.html
Selenium Sulfide ·
Topical - U.S. Brands: Glo-Sel; Selsun http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202520.html
Sildenafil ·
Systemic - U.S. Brands: Viagra http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203533.html
Sodium Benzoate and Sodium Phenylacetate ·
Systemic - U.S. Brands: Ucephan http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202524.html
406 Tea
Sodium Bicarbonate ·
Systemic - U.S. Brands: Bell/ans; Citrocarbonate http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202525.html
Sodium Fluoride ·
Systemic - U.S. Brands: Fluoritab; Fluorodex; Flura; Flura-Drops; Flura-Loz; Karidium; Luride; Pediaflor; Pharmaflur; Phos-Flur http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202527.html
Sodium Phenylbutyrate ·
Systemic - U.S. Brands: Buphenyl http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202916.html
Spermicides ·
Vaginal - U.S. Brands: Advantage 24; Because; Conceptrol Contraceptive Inserts; Conceptrol Gel; Delfen; Emko; Emko Pre-Fil; Encare; Gynol II Extra Strength Contraceptive Jelly; Gynol II Original Formula Contraceptive Jelly; Koromex Cream; Koromex Crystal Clear Gel; Koromex Fo http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202531.html
Sucralfate ·
Oral - U.S. Brands: Carafate http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202533.html
Sulfonamides ·
Systemic - U.S. Brands: Gantanol; Gantrisin; Thiosulfil Forte; Urobak http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202540.html
Sulfonamides and Trimethoprim ·
Systemic - U.S. Brands: Bactrim; Bactrim DS; Bactrim I.V. Bactrim Pediatric; Cofatrim Forte; Cotrim; Cotrim DS; Cotrim Pediatric; Septra; Septra DS; Septra Grape Suspension; Septra I.V. Septra Suspension; Sulfatrim; Sulfatrim Pediatric; Sulfatrim S/S; Sulfatrim Suspension; S http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202781.html
Sumatriptan ·
Systemic - U.S. Brands: Imitrex http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202665.html
Tetracyclines ·
Systemic - U.S. Brands: Achromycin V; Declomycin; Doryx; Dynacin; Minocin; Monodox; Terramycin; Vibramycin; Vibra-Tabs http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202552.html
·
Topical - U.S. Brands: Achromycin; Aureomycin; Meclan; Topicycline http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202553.html
Researching Medications 407
Theophylline and Guaifenesin ·
Systemic - U.S. Brands: Bronchial; Elixophyllin-GG; Glyceryl-T; Quibron; Quibron-300; Theocon; Theolate http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202557.html
Theophylline, Ephedrine, and Hydroxyzine ·
Systemic - U.S. Brands: Marax; Marax-DF http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202555.html
Thiabendazole ·
Systemic - U.S. Brands: Mintezol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202558.html
Tinzaparin ·
Systemic - U.S. Brands: Innohep http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500175.html
Tolterodine ·
Systemic - U.S. Brands: Detrol http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203475.html
Topiramate ·
Systemic - U.S. Brands: Topamax http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203085.html
Tramadol ·
Systemic - U.S. Brands: Ultram http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202789.html
Valproic Acid ·
Systemic - U.S. Brands: Depacon; Depakene; Depakote; Depakote Sprinkle http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202588.html
Vancomycin ·
Oral - U.S. Brands: Vancocin http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202589.html
Zanamivir ·
Inhalation--Systemic - U.S. Brands: Relenza http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500004.html
Zidovudine ·
Systemic - U.S. Brands: Retrovir http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202602.html
Zolmitriptan ·
Systemic - U.S. Brands: Zomig http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203426.html
408 Tea
Commercial Databases In addition to the medications listed in the USP above, a number of commercial sites are available by subscription to physicians and their institutions. Or, you may be able to access these sources from your local medical library.
Mosby’s Drug ConsultÔ Mosby’s Drug ConsultÔ database (also available on CD-ROM and book format) covers 45,000 drug products including generics and international brands. It provides prescribing information, drug interactions, and patient information. Subscription information is available at the following hyperlink: http://www.mosbysdrugconsult.com/.
PDRhealth The PDRhealth database is a free-to-use, drug information search engine that has been written for the public in layman’s terms. It contains FDA-approved drug information adapted from the Physicians’ Desk Reference (PDR) database. PDRhealth can be searched by brand name, generic name, or indication. It features multiple drug interactions reports. Search PDRhealth at http://www.pdrhealth.com/drug_info/index.html.
Other Web Sites Drugs.com (www.drugs.com) reproduces the information in the Pharmacopeia as well as commercial information. You may also want to consider the Web site of the Medical Letter, Inc. (http://www.medletter.com/) which allows users to download articles on various drugs and therapeutics for a nominal fee.
Researching Orphan Drugs Although the list of orphan drugs is revised on a daily basis, you can quickly research orphan drugs that might be applicable to tea by using the database managed by the National Organization for Rare Disorders, Inc. (NORD), at http://www.rarediseases.org/. Scroll down the page, and on the left toolbar, click on “Orphan Drug Designation Database.” On this page (http://www.rarediseases.org/search/noddsearch.html), type “tea” (or synonyms) into the search box, and click “Submit Query.” When you receive your results, note that not all of the drugs may be relevant, as some may have been withdrawn from orphan status. Write down or print out the name of each drug and the relevant contact information. From there, visit the Pharmacopeia Web site and type the name of each orphan drug into the search box at http://www.nlm.nih.gov/medlineplus/druginformation.html. You may need to contact the sponsor or NORD for further information. NORD conducts “early access programs for investigational new drugs (IND) under the Food and Drug Administration’s (FDA’s) approval ‘Treatment INDs’ programs which allow for a limited number of individuals to receive investigational drugs before FDA marketing approval.” If the orphan product about which you are seeking information is approved for
Researching Medications 409
marketing, information on side effects can be found on the product’s label. If the product is not approved, you may need to contact the sponsor. The following is a list of orphan drugs currently listed in the NORD Orphan Drug Designation Database for tea: ·
Choline chloride (trade name: Intrachol) http://www.rarediseases.org/nord/search/nodd_full?code=636
·
N-acetylgalactosamine-4-sulfata se, recombinant hu http://www.rarediseases.org/nord/search/nodd_full?code=968
If you have any questions about a medical treatment, the FDA may have an office near you. Look for their number in the blue pages of the phone book. You can also contact the FDA through its toll-free number, 1-888-INFO-FDA (1-888-463-6332), or on the World Wide Web at www.fda.gov.
411
APPENDICES
413
APPENDIX A. PHYSICIAN RESOURCES Overview In this chapter, we focus on databases and Internet-based guidelines and information resources created or written for a professional audience.
NIH Guidelines Commonly referred to as “clinical” or “professional” guidelines, the National Institutes of Health publish physician guidelines for the most common diseases. Publications are available at the following by relevant Institute12: ·
Office of the Director (OD); guidelines consolidated across agencies available at http://www.nih.gov/health/consumer/conkey.htm
·
National Institute of General Medical Sciences (NIGMS); fact sheets available at http://www.nigms.nih.gov/news/facts/
·
National Library of Medicine (NLM); extensive encyclopedia (A.D.A.M., Inc.) with guidelines: http://www.nlm.nih.gov/medlineplus/healthtopics.html
·
National Cancer Institute (NCI); guidelines available at http://www.cancer.gov/cancerinfo/list.aspx?viewid=5f35036e-5497-4d86-8c2c714a9f7c8d25
·
National Eye Institute (NEI); guidelines available at http://www.nei.nih.gov/order/index.htm
·
National Heart, Lung, and Blood Institute (NHLBI); guidelines available at http://www.nhlbi.nih.gov/guidelines/index.htm
·
National Human Genome Research Institute (NHGRI); research available at http://www.genome.gov/page.cfm?pageID=10000375
·
National Institute on Aging (NIA); guidelines available at http://www.nia.nih.gov/health/
12
These publications are typically written by one or more of the various NIH Institutes.
414 Tea
·
National Institute on Alcohol Abuse and Alcoholism (NIAAA); guidelines available at http://www.niaaa.nih.gov/publications/publications.htm
·
National Institute of Allergy and Infectious Diseases (NIAID); guidelines available at http://www.niaid.nih.gov/publications/
·
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); fact sheets and guidelines available at http://www.niams.nih.gov/hi/index.htm
·
National Institute of Child Health and Human Development (NICHD); guidelines available at http://www.nichd.nih.gov/publications/pubskey.cfm
·
National Institute on Deafness and Other Communication Disorders (NIDCD); fact sheets and guidelines at http://www.nidcd.nih.gov/health/
·
National Institute of Dental and Craniofacial Research (NIDCR); guidelines available at http://www.nidr.nih.gov/health/
·
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); guidelines available at http://www.niddk.nih.gov/health/health.htm
·
National Institute on Drug Abuse (NIDA); guidelines available at http://www.nida.nih.gov/DrugAbuse.html
·
National Institute of Environmental Health Sciences (NIEHS); environmental health information available at http://www.niehs.nih.gov/external/facts.htm
·
National Institute of Mental Health (NIMH); guidelines available at http://www.nimh.nih.gov/practitioners/index.cfm
·
National Institute of Neurological Disorders and Stroke (NINDS); neurological disorder information pages available at http://www.ninds.nih.gov/health_and_medical/disorder_index.htm
·
National Institute of Nursing Research (NINR); publications on selected illnesses at http://www.nih.gov/ninr/news-info/publications.html
·
National Institute of Biomedical Imaging and Bioengineering; general information at http://grants.nih.gov/grants/becon/becon_info.htm
·
Center for Information Technology (CIT); referrals to other agencies based on keyword searches available at http://kb.nih.gov/www_query_main.asp
·
National Center for Complementary and Alternative Medicine (NCCAM); health information available at http://nccam.nih.gov/health/
·
National Center for Research Resources (NCRR); various information directories available at http://www.ncrr.nih.gov/publications.asp
·
Office of Rare Diseases; various fact sheets available at http://rarediseases.info.nih.gov/html/resources/rep_pubs.html
·
Centers for Disease Control and Prevention; various fact sheets on infectious diseases available at http://www.cdc.gov/publications.htm
Physician Resources 415
NIH Databases In addition to the various Institutes of Health that publish professional guidelines, the NIH has designed a number of databases for professionals.13 Physician-oriented resources provide a wide variety of information related to the biomedical and health sciences, both past and present. The format of these resources varies. Searchable databases, bibliographic citations, full-text articles (when available), archival collections, and images are all available. The following are referenced by the National Library of Medicine:14 ·
Bioethics: Access to published literature on the ethical, legal, and public policy issues surrounding healthcare and biomedical research. This information is provided in conjunction with the Kennedy Institute of Ethics located at Georgetown University, Washington, D.C.: http://www.nlm.nih.gov/databases/databases_bioethics.html
·
HIV/AIDS Resources: Describes various links and databases dedicated to HIV/AIDS research: http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html
·
NLM Online Exhibitions: Describes “Exhibitions in the History of Medicine”: http://www.nlm.nih.gov/exhibition/exhibition.html. Additional resources for historical scholarship in medicine: http://www.nlm.nih.gov/hmd/hmd.html
·
Biotechnology Information: Access to public databases. The National Center for Biotechnology Information conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information for the better understanding of molecular processes affecting human health and disease: http://www.ncbi.nlm.nih.gov/
·
Population Information: The National Library of Medicine provides access to worldwide coverage of population, family planning, and related health issues, including family planning technology and programs, fertility, and population law and policy: http://www.nlm.nih.gov/databases/databases_population.html
·
Cancer Information: Access to cancer-oriented databases: http://www.nlm.nih.gov/databases/databases_cancer.html
·
Profiles in Science: Offering the archival collections of prominent twentieth-century biomedical scientists to the public through modern digital technology: http://www.profiles.nlm.nih.gov/
·
Chemical Information: Provides links to various chemical databases and references: http://sis.nlm.nih.gov/Chem/ChemMain.html
·
Clinical Alerts: Reports the release of findings from the NIH-funded clinical trials where such release could significantly affect morbidity and mortality: http://www.nlm.nih.gov/databases/alerts/clinical_alerts.html
·
Space Life Sciences: Provides links and information to space-based research (including NASA): http://www.nlm.nih.gov/databases/databases_space.html
·
MEDLINE: Bibliographic database covering the fields of medicine, nursing, dentistry, veterinary medicine, the healthcare system, and the pre-clinical sciences: http://www.nlm.nih.gov/databases/databases_medline.html
13
Remember, for the general public, the National Library of Medicine recommends the databases referenced in MEDLINEplus (http://medlineplus.gov/ or http://www.nlm.nih.gov/medlineplus/databases.html). 14 See http://www.nlm.nih.gov/databases/databases.html.
416 Tea
·
Toxicology and Environmental Health Information (TOXNET): Databases covering toxicology and environmental health: http://sis.nlm.nih.gov/Tox/ToxMain.html
·
Visible Human Interface: Anatomically detailed, three-dimensional representations of normal male and female human bodies: http://www.nlm.nih.gov/research/visible/visible_human.html The Combined Health Information Database
A comprehensive source of information on clinical guidelines written for professionals is the Combined Health Information Database. You will need to limit your search to one of the following: Brochure/Pamphlet, Fact Sheet, or Information Package, and “tea” using the “Detailed Search” option. Go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find associations, use the drop boxes at the bottom of the search page where “You may refine your search by.” For the publication date, select “All Years.” Select your preferred language and the format option “Fact Sheet.” Type “tea” (or synonyms) into the “For these words:” box. The following is a sample result: ·
Cat's Claw (Uncaria Tomentosa) Contact: AIDS Project Los Angeles, 3550 Wilshire Blvd Ste 300, Los Angeles, CA, 900102404, (213) 201-1600, http://www.apla.org. Summary: This packet is a compilation of material on Uncaria Tomentosa, a Peruvian plant being used in the treatment of AIDS. The information in this packet includes promotional material from the companies distributing the herb, as well as European journal article reprints. Alkaloids have been extracted and isolated from the bark of Uncaria Tomentosa and their success in the treatment of a variety of illnesses is being tested in Europe. An herbal tea called Cat's Claw is made by steeping the seeds, bark, and root of the Uncaria Tomentosa, much in the same way that it was prepared by the Incan Indians who discovered its medicinal properties. A newsletter devoted to Cat's Claw is also included. The newsletter features success stories from patients with a wide variety of illnesses and herpetic infections who have benefitted from Uncaria Tomentosa.
·
Herbs (General Information) Contact: AIDS Project Los Angeles, 3550 Wilshire Blvd Ste 300, Los Angeles, CA, 900102404, (213) 201-1600, http://www.apla.org. Summary: This report is a collection of articles and guidelines forming a compendium of herbs that have been used, or are recommended by, the authors for medical purposes. The first article presents general information on 29 medicinal herbs used in Western herbalism, including algae, aloe, and myrrh. The author includes simple formulas for using the herbs, and a list of resources. A second article briefly highlights herbs used as immune boosters, such as pau d'arco. Abstracts of medical research using herbs are presented for schizandra, prunella, ganoderma, echinacea, viola, isatis, ginseng, eleuthero ginseng, lentinan, astralagus, iscador, silybum marianum, polyporus, tremella, poria, and Chinese herbs. Fact sheets indicate the origins, traditional uses, chemical constituents, and pharmacological effects of the reishi mushroom and three forms of dried roots. An article on the Bach Flower Remedies discusses how practitioners use the essence of flowers to contribute to emotional healing. The report includes a list of food supplements that have been known to help the HIV virus, very
Physician Resources 417
briefly defining each. An index and a directory of herb combinations match herbal formulas and dosage programs with various medical conditions, including AIDS and Candida Albicans. Other articles discuss tea tree oil, medicinal herbs indigenous to the State of Virginia, and Enhance herbal formula for immune enhancement for chronic viral syndromes.
The NLM Gateway15 The NLM (National Library of Medicine) Gateway is a Web-based system that lets users search simultaneously in multiple retrieval systems at the U.S. National Library of Medicine (NLM). It allows users of NLM services to initiate searches from one Web interface, providing one-stop searching for many of NLM’s information resources or databases.16 To use the NLM Gateway, simply go to the search site at http://gateway.nlm.nih.gov/gw/Cmd. Type “tea” (or synonyms) into the search box and click “Search.” The results will be presented in a tabular form, indicating the number of references in each database category. Results Summary Category Journal Articles Books / Periodicals / Audio Visual Consumer Health Meeting Abstracts Other Collections Total
Items Found 8511 228 100 30 0 8869
HSTAT17 HSTAT is a free, Web-based resource that provides access to full-text documents used in healthcare decision-making.18 These documents include clinical practice guidelines, quickreference guides for clinicians, consumer health brochures, evidence reports and technology assessments from the Agency for Healthcare Research and Quality (AHRQ), as well as AHRQ’s Put Prevention Into Practice.19 Simply search by “tea” (or synonyms) at the following Web site: http://text.nlm.nih.gov.
15
Adapted from NLM: http://gateway.nlm.nih.gov/gw/Cmd?Overview.x.
16
The NLM Gateway is currently being developed by the Lister Hill National Center for Biomedical Communications (LHNCBC) at the National Library of Medicine (NLM) of the National Institutes of Health (NIH). 17 Adapted from HSTAT: http://www.nlm.nih.gov/pubs/factsheets/hstat.html. 18 19
The HSTAT URL is http://hstat.nlm.nih.gov/.
Other important documents in HSTAT include: the National Institutes of Health (NIH) Consensus Conference Reports and Technology Assessment Reports; the HIV/AIDS Treatment Information Service (ATIS) resource documents; the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment (SAMHSA/CSAT) Treatment Improvement Protocols (TIP) and Center for Substance Abuse Prevention (SAMHSA/CSAP) Prevention Enhancement Protocols System (PEPS); the Public Health Service (PHS) Preventive Services Task Force's Guide to Clinical Preventive Services; the independent, nonfederal Task Force on Community Services’ Guide to Community Preventive Services; and the Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) health technology evaluations.
418 Tea
Coffee Break: Tutorials for Biologists20 Coffee Break is a general healthcare site that takes a scientific view of the news and covers recent breakthroughs in biology that may one day assist physicians in developing treatments. Here you will find a collection of short reports on recent biological discoveries. Each report incorporates interactive tutorials that demonstrate how bioinformatics tools are used as a part of the research process. Currently, all Coffee Breaks are written by NCBI staff.21 Each report is about 400 words and is usually based on a discovery reported in one or more articles from recently published, peer-reviewed literature.22 This site has new articles every few weeks, so it can be considered an online magazine of sorts. It is intended for general background information. You can access the Coffee Break Web site at the following hyperlink: http://www.ncbi.nlm.nih.gov/Coffeebreak/.
Other Commercial Databases In addition to resources maintained by official agencies, other databases exist that are commercial ventures addressing medical professionals. Here are some examples that may interest you: ·
CliniWeb International: Index and table of contents to selected clinical information on the Internet; see http://www.ohsu.edu/cliniweb/.
·
Medical World Search: Searches full text from thousands of selected medical sites on the Internet; see http://www.mwsearch.com/.
20 Adapted 21
from http://www.ncbi.nlm.nih.gov/Coffeebreak/Archive/FAQ.html.
The figure that accompanies each article is frequently supplied by an expert external to NCBI, in which case the source of the figure is cited. The result is an interactive tutorial that tells a biological story. 22 After a brief introduction that sets the work described into a broader context, the report focuses on how a molecular understanding can provide explanations of observed biology and lead to therapies for diseases. Each vignette is accompanied by a figure and hypertext links that lead to a series of pages that interactively show how NCBI tools and resources are used in the research process.
419
APPENDIX B. PATIENT RESOURCES Overview Official agencies, as well as federally funded institutions supported by national grants, frequently publish a variety of guidelines written with the patient in mind. These are typically called “Fact Sheets” or “Guidelines.” They can take the form of a brochure, information kit, pamphlet, or flyer. Often they are only a few pages in length. Since new guidelines on tea can appear at any moment and be published by a number of sources, the best approach to finding guidelines is to systematically scan the Internet-based services that post them.
Patient Guideline Sources The remainder of this chapter directs you to sources which either publish or can help you find additional guidelines on topics related to tea. Due to space limitations, these sources are listed in a concise manner. Do not hesitate to consult the following sources by either using the Internet hyperlink provided, or, in cases where the contact information is provided, contacting the publisher or author directly.
The National Institutes of Health The NIH gateway to patients is located at http://health.nih.gov/. From this site, you can search across various sources and institutes, a number of which are summarized below.
Topic Pages: MEDLINEplus The National Library of Medicine has created a vast and patient-oriented healthcare information portal called MEDLINEplus. Within this Internet-based system are “health topic pages” which list links to available materials relevant to tea. To access this system, log on to http://www.nlm.nih.gov/medlineplus/healthtopics.html. From there you can either search using the alphabetical index or browse by broad topic areas. Recently, MEDLINEplus listed the following when searched for “tea”:
420 Tea
·
Other guides Antioxidants http://www.nlm.nih.gov/medlineplus/antioxidants.html Cancer Alternative Therapy http://www.nlm.nih.gov/medlineplus/canceralternativetherapy.html Dietary Supplements http://www.nlm.nih.gov/medlineplus/dietarysupplements.html Food Safety http://www.nlm.nih.gov/medlineplus/foodsafety.html
Within the health topic page dedicated to tea, the following was listed: ·
General/Overviews Smell and Taste Disorders Source: American Academy of Otolaryngology-Head and Neck Surgery, Inc. http://www.entnet.org/healthinfo/topics/smell_taste.cfm Smell and Taste Disorders Source: Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=NU00236
·
Nutrition Nutrition Tips to Improve Your Taste for Food Source: Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=HQ01135
·
Specific Conditions/Aspects Loss of Taste and Smell Stinks! Source: American Rhinologic Society http://american-rhinologic.org/cgibin/menu.cgi?m=main.menu&state=1001125555100000001000000&citem=7&f=patie ntinfo.loss.phtml Sensory Dysfunction: Problems With Smell or Taste Source: American Academy of Family Physicians http://familydoctor.org/handouts/489.html
·
From the National Institutes of Health Smell and Smell Disorders Source: National Institute on Deafness and Other Communication Disorders http://www.nidcd.nih.gov/health/smelltaste/smell.asp Taste and Taste Disorders Source: National Institute on Deafness and Other Communication Disorders http://www.nidcd.nih.gov/health/smelltaste/taste.asp
Patient Resources 421
·
Research Discovery of Taste Receptors May Make Bitter a Bygone Taste Source: National Institute of Dental and Craniofacial Research http://www.nidcr.nih.gov/news/digest/may00_2.asp Scientist Finds the Gene That Determines Major Sensitivity to Bitter Taste Source: National Institute on Deafness and Other Communication Disorders http://www.nih.gov/news/pr/feb2003/nidcd-20.htm Taste Intensity Source: Society for Neuroscience http://www.sfn.org/content/Publications/BrainBriefings/taste.html
You may also choose to use the search utility provided by MEDLINEplus at the following Web address: http://www.nlm.nih.gov/medlineplus/. Simply type a keyword into the search box and click “Search.” This utility is similar to the NIH search utility, with the exception that it only includes materials that are linked within the MEDLINEplus system (mostly patient-oriented information). It also has the disadvantage of generating unstructured results. We recommend, therefore, that you use this method only if you have a very targeted search. The Combined Health Information Database (CHID) CHID Online is a reference tool that maintains a database directory of thousands of journal articles and patient education guidelines on tea. CHID offers summaries that describe the guidelines available, including contact information and pricing. CHID’s general Web site is http://chid.nih.gov/. To search this database, go to http://chid.nih.gov/detail/detail.html. In particular, you can use the advanced search options to look up pamphlets, reports, brochures, and information kits. The following was recently posted in this archive: ·
NCI FACT SHEET: Tea and Cancer Prevention Source: Bethesda, MD: National Cancer Institute. 2002. 3 p. Contact: Available from National Cancer Institute. Publications Ordering Service, P.O. Box 24128, Baltimore, MD 21227. (800) 4-CANCER or (800) 422-6237; TTY: (800) 3328615; FAX: (301) 330-7968. PRICE: Free. Summary: This fact sheet from the National Cancer Institute (NCI) discusses tea and its possible use in the prevention and treatment of a variety of cancers. In a question and answer format, the fact sheet discusses the antioxidant levels found in tea, particularly green and black tea; findings from laboratory and human studies of tea; and NCIsupported clinical trials of tea. 5 references.
The NIH Search Utility The NIH search utility allows you to search for documents on over 100 selected Web sites that comprise the NIH-WEB-SPACE. Each of these servers is “crawled” and indexed on an ongoing basis. Your search will produce a list of various documents, all of which will relate in some way to tea. The drawbacks of this approach are that the information is not organized by theme and that the references are often a mix of information for professionals
422 Tea
and patients. Nevertheless, a large number of the listed Web sites provide useful background information. We can only recommend this route, therefore, for relatively rare or specific disorders, or when using highly targeted searches. To use the NIH search utility, visit the following Web page: http://search.nih.gov/index.html.
Additional Web Sources
A number of Web sites are available to the public that often link to government sites. These can also point you in the direction of essential information. The following is a representative sample: ·
AOL: http://search.aol.com/cat.adp?id=168&layer=&from=subcats
·
Family Village: http://www.familyvillage.wisc.edu/specific.htm
·
Google: http://directory.google.com/Top/Health/Conditions_and_Diseases/
·
Med Help International: http://www.medhelp.org/HealthTopics/A.html
·
Open Directory Project: http://dmoz.org/Health/Conditions_and_Diseases/
·
Yahoo.com: http://dir.yahoo.com/Health/Diseases_and_Conditions/
·
WebMDÒHealth: http://my.webmd.com/health_topics
Finding Associations There are several Internet directories that provide lists of medical associations with information on or resources relating to tea. By consulting all of associations listed in this chapter, you will have nearly exhausted all sources for patient associations concerned with tea.
The National Health Information Center (NHIC) The National Health Information Center (NHIC) offers a free referral service to help people find organizations that provide information about tea. For more information, see the NHIC’s Web site at http://www.health.gov/NHIC/ or contact an information specialist by calling 1800-336-4797.
Directory of Health Organizations The Directory of Health Organizations, provided by the National Library of Medicine Specialized Information Services, is a comprehensive source of information on associations. The Directory of Health Organizations database can be accessed via the Internet at http://www.sis.nlm.nih.gov/Dir/DirMain.html. It is composed of two parts: DIRLINE and Health Hotlines. The DIRLINE database comprises some 10,000 records of organizations, research centers, and government institutes and associations that primarily focus on health and biomedicine. To access DIRLINE directly, go to the following Web site: http://dirline.nlm.nih.gov/.
Patient Resources 423
Simply type in “tea” (or a synonym), and you will receive information on all relevant organizations listed in the database. Health Hotlines directs you to toll-free numbers to over 300 organizations. You can access this database directly at http://www.sis.nlm.nih.gov/hotlines/. On this page, you are given the option to search by keyword or by browsing the subject list. When you have received your search results, click on the name of the organization for its description and contact information.
The Combined Health Information Database Another comprehensive source of information on healthcare associations is the Combined Health Information Database. Using the “Detailed Search” option, you will need to limit your search to “Organizations” and “tea”. Type the following hyperlink into your Web browser: http://chid.nih.gov/detail/detail.html. To find associations, use the drop boxes at the bottom of the search page where “You may refine your search by.” For publication date, select “All Years.” Then, select your preferred language and the format option “Organization Resource Sheet.” Type “tea” (or synonyms) into the “For these words:” box. You should check back periodically with this database since it is updated every three months. The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. has prepared a Web site that provides, at no charge, lists of associations organized by health topic. You can access this database at the following Web site: http://www.rarediseases.org/search/orgsearch.html. Type “tea” (or a synonym) into the search box, and click “Submit Query.”
425
APPENDIX C. FINDING MEDICAL LIBRARIES Overview In this Appendix, we show you how to quickly find a medical library in your area.
Preparation Your local public library and medical libraries have interlibrary loan programs with the National Library of Medicine (NLM), one of the largest medical collections in the world. According to the NLM, most of the literature in the general and historical collections of the National Library of Medicine is available on interlibrary loan to any library. If you would like to access NLM medical literature, then visit a library in your area that can request the publications for you.23
Finding a Local Medical Library The quickest method to locate medical libraries is to use the Internet-based directory published by the National Network of Libraries of Medicine (NN/LM). This network includes 4626 members and affiliates that provide many services to librarians, health professionals, and the public. To find a library in your area, simply visit http://nnlm.gov/members/adv.html or call 1-800-338-7657.
Medical Libraries in the U.S. and Canada In addition to the NN/LM, the National Library of Medicine (NLM) lists a number of libraries with reference facilities that are open to the public. The following is the NLM’s list and includes hyperlinks to each library’s Web site. These Web pages can provide information on hours of operation and other restrictions. The list below is a small sample of
23
Adapted from the NLM: http://www.nlm.nih.gov/psd/cas/interlibrary.html.
426 Tea
libraries recommended by the National Library of Medicine (sorted alphabetically by name of the U.S. state or Canadian province where the library is located)24: ·
Alabama: Health InfoNet of Jefferson County (Jefferson County Library Cooperative, Lister Hill Library of the Health Sciences), http://www.uab.edu/infonet/
·
Alabama: Richard M. Scrushy Library (American Sports Medicine Institute)
·
Arizona: Samaritan Regional Medical Center: The Learning Center (Samaritan Health System, Phoenix, Arizona), http://www.samaritan.edu/library/bannerlibs.htm
·
California: Kris Kelly Health Information Center (St. Joseph Health System, Humboldt), http://www.humboldt1.com/~kkhic/index.html
·
California: Community Health Library of Los Gatos, http://www.healthlib.org/orgresources.html
·
California: Consumer Health Program and Services (CHIPS) (County of Los Angeles Public Library, Los Angeles County Harbor-UCLA Medical Center Library) - Carson, CA, http://www.colapublib.org/services/chips.html
·
California: Gateway Health Library (Sutter Gould Medical Foundation)
·
California: Health Library (Stanford University Medical Center), http://wwwmed.stanford.edu/healthlibrary/
·
California: Patient Education Resource Center - Health Information and Resources (University of California, San Francisco), http://sfghdean.ucsf.edu/barnett/PERC/default.asp
·
California: Redwood Health Library (Petaluma Health Care District), http://www.phcd.org/rdwdlib.html
·
California: Los Gatos PlaneTree Health Library, http://planetreesanjose.org/
·
California: Sutter Resource Library (Sutter Hospitals Foundation, Sacramento), http://suttermedicalcenter.org/library/
·
California: Health Sciences Libraries (University of California, Davis), http://www.lib.ucdavis.edu/healthsci/
·
California: ValleyCare Health Library & Ryan Comer Cancer Resource Center (ValleyCare Health System, Pleasanton), http://gaelnet.stmarysca.edu/other.libs/gbal/east/vchl.html
·
California: Washington Community Health Resource Library (Fremont), http://www.healthlibrary.org/
·
Colorado: William V. Gervasini Memorial Library (Exempla Healthcare), http://www.saintjosephdenver.org/yourhealth/libraries/
·
Connecticut: Hartford Hospital Health Science Libraries (Hartford Hospital), http://www.harthosp.org/library/
·
Connecticut: Healthnet: Connecticut Consumer Health Information Center (University of Connecticut Health Center, Lyman Maynard Stowe Library), http://library.uchc.edu/departm/hnet/
24
Abstracted from http://www.nlm.nih.gov/medlineplus/libraries.html.
Finding Medical Libraries 427
·
Connecticut: Waterbury Hospital Health Center Library (Waterbury Hospital, Waterbury), http://www.waterburyhospital.com/library/consumer.shtml
·
Delaware: Consumer Health Library (Christiana Care Health System, Eugene du Pont Preventive Medicine & Rehabilitation Institute, Wilmington), http://www.christianacare.org/health_guide/health_guide_pmri_health_info.cfm
·
Delaware: Lewis B. Flinn Library (Delaware Academy of Medicine, Wilmington), http://www.delamed.org/chls.html
·
Georgia: Family Resource Library (Medical College of Georgia, Augusta), http://cmc.mcg.edu/kids_families/fam_resources/fam_res_lib/frl.htm
·
Georgia: Health Resource Center (Medical Center of Central Georgia, Macon), http://www.mccg.org/hrc/hrchome.asp
·
Hawaii: Hawaii Medical Library: Consumer Health Information Service (Hawaii Medical Library, Honolulu), http://hml.org/CHIS/
·
Idaho: DeArmond Consumer Health Library (Kootenai Medical Center, Coeur d’Alene), http://www.nicon.org/DeArmond/index.htm
·
Illinois: Health Learning Center of Northwestern Memorial Hospital (Chicago), http://www.nmh.org/health_info/hlc.html
·
Illinois: Medical Library (OSF Saint Francis Medical Center, Peoria), http://www.osfsaintfrancis.org/general/library/
·
Kentucky: Medical Library - Services for Patients, Families, Students & the Public (Central Baptist Hospital, Lexington), http://www.centralbap.com/education/community/library.cfm
·
Kentucky: University of Kentucky - Health Information Library (Chandler Medical Center, Lexington), http://www.mc.uky.edu/PatientEd/
·
Louisiana: Alton Ochsner Medical Foundation Library (Alton Ochsner Medical Foundation, New Orleans), http://www.ochsner.org/library/
·
Louisiana: Louisiana State University Health Sciences Center Medical LibraryShreveport, http://lib-sh.lsuhsc.edu/
·
Maine: Franklin Memorial Hospital Medical Library (Franklin Memorial Hospital, Farmington), http://www.fchn.org/fmh/lib.htm
·
Maine: Gerrish-True Health Sciences Library (Central Maine Medical Center, Lewiston), http://www.cmmc.org/library/library.html
·
Maine: Hadley Parrot Health Science Library (Eastern Maine Healthcare, Bangor), http://www.emh.org/hll/hpl/guide.htm
·
Maine: Maine Medical Center Library (Maine Medical Center, Portland), http://www.mmc.org/library/
·
Maine: Parkview Hospital (Brunswick), http://www.parkviewhospital.org/
·
Maine: Southern Maine Medical Center Health Sciences Library (Southern Maine Medical Center, Biddeford), http://www.smmc.org/services/service.php3?choice=10
·
Maine: Stephens Memorial Hospital’s Health Information Library (Western Maine Health, Norway), http://www.wmhcc.org/Library/
428 Tea
·
Manitoba, Canada: Consumer & Patient Health Information Service (University of Manitoba Libraries), http://www.umanitoba.ca/libraries/units/health/reference/chis.html
·
Manitoba, Canada: J.W. Crane Memorial Library (Deer Lodge Centre, Winnipeg), http://www.deerlodge.mb.ca/crane_library/about.asp
·
Maryland: Health Information Center at the Wheaton Regional Library (Montgomery County, Dept. of Public Libraries, Wheaton Regional Library), http://www.mont.lib.md.us/healthinfo/hic.asp
·
Massachusetts: Baystate Medical Center Library (Baystate Health System), http://www.baystatehealth.com/1024/
·
Massachusetts: Boston University Medical Center Alumni Medical Library (Boston University Medical Center), http://med-libwww.bu.edu/library/lib.html
·
Massachusetts: Lowell General Hospital Health Sciences Library (Lowell General Hospital, Lowell), http://www.lowellgeneral.org/library/HomePageLinks/WWW.htm
·
Massachusetts: Paul E. Woodard Health Sciences Library (New England Baptist Hospital, Boston), http://www.nebh.org/health_lib.asp
·
Massachusetts: St. Luke’s Hospital Health Sciences Library (St. Luke’s Hospital, Southcoast Health System, New Bedford), http://www.southcoast.org/library/
·
Massachusetts: Treadwell Library Consumer Health Reference Center (Massachusetts General Hospital), http://www.mgh.harvard.edu/library/chrcindex.html
·
Massachusetts: UMass HealthNet (University of Massachusetts Medical School, Worchester), http://healthnet.umassmed.edu/
·
Michigan: Botsford General Hospital Library - Consumer Health (Botsford General Hospital, Library & Internet Services), http://www.botsfordlibrary.org/consumer.htm
·
Michigan: Helen DeRoy Medical Library (Providence Hospital and Medical Centers), http://www.providence-hospital.org/library/
·
Michigan: Marquette General Hospital - Consumer Health Library (Marquette General Hospital, Health Information Center), http://www.mgh.org/center.html
·
Michigan: Patient Education Resouce Center - University of Michigan Cancer Center (University of Michigan Comprehensive Cancer Center, Ann Arbor), http://www.cancer.med.umich.edu/learn/leares.htm
·
Michigan: Sladen Library & Center for Health Information Resources - Consumer Health Information (Detroit), http://www.henryford.com/body.cfm?id=39330
·
Montana: Center for Health Information (St. Patrick Hospital and Health Sciences Center, Missoula)
·
National: Consumer Health Library Directory (Medical Library Association, Consumer and Patient Health Information Section), http://caphis.mlanet.org/directory/index.html
·
National: National Network of Libraries of Medicine (National Library of Medicine) provides library services for health professionals in the United States who do not have access to a medical library, http://nnlm.gov/
·
National: NN/LM List of Libraries Serving the Public (National Network of Libraries of Medicine), http://nnlm.gov/members/
Finding Medical Libraries 429
·
Nevada: Health Science Library, West Charleston Library (Las Vegas-Clark County Library District, Las Vegas), http://www.lvccld.org/special_collections/medical/index.htm
·
New Hampshire: Dartmouth Biomedical Libraries (Dartmouth College Library, Hanover), http://www.dartmouth.edu/~biomed/resources.htmld/conshealth.htmld/
·
New Jersey: Consumer Health Library (Rahway Hospital, Rahway), http://www.rahwayhospital.com/library.htm
·
New Jersey: Dr. Walter Phillips Health Sciences Library (Englewood Hospital and Medical Center, Englewood), http://www.englewoodhospital.com/links/index.htm
·
New Jersey: Meland Foundation (Englewood Hospital and Medical Center, Englewood), http://www.geocities.com/ResearchTriangle/9360/
·
New York: Choices in Health Information (New York Public Library) - NLM Consumer Pilot Project participant, http://www.nypl.org/branch/health/links.html
·
New York: Health Information Center (Upstate Medical University, State University of New York, Syracuse), http://www.upstate.edu/library/hic/
·
New York: Health Sciences Library (Long Island Jewish Medical Center, New Hyde Park), http://www.lij.edu/library/library.html
·
New York: ViaHealth Medical Library (Rochester General Hospital), http://www.nyam.org/library/
·
Ohio: Consumer Health Library (Akron General Medical Center, Medical & Consumer Health Library), http://www.akrongeneral.org/hwlibrary.htm
·
Oklahoma: The Health Information Center at Saint Francis Hospital (Saint Francis Health System, Tulsa), http://www.sfh-tulsa.com/services/healthinfo.asp
·
Oregon: Planetree Health Resource Center (Mid-Columbia Medical Center, The Dalles), http://www.mcmc.net/phrc/
·
Pennsylvania: Community Health Information Library (Milton S. Hershey Medical Center, Hershey), http://www.hmc.psu.edu/commhealth/
·
Pennsylvania: Community Health Resource Library (Geisinger Medical Center, Danville), http://www.geisinger.edu/education/commlib.shtml
·
Pennsylvania: HealthInfo Library (Moses Taylor Hospital, Scranton), http://www.mth.org/healthwellness.html
·
Pennsylvania: Hopwood Library (University of Pittsburgh, Health Sciences Library System, Pittsburgh), http://www.hsls.pitt.edu/guides/chi/hopwood/index_html
·
Pennsylvania: Koop Community Health Information Center (College of Physicians of Philadelphia), http://www.collphyphil.org/kooppg1.shtml
·
Pennsylvania: Learning Resources Center - Medical Library (Susquehanna Health System, Williamsport), http://www.shscares.org/services/lrc/index.asp
·
Pennsylvania: Medical Library (UPMC Health System, Pittsburgh), http://www.upmc.edu/passavant/library.htm
·
Quebec, Canada: Medical Library (Montreal General Hospital), http://www.mghlib.mcgill.ca/
430 Tea
·
South Dakota: Rapid City Regional Hospital Medical Library (Rapid City Regional Hospital), http://www.rcrh.org/Services/Library/Default.asp
·
Texas: Houston HealthWays (Houston Academy of Medicine-Texas Medical Center Library), http://hhw.library.tmc.edu/
·
Washington: Community Health Library (Kittitas Valley Community Hospital), http://www.kvch.com/
·
Washington: Southwest Washington Medical Center Library (Southwest Washington Medical Center, Vancouver), http://www.swmedicalcenter.com/body.cfm?id=72
431
ONLINE GLOSSARIES The Internet provides access to a number of free-to-use medical dictionaries. The National Library of Medicine has compiled the following list of online dictionaries: ·
ADAM Medical Encyclopedia (A.D.A.M., Inc.), comprehensive medical reference: http://www.nlm.nih.gov/medlineplus/encyclopedia.html
·
MedicineNet.com Medical Dictionary (MedicineNet, Inc.): http://www.medterms.com/Script/Main/hp.asp
·
Merriam-Webster Medical Dictionary (Inteli-Health, Inc.): http://www.intelihealth.com/IH/
·
Multilingual Glossary of Technical and Popular Medical Terms in Eight European Languages (European Commission) - Danish, Dutch, English, French, German, Italian, Portuguese, and Spanish: http://allserv.rug.ac.be/~rvdstich/eugloss/welcome.html
·
On-line Medical Dictionary (CancerWEB): http://cancerweb.ncl.ac.uk/omd/
·
Rare Diseases Terms (Office of Rare Diseases): http://ord.aspensys.com/asp/diseases/diseases.asp
·
Technology Glossary (National Library of Medicine) - Health Care Technology: http://www.nlm.nih.gov/nichsr/ta101/ta10108.htm
Beyond these, MEDLINEplus contains a very patient-friendly encyclopedia covering every aspect of medicine (licensed from A.D.A.M., Inc.). The ADAM Medical Encyclopedia can be accessed at http://www.nlm.nih.gov/medlineplus/encyclopedia.html. ADAM is also available on commercial Web sites such as drkoop.com (http://www.drkoop.com/) and Web MD (http://my.webmd.com/adam/asset/adam_disease_articles/a_to_z/a). The NIH suggests the following Web sites in the ADAM Medical Encyclopedia when searching for information on tea: ·
Basic Guidelines for Tea Tearing - increased Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003036.htm
·
Signs & Symptoms for Tea Changes in vision Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003029.htm Headache Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003024.htm Itching Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003217.htm Joint aches Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003261.htm
432 Tea
Loss of vision Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003040.htm Muscle aches Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003178.htm Nasal congestion Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003049.htm Runny nose Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003051.htm Stress Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003211.htm Vomiting Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003117.htm Watery eyes Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003034.htm Yawning Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003096.htm ·
Background Topics for Tea Physical examination Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002274.htm
Online Dictionary Directories The following are additional online directories compiled by the National Library of Medicine, including a number of specialized medical dictionaries: ·
Medical Dictionaries: Medical & Biological (World Health Organization): http://www.who.int/hlt/virtuallibrary/English/diction.htm#Medical
·
MEL-Michigan Electronic Library List of Online Health and Medical Dictionaries (Michigan Electronic Library): http://mel.lib.mi.us/health/health-dictionaries.html
·
Patient Education: Glossaries (DMOZ Open Directory Project): http://dmoz.org/Health/Education/Patient_Education/Glossaries/
·
Web of Online Dictionaries (Bucknell University): http://www.yourdictionary.com/diction5.html#medicine
433
TEA DICTIONARY The definitions below are derived from official public sources, including the National Institutes of Health [NIH] and the European Union [EU]. 1,2-Dimethylhydrazine: A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals. [NIH] Abdomen: That portion of the body that lies between the thorax and the pelvis. [NIH] Abdominal: Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs. [NIH] Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region. [NIH] Aberrant: Wandering or deviating from the usual or normal course. [EU] Ablation: The removal of an organ by surgery. [NIH] Acatalasia: A rare autosomal recessive disorder resulting from the absence of catalase activity. Though usually asymptomatic, a syndrome of oral ulcerations and gangrene may be present. [NIH] Acceptor: A substance which, while normally not oxidized by oxygen or reduced by hydrogen, can be oxidized or reduced in presence of a substance which is itself undergoing oxidation or reduction. [NIH] Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak antiinflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. [NIH] Acetone: A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis. [NIH] Acetylcholine: A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. [NIH] Acetylcysteine: The N-acetyl derivative of cysteine. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. [NIH] Acetylgalactosamine: The N-acetyl derivative of galactosamine. [NIH] Acne: A disorder of the skin marked by inflammation of oil glands and hair glands. [NIH] Acuity: Clarity or clearness, especially of the vision. [EU] Acupuncture Analgesia: Analgesia produced by the insertion of acupuncture needles at certain points in the body. These activate the small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary hypothalamus - to produce analgesia. [NIH] Acute lymphoblastic leukemia: ALL. A quickly progressing disease in which too many immature white blood cells called lymphoblasts are found in the blood and bone marrow. Also called acute lymphocytic leukemia. [NIH] Acyl: Chemical signal used by bacteria to communicate. [NIH]
434 Tea
Adaptability: Ability to develop some form of tolerance to conditions extremely different from those under which a living organism evolved. [NIH] Adaptation: 1. The adjustment of an organism to its environment, or the process by which it enhances such fitness. 2. The normal ability of the eye to adjust itself to variations in the intensity of light; the adjustment to such variations. 3. The decline in the frequency of firing of a neuron, particularly of a receptor, under conditions of constant stimulation. 4. In dentistry, (a) the proper fitting of a denture, (b) the degree of proximity and interlocking of restorative material to a tooth preparation, (c) the exact adjustment of bands to teeth. 5. In microbiology, the adjustment of bacterial physiology to a new environment. [EU] Adduct: Complex formed when a carcinogen combines with DNA or a protein. [NIH] Adenine: A purine base and a fundamental unit of adenine nucleotides. [NIH] Adenocarcinoma: A malignant epithelial tumor with a glandular organization. [NIH] Adenosine: A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. [NIH] Adenovirus: A group of viruses that cause respiratory tract and eye infections. Adenoviruses used in gene therapy are altered to carry a specific tumor-fighting gene. [NIH] Adhesives: Substances that cause the adherence of two surfaces. They include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins, or latex. [NIH] Adjustment: The dynamic process wherein the thoughts, feelings, behavior, and biophysiological mechanisms of the individual continually change to adjust to the environment. [NIH] Adjuvant: A substance which aids another, such as an auxiliary remedy; in immunology, nonspecific stimulator (e.g., BCG vaccine) of the immune response. [EU] Adjuvant Therapy: Treatment given after the primary treatment to increase the chances of a cure. Adjuvant therapy may include chemotherapy, radiation therapy, or hormone therapy. [NIH]
Adrenal Cortex: The outer layer of the adrenal gland. It secretes mineralocorticoids, androgens, and glucocorticoids. [NIH] Adrenal Glands: Paired glands situated in the retroperitoneal tissues at the superior pole of each kidney. [NIH] Adrenal Medulla: The inner part of the adrenal gland; it synthesizes, stores and releases catecholamines. [NIH] Adrenergic: Activated by, characteristic of, or secreting epinephrine or substances with similar activity; the term is applied to those nerve fibres that liberate norepinephrine at a synapse when a nerve impulse passes, i.e., the sympathetic fibres. [EU] Adsorption: The condensation of gases, liquids, or dissolved substances on the surfaces of solids. It includes adsorptive phenomena of bacteria and viruses as well as of tissues treated with exogenous drugs and chemicals. [NIH] Adsorptive: It captures volatile compounds by binding them to agents such as activated carbon or adsorptive resins. [NIH] Adverse Effect: An unwanted side effect of treatment. [NIH] Aerobic: In biochemistry, reactions that need oxygen to happen or happen when oxygen is present. [NIH] Aerobic Metabolism: A chemical process in which oxygen is used to make energy from carbohydrates (sugars). Also known as aerobic respiration, oxidative metabolism, or cell
Dictionary 435
respiration. [NIH] Aerobic Respiration: A chemical process in which oxygen is used to make energy from carbohydrates (sugars). Also known as oxidative metabolism, cell respiration, or aerobic metabolism. [NIH] Aerosol: A solution of a drug which can be atomized into a fine mist for inhalation therapy. [EU]
Affinity: 1. Inherent likeness or relationship. 2. A special attraction for a specific element, organ, or structure. 3. Chemical affinity; the force that binds atoms in molecules; the tendency of substances to combine by chemical reaction. 4. The strength of noncovalent chemical binding between two substances as measured by the dissociation constant of the complex. 5. In immunology, a thermodynamic expression of the strength of interaction between a single antigen-binding site and a single antigenic determinant (and thus of the stereochemical compatibility between them), most accurately applied to interactions among simple, uniform antigenic determinants such as haptens. Expressed as the association constant (K litres mole -1), which, owing to the heterogeneity of affinities in a population of antibody molecules of a given specificity, actually represents an average value (mean intrinsic association constant). 6. The reciprocal of the dissociation constant. [EU] Aflatoxins: A group of closely related toxic metabolites that are designated mycotoxins. They are produced by Aspergillus flavus and A. parasiticus. Members of the group include aflatoxin B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, aflatoxin M1, and aflatoxin M2. [NIH] Agar: A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis. [NIH]
Agonist: In anatomy, a prime mover. In pharmacology, a drug that has affinity for and stimulates physiologic activity at cell receptors normally stimulated by naturally occurring substances. [EU] Airway: A device for securing unobstructed passage of air into and out of the lungs during general anesthesia. [NIH] Airway Obstruction: Any hindrance to the passage of air into and out of the lungs. [NIH] AK: Enzyme of the biosynthetic pathway. [NIH] Akathisia: 1. A condition of motor restlessness in which there is a feeling of muscular quivering, an urge to move about constantly, and an inability to sit still, a common extrapyramidal side effect of neuroleptic drugs. 2. An inability to sit down because of intense anxiety at the thought of doing so. [EU] Albumin: 1. Any protein that is soluble in water and moderately concentrated salt solutions and is coagulable by heat. 2. Serum albumin; the major plasma protein (approximately 60 per cent of the total), which is responsible for much of the plasma colloidal osmotic pressure and serves as a transport protein carrying large organic anions, such as fatty acids, bilirubin, and many drugs, and also carrying certain hormones, such as cortisol and thyroxine, when their specific binding globulins are saturated. Albumin is synthesized in the liver. Low serum levels occur in protein malnutrition, active inflammation and serious hepatic and renal disease. [EU] Aldehydes: Organic compounds containing a carbonyl group in the form -CHO. [NIH] Aldose Reductase Inhibitor: A class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes. Aldose reductase is an enzyme that is normally present in the eye and in many other parts of the body. It helps change glucose (sugar) into a
436 Tea
sugar alcohol called sorbitol. Too much sorbitol trapped in eye and nerve cells can damage these cells, leading to retinopathy and neuropathy. Drugs that prevent or slow (inhibit) the action of aldose reductase are being studied as a way to prevent or delay these complications of diabetes. [NIH] Alertness: A state of readiness to detect and respond to certain specified small changes occurring at random intervals in the environment. [NIH] Algorithms: A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. [NIH] Alimentary: Pertaining to food or nutritive material, or to the organs of digestion. [EU] Alkaline: Having the reactions of an alkali. [EU] Alkaline Phosphatase: An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1. [NIH] Alkaloid: A member of a large group of chemicals that are made by plants and have nitrogen in them. Some alkaloids have been shown to work against cancer. [NIH] Alkylation: The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. [NIH] Allergen: An antigenic substance capable of producing immediate-type hypersensitivity (allergy). [EU] Allergic Rhinitis: Inflammation of the nasal mucous membrane associated with hay fever; fits may be provoked by substances in the working environment. [NIH] Allium: A genus of liliaceous herbs containing onions (Allium cepa), garlic (Allium sativum), and others; many produce pungent, often bacteriostatic and physiologically active compounds and are used as food, condiment, and medicament, the latter in traditional medicine. [NIH] Allograft: An organ or tissue transplant between two humans. [NIH] Allylamine: Possesses an unusual and selective cytotoxicity for vascular smooth muscle cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation. [NIH] Aloe: A genus of the family Liliaceae containing anthraquinone glycosides such as aloinemodin or aloe-emodin (emodin). [NIH] Alpha Particles: Positively charged particles composed of two protons and two neutrons, i.e., helium nuclei, emitted during disintegration of very heavy isotopes; a beam of alpha particles or an alpha ray has very strong ionizing power, but weak penetrability. [NIH] Alpha-1: A protein with the property of inactivating proteolytic enzymes such as leucocyte collagenase and elastase. [NIH] Alternative medicine: Practices not generally recognized by the medical community as standard or conventional medical approaches and used instead of standard treatments. Alternative medicine includes the taking of dietary supplements, megadose vitamins, and herbal preparations; the drinking of special teas; and practices such as massage therapy, magnet therapy, spiritual healing, and meditation. [NIH] Alum: A type of immune adjuvant (a substance used to help boost the immune response to a vaccine). Also called aluminum sulfate. [NIH] Aluminum: A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. [NIH] Aluminum Hydroxide: Hydrated aluminum. A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an
Dictionary 437
adjuvant in bacterins and vaccines, in water purification, etc. [NIH] Alveoli: Tiny air sacs at the end of the bronchioles in the lungs. [NIH] Amber: A yellowish fossil resin, the gum of several species of coniferous trees, found in the alluvial deposits of northeastern Germany. It is used in molecular biology in the analysis of organic matter fossilized in amber. [NIH] Ameliorating: A changeable condition which prevents the consequence of a failure or accident from becoming as bad as it otherwise would. [NIH] Amine: An organic compound containing nitrogen; any member of a group of chemical compounds formed from ammonia by replacement of one or more of the hydrogen atoms by organic (hydrocarbon) radicals. The amines are distinguished as primary, secondary, and tertiary, according to whether one, two, or three hydrogen atoms are replaced. The amines include allylamine, amylamine, ethylamine, methylamine, phenylamine, propylamine, and many other compounds. [EU] Amino Acid Sequence: The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation. [NIH] Amino Acids: Organic compounds that generally contain an amino (-NH2) and a carboxyl (COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. [NIH] Amino Acids: Organic compounds that generally contain an amino (-NH2) and a carboxyl (COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. [NIH] Ammonia: A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. [NIH] Amphetamines: Analogs or derivatives of amphetamine. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopression, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation. [NIH] Amplification: The production of additional copies of a chromosomal DNA sequence, found as either intrachromosomal or extrachromosomal DNA. [NIH] Amylases: A group of amylolytic enzymes that cleave starch, glycogen, and related alpha1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-. [NIH] Amyloid: A general term for a variety of different proteins that accumulate as extracellular fibrils of 7-10 nm and have common structural features, including a beta-pleated sheet conformation and the ability to bind such dyes as Congo red and thioflavine (Kandel, Schwartz, and Jessel, Principles of Neural Science, 3rd ed). [NIH] Amyloidosis: A group of diseases in which protein is deposited in specific organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (with no known cause) or secondary (caused by another disease, including some types of cancer). Generally, primary amyloidosis affects the nerves, skin, tongue, joints, heart, and liver; secondary amyloidosis often affects the spleen, kidneys, liver, and adrenal glands. [NIH] Anaemia: A reduction below normal in the number of erythrocytes per cu. mm., in the quantity of haemoglobin, or in the volume of packed red cells per 100 ml. of blood which occurs when the equilibrium between blood loss (through bleeding or destruction) and blood production is disturbed. [EU] Anaerobic: 1. Lacking molecular oxygen. 2. Growing, living, or occurring in the absence of
438 Tea
molecular oxygen; pertaining to an anaerobe. [EU] Anaesthesia: Loss of feeling or sensation. Although the term is used for loss of tactile sensibility, or of any of the other senses, it is applied especially to loss of the sensation of pain, as it is induced to permit performance of surgery or other painful procedures. [EU] Anal: Having to do with the anus, which is the posterior opening of the large bowel. [NIH] Analgesic: An agent that alleviates pain without causing loss of consciousness. [EU] Analog: In chemistry, a substance that is similar, but not identical, to another. [NIH] Analogous: Resembling or similar in some respects, as in function or appearance, but not in origin or development;. [EU] Anaphylatoxins: The family of peptides C3a, C4a, C5a, and C5a des-arginine produced in the serum during complement activation. They produce smooth muscle contraction, mast cell histamine release, affect platelet aggregation, and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from strongest to weakest is C5a, C3a, C4a, and C5a des-arginine. The latter is the so-called "classical" anaphylatoxin but shows no spasmogenic activity though it contains some chemotactic ability. [NIH] Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered antigen. The reaction may include rapidly progressing urticaria, respiratory distress, vascular collapse, systemic shock, and death. [NIH] Anaplasia: Loss of structural differentiation and useful function of neoplastic cells. [NIH] Anatomical: Pertaining to anatomy, or to the structure of the organism. [EU] Androgen-Binding Protein: Carrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. They participate in the transport of androgens. Androgen-binding protein has the same amino acid sequence as sex hormone binding-globulin. They differ by their sites of synthesis and post-translational oligosacaccharide modifications. [NIH] Androgens: A class of sex hormones associated with the development and maintenance of the secondary male sex characteristics, sperm induction, and sexual differentiation. In addition to increasing virility and libido, they also increase nitrogen and water retention and stimulate skeletal growth. [NIH] Anemia: A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin. [NIH] Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. [NIH] Anginal: Pertaining to or characteristic of angina. [EU] Angiogenesis: Blood vessel formation. Tumor angiogenesis is the growth of blood vessels from surrounding tissue to a solid tumor. This is caused by the release of chemicals by the tumor. [NIH] Animal model: An animal with a disease either the same as or like a disease in humans. Animal models are used to study the development and progression of diseases and to test new treatments before they are given to humans. Animals with transplanted human cancers or other tissues are called xenograft models. [NIH] Anionic: Pertaining to or containing an anion. [EU] Anions: Negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis. [NIH] Ankle: That part of the lower limb directly above the foot. [NIH]
Dictionary 439
Anode: Electrode held at a positive potential with respect to a cathode. [NIH] Antagonism: Interference with, or inhibition of, the growth of a living organism by another living organism, due either to creation of unfavorable conditions (e. g. exhaustion of food supplies) or to production of a specific antibiotic substance (e. g. penicillin). [NIH] Anterior chamber: The space in front of the iris and behind the cornea. [NIH] Antiangiogenic: Having to do with reducing the growth of new blood vessels. [NIH] Antibacterial: A substance that destroys bacteria or suppresses their growth or reproduction. [EU] Antibiotic: A drug used to treat infections caused by bacteria and other microorganisms. [NIH]
Antibodies: Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the antigen that induced their synthesis in cells of the lymphoid series (especially plasma cells), or with an antigen closely related to it. [NIH] Antibody: A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen. [NIH] Anticarcinogenic: Pertaining to something that prevents or delays the development of cancer. [NIH] Anticholinergic: An agent that blocks the parasympathetic nerves. Called also parasympatholytic. [EU] Anticoagulant: A drug that helps prevent blood clots from forming. Also called a blood thinner. [NIH] Antidiabetic: An agent that prevents or alleviates diabetes. [EU] Antiemetic: An agent that prevents or alleviates nausea and vomiting. Also antinauseant. [EU]
Antifungal: Destructive to fungi, or suppressing their reproduction or growth; effective against fungal infections. [EU] Antigen: Any substance which is capable, under appropriate conditions, of inducing a specific immune response and of reacting with the products of that response, that is, with specific antibody or specifically sensitized T-lymphocytes, or both. Antigens may be soluble substances, such as toxins and foreign proteins, or particulate, such as bacteria and tissue cells; however, only the portion of the protein or polysaccharide molecule known as the antigenic determinant (q.v.) combines with antibody or a specific receptor on a lymphocyte. Abbreviated Ag. [EU] Antigen-Antibody Complex: The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes immune complex diseases. [NIH] Antihypertensive: An agent that reduces high blood pressure. [EU] Anti-infective: An agent that so acts. [EU] Anti-inflammatory: Having to do with reducing inflammation. [NIH] Anti-Inflammatory Agents: Substances that reduce or suppress inflammation. [NIH] Antimicrobial: Killing microorganisms, or suppressing their multiplication or growth. [EU] Antimycotic: Suppressing the growth of fungi. [EU]
440 Tea
Antineoplastic: Inhibiting or preventing the development of neoplasms, checking the maturation and proliferation of malignant cells. [EU] Antineoplastic Agents: Substances that inhibit or prevent the proliferation of neoplasms. [NIH]
Antioxidant: A substance that prevents damage caused by free radicals. Free radicals are highly reactive chemicals that often contain oxygen. They are produced when molecules are split to give products that have unpaired electrons. This process is called oxidation. [NIH] Antiproliferative: Counteracting a process of proliferation. [EU] Antipsychotic: Effective in the treatment of psychosis. Antipsychotic drugs (called also neuroleptic drugs and major tranquilizers) are a chemically diverse (including phenothiazines, thioxanthenes, butyrophenones, dibenzoxazepines, dibenzodiazepines, and diphenylbutylpiperidines) but pharmacologically similar class of drugs used to treat schizophrenic, paranoid, schizoaffective, and other psychotic disorders; acute delirium and dementia, and manic episodes (during induction of lithium therapy); to control the movement disorders associated with Huntington's chorea, Gilles de la Tourette's syndrome, and ballismus; and to treat intractable hiccups and severe nausea and vomiting. Antipsychotic agents bind to dopamine, histamine, muscarinic cholinergic, a-adrenergic, and serotonin receptors. Blockade of dopaminergic transmission in various areas is thought to be responsible for their major effects : antipsychotic action by blockade in the mesolimbic and mesocortical areas; extrapyramidal side effects (dystonia, akathisia, parkinsonism, and tardive dyskinesia) by blockade in the basal ganglia; and antiemetic effects by blockade in the chemoreceptor trigger zone of the medulla. Sedation and autonomic side effects (orthostatic hypotension, blurred vision, dry mouth, nasal congestion and constipation) are caused by blockade of histamine, cholinergic, and adrenergic receptors. [EU] Antipyretic: An agent that relieves or reduces fever. Called also antifebrile, antithermic and febrifuge. [EU] Antiseptic: A substance that inhibits the growth and development of microorganisms without necessarily killing them. [EU] Antithrombotic: Preventing or interfering with the formation of thrombi; an agent that so acts. [EU] Antiviral: Destroying viruses or suppressing their replication. [EU] Anus: The opening of the rectum to the outside of the body. [NIH] Anxiety: Persistent feeling of dread, apprehension, and impending disaster. [NIH] Aorta: The main trunk of the systemic arteries. [NIH] Aperture: A natural hole of perforation, especially one in a bone. [NIH] Apnea: A transient absence of spontaneous respiration. [NIH] Apolipoproteins: The protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed. They play an important role in lipid transport and metabolism. [NIH] Apomorphine: A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. [NIH] Aponeurosis: Tendinous expansion consisting of a fibrous or membranous sheath which serves as a fascia to enclose or bind a group of muscles. [NIH] Apoptosis: One of the two mechanisms by which cell death occurs (the other being the pathological process of necrosis). Apoptosis is the mechanism responsible for the
Dictionary 441
physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA (DNA fragmentation) at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. [NIH] Aqueous: Having to do with water. [NIH] Arachidonate 12-Lipoxygenase: An enzyme that catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate (12-HPETE) which is itself rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate (12-HETE). The 12-hydroperoxides are preferentially formed in platelets. EC 1.13.11.31. [NIH] Arachidonate 15-Lipoxygenase: An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate (15-HPETE) which is rapidly converted to 15-hydroxy5,8,11,13-eicosatetraenoate (15-HETE). The 15-hydroperoxides are preferentially formed in neutrophils and lymphocytes. EC 1.13.11.33. [NIH] Arachidonate Lipoxygenases: Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates (HPETES). These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids (HETES). The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . [NIH] Arachidonic Acid: An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes. [NIH] Arginine: An essential amino acid that is physiologically active in the L-form. [NIH] Argon: A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used. [NIH] Aromatase: An enzyme which converts androgens to estrogens by desaturating ring A of the steroid. This enzyme complex is located in the endoplasmic reticulum of estrogenproducing cells including ovaries, placenta, testicular Sertoli and Leydig cells, adipose, and brain tissues. The enzyme complex has two components, one of which is the CYP19 gene product, the aromatase cytochrome P-450. The other component is NADPH-cytochrome P450 reductase which transfers reducing equivalents to P-450(arom). EC 1.14.13.-. [NIH] Aromatic: Having a spicy odour. [EU] Arterial: Pertaining to an artery or to the arteries. [EU] Arteries: The vessels carrying blood away from the heart. [NIH] Arteriolar: Pertaining to or resembling arterioles. [EU] Arterioles: The smallest divisions of the arteries located between the muscular arteries and the capillaries. [NIH] Arteriolosclerosis: Sclerosis and thickening of the walls of the smaller arteries (arterioles). Hyaline arteriolosclerosis, in which there is homogeneous pink hyaline thickening of the arteriolar walls, is associated with benign nephrosclerosis. Hyperplastic arteriolosclerosis, in which there is a concentric thickening with progressive narrowing of the lumina may be associated with malignant hypertension, nephrosclerosis, and scleroderma. [EU] Arteriosclerosis: Thickening and loss of elasticity of arterial walls. Atherosclerosis is the most common form of arteriosclerosis and involves lipid deposition and thickening of the
442 Tea
intimal cell layers within arteries. Additional forms of arteriosclerosis involve calcification of the media of muscular arteries (Monkeberg medial calcific sclerosis) and thickening of the walls of small arteries or arterioles due to cell proliferation or hyaline deposition (arteriolosclerosis). [NIH] Arteriovenous: Both arterial and venous; pertaining to or affecting an artery and a vein. [EU] Arteriovenous Fistula: An abnormal communication between an artery and a vein. [NIH] Arthroplasty: Surgical reconstruction of a joint to relieve pain or restore motion. [NIH] Articular: Of or pertaining to a joint. [EU] Ascites: Accumulation or retention of free fluid within the peritoneal cavity. [NIH] Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [NIH] Aspartame: Flavoring agent sweeter than sugar, metabolized as phenylalanine and aspartic acid. [NIH] Aspartic: The naturally occurring substance is L-aspartic acid. One of the acidic-amino-acids is obtained by the hydrolysis of proteins. [NIH] Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. [NIH] Aspiration: The act of inhaling. [NIH] Aspirin: A drug that reduces pain, fever, inflammation, and blood clotting. Aspirin belongs to the family of drugs called nonsteroidal anti-inflammatory agents. It is also being studied in cancer prevention. [NIH] Assay: Determination of the amount of a particular constituent of a mixture, or of the biological or pharmacological potency of a drug. [EU] Astringent: Causing contraction, usually locally after topical application. [EU] Astrocytes: The largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the blood brain barrier. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with microglia) respond to injury. Astrocytes have high- affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitter, but their role in signaling (as in many other functions) is not well understood. [NIH] Astrocytoma: A tumor that begins in the brain or spinal cord in small, star-shaped cells called astrocytes. [NIH] Asymptomatic: Having no signs or symptoms of disease. [NIH] Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharnyx, larnyx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or peripheral nerve diseases. Motor ataxia may be associated with cerebellar diseases; cerebral cortex diseases; thalamic diseases; basal ganglia diseases; injury to the red nucleus; and other conditions. [NIH] Atmospheric Pressure: The pressure at any point in an atmosphere due solely to the weight
Dictionary 443
of the atmospheric gases above the point concerned. [NIH] Atopic: Pertaining to an atopen or to atopy; allergic. [EU] ATP: ATP an abbreviation for adenosine triphosphate, a compound which serves as a carrier of energy for cells. [NIH] Atrial: Pertaining to an atrium. [EU] Atrial Fibrillation: Disorder of cardiac rhythm characterized by rapid, irregular atrial impulses and ineffective atrial contractions. [NIH] Atrophic Gastritis: Chronic irritation of the stomach lining. Causes the stomach lining and glands to wither away. [NIH] Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [NIH] Attenuated: Strain with weakened or reduced virulence. [NIH] Atypical: Irregular; not conformable to the type; in microbiology, applied specifically to strains of unusual type. [EU] Autacoids: A chemically diverse group of substances produced by various tissues in the body that cause slow contraction of smooth muscle; they have other intense but varied pharmacologic activities. [NIH] Autoantibodies: Antibodies that react with self-antigens (autoantigens) of the organism that produced them. [NIH] Autoantigens: Endogenous tissue constituents that have the ability to interact with autoantibodies and cause an immune response. [NIH] Autonomic: Self-controlling; functionally independent. [EU] Avian: A plasmodial infection in birds. [NIH] Axillary: Pertaining to the armpit area, including the lymph nodes that are located there. [NIH]
Axillary Artery: The continuation of the subclavian artery; it distributes over the upper limb, axilla, chest and shoulder. [NIH] Axons: Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body. [NIH] Azoxymethane: A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas. [NIH] Bacteria: Unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. [NIH] Bacterial Infections: Infections by bacteria, general or unspecified. [NIH] Bacteriophage: A virus whose host is a bacterial cell; A virus that exclusively infects bacteria. It generally has a protein coat surrounding the genome (DNA or RNA). One of the coliphages most extensively studied is the lambda phage, which is also one of the most important. [NIH] Bacteriophage lambda: A temperate inducible phage and type species of the genus lambdalike Phages, in the family Siphoviridae. Its natural host is E. coli K12. Its virion contains linear double-stranded DNA, except for 12 complementary bases at the 5'-termini of the polynucleotide chains. The DNA circularizes on infection. [NIH] Bacteriostatic: 1. Inhibiting the growth or multiplication of bacteria. 2. An agent that inhibits
444 Tea
the growth or multiplication of bacteria. [EU] Bacterium: Microscopic organism which may have a spherical, rod-like, or spiral unicellular or non-cellular body. Bacteria usually reproduce through asexual processes. [NIH] Bacteriuria: The presence of bacteria in the urine with or without consequent urinary tract infection. Since bacteriuria is a clinical entity, the term does not preclude the use of urine/microbiology for technical discussions on the isolation and segregation of bacteria in the urine. [NIH] Basal cell carcinoma: A type of skin cancer that arises from the basal cells, small round cells found in the lower part (or base) of the epidermis, the outer layer of the skin. [NIH] Basal Cell Nevus Syndrome: Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant. [NIH] Basal cells: Small, round cells found in the lower part (or base) of the epidermis, the outer layer of the skin. [NIH] Basal Ganglia: Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres. [NIH] Basal Ganglia Diseases: Diseases of the basal ganglia including the putamen; globus pallidus; claustrum; amygdala; and caudate nucleus. Dyskinesias (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include cerebrovascular disease; neurodegenerative diseases; and craniocerebral trauma. [NIH] Base: In chemistry, the nonacid part of a salt; a substance that combines with acids to form salts; a substance that dissociates to give hydroxide ions in aqueous solutions; a substance whose molecule or ion can combine with a proton (hydrogen ion); a substance capable of donating a pair of electrons (to an acid) for the formation of a coordinate covalent bond. [EU] Basophil: A type of white blood cell. Basophils are granulocytes. [NIH] Benign: Not cancerous; does not invade nearby tissue or spread to other parts of the body. [NIH]
Benzaldehyde: A colorless oily liquid used as a flavoring agent and to make dyes, perfumes, and pharmaceuticals. Benzaldehyde is chemically related to benzene. [NIH] Benzene: Toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide. [NIH] Benzoic Acid: A fungistatic compound that is widely used as a food preservative. It is conjugated to glycine in the liver and excreted as hippuric acid. [NIH] Beta carotene: A vitamin A precursor. Beta carotene belongs to the family of fat-soluble vitamins called carotenoids. [NIH] Beta Rays: A stream of positive or negative electrons ejected with high energy from a disintegrating atomic nucleus; most biomedically used isotopes emit negative particles (electrons or negatrons, rather than positrons). Cathode rays are low-energy negative electrons produced in cathode ray tubes, also called television tubes or oscilloscopes. [NIH] Beta-Endorphin: A peptide consisting of amino acid sequence 61-91 of the endogenous pituitary hormone beta-lipotropin. The first four amino acids show a common tetrapeptide sequence with methionine- and leucine enkephalin. The compound shows opiate-like activity. Injection of beta-endorphin induces a profound analgesia of the whole body for
Dictionary 445
several hours. This action is reversed after administration of naloxone. [NIH] Beta-glucans: Polysaccharides made by several types of mushrooms. Beta-glucans have been used to treat patients with gastric cancer and colorectal cancer. They may be able to stimulate the immune system. [NIH] Beta-pleated: Particular three-dimensional pattern of amyloidoses. [NIH] Beta-Thromboglobulin: A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, preeclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders. [NIH] Bile: An emulsifying agent produced in the liver and secreted into the duodenum. Its composition includes bile acids and salts, cholesterol, and electrolytes. It aids digestion of fats in the duodenum. [NIH] Bile Acids: Acids made by the liver that work with bile to break down fats. [NIH] Bile Acids and Salts: Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. [NIH] Bile Ducts: Tubes that carry bile from the liver to the gallbladder for storage and to the small intestine for use in digestion. [NIH] Bile Pigments: Pigments that give a characteristic color to bile including: bilirubin, biliverdine, and bilicyanin. [NIH] Biliary: Having to do with the liver, bile ducts, and/or gallbladder. [NIH] Bilirubin: A bile pigment that is a degradation product of heme. [NIH] Bioassay: Determination of the relative effective strength of a substance (as a vitamin, hormone, or drug) by comparing its effect on a test organism with that of a standard preparation. [NIH] Bioavailability: The degree to which a drug or other substance becomes available to the target tissue after administration. [EU] Bioavailable: The ability of a drug or other substance to be absorbed and used by the body. Orally bioavailable means that a drug or other substance that is taken by mouth can be absorbed and used by the body. [NIH] Biochemical: Relating to biochemistry; characterized by, produced by, or involving chemical reactions in living organisms. [EU] Biological Markers: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc. [NIH] Biological Transport: The movement of materials (including biochemical substances and drugs) across cell membranes and epithelial layers, usually by passive diffusion. [NIH] Biomarkers: Substances sometimes found in an increased amount in the blood, other body fluids, or tissues and that may suggest the presence of some types of cancer. Biomarkers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast,
446 Tea
pancreas, and GI tract cancers), and PSA (prostate cancer). Also called tumor markers. [NIH] Biopsy: Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body. [NIH] Biosynthesis: The building up of a chemical compound in the physiologic processes of a living organism. [EU] Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., genetic engineering) is a central focus; laboratory methods used include transfection and cloning technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. [NIH] Biotic: Pertaining to living organisms in their ecological rather than their physiological relations. [NIH] Biotransformation: The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alteration may be either nonsynthetic (oxidation-reduction, hydrolysis) or synthetic (glucuronide formation, sulfate conjugation, acetylation, methylation). This also includes metabolic detoxication and clearance. [NIH] Bladder: The organ that stores urine. [NIH] Blastocyst: The mammalian embryo in the post-morula stage in which a fluid-filled cavity, enclosed primarily by trophoblast, contains an inner cell mass which becomes the embryonic disc. [NIH] Blood Coagulation: The process of the interaction of blood coagulation factors that results in an insoluble fibrin clot. [NIH] Blood Coagulation Factors: Endogenous substances, usually proteins, that are involved in the blood coagulation process. [NIH] Blood Glucose: Glucose in blood. [NIH] Blood pressure: The pressure of blood against the walls of a blood vessel or heart chamber. Unless there is reference to another location, such as the pulmonary artery or one of the heart chambers, it refers to the pressure in the systemic arteries, as measured, for example, in the forearm. [NIH] Blood vessel: A tube in the body through which blood circulates. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins. [NIH] Blood-Brain Barrier: Specialized non-fenestrated tightly-joined endothelial cells (tight junctions) that form a transport barrier for certain substances between the cerebral capillaries and the brain tissue. [NIH] Blot: To transfer DNA, RNA, or proteins to an immobilizing matrix such as nitrocellulose. [NIH]
Blushing: Involuntary reddening, especially of the face, associated with feelings of embarrassment, confusion, or shame. [NIH] Body Fluids: Liquid components of living organisms. [NIH] Body Regions: Anatomical areas of the body. [NIH] Bolus: A single dose of drug usually injected into a blood vessel over a short period of time. Also called bolus infusion. [NIH] Bolus infusion: A single dose of drug usually injected into a blood vessel over a short
Dictionary 447
period of time. Also called bolus. [NIH] Bone Cements: Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste. [NIH] Bone Marrow: The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. [NIH] Boron: A trace element with the atomic symbol B, atomic number 5, and atomic weight 10.81. Boron-10, an isotope of boron, is used as a neutron absorber in boron neutron capture therapy. [NIH] Bowel: The long tube-shaped organ in the abdomen that completes the process of digestion. There is both a small and a large bowel. Also called the intestine. [NIH] Bowel Movement: Body wastes passed through the rectum and anus. [NIH] Brachial: All the nerves from the arm are ripped from the spinal cord. [NIH] Brachial Artery: The continuation of the axillary artery; it branches into the radial and ulnar arteries. [NIH] Brachytherapy: A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. [NIH] Bradykinin: A nonapeptide messenger that is enzymatically produced from kallidin in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from mast cells during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. [NIH] Branch: Most commonly used for branches of nerves, but applied also to other structures. [NIH]
Breakdown: A physical, metal, or nervous collapse. [NIH] Breeding: The science or art of changing the constitution of a population of plants or animals through sexual reproduction. [NIH] Bronchi: The larger air passages of the lungs arising from the terminal bifurcation of the trachea. [NIH] Bronchial: Pertaining to one or more bronchi. [EU] Bronchioles: The tiny branches of air tubes in the lungs. [NIH] Bronchitis: Inflammation (swelling and reddening) of the bronchi. [NIH] Buccal: Pertaining to or directed toward the cheek. In dental anatomy, used to refer to the buccal surface of a tooth. [EU] Budesonide: A glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis. [NIH] Burning Mouth Syndrome: A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders. [NIH]
448 Tea
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (burns, chemical), electricity (burns, electric), or the like. [NIH] Burns, Electric: Burns produced by contact with electric current or from a sudden discharge of electricity. [NIH] Bypass: A surgical procedure in which the doctor creates a new pathway for the flow of body fluids. [NIH] Cadmium: An element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to cadmium poisoning. [NIH] Cadmium Poisoning: Poisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis. [NIH] Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling. [NIH] Calcification: Deposits of calcium in the tissues of the breast. Calcification in the breast can be seen on a mammogram, but cannot be detected by touch. There are two types of breast calcification, macrocalcification and microcalcification. Macrocalcifications are large deposits and are usually not related to cancer. Microcalcifications are specks of calcium that may be found in an area of rapidly dividing cells. Many microcalcifications clustered together may be a sign of cancer. [NIH] Calcium: A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. [NIH] Calcium Oxalate: The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi. [NIH] Calculi: An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones. [NIH] Callus: A callosity or hard, thick skin; the bone-like reparative substance that is formed round the edges and fragments of broken bone. [NIH] Camptothecin: An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA topoisomerase. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. [NIH] Candidiasis: Infection with a fungus of the genus Candida. It is usually a superficial infection of the moist cutaneous areas of the body, and is generally caused by C. albicans; it most commonly involves the skin (dermatocandidiasis), oral mucous membranes (thrush, def. 1), respiratory tract (bronchocandidiasis), and vagina (vaginitis). Rarely there is a systemic infection or endocarditis. Called also moniliasis, candidosis, oidiomycosis, and formerly blastodendriosis. [EU] Cannabis: The hemp plant Cannabis sativa. Products prepared from the dried flowering tops of the plant include marijuana, hashish, bhang, and ganja. [NIH]
Dictionary 449
Capillary: Any one of the minute vessels that connect the arterioles and venules, forming a network in nearly all parts of the body. Their walls act as semipermeable membranes for the interchange of various substances, including fluids, between the blood and tissue fluid; called also vas capillare. [EU] Capillary Fragility: The lack of resistance, or susceptibility, of capillaries to damage or disruption under conditions of increased stress. [NIH] Capsules: Hard or soft soluble containers used for the oral administration of medicine. [NIH] Carbohydrate: An aldehyde or ketone derivative of a polyhydric alcohol, particularly of the pentahydric and hexahydric alcohols. They are so named because the hydrogen and oxygen are usually in the proportion to form water, (CH2O)n. The most important carbohydrates are the starches, sugars, celluloses, and gums. They are classified into mono-, di-, tri-, polyand heterosaccharides. [EU] Carbon Dioxide: A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. [NIH] Carboxy: Cannabinoid. [NIH] Carboxylic Acids: Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. [NIH] Carcinogen: Any substance that causes cancer. [NIH] Carcinogenesis: The process by which normal cells are transformed into cancer cells. [NIH] Carcinogenic: Producing carcinoma. [EU] Carcinoma: Cancer that begins in the skin or in tissues that line or cover internal organs. [NIH]
Cardia: That part of the stomach surrounded by the esophagogastric junction, characterized by the lack of acid-forming cells. [NIH] Cardiac: Having to do with the heart. [NIH] Cardiorespiratory: Relating to the heart and lungs and their function. [EU] Cardiotonic: 1. Having a tonic effect on the heart. 2. An agent that has a tonic effect on the heart. [EU] Cardiovascular: Having to do with the heart and blood vessels. [NIH] Cardiovascular disease: Any abnormal condition characterized by dysfunction of the heart and blood vessels. CVD includes atherosclerosis (especially coronary heart disease, which can lead to heart attacks), cerebrovascular disease (e.g., stroke), and hypertension (high blood pressure). [NIH] Carmine: Coloring matter from the insect Coccus cacti L. It is used in foods, pharmaceuticals, toiletries, etc., as a dye, and also has use as a microscopic stain and biological marker. [NIH] Carotene: The general name for a group of pigments found in green, yellow, and leafy vegetables, and yellow fruits. The pigments are fat-soluble, unsaturated aliphatic hydrocarbons functioning as provitamins and are converted to vitamin A through enzymatic processes in the intestinal wall. [NIH] Carotenoids: Substance found in yellow and orange fruits and vegetables and in dark green, leafy vegetables. May reduce the risk of developing cancer. [NIH] Carrier Proteins: Transport proteins that carry specific substances in the blood or across cell membranes. [NIH]
450 Tea
Case report: A detailed report of the diagnosis, treatment, and follow-up of an individual patient. Case reports also contain some demographic information about the patient (for example, age, gender, ethnic origin). [NIH] Case-Control Studies: Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group. [NIH] Caspase: Enzyme released by the cell at a crucial stage in apoptosis in order to shred all cellular proteins. [NIH] Catabolism: Any destructive metabolic process by which organisms convert substances into excreted compounds. [EU] Catalase: An oxidoreductase that catalyzes the conversion of hydrogen peroxide to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in acatalasia. EC 1.11.1.6. [NIH] Cataracts: In medicine, an opacity of the crystalline lens of the eye obstructing partially or totally its transmission of light. [NIH] Catechin: Extracted from Uncaria gambier, Acacia catechu and other plants; it stabilizes collagen and is therefore used in tanning and dyeing; it prevents capillary fragility and abnormal permeability, but was formerly used as an antidiarrheal. [NIH] Catechol: A chemical originally isolated from a type of mimosa tree. Catechol is used as an astringent, an antiseptic, and in photography, electroplating, and making other chemicals. It can also be man-made. [NIH] Catecholamine: A group of chemical substances manufactured by the adrenal medulla and secreted during physiological stress. [NIH] Cathode: An electrode, usually an incandescent filament of tungsten, which emits electrons in an X-ray tube. [NIH] Cations: Postively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. [NIH] Causal: Pertaining to a cause; directed against a cause. [EU] Cause of Death: Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. [NIH] Cecum: The beginning of the large intestine. The cecum is connected to the lower part of the small intestine, called the ileum. [NIH] Cell: The individual unit that makes up all of the tissues of the body. All living things are made up of one or more cells. [NIH] Cell Adhesion: Adherence of cells to surfaces or to other cells. [NIH] Cell Adhesion Molecules: Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis. [NIH] Cell Cycle: The complex series of phenomena, occurring between the end of one cell division and the end of the next, by which cellular material is divided between daughter cells. [NIH] Cell Death: The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. [NIH] Cell Differentiation: Progressive restriction of the developmental potential and increasing
Dictionary 451
specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs. [NIH] Cell Division: The fission of a cell. [NIH] Cell Extracts: Preparations of cell constituents or subcellular materials, isolates, or substances. [NIH] Cell membrane: Cell membrane = plasma membrane. The structure enveloping a cell, enclosing the cytoplasm, and forming a selective permeability barrier; it consists of lipids, proteins, and some carbohydrates, the lipids thought to form a bilayer in which integral proteins are embedded to varying degrees. [EU] Cell proliferation: An increase in the number of cells as a result of cell growth and cell division. [NIH] Cell Respiration: The metabolic process of all living cells (animal and plant) in which oxygen is used to provide a source of energy for the cell. [NIH] Cell Size: The physical dimensions of a cell. It refers mainly to changes in dimensions correlated with physiological or pathological changes in cells. [NIH] Cell Survival: The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. [NIH] Cellulase: An enzyme isolated from fungi and bacteria. It catalyzes the endohydrolysis of 1,4-beta-glucosidic linkages in cellulose, lichenin, and cereal beta-glucans. EC 3.2.1.4. [NIH] Cellulose: A polysaccharide with glucose units linked as in cellobiose. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. [NIH] Central Nervous System: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. [NIH] Centrifugation: A method of separating organelles or large molecules that relies upon differential sedimentation through a preformed density gradient under the influence of a gravitational field generated in a centrifuge. [NIH] Centromere: The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. [NIH] Cerebellar: Pertaining to the cerebellum. [EU] Cerebral: Of or pertaining of the cerebrum or the brain. [EU] Cerebral Arteries: The arteries supplying the cerebral cortex. [NIH] Cerebral hemispheres: The two halves of the cerebrum, the part of the brain that controls muscle functions of the body and also controls speech, emotions, reading, writing, and learning. The right hemisphere controls muscle movement on the left side of the body, and the left hemisphere controls muscle movement on the right side of the body. [NIH] Cerebrovascular: Pertaining to the blood vessels of the cerebrum, or brain. [EU] Cerebrum: The largest part of the brain. It is divided into two hemispheres, or halves, called the cerebral hemispheres. The cerebrum controls muscle functions of the body and also controls speech, emotions, reading, writing, and learning. [NIH] Cervical: Relating to the neck, or to the neck of any organ or structure. Cervical lymph nodes are located in the neck; cervical cancer refers to cancer of the uterine cervix, which is the lower, narrow end (the "neck") of the uterus. [NIH]
452 Tea
Cervix: The lower, narrow end of the uterus that forms a canal between the uterus and vagina. [NIH] Chamomile: Common name for several daisy-like species native to Europe and Western Asia, now naturalized in the United States and Australia. The dried flower-heads of two species, Anthemis nobilis (Chamaemelum nobile) and Matricaria recutita, have specific use as herbs. They are administered as tea, extracts, tinctures, or ointments. Chamomile contains choline, coumarins, cyanogenic glycosides, flavonoids, salicylate derivatives, tannins, and volatile oils. [NIH] Character: In current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual. [NIH] Charybdotoxin: A 37-amino acid residue peptide isolated from the scorpion Leiurus quinquestriatus hebraeus. It is a neurotoxin that inhibits calcium activated potassium channels. [NIH] Cheilitis: Inflammation of the lips. It is of various etiologies and degrees of pathology. [NIH] Chemoprevention: The use of drugs, vitamins, or other agents to try to reduce the risk of, or delay the development or recurrence of, cancer. [NIH] Chemopreventive: Natural or synthetic compound used to intervene in the early precancerous stages of carcinogenesis. [NIH] Chemoprotective: A quality of some drugs used in cancer treatment. Chemoprotective agents protect healthy tissue from the toxic effects of anticancer drugs. [NIH] Chemoreceptor: A receptor adapted for excitation by chemical substances, e.g., olfactory and gustatory receptors, or a sense organ, as the carotid body or the aortic (supracardial) bodies, which is sensitive to chemical changes in the blood stream, especially reduced oxygen content, and reflexly increases both respiration and blood pressure. [EU] Chemotactic Factors: Chemical substances that attract or repel cells or organisms. The concept denotes especially those factors released as a result of tissue injury, invasion, or immunologic activity, that attract leukocytes, macrophages, or other cells to the site of infection or insult. [NIH] Chemotherapeutics: Noun plural but singular or plural in constructions : chemotherapy. [EU]
Chemotherapy: Treatment with anticancer drugs. [NIH] Chest wall: The ribs and muscles, bones, and joints that make up the area of the body between the neck and the abdomen. [NIH] Chlorhexidine: Disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. [NIH] Chlorine: A greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching. [NIH] Chlorogenic Acid: A naturally occuring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68). [NIH] Chlorophyll: Porphyrin derivatives containing magnesium that act to convert light energy in photosynthetic organisms. [NIH] Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs
Dictionary 453
in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking dopamine receptors. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. [NIH] Cholangiography: Radiographic examination of the bile ducts. [NIH] Cholera: An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is vibrio cholerae. This condition can lead to severe dehydration in a matter of hours unless quickly treated. [NIH] Cholesterol: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. [NIH] Cholesterol Esters: Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. [NIH] Choline: A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. [NIH] Cholinergic: Resembling acetylcholine in pharmacological action; stimulated by or releasing acetylcholine or a related compound. [EU] Chorda Tympani Nerve: A branch of the facial (7th cranial) nerve which passes through the middle ear and continues through the petrotympanic fissure. The chorda tympani nerve carries taste sensation from the anterior two-thirds of the tongue and conveys parasympathetic efferents to the salivary glands. [NIH] Chorea: Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as choreatic disorders. Chorea is also a frequent manifestation of basal ganglia diseases. [NIH] Choriocarcinoma: A malignant tumor of trophoblastic epithelium characterized by secretion of large amounts of chorionic gonadotropin. It usually originates from chorionic products of conception (i.e., hydatidiform mole, normal pregnancy, or following abortion), but can originate in a teratoma of the testis, mediastinum, or pineal gland. [NIH] Choroid: The thin, highly vascular membrane covering most of the posterior of the eye between the retina and sclera. [NIH] Chromatin: The material of chromosomes. It is a complex of DNA, histones, and nonhistone proteins (chromosomal proteins, non-histone) found within the nucleus of a cell. [NIH] Chromosomal: Pertaining to chromosomes. [EU] Chromosome: Part of a cell that contains genetic information. Except for sperm and eggs, all human cells contain 46 chromosomes. [NIH] Chromosome Aberrations: Deviations from the normal number or structure of chromosomes, not necessarily associated with disease. [NIH] Chronic: A disease or condition that persists or progresses over a long period of time. [NIH] Chronic Disease: Disease or ailment of long duration. [NIH] Chronic Obstructive Pulmonary Disease: Collective term for chronic bronchitis and emphysema. [NIH] Chronic renal: Slow and progressive loss of kidney function over several years, often resulting in end-stage renal disease. People with end-stage renal disease need dialysis or
454 Tea
transplantation to replace the work of the kidneys. [NIH] Chylomicrons: A class of lipoproteins that carry dietary cholesterol and triglycerides from the small intestines to the tissues. [NIH] Chymopapain: A cysteine endopeptidase isolated from papaya latex. Preferential cleavage at glutamic and aspartic acid residues. EC 3.4.22.6. [NIH] Chymotrypsin: A serine endopeptidase secreted by the pancreas as its zymogen, chymotrypsinogen and carried in the pancreatic juice to the duodenum where it is activated by trypsin. It selectively cleaves aromatic amino acids on the carboxyl side. [NIH] Cimetidine: A histamine congener, it competitively inhibits histamine binding to H2 receptors. Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrin output. It also blocks the activity of cytochrome P450. [NIH] CIS: Cancer Information Service. The CIS is the National Cancer Institute's link to the public, interpreting and explaining research findings in a clear and understandable manner, and providing personalized responses to specific questions about cancer. Access the CIS by calling 1-800-4-CANCER, or by using the Web site at http://cis.nci.nih.gov. [NIH] Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. [NIH] Citrus: Any tree or shrub of the Rue family or the fruit of these plants. [NIH] Claviceps: A genus of ascomycetous fungi, family Clavicipitaceae, order Hypocreales, parasitic on various grasses. The sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ergotism. [NIH] Clear cell carcinoma: A rare type of tumor of the female genital tract in which the inside of the cells looks clear when viewed under a microscope. [NIH] Cleave: A double-stranded cut in DNA with a restriction endonuclease. [NIH] Clinical Medicine: The study and practice of medicine by direct examination of the patient. [NIH]
Clinical study: A research study in which patients receive treatment in a clinic or other medical facility. Reports of clinical studies can contain results for single patients (case reports) or many patients (case series or clinical trials). [NIH] Clinical trial: A research study that tests how well new medical treatments or other interventions work in people. Each study is designed to test new methods of screening, prevention, diagnosis, or treatment of a disease. [NIH] Cloning: The production of a number of genetically identical individuals; in genetic engineering, a process for the efficient replication of a great number of identical DNA molecules. [NIH] Clotrimazole: An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [NIH] Coagulation: 1. The process of clot formation. 2. In colloid chemistry, the solidification of a sol into a gelatinous mass; an alteration of a disperse phase or of a dissolved solid which causes the separation of the system into a liquid phase and an insoluble mass called the clot or curd. Coagulation is usually irreversible. 3. In surgery, the disruption of tissue by physical means to form an amorphous residuum, as in electrocoagulation and photocoagulation. [EU]
Dictionary 455
Coal: A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions. [NIH] Cobalt: A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis. [NIH] Coca: Any of several South American shrubs of the Erythroxylon genus (and family) that yield cocaine; the leaves are chewed with alum for CNS stimulation. [NIH] Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. [NIH] Coculture: The culturing of normal cells or tissues with infected or latently infected cells or tissues of the same kind (From Dorland, 28th ed, entry for cocultivation). It also includes culturing of normal cells or tissues with other normal cells or tissues. [NIH] Cod Liver Oil: Oil obtained from fresh livers of the cod family, Gadidae. It is a source of vitamins A and D. [NIH] Coenzyme: An organic nonprotein molecule, frequently a phosphorylated derivative of a water-soluble vitamin, that binds with the protein molecule (apoenzyme) to form the active enzyme (holoenzyme). [EU] Cofactor: A substance, microorganism or environmental factor that activates or enhances the action of another entity such as a disease-causing agent. [NIH] Cognition: Intellectual or mental process whereby an organism becomes aware of or obtains knowledge. [NIH] Cognitive restructuring: A method of identifying and replacing fear-promoting, irrational beliefs with more realistic and functional ones. [NIH] Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. [NIH] Colic: Paroxysms of pain. This condition usually occurs in the abdominal region but may occur in other body regions as well. [NIH] Coliphages: Viruses whose host is Escherichia coli. [NIH] Colitis: Inflammation of the colon. [NIH] Collagen: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of skin, connective tissue, and the organic substance of bones and teeth. Different forms of collagen are produced in the body but all consist of three alpha-polypeptide chains arranged in a triple helix. Collagen is differentiated from other fibrous proteins, such as elastin, by the content of proline, hydroxyproline, and hydroxylysine; by the absence of tryptophan; and particularly by the high content of polar groups which are responsible for its swelling properties. [NIH] Collagenases: Enzymes that catalyze the degradation of collagen by acting on the peptide bonds. EC 3.4.24.-. [NIH]
456 Tea
Collapse: 1. A state of extreme prostration and depression, with failure of circulation. 2. Abnormal falling in of the walls of any part of organ. [EU] Colloidal: Of the nature of a colloid. [EU] Colorectal: Having to do with the colon or the rectum. [NIH] Colorectal Cancer: Cancer that occurs in the colon (large intestine) or the rectum (the end of the large intestine). A number of digestive diseases may increase a person's risk of colorectal cancer, including polyposis and Zollinger-Ellison Syndrome. [NIH] Combinatorial: A cut-and-paste process that churns out thousands of potentially valuable compounds at once. [NIH] Comet Assay: A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a "comet with tail" formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage. [NIH] Comfrey: Perennial herb Symphytum officinale, in the family Boraginaceae, used topically for wound healing. It contains allantoin, carotene, essential oils (oils, volatile), glycosides, mucilage, resin, saponins, tannins, triterpenoids, vitamin B12, and zinc. Comfrey also contains pyrrolizidine alkaloids and is hepatotoxic if ingested. [NIH] Commensal: 1. Living on or within another organism, and deriving benefit without injuring or benefiting the other individual. 2. An organism living on or within another, but not causing injury to the host. [EU] Communis: Common tendon of the rectus group of muscles that surrounds the optic foramen and a portion of the superior orbital fissure, to the anterior margin of which it is attached at the spina recti lateralis. [NIH] Complement: A term originally used to refer to the heat-labile factor in serum that causes immune cytolysis, the lysis of antibody-coated cells, and now referring to the entire functionally related system comprising at least 20 distinct serum proteins that is the effector not only of immune cytolysis but also of other biologic functions. Complement activation occurs by two different sequences, the classic and alternative pathways. The proteins of the classic pathway are termed 'components of complement' and are designated by the symbols C1 through C9. C1 is a calcium-dependent complex of three distinct proteins C1q, C1r and C1s. The proteins of the alternative pathway (collectively referred to as the properdin system) and complement regulatory proteins are known by semisystematic or trivial names. Fragments resulting from proteolytic cleavage of complement proteins are designated with lower-case letter suffixes, e.g., C3a. Inactivated fragments may be designated with the suffix 'i', e.g. C3bi. Activated components or complexes with biological activity are designated by a bar over the symbol e.g. C1 or C4b,2a. The classic pathway is activated by the binding of C1 to classic pathway activators, primarily antigen-antibody complexes containing IgM, IgG1, IgG3; C1q binds to a single IgM molecule or two adjacent IgG molecules. The alternative pathway can be activated by IgA immune complexes and also by nonimmunologic materials including bacterial endotoxins, microbial polysaccharides, and cell walls. Activation of the classic pathway triggers an enzymatic cascade involving C1, C4, C2 and C3; activation of the alternative pathway triggers a cascade involving C3 and factors B, D and P. Both result in the cleavage of C5 and the formation of the membrane attack complex. Complement activation also results in the formation of many biologically active complement fragments that act as anaphylatoxins, opsonins, or chemotactic factors. [EU] Complementary and alternative medicine: CAM. Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices are not considered standard medical approaches. CAM includes dietary supplements,
Dictionary 457
megadose vitamins, herbal preparations, special teas, massage therapy, magnet therapy, spiritual healing, and meditation. [NIH] Complementary medicine: Practices not generally recognized by the medical community as standard or conventional medical approaches and used to enhance or complement the standard treatments. Complementary medicine includes the taking of dietary supplements, megadose vitamins, and herbal preparations; the drinking of special teas; and practices such as massage therapy, magnet therapy, spiritual healing, and meditation. [NIH] Complete remission: The disappearance of all signs of cancer. Also called a complete response. [NIH] Compress: A plug used to occludate an orifice in the control of bleeding, or to mop up secretions; an absorbent pad. [NIH] Computational Biology: A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories applicable to molecular biology and areas of computer-based techniques for solving biological problems including manipulation of models and datasets. [NIH] Computer Simulation: Computer-based representation of physical systems and phenomena such as chemical processes. [NIH] Conception: The onset of pregnancy, marked by implantation of the blastocyst; the formation of a viable zygote. [EU] Condiments: Aromatic substances added to food before or after cooking to enhance its flavor. These are usually of vegetable origin. [NIH] Cone: One of the special retinal receptor elements which are presumed to be primarily concerned with perception of light and color stimuli when the eye is adapted to light. [NIH] Confounding: Extraneous variables resulting in outcome effects that obscure or exaggerate the "true" effect of an intervention. [NIH] Confusion: A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation. [NIH] Congestion: Excessive or abnormal accumulation of blood in a part. [EU] Conjugated: Acting or operating as if joined; simultaneous. [EU] Conjugation: 1. The act of joining together or the state of being conjugated. 2. A sexual process seen in bacteria, ciliate protozoa, and certain fungi in which nuclear material is exchanged during the temporary fusion of two cells (conjugants). In bacterial genetics a form of sexual reproduction in which a donor bacterium (male) contributes some, or all, of its DNA (in the form of a replicated set) to a recipient (female) which then incorporates differing genetic information into its own chromosome by recombination and passes the recombined set on to its progeny by replication. In ciliate protozoa, two conjugants of separate mating types exchange micronuclear material and then separate, each now being a fertilized cell. In certain fungi, the process involves fusion of two gametes, resulting in union of their nuclei and formation of a zygote. 3. In chemistry, the joining together of two compounds to produce another compound, such as the combination of a toxic product with some substance in the body to form a detoxified product, which is then eliminated. [EU] Conjunctiva: The mucous membrane that lines the inner surface of the eyelids and the anterior part of the sclera. [NIH] Conjunctivitis: Inflammation of the conjunctiva, generally consisting of conjunctival hyperaemia associated with a discharge. [EU]
458 Tea
Connective Tissue: Tissue that supports and binds other tissues. It consists of connective tissue cells embedded in a large amount of extracellular matrix. [NIH] Connective Tissue: Tissue that supports and binds other tissues. It consists of connective tissue cells embedded in a large amount of extracellular matrix. [NIH] Consciousness: Sense of awareness of self and of the environment. [NIH] Constipation: Infrequent or difficult evacuation of feces. [NIH] Constrict: Tighten; narrow. [NIH] Constriction: The act of constricting. [NIH] Consumption: Pulmonary tuberculosis. [NIH] Contact dermatitis: Inflammation of the skin with varying degrees of er